Citrus Sinensis ID: 044076
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 506 | 2.2.26 [Sep-21-2011] | |||||||
| Q84M93 | 486 | Mitogen-activated protein | yes | no | 0.946 | 0.985 | 0.689 | 0.0 | |
| Q5Z9J0 | 580 | Mitogen-activated protein | yes | no | 0.936 | 0.817 | 0.721 | 0.0 | |
| Q9LV37 | 510 | Mitogen-activated protein | no | no | 0.936 | 0.929 | 0.707 | 0.0 | |
| Q9C9U4 | 576 | Mitogen-activated protein | no | no | 0.936 | 0.822 | 0.673 | 0.0 | |
| Q6L5F7 | 582 | Mitogen-activated protein | no | no | 0.901 | 0.783 | 0.692 | 0.0 | |
| Q0E459 | 506 | Mitogen-activated protein | no | no | 0.934 | 0.934 | 0.684 | 0.0 | |
| A2X0M1 | 506 | Mitogen-activated protein | N/A | no | 0.934 | 0.934 | 0.684 | 0.0 | |
| Q9LM33 | 589 | Mitogen-activated protein | no | no | 0.918 | 0.789 | 0.677 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.826 | 0.771 | 0.725 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.822 | 0.835 | 0.728 | 0.0 |
| >sp|Q84M93|MPK17_ARATH Mitogen-activated protein kinase 17 OS=Arabidopsis thaliana GN=MPK17 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 710 bits (1833), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/506 (68%), Positives = 412/506 (81%), Gaps = 27/506 (5%)
Query: 1 MFDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI 60
M +KEFFTEYGEASQY+IQE++G GSYGVVASA HTG KVAIKKM VFEHVSDA RI
Sbjct: 1 MLEKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRI 60
Query: 61 LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
LREIKLLR+L+HPDIVEIKHIMLPPCR+EFKDIYVVFELMESDL V+K NDDLTP+HHQ
Sbjct: 61 LREIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQ 120
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
FFLYQLLR LK++HSA+VFHRDLKPKNILANADCK+KICD GLARVSFTD+PSA+FWTDY
Sbjct: 121 FFLYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDY 180
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
VATRWYRAPELCGSF+S YTPAID+WS+GCIFAE+LTG+PLFPG+NV HQL+LVTDLLGT
Sbjct: 181 VATRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGT 240
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
PS +++ IRNEKA++YL ++RRK VPF+HKFP DP+AL+LLQRL+AFDPKDRPSAEE
Sbjct: 241 PSPITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEE 300
Query: 301 IRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVREL 360
ALADPYF GLAN++ EPSR+PISKL FEFERRKL +DDVREL
Sbjct: 301 ------------------ALADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVREL 342
Query: 361 IYREILEYHPHMLEEYLQGTD--HTHFMYPSGVDQFKQQFARLEEQYGKRERHI--PLRR 416
+YREILEYHP ML+EYLQG + ++HF+YPSGVDQFKQ+FARLEE E H P +R
Sbjct: 343 MYREILEYHPQMLQEYLQGEENINSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQR 402
Query: 417 KYTSLPRERISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQH 476
KYTSLPRER+ +SEDE +D + + +ASV + +PP P A S++ S +
Sbjct: 403 KYTSLPRERVCSSEDEGSDSVHA-QSSSASV----VFTPPQTPNTATGLSSQKASQVDKA 457
Query: 477 GSSSQKCGVLLRSDSMSASKCVGVNG 502
+ ++ L+RSDS+ AS+CVGV+
Sbjct: 458 ATPVKRSACLMRSDSICASRCVGVSS 483
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q5Z9J0|MPK12_ORYSJ Mitogen-activated protein kinase 12 OS=Oryza sativa subsp. japonica GN=MPK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 709 bits (1831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/496 (72%), Positives = 404/496 (81%), Gaps = 22/496 (4%)
Query: 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREI 64
EFFTEYGEASQY+IQE+IG GSYGVVA+A+DT TGE+VAIKK+ +VFEHVSDATRILREI
Sbjct: 76 EFFTEYGEASQYQIQEVIGKGSYGVVAAAVDTRTGERVAIKKINDVFEHVSDATRILREI 135
Query: 65 KLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY 124
KLLR+L+HPDIVEIKHIMLPP RREF+DIYVVFELMESDL QVI+ANDDLTPEH+QFFLY
Sbjct: 136 KLLRLLRHPDIVEIKHIMLPPSRREFQDIYVVFELMESDLHQVIRANDDLTPEHYQFFLY 195
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
QLLRALKYIH+ANVFHRDLKPKNILAN+DCKLKICDFGLAR SF D PSAIFWTDYVATR
Sbjct: 196 QLLRALKYIHAANVFHRDLKPKNILANSDCKLKICDFGLARASFNDAPSAIFWTDYVATR 255
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG+NV HQLD++TDLLGTPS+E
Sbjct: 256 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGKNVVHQLDIITDLLGTPSSE 315
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFT 304
+++ IRNEKA+RYLS++R+K AVPFS KF DPLALRLL+RLLAFDPKDR SAEE
Sbjct: 316 TLSRIRNEKARRYLSTMRKKHAVPFSQKFRNTDPLALRLLERLLAFDPKDRSSAEE---- 371
Query: 305 EIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364
ALADPYF LAN+E EPSR PISKL FEFERRKL KDDVRELIYRE
Sbjct: 372 --------------ALADPYFASLANVEREPSRHPISKLEFEFERRKLTKDDVRELIYRE 417
Query: 365 ILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSLPRE 424
ILEYHP ML+EY++G + F+YPSGVD+FK+QFA LEE Y K ER PL+RK+ SLPRE
Sbjct: 418 ILEYHPQMLQEYMKGGEQISFLYPSGVDRFKRQFAHLEENYSKGERGSPLQRKHASLPRE 477
Query: 425 RISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSSSQKCG 484
R+ S+D Q + ++R+A T SPP + SA N +T SS
Sbjct: 478 RVGVSKDGYNQQNTNDQERSADSVARTTVSPPMSQDAQQHGSAGQNGVTSTDLSSRS--- 534
Query: 485 VLLRSDSMSASKCVGV 500
L+S S+SASKCV V
Sbjct: 535 -YLKSASISASKCVAV 549
|
May be involved in defense signaling pathway. Phosphorylates EREBP1 transcriptional activator in vitro. Enhances DNA-binding activity of EREBP1 to the GCC box element of pathogenesis-related (PR) gene promoters. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LV37|MPK9_ARATH Mitogen-activated protein kinase 9 OS=Arabidopsis thaliana GN=MPK9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 709 bits (1829), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/499 (70%), Positives = 412/499 (82%), Gaps = 25/499 (5%)
Query: 2 FDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRIL 61
+ EFFTEYGEAS+Y+IQE+IG GSYGVVASAIDTH+GEKVAIKK+ +VFEHVSDATRIL
Sbjct: 9 LETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHVSDATRIL 68
Query: 62 REIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQF 121
REIKLLR+L+HPDIVEIKH+MLPP RREF+DIYVVFELMESDL QVIKANDDLTPEH+QF
Sbjct: 69 REIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQF 128
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYV 181
FLYQLLR LK+IH+ANVFHRDLKPKNILAN+DCKLKICDFGLARVSF D PSAIFWTDYV
Sbjct: 129 FLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSAIFWTDYV 188
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NV HQLD++TDLLGTP
Sbjct: 189 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIMTDLLGTP 248
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
E+IA IRNEKA+RYL ++RRK VPF+HKFP DPLALRLL RLLAFDPKDRPSAEE
Sbjct: 249 PPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKDRPSAEE- 307
Query: 302 RFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELI 361
ALADPYF+GLAN++ EPS +PI KL FEFERRK+ K+DVRELI
Sbjct: 308 -----------------ALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELI 350
Query: 362 YREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSL 421
YREILEYHP ML+EYL+G + T FMYPSGVD+FK+QFA LEE YGK E+ PL+R++ SL
Sbjct: 351 YREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASL 410
Query: 422 PRERISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSSSQ 481
PRER+ + E ++ R+ + TL+SPP+ ++ + + + T Q G S++
Sbjct: 411 PRERVPAPKKENGSHNHDIENRSIASLVTTLESPPT----SQHEGSDYRNGTSQTGYSAR 466
Query: 482 KCGVLLRSDSMSASKCVGV 500
LL+S S+SASKC+G+
Sbjct: 467 S---LLKSASISASKCIGM 482
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9C9U4|MPK15_ARATH Mitogen-activated protein kinase 15 OS=Arabidopsis thaliana GN=MPK15 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/502 (67%), Positives = 404/502 (80%), Gaps = 28/502 (5%)
Query: 3 DKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR 62
+ EFFTEYGEA++Y+IQE++G GSYGVV SAIDTHTGE+VAIKK+ +VF+H+SDATRILR
Sbjct: 77 NAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDATRILR 136
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFF 122
EIKLLR+L HPD+VEIKHIMLPP RREF+D+YVVFELMESDL QVIKANDDLTPEHHQFF
Sbjct: 137 EIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPEHHQFF 196
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
LYQLLR LKY+H+ANVFHRDLKPKNILANADCKLKICDFGLARVSF D P+AIFWTDYVA
Sbjct: 197 LYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVA 256
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
TRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L G+PLFPG+NV HQLD++TD LGTP
Sbjct: 257 TRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDFLGTPP 316
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
E+I+ IRN+KA+RYL ++R+K VPFS KFP ADP ALRLL+RL+AFDPKDRPSAEE
Sbjct: 317 PEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPSAEE-- 374
Query: 303 FTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIY 362
ALADPYF+GL++ EPS +PISKL FEFER+KL KDD+RELIY
Sbjct: 375 ----------------ALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIY 418
Query: 363 REILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSLP 422
REILEYHP MLEEYL+G + FMYPSGVD+F++QFA LEE G R L+R++ SLP
Sbjct: 419 REILEYHPQMLEEYLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLP 478
Query: 423 RERISTSEDEATDQ-TDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSSSQ 481
RER+ S++E ++ ++ +++RT + +TL SP + Q A G G S++
Sbjct: 479 RERVPASKNETVEERSNDIERRTTAAVASTLDSPKA------SQQAEGTENGGGGGYSAR 532
Query: 482 KCGVLLRSDSMSASKCVGVNGK 503
L++S S+S SKC+GV K
Sbjct: 533 N---LMKSSSISGSKCIGVQSK 551
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5F7|MPK17_ORYSJ Mitogen-activated protein kinase 17 OS=Oryza sativa subsp. japonica GN=MPK17 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 692 bits (1786), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/495 (69%), Positives = 393/495 (79%), Gaps = 39/495 (7%)
Query: 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREI 64
+FFTEYGEA++Y++ E+IG GSYGVVA+A+DT TGE+VAIKK+ +VF+HVSDATRILREI
Sbjct: 94 DFFTEYGEANRYKVSEVIGKGSYGVVAAAVDTQTGERVAIKKINDVFDHVSDATRILREI 153
Query: 65 KLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY 124
KLLR+L+HPDIVEIKHIMLPP RREF+DIYV+FELMESDL QVIKANDDLTPEHHQFFLY
Sbjct: 154 KLLRLLRHPDIVEIKHIMLPPSRREFRDIYVIFELMESDLHQVIKANDDLTPEHHQFFLY 213
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
QLLR +KYIH+A+VFHRDLKPKNILANADCKLK+CDFGLARVSF DTPSAIFWTDYVATR
Sbjct: 214 QLLRGMKYIHAASVFHRDLKPKNILANADCKLKVCDFGLARVSFNDTPSAIFWTDYVATR 273
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
WYRAPELCGSFFSKYTPAIDIWS+GCIFAELLTG+PLFPG+NV HQLDL+TDLLGTPSAE
Sbjct: 274 WYRAPELCGSFFSKYTPAIDIWSVGCIFAELLTGKPLFPGKNVVHQLDLMTDLLGTPSAE 333
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFT 304
S+A IRNEKA+RYLS++R+K VPF+ KFPG DP+AL LL+RLLAFDPKDRPSAEE
Sbjct: 334 SLAKIRNEKARRYLSNMRKKPRVPFTKKFPGVDPMALHLLERLLAFDPKDRPSAEE---- 389
Query: 305 EIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364
AL DPYF+GLAN E EP +PISKL FEFE+RKL KDDVRELIYRE
Sbjct: 390 --------------ALTDPYFNGLANSEREPIAQPISKLEFEFEKRKLAKDDVRELIYRE 435
Query: 365 ILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSLPRE 424
ILEYHPHML+EYL+G D FMYPSGVD+FK+QFA LEE K E+ P R+ SLPRE
Sbjct: 436 ILEYHPHMLQEYLRGGDQMSFMYPSGVDRFKRQFAHLEEGVSKGEKSSPQLRQNASLPRE 495
Query: 425 RISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSSSQKCG 484
R + D+ + A++ S P L SAR
Sbjct: 496 R-AIGNKHGDDEYHAKLNVGEKPCHASVTDGISKP----LMSARS--------------- 535
Query: 485 VLLRSDSMSASKCVG 499
LL+S+S+SASKC+G
Sbjct: 536 -LLKSESISASKCIG 549
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q0E459|MPK13_ORYSJ Mitogen-activated protein kinase 13 OS=Oryza sativa subsp. japonica GN=MPK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 681 bits (1758), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/494 (68%), Positives = 398/494 (80%), Gaps = 21/494 (4%)
Query: 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREI 64
EFFTEYGEASQY+IQE++G GSYGVVA+A+DTHTGE+VAIKK+ +VFEHVSDA RILREI
Sbjct: 2 EFFTEYGEASQYQIQEVVGKGSYGVVAAAVDTHTGERVAIKKINDVFEHVSDAIRILREI 61
Query: 65 KLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY 124
K+LR+L+HPDIV IKHIMLPP RREF+DIYVVFELMESDL QVI+AN DL+PEHH+FFLY
Sbjct: 62 KVLRLLRHPDIVVIKHIMLPPTRREFRDIYVVFELMESDLHQVIEANHDLSPEHHRFFLY 121
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
QLL ALKYIHSANVFHRDLKPKNILAN+DCKLKICDFGLARV+F D+PS IFWTDYVATR
Sbjct: 122 QLLCALKYIHSANVFHRDLKPKNILANSDCKLKICDFGLARVAFNDSPSTIFWTDYVATR 181
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGRPLFPGRNV HQLDL+TDLLGTPS+E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEILTGRPLFPGRNVVHQLDLITDLLGTPSSE 241
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFT 304
+++ IRNE A+ YL+ ++RK +PFSHKF ADPLALRLL+RLLAFDPKDRP+AEE
Sbjct: 242 TLSRIRNENARGYLTGMQRKHPIPFSHKFHNADPLALRLLERLLAFDPKDRPTAEE---- 297
Query: 305 EIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364
ALADPYF G++ L EPSR P+SK FEFERRKL KDDVRE+IYRE
Sbjct: 298 --------------ALADPYFRGISKLSREPSRLPVSKFEFEFERRKLTKDDVREMIYRE 343
Query: 365 ILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSLPRE 424
ILEYHP ML+EY++G + F+YPSGVD+FK+QFA LEE Y + ER PLRR++ SLPRE
Sbjct: 344 ILEYHPQMLQEYIRGGEQISFLYPSGVDRFKRQFAHLEENYSRGERSTPLRRQHASLPRE 403
Query: 425 RISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSSSQKCG 484
R+ +S D +D+ ++R S T+ SP PR E R ++ + +
Sbjct: 404 RVCSSVDSNNQDSDNEERRAISSIARTMISP---PRSQEKGKNRASAYPNGIINLNSNPK 460
Query: 485 VLLRSDSMSASKCV 498
+ L+S S+SAS C+
Sbjct: 461 IYLKSASISASTCI 474
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|A2X0M1|MPK13_ORYSI Mitogen-activated protein kinase 13 OS=Oryza sativa subsp. indica GN=MPK13 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 681 bits (1758), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/494 (68%), Positives = 398/494 (80%), Gaps = 21/494 (4%)
Query: 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREI 64
EFFTEYGEASQY+IQE++G GSYGVVA+A+DTHTGE+VAIKK+ +VFEHVSDA RILREI
Sbjct: 2 EFFTEYGEASQYQIQEVVGKGSYGVVAAAVDTHTGERVAIKKINDVFEHVSDAIRILREI 61
Query: 65 KLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY 124
K+LR+L+HPDIV IKHIMLPP RREF+DIYVVFELMESDL QVI+AN DL+PEHH+FFLY
Sbjct: 62 KVLRLLRHPDIVVIKHIMLPPTRREFRDIYVVFELMESDLHQVIEANHDLSPEHHRFFLY 121
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
QLL ALKYIHSANVFHRDLKPKNILAN+DCKLKICDFGLARV+F D+PS IFWTDYVATR
Sbjct: 122 QLLCALKYIHSANVFHRDLKPKNILANSDCKLKICDFGLARVAFNDSPSTIFWTDYVATR 181
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGRPLFPGRNV HQLDL+TDLLGTPS+E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEILTGRPLFPGRNVVHQLDLITDLLGTPSSE 241
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFT 304
+++ IRNE A+ YL+ ++RK +PFSHKF ADPLALRLL+RLLAFDPKDRP+AEE
Sbjct: 242 TLSRIRNENARGYLTGMQRKHPIPFSHKFHNADPLALRLLERLLAFDPKDRPTAEE---- 297
Query: 305 EIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364
ALADPYF G++ L EPSR P+SK FEFERRKL KDDVRE+IYRE
Sbjct: 298 --------------ALADPYFRGISKLSREPSRLPVSKFEFEFERRKLTKDDVREMIYRE 343
Query: 365 ILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSLPRE 424
ILEYHP ML+EY++G + F+YPSGVD+FK+QFA LEE Y + ER PLRR++ SLPRE
Sbjct: 344 ILEYHPQMLQEYIRGGEQISFLYPSGVDRFKRQFAHLEENYSRGERSTPLRRQHASLPRE 403
Query: 425 RISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSSSQKCG 484
R+ +S D +D+ ++R S T+ SP PR E R ++ + +
Sbjct: 404 RVCSSVDSNNQDSDNEERRAISSIARTMISP---PRSQEKGKNRASAYPNGIINLNSNPK 460
Query: 485 VLLRSDSMSASKCV 498
+ L+S S+SAS C+
Sbjct: 461 IYLKSASISASTCI 474
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LM33|MPK8_ARATH Mitogen-activated protein kinase 8 OS=Arabidopsis thaliana GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 681 bits (1757), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/506 (67%), Positives = 402/506 (79%), Gaps = 41/506 (8%)
Query: 3 DKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR 62
+ EFFTEYGEA++Y+IQE++G GSYGVVASA+D+HTGE+VAIKK+ +VFEHVSDATRILR
Sbjct: 91 ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVFEHVSDATRILR 150
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFF 122
EIKLLR+L+HPD+VEIKHIMLPP RREF+DIYVVFELMESDL QVIKANDDLTPEH+QFF
Sbjct: 151 EIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFF 210
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
LYQLLR LKY+H+ANVFHRDLKPKNILANADCKLKICDFGLARVSF D P+AIFWTDYVA
Sbjct: 211 LYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVA 270
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
TRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L G+PLFPG+NV HQLDL+TD LGTP
Sbjct: 271 TRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLMTDFLGTPP 330
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
ESI+ IRNEKA+RYLSS+R+K VPFSHKFP ADPLALRLL+RLLAFDPKDR SAE+
Sbjct: 331 PESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFDPKDRASAED-- 388
Query: 303 FTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIY 362
ALADPYF GL+N E EP+ +PISKL F+FER+KL+KDDVRELIY
Sbjct: 389 ----------------ALADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIY 432
Query: 363 REILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGK-----RERHIPLRRK 417
REILEYHP MLEEYL+G D FMYPSGVD+FK+QFA LEE GK R L R
Sbjct: 433 REILEYHPQMLEEYLRGGDQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRSTALHRH 492
Query: 418 YTSLPRERISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHG 477
+ SLPRER+ E +++ +++R A+ +TL+S ++ G + ++
Sbjct: 493 HASLPRERVPAPNGETAEESSDVERRAAAAVASTLESE---------EADNGGGYSARN- 542
Query: 478 SSSQKCGVLLRSDSMSASKCVGVNGK 503
L++S S+S SKC+GV K
Sbjct: 543 --------LMKSASISGSKCIGVQSK 560
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 677 bits (1747), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/444 (72%), Positives = 374/444 (84%), Gaps = 26/444 (5%)
Query: 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREI 64
+FFTEYGE ++Y+I+E+IG GSYGVV SA+DTHTG+KVAIKK+ ++FEHVSDATRILREI
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILREI 61
Query: 65 KLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY 124
KLLR+L+HPDIVEIKHI+LPP RREFKDIYVVFELMESDL QVIKANDDLTPEH+QFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
QLLR LKYIH+ANVFHRDLKPKNILANADCKLKICDFGLARV+F+DTP+AIFWTDY+ATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIATR 181
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG+PLFPG+NV HQLD++TDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSPE 241
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFT 304
+I+ IRNEKA+RYL+S+RRK +PF+ KFP ADPLA+RLL+R+LAFDPKDRPSAEE
Sbjct: 242 TISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEE---- 297
Query: 305 EIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364
ALADPYF +AN++ EPS +PI+KL FEFERR++ K+D+RELIYRE
Sbjct: 298 --------------ALADPYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYRE 343
Query: 365 ILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSLPRE 424
ILEYHP ML E+L+GT+ T FMYPS VD FK+QFA LEE Y K P R++ SLPR
Sbjct: 344 ILEYHPKMLREFLEGTESTGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRP 403
Query: 425 RISTSEDEATDQTDSLKKRTASVT 448
+ S D+ + TASVT
Sbjct: 404 CVVYS--------DNRPQSTASVT 419
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 676 bits (1743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 316/434 (72%), Positives = 370/434 (85%), Gaps = 18/434 (4%)
Query: 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREI 64
+FFTEYGE ++Y+I+E+IG GSYGVV SA+DTHTGEKVAIKK+ ++FEHVSDATRILREI
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILREI 61
Query: 65 KLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY 124
KLLR+L+HPDIVEIKHI+LPP RREFKDIYVVFELMESDL QVIKANDDLTPEH+QFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
QLLR LKYIH+ANVFHRDLKPKNILANADCKLKICDFGLARV+F+DTP+AIFWTDYVATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVATR 181
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG+PLFPG+NV HQLD++TDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSTE 241
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFT 304
+I+ IRNEKA+RYLSS+RRK +PF+ KFP ADPLALRLL+R+L+F+PKDRP+AEE
Sbjct: 242 AISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEE---- 297
Query: 305 EIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364
ALADPYF +AN++ EPS +P++KL FEFERR++ K+D+RELIYR+
Sbjct: 298 --------------ALADPYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRD 343
Query: 365 ILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSLPRE 424
ILEYHP+ML EYL+GT+ FMYPS VD FK+QFA LEE Y K P R++ SLPR
Sbjct: 344 ILEYHPNMLREYLEGTESAGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRP 403
Query: 425 RISTSEDEATDQTD 438
+ S+D + +
Sbjct: 404 SVLYSDDRPQNTAN 417
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 506 | ||||||
| 297737701 | 613 | unnamed protein product [Vitis vinifera] | 0.966 | 0.797 | 0.726 | 0.0 | |
| 359472622 | 612 | PREDICTED: mitogen-activated protein kin | 0.964 | 0.797 | 0.724 | 0.0 | |
| 255570122 | 503 | big map kinase/bmk, putative [Ricinus co | 0.950 | 0.956 | 0.725 | 0.0 | |
| 359491016 | 601 | PREDICTED: mitogen-activated protein kin | 0.940 | 0.792 | 0.732 | 0.0 | |
| 399106776 | 594 | MAP kinase [Nicotiana tabacum] | 0.938 | 0.799 | 0.720 | 0.0 | |
| 148909795 | 612 | unknown [Picea sitchensis] | 0.944 | 0.781 | 0.711 | 0.0 | |
| 399106778 | 590 | MAP kinase [Nicotiana tabacum] | 0.940 | 0.806 | 0.699 | 0.0 | |
| 224108327 | 500 | predicted protein [Populus trichocarpa] | 0.950 | 0.962 | 0.704 | 0.0 | |
| 60460041 | 578 | putative MAPK protein kinase [Triticum a | 0.936 | 0.820 | 0.705 | 0.0 | |
| 92870989 | 606 | Serine/threonine protein kinase, active | 0.934 | 0.780 | 0.714 | 0.0 |
| >gi|297737701|emb|CBI26902.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 765 bits (1975), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/509 (72%), Positives = 421/509 (82%), Gaps = 20/509 (3%)
Query: 1 MFDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI 60
M DKEFFTEYGEA+QYEIQE++G GSYGVVASA++THTGE+VAIKK+ +VFE+VSDATRI
Sbjct: 98 MLDKEFFTEYGEATQYEIQEVVGKGSYGVVASAVNTHTGERVAIKKINDVFENVSDATRI 157
Query: 61 LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
LREIKLLR+L+HPDIV+IKHIMLPP RREFKDIYVVFELMESDL QVIKANDDLTPEH+Q
Sbjct: 158 LREIKLLRLLRHPDIVQIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 217
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
FFLYQLLRALKYIH+ANVFHRDLKPKNILANADCKLKICDFGLARVSF DTPS IFWTDY
Sbjct: 218 FFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDTPSTIFWTDY 277
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
VATRWYRAPELCG FFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NV QLDL+TDLLGT
Sbjct: 278 VATRWYRAPELCGCFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVQQLDLMTDLLGT 337
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
PS ESIA IRNEKAKRYL+++R+K +PFS KFP ADPLA+RLL+RLLAFDPK+RPSAEE
Sbjct: 338 PSYESIARIRNEKAKRYLNNMRKKSPIPFSQKFPNADPLAVRLLERLLAFDPKNRPSAEE 397
Query: 301 IRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVREL 360
IRFT DPYFHGLAN + EP +PISK +FEFERR++ K+DVREL
Sbjct: 398 IRFT-----------------DPYFHGLANADYEPCTQPISKFLFEFERRRMTKEDVREL 440
Query: 361 IYREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTS 420
IYREILEYHP ML+EYLQGTD T FMYPSGVD+FKQQFA LEE +GK ER P R++ S
Sbjct: 441 IYREILEYHPQMLQEYLQGTDLTSFMYPSGVDRFKQQFAHLEEHHGKGERTAPRLRQHAS 500
Query: 421 LPRERISTSEDEATDQTDSLKKRT-ASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSS 479
LPRER+ D+ QT+ +KRT ASV R TLQSPP +SA TMQ+G++
Sbjct: 501 LPRERVCAPIDDPVSQTNDFEKRTAASVGRTTLQSPPRFQAINVSESANKKVTTMQNGAN 560
Query: 480 SQKCGV--LLRSDSMSASKCVGVNGKYCD 506
L++S S+SASKC+ V + C+
Sbjct: 561 KPNYSACSLMKSPSISASKCMEVKERDCE 589
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472622|ref|XP_002284377.2| PREDICTED: mitogen-activated protein kinase 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 762 bits (1967), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/509 (72%), Positives = 420/509 (82%), Gaps = 21/509 (4%)
Query: 1 MFDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI 60
M DKEFFTEYGEA+QYEIQE++G GSYGVVASA++THTGE+VAIKK+ +VFE+VSDATRI
Sbjct: 98 MLDKEFFTEYGEATQYEIQEVVGKGSYGVVASAVNTHTGERVAIKKINDVFENVSDATRI 157
Query: 61 LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
LREIKLLR+L+HPDIV+IKHIMLPP RREFKDIYVVFELMESDL QVIKANDDLTPEH+Q
Sbjct: 158 LREIKLLRLLRHPDIVQIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 217
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
FFLYQLLRALKYIH+ANVFHRDLKPKNILANADCKLKICDFGLARVSF DTPS IFWTDY
Sbjct: 218 FFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDTPSTIFWTDY 277
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
VATRWYRAPELCG FFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NV QLDL+TDLLGT
Sbjct: 278 VATRWYRAPELCGCFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVQQLDLMTDLLGT 337
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
PS ESIA IRNEKAKRYL+++R+K +PFS KFP ADPLA+RLL+RLLAFDPK+RPSAEE
Sbjct: 338 PSYESIARIRNEKAKRYLNNMRKKSPIPFSQKFPNADPLAVRLLERLLAFDPKNRPSAEE 397
Query: 301 IRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVREL 360
ALADPYFHGLAN + EP +PISK +FEFERR++ K+DVREL
Sbjct: 398 ------------------ALADPYFHGLANADYEPCTQPISKFLFEFERRRMTKEDVREL 439
Query: 361 IYREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTS 420
IYREILEYHP ML+EYLQGTD T FMYPSGVD+FKQQFA LEE +GK ER P R++ S
Sbjct: 440 IYREILEYHPQMLQEYLQGTDLTSFMYPSGVDRFKQQFAHLEEHHGKGERTAPRLRQHAS 499
Query: 421 LPRERISTSEDEATDQTDSLKKRT-ASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSS 479
LPRER+ D+ QT+ +KRT ASV R TLQSPP +SA TMQ+G++
Sbjct: 500 LPRERVCAPIDDPVSQTNDFEKRTAASVGRTTLQSPPRFQAINVSESANKKVTTMQNGAN 559
Query: 480 SQKCGV--LLRSDSMSASKCVGVNGKYCD 506
L++S S+SASKC+ V + C+
Sbjct: 560 KPNYSACSLMKSPSISASKCMEVKERDCE 588
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570122|ref|XP_002526023.1| big map kinase/bmk, putative [Ricinus communis] gi|223534670|gb|EEF36363.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/518 (72%), Positives = 423/518 (81%), Gaps = 37/518 (7%)
Query: 1 MFDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI 60
M +KEFFTEYGEASQYEIQE+IG GSYGVVASAIDTHTGEKVAIKKM +FEHVSDATRI
Sbjct: 1 MLEKEFFTEYGEASQYEIQEVIGKGSYGVVASAIDTHTGEKVAIKKMNNIFEHVSDATRI 60
Query: 61 LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
LREIKLLR+LKHPDIVEIKHIMLPP REFKDIYVVFELMESDL QVIK NDDLTPEHHQ
Sbjct: 61 LREIKLLRLLKHPDIVEIKHIMLPPSPREFKDIYVVFELMESDLHQVIKLNDDLTPEHHQ 120
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
FFLYQLLRALKYIHSA+VFHRDLKPKNILANADCKLK+CDFGLARVSFT+ PSAIFWTDY
Sbjct: 121 FFLYQLLRALKYIHSAHVFHRDLKPKNILANADCKLKLCDFGLARVSFTNAPSAIFWTDY 180
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
VATRWYRAPELCGSF SKYTPAIDIWSIGCIFAELLTG+PLFPG+NV H+LD++TD+LGT
Sbjct: 181 VATRWYRAPELCGSFSSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHELDIITDVLGT 240
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
PS ESIA I NEKA++YL+S+R+K VP S K P ADP+ALRLL+ LLAFDPKDRPSAEE
Sbjct: 241 PSEESIARIGNEKARKYLNSMRKKRPVPLSKKIPNADPMALRLLEHLLAFDPKDRPSAEE 300
Query: 301 IRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVREL 360
ALADPYF GLAN E EPSR+PISKL FEFERRKL KDDVREL
Sbjct: 301 ------------------ALADPYFDGLANKENEPSRQPISKLEFEFERRKLTKDDVREL 342
Query: 361 IYREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKY-T 419
IYREILEYHP ML+EYL+GTD THF+YPSGVD+F++QFA LEE G+ ER+ PL RK+ T
Sbjct: 343 IYREILEYHPEMLKEYLRGTDQTHFVYPSGVDRFREQFAHLEEGNGRSERNSPLHRKHAT 402
Query: 420 SLPRERISTSEDEATDQTDSLKKRTASVTRATLQSPPS------------LPRFAELQSA 467
SLPRERI TS+++ +K+ ++SVTRATLQSPP + EL+S
Sbjct: 403 SLPRERICTSDEDDI----VIKRSSSSVTRATLQSPPQSEATEELELTEEVQSTEELESL 458
Query: 468 RGNSLTMQHGSSSQKCGV--LLRSDSMSASKCVGVNGK 503
N++ MQ S+ KC L++SDS+ AS C+G+ G
Sbjct: 459 NRNAVAMQTSSNKPKCSTRSLMKSDSICASMCIGMVGN 496
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491016|ref|XP_003634202.1| PREDICTED: mitogen-activated protein kinase 9-like [Vitis vinifera] gi|297734305|emb|CBI15552.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1947), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/500 (73%), Positives = 413/500 (82%), Gaps = 24/500 (4%)
Query: 1 MFDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI 60
M + EFFTEYGEAS+Y++QE++G GSYGVV SAIDTHTGEKVAIKK+ +VFEHVSDATRI
Sbjct: 95 MPETEFFTEYGEASRYQVQEVVGKGSYGVVGSAIDTHTGEKVAIKKINDVFEHVSDATRI 154
Query: 61 LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
LREIKLLR+L+HPDIVEIKHIMLPP RREF+DIYVVFELMESDL QVIKANDDLTPEH+Q
Sbjct: 155 LREIKLLRLLRHPDIVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQ 214
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
FFLYQLLR LKYIH+ANVFHRDLKPKNILANADCKLKICDFGLARVSF D PSAIFWTDY
Sbjct: 215 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 274
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NV HQLDL+TDLLGT
Sbjct: 275 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGT 334
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
PSAESIA IRNEKA+RYLS++R+K ++PFS KFP ADPLAL L++RLLAFDPKDRP+AEE
Sbjct: 335 PSAESIARIRNEKARRYLSTMRKKPSIPFSQKFPDADPLALHLVERLLAFDPKDRPTAEE 394
Query: 301 IRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVREL 360
ALADPYF GLAN++ EPS +PISKL FEFERRKL KDDVREL
Sbjct: 395 ------------------ALADPYFDGLANVDREPSTQPISKLEFEFERRKLTKDDVREL 436
Query: 361 IYREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTS 420
IYREILEYHP ML+EYL+G D T FMYPSGVD+FK+QFA LEE YGK ER PL+R++ S
Sbjct: 437 IYREILEYHPQMLQEYLRGGDQTSFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHAS 496
Query: 421 LPRERISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSSS 480
LPRER+ +EA D+ +KR+A+ TL+SPP + G S Q S
Sbjct: 497 LPRERVCAPINEAADENKEFEKRSAASVATTLESPPKAEGLEKGNVENGPSKPNQSARS- 555
Query: 481 QKCGVLLRSDSMSASKCVGV 500
LL+S S+SASKC+GV
Sbjct: 556 -----LLKSASISASKCIGV 570
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399106776|gb|AFP20221.1| MAP kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/501 (72%), Positives = 411/501 (82%), Gaps = 26/501 (5%)
Query: 3 DKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR 62
+ EFFTEYGEAS+Y+IQE+IG GSYGVVASA+DT TGE+VAIKK+ +VFEHVSDATRILR
Sbjct: 88 EAEFFTEYGEASRYQIQEVIGKGSYGVVASAVDTKTGERVAIKKIHDVFEHVSDATRILR 147
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFF 122
EIKLLR+L+HPDIVEIKHIMLPP RREFKDIYVVFELMESDL QVIKANDDLTPEH+QFF
Sbjct: 148 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF 207
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
LYQLLR LKYIH+ANVFHRDLKPKNILANADCKLKICDFGLARVSF DTPSAIFWTDYVA
Sbjct: 208 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDTPSAIFWTDYVA 267
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NV HQLDL+TDLLGTP
Sbjct: 268 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDLMTDLLGTPP 327
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
E++A IRNEKA+RYLS++R+K VPFS KFP DP ALRLL+ LLAFDPKDRPSAEE
Sbjct: 328 PETVAKIRNEKARRYLSNMRKKPPVPFSQKFPHVDPFALRLLECLLAFDPKDRPSAEE-- 385
Query: 303 FTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIY 362
AL DPYF GL+N++ EPS PISKL FEFERRKL K+DVRELIY
Sbjct: 386 ----------------ALGDPYFRGLSNVDREPSTHPISKLEFEFERRKLAKEDVRELIY 429
Query: 363 REILEYHPHMLEEYLQGTDHTH-FMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSL 421
REILEYHP ML+EYL+G D T FMYPSGVD+FK+QFA LEE YGK ER PL+R++ SL
Sbjct: 430 REILEYHPQMLQEYLRGGDQTSGFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHASL 489
Query: 422 PRERISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSSSQ 481
PRER+ +DE + Q D +KRT++ +TLQSPP + + + + MQ+G +
Sbjct: 490 PRERVPAPKDETSSQNDDFEKRTSASVASTLQSPP-----GQSEGSENSDANMQNGPNKA 544
Query: 482 KCGV--LLRSDSMSASKCVGV 500
LL+S S+SASKC+ V
Sbjct: 545 NYSARSLLKSASISASKCIEV 565
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|148909795|gb|ABR17985.1| unknown [Picea sitchensis] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/503 (71%), Positives = 409/503 (81%), Gaps = 25/503 (4%)
Query: 2 FDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRIL 61
+ EFFTEYGEA++Y+IQE++G GSYGVV+SAIDTHTGEKVAIKK+ +VFEHVSDATRIL
Sbjct: 78 LETEFFTEYGEANRYQIQEVVGKGSYGVVSSAIDTHTGEKVAIKKINDVFEHVSDATRIL 137
Query: 62 REIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQF 121
REIKLLR+L+HPDIVEIKHIMLPP RREFKDIYVVFELMESDL QVIKANDDLTPEH+QF
Sbjct: 138 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 197
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYV 181
FLYQLLRALKYIH+ANVFHRDLKPKNILANADCKLKICDFGLARVSF D PSAIFWTDYV
Sbjct: 198 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDYV 257
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
ATRWYRAPELCGSFF+KYTPAIDIWSIGCIFAE+LTG+PLFPG+NV HQLD++TDLLGTP
Sbjct: 258 ATRWYRAPELCGSFFTKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIMTDLLGTP 317
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
SAE++A IRNEKA+RYLS++R+K PFS KFP DP A+RLL+R+LAFDPKDRPSAEE
Sbjct: 318 SAETLARIRNEKARRYLSNMRKKQPTPFSQKFPNVDPFAIRLLERMLAFDPKDRPSAEE- 376
Query: 302 RFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELI 361
ALADPYF+GLA +E EPS +PISKL FEFERR++ K+DVRELI
Sbjct: 377 -----------------ALADPYFNGLAKVEREPSTQPISKLEFEFERRRVTKEDVRELI 419
Query: 362 YREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSL 421
YREILEYHP ML+EYL G ++ +FMYPS VD FK+QFA LEE Y K E PL R++ SL
Sbjct: 420 YREILEYHPQMLQEYLCGANNANFMYPSAVDMFKRQFAHLEEHYSKGENSTPLGRQHASL 479
Query: 422 PRER-ISTSEDEATDQTDSLKKR---TASVTRATLQSPPSLPRFAELQSARGNSLTMQHG 477
PRER I E+ DS K++ TASVT+ATLQSP PR + SLT
Sbjct: 480 PRERVIEFRENPTKHSKDSEKQQERSTASVTKATLQSP---PRTQGTVNDSAVSLTNGAS 536
Query: 478 SSSQKCGVLLRSDSMSASKCVGV 500
+ L++S S+SASKC+ V
Sbjct: 537 KTVPDPRNLVKSASISASKCIVV 559
|
Source: Picea sitchensis Species: Picea sitchensis Genus: Picea Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399106778|gb|AFP20222.1| MAP kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/505 (69%), Positives = 410/505 (81%), Gaps = 29/505 (5%)
Query: 2 FDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRIL 61
+ EFFTEYGEAS+Y++QE+IG GSYGVV SA+DTHTGE+VAIKK+ +VF+HVSDATRIL
Sbjct: 86 LETEFFTEYGEASRYQVQEVIGKGSYGVVGSAVDTHTGERVAIKKINDVFDHVSDATRIL 145
Query: 62 REIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQF 121
REIKLLR+L+HPDIVEIKHIMLPP RREFKDIYVVFELMESDL QVIKAN+DLT EH+QF
Sbjct: 146 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANNDLTAEHYQF 205
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYV 181
FLYQL+R LKYIH+AN+FHRDLKPKNILANADCKLKICDFGLARVSF D PSAIFWTDYV
Sbjct: 206 FLYQLMRGLKYIHTANIFHRDLKPKNILANADCKLKICDFGLARVSFNDVPSAIFWTDYV 265
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL+G+PLFPG+NV HQLDL+TDLLGTP
Sbjct: 266 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLSGKPLFPGKNVVHQLDLITDLLGTP 325
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
E++A IRNEKA+RYLSS+R+K VPF KFP ADPLALRLL+RL+AFDPKDRPSAEE
Sbjct: 326 PPETVAKIRNEKARRYLSSMRKKQPVPFEKKFPNADPLALRLLERLIAFDPKDRPSAEE- 384
Query: 302 RFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELI 361
AL+DPYF GL+N + EPSR PISKL FEFE+RKL K+DVRELI
Sbjct: 385 -----------------ALSDPYFRGLSNADHEPSRPPISKLEFEFEKRKLAKEDVRELI 427
Query: 362 YREILEYHPHMLEEYLQGTDHTH-FMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTS 420
YREILEYHP ML+EYL G D T FMYPSGVD+FK+QFA LEE YGK ER PL+R++ S
Sbjct: 428 YREILEYHPQMLQEYLSGGDQTSGFMYPSGVDRFKRQFAHLEEHYGKGERSTPLQRQHAS 487
Query: 421 LPRERISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGS-- 478
LPRER+ +++ + Q + +KRT S LQS P + + + + + Q+GS
Sbjct: 488 LPRERVPAPKNDTSSQNNDCEKRTVST---ALQSSP-----GQSEGSENSIVGTQNGSNQ 539
Query: 479 SSQKCGVLLRSDSMSASKCVGVNGK 503
++ LL+S S+SASKCV V +
Sbjct: 540 ANNSARSLLKSASISASKCVEVKNR 564
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108327|ref|XP_002314806.1| predicted protein [Populus trichocarpa] gi|222863846|gb|EEF00977.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/515 (70%), Positives = 414/515 (80%), Gaps = 34/515 (6%)
Query: 1 MFDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI 60
M D++FFTEYGEASQYEIQE++G GSYGVVASAIDTHTGE+VAIKKM VFEHVSDATRI
Sbjct: 1 MLDRDFFTEYGEASQYEIQEVVGKGSYGVVASAIDTHTGERVAIKKMNNVFEHVSDATRI 60
Query: 61 LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
LREIKLLR+LKH DIVEIKHIMLPP REFKD+YVVFELMESDL QVIK NDDLTPEHHQ
Sbjct: 61 LREIKLLRLLKHADIVEIKHIMLPPSPREFKDVYVVFELMESDLHQVIKLNDDLTPEHHQ 120
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
FFLYQLLR LKYIH+ NVFHRDLKPKNILANADCK+K+CDFGLARVSFT+ PSAIFWTDY
Sbjct: 121 FFLYQLLRGLKYIHTGNVFHRDLKPKNILANADCKVKLCDFGLARVSFTNAPSAIFWTDY 180
Query: 181 VATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL 231
VATRWYRAPELCGSF +YTPAIDIWSIGCIFAELLTG+PLFPG+NV HQL
Sbjct: 181 VATRWYRAPELCGSFCLTFFLKICVLQYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFD 291
+L+TDLLGTP+A++IA + NEKA++YLSS+R+K +PFS KFP D AL +L+RLLAFD
Sbjct: 241 ELITDLLGTPAADTIARVGNEKARKYLSSMRKKQPIPFSKKFPDVDRSALCILERLLAFD 300
Query: 292 PKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRK 351
PKDRPSAEE ALAD YF GLA+ E+EPSR+PISKL FEFERRK
Sbjct: 301 PKDRPSAEE------------------ALADLYFDGLADKEQEPSRQPISKLEFEFERRK 342
Query: 352 LIKDDVRELIYREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERH 411
L +DDVRELIYREILEYHP ML+EYLQGTD THF+YPSGVD+FK+QFA LEE GK +R+
Sbjct: 343 LTRDDVRELIYREILEYHPEMLKEYLQGTDQTHFVYPSGVDRFKEQFAHLEEGDGKSDRN 402
Query: 412 IPLRRKY-TSLPRERISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGN 470
P RK+ TSLPRERI T A + +++K+ T+S++RA QSP ELQSA N
Sbjct: 403 SPHHRKHATSLPRERICT----ADETENTVKRSTSSLSRAAKQSPQKSEATEELQSANRN 458
Query: 471 SLTMQHGSSSQKCG--VLLRSDSMSASKCVGVNGK 503
++ MQ S+ KC LLRSDS+ AS VG+ G
Sbjct: 459 AVAMQTSSTKPKCSPRTLLRSDSICASTSVGLIGN 493
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|60460041|gb|AAX20165.1| putative MAPK protein kinase [Triticum aestivum] gi|84795226|gb|ABC65849.1| mitogen-activated protein kinase MAPK1e [Triticum aestivum] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/503 (70%), Positives = 404/503 (80%), Gaps = 29/503 (5%)
Query: 1 MFDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI 60
+ +KEFFTEYGEASQY+IQE++G GSYGVVA+AIDT TGE+VAIKK+ +VFEHVSDATRI
Sbjct: 72 IMEKEFFTEYGEASQYQIQEVVGKGSYGVVAAAIDTRTGERVAIKKINDVFEHVSDATRI 131
Query: 61 LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
LRE+KLLR+L+HPD+VEIKHIMLPP RREF+DIYVVFELMESDL QVI+ANDDLT EH+Q
Sbjct: 132 LREVKLLRLLRHPDVVEIKHIMLPPSRREFQDIYVVFELMESDLHQVIRANDDLTAEHYQ 191
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
FFLYQLLRALKYIH ANVFHRDLKPKNILANADCKLKICDFGLARVSF D PSAIFWTDY
Sbjct: 192 FFLYQLLRALKYIHGANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSAIFWTDY 251
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG+NV HQLD++TDLLGT
Sbjct: 252 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGKNVVHQLDIITDLLGT 311
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
PS+E+++ IRNEKA+RYLS +R+K VP + KFP ADPLA+RLL RLLAFDPKDRPSAEE
Sbjct: 312 PSSETLSRIRNEKARRYLSCMRKKHPVPLTQKFPNADPLAVRLLGRLLAFDPKDRPSAEE 371
Query: 301 IRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVREL 360
ALADPYF LAN+E EPSR PISKL FEFERRK+ KDDVREL
Sbjct: 372 ------------------ALADPYFASLANVEREPSRHPISKLEFEFERRKVTKDDVREL 413
Query: 361 IYREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTS 420
IYREILEYHP MLEEY++G D F+YPSGVD+FK+QFA LEE Y K ER PL+RK+ S
Sbjct: 414 IYREILEYHPQMLEEYMKGGDQISFLYPSGVDRFKRQFAHLEEHYSKGERGSPLQRKHAS 473
Query: 421 LPRERISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSS- 479
LPR+R+ S D +Q S ++ +A SP Q ++ + Q+G S
Sbjct: 474 LPRQRVGASNDGNNEQHISDQEMSAEPDAHGTVSP---------QKSQDAAGVGQNGLSP 524
Query: 480 -SQKCGVLLRSDSMSASKCVGVN 501
S L+S S+SASKCV VN
Sbjct: 525 TSLSSRTYLKSASISASKCVVVN 547
|
Source: Triticum aestivum Species: Triticum aestivum Genus: Triticum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|92870989|gb|ABE80150.1| Serine/threonine protein kinase, active site [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 720 bits (1859), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/501 (71%), Positives = 403/501 (80%), Gaps = 28/501 (5%)
Query: 3 DKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR 62
+ EFFTEYGEASQY++QEIIG GSYGVV SAIDTHTG+KVAIKK+ VFEHVSDATRILR
Sbjct: 105 ETEFFTEYGEASQYQVQEIIGKGSYGVVCSAIDTHTGQKVAIKKINHVFEHVSDATRILR 164
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFF 122
EIKLLR+L+HPDIVEI+HIMLPP RREF+DIYVVFELMESDL QVIKAN DLTP+HHQFF
Sbjct: 165 EIKLLRLLRHPDIVEIRHIMLPPSRREFRDIYVVFELMESDLHQVIKANHDLTPQHHQFF 224
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
LYQLLR LK+IH+ANVFHRDLKPKNILANADCKLKICDFGLARVSF D PS IFWTDYVA
Sbjct: 225 LYQLLRGLKFIHTANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPSTIFWTDYVA 284
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
TRWYRAPELCGSFFSKYTP IDIWSIGCIFAE+LTGRPLFPG+NV HQLD++TDLLGTP
Sbjct: 285 TRWYRAPELCGSFFSKYTPGIDIWSIGCIFAEMLTGRPLFPGKNVVHQLDIMTDLLGTPP 344
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
ESIA IRNEKA+RYL+S+R+K VPFS KFP DPLALR+L+RLLAFDPK+RPSAEE
Sbjct: 345 PESIARIRNEKARRYLNSMRKKQPVPFSQKFPNIDPLALRILERLLAFDPKNRPSAEE-- 402
Query: 303 FTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIY 362
AL+DPYFHGL+N++ EPS PISKL FEFERRK+ KDDVRELIY
Sbjct: 403 ----------------ALSDPYFHGLSNIDREPSTHPISKLEFEFERRKVTKDDVRELIY 446
Query: 363 REILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKR-ERHIPLRRKYTSL 421
REILEYHP MLEEY++G D T FMYPSGVD+FK+QFA LEE YGK+ ER PL+R++ SL
Sbjct: 447 REILEYHPQMLEEYIRGGDQTSFMYPSGVDRFKRQFAHLEEHYGKKGERISPLQRQHASL 506
Query: 422 PRERISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSARGNSLTMQHGSSSQ 481
PRER+ TS++E + D T + LQSPP S N L + S
Sbjct: 507 PRERVHTSKNENNENND-----IEMPTGSDLQSPPGSNVTDAENSGAQNGLAKPNYSPRS 561
Query: 482 KCGVLLRSDSMSASKCVGVNG 502
LL+S S+SASKC+ V G
Sbjct: 562 ----LLKSASISASKCIDVKG 578
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 506 | ||||||
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.592 | 0.501 | 0.77 | 3.3e-160 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.588 | 0.484 | 0.744 | 1.8e-159 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.861 | 0.897 | 0.638 | 3e-149 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.861 | 0.740 | 0.604 | 1.5e-138 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.934 | 0.927 | 0.587 | 7.4e-137 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.843 | 0.753 | 0.608 | 4.7e-135 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.699 | 0.614 | 0.689 | 2.3e-133 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.699 | 0.584 | 0.666 | 5.2e-129 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.559 | 0.534 | 0.506 | 2.5e-83 | |
| TAIR|locus:2043904 | 395 | MPK6 "MAP kinase 6" [Arabidops | 0.529 | 0.678 | 0.532 | 1.1e-80 |
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1260 (448.6 bits), Expect = 3.3e-160, Sum P(2) = 3.3e-160
Identities = 231/300 (77%), Positives = 265/300 (88%)
Query: 1 MFDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI 60
M + EFFTEYG+A++Y I E+IG GSYGVV +AIDT TGEKVAIKK+ +VFEHVSDA RI
Sbjct: 10 MKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVFEHVSDALRI 69
Query: 61 LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
LRE+KLLR+L+HPDIVEIK IMLPP +REFKDIYVVFELMESDL QVIKANDDLT EHHQ
Sbjct: 70 LREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ 129
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
FFLYQ+LRALKY+H+ANV+HRDLKPKNILANA+CKLK+CDFGLARVSF DTP+ +FWTDY
Sbjct: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDTPTTVFWTDY 189
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
VATRWYRAPELCGSF SKYTPAIDIWSIGCIFAE+LTG+PLFPG++V HQLDL+TDLLGT
Sbjct: 190 VATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPXXXXXXXXXXXFDPKDRPSAEE 300
P +E+IAG+RNEKA++YL+ +R+K VPFS KFP ADP FDPKDRP+A E
Sbjct: 250 PKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFDPKDRPTAAE 309
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1232 (438.7 bits), Expect = 1.8e-159, Sum P(2) = 1.8e-159
Identities = 222/298 (74%), Positives = 263/298 (88%)
Query: 3 DKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR 62
+ EFFTEYG+A++Y I E+IG GSYGVV +AIDTHTGEKVAIKK+ +VFEH+SDA RILR
Sbjct: 12 EMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVFEHISDALRILR 71
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFF 122
E+KLLR+L+HPDIVEIK IMLPP +REFKDIYVVFELMESDL QVIKANDDLT EHHQFF
Sbjct: 72 EVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF 131
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
LYQ+LRALK++H+ANV+HRDLKPKNILANA+CKLK+CDFGLARV+F DTP+ +FWTDYVA
Sbjct: 132 LYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDTPTTVFWTDYVA 191
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
TRWYRAPELCGSFFSKYTPAID+WSIGCIFAE+LTG+PLFPG++V HQL+L+TDLLGTP
Sbjct: 192 TRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQLELITDLLGTPK 251
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPXXXXXXXXXXXFDPKDRPSAEE 300
+E+I+G+RN+KA++YL+ +R+K V FS KF ADP FDPKDRP+ E
Sbjct: 252 SETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFDPKDRPTPAE 309
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1457 (517.9 bits), Expect = 3.0e-149, P = 3.0e-149
Identities = 293/459 (63%), Positives = 349/459 (76%)
Query: 1 MFDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI 60
M +KEFFTEYGEASQY+IQE++G GSYGVVASA HTG KVAIKKM VFEHVSDA RI
Sbjct: 1 MLEKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRI 60
Query: 61 LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
LREIKLLR+L+HPDIVEIKHIMLPPCR+EFKDIYVVFELMESDL V+K NDDLTP+HHQ
Sbjct: 61 LREIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQ 120
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
FFLYQLLR LK++HSA+VFHRDLKPKNILANADCK+KICD GLARVSFTD+PSA+FWTDY
Sbjct: 121 FFLYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDY 180
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
VATRWYRAPELCGSF+S YTPAID+WS+GCIFAE+LTG+PLFPG+NV HQL+LVTDLLGT
Sbjct: 181 VATRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGT 240
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPXXXXXXXXXXXFDPKDRPSAEE 300
PS +++ IRNEKA++YL ++RRK VPF+HKFP DP FDPKDRPSAEE
Sbjct: 241 PSPITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEE 300
Query: 301 IRFTEIVFNWLFLYFYVLALAD--PYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVR 358
YF LA D P ++ LE E R+ +++ + R+L+ ++
Sbjct: 301 ALADP--------YFQGLANVDYEPSRQPISKLEFEFERRKLTR----DDVRELMYREIL 348
Query: 359 ELIYREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHI--PLRR 416
E + + EY EE + ++HF+YPSGVDQFKQ+FARLEE E H P +R
Sbjct: 349 EYHPQMLQEYLQG--EENI----NSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQR 402
Query: 417 KYTSLPRERISTSEDEATDQTDSLKKRTASVTRATLQSP 455
KYTSLPRER+ +SEDE +D + + +ASV Q+P
Sbjct: 403 KYTSLPRERVCSSEDEGSDSVHA-QSSSASVVFTPPQTP 440
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1356 (482.4 bits), Expect = 1.5e-138, P = 1.5e-138
Identities = 275/455 (60%), Positives = 333/455 (73%)
Query: 3 DKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR 62
+ EFFTEYGEA++Y+IQE++G GSYGVVASA+D+HTGE+VAIKK+ +VFEHVSDATRILR
Sbjct: 91 ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVFEHVSDATRILR 150
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFF 122
EIKLLR+L+HPD+VEIKHIMLPP RREF+DIYVVFELMESDL QVIKANDDLTPEH+QFF
Sbjct: 151 EIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFF 210
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
LYQLLR LKY+H+ANVFHRDLKPKNILANADCKLKICDFGLARVSF D P+AIFWTDYVA
Sbjct: 211 LYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVA 270
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
TRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L G+PLFPG+NV HQLDL+TD LGTP
Sbjct: 271 TRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLMTDFLGTPP 330
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPXXXXXXXXXXXFDPKDRPSAEEIR 302
ESI+ IRNEKA+RYLSS+R+K VPFSHKFP ADP FDPKDR SAE+
Sbjct: 331 PESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFDPKDRASAEDA- 389
Query: 303 FTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVREL-- 360
+ F+ L + +P ++ LE + RK KLV + + R+LI ++ E
Sbjct: 390 LADPYFSGLSN-----SEREPTTQPISKLEFDFERK---KLVKD-DVRELIYREILEYHP 440
Query: 361 -IYREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYT 419
+ E L + Y G D + ++ + G R L R +
Sbjct: 441 QMLEEYLRGGDQLSFMYPSGVDRFKRQFA----HLEENQGKPGAAGGGRST--ALHRHHA 494
Query: 420 SLPRERISTSEDEATDQTDSLKKRTASVTRATLQS 454
SLPRER+ E +++ +++R A+ +TL+S
Sbjct: 495 SLPRERVPAPNGETAEESSDVERRAAAAVASTLES 529
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1340 (476.8 bits), Expect = 7.4e-137, P = 7.4e-137
Identities = 291/495 (58%), Positives = 341/495 (68%)
Query: 3 DKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR 62
+ EFFTEYGEAS+Y+IQE+IG GSYGVVASAIDTH+GEKVAIKK+ +VFEHVSDATRILR
Sbjct: 10 ETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHVSDATRILR 69
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFF 122
EIKLLR+L+HPDIVEIKH+MLPP RREF+DIYVVFELMESDL QVIKANDDLTPEH+QFF
Sbjct: 70 EIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFF 129
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
LYQLLR LK+IH+ANVFHRDLKPKNILAN+DCKLKICDFGLARVSF D PSAIFWTDYVA
Sbjct: 130 LYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSAIFWTDYVA 189
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NV HQLD++TDLLGTP
Sbjct: 190 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIMTDLLGTPP 249
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPXXXXXXXXXXXFDPKDRPSAEEIR 302
E+IA IRNEKA+RYL ++RRK VPF+HKFP DP FDPKDRPSAEE
Sbjct: 250 PEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKDRPSAEEAL 309
Query: 303 FTEIVFNWLFLYFYVLALAD--PYFHGLANLEEEPSRKPISKL-VFEFERRKLIKDDVRE 359
YFY LA D P + LE E R+ I+K V E R++++ +
Sbjct: 310 ADP--------YFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQM 361
Query: 360 LIYREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYT 419
L +E L Y G D + ++ + + E+ + +H L R+
Sbjct: 362 L--QEYLRGGEQTSFMYPSGVDRFKRQFA----HLEENYGKGEKGSPLQRQHASLPRERV 415
Query: 420 SLPR-ERISTSEDEATDQTDSLKKRTASVTRATLQSPPSLPRFAELQSA-RGNSLTMQHG 477
P+ E S + D SL T + T Q S R Q+ SL
Sbjct: 416 PAPKKENGSHNHDIENRSIASLV--TTLESPPTSQHEGSDYRNGTSQTGYSARSLLKSAS 473
Query: 478 SSSQKC-GVLLRSDS 491
S+ KC G+ R+ S
Sbjct: 474 ISASKCIGMKPRNKS 488
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1323 (470.8 bits), Expect = 4.7e-135, P = 4.7e-135
Identities = 267/439 (60%), Positives = 318/439 (72%)
Query: 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREI 64
+FFTEYGE S+Y I+E+IG GSYGVV SA DTHTGEKVAIKK+ ++FEHVSDATRILREI
Sbjct: 14 DFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIFEHVSDATRILREI 73
Query: 65 KLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY 124
KLLR+L+HPDIVEIKHI+LPP RREF+DIYVVFELMESDL QVIKANDDLTPEH+QFFLY
Sbjct: 74 KLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
QLLR LKYIH+ANVFHRDLKPKNILANADCKLKICDFGLARV+F DTP+AIFWTDYVATR
Sbjct: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG+PLFPG+NV HQLDL+TD+LGTPSAE
Sbjct: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDLMTDMLGTPSAE 253
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPXXXXXXXXXXXFDPKDRPSAEEIRFT 304
+I +RNEKA+RYLSS+R+K +PFSHKFP DP F+PKDRP+AEE
Sbjct: 254 AIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFEPKDRPTAEEA-LA 312
Query: 305 EIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKL-VFEFERRKLIKDDVRELIYR 363
++ F L +P + LE E R+ I+K V E R+ ++ + L +
Sbjct: 313 DVYFKGL-----AKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYHPKML--K 365
Query: 364 EILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYTSLPR 423
E L+ Y +H + + +K + + R++H L R
Sbjct: 366 EYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPE---RQQHASLPRACVLYSD 422
Query: 424 ERISTSEDEATDQTDSLKK 442
++ + + TD L K
Sbjct: 423 NNHPVAQQSSAEVTDGLSK 441
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1307 (465.1 bits), Expect = 2.3e-133, P = 2.3e-133
Identities = 251/364 (68%), Positives = 294/364 (80%)
Query: 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREI 64
EFFTEYGEA++Y+IQE++G GSYGVV SAIDTHTGE+VAIKK+ +VF+H+SDATRILREI
Sbjct: 79 EFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDATRILREI 138
Query: 65 KLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY 124
KLLR+L HPD+VEIKHIMLPP RREF+D+YVVFELMESDL QVIKANDDLTPEHHQFFLY
Sbjct: 139 KLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPEHHQFFLY 198
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
QLLR LKY+H+ANVFHRDLKPKNILANADCKLKICDFGLARVSF D P+AIFWTDYVATR
Sbjct: 199 QLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFWTDYVATR 258
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
WYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L G+PLFPG+NV HQLD++TD LGTP E
Sbjct: 259 WYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDFLGTPPPE 318
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPXXXXXXXXXXXFDPKDRPSAEEIRFT 304
+I+ IRN+KA+RYL ++R+K VPFS KFP ADP FDPKDRPSAEE
Sbjct: 319 AISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPSAEEA-LA 377
Query: 305 EIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364
+ FN L + +P ++ LE E RK ++K + R+LI ++ E +
Sbjct: 378 DPYFNGLSS-----KVREPSTQPISKLEFEFERKKLTK----DDIRELIYREILEYHPQM 428
Query: 365 ILEY 368
+ EY
Sbjct: 429 LEEY 432
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1266 (450.7 bits), Expect = 5.2e-129, P = 5.2e-129
Identities = 246/369 (66%), Positives = 298/369 (80%)
Query: 3 DKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR 62
+ EFF++YG+A+++++QE+IG GSYGVV SAIDT TGEKVAIKK+ ++FEH+SDA RILR
Sbjct: 12 EMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIFEHISDAARILR 71
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFF 122
EIKLLR+L+HPDIVEIKHIMLPP RREFKDIYVVFELMESDL QVIKANDDLT EH+QFF
Sbjct: 72 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTREHYQFF 131
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
LYQLLRALKYIH+ANV+HRDLKPKNILANA+CKLKICDFGLARV+F DTP+ IFWTDYVA
Sbjct: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
TRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L G+PLFPG+NV HQLDL+TDLLGTPS
Sbjct: 192 TRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQLDLMTDLLGTPS 251
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPXXXXXXXXXXXFDPKDRPSAEEIR 302
++I+ +RNEKA+RYL+S+R+K +PF+ KFP ADP FDPKDRP+AEE
Sbjct: 252 LDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFDPKDRPTAEEAL 311
Query: 303 FTEIVFNWLFLYFYVLALAD--PYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVREL 360
YF LA + P + +E E R+ ++K E + R+LI ++ E
Sbjct: 312 ADP--------YFKGLAKVEREPSCQPITKMEFEFERRKVTK---E-DIRELISREILEY 359
Query: 361 IYREILEYH 369
+ ++L+ H
Sbjct: 360 -HPQLLKDH 367
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 2.5e-83, Sum P(2) = 2.5e-83
Identities = 145/286 (50%), Positives = 198/286 (69%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y I + IG G+YGVV SA D TGEKVAIKK+ + F+++ D R LREI LLR KH +
Sbjct: 148 RYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHEN 207
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
++ IK I+ P + +F+D+Y+V ELM++DL Q+I + L+ +H Q+F+YQ+LR LK+IH
Sbjct: 208 LISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIH 267
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
SANV HRDLKP N+L N DC LKICD GLARV D F T+YVATRWYRAPE+ S
Sbjct: 268 SANVLHRDLKPSNLLINEDCLLKICDLGLARVE--DATHQGFMTEYVATRWYRAPEVILS 325
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254
+ +KYT AIDIWS+GCIFAELL +PLF G++ HQ+ L+ + +G+PS E I I NE+A
Sbjct: 326 W-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQA 384
Query: 255 KRYLSSLRRKWAVPFSHKFPGADPXXXXXXXXXXXFDPKDRPSAEE 300
++++ ++ + V F++ FP A+P FDP R + EE
Sbjct: 385 RQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEE 430
|
|
| TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 733 (263.1 bits), Expect = 1.1e-80, Sum P(2) = 1.1e-80
Identities = 146/274 (53%), Positives = 187/274 (68%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
IG G+YG+V SA+++ T E VAIKK+ F++ DA R LREIKLLR + H +IV I+ I
Sbjct: 69 IGKGAYGIVCSAMNSETNESVAIKKIANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDI 128
Query: 82 MLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHR 141
+ PP R F D+Y+ +ELM++DL Q+I++N L+ EH Q+FLYQ+LR LKYIHSANV HR
Sbjct: 129 IPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR 188
Query: 142 DLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTP 201
DLKP N+L NA+C LKICDFGLARV T + F T+YV TRWYRAPEL + S YT
Sbjct: 189 DLKPSNLLLNANCDLKICDFGLARV----TSESDFMTEYVVTRWYRAPELLLNS-SDYTA 243
Query: 202 AIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSL 261
AID+WS+GCIF EL+ +PLFPGR+ HQL L+ +L+GTPS E + + NE AKRY+ L
Sbjct: 244 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELEFL-NENAKRYIRQL 302
Query: 262 RRKWAVPFSHKFPGADPXXXXXXXXXXXFDPKDR 295
+ KFP P FDP+ R
Sbjct: 303 PPYPRQSITDKFPTVHPLAIDLIEKMLTFDPRRR 336
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LV37 | MPK9_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7074 | 0.9367 | 0.9294 | no | no |
| Q5Z9J0 | MPK12_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7217 | 0.9367 | 0.8172 | yes | no |
| Q53N72 | MPK15_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7281 | 0.8221 | 0.8353 | no | no |
| Q84M93 | MPK17_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.6897 | 0.9466 | 0.9855 | yes | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.6842 | 0.9347 | 0.9347 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.991 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00030495001 | SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (516 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 506 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-175 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-149 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-137 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-129 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-118 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-114 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-105 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-100 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-96 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-96 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-90 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-88 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-87 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-84 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-83 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-83 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-80 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-79 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-79 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-77 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-76 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-76 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-73 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-70 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-70 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-66 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-66 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-65 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-64 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-63 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-62 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-62 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-62 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-61 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-59 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-59 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-58 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-57 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-57 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-56 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-55 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-55 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-55 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-55 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-55 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-54 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-52 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-52 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-51 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-46 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-45 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-44 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-43 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-42 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-41 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-40 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-39 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-36 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-34 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-33 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-14 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-04 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 680 bits (1757), Expect = 0.0
Identities = 292/356 (82%), Positives = 319/356 (89%), Gaps = 18/356 (5%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y+IQE+IG GSYGVV SAIDTHTGEKVAIKK+ +VFEHVSDATRILREIKLLR+L+HPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
IVEIKHIMLPP RREFKDIYVVFELMESDL QVIKANDDLTPEHHQFFLYQLLRALKYIH
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
+ANVFHRDLKPKNILANADCKLKICDFGLARV+F DTP+AIFWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254
FFSKYTPAIDIWSIGCIFAE+LTG+PLFPG+NV HQLDL+TDLLGTPS E+I+ +RNEKA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLY 314
+RYLSS+R+K VPFS KFP ADPLALRLL+RLLAFDPKDRP+AEE
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE-------------- 286
Query: 315 FYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370
ALADPYF GLA +E EPS +PI+KL FEFERR+L K+DVRELIYREILEYHP
Sbjct: 287 ----ALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 495 bits (1277), Expect = e-175
Identities = 186/349 (53%), Positives = 238/349 (68%), Gaps = 20/349 (5%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
YE+ + IG G+YGVV SA+D TG KVAIKK+ VF+ + DA RILREIKLLR L+H +I
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
+ + I+ PP +F D+Y+V ELME+DL +VIK+ LT +H Q+FLYQ+LR LKY+HS
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS 121
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
ANV HRDLKP NIL N++C LKICDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 122 ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS- 180
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255
S+YT AIDIWS+GCIFAELLT +PLFPGR+ QL+L+ ++LGTPS E + I +EKA+
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240
Query: 256 RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYF 315
YL SL +K P S FPGA P A+ LL+++L FDPK R +A+E
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE--------------- 285
Query: 316 YVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364
ALA PY L + E+EP KP F F+ +L +++++ELIY E
Sbjct: 286 ---ALAHPYLAQLHDPEDEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 429 bits (1105), Expect = e-149
Identities = 184/358 (51%), Positives = 242/358 (67%), Gaps = 26/358 (7%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
++Y + IG G+YG+V SA ++ T EKVAIKK+ F++ DA R LREIKLLR L H
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
+++ IK IM PP R F D+Y+V+ELM++DL Q+I+++ L+ +H Q+FLYQLLR LKYI
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
HSANV HRDLKP N+L NA+C LKICDFGLAR + F T+YV TRWYRAPEL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD---FMTEYVVTRWYRAPELLL 181
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253
+ S+YT AID+WS+GCIFAELL +PLFPG++ HQL L+T+LLG+PS E + IRNEK
Sbjct: 182 N-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFL 313
A+RY+ SL F+ FP A+PLA+ LL+++L FDP R + EE
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEE------------- 287
Query: 314 YFYVLALADPYFHGLANLEEEPS-RKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370
ALA PY L + +EP + P S F+FE L ++D++ELIY E+L YHP
Sbjct: 288 -----ALAHPYLASLHDPSDEPVCQTPFS---FDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 398 bits (1025), Expect = e-137
Identities = 167/355 (47%), Positives = 223/355 (62%), Gaps = 24/355 (6%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
+Y+ IG G+YG+V SA TG KVAIKK+ FEH + R LREIK+LR KH
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILRRFKH 62
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+I+ I I+ PP F D+Y+V ELME+DL ++IK L+ +H Q+FLYQ+LR LKY
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKY 121
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
IHSANV HRDLKP N+L N +C LKICDFGLAR++ + F T+YVATRWYRAPE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
+ YT AIDIWS+GCI AE+L+ RPLFPG++ HQL+L+ +LGTPS E + I +
Sbjct: 182 LNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLF 312
+A+ Y+ SL K VP++ FP ADP AL LL ++L F+P R + EE
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE------------ 288
Query: 313 LYFYVLALADPYFHGLANLEEEP-SRKPISKLVFEFERRKLIKDDVRELIYREIL 366
ALA PY + +EP + +P F+ L K+ ++ELI+ EI+
Sbjct: 289 ------ALAHPYLEQYHDPSDEPVAEEPFPFDFELFD--DLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 378 bits (973), Expect = e-129
Identities = 170/352 (48%), Positives = 234/352 (66%), Gaps = 23/352 (6%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
S+Y+ E IG G+YGVV SAIDT +G+KVAIKK+ F+ + A R LRE+K+LR KH
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
+I+ I+ I+ PP +FKD+YVV +LMESDL +I ++ LT EH ++FLYQLLR LKYI
Sbjct: 65 NIIAIRDILRPP-GADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLAR-VSFTDTPSAIFWTDYVATRWYRAPELC 192
HSANV HRDLKP N+L N DC+L+I DFG+AR +S + T F T+YVATRWYRAPEL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
S +YT AID+WS+GCIFAE+L R LFPG+N HQL L+ +LG+PS E + I ++
Sbjct: 184 LS-LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLF 312
+ ++Y+ +L RK VP+S FP A P AL LL ++L FDP++R + E+
Sbjct: 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ------------ 290
Query: 313 LYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364
AL P+ + ++EP+ P F+FE +L ++ ++E I +E
Sbjct: 291 ------ALQHPFLAQYHDPDDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 350 bits (901), Expect = e-118
Identities = 154/357 (43%), Positives = 211/357 (59%), Gaps = 31/357 (8%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-H 72
+YEI + +G G+YG+V AID T E VA+KK+ + F + +DA R REI L+ L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 73 PDIVEIKHIMLPPCRREF-KDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
P+IV++ +++ + E KDIY+VFE ME+DL VI+AN L H ++ +YQLL+ALK
Sbjct: 67 PNIVKLLNVI----KAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALK 121
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARV--SFTDTPSAIFWTDYVATRWYRAP 189
YIHS NV HRDLKP NIL N+DC++K+ DFGLAR + P TDYVATRWYRAP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 190 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
E L GS ++YT +D+WS+GCI E+L G+PLFPG + +QL+ + +++G PSAE I
Sbjct: 182 EILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVF 308
I++ A L SL + P P A AL LL++LL F+P R +AEE
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE-------- 291
Query: 309 NWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREI 365
AL PY N +EP + + + KL + R +Y EI
Sbjct: 292 ----------ALEHPYVAQFHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 340 bits (873), Expect = e-114
Identities = 151/364 (41%), Positives = 212/364 (58%), Gaps = 30/364 (8%)
Query: 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL 67
T + +Y+ +G G+YG V SA DT TG KVAIKK+ F+ A R RE++LL
Sbjct: 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 68 RMLKHPDIVEIKHIMLPPCRRE-FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQL 126
+ + H +++ + + P E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQI 127
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
LR LKYIHSA + HRDLKP NI N DC+LKI DFGLAR + + T YVATRWY
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWY 181
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
RAPE+ ++ Y +DIWS+GCI AELLTG+ LFPG + QL + +L+GTP E +
Sbjct: 182 RAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEI 306
I +E A+ Y+ SL + F F GA+PLA+ LL+++L DP R +A E
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE------ 294
Query: 307 VFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREIL 366
ALA PY + E+EP P + FE R L D+ +EL+Y+EI+
Sbjct: 295 ------------ALAHPYLAEYHDPEDEPVAPPYDQS---FESRDLTVDEWKELVYKEIM 339
Query: 367 EYHP 370
+ P
Sbjct: 340 NFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 317 bits (814), Expect = e-105
Identities = 160/355 (45%), Positives = 217/355 (61%), Gaps = 29/355 (8%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHT--GEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-H 72
YE+ + +G G+YG+V SA + T E VAIKK+ VF A R LRE+KLLR + H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+I + + M F ++Y+ ELME+DL Q+I++ LT H Q F+YQ+L LKY
Sbjct: 62 KNITCL-YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP--SAIFWTDYVATRWYRAPE 190
IHSANV HRDLKP N+L NADC+LKICDFGLAR F++ P +A F T+YVATRWYRAPE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYRAPE 179
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
+ S F YT AID+WS+GCI AELL +P+F G++ QL+ + +LGTP E+++ I
Sbjct: 180 IMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNW 310
+ KA+ Y+ SL PF FP A+PLAL LL++LLAFDP R S EE
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEE---------- 288
Query: 311 LFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREI 365
AL PY + ++EP + F FE + +++R++I E+
Sbjct: 289 --------ALEHPYLAIWHDPDDEPVCQ--KPFDFSFESEDSM-EELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 301 bits (773), Expect = e-100
Identities = 133/312 (42%), Positives = 175/312 (56%), Gaps = 31/312 (9%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
Y+ IG G+YGVV A D TGE VAIKK+K FE LREIKLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLRALKYIH 134
+++ + D+Y+VFE M++DL ++IK PE + +LYQLL+ L + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-LCG 193
S + HRDLKP+N+L N + LK+ DFGLAR + +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---PYTHYVVTRWYRAPELLLG 172
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253
Y+ +DIWS+GCIFAELL+ RPLFPG++ QL + LGTP E +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-L 229
Query: 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFL 313
A+ Y S +K +P FP A P AL LL ++L +DP R +AE+
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ------------- 276
Query: 314 YFYVLALADPYF 325
ALA PYF
Sbjct: 277 -----ALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 292 bits (750), Expect = 2e-96
Identities = 126/314 (40%), Positives = 173/314 (55%), Gaps = 36/314 (11%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRMLKHP 73
YE E +G G+YGVV A D TGE VA+KK++ ++ + LREI LL+ LKHP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHP 58
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKY 132
+IV++ ++ + +Y+VFE + DL + + L+P + +YQLLR L Y
Sbjct: 59 NIVKLLDVIH-----TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-L 191
HS + HRDLKP+NIL N D LK+ DFGLAR +F P + T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AFG-IPLRTY-THEVVTLWYRAPEIL 170
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
GS Y+ A+DIWS+GCIFAE++TG+PLFPG + QL + +LGTP+ ES G+
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWL 311
K Y + + P DP + LL ++L ++P R SA+E
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE----------- 275
Query: 312 FLYFYVLALADPYF 325
AL PYF
Sbjct: 276 -------ALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 292 bits (750), Expect = 9e-96
Identities = 151/364 (41%), Positives = 218/364 (59%), Gaps = 42/364 (11%)
Query: 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIK 65
F T + ++Y + +G+G++G+V SA D TG+ VAIKK+ + F A R RE+K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 66 LLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQ 125
LL+ L+H +I+ + I + P +DIY V EL+ +DL +++ + L + Q+FLYQ
Sbjct: 62 LLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQ 116
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW 185
+LR LKY+HSA V HRDLKP NIL N +C LKICDFGLAR+ T YV+TR+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM------TGYVSTRY 170
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
YRAPE+ ++ KY +DIWS GCIFAE+L G+PLFPG++ +Q ++TDLLGTP +
Sbjct: 171 YRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305
I I +E R++ SL ++ VPFS KF ADP A+ LL+++L FDP+ R SA E
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE----- 284
Query: 306 IVFNWLFLYFYVLALADPY---FHGLANLEEEPSRKPISKLVFE--FERRKLIKDDVREL 360
ALA PY +H +P+ +P+++ F+ F L D + +
Sbjct: 285 -------------ALAHPYLAPYH-------DPTDEPVAEEKFDWSFNDADLPVDTWKVM 324
Query: 361 IYRE 364
+Y E
Sbjct: 325 MYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 1e-90
Identities = 148/373 (39%), Positives = 206/373 (55%), Gaps = 52/373 (13%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
IG G++GVV S D G++VA+KKM VF+++ R+ RE+K+L KH +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 82 MLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHR 141
+ PP F++IYVV ELM+SDL ++I + L+ +H + FLYQ+LR LKY+HSA + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 142 DLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-LCGSFFSKYT 200
D+KP N+L N++C LKICDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 201 PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSS 260
A+DIWS+GCIFAELL R LF ++ QLDL+TDLLGTPS E++ E A+ ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHI-- 240
Query: 261 LRRKWAVP-FSHKFPGADPL---ALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFY 316
LR P + + A+ LL R+L FDP R SA +
Sbjct: 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD---------------- 284
Query: 317 VLALADPY-------FHG-------------LANLEEEPSRKPISKLVFEFERRKLIKDD 356
ALA PY +H + + EPS P E+E+
Sbjct: 285 --ALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFD--DEYEKNLTSVRQ 340
Query: 357 VRELIYREILEYH 369
V+E +++ ILE
Sbjct: 341 VKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 271 bits (695), Expect = 5e-88
Identities = 118/294 (40%), Positives = 164/294 (55%), Gaps = 23/294 (7%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
YE IG G+YG V A + TGE VA+KK++ E +REIKLL+ L+HP+I
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDLDQVI-KANDDLTPEHHQFFLYQLLRALKYIH 134
V +K I+ + IY+VFE M+ DL ++ T + ++ QLL L+Y+H
Sbjct: 61 VRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-LCG 193
S + HRD+K NIL N D LK+ DFGLAR +T SA + T+ V T WYR PE L G
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELLLG 175
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN-- 251
+ ++Y P +D+WS+GCI AEL G+P+F G QL+ + +L G+P+ E+ G+
Sbjct: 176 A--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233
Query: 252 -----EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ K Y LR F H DP AL LL +LL DPK R SA++
Sbjct: 234 WFENLKPKKPYKRRLREF----FKHLI---DPSALDLLDKLLTLDPKKRISADQ 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 271 bits (694), Expect = 3e-87
Identities = 146/357 (40%), Positives = 213/357 (59%), Gaps = 30/357 (8%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y+ +G G+YG V +A DT TG +VA+KK+ F+ + A R RE++LL+ +KH +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 75 IVEIKHIMLPPCR-REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
++ + + P EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LR LKYI
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
HSA++ HRDLKP N+ N DC+LKI DFGLAR + + T YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 190
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253
++ Y +DIWS+GCI AELLTGR LFPG + QL L+ L+GTP AE + I +E
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFL 313
A+ Y+ SL + + F++ F GA+PLA+ LL+++L D R +A +
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ------------- 296
Query: 314 YFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370
ALA YF + ++EP P + FE R L+ D+ + L Y E++ + P
Sbjct: 297 -----ALAHAYFAQYHDPDDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 260 bits (666), Expect = 9e-84
Identities = 113/293 (38%), Positives = 165/293 (56%), Gaps = 23/293 (7%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPD 74
Y++ + +G G++G V A + TGE VAIKKMK+ F + LRE+K LR L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDD--LTPEHHQFFLYQLLRALKY 132
IV++K + RE ++Y VFE ME +L Q++K + + +YQ+L+ L +
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL- 191
IH FHRDLKP+N+L + +KI DFGLAR + P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 192 --CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES-IAG 248
S Y+ +DIW++GCI AEL T RPLFPG + QL + +LGTP+ + G
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ + + P A P A+ L++ +L +DPK RP+A +
Sbjct: 227 YKLASKLGF--RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 261 bits (667), Expect = 4e-83
Identities = 140/350 (40%), Positives = 203/350 (58%), Gaps = 30/350 (8%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
+G G+YG V SA DT +KVA+KK+ F+ + A R RE++LL+ +KH +++ + +
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 82 MLPPCRRE-FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFH 140
P E F ++Y+V LM +DL+ ++K L+ EH QF +YQLLR LKYIHSA + H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYIHSAGIIH 141
Query: 141 RDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYT 200
RDLKP N+ N DC+L+I DFGLAR + + T YVATRWYRAPE+ ++ Y
Sbjct: 142 RDLKPSNVAVNEDCELRILDFGLARQADDEM------TGYVATRWYRAPEIMLNWM-HYN 194
Query: 201 PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSS 260
+DIWS+GCI AELL G+ LFPG + QL + +++GTPS E + I +E A++Y+ S
Sbjct: 195 QTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQS 254
Query: 261 LRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320
L F GA+PLA+ LL+++L D R SA E AL
Sbjct: 255 LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE------------------AL 296
Query: 321 ADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370
A PYF + E+EP +P + E ++ ++ +EL Y E+ + P
Sbjct: 297 AHPYFSQYHDPEDEPEAEPYDESP---ENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 7e-83
Identities = 108/287 (37%), Positives = 147/287 (51%), Gaps = 40/287 (13%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
YEI E +G GS+G V A D TG+ VAIK +K+ D RILREIK+L+ LKHP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 76 VEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V + + +Y+V E E DL ++K L+ + +F+L Q+L AL+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
S + HRDLKP+NIL + D +K+ DFGLAR T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKL---TTFVGTPEYMAPEVLLG 170
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254
Y A+DIWS+G I ELLTG+P FPG + QL + +G P
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPK------------ 213
Query: 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
PF P A L+++LL DP+ R +AEE
Sbjct: 214 ------------PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 3e-80
Identities = 132/350 (37%), Positives = 194/350 (55%), Gaps = 31/350 (8%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
+G G+YG V SAID TGEKVAIKK+ F+ A R RE+ LL+ ++H +++ + +
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 82 MLP-PCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFH 140
EF+D Y+V M++DL +++ L+ + Q+ +YQ+L LKYIHSA + H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIH 140
Query: 141 RDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYT 200
RDLKP N+ N DC+LKI DFGLAR + + T YV TRWYRAPE+ ++ Y
Sbjct: 141 RDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTRWYRAPEVILNWM-HYN 193
Query: 201 PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSS 260
+DIWS+GCI AE+LTG+ LF G++ QL + + G P E + + ++ AK Y+ S
Sbjct: 194 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS 253
Query: 261 LRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320
L + FS FP A P A+ LL+++L D R +A E AL
Sbjct: 254 LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATE------------------AL 295
Query: 321 ADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370
PYF + +EE ++P E KL D+ ++ IY+E+ + P
Sbjct: 296 EHPYFDSFRDADEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 1e-79
Identities = 127/318 (39%), Positives = 164/318 (51%), Gaps = 38/318 (11%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRI--LREIKLLRMLK 71
+YE + +G G+Y VV A D TG VAIKK+K + D LREIKLL+ LK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRAL 130
HP+I+ L +I +VFE ME+DL++VIK LTP + ++ LR L
Sbjct: 61 HPNIIG-----LLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
+Y+HS + HRDLKP N+L +D LK+ DFGLAR SF P+ T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRAPE 172
Query: 191 LCGSFF--SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
L F Y +D+WS+GCIFAELL P PG + QL + + LGTP+ E+ G
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVF 308
+ Y+ P FP A AL LLQRLL +P R +A +
Sbjct: 230 VT--SLPDYVEFKPFP-PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ-------- 278
Query: 309 NWLFLYFYVLALADPYFH 326
AL PYF
Sbjct: 279 ----------ALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 1e-79
Identities = 135/372 (36%), Positives = 207/372 (55%), Gaps = 36/372 (9%)
Query: 6 FFTEYGEASQYEIQEI------IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR 59
++ + + +E+ + +G G+YG V SA+D TG KVAIKK+ F+ A R
Sbjct: 1 YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 60 ILREIKLLRMLKHPDIVEIKHIMLPPCRRE-FKDIYVVFELMESDLDQVIKANDDLTPEH 118
RE++LL+ +KH +++ + + P + F D Y+V M +DL +++K ++ L+ +
Sbjct: 61 AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDR 119
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT 178
QF +YQ+L+ LKYIH+A + HRDLKP N+ N DC+LKI DFGLAR + ++ T
Sbjct: 120 IQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------T 173
Query: 179 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238
YV TRWYRAPE+ ++ YT +DIWS+GCI AE+LTG+PLF G + QL + +
Sbjct: 174 GYVVTRWYRAPEVILNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
GTPS E + +++E AK Y+ L R F P A+PLA+ +L+++L D + R +A
Sbjct: 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA 292
Query: 299 EEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVR 358
E ALA PYF + E+E P F+ ++ +
Sbjct: 293 AE------------------ALAHPYFEEFHDPEDETEAPPYDD---SFDEVDQSLEEWK 331
Query: 359 ELIYREILEYHP 370
L + EIL + P
Sbjct: 332 RLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 6e-77
Identities = 117/298 (39%), Positives = 165/298 (55%), Gaps = 32/298 (10%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM--KEVFEHVSDATRILREIKLLRMLKH 72
+Y+I IG G++G+V A D TGE VA+KK+ + + + + LREIK L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI--PNQALREIKALQACQH 58
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDD-LTPEHHQFFLYQLLRALK 131
P +V++ + +V E M SDL +V++ + L + ++ LL+ +
Sbjct: 59 PYVVKLLDVF-----PHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
Y+H+ + HRDLKP N+L +AD LKI DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPEL 171
Query: 192 C-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
G+ KY P +D+W++GCIFAELL G PLFPG N QL +V LGTP+ E+ G+
Sbjct: 172 LYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 251 NEKAKRYLSSLRRKWAVPFSHK--------FPGADPLALRLLQRLLAFDPKDRPSAEE 300
SL + F FP A P AL LL+ LL +DP R SA E
Sbjct: 230 ---------SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 1e-76
Identities = 117/296 (39%), Positives = 164/296 (55%), Gaps = 28/296 (9%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
YE+ ++G G+YGVV + TGE VAIKK KE + LRE+K+LR L+H +I
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDD-LTPEHHQFFLYQLLRALKYIH 134
V +K RR+ + +Y+VFE +E L ++++A+ L P+ + +++QLL+A+ Y H
Sbjct: 63 VNLKEA----FRRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-LCG 193
S N+ HRD+KP+NIL + LK+CDFG AR A TDYVATRWYRAPE L G
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLVG 175
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT-PSAESIAGIRNE 252
+ Y +D+W+IGCI AELL G PLFPG + QL L+ LG P +
Sbjct: 176 D--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH---QELFS 230
Query: 253 KAKRYLSSLRRKWAVP-------FSHKFPGA-DPLALRLLQRLLAFDPKDRPSAEE 300
R+ A P ++PG AL L+ L DPK+R + +E
Sbjct: 231 SNPRF-----AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 8e-76
Identities = 97/287 (33%), Positives = 140/287 (48%), Gaps = 34/287 (11%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
YE+ +G GS+G V A TG+ VA+K +K+ E REI++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 76 VEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V + + +Y+V E E DL + L+ + + Q+LR L+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
S + HRDLKP+NIL + + +KI DFGLA+ + S T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254
+ Y P +D+WS+G I ELLTG+P F G N+ QL + I I
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL------------QLIRRI----- 214
Query: 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
L G++ A L+++ L DP RP+AEEI
Sbjct: 215 ------LGPPLEFDEPKWSSGSEE-AKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 1e-73
Identities = 127/370 (34%), Positives = 194/370 (52%), Gaps = 50/370 (13%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+Y+ + IG G+ G+V +A DT TG+ VAIKK+ F++V+ A R RE+ L++++ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 74 DIVEIKHIMLPPCR-REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+I+ + ++ P EF+D+Y+V ELM+++L QVI DL E + LYQ+L +K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+HSA + HRDLKP NI+ +DC LKI DFGLAR + T T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVI 189
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
Y +DIWS+GCI E++ G LFPG + Q + + + LGTPS E ++ +
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPL---------------ALRLLQRLLAFDPKDRPS 297
+ Y+ + + F FP D L A LL ++L DP+ R S
Sbjct: 247 TVRNYVENRPKYAGYSFEELFP--DVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304
Query: 298 AEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEE--EPSRKPISKLVFEFERRKLIKD 355
++ AL PY + + E P P + R+ +
Sbjct: 305 VDD------------------ALQHPYINVWYDPSEVEAPPPAPYDH---SIDEREHTVE 343
Query: 356 DVRELIYREI 365
+ +ELIY+E+
Sbjct: 344 EWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 1e-70
Identities = 128/350 (36%), Positives = 184/350 (52%), Gaps = 61/350 (17%)
Query: 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI---LREIKL 66
+ S+Y +G GS G+V SA+D+ ++VA+KK+ ++D + LREIK+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 67 LRMLKHPDIVEIKHIMLPPCRR---------EFKDIYVVFELMESDLDQVIKANDDLTPE 117
+R L H +IV++ ++ P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 118 HHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLARVSFTDTPSAIF 176
H + F+YQLLR LKYIHSANV HRDLKP N+ N D LKI DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD 236
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTG+PLF G AH+L+ +
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAG---AHELEQMQL 230
Query: 237 LLGTPSAESIAGIRNE-----------KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQ 285
+L ES+ +R E + RR P PG +P AL L+
Sbjct: 231 IL-----ESVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPGVNPEALDFLE 281
Query: 286 RLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEP 335
++L F+P DR +AEE AL PY + +EP
Sbjct: 282 QILTFNPMDRLTAEE------------------ALMHPYMSCYSCPFDEP 313
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 2e-70
Identities = 121/322 (37%), Positives = 165/322 (51%), Gaps = 47/322 (14%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRMLKHP 73
YE I G+YGVV A D TGE VA+KK+K E + I LREI +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHP 64
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKY 132
+IV +K +++ IY+V E +E DL +++ + + QLL + +
Sbjct: 65 NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-L 191
+H + HRDLK N+L N LKICDFGLAR + +T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELL 178
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE------S 245
G+ +Y+ AID+WS+GCIFAELLT +PLFPG++ QL+ + LLGTP+ +
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFP--GADPLALRLLQRLLAFDPKDRPSAEEIRF 303
+ G + + +Y + RK KFP LL RLL +DP R SAE+
Sbjct: 237 LPGAKKKTFTKYPYNQLRK-------KFPALSLSDNGFDLLNRLLTYDPAKRISAED--- 286
Query: 304 TEIVFNWLFLYFYVLALADPYF 325
AL PYF
Sbjct: 287 ---------------ALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 2e-66
Identities = 118/295 (40%), Positives = 167/295 (56%), Gaps = 23/295 (7%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRMLK 71
+++E IG G+YG+V A DT +GE VA+KK++ ++ D I LREI LL L+
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLR 64
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLRAL 130
HP+IVE+K +++ + I++V E E DL ++ E + + QLLR L
Sbjct: 65 HPNIVELKEVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGL 121
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
+Y+H + HRDLK N+L LKI DFGLAR + + T V T WYRAPE
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTLWYRAPE 178
Query: 191 -LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
L G + YT AID+W++GCI AELL +PL PG++ QLDL+ LLGTP+ G
Sbjct: 179 LLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236
Query: 250 RN-EKAKRYLSSLRRKWAVPFS---HKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ ++ +L ++ P++ HKFP LRLL LL +DPK R +AEE
Sbjct: 237 SDLPLVGKF--TLPKQ---PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 5e-66
Identities = 112/337 (33%), Positives = 162/337 (48%), Gaps = 58/337 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-----KEVFEHVSDATRILREIKLLR 68
YEI +G G++G V A TG VA+KK+ K+ F ++ LREIK+L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-PIT----ALREIKILK 62
Query: 69 MLKHPDIVEIKHIML---PPCRREFKDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLY 124
LKHP++V + + + +R+ +Y+V M+ DL +++ LT + ++
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP--------SAIF 176
QLL + Y+H ++ HRD+K NIL + LKI DFGLAR P
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 177 WTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVT 235
+T+ V TRWYR PEL G +YT A+DIW IGC+FAE+ T RP+ G++ QL L+
Sbjct: 183 YTNLVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240
Query: 236 DLLGTPSAESIAGIR-------NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLL 288
L GTP+ E+ G R Y +L +F P L LL +LL
Sbjct: 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--------RFGKLGPEGLDLLSKLL 292
Query: 289 AFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325
+ DP R +A + AL PYF
Sbjct: 293 SLDPYKRLTASD------------------ALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-65
Identities = 121/317 (38%), Positives = 159/317 (50%), Gaps = 37/317 (11%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK---H 72
YE IG G+YG V A D +TG VA+KK++ LREI LL+ L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIK--ANDDLTPEHHQFFLYQLLRAL 130
P+IV + + P + +VFE ++ DL + L PE + + QLLR +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARV-SFTDTPSAIFWTDYVATRWYRAP 189
++HS + HRDLKP+NIL +D ++KI DFGLAR+ SF A+ T V T WYRAP
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MAL--TSVVVTLWYRAP 175
Query: 190 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
E L S Y +D+WS+GCIFAEL RPLF G + A QLD + D++G PS E
Sbjct: 176 EVLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP- 231
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVF 308
RN R SS F P L LL+++L F+P R SA E
Sbjct: 232 -RNVSLPR--SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE-------- 280
Query: 309 NWLFLYFYVLALADPYF 325
AL PYF
Sbjct: 281 ----------ALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 6e-64
Identities = 118/315 (37%), Positives = 167/315 (53%), Gaps = 35/315 (11%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
++ E +G G+Y V + TGE VA+K++ E + +T I REI L++ LKH +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKHEN 59
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDD---LTPEHHQFFLYQLLRALK 131
IV + ++ E K + +VFE M+ DL + + + L P + F YQLL+ +
Sbjct: 60 IVRLHDVI----HTENK-LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE- 190
+ H V HRDLKP+N+L N +LK+ DFGLAR +F P F + V T WYRAP+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AF-GIPVNTFSNE-VVTLWYRAPDV 171
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
L GS Y+ +IDIWS+GCI AE++TGRPLFPG N QL + ++GTP+ + GI
Sbjct: 172 LLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNW 310
Y + R FP ADPL + LL RLL +P+ R SA +
Sbjct: 230 Q--LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD---------- 277
Query: 311 LFLYFYVLALADPYF 325
AL P+F
Sbjct: 278 --------ALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 6e-63
Identities = 115/291 (39%), Positives = 165/291 (56%), Gaps = 16/291 (5%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+YE IG GSYGVV + TG+ VAIKK E + LREI++L+ LKHP+
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPN 61
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLRALKYI 133
+V + + RR+ K +++VFE + + ++ N PEH + ++Q L+A+ +
Sbjct: 62 LVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL-C 192
H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAPEL
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAPELLV 173
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG--TPSAESIAGIR 250
G ++Y P +D+W+IGC+FAELLTG+PL+PG++ QL L+ LG P + I
Sbjct: 174 GD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI--FS 229
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ + LS + P KFP AL L+ L DP +R S EE+
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 2e-62
Identities = 121/316 (38%), Positives = 164/316 (51%), Gaps = 39/316 (12%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSD---ATRILREIKLLRMLKH 72
Y+ E IG G+YGVV A D TGE VA+KK++ E + +T I REI LL+ L H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAI-REISLLKELNH 57
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVI--KANDDLTPEHHQFFLYQLLRAL 130
P+IV + ++ +Y+VFE ++ DL + + L P + +LYQLL+ +
Sbjct: 58 PNIVRLLDVV-----HSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
Y HS V HRDLKP+N+L + + LK+ DFGLAR +F P + T V T WYRAPE
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AF-GVPVRTY-THEVVTLWYRAPE 169
Query: 191 -LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
L GS Y+ +DIWSIGCIFAE++ RPLFPG + QL + LGTP + G+
Sbjct: 170 ILLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227
Query: 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFN 309
Y + + S P D L LL ++L +DP R SA+
Sbjct: 228 --TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA--------- 276
Query: 310 WLFLYFYVLALADPYF 325
AL PYF
Sbjct: 277 ---------ALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 2e-62
Identities = 108/289 (37%), Positives = 166/289 (57%), Gaps = 18/289 (6%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPD 74
Y+I IG G++ V A TG+ AIK MK+ F+ + LREI+ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLRALKYI 133
I+ + ++ R+ + +VFELM+ +L ++IK PE + ++YQLL++L ++
Sbjct: 60 ILRLIEVLF---DRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE--L 191
H +FHRD+KP+NIL D LK+ DFG R ++ P +T+Y++TRWYRAPE L
Sbjct: 117 HRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYRAPECLL 171
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
+ Y P +DIW++GC+F E+L+ PLFPG N Q+ + D+LGTP AE + R
Sbjct: 172 TDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ Y ++ P A L LL++LLA+DP +R +A++
Sbjct: 229 SRHMNYNFPSKK--GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ 275
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 6e-62
Identities = 117/345 (33%), Positives = 160/345 (46%), Gaps = 63/345 (18%)
Query: 15 QYEIQEIIGIGSYGVV--ASAIDTHTGEKVAIKKMKEVFEH---VSDATRILREIKLLRM 69
+YEI+ IG G+YG V A + G++ AIKK K E +S + REI LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQF-------F 122
LKH ++V + + L + +Y++F+ E DL Q+IK +
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIK--FHRQAKRVSIPPSMVKSL 113
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCK----LKICDFGLARVSFTDTPSAIFWT 178
L+Q+L + Y+HS V HRDLKP NIL + +KI D GLAR + P
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLAD 171
Query: 179 D--YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV-------- 227
V T WYRAPEL G+ YT AIDIW+IGCIFAELLT P+F GR
Sbjct: 172 LDPVVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229
Query: 228 -AHQLDLVTDLLGTPSAESIAGIRN--EKAKRYLSSLRRKWA----VPFSHKFPGADPLA 280
QL+ + ++LGTP+ + I+ E + + + K D
Sbjct: 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG 289
Query: 281 LRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325
LL++LL +DP R +AEE AL PYF
Sbjct: 290 FDLLRKLLEYDPTKRITAEE------------------ALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 2e-61
Identities = 127/367 (34%), Positives = 194/367 (52%), Gaps = 43/367 (11%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y+ + IG G+ G+V +A DT G VA+KK+ F++ + A R RE+ LL+ + H +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 75 IVEIKHIMLP-PCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
I+ + ++ P EF+D+Y+V ELM+++L QVI +L E + LYQ+L +K++
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHL 139
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
HSA + HRDLKP NI+ +DC LKI DFGLAR + T+ T YV TR+YRAPE+
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN----FMMTPYVVTRYYRAPEVIL 195
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253
Y +DIWS+GCI EL+ G +F G + Q + V + LGTPSAE + ++
Sbjct: 196 GM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PT 252
Query: 254 AKRYLSSLRRKWAVPFSHKFPG--------ADPL----ALRLLQRLLAFDPKDRPSAEEI 301
+ Y+ + + + F FP D L A LL ++L DP R S +E
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE- 311
Query: 302 RFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKP-ISKLVFEFERRKLIKDDVREL 360
AL PY + E + P I + E R+ ++ +EL
Sbjct: 312 -----------------ALRHPYITVWYDPAEAEAPPPQIYDA--QLEEREHAIEEWKEL 352
Query: 361 IYREILE 367
IY+E+++
Sbjct: 353 IYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-59
Identities = 112/298 (37%), Positives = 168/298 (56%), Gaps = 30/298 (10%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+YE ++G GSYG+V TG+ VAIKK E + +REI++L+ L+H +
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
+V ++ RR+ K +Y+VFE ++ LD + K + L + +L+Q+LR +++
Sbjct: 62 LVN----LIEVFRRK-KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL-C 192
HS N+ HRD+KP+NIL + +K+CDFG AR P ++ TDYVATRWYRAPEL
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATRWYRAPELLV 173
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT--PSAESI---- 246
G +KY A+DIW++GC+ E+LTG PLFPG + QL + LG P + I
Sbjct: 174 GD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 247 ---AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
AG+R + K + L + +FP L L L ++ L DP DRPS+ ++
Sbjct: 232 PLFAGMRLPEVKE-IEPLEK--------RFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 2e-59
Identities = 114/312 (36%), Positives = 155/312 (49%), Gaps = 52/312 (16%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR-------------ILREIKLLR 68
+G G+YG V A DT TG+ VAIKK+K + E +D T+ LRE+K++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLR 128
+KH +I+ + + +F I +V ++M SDL +V+ LT + L Q+L
Sbjct: 76 EIKHENIMGLVDVY---VEGDF--INLVMDIMASDLKKVVDRKIRLTESQVKCILLQILN 130
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR-----VSFTDTPSAIF------W 177
L +H HRDL P NI N+ KI DFGLAR
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 178 TDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD 236
T V T WYRAPEL G+ KY A+D+WS+GCIFAELLTG+PLFPG N QL + +
Sbjct: 191 TSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248
Query: 237 LLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHK--------FPGADPLALRLLQRLL 288
LLGTP+ + N + L F+ + FP A A+ LLQ LL
Sbjct: 249 LLGTPNED------NWPQAKKLPLY-----TEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297
Query: 289 AFDPKDRPSAEE 300
+P +R SA+E
Sbjct: 298 KLNPLERISAKE 309
|
Length = 335 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 2e-58
Identities = 114/289 (39%), Positives = 160/289 (55%), Gaps = 15/289 (5%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+YE E IG G+YG V A + T E VA+K+++ + + LREI LL+ LKH +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYI 133
IV + ++ K + +VFE + DL + + N D+ PE + F++QLL+ L +
Sbjct: 61 IVRLYDVLHSD-----KKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-LC 192
HS NV HRDLKP+N+L N + +LK+ DFGLAR +F P + + V T WYR P+ L
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AF-GIPVRCYSAE-VVTLWYRPPDVLF 172
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
G+ Y+ +ID+WS GCIFAEL GRPLFPG +V QL + LLGTP+ ES G+
Sbjct: 173 GA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ + P + LLQ LL +P R SAEE
Sbjct: 231 LPDYKPYPMYPA--TTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 3e-57
Identities = 110/297 (37%), Positives = 163/297 (54%), Gaps = 19/297 (6%)
Query: 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM 69
+G+ Y+ + +G GSY V TG+ VA+K+++ E + T I RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKD 59
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVI-KANDDLTPEHHQFFLYQLLR 128
LKH +IV + I+ K + +VFE +++DL Q + L+ + + FL+QLLR
Sbjct: 60 LKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
L Y H V HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAK--SVPSKTY-SNEVVTLWYRP 171
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG-RNVAHQLDLVTDLLGTPSAESI 246
P+ L GS ++Y+ ++D+W +GCIF E+ TGRPLFPG +V QL + +LGTP+ E+
Sbjct: 172 PDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 247 AGI-RNEKAKRYLSSLRRKWAVPFSHKFP--GADPLALRLLQRLLAFDPKDRPSAEE 300
G+ N + K Y S P + P P L + L ++PK R SA E
Sbjct: 230 PGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 8e-57
Identities = 112/288 (38%), Positives = 156/288 (54%), Gaps = 25/288 (8%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
E IG G+YGVV A + TGE VA+KK++ E + +REI LL+ L HP+IV++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 80 HIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH------QFFLYQLLRALKYI 133
++ +Y+VFE + DL + + D +P + +L+QLL+ L +
Sbjct: 66 DVI-----HTENKLYLVFEFLHQDLKKFM----DASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-LC 192
HS V HRDLKP+N+L N + +K+ DFGLAR + +T V T WYRAPE L
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPEILL 173
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
G + Y+ A+DIWS+GCIFAE++T R LFPG + QL + LGTP G+
Sbjct: 174 GCKY--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV--T 229
Query: 253 KAKRYLSSLRRKWAV-PFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299
Y S KWA FS P D LL ++L +DP R SA+
Sbjct: 230 SLPDYKPSF-PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 7e-56
Identities = 109/307 (35%), Positives = 147/307 (47%), Gaps = 31/307 (10%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-----KEVFEHVSDATRILREIKL 66
E S+YE IG G++G V A T + VA+KK+ KE F + LREIK+
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA-----LREIKI 64
Query: 67 LRMLKHPDIVEIKHIMLPPCRRE------FK-DIYVVFELMESDLDQVIK-ANDDLTPEH 118
L++LKH ++V + I CR + +K Y+VFE E DL ++ N T
Sbjct: 65 LQLLKHENVVNLIEI----CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV-SFTDTPSAIFW 177
+ + LL L YIH + HRD+K NIL D LK+ DFGLAR S + +
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 178 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD 236
T+ V T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL L++
Sbjct: 181 TNRVVTLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238
Query: 237 LLGTPSAESIAGIRN---EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPK 293
L G+ + E G+ K +RK DP AL L+ +LL DP
Sbjct: 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV--KDPHALDLIDKLLVLDPA 296
Query: 294 DRPSAEE 300
R A+
Sbjct: 297 KRIDADT 303
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-55
Identities = 109/298 (36%), Positives = 155/298 (52%), Gaps = 24/298 (8%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
++I IG G+YG V A D TGE VA+KK++ E +REIK+LR L H +I
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 76 VEIKHIMLPPC-----RREFKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRA 129
V +K I+ +++ Y+VFE M+ DL ++++ + +H + F+ QLL
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
L Y H N HRD+K NIL N ++K+ DFGLAR+ ++ +T+ V T WYR P
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYRPP 186
Query: 190 ELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT------PS 242
EL G +Y PAID+WS GCI EL T +P+F QL+L++ L G+ P
Sbjct: 187 ELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ K K+ RR+ FS P AL LL +L DP R +AEE
Sbjct: 245 VIKLPYFNTMKPKK---QYRRRLREEFSF-IP---TPALDLLDHMLTLDPSKRCTAEE 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 4e-55
Identities = 114/325 (35%), Positives = 160/325 (49%), Gaps = 48/325 (14%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH-PD 74
YE E IG G+YG V A D +TG+ VA+KK + + LREI LL+ML
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKAN-----DDLTPEHHQFFLYQLLRA 129
IV + + + +Y+VFE ++SDL + + +N L + + F+YQLL+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 130 LKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
+ + H V HRDLKP+N+L + LKI D GL R +F+ + +T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKS--YTHEIVTLWYRA 179
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG + QL + LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 248 GIRNEKAKRYLSSLRRKWAV-------PFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
G+ R W S P P L LLQ++L +DP R SA+
Sbjct: 238 GVSK----------LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287
Query: 301 IRFTEIVFNWLFLYFYVLALADPYF 325
AL PYF
Sbjct: 288 ------------------ALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 5e-55
Identities = 127/388 (32%), Positives = 202/388 (52%), Gaps = 53/388 (13%)
Query: 3 DKEFFT-EYGEAS-----QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSD 56
D F++ E G+++ +Y+ + IG G+ G+V +A D VAIKK+ F++ +
Sbjct: 7 DNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH 66
Query: 57 ATRILREIKLLRMLKHPDIVEIKHIMLP-PCRREFKDIYVVFELMESDLDQVIKANDDLT 115
A R RE+ L++ + H +I+ + ++ P EF+D+Y+V ELM+++L QVI+ +L
Sbjct: 67 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELD 124
Query: 116 PEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175
E + LYQ+L +K++HSA + HRDLKP NI+ +DC LKI DFGLAR + T +
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SF 180
Query: 176 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVT 235
T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + Q + V
Sbjct: 181 MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPG----AD--------PLALRL 283
+ LGTP E + ++ + Y+ + + F FP AD A L
Sbjct: 239 EQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 297
Query: 284 LQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY---FHGLANLEEEPSRKPI 340
L ++L D R S +E AL PY ++ + E P + P
Sbjct: 298 LSKMLVIDASKRISVDE------------------ALQHPYINVWYDPSEAEAPPPKIPD 339
Query: 341 SKLVFEFERRKLIKDDVRELIYREILEY 368
+L + R+ ++ +ELIY+E+++
Sbjct: 340 KQL----DEREHTIEEWKELIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 5e-55
Identities = 122/368 (33%), Positives = 194/368 (52%), Gaps = 47/368 (12%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y+ + IG G+ G+V +A D VAIKK+ F++ + A R RE+ L++ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 75 IVEIKHIMLP-PCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
I+ + ++ P EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L +K++
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHL 135
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
HSA + HRDLKP NI+ +DC LKI DFGLAR + T + T YV TR+YRAPE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVVTRYYRAPEVIL 191
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253
Y +DIWS+GCI E++ + LFPGR+ Q + V + LGTP E + ++
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248
Query: 254 AKRYLSSLRRKWAVPFSHKFPGA------------DPLALRLLQRLLAFDPKDRPSAEEI 301
+ Y+ + + + F FP + A LL ++L DP R S +E
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE- 307
Query: 302 RFTEIVFNWLFLYFYVLALADPY---FHGLANLEEEPSRKPISKLVFEFERRKLIKDDVR 358
AL PY ++ A +E P + +L + R+ ++ +
Sbjct: 308 -----------------ALQHPYINVWYDPAEVEAPPPQIYDKQL----DEREHTIEEWK 346
Query: 359 ELIYREIL 366
ELIY+E++
Sbjct: 347 ELIYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 9e-55
Identities = 108/292 (36%), Positives = 163/292 (55%), Gaps = 20/292 (6%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLKHPD 74
Y E IG G+YGVV + TG+ VA+KK++ E E +T I REI LL+ L+HP+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-REISLLKELQHPN 60
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQ---VIKANDDLTPEHHQFFLYQLLRALK 131
IV ++ +++ R +Y++FE + DL + + + E + +LYQ+L+ +
Sbjct: 61 IVCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE- 190
+ HS V HRDLKP+N+L + +K+ DFGLAR +F P ++ T V T WYRAPE
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AF-GIPVRVY-THEVVTLWYRAPEV 172
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
L GS +Y+ +DIWSIG IFAE+ T +PLF G + QL + +LGTP+ + G+
Sbjct: 173 LLGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV- 229
Query: 251 NEKAKRYLSSLRRKWAVPF-SHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
Y ++ KW D L LL+++L +DP R SA++
Sbjct: 230 -TSLPDYKNTF-PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 2e-54
Identities = 109/288 (37%), Positives = 163/288 (56%), Gaps = 16/288 (5%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
QYE E IG G+YGVV A D T E +A+KK++ E + +REI LL+ ++H +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH--QFFLYQLLRALKY 132
IV ++ ++ K +Y+VFE ++ DL + + ++ D + +LYQ+LR + Y
Sbjct: 63 IVRLQDVV-----HSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 133 IHSANVFHRDLKPKNILANADCK-LKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE- 190
HS V HRDLKP+N+L + LK+ DFGLAR +F P F T V T WYRAPE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AF-GIPVRTF-THEVVTLWYRAPEI 174
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
L GS Y+ +DIWS+GCIFAE++ +PLFPG + +L + +LGTP+ E+ G+
Sbjct: 175 LLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
+ Y S+ + + P +P + LL ++L DP R +A
Sbjct: 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA 278
|
Length = 294 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-52
Identities = 118/323 (36%), Positives = 168/323 (52%), Gaps = 34/323 (10%)
Query: 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM 69
+G+ Y + +G G+Y V T VA+K+++ E + T I RE+ LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLR 128
LKH +IV + I+ K + +VFE ++ DL Q + + H+ + FL+QLLR
Sbjct: 61 LKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
L Y H V HRDLKP+N+L N +LK+ DFGLAR T + +++ V T WYR
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT---YSNEVVTLWYRP 172
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
P+ L GS + Y+ ID+W +GCIF E+ TGRPLFPG V QL + +LGTP+ E+
Sbjct: 173 PDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230
Query: 248 GI-RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEI 306
GI NE+ K Y + + A + P D LL +LL F+ + R SAEE
Sbjct: 231 GILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE------ 282
Query: 307 VFNWLFLYFYVLALADPYFHGLA 329
A+ PYFH L
Sbjct: 283 ------------AMKHPYFHCLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 4e-52
Identities = 111/293 (37%), Positives = 164/293 (55%), Gaps = 16/293 (5%)
Query: 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM 69
+G+ Y + +G G+Y V T VA+K+++ E + T I RE+ LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKN 59
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLR 128
LKH +IV + I+ + + +VFE ++SDL Q + +L H+ + F++QLLR
Sbjct: 60 LKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
L Y H + HRDLKP+N+L N +LK+ DFGLAR T + +++ V T WYR
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT---YSNEVVTLWYRP 171
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
P+ L GS ++Y+ ID+W +GCI E+ TGRP+FPG V +L L+ LLGTP+ E+
Sbjct: 172 PDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229
Query: 248 GI-RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299
GI NE+ + YL R A P + P D + LL LL ++ K R SAE
Sbjct: 230 GITSNEEFRSYLFPQYR--AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAE 280
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 2e-51
Identities = 112/294 (38%), Positives = 164/294 (55%), Gaps = 16/294 (5%)
Query: 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM 69
+G+ Y E +G G+Y V T VA+K+++ E + T I RE+ LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLR 128
LKH +IV + I+ K + +VFE ++ DL Q + ++ H+ + FLYQ+LR
Sbjct: 61 LKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
L Y H V HRDLKP+N+L N +LK+ DFGLAR T + +++ V T WYR
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT---YSNEVVTLWYRP 172
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
P+ L GS S+Y+ ID+W +GCIF E+ +GRPLFPG V +L L+ LLGTP+ E+
Sbjct: 173 PDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
Query: 248 GI-RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
GI N++ K Y + + P + P D + LL + L ++ K R SAEE
Sbjct: 231 GISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 6e-50
Identities = 106/297 (35%), Positives = 168/297 (56%), Gaps = 27/297 (9%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+++E+ ++G G+YGVV T E VAIKK K+ E+ LRE+K+LR LK
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKY 132
+IVE+K RR K +Y+VFE +E ++ ++++ + + PE + ++YQL++A+ +
Sbjct: 61 NIVELKEAF----RRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
H ++ HRD+KP+N+L + + LK+CDFG AR + ++ +A + T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANY-TEYVATRWYRSPELL 173
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI------ 246
+ Y A+D+WS+GCI EL G+PLFPG + QL + +LG AE +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 247 ---AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
G+R S RR + + L L++ LL +P DR E+
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGI--------LSGVLLDLMKNLLKLNPTDRYLTEQ 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 5e-48
Identities = 74/282 (26%), Positives = 123/282 (43%), Gaps = 35/282 (12%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
E++G GS+G V A+D TGE +A+K ++ + + + REI++L L+HP+IV
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 80 HIMLPPCRREFKDIYVVFELM-ESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANV 138
E + + E + L ++K L + + Q+L L Y+HS +
Sbjct: 66 GSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGI 122
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSK 198
HRD+K NIL ++D +K+ DFG A+ T ++ APE+ +
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT-GSVRGTPYWMAPEVIRG--EE 179
Query: 199 YTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYL 258
Y A DIWS+GC E+ TG+P + + + + + + + I
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWS--ELGNPMAALYKIGSSGEPPEI------------ 225
Query: 259 SSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
P A L++ L DPK RP+A+E
Sbjct: 226 ---------P-----EHLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-46
Identities = 71/197 (36%), Positives = 108/197 (54%), Gaps = 13/197 (6%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
+G G +G V A D TG+KVAIK +K+ S +LREI++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 82 MLPPCRREFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVF 139
+ +Y+V E E L ++K N+ L+ + L Q+L L+Y+HS +
Sbjct: 60 FE-----DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 140 HRDLKPKNIL-ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSK 198
HRDLKP+NIL + + K+K+ DFGL+++ +D V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVL-LGKGY 170
Query: 199 YTPAIDIWSIGCIFAEL 215
Y+ DIWS+G I EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 159 bits (406), Expect = 1e-45
Identities = 90/298 (30%), Positives = 138/298 (46%), Gaps = 57/298 (19%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLKH 72
+YEI + IG GS+G V G+ +K++ ++S+ R L E+K+L+ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNH 58
Query: 73 PDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKA---NDDLTPEHHQ--FFL 123
P+I++ F++ + +V E + DL Q IK PE Q +
Sbjct: 59 PNIIK--------YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWF 109
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT 183
QL ALKY+HS + HRD+KP+NI ++ +K+ DFG+++V + A V T
Sbjct: 110 VQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGT 166
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
+Y +PELC + Y DIWS+GC+ EL T + F G N L+L +L
Sbjct: 167 PYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKIL----K 217
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
I + +Y S LR L+ LL DP++RPS +I
Sbjct: 218 GQYPPIPS----QYSSELR-------------------NLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 1e-44
Identities = 110/299 (36%), Positives = 165/299 (55%), Gaps = 23/299 (7%)
Query: 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM 69
+G A+ Y E +G GSY V I G+ VA+K + E T I RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKG 59
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQ-VIKANDDLTPEHHQFFLYQLLR 128
LKH +IV + I+ + + VFE M +DL Q +I+ L P + + F++QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
L YIH ++ HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAK--SIPSQTYSSE-VVTLWYRP 171
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG-RNVAHQLDLVTDLLGTPSAESI 246
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG +V QL+ + +LG P+ ++
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229
Query: 247 AGIR---NEKAKRYLSSLRRKWAVPFSH--KFPGADPLALRLLQRLLAFDPKDRPSAEE 300
G+ N K + +L ++ V + + P A+ LA ++L PKDR SA++
Sbjct: 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA----SQMLMMFPKDRISAQD 284
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 158 bits (399), Expect = 2e-43
Identities = 95/338 (28%), Positives = 147/338 (43%), Gaps = 37/338 (10%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDA-TRILREIKLLRMLKHPD 74
Y I +G GS+G V A D + VA+K + + E S R LREI++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 75 -IVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD---LTPEHHQFFLYQLLRA 129
IV++ ++ +Y+V E ++ L+ ++K L+ F L Q+L A
Sbjct: 59 NIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 130 LKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLARV---SFTDTPSAIFWTDYVATRW 185
L+Y+HS + HRD+KP+NIL + D +K+ DFGLA++ + + + V T
Sbjct: 114 LEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 186 YRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
Y APE+ G + + + DIWS+G ELLTG P F G + +
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI------- 226
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFT 304
I S L S A LL++LLA DPK+R S+
Sbjct: 227 ----ILELPTPSLASPLSPSNPELIS-------KAASDLLKKLLAKDPKNRLSSSSDLSH 275
Query: 305 EIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISK 342
+++ + + L P L PS + +
Sbjct: 276 DLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALIS 313
|
Length = 384 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 154 bits (389), Expect = 5e-43
Identities = 101/296 (34%), Positives = 151/296 (51%), Gaps = 28/296 (9%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEK-VAIKKMKEVFEHVSDATRILREIKLLRMLK-- 71
QYE IG G+YG V A D G + VA+K+++ +RE+ +LR L+
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 72 -HPDIVEIKHI-MLPPCRREFKDIYVVFELMESDLDQVIKANDD--LTPEHHQFFLYQLL 127
HP++V + + + RE K + +VFE ++ DL + + + E + ++QLL
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV-SFTDTPSAIFWTDYVATRWY 186
R L ++HS V HRDLKP+NIL + ++K+ DFGLAR+ SF +++ V T WY
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-----VVTLWY 175
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE-- 244
RAPE+ S Y +D+WS+GCIFAE+ +PLF G + QL + D++G P E
Sbjct: 176 RAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233
Query: 245 --SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
+A R + A P D L LL + L F+P R SA
Sbjct: 234 PRDVALPRQAFHSKS--------AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 3e-42
Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 45/288 (15%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+EI E IG G +G V A TG++VAIK +K + +I+ EI++L+ KHP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNI 59
Query: 76 VE-IKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHH-QFFLYQLLRALKY 132
V+ + ++++V E L ++K+ + E + +LL+ L+Y
Sbjct: 60 VKYYGSYLKK------DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+HS + HRD+K NIL +D ++K+ DFGL+ +DT + V T ++ APE+
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI 169
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
Y DIWS+G EL G+P + +L + L + G+RN
Sbjct: 170 --NGKPYDYKADIWSLGITAIELAEGKPPY------SELPPMKALFKIAT-NGPPGLRNP 220
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ KW+ F F L++ L +P+ RP+AE+
Sbjct: 221 E----------KWSDEF-KDF----------LKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 110/300 (36%), Positives = 168/300 (56%), Gaps = 27/300 (9%)
Query: 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM 69
+G+A YE E +G GSY V G+ VA+K ++ E + T I RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKG 59
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVI-KANDDLTPEHHQFFLYQLLR 128
LKH +IV + I+ + + +VFE + +DL Q + K L PE+ + FL+QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
L YIH + HRDLKP+N+L + +LK+ DFGLAR PS + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAK--SVPSHTY-SNEVVTLWYRP 171
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG-RNVAHQLDLVTDLLGTPSAESI 246
P+ L GS ++Y+ +D+W +GCIF E++ G FPG +++ QL+ + +LGTP+ ++
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 247 AGIRN------EKAKRYLS-SLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299
G+ + E+ Y +LR+ W S+ A+ LA +LLQ PK+R SA+
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWN-KLSY-VNHAEDLASKLLQ----CFPKNRLSAQ 283
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 122/381 (32%), Positives = 181/381 (47%), Gaps = 72/381 (18%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
Y++ IIG GS+GVV AI T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 76 VEIKHIMLPPC-RREFKDIY--VVFELMESDLDQVIK----ANDDLTPEHHQFFLYQLLR 128
+ +K C ++ K+I+ VV E + + + +K N L + + YQL R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 129 ALKYIHSANVFHRDLKPKNILANADC-KLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
AL YIHS + HRDLKP+N+L + + LK+CDFG A+ S Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS----VSYICSRFYR 237
Query: 188 APEL-CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APEL G+ + YT ID+WS+GCI AE++ G P+F G++ QL + +LGTP+ + +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADP-LALRLLQRLLAFDPKDRPSAEEIRFTE 305
+ A ++ K FP P A+ + + L ++P R + E
Sbjct: 296 KEMNPNYADIKFPDVKPK---DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE----- 347
Query: 306 IVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKL---------VFEFE-------- 348
ALADP+F L R P KL +F F
Sbjct: 348 -------------ALADPFFDDL--------RDPCIKLPKYIDKLPDLFNFCDAEIKEMS 386
Query: 349 ---RRKLIKDDVRELIYREIL 366
RRK+I E Y+E L
Sbjct: 387 DACRRKIIPKCTYE-AYKEFL 406
|
Length = 440 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 93/302 (30%), Positives = 132/302 (43%), Gaps = 58/302 (19%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLKH 72
YE+ E IG GS+G V G+ + K++ + ++++ + ++ E+ +LR LKH
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKH 58
Query: 73 PDIVE-IKHIMLPPCRREFKDIYVVFELMES-DLDQVI---KANDDLTPEHH--QFFLYQ 125
P+IV I+ R + +Y+V E E DL Q+I K E + Q
Sbjct: 59 PNIVRYYDRIID----RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-Q 113
Query: 126 LLRALKYIH-----SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
LL AL H V HRDLKP NI +A+ +K+ DFGLA++ D+ A Y
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---KTY 170
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
V T +Y +PE Y DIWS+GC+ EL P F RN QL L
Sbjct: 171 VGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQL------- 218
Query: 241 PSAESIA-GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299
A I G RY S L +++ +L DP RPS E
Sbjct: 219 --ASKIKEGKFRRIPYRYSSELN-------------------EVIKSMLNVDPDKRPSTE 257
Query: 300 EI 301
E+
Sbjct: 258 EL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 74/209 (35%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
Y++ ++IG G++GVV ++ TG+ VAIK++ I++EI LL+ LKHP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHH-QFFLYQLLRALKY 132
IV K+I +Y++ E E+ L Q+IK PE ++YQ+L+ L Y
Sbjct: 61 IV--KYI---GSIETSDSLYIILEYAENGSLRQIIKKFGPF-PESLVAVYVYQVLQGLAY 114
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLA-RVSFTDTPSAIFWTDYVATRWYRAPEL 191
+H V HRD+K NIL D +K+ DFG+A +++ V T ++ APE+
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAPEV 170
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRP 220
S + A DIWS+GC ELLTG P
Sbjct: 171 IE--MSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 101/290 (34%), Positives = 147/290 (50%), Gaps = 17/290 (5%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK--- 71
QYE IG+G+YG V A D H+G VA+K ++ +RE+ LL+ L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 72 HPDIVEIKHIMLPP-CRREFKDIYVVFELMESDLDQVIKA--NDDLTPEHHQFFLYQLLR 128
HP+IV + + RE K + +VFE ++ DL + L E + + Q LR
Sbjct: 61 HPNIVRLMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
L ++H+ + HRDLKP+NIL + ++K+ DFGLAR+ + T V T WYRA
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVVVTLWYRA 175
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
PE+ S Y +D+WS+GCIFAE+ +PLF G + A QL + DL+G P +
Sbjct: 176 PEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP- 232
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
R+ R S R P P + +LL +L F+P R SA
Sbjct: 233 -RDVTLPRGAFSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISA 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 90/300 (30%), Positives = 134/300 (44%), Gaps = 67/300 (22%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLKHP 73
Y+ E IG G+ G V A D TG++VAIKKM+ + + I+ EI +++ KHP
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----LRKQNKELIINEILIMKDCKHP 75
Query: 74 DIVE-IKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRAL 130
+IV+ +++VV E M+ L +I N + + ++L+ L
Sbjct: 76 NIVDYYD------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFTDTPSAIFWTDYV 181
+Y+HS NV HRD+K NIL + D +K+ DFG A R S TP +W
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTP---YWM--- 183
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
APE+ Y P +DIWS+G + E+ G P + L L+T G P
Sbjct: 184 ------APEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP 234
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
++N + KW S +F L + L DP+ RPSAEE+
Sbjct: 235 P------LKNPE----------KW----SPEF-------KDFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 79/303 (26%), Positives = 125/303 (41%), Gaps = 67/303 (22%)
Query: 17 EIQEIIGIGSYGVV----ASAIDTHTGEKVAIKKMKEVFEHVSDATR-ILREIKLLRMLK 71
+ + +G G++G V +VA+K +KE + LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE--DASEQQIEEFLREARIMRKLD 59
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLLRA 129
HP++V++ + + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 60 HPNVVKLLGVCTEE-----EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT------ 183
++Y+ S N HRDL +N L + +KI DFGL+R + D DY
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKLP 166
Query: 184 -RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGT 240
RW APE S K+T D+WS G + E+ T G +PG + L+ +
Sbjct: 167 IRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL------ 216
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLAL-RLLQRLLAFDPKDRPSAE 299
G R + P P L L+ + A DP+DRP+
Sbjct: 217 -----KNGYRLPQ--------------------PPNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 300 EIR 302
E+
Sbjct: 252 ELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-35
Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 56/291 (19%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMK--EVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
+G GS+G V TG+ A+K +K ++ + + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 80 HIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
F+ +Y+V E +L + + E +F+ +++ AL+Y+HS
Sbjct: 60 --------YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS 111
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
+ +RDLKP+NIL +AD +K+ DFGLA+ ++ + T Y APE+
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG- 167
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255
Y A+D WS+G + E+LTG+P F +
Sbjct: 168 -KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------------------EIYEKILKD 208
Query: 256 RYLSSLRRKWAVPFSHKFP-GADPLALRLLQRLLAFDPKDR---PSAEEIR 302
+FP P A L+ LL DP R AEEI+
Sbjct: 209 PL--------------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIK 245
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 80/302 (26%), Positives = 125/302 (41%), Gaps = 70/302 (23%)
Query: 20 EIIGIGSYGVV----ASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLKHP 73
+ +G G++G V +VA+K +KE S+ LRE +++R L HP
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRKLDHP 61
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD--LTPEHHQFFLYQLLRAL 130
+IV++ + + + +V E M DL ++ N L+ F Q+ R +
Sbjct: 62 NIVKLLGVCTEE-----EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT------- 183
+Y+ S N HRDL +N L + +KI DFGL+R ++ DY
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--------DLYDDDYYKVKGGKLPI 168
Query: 184 RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTP 241
RW APE S K+T D+WS G + E+ T G +PG + A L+ +
Sbjct: 169 RWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL------- 217
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLAL-RLLQRLLAFDPKDRPSAEE 300
G R K P P L +L+ + A DP+DRP+ E
Sbjct: 218 ----KKGYRLPK--------------------PPNCPPELYKLMLQCWAEDPEDRPTFSE 253
Query: 301 IR 302
+
Sbjct: 254 LV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 1e-33
Identities = 112/337 (33%), Positives = 158/337 (46%), Gaps = 61/337 (18%)
Query: 22 IGIGSYGVV--ASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
+G G+YG V A D A+K++ E + REI LLR LKHP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 80 HIMLPPCRREFKDIYVVFELMESDLDQVIK------AND---DLTPEHHQFFLYQLLRAL 130
+ L R+ ++++F+ E DL +IK AN L + LYQ+L +
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 131 KYIHSANVFHRDLKPKNILANADC----KLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
Y+H+ V HRDLKP NIL + ++KI D G AR+ + V T WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 187 RAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR-------NVAH--QLDLVTD 236
RAPEL G+ YT AIDIW+IGCIFAELLT P+F R N H QLD + +
Sbjct: 182 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239
Query: 237 LLGTPSAESIAGIRN-EKAKRYLSSLRRKWAVPFS-------HKFPGADPLALRLLQRLL 288
++G P+ + I+ + + RR S HK D A LLQ+LL
Sbjct: 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK-PDSKAFHLLQKLL 298
Query: 289 AFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325
DP R ++E+ A+ DPYF
Sbjct: 299 TMDPIKRITSEQ------------------AMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 35/289 (12%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
IG G++G V +A++ TGE +A+K+++ I E+K+L +LKHP++V+ +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 82 MLPPCRREFKDIYVVFEL-MESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFH 140
+ RE +Y+ E L+++++ L + + QLL L Y+HS + H
Sbjct: 68 EV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 141 RDLKPKNILANADCKLKICDFGLA-RVSFTDTPSAIFWTDYVATRWYRAPEL-CGSFFSK 198
RD+KP NI + + +K+ DFG A ++ T T Y APE+ G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 199 YTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYL 258
+ A DIWS+GC+ E+ TG+ + +LD NE +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPW------SELD------------------NEFQIMFH 218
Query: 259 SSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIV 307
K +P S + P L R L DPK RP+A E+ V
Sbjct: 219 VGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 8e-33
Identities = 113/337 (33%), Positives = 157/337 (46%), Gaps = 61/337 (18%)
Query: 22 IGIGSYGVVASA--IDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
+G G+YG V A D ++ A+K++ E + REI LLR LKHP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 80 HIMLPPCRREFKDIYVVFELMESDLDQVIK------AND---DLTPEHHQFFLYQLLRAL 130
+ L R+ ++++F+ E DL +IK AN L + LYQ+L +
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 131 KYIHSANVFHRDLKPKNILANADC----KLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
Y+H+ V HRDLKP NIL + ++KI D G AR+ + V T WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 187 RAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR-------NVAH--QLDLVTD 236
RAPEL G+ YT AIDIW+IGCIFAELLT P+F R N H QLD +
Sbjct: 182 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 237 LLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFS--------HKFPGADPLALRLLQRLL 288
++G P+ + IR L R+ S HK D LLQ+LL
Sbjct: 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVK-PDSKVFLLLQKLL 298
Query: 289 AFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325
DP R ++E+ AL DPYF
Sbjct: 299 TMDPTKRITSEQ------------------ALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 86/325 (26%), Positives = 137/325 (42%), Gaps = 86/325 (26%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK-----------KMKEVFEHVSDATRILR 62
++ +IIG GS+ V A + T ++ AIK K+K V I +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVK--------IEK 52
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEH 118
E+ L R+ HP I+++ + F+D +Y V E + +L Q I+ L +
Sbjct: 53 EV-LTRLNGHPGIIKLYY--------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC 103
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV------------ 166
+F+ ++L AL+Y+HS + HRDLKP+NIL + D +KI DFG A+V
Sbjct: 104 TRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 167 -----SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPL 221
+ + +V T Y +PEL + D+W++GCI ++LTG+P
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPP 221
Query: 222 FPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLAL 281
F G N + L F FP P A
Sbjct: 222 FRGSNEYLTFQKILKL----------------------------EYSFPPNFP---PDAK 250
Query: 282 RLLQRLLAFDPKDRP----SAEEIR 302
L+++LL DP+DR +E++
Sbjct: 251 DLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 75/301 (24%), Positives = 120/301 (39%), Gaps = 62/301 (20%)
Query: 17 EIQEIIGIGSYGVVASAI----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
E+ + +G G++G V T KVA+K +KE + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQF-FLYQLLRAL 130
P+IV + + C + + +Y+V E M DL ++ + + Q+ + +
Sbjct: 61 PNIVRLLGV----CTQG-EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD--------TPSAIFWTDYVA 182
+Y+ S N HRDL +N L + +KI DFGL+R + D I W
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM---- 171
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
APE K+T D+WS G + E+ T LG
Sbjct: 172 -----APESL--KDGKFTSKSDVWSFGVLLWEIFT--------------------LG--- 201
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLAL-RLLQRLLAFDPKDRPSAEEI 301
+ G+ NE+ L R P P L L+ + A+DP+DRP+ E+
Sbjct: 202 EQPYPGMSNEEVLELLEDGYR-------LPRPENCPDELYELMLQCWAYDPEDRPTFSEL 254
Query: 302 R 302
Sbjct: 255 V 255
|
Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 78/302 (25%), Positives = 127/302 (42%), Gaps = 47/302 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDAT----RILREIKLLRM 69
S E +++G GS GVV TG+ A+KK+ HV ++LRE+K LR
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-----HVDGDEEFRKQLLRELKTLRS 55
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLR 128
+ P +V+ I +V E M+ L ++K + + Q+L+
Sbjct: 56 CESPYVVKCYGAFYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILK 110
Query: 129 ALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
L Y+H+ ++ HRD+KP N+L N+ ++KI DFG+++V + T +V T Y
Sbjct: 111 GLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNT-FVGTVTYM 167
Query: 188 APELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
+PE Y+ A DIWS+G E G+ F +L+ + P A
Sbjct: 168 SPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPA 225
Query: 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIV 307
+ + + ++S LQ+ DPK RPSA E+ +
Sbjct: 226 EEFSPEFRDFIS----------------------ACLQK----DPKKRPSAAELLQHPFI 259
Query: 308 FN 309
Sbjct: 260 KK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 82/305 (26%), Positives = 136/305 (44%), Gaps = 56/305 (18%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKE---VFEHVSDATRILREIKLLRMLKHPDIVEI 78
I G+YG V A TG+ AIK +K+ + ++ D ++L E +L + P +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVKL 58
Query: 79 KHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN 137
+ + K++Y+V E + DL +++ L + + ++ +++ AL+Y+HS
Sbjct: 59 YY-----SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY-----VATRWYRAPELC 192
+ HRDLKP NIL +++ LK+ DFGL++V + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
++ +D WS+GCI E L G P F G E I N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETP---------------EEIFQNILNG 216
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP---SAEEIR----FTE 305
K + + A+ L+ +LL DP+ R S EEI+ F
Sbjct: 217 KIEWP--------------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 306 IVFNW 310
I +W
Sbjct: 263 I--DW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 53/289 (18%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVS-DATR-ILREIKLLRMLKH 72
+E+ +IG G++G V T + A+K M + + V + R +L E ++L+ L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNH 59
Query: 73 PDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLR 128
P +V + F+D +Y+V +L+ DL + + E +F++ +++
Sbjct: 60 PFLVNL--------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL 111
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
AL+Y+HS + HRD+KP NIL + + I DF +A DT + T T Y A
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMA 167
Query: 189 PELCGSFFSK-YTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
PE+ + Y+ A+D WS+G E L G+ + G S
Sbjct: 168 PEV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH----------------SRTIRD 208
Query: 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALR-LLQRLLAFDPKDR 295
IR ++ +P + +LL DP+ R
Sbjct: 209 QIRAKQETA-------------DVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 74/308 (24%), Positives = 120/308 (38%), Gaps = 75/308 (24%)
Query: 20 EIIGIGSYGVV--ASAIDTHTGE-KVAIKKMKEVFEHVSDATR--ILREIKLLRMLKHPD 74
+ +G G++G V +VA+K +KE S+ R L+E ++++ L HP+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE---DASEEERKDFLKEARVMKKLGHPN 57
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKAN---------DDLTPEHHQFFLY 124
+V + + C E + +Y+V E ME DL ++ + L+ + F
Sbjct: 58 VVRLLGV----CTEE-EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR--------VSFTDTPSAIF 176
Q+ + ++Y+ S HRDL +N L D +KI DFGL+R T I
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 177 WTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLV 234
W APE S +T D+WS G + E+ T G +PG + L+ +
Sbjct: 173 WM---------APE---SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220
Query: 235 TDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD 294
G R K + L L+ DP+D
Sbjct: 221 RK-----------GYRLPKPEYCPDELY-------------------ELMLSCWQLDPED 250
Query: 295 RPSAEEIR 302
RP+ E+
Sbjct: 251 RPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 77/294 (26%), Positives = 121/294 (41%), Gaps = 53/294 (18%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKK--MKEVFEHVSDATRILREIKLLRMLKHP 73
Y ++G G++G T V K+ + + E L EI +L +L+HP
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA--LNEIVILSLLQHP 59
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQ--FFLYQLL 127
+I+ + F D + ME L I E ++L+Q++
Sbjct: 60 NIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
A+ YIH A + HRD+K NI +K+ DFG++++ ++ A V T +Y
Sbjct: 112 SAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA---ETVVGTPYYM 168
Query: 188 APELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
+PELC KY DIW++GC+ ELLT + F N L+LV + +
Sbjct: 169 SPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKI--------VQ 215
Query: 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
G Y S L L+ LL DP+ RP+A+E+
Sbjct: 216 GNYTPVVSVYSSELI-------------------SLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 68/207 (32%), Positives = 110/207 (53%), Gaps = 18/207 (8%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLKHP 73
++I++ IG G + VV AI G VA+KK++ +FE + R L+EI LL+ L HP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIK---ANDDLTPEHHQF-FLYQLLR 128
++++ + E ++ +V EL ++ DL ++IK L PE + + QL
Sbjct: 63 NVIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
AL+++HS + HRD+KP N+ A +K+ D GL R + T +A V T +Y +
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMS 174
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAEL 215
PE + Y DIWS+GC+ E+
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSD-ATRILREIKLLRMLKH 72
+ + E IG GS+G V AID T + VAIK + E D I +EI+ L +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRAL 130
P I + L + ++++ E S LD ++K L + F L ++L L
Sbjct: 59 PYITKYYGSFLKGSK-----LWIIMEYCGGGSCLD-LLKPGK-LDETYIAFILREVLLGL 111
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFTDTPSAIFWTDYV 181
+Y+H HRD+K NIL + + +K+ DFG++ R +F TP FW
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTP---FWM--- 165
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRP 220
APE+ S Y DIWS+G EL G P
Sbjct: 166 ------APEVIKQ--SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 7e-26
Identities = 71/211 (33%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
++I E +G GSYG V AI TG+ VAIK + V E + + I++EI +L+ P
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQE---IIKEISILKQCDSPY 59
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELME-----SDLDQVIKANDDLTPEHHQFFLYQLLRA 129
IV+ + D+++V ME S D + N LT E LYQ L+
Sbjct: 60 IVKYY-----GSYFKNTDLWIV---MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
L+Y+HS HRD+K NIL N + + K+ DFG VS T + + T ++ AP
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG---VSGQLTDTMAKRNTVIGTPFWMAP 168
Query: 190 ELCGSFFSKYTPAIDIWSIGCIFAELLTGRP 220
E+ Y DIWS+G E+ G+P
Sbjct: 169 EVIQE--IGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 55/292 (18%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKM------KEVFEHVSDATRILREIKLLRMLKHP 73
E++G GS+G V ++ G+ A+K++ + E V ++ +EI LL L+HP
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK---QLEQEIALLSKLQHP 62
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+IV+ RE ++Y+ EL+ L +++K + + Q+L L+Y
Sbjct: 63 NIVQYLG-----TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEY 117
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+H N HRD+K NIL + + +K+ DFG+A+ + F + + ++ APE+
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----FAKSFKGSPYWMAPEVI 173
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL---GTPSAESIAGI 249
Y A DIWS+GC E+ TG+P + QL+ V + + I
Sbjct: 174 AQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSKELPPIPDH 226
Query: 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+++AK ++ L+ LQR DP RP+A E+
Sbjct: 227 LSDEAKDFI----------------------LKCLQR----DPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 79/310 (25%), Positives = 126/310 (40%), Gaps = 78/310 (25%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKM---KEVFEHVSDATR-----ILREIKLLRMLK 71
E+IG G+YG V A++ TGE +A+K++ + + + EI+ L+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMESDLD------------QVIKANDDLTPEHH 119
H +IV+ Y+ FE E L ++ +
Sbjct: 67 HLNIVQ----------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110
Query: 120 QFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR--------VSFTDT 171
+FF Q+L L Y+HS + HRDLK N+L +AD KI DFG+++
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL 231
++FW APE+ S+ Y+ +DIWS+GC+ E+ GR P +
Sbjct: 171 QGSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR--PWSDE---- 215
Query: 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFD 291
E+IA + L + R +P P+AL L +
Sbjct: 216 ------------EAIAAMFK------LGNKRSAPPIP-PDVSMNLSPVALDFLNACFTIN 256
Query: 292 PKDRPSAEEI 301
P +RP+A E+
Sbjct: 257 PDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDA---TRILREIKLLRMLKHPDIVEI 78
+G+G +G V A+K +K+ H+ + I E ++L HP IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKR--HIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 79 KHIMLPPCRREFKDIYVVFELMES----DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
R FKD ++ LME +L +++ +F++ ++ A +Y+H
Sbjct: 59 --------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
+ + +RDLKP+N+L +++ +K+ DFG A+ + + WT + T Y APE+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPEII-- 164
Query: 195 FFSK-YTPAIDIWSIGCIFAELLTGRPLF 222
+K Y ++D WS+G + ELLTGRP F
Sbjct: 165 -LNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPD 74
+E+ E+IG G+YG V A TG+ VAIK M + + I E +LR HP+
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSNHPN 64
Query: 75 IVEIKHIML---PPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHH-QFFLYQL 126
I + PP +++V EL +DL + ++ E + L +
Sbjct: 65 IATFYGAFIKKNPPGND--DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFTDTPSAIFW 177
LR L Y+H V HRD+K +NIL + ++K+ DFG++ R +F TP +W
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTP---YW 179
Query: 178 TDYVATRWYRAPE--LCG-SFFSKYTPAIDIWSIGCIFAELLTGRP 220
APE C + Y D+WS+G EL G+P
Sbjct: 180 M---------APEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 37/222 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK--------KMKEVFEHVSDATRILREIK 65
+E + +G GS+G V +G+ A+K K+K+V EHV L E +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQV-EHV------LNEKR 53
Query: 66 LLRMLKHPDIVEIKHIMLPPCRREFKD---IYVVFELME-SDLDQVIKANDDLTPEHHQF 121
+L+ ++HP +V F+D +Y+V E + +L ++ + +F
Sbjct: 54 ILQSIRHPFLVN--------LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF 105
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYV 181
+ Q++ AL+Y+HS ++ +RDLKP+N+L ++D +KI DFG A+ T +T
Sbjct: 106 YAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LC 159
Query: 182 ATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGRPLF 222
T Y APE+ SK Y A+D W++G + E+L G P F
Sbjct: 160 GTPEYLAPEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 77/299 (25%), Positives = 122/299 (40%), Gaps = 49/299 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK-----KMKEVFEHVSDATRILREIKLLR 68
YE+ E+IG+G+ VV +AI EKVAIK K + + + +E++ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE------LRKEVQAMS 54
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKA--NDDLTPEHH-QFFL 123
HP++V+ + ++++V + S LD ++K+ E L
Sbjct: 55 QCNHPNVVKYYTSFV-----VGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVL 108
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP-SAIFWTDYVA 182
++L+ L+Y+HS HRD+K NIL D +KI DFG++ + +V
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVG 168
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
T + APE+ Y DIWS G EL TG P L+ L P
Sbjct: 169 TPCWMAPEVMEQ-VHGYDFKADIWSFGITAIELATGAA--PYSKYPPMKVLMLTLQNDPP 225
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ K+Y S R +++ L DP RP+AEE+
Sbjct: 226 SLET----GADYKKYSKSFR-------------------KMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 76/268 (28%), Positives = 119/268 (44%), Gaps = 27/268 (10%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK---EVFEHVSDATRILREIKLLRML 70
S Y+ E+IG G+YG V TG VA+K + + VSD I RE+ LL L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQL 56
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRA 129
+ I + ++++ E E + ++KA + ++ + ++L A
Sbjct: 57 RQSQPPNI--TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVA 113
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
LKYIH V HRD+K NIL +K+CDFG+A S + +V T ++ AP
Sbjct: 114 LKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSK--RSTFVGTPYWMAP 170
Query: 190 ELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLV--------TDLLGTP 241
E+ Y DIWS+G E+ TG P + + + L+ D +
Sbjct: 171 EVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSK 229
Query: 242 S-AESIAGIRNEKAKRYLSS---LRRKW 265
E +A +E+ K LS+ L+ KW
Sbjct: 230 LLREFVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 88/306 (28%), Positives = 126/306 (41%), Gaps = 69/306 (22%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
YE+ + IG G+YG V A D TGE VAIK +K E D I +EI +L+ +HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQFFLYQLLRA 129
+IV L RR+ +++V E D+ QV L+ + + L+
Sbjct: 61 NIVAYFGSYL---RRD--KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKG 113
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFTDTPSAIFWTDY 180
L Y+H HRD+K NIL D +K+ DFG++ R SF TP +W
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP---YWM-- 168
Query: 181 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRP----LFPGRNVAHQLDLVT 235
APE Y DIW++G EL +P L P R
Sbjct: 169 -------APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---------- 211
Query: 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR 295
A + N + L + KW+ F H F +++ L DPK R
Sbjct: 212 -------ALFLISKSNFPPPK-LKD-KEKWSPVF-HDF----------IKKCLTKDPKKR 251
Query: 296 PSAEEI 301
P+A ++
Sbjct: 252 PTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 78/287 (27%), Positives = 123/287 (42%), Gaps = 54/287 (18%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR------EIKLLRMLKHPDI 75
IG GS G+V A D TG +VA+KKM D + R E+ ++R +HP+I
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--------DLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
VE+ L +++VV E +E I + + E +L+AL ++H+
Sbjct: 79 VEMYSSYLVG-----DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHA 133
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGL-ARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
V HRD+K +IL +D ++K+ DFG A+VS + P V T ++ APE+
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRR---KSLVGTPYWMAPEVISR 189
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254
Y +DIWS+G + E++ G P + P +++ IR+
Sbjct: 190 --LPYGTEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLQAMKRIRDNLP 232
Query: 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
P P L R+L DP R +A E+
Sbjct: 233 -------------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR-----ILREIKLLRMLKHPD 74
+++G G++G V D TG ++A+K++ F+ S T+ + EI+LL+ L+H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
IV+ C R+ + + + E M S DQ +KA LT + + Q+L ++Y
Sbjct: 66 IVQYYG-----CLRDDETLSIFMEYMPGGSVKDQ-LKAYGALTETVTRKYTRQILEGVEY 119
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+HS + HRD+K NIL ++ +K+ DFG ++ T S T ++ +PE+
Sbjct: 120 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
Y D+WS+GC E+LT +P P E++A I
Sbjct: 180 SG--EGYGRKADVWSVGCTVVEMLTEKP--PWAEF----------------EAMAAIFKI 219
Query: 253 KAKRYLSSLRRKWAVPFSHKFP-GADPLALRLLQRLLAFDPKDRPSAEEI 301
+ P + + P P A L+R + K RPSAEE+
Sbjct: 220 ATQ------------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRMLKH 72
+++ + +G GSYG V + A+K++ +S R + EI++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVI---KANDDLTPEHH--QFFLYQL 126
P+I+ K L + + +V E DL + I K L PE + F+ QL
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV---SFTDTPSAIFWTDYVAT 183
LR L+ +H + HRDLK NIL A+ +KI D G+++V + T + T
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT--------QIGT 164
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA 228
Y APE+ Y+ DIWS+GC+ E+ T P F R++
Sbjct: 165 PHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDA--TRILREIKLLRMLKHPDIVEIK 79
+G G+ GVV+ + TG+ +A +K + +++A +ILRE+ +L P IV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMA---VKTIRLEINEAIQKQILRELDILHKCNSPYIVG-- 63
Query: 80 HIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHH-QFFLYQLLRALKYIHSA- 136
DI + E M+ LD+++K PE +L+ L Y+H
Sbjct: 64 --FYGAFYNN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 137 NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFF 196
+ HRD+KP NIL N+ ++K+CDFG++ ++ + +V T Y APE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNSLA----KTFVGTSSYMAPERIQG-- 173
Query: 197 SKYTPAIDIWSIGCIFAELLTGRPLFP 223
+ Y+ DIWS+G EL TGR FP
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR--FP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-22
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+EI IG GS+GVV + A+K++ + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD--LTPEHHQFFLYQLLRALKY 132
I++ + + +V E E+ DL +++K L + F Q+L L +
Sbjct: 62 --IRYY---ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+HS + HRD+K N+ +A +KI D G+A++ + + F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN 226
Y D+W++G + E TG+ F N
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANN 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 8e-22
Identities = 73/301 (24%), Positives = 129/301 (42%), Gaps = 64/301 (21%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR----ILREIKLLRMLKHPDI 75
+ +G G++ A D TG +A+K++ V S+ + +EI+L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQF----------FLYQ 125
+ + + C +++V E M A ++ ++ + Q
Sbjct: 66 IRM---LGATCEDSHFNLFV--EWM---------AGGSVSHLLSKYGAFKEAVIINYTEQ 111
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCK-LKICDFGLA-RVSFTDTPSAIFWTDYVAT 183
LLR L Y+H + HRD+K N+L ++ + L+I DFG A R++ T + F + T
Sbjct: 112 LLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDL---LGT 240
+ APE+ +Y + D+WS+GC+ E+ T +P + ++ L L+ +
Sbjct: 172 IAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA 229
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
PS +P H PG + LR L+ P+DRP + E
Sbjct: 230 PS------------------------IP-EHLSPGLRDVTLRCLEL----QPEDRPPSRE 260
Query: 301 I 301
+
Sbjct: 261 L 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
++I +G G YG V A TGE VA+K+M K + +++ +L E +L K
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQFFLYQLLR 128
+V++ + F+D ++ ME D ++ L+ +H +F++ ++
Sbjct: 61 EWLVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE 112
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
A+ +H HRDLKP+N L +A +K+ DFGL++ T S + DY+ A
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------A 166
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV 227
PE+ Y +D WS+GC+ E L G P F G
Sbjct: 167 PEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 85/335 (25%), Positives = 133/335 (39%), Gaps = 74/335 (22%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+E+ ++IG G++G V D TG+ A+K +++ + +R + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI------ 54
Query: 74 DIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRA 129
+ + + F+D +Y+V E M DL ++ D E +F++ +L+ A
Sbjct: 55 -LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLA----------------RVSFTDTPS 173
L +H HRD+KP NIL +AD +K+ DFGL
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 174 AIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222
+ D+ V T Y APE L G + Y D WS+G I E+L G P F
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 223 PGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALR 282
++++ N K + SLR P P A+
Sbjct: 231 -------------------YSDTLQETYN-KIINWKESLRF----PPDPPVS---PEAID 263
Query: 283 LLQRLLAFDPKDR-PSAEEIR----FTEIVFNWLF 312
L+ RLL DP+DR S EEI+ F I + L
Sbjct: 264 LICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLR 297
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 71/216 (32%), Positives = 109/216 (50%), Gaps = 24/216 (11%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLKHP 73
QY + ++G GS+G ++ +K A+K+++ + +R +E LL +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--KEAVLLAKMKHP 58
Query: 74 DIVEIKHIMLPPCRREFK---DIYVVFELMES-DLDQVIK-ANDDLTPEHH--QFFLYQL 126
+IV K F+ +Y+V E + DL Q IK L PE Q+F+ Q+
Sbjct: 59 NIVAFKE--------SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV-QM 109
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
+++IH V HRD+K KNI + K+K+ DFG AR+ +P A + YV T +Y
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--LTSPGA-YACTYVGTPYY 166
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222
PE+ + Y DIWS+GCI EL T + F
Sbjct: 167 VPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 79/294 (26%), Positives = 131/294 (44%), Gaps = 51/294 (17%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLKH 72
+YE ++G G++G+V + V IK++ E ++ R E ++L++L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP--VEQMTKDERLAAQNECQVLKLLSH 58
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVI-KANDDLTPEHH--QFFLYQLLR 128
P+I+E L E K + +V E L + I K + L E FF+ Q+L
Sbjct: 59 PNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV-QILL 112
Query: 129 ALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
AL ++H+ + HRDLK +NIL + +KI DFG++++ + + + V T Y
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV----VGTPCYI 168
Query: 188 APELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
+PELC Y DIW++GC+ EL + + F N+ LV ++ +
Sbjct: 169 SPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIM--------S 215
Query: 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
G + RY LR +L+ +L DP RP +I
Sbjct: 216 GTFAPISDRYSPDLR-------------------QLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK--EVF-----EHVSDATRILREIKL 66
E + +G G++G V D + A+K M EV +HV + R+L+E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS- 59
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQFF 122
HP I+ + D ++ LME +L ++ + + F+
Sbjct: 60 -----HPFIIRLFW--------TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY 106
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
+++ AL+Y+HS + +RDLKP+NIL + + +K+ DFG A+ T WT
Sbjct: 107 ASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCG 160
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN 226
T Y APE+ S + A+D W++G + E+L G P F N
Sbjct: 161 TPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 33/237 (13%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y E IG G+ G V +AID TG++VAIK+M + I+ EI ++R KHP+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPN 77
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELM----------ESDLDQVIKANDDLTPEHHQFFLY 124
IV L +++VV E + E+ +D+ A
Sbjct: 78 IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAA----------VCR 122
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
+ L+AL+++HS V HRD+K NIL D +K+ DFG TP + V T
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTP 179
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
++ APE+ Y P +DIWS+G + E++ G P + N L L+ GTP
Sbjct: 180 YWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKMK--EVFEHVSDATRIL-----REIKLLRMLKHP 73
+IG GS+G V ++ +GE +A+K+++ V D R + REI LL+ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
+IV+ L YV + + L+ + L + F+ Q+L+ L Y+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV----RNFVRQILKGLNYL 122
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
H+ + HRD+K NIL + +KI DFG+++ ++ S T R P L G
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST-------KTNGAR-PSLQG 174
Query: 194 SFF---------SKYTPAIDIWSIGCIFAELLTGRPLFP 223
S F + YT DIWS+GC+ E+LTG+ FP
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLK 71
+ ++I++ IG G + V A + VA+KK+ ++FE + R ++EI LL+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKV-QIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVI---KANDDLTPEHHQF-FLYQL 126
HP++++ + E ++ +V EL ++ DL Q+I K L PE + + QL
Sbjct: 61 HPNVIKYLDSFI-----EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
A++++HS V HRD+KP N+ A +K+ D GL R + T +A V T +Y
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYY 172
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAEL 215
+PE + Y DIWS+GC+ E+
Sbjct: 173 MSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 69/232 (29%), Positives = 112/232 (48%), Gaps = 15/232 (6%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y E IG G+ G V +A+D TG++VAI++M + I+ EI ++R K+P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
IV L +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGL-ARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
S V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
Y P +DIWS+G + E++ G P + N L L+ GTP ++
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQN 238
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKM----KEVFEHVSDATRILREIKLLRMLKHPDIVE 77
IG GS+G V A D T E VAIKKM K+ E D I++E++ L+ L+HP+ +E
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---IIKEVRFLQQLRHPNTIE 79
Query: 78 IKHIMLPPCRREFKDIYVVFELME------SDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
K L RE + + +ME SD+ +V K L + L+ L
Sbjct: 80 YKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLA 129
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
Y+HS HRD+K NIL +K+ DFG A + +P+ F V T ++ APE+
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPANSF----VGTPYWMAPEV 182
Query: 192 CGSF-FSKYTPAIDIWSIGCIFAELLTGR-PLF 222
+ +Y +D+WS+G EL + PLF
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 70/207 (33%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKM----KEVFEHVSDATRILREIKLLRMLKHPDIVE 77
IG GS+G V A ++HT E VA+KKM K+ E D I++E+K L+ LKHP+ +E
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD---IIKEVKFLQQLKHPNTIE 85
Query: 78 IKHIMLPPCRREFKDIYVVFELM---ESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
K C + ++V E SDL +V K L + L+ L Y+H
Sbjct: 86 YKG-----CYLKEHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH 138
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
S N+ HRD+K NIL ++K+ DFG A S +P+ +V T ++ APE+ +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPA----NSFVGTPYWMAPEVILA 191
Query: 195 F-FSKYTPAIDIWSIGCIFAELLTGRP 220
+Y +D+WS+G EL +P
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 69/221 (31%), Positives = 113/221 (51%), Gaps = 33/221 (14%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEK---VAIKKMKEVFEHVSDATR--ILREIKL 66
+AS +I+++IG G +G V S G++ VAIK +K + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQ 125
+ HP+I+ ++ ++ + K + +V E ME+ LD ++ +D QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENGSLDAFLRKHDG------QFTVIQ 107
Query: 126 L---LRA----LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT 178
L LR +KY+ HRDL +NIL N++ K+ DFGL+RV D P A + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 179 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
+ RW APE + K+T A D+WS G + E+++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 15/223 (6%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+YEI + IG GS+G + A E IK++ V + +E+ LL +KHP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLY--QLLRALK 131
IV +E +++V E + DL + I + Q + Q+ LK
Sbjct: 61 IVTFFASF-----QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 132 YIHSANVFHRDLKPKNILANADCKL-KICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
+IH + HRD+K +NI + + + K+ DFG+AR D+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSME--LAYTCVGTPYYLSPE 172
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233
+C + Y DIWS+GC+ EL T + F G N+ HQL L
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-HQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 19 QEIIGIGSYGVVASAIDTHTGEK---VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
Q++IG G +G V I G K VAIK +K + L E ++ H +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKAND-DLTPEHHQFFLYQLLRALKYI 133
+ ++ ++ +FK ++ E ME+ LD+ ++ +D + + L + +KY+
Sbjct: 69 IRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD--YVATRWYRAPEL 191
N HRDL +NIL N++ + K+ DFGL+RV D P + T + RW APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAPEA 181
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLT 217
+ K+T A D+WS G + E+++
Sbjct: 182 IA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 4e-20
Identities = 71/232 (30%), Positives = 111/232 (47%), Gaps = 15/232 (6%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y E IG G+ G V +AID TG++VAIK+M + I+ EI ++R K+P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
IV L +++VV E + + + + L+AL ++H
Sbjct: 78 IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGL-ARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
S V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
Y P +DIWS+G + E++ G P + N L L+ GTP ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQN 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
IG GS G+V A + HTG++VA+KKM + E+ ++R H ++V++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 82 MLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHR 141
L +++VV E +E I + + E +LRAL Y+H+ V HR
Sbjct: 88 YLVG-----DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 142 DLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTP 201
D+K +IL +D ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 202 AIDIWSIGCIFAELLTGRP 220
+DIWS+G + E++ G P
Sbjct: 198 EVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
IG GS G+V A + H+G +VA+K M + E+ ++R +H ++VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 82 MLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHR 141
L ++++V+ E ++ I + L E +L+AL Y+HS V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 142 DLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTP 201
D+K +IL D ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 202 AIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSL 261
+DIWS+G + E++ G P + +++ +R+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPY---------------FSDSPVQAMKRLRDSPP------- 234
Query: 262 RRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
P P+ L+R+L +P++R +A+E+
Sbjct: 235 ------PKLKNAHKISPVLRDFLERMLTREPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 73/280 (26%), Positives = 119/280 (42%), Gaps = 40/280 (14%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
IG GS G+V A +G+ VA+KKM + E+ ++R +H ++VE+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 82 MLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHR 141
L +++VV E +E I + + E +L+AL +H+ V HR
Sbjct: 86 YLVG-----DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 142 DLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTP 201
D+K +IL D ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 202 AIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSL 261
+DIWS+G + E++ G P + P +++ IR+ + L +L
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------FNEPPLKAMKMIRDNLPPK-LKNL 239
Query: 262 RRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ P L RLL DP R +A E+
Sbjct: 240 HK------------VSPSLKGFLDRLLVRDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEK---VAIKKMKEVFEHVSDATRI--LREIKLL 67
S I+++IG G +G V G+K VAIK +K SD R+ L E ++
Sbjct: 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIM 59
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQ 125
HP+I+ ++ ++ + + + ++ E ME+ LD+ ++ ND T L
Sbjct: 60 GQFDHPNIIRLEGVVT-----KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRG 114
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD--YVAT 183
+ +KY+ N HRDL +NIL N++ K+ DFGL+R + A + T +
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYTTKGGKIPI 172
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
RW APE + K+T A D+WS G + E+++
Sbjct: 173 RW-TAPEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 37/233 (15%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH-----------VSDATRILREI 64
Y + E +G G++G V + G+ + +KE+ H I+ E+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQN--LLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 65 KLLR-MLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQF- 121
+++ L+HP+IV L E +Y+V +L+E + L + + L + +F
Sbjct: 60 TIIKEQLRHPNIVRYYKTFL-----ENDRLYIVMDLIEGAPLGEHFNS---LKEKKQRFT 111
Query: 122 ------FLYQLLRALKYIHSAN-VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174
Q++ AL+Y+H + HRDL P NI+ D K+ I DFGLA+ P +
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPES 168
Query: 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV 227
T V T Y PE+ + Y D+W+ GCI ++ T +P F N+
Sbjct: 169 -KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNM 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 75/290 (25%), Positives = 125/290 (43%), Gaps = 43/290 (14%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y + IG GS+G G++ IK++ + +E+ +L +KHP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQF--FLYQLLRALK 131
IV+ + E ++Y+V + E DL + I A + Q + Q+ ALK
Sbjct: 61 IVQYQESF-----EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
++H + HRD+K +NI D +K+ DFG+ARV + A + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
C + Y DIW++GC+ E+ T + F N+ +LV + I G
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLVLKI--------IRGSYP 219
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ Y LR L+ +L +P+DRPS I
Sbjct: 220 PVSSHYSYDLR-------------------NLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 67/218 (30%), Positives = 111/218 (50%), Gaps = 18/218 (8%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLK 71
+ + I++ IG G + V A G VA+KK+ ++F+ + R ++EI LL+ L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLN 60
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVI---KANDDLTPEHHQF-FLYQL 126
HP++++ + E ++ +V EL ++ DL ++I K L PE + + QL
Sbjct: 61 HPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
AL+++HS V HRD+KP N+ A +K+ D GL R + T +A V T +Y
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYY 172
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG 224
+PE + Y DIWS+GC+ E+ + F G
Sbjct: 173 MSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK--------KMKEVFEHVSDATRILREIK 65
S +E+ E +G GS+G V A TGE AIK KMK+V +HV+ IL E
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV-QHVAQEKSILME-- 74
Query: 66 LLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQ 125
L HP IV + R F +VV + + L + + +D+ +F+ +
Sbjct: 75 ----LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA----KFYHAE 126
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW 185
L+ A +Y+HS ++ +RDLKP+N+L + +K+ DFG A+ P F T
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTF--TLCGTPE 180
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222
Y APE+ S + A+D W++G + E + G P F
Sbjct: 181 YLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 72/245 (29%), Positives = 111/245 (45%), Gaps = 23/245 (9%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV---SDATRILREIKLLRMLKHPDIVEI 78
IG GS+G V T A+K +++ H+ S+ T L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 79 KHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN 137
K P + +Y+V + +L ++ +F+ +LL AL+ +H N
Sbjct: 59 KFSFQSP-----EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFS 197
V +RDLKP+NIL + + +CDFGL +++ D + T Y APEL
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH-- 168
Query: 198 KYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL-DLVTDLLGTPSAESIAGIRNEKAKR 256
YT A+D W++G + E+LTG P F NV ++ + L P G AK
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD-----GFD-RDAKD 222
Query: 257 YLSSL 261
L L
Sbjct: 223 LLIGL 227
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-19
Identities = 83/297 (27%), Positives = 125/297 (42%), Gaps = 53/297 (17%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE---HVSDATRILREIKLLRMLK 71
+Y +Q+ +G GS+G V D + +K +KE+ + ++ + +E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLD---QVIKANDDLTPEHHQF-FLYQL 126
HP IV+ L E ++ E E DLD + +K E+ + QL
Sbjct: 61 HPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
L + Y+H + HRDLK KNI + LKI DFG++R+ A T + T +Y
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTGTPYY 171
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL--GTPSAE 244
+PE Y DIWS+GCI E+ F G+N L +V ++ TPS
Sbjct: 172 MSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPSL- 225
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ Y L ++Q +L DP RPSA EI
Sbjct: 226 ---------PETYSRQLN-------------------SIMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 69/226 (30%), Positives = 105/226 (46%), Gaps = 36/226 (15%)
Query: 15 QYEIQE-----IIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM 69
+YE E ++G G+YG+V +A D T ++AIK++ E + EI L
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSY 61
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES----DLDQVIKANDDLTPEHHQ---FF 122
LKH +IV+ L + +F ME L ++++ ++ Q F+
Sbjct: 62 LKHRNIVQ----YLGSDSE--NGFFKIF--MEQVPGGSLSALLRSKWGPLKDNEQTIIFY 113
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFG----LARVS-FTDTPSAIF 176
Q+L LKY+H + HRD+K N+L N +KI DFG LA ++ T+T
Sbjct: 114 TKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET----- 168
Query: 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222
+ T Y APE+ Y DIWS+GC E+ TG+P F
Sbjct: 169 ---FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 60/293 (20%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
+G G YG V + VA+K +KE V + L+E +++ +KHP++V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQ---- 66
Query: 82 MLPPCRREFKDIYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANV 138
+L C RE Y++ E M +L ++ + ++ + Q+ A++Y+ N
Sbjct: 67 LLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA-------IFWTDYVATRWYRAPEL 191
HRDL +N L + +K+ DFGL+R+ DT +A I WT APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------APE- 175
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
++K++ D+W+ G + E+ T G +PG +++ +L+ G R
Sbjct: 176 -SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----------GYR 223
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRF 303
E+ G P L++ ++P DRPS EI
Sbjct: 224 MERP-------------------EGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 3e-18
Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 15/232 (6%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y E IG G+ G V +AID TG++VAIK++ + I+ EI +++ LK+P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
IV L +++VV E + + + + L+AL+++H
Sbjct: 78 IVNFLDSFLVG-----DELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGL-ARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
+ V HRD+K N+L D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
Y P +DIWS+G + E++ G P + N L L+ GTP ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQN 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 33/222 (14%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEK---VAIKKMKEVFEHVSDATR--ILREIKL 66
+ S +I+E+IG G +G V G++ VAIK +K + ++ R L E +
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASI 58
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQ 125
+ HP+I+ ++ ++ + ++ E ME+ LD ++ ND QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVVTKSR-----PVMIITEFMENGALDSFLRQNDG------QFTVIQ 107
Query: 126 L---LRA----LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT 178
L LR +KY+ N HRDL +NIL N++ K+ DFGL+R DT + +
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 179 DY---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
+ RW APE + K+T A D+WS G + E+++
Sbjct: 168 SLGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 87/297 (29%), Positives = 136/297 (45%), Gaps = 35/297 (11%)
Query: 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM----KEVFEHVSDATRIL 61
FF E E +++EI G GS+G V A D T E VAIKKM K+ E D I+
Sbjct: 18 FFKEDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---II 73
Query: 62 REIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQF 121
+E+K L+ +KHP+ +E K L RE V+ + S D + L
Sbjct: 74 KEVKFLQRIKHPNSIEYKGCYL----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 129
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYV 181
+ L+ L Y+HS N+ HRD+K NIL ++K+ DFG A ++ +P+ +V
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPA----NSFV 182
Query: 182 ATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGR-PLFPGRNVAHQLDLVTDLLG 239
T ++ APE+ + +Y +D+WS+G EL + PLF ++ ++ L
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYH 235
Query: 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP 296
ES NE + + R + K P P + LL+ + ++RP
Sbjct: 236 IAQNESPTLQSNEWSDYF-----RNFVDSCLQKIPQDRPTSEELLKHMFVL--RERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 9/211 (4%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK---EVFEHVSDATRILREIKLLRML 70
+ + + +++G G++G V D TG ++A+K+++ E E + + EI+LL+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELM-ESDLDQVIKANDDLTPEHHQFFLYQLLRA 129
H IV+ + P R + E M + +K+ LT + + Q+L
Sbjct: 62 LHERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
+ Y+HS + HRD+K NIL ++ +K+ DFG ++ T S T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 190 ELCGSFFSKYTPAIDIWSIGCIFAELLTGRP 220
E+ Y DIWS+GC E+LT +P
Sbjct: 179 EVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-18
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 38 TGEKVAIKKMKEVFEHVSDA---TRILREIKLLRMLKHPDIVE-IKHIMLPPCRREFKDI 93
TG +VAIK ++ + + R RE L L HP+IV + PP +
Sbjct: 2 TGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-----L 54
Query: 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNI-LAN 151
+ VFE + L +V+ A+ L + Q+L AL H+ + HRDLKP+NI ++
Sbjct: 55 FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 152 ADCK--LKICDFGLAR----VSFTDTPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAID 204
+ K+ DFG+ V D + T+ + T Y APE L G TP D
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSD 171
Query: 205 IWSIGCIFAELLTGRPLFPGRNVA 228
+++ G IF E LTG+ + G +VA
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVA 195
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 81/301 (26%), Positives = 130/301 (43%), Gaps = 57/301 (18%)
Query: 22 IGIGSYGVVASA----IDTHTGEKVAIKKMK--EVFEHVSDATRILREIKLLRMLKHPDI 75
+G G +G V + +TGE+VA+K + +H SD REI++LR L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLY--QLLRALKY 132
V+ K + P R + ++ E + S L ++ + D + L+ Q+ + + Y
Sbjct: 69 VKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQI-NLKRLLLFSSQICKGMDY 124
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR-------- 184
+ S HRDL +NIL ++ +KI DFGLA+V D DY +
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED-------KDYYYVKEPGESPIF 177
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSA 243
WY APE C SK++ A D+WS G EL T G P +P A
Sbjct: 178 WY-APE-CLR-TSKFSSASDVWSFGVTLYELFTYGDPSQ-----------------SPPA 217
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPL---ALRLLQRLLAFDPKDRPSAEE 300
E + I + + ++ L + + P L++ +P+DRPS +
Sbjct: 218 EFLRMIGIAQGQMIVTRLLEL--LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFAD 275
Query: 301 I 301
+
Sbjct: 276 L 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 47/214 (21%)
Query: 41 KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100
KVA+K +K L+E ++++ L+H +V++ + C E + IY+V E M
Sbjct: 32 KVAVKTLKP---GTMSPEAFLQEAQIMKKLRHDKLVQLYAV----CSEE-EPIYIVTEYM 83
Query: 101 ES-DLDQVIKANDDLTPEHHQFFLYQLL-------RALKYIHSANVFHRDLKPKNILANA 152
L +K + E + L QL+ + Y+ S N HRDL +NIL
Sbjct: 84 SKGSLLDFLK-----SGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE 138
Query: 153 DCKLKICDFGLARVSFTDTPSA-------IFWTDYVATRWYRAPE--LCGSFFSKYTPAI 203
+ KI DFGLAR+ D +A I WT APE G F K
Sbjct: 139 NLVCKIADFGLARLIEDDEYTAREGAKFPIKWT---------APEAANYGRFTIKS---- 185
Query: 204 DIWSIGCIFAELLT-GRPLFPG---RNVAHQLDL 233
D+WS G + E++T GR +PG R V Q++
Sbjct: 186 DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 85/303 (28%), Positives = 135/303 (44%), Gaps = 61/303 (20%)
Query: 22 IGIGSYGVVA----SAIDTHTGEKVAIKKMKE-VFEHVSDATRILREIKLLRMLKHPDIV 76
+G G++G V + +TGE VA+KK++ EH+ D REI++L+ L+H +IV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQHDNIV 68
Query: 77 EIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLY--QLLRALKY 132
+ K + RR + +V E + S D + K + L +H + LY Q+ + ++Y
Sbjct: 69 KYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL--DHRKLLLYASQICKGMEY 123
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT---------PSAIFWTDYVAT 183
+ S HRDL +NIL ++ ++KI DFGL +V D S IFW
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY----- 178
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
APE SK++ A D+WS G + EL T +D +P A
Sbjct: 179 ----APESLTE--SKFSVASDVWSFGVVLYELFT----------------YSDKSCSPPA 216
Query: 244 ESIAGIRNEKAK-----RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
E + + N+K + L+ +P PG +++ DP RPS
Sbjct: 217 EFMRMMGNDKQGQMIVYHLIELLKNNGRLPAP---PGCPAEIYAIMKECWNNDPSQRPSF 273
Query: 299 EEI 301
E+
Sbjct: 274 SEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDA-------TRILREIKLLRMLKH 72
E++G G+YG V + T+ G+ +A+K +V S+ ++ E+ LL+ LKH
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVK---QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQFFLYQLLR 128
+IV+ L C + + +F ME + ++ L + Q+L
Sbjct: 62 VNIVQ----YLGTCLDD--NTISIF--MEFVPGGSISSILNRFGPLPEPVFCKYTKQILD 113
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR----VSFTDTPSAIFWTDYVATR 184
+ Y+H+ V HRD+K N++ + +K+ DFG AR V T S + + + T
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTP 172
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRP 220
++ APE+ S Y DIWSIGC E+ TG+P
Sbjct: 173 YWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 7/208 (3%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK---EVFEHVSDATRILREIKLLRMLKH 72
+ + +++G G++G V D TG ++A+K++ + E + + EI+LL+ L+H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
IV+ + P ++ I+V + S DQ +KA LT + + Q+L+ + Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEYMPGGSIKDQ-LKAYGALTENVTRRYTRQILQGVSY 121
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+HS + HRD+K NIL ++ +K+ DFG ++ T S T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRP 220
Y D+WS+ C E+LT +P
Sbjct: 182 SG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 9e-17
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 22 IGIGSYGVVASAIDTHTGE-----KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
+G G +GVV H G+ VAIK ++E D + E K++ L HP++V
Sbjct: 12 LGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDD---FIEEAKVMMKLSHPNLV 62
Query: 77 EIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKANDDLTPEHHQFFL---YQLLRALKY 132
++ + + + I++V E M + L ++ ++ L + A++Y
Sbjct: 63 QLYGVCT-----KQRPIFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEY 115
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+ S HRDL +N L D +K+ DFGLAR D ++ T + +W PE+
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-PVKW-APPEVF 173
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTG 218
+S+++ D+WS G + E+ +
Sbjct: 174 D--YSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 20 EIIGIGSYG---VVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
+++G GS+G +V G+ A+K +K+ V D R E +L + HP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 77 EIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
++ + + +Y++ + + DL + T E +F+L +L AL ++HS
Sbjct: 62 KLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
+ +RDLKP+NIL + + +K+ DFGL++ S A + T Y APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR- 172
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGRN 226
+T + D WS G + E+LTG F G++
Sbjct: 173 -RGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 9e-17
Identities = 80/306 (26%), Positives = 124/306 (40%), Gaps = 67/306 (21%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSD--ATRILREIKLLRMLKH-----PD 74
I G++G V A TG+ AIK +K+ SD A + +K R + P
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKK-----SDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 75 IVEIKHIMLPPCRREFKD-IYVVFE-LMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+ ++ + + KD +Y+V E L D +IK L + + ++ +++ ++
Sbjct: 59 VAKLYYSF------QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-L 191
+H + HRD+KP+N+L + LK+ DFGL+R + +V T Y APE +
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-------KFVGTPDYLAPETI 165
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
G D WS+GC+ E L G P F TP
Sbjct: 166 LGV---GDDKMSDWWSLGCVIFEFLFGYPPFHA--------------ETP---------- 198
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA---EEIR----FT 304
+ + S R W P A+ L+ RLL DP R A +EI+ F
Sbjct: 199 DAVFDNILSRRINWP---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
Query: 305 EIVFNW 310
I NW
Sbjct: 256 SI--NW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM----KEVFEHVSDATRIL 61
FF + E +++EI G GS+G V A D E VAIKKM K+ E D I+
Sbjct: 8 FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD---II 63
Query: 62 REIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQF 121
+E++ L+ L+HP+ ++ + L RE V+ + S D + L
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYL----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYV 181
+ L+ L Y+HS N+ HRD+K NIL + +K+ DFG A + P+ +V
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APA----NXFV 172
Query: 182 ATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRP 220
T ++ APE+ + +Y +D+WS+G EL +P
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 82/295 (27%), Positives = 128/295 (43%), Gaps = 54/295 (18%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLKHP 73
Y ++G GSYG V+ G++ IKK+ + S R +E +LL LKHP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND-DLTPEHH--QFFLYQLLRA 129
+IV + E +Y+V E DL +K L PE+ ++F+ Q+ A
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMA 114
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV--SFTDTPSAIFWTDYVATRWYR 187
L+Y+H ++ HRDLK +N+ +K+ D G+ARV + D S + T Y Y
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY-----YM 169
Query: 188 APELCGSFFSK-YTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
+PEL F +K Y D+W++GC E+ T + F +++ LV + I
Sbjct: 170 SPEL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVYRI--------I 215
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
G K Y P L+ +L+ P+ RPS + I
Sbjct: 216 EGKLPPMPKDY-------------------SPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 71/289 (24%), Positives = 118/289 (40%), Gaps = 47/289 (16%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
+G G+ G V +TG + K + +ILRE+++ + K P IV+
Sbjct: 7 SRLGEGAGGSVTKCRLKNTG-MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 80 HIMLPPCRREFKDIYVVFELMES-DLDQV---IKANDDLTPEHHQFFLYQ-LLRALKYIH 134
L I + E E LD + +K E + + +L+ L Y+H
Sbjct: 66 GAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGL---ARVSFTDTPSAIFWTDYVATRWYRAPE- 190
S + HRD+KP NIL ++K+CDFG+ S T + T +Y APE
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT--------FTGTSFYMAPER 174
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFP--GRNVAHQLDLVTDLLGTPSAESIAG 248
+ G Y+ D+WS+G E+ R FP G ++L++ ++ P+ E
Sbjct: 175 IQG---KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE---- 227
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS 297
+++E KW+ F +++ L DP RP+
Sbjct: 228 LKDEP------GNGIKWSEEFKD-----------FIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMK---EVFEHVSDATRILREIKLLRMLKHPDIV 76
+++G G++G V D TG ++A K+++ E E + + + EI+LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 77 EIKHIMLPPCRREF--KDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+ C R+ K + + E M S DQ +KA LT + + Q+L + Y
Sbjct: 68 QYYG-----CLRDRAEKTLTIFMEYMPGGSVKDQ-LKAYGALTESVTRKYTRQILEGMSY 121
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+HS + HRD+K NIL ++ +K+ DFG ++ T S T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRP 220
Y D+WS+GC E+LT +P
Sbjct: 182 SG--EGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 31/224 (13%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
+G G +G V + +T VA+K +K D L E ++++ L+HP ++++ +
Sbjct: 14 LGAGQFGEVWEGLWNNTTP-VAVKTLKP---GTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 82 MLPPCRREFKDIYVVFELM--ESDLDQVIK-ANDDLTPEHHQFFLYQLLRALKYIHSANV 138
C E + IY+V ELM S L+ + A L Q+ + Y+ + N
Sbjct: 70 ----CTLE-EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA-------IFWTDYVATRWYRAPEL 191
HRDL +N+L + K+ DFGLARV D A I WT APE
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT---------APE- 174
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLV 234
+ +++++ D+WS G + E++T GR +PG A L V
Sbjct: 175 -AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 89/302 (29%), Positives = 131/302 (43%), Gaps = 64/302 (21%)
Query: 17 EIQEII---GIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLKH 72
+I EII G G++G V A TG A K ++ E E + D + EI +L KH
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKH 61
Query: 73 PDIVEIKH---------IMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFL 123
P+IV + I++ EF D + +M +L++ LT ++
Sbjct: 62 PNIVGLYEAYFYENKLWILI-----EFCDGGALDSIML-ELERG------LTEPQIRYVC 109
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL-ARVSFTDTPSAIFWTDYVA 182
Q+L AL ++HS V HRDLK NIL D +K+ DFG+ A+ T F +
Sbjct: 110 RQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF----IG 165
Query: 183 TRWYRAPEL--CGSFFSK-YTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239
T ++ APE+ C +F Y DIWS+G EL P P H+L+ + LL
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PH----HELNPMRVLLK 219
Query: 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299
+E + KW+ F + F L+ L DP DRP+A
Sbjct: 220 ILKSEPPTLDQP-----------SKWSSSF-NDF----------LKSCLVKDPDDRPTAA 257
Query: 300 EI 301
E+
Sbjct: 258 EL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 17/218 (7%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIK-LLRMLKHPDIVE 77
++IG GS+G V A G+ A+K + K++ + + I+ E LL+ +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 78 IKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA 136
+ + + + +Y V + + +L ++ +F+ ++ AL Y+HS
Sbjct: 61 LHYSF-----QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 137 NVFHRDLKPKNILANADCKLKICDFGLAR--VSFTDTPSAIFWTDYVATRWYRAPELCGS 194
N+ +RDLKP+NIL ++ + + DFGL + ++ +DT T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT-----TTFCGTPEYLAPEVIRK 170
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLD 232
Y +D W +G + E+L G P F R+VA D
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 17 EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
++ IG G +G V + G+KVA+K +K+ + A L E ++ L+HP++V
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLV 63
Query: 77 EIKHIMLPPCRREFKDIYVVFELME--SDLDQV-IKANDDLTPEHHQFFLYQLLRALKYI 133
++ ++L + +Y+V E M S +D + + +T F + ++Y+
Sbjct: 64 QLLGVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF---WTDYVATRWYRAPE 190
N HRDL +N+L + D K+ DFGLA+ + S WT APE
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT---------APE 169
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFP 223
K++ D+WS G + E+ + GR +P
Sbjct: 170 ALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 41/201 (20%)
Query: 41 KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100
KVAIK +K+ L E L++ L+HP +V + ++ + IY++ E M
Sbjct: 32 KVAIKSLKQ---GSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIYIITEYM 82
Query: 101 ES-DLDQVIKANDDLTPEHHQFFLYQLL-------RALKYIHSANVFHRDLKPKNILANA 152
E+ L +K TPE + + +L+ + +I N HRDL+ NIL +
Sbjct: 83 ENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE 137
Query: 153 DCKLKICDFGLARV----SFTDTPSAIF---WTDYVATRWYRAPELCGSFFSKYTPAIDI 205
KI DFGLAR+ +T A F WT APE + +T D+
Sbjct: 138 TLCCKIADFGLARLIEDNEYTAREGAKFPIKWT---------APEAIN--YGTFTIKSDV 186
Query: 206 WSIGCIFAELLT-GRPLFPGR 225
WS G + E++T GR +PG
Sbjct: 187 WSFGILLTEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 63/254 (24%), Positives = 117/254 (46%), Gaps = 22/254 (8%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLR---MLKHPDIVE 77
IG G++G V T A+K + K+ + + E +L + + P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 78 IKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA 136
+K D+Y+V + M +L ++ + + +F++ +L+ AL+++H
Sbjct: 61 LKFSFQTD-----SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 137 NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFF 196
++ +RDLKP+NIL +A + +CDFGL++ + TD + + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 197 SKYTPAIDIWSIGCIFAELLTGRPLFPG-------RNVAH-QLDLVTDLLGTPSAESIAG 248
YT +D WS+G + E+ G F RN+A ++ ++L + + G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG 231
Query: 249 IRNEKAKRYLSSLR 262
+ N + L + R
Sbjct: 232 LLNRNPQHRLGAHR 245
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 72/224 (32%), Positives = 103/224 (45%), Gaps = 57/224 (25%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLKHPDIV---- 76
+G G+ GVV + +G +A K + E+ + +I+RE+K+L P IV
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIR--NQIIRELKVLHECNSPYIVGFYG 66
Query: 77 ------EIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFL----YQ 125
EI M E M+ LDQV+K + PE+ L
Sbjct: 67 AFYSDGEISICM---------------EHMDGGSLDQVLKKAGRI-PEN---ILGKISIA 107
Query: 126 LLRALKYI---HSANVFHRDLKPKNILANADCKLKICDFGLARVS--FTDTPSAIFWTDY 180
+LR L Y+ H + HRD+KP NIL N+ ++K+CDFG VS D+ + F
Sbjct: 108 VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSF---- 158
Query: 181 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFP 223
V TR Y +PE L G + YT DIWS+G E+ GR +P
Sbjct: 159 VGTRSYMSPERLQG---THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 39/285 (13%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
+G G+ G V+ TG +A KK+ + S +ILRE++++ + P IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 82 MLPPCRREFKDIYVVFELMESD-LDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN-VF 139
L +I + E M+ LD++ K + E ++ L Y+++ + +
Sbjct: 72 FLNE-----NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 140 HRDLKPKNILANADCKLKICDFGLARV---SFTDTPSAIFWTDYVATRWYRAPELCGSFF 196
HRD+KP NIL N+ ++K+CDFG++ S DT +V T Y +PE
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--------FVGTSTYMSPERIQG-- 176
Query: 197 SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256
KYT D+WS+G EL G+ FP D D +G + + I E R
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGI--LDLLQQIVQEPPPR 232
Query: 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
SS FP + L DP +RP+ +++
Sbjct: 233 LPSS-----------DFP---EDLRDFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 80/309 (25%), Positives = 124/309 (40%), Gaps = 76/309 (24%)
Query: 17 EIQEIIGIGSYGVVASAIDT-HTGEK--VAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ IG G +G V + EK VA+K K S + L+E ++R HP
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-SVREKFLQEAYIMRQFDHP 67
Query: 74 DIVE-IKHIMLPPCRREFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRAL 130
IV+ I I P +++V EL +L ++ N L + YQL AL
Sbjct: 68 HIVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD----YVATR-- 184
Y+ S HRD+ +N+L ++ +K+ DFGL+R + + Y A++
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-----------YLEDESYYKASKGK 169
Query: 185 ----WYRAPELCGSFFSKYTPAIDIWSIG-CIFAELLTG-RPLFPGRNVAHQLDLVTDLL 238
W APE F ++T A D+W G C++ L+ G +P
Sbjct: 170 LPIKWM-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ---------------- 210
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
G + + I I E +R +P P P L+ + A+DP RP
Sbjct: 211 GVKNNDVIGRI--ENGER----------LPMPPNCP---PTLYSLMTKCWAYDPSKRP-- 253
Query: 299 EEIRFTEIV 307
RFTE+
Sbjct: 254 ---RFTELK 259
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 29/232 (12%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
++ ++ +G G +G V + +VAIK +K + + +E++ L+ L+H
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKS--DDLLKQQDFQKEVQALKRLRHK 62
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD--LTPEHHQFFLYQLLRAL 130
++ + + C + +Y++ ELME L +++ + L Q+ +
Sbjct: 63 HLISL-FAV---CSVG-EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARV------SFTDTPSAIFWTDYVATR 184
Y+ N HRDL +NIL D K+ DFGLAR+ +D WT
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT------ 171
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVT 235
APE ++ D+WS G + E+ T G+ +PG N D +T
Sbjct: 172 ---APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 65/255 (25%), Positives = 100/255 (39%), Gaps = 62/255 (24%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-------KEVFEHVSDATRILREIKL 66
+E ++IG G++G V TG A+KK+ KE HV IL E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD- 59
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQFF 122
+P +V++ + F+D ++ +ME D+ ++ D T E +F+
Sbjct: 60 -----NPWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY 106
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL------------ARVSFTD 170
+ + + A+ IH HRD+KP N+L +A +K+ DFGL R+
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 171 TPSAIFWTDY-----------------------VATRWYRAPELCGSFFSKYTPAIDIWS 207
PS V T Y APE+ + Y D WS
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWS 224
Query: 208 IGCIFAELLTGRPLF 222
+G I E+L G P F
Sbjct: 225 LGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 26/218 (11%)
Query: 17 EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKL-LRMLKHPDI 75
E+ E +G G+YGVV TG +A+K+++ R+L ++ + +R + P
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYT 62
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDLDQVIK---ANDDLTPEHHQFFL----YQLLR 128
V + RE D+++ E+M++ LD+ K PE L +++
Sbjct: 63 VTFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPED---ILGKIAVSIVK 114
Query: 129 ALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
AL+Y+HS +V HRD+KP N+L N + ++K+CDFG++ D+ + T + Y
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG-YLVDSVAK---TIDAGCKPYM 170
Query: 188 APELCGSFFSK--YTPAIDIWSIGCIFAELLTGRPLFP 223
APE ++ Y D+WS+G EL TGR FP
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGR--FP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 12/212 (5%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLKHPDIVEI 78
+++G G++G V + +G+ A+K +K EV + L E ++L+ +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 79 KHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANV 138
K+ R F YV + L + ++D T +F+ +++ AL Y+HS +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT----RFYGAEIVSALDYLHSGKI 116
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSK 198
+RDLK +N++ + D +KI DFGL + TD + + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 199 YTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQ 230
Y A+D W +G + E++ GR P N H+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 71/227 (31%), Positives = 103/227 (45%), Gaps = 45/227 (19%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLK 71
S+ E IG G+ G V I TG A +K ++ + D R I REI++LR +
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYA---LKVIYGNHEDTVRRQICREIEILRDVN 130
Query: 72 HPDIVEIKHIMLPPCRREFK---DIYVVFELMESDLDQVIKANDDLTPEH--HQFFL--- 123
HP++V+ C F +I V+ E M+ L H + FL
Sbjct: 131 HPNVVK--------CHDMFDHNGEIQVLLEFMD---------GGSLEGTHIADEQFLADV 173
Query: 124 -YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV-SFTDTPSAIFWTDYV 181
Q+L + Y+H ++ HRD+KP N+L N+ +KI DFG++R+ + T P V
Sbjct: 174 ARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC----NSSV 229
Query: 182 ATRWYRAPE-----LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFP 223
T Y +PE L + Y A DIWS+G E GR FP
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGY--AGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 91/340 (26%), Positives = 136/340 (40%), Gaps = 70/340 (20%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
E + + I E G+ G + ID T E V IK + AT E +LR +
Sbjct: 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIK----AGQRGGTAT----EAHILRAIN 141
Query: 72 HPDIVEIKH---------IMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFF 122
HP I+++K ++LP R D+Y + I D L E
Sbjct: 142 HPSIIQLKGTFTYNKFTCLILP---RYKTDLYCYLAAKRN-----IAICDILAIER---- 189
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF-WTDYV 181
+LRA++Y+H + HRD+K +NI N + + DFG A + + W +
Sbjct: 190 --SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR-PLFPGRNV------AHQLDLV 234
AT APEL Y PA+DIWS G + E+ T LF + Q+ L+
Sbjct: 248 AT---NAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302
Query: 235 TDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQ--------- 285
GT E + + Y+ ++ S + PG+ PL L +
Sbjct: 303 IRRSGTHPNEFPIDAQANLDEIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLI 356
Query: 286 -RLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324
++LAFD RPSA E + + F F + DPY
Sbjct: 357 CKMLAFDAHHRPSA------EALLD--FAAFQ--DIPDPY 386
|
Length = 391 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 80/312 (25%), Positives = 132/312 (42%), Gaps = 60/312 (19%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIK-LLRMLKHPD 74
++++ ++G G +G V + TG+ A+K MK+ + E + +L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 75 IVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHH-QFFLYQLLRA 129
I ++++ F+D +Y+V E DL ++ +D E QF+L +L+ A
Sbjct: 63 IPQLQY--------AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
+ +H HRD+KP+N+L + +K+ DFG A + + V T Y AP
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYIAP 172
Query: 190 ELC----GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
E+ G Y D WS+G I E++ GR F SA++
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT---------------SAKT 217
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLA----LRLLQRLLAFDPKDRPSAEEI 301
I N +R+L KFP DP L L+Q LL K+R E +
Sbjct: 218 YNNIMNF--QRFL-------------KFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGL 260
Query: 302 R----FTEIVFN 309
F++I +N
Sbjct: 261 CCHPFFSKIDWN 272
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 66/245 (26%), Positives = 109/245 (44%), Gaps = 53/245 (21%)
Query: 14 SQYEIQEIIGIGSYGVVASA----IDTHTGE-KVAIKKMKEVFEHVSDATRILREIKLLR 68
+ + + +G G++G V A +D VA+K +K+ D + ++ E+++++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMK 70
Query: 69 ML-KHPDIVEIKHIMLPPCRREFKDIYVVFEL-----------------MESDLDQVIKA 110
M+ KH +I+ +L C +E +YVV E + D
Sbjct: 71 MIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 111 NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170
+ LT + F YQ+ R ++++ S HRDL +N+L D +KI DFGLAR
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----- 180
Query: 171 TPSAIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GR 219
I DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233
Query: 220 PLFPG 224
P +PG
Sbjct: 234 P-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 9e-15
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 22 IGIGSYGVVASAIDTHTGE-----KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
+G G +GVV H G+ KVAIK + E D + E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLV 62
Query: 77 EIKHIMLPPCRREFKDIYVVFELMESD--LDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
++ + C ++ K +Y+V E ME+ L+ + + L+ + + ++Y+
Sbjct: 63 QLYGV----CTQQ-KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
+ HRDL +N L ++ +K+ DFG+ R D ++ + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 195 FFSKYTPAIDIWSIGCIFAELLT 217
FSKY+ D+WS G + E+ T
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPD 74
+EI E IG G+YG V ++ G K A+K + + H D I E +L+ L HP+
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDE-EIEAEYNILKALSDHPN 76
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELME----SDLDQ-VIKANDDLTPEHHQFFLYQLLRA 129
+V+ + + +++V EL +DL + +K + + + L++ L
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
L+++H HRD+K NIL + +K+ DFG VS T + + V T ++ AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 190 ELCG---SFFSKYTPAIDIWSIGCIFAELLTGRP 220
E+ S Y D+WS+G EL G P
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 71/239 (29%), Positives = 112/239 (46%), Gaps = 31/239 (12%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH-- 72
E IG G+ G V TG +A+K+M+ + + RIL ++ ++ + H
Sbjct: 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT-GNKEENKRILMDLDVV-LKSHDC 73
Query: 73 PDIVEIKHIMLPPCRREF---KDIYVVFELMESDLDQVIKANDDLTPEHHQFFL-YQLLR 128
P IV+ C F D+++ ELM + LD+++K PE + +++
Sbjct: 74 PYIVK--------CYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 129 ALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLA-RV--SFTDTPSAIFWTDYVATR 184
AL Y+ V HRD+KP NIL +A +K+CDFG++ R+ S T SA
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA-------GCA 178
Query: 185 WYRAPELCG--SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
Y APE KY D+WS+G EL TG+ FP +N + +++T +L
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDA-TRILREIKLLRML-KHP 73
+EI E IG G+YG V + G A+K + + +SD I E +L+ L HP
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVK----ILDPISDVDEEIEAEYNILQSLPNHP 79
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESD-----LDQVIKANDDLTPEHHQFFLYQLLR 128
++V+ + + +++V EL + ++ L + LY L
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
L+++H+ + HRD+K NIL + +K+ DFG VS T + + V T ++ A
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWMA 196
Query: 189 PELCG---SFFSKYTPAIDIWSIGCIFAELLTGRP 220
PE+ + Y D+WS+G EL G P
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIK--KMKEVFEHVSDATRILREIKLLRMLKHPDIVE 77
E IG GS+G V ID T E VAIK ++E + + D I +EI +L P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED---IQQEITVLSQCDSPYITR 66
Query: 78 IKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN 137
L + ++++ E + + L + L ++L+ L Y+HS
Sbjct: 67 YYGSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFS 197
HRD+K N+L + +K+ DFG+A TDT I +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDT--QIKRNTFVGTPFWMAPEVIKQ--S 176
Query: 198 KYTPAIDIWSIGCIFAELLTGRP 220
Y DIWS+G EL G P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 21 IIGIGSYGVVASA-----IDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPD 74
+G G++G V A + KVA+K +K H S+ ++ E+K++ L H +
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSHLGNHEN 100
Query: 75 IVEIKHIMLPPCRREFKDIYVVFEL-MESDLDQVIKANDD--LTPEHHQFFLYQLLRALK 131
IV +L C I V+ E DL ++ + LT E F YQ+ + +
Sbjct: 101 IVN----LLGACTIG-GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
++ S N HRDL +N+L +KICDFGLAR D+ + + +W APE
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM-APE- 213
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG 224
F YT D+WS G + E+ + G +PG
Sbjct: 214 -SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 58/186 (31%), Positives = 94/186 (50%), Gaps = 14/186 (7%)
Query: 37 HTGEKVAIKKMKEVF--EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF-KDI 93
+TGE+VA+K +K H++D + +EI++LR L H +IV+ K I C + I
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGI----CTEDGGNGI 83
Query: 94 YVVFELMES-DLDQVIKANDDLTPEHHQF-FLYQLLRALKYIHSANVFHRDLKPKNILAN 151
++ E + S L + + N + Q + Q+ + + Y+ S HRDL +N+L
Sbjct: 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 143
Query: 152 ADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 211
++ ++KI DFGL + TD D + ++ APE SK+ A D+WS G
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVT 201
Query: 212 FAELLT 217
ELLT
Sbjct: 202 LYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 17 EIQEIIGIGSYGVVASAI-DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
++++ +G G +G V A + HT KVA+K MK V L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMES----DLDQVIKANDDLTPEHHQFFLYQLLRALK 131
V++ ++ + IY++ E M D + + + P+ F Q+ +
Sbjct: 64 VKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-QIAEGMA 116
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARV----SFTDTPSAIFWTDYVATRWYR 187
+I N HRDL+ NIL +A KI DFGLARV +T A F +W
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-----PIKW-T 170
Query: 188 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG 224
APE F +T D+WS G + E++T GR +PG
Sbjct: 171 APEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEI 78
+++G G++G V + TG A+K + KEV + + E ++L+ +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 79 KHIMLPPCRREFKDIY-----VVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
K+ R F Y + F L + T E +F+ +++ AL+Y+
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYL 111
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
HS +V +RD+K +N++ + D +KI DFGL + +D + + T Y APE+
Sbjct: 112 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLE 168
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQ 230
+ Y A+D W +G + E++ GR P N H+
Sbjct: 169 D--NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 48/293 (16%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+E+ + IG G+YG V A + +TGE AIK +K E D + +EI +++ KH +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V L RR+ +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYL---RRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGL-ARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
S HRD+K NIL + +K+ DFG+ A+++ T F + T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF----IGTPYWMAPEVAA 179
Query: 194 -SFFSKYTPAIDIWSIGCIFAELLTGRP----LFPGRNVAHQLDLVTDLLGTPSAESIAG 248
Y DIW++G EL +P L P R + L T S
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---------FLMTKSNFQPPK 230
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+++ + KW+ F H ++ L +PK RP+AE++
Sbjct: 231 LKD----------KMKWSNSFHH-----------FVKMALTKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 17/228 (7%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEK----VAIKKMKEVFEHVSDATRILREIKLLRM 69
++ E +++G G++G V + GEK VAIK ++E ++ IL E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN-KEILDEAYVMAS 65
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLL 127
+ HP +V + I L + ++ +LM LD V D++ ++ + Q+
Sbjct: 66 VDHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
+ + Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM- 178
Query: 188 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLV 234
A E YT D+WS G EL+T G + G DL+
Sbjct: 179 ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIK--KMKEVFEHVSDATRILREIKLLRMLKHPDIVE 77
E IG GS+G V ID T + VAIK ++E + + D I +EI +L P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED---IQQEITVLSQCDSPYVTK 66
Query: 78 IKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
L + ++++ E + S LD + D T L ++L+ L Y+HS
Sbjct: 67 YYGSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDET--QIATILREILKGLDYLHS 119
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
HRD+K N+L + ++K+ DFG+A TDT I +V T ++ APE+
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDT--QIKRNTFVGTPFWMAPEVIKQ- 175
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRP 220
S Y DIWS+G EL G P
Sbjct: 176 -SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 18 IQEIIGIGSYGVVASAIDTHTG-----EKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
+QEI G G +G+V G KVAIK ++E D + E +++ L H
Sbjct: 9 VQEI-GSGQFGLV------WLGYWLEKRKVAIKTIREGAMSEED---FIEEAQVMMKLSH 58
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKAND-DLTPEHHQFFLYQLLRAL 130
P +V++ + E I +VFE ME L ++A + E + +
Sbjct: 59 PKLVQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
Y+ S+NV HRDL +N L + +K+ DFG+ R D ++ T + +W +PE
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKW-SSPE 171
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLT 217
+ FSKY+ D+WS G + E+ +
Sbjct: 172 VFS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 64/248 (25%), Positives = 113/248 (45%), Gaps = 41/248 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDAT--RILREIKLLRMLK 71
+ E+ + +G G+YG V + TG +A MKE+ + ++ +I+ E+ +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMA---MKEIRLELDESKFNQIIMELDILHKAV 57
Query: 72 HPDIVEI-KHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLT--PEHH-QFFLYQL 126
P IV+ + +Y+ E M++ LD++ PE + Y +
Sbjct: 58 SPYIVDFYGAFFIEGA------VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV 111
Query: 127 LRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGL-----ARVSFTDTPSAIFWTDY 180
++ LK++ N+ HRD+KP N+L N + ++K+CDFG+ A ++ T+
Sbjct: 112 VKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN---------- 161
Query: 181 VATRWYRAPE----LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR---NVAHQLDL 233
+ + Y APE + YT D+WS+G E+ GR +P N+ QL
Sbjct: 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA 221
Query: 234 VTDLLGTP 241
+ D G P
Sbjct: 222 IVD--GDP 227
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 45/286 (15%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
E IG G++G V + +VA+K + + L+E ++L+ HP+IV++
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 80 HIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN 137
+ + + + IY+V EL+ S L + K + LT + ++Y+ S N
Sbjct: 59 GVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFS 197
HRDL +N L + LKI DFG++R + + +W APE +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALN--YG 170
Query: 198 KYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256
+YT D+WS G + E + G +PG + N++ +
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMS------------------------NQQTRE 206
Query: 257 YLSSLRRKWAVPFSHKFPGADPLAL-RLLQRLLAFDPKDRPSAEEI 301
+ S R A P P + RL+ + A+DP++RPS EI
Sbjct: 207 RIESGYRMPA-------PQLCPEEIYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 78/290 (26%), Positives = 131/290 (45%), Gaps = 47/290 (16%)
Query: 1 MFDKEFFTEYGE-----ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVS 55
+ F+ GE +++I ++G G++G V A D E A+K ++ V ++
Sbjct: 111 REEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTR 170
Query: 56 DATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD-----IYVVFELMESDLDQVIKA 110
DA +I EI+ + ++ D + +M +R F++ V+ + LD ++K
Sbjct: 171 DA-KI--EIQFMEKVRQADPADRFPLM--KIQRYFQNETGHMCIVMPKYGPCLLDWIMK- 224
Query: 111 NDDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANAD---------------- 153
+ + H ++Q AL Y H+ ++ H DLKP+NIL
Sbjct: 225 HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 154 CKLKICDFGLA---RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 210
C+++ICD G R S T AI V+TR YR+PE+ Y+ D+WS+GC
Sbjct: 285 CRVRICDLGGCCDERHSRT----AI-----VSTRHYRSPEVVLGLGWMYS--TDMWSMGC 333
Query: 211 IFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSS 260
I EL TG+ L+ + L L+ LG +E E+A+ +S
Sbjct: 334 IIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNS 383
|
Length = 467 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 18/234 (7%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIK-LLRMLKHPDIVE 77
++IG GS+G V A G A+K + K+ + I+ E LL+ LKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 78 IKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA 136
+ + + +Y V + + +L ++ +F+ ++ A+ Y+HS
Sbjct: 61 LHYSFQTA-----EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 137 NVFHRDLKPKNILANADCKLKICDFGLAR--VSFTDTPSAIFWTDYVATRWYRAPELCGS 194
N+ +RDLKP+NIL ++ + + DFGL + V +T S + T Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-----FCGTPEYLAPEVLRK 170
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLD-LVTDLLGTPSAESIA 247
Y +D W +G + E+L G P F R+V+ D ++ L P +++A
Sbjct: 171 --EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA 222
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 48/189 (25%), Positives = 84/189 (44%), Gaps = 38/189 (20%)
Query: 120 QFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD 179
+ ++ +++ AL ++H + +RD+K +NIL +++ + + DFGL++ + +
Sbjct: 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--S 165
Query: 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239
+ T Y APE+ + A+D WS+G + ELLTG F
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF----------------- 208
Query: 240 TPSAESIAGIRN---EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR- 295
++ G +N E ++R L S PF A +Q+LL DPK R
Sbjct: 209 -----TVDGEQNSQSEISRRILKS-----KPPFPKTM---SAEARDFIQKLLEKDPKKRL 255
Query: 296 --PSAEEIR 302
A+EI+
Sbjct: 256 GANGADEIK 264
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 47/227 (20%)
Query: 20 EIIGIGSYGVV-----ASAIDTHTGEKVAIKKMKEVFEHVSDATR-ILREIKLLRMLKHP 73
+G G++G V + E VA+K +KE +DA + RE +LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHE 68
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKAND--------------DLTPEH 118
+IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 69 NIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT 178
Q+ + Y+ S + HRDL +N L D +KI DFG++R ++ T
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVYTT 175
Query: 179 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
DY + RW PE + K+T D+WS G + E+ T
Sbjct: 176 DYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRML-KHPDIVEI 78
++G GS+G V A T E A+K + K+V D + E ++L + KHP + +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ- 60
Query: 79 KHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN 137
L C + ++ V E + DL I+ + +F+ +++ L+++H
Sbjct: 61 ----LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG 116
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFS 197
+ +RDLK N+L +++ +KI DFG+ + + + + T Y APE+ +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS--YQ 171
Query: 198 KYTPAIDIWSIGCIFAELLTGRPLFPGRN 226
Y PA+D W++G + E+L G+ F G +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 26/228 (11%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEI 78
+++G G++G V + TG+ A+K + KEV + L E ++L+ +HP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 79 KHIMLPPCRREFKDIYV-----VFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
K+ R F Y F L + + + +F+ +++ AL Y+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALGYL 111
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLAR--VSFTDTPSAIFWTDYVATRWYRAPEL 191
HS +V +RDLK +N++ + D +KI DFGL + +S T + T Y APE+
Sbjct: 112 HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYLAPEV 166
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR--NVAHQLDLVTDL 237
+ Y A+D W +G + E++ GR F + +L L+ ++
Sbjct: 167 LED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 21 IIGIGSYGVVASAIDTH---TGEKVAIKKMKE--VFEHVSDATRILREIKLLRMLKHPDI 75
++G G YG V TG+ A+K +K+ + + D E +L +KHP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 76 VEIKHIMLPPCRREFKDIYVVFE-LMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V++ + + +Y++ E L +L ++ + F+L ++ AL+++H
Sbjct: 63 VDLIYAF-----QTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
+ +RDLKP+NIL +A +K+ DFGL + S + + T Y APE+
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE---GTVTHTFCGTIEYMAPEILMR 174
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN 226
S + A+D WS+G + ++LTG P F N
Sbjct: 175 --SGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 79/312 (25%), Positives = 130/312 (41%), Gaps = 66/312 (21%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-------EHVSDATRILREIKLLRMLKHP 73
++G G +G V A TGE AIK +K+ E + RI R HP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER---HP 62
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLRALKY 132
+V L C + + V E + D ++ + D+ E F+ ++ L+Y
Sbjct: 63 FLVN-----LFACFQTEDHVCFVMEYA-AGGDLMMHIHTDVFSEPRAVFYAACVVLGLQY 116
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLAR--VSFTDTPSAIFWTDYVATRWYRAPE 190
+H + +RDLK N+L + + +KI DFGL + + F D S + T + APE
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEFLAPE 171
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
+ + YT A+D W +G + E+L G FPG + E I
Sbjct: 172 VLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDD---------------EEEVFDSIV 214
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAEEIR--- 302
N++ RY L R+ A+ +++RLL +P+ R AE+++
Sbjct: 215 NDEV-RYPRFLSRE---------------AISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258
Query: 303 -FTEIVFNWLFL 313
F +I ++ L
Sbjct: 259 FFRDINWDDLLA 270
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 41 KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100
KVA+K +K L E ++++ L+H +V++ ++ + IY+V E M
Sbjct: 32 KVAVKTLKP---GTMSPESFLEEAQIMKKLRHDKLVQLYAVV------SEEPIYIVTEYM 82
Query: 101 -ESDLDQVIKANDDLTPEHHQF--FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLK 157
+ L +K + + Q+ + YI N HRDL+ NIL K
Sbjct: 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCK 142
Query: 158 ICDFGLARV----SFTDTPSAIF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 210
I DFGLAR+ +T A F WT APE + + ++T D+WS G
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFPIKWT---------APE--AALYGRFTIKSDVWSFGI 191
Query: 211 IFAELLT-GRPLFPGRNVAHQLDLV 234
+ EL+T GR +PG N L+ V
Sbjct: 192 LLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
YE+ + +G G+YG V A + HTGE A+K +K E D + I +EI +++ KH +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V L R + +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYL--SREK---LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGL-ARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
S HRD+K NIL + +K+ DFG+ A+++ T F + T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF----IGTPYWMAPEVAA 179
Query: 194 -SFFSKYTPAIDIWSIGCIFAELLTGRP 220
Y DIW++G EL +P
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 71/299 (23%), Positives = 136/299 (45%), Gaps = 46/299 (15%)
Query: 16 YEIQEIIGIGSYGVV--ASAIDTH-TGEKVAIKKMKEVF----EHVSDATRILREIKLLR 68
+E+ +++G G+YG V + H +G+ A+K +K+ ++ TR R++ L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEH 60
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLR 128
+ + P +V + + + Y+ + + L Q + + Q + +++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVL 116
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
AL+++H + +RD+K +NIL +++ + + DFGL++ D + + T Y A
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMA 174
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
P++ + A+D WS+G + ELLTG F ++ G
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF----------------------TVDG 212
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR----PS-AEEIR 302
+N +A+ +S K P+ + LA ++QRLL DPK R PS A+EI+
Sbjct: 213 EKNSQAE--ISRRILKSEPPYPQEM---SALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLKH 72
+ + EIIG G +G V +TG+KVA+K +K +V A L E ++ L H
Sbjct: 6 QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHH 58
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELM-ESDLDQVIKANDDL---TPEHHQFFLYQLLR 128
++V + ++L +Y+V ELM + +L ++ + QF L +
Sbjct: 59 KNLVRLLGVIL------HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL-DVAE 111
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF---WTDYVATRW 185
++Y+ S + HRDL +NIL + D K+ DFGLARV ++ WT
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT------- 164
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFP 223
APE K++ D+WS G + E+ + GR +P
Sbjct: 165 --APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 17/218 (7%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKV--AIKKM-KEVFEHVSDATRILREIK-LLRMLKHPDI 75
++IG GS+G V A H E+ A+K + K+ + I+ E LL+ +KHP +
Sbjct: 1 KVIGKGSFGKVLLA--RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V + H + +Y V + + +L ++ +F+ ++ AL Y+H
Sbjct: 59 VGL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
S N+ +RDLKP+NIL ++ + + DFGL + + + + + T Y APE+
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYLAPEVLHK 170
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLD 232
Y +D W +G + E+L G P F RN A D
Sbjct: 171 --QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
++G GS+G V A T E AIK +K +V D + E ++L + P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 80 HIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANV 138
H C + +Y V E + DL I+ H F+ ++ L ++HS +
Sbjct: 67 H----SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSK 198
+RDLK N++ +++ +KI DFG+ + + D + + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---GVTTKTFCGTPDYIAPEIIA--YQP 177
Query: 199 YTPAIDIWSIGCIFAELLTGRPLFPGRN 226
Y ++D W+ G + E+L G+ F G +
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 17/217 (7%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIK-LLRMLKHPDIVEI 78
+IG GS+G V A G+ A+K + K+ + I+ E LL+ +KHP +V +
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 79 KHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN 137
+ +Y V + + +L ++ +F+ ++ AL Y+HS N
Sbjct: 62 HYSFQTA-----DKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN 116
Query: 138 VFHRDLKPKNILANADCKLKICDFGLAR--VSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
+ +RDLKP+NIL ++ + + DFGL + + + T S + T Y APE+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FCGTPEYLAPEVLRK- 170
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLD 232
Y +D W +G + E+L G P F R+ A D
Sbjct: 171 -QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIK--KMKEVFEHVSDATRILREIKLLRMLKHPDIVE 77
E IG GS+G V ID T + VAIK ++E + + D I +EI +L P + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED---IQQEITVLSQCDSPYVTK 66
Query: 78 IKHIMLPPCRREFKDIYVVFELM--ESDLDQVIKANDDLTPEHHQF----FLYQLLRALK 131
L + ++++ E + S LD + D +F L ++L+ L
Sbjct: 67 YYGSYLKGTK-----LWIIMEYLGGGSALDLLRAGPFD------EFQIATMLKEILKGLD 115
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
Y+HS HRD+K N+L + +K+ DFG+A TDT I +V T ++ APE+
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDT--QIKRNTFVGTPFWMAPEV 172
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRP 220
S Y DIWS+G EL G P
Sbjct: 173 IQQ--SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+ QEI+G G+ G V A T +A+K + V +I+ E+++L P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPY 60
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEH-HQFFLYQLLRALKY 132
I+ R I + E M+ LD K PEH +++ L Y
Sbjct: 61 IIGFYGAFFVENR-----ISICTEFMDGGSLDVYRK-----IPEHVLGRIAVAVVKGLTY 110
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+ S + HRD+KP N+L N ++K+CDFG++ T ++I T YV T Y APE
Sbjct: 111 LWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKT-YVGTNAYMAPERI 165
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFP 223
+Y D+WS+G F EL GR FP
Sbjct: 166 SG--EQYGIHSDVWSLGISFMELALGR--FP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEI 78
+++G GS+G V A T E AIK + K+V D + E ++L +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53
Query: 79 KHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
KH L F+ +F +ME DL I+ + +F+ ++ AL ++H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
V +RDLK NIL +A+ K+ DFG+ + + + T + T Y APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN---GVTTTTFCGTPDYIAPEILQE 170
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN 226
+Y P++D W++G + E++ G+P F N
Sbjct: 171 L--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 77/316 (24%), Positives = 122/316 (38%), Gaps = 87/316 (27%)
Query: 18 IQEIIGIGSYGVV-----ASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRML 70
I+E+ G GS+G+V + +VAIK V E+ S RI L E +++
Sbjct: 11 IREL-GQGSFGMVYEGLAKGVVKGEPETRVAIKT---VNENASMRERIEFLNEASVMKEF 66
Query: 71 KHPDIVEIKHIML---PPCRREFKDIYVVFELM-ESDLDQVIKA-------NDDLTPEHH 119
+V + ++ P VV ELM + DL +++ N L P
Sbjct: 67 NCHHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118
Query: 120 QFFLY---QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176
Q F+ ++ + Y+ + HRDL +N + D +KI DFG+ R I+
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIY 170
Query: 177 WTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA 228
TDY + RW APE +T D+WS G + E+ T
Sbjct: 171 ETDYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMAT----------- 216
Query: 229 HQLDLVTDLLGTPSAESIAGIRNEKAKRYLSS---LRRKWAVPFSHKFPGADPLALRLLQ 285
L + G+ NE+ +++ L P D L L L++
Sbjct: 217 ---------LA---EQPYQGLSNEEVLKFVIDGGHLDLPENCP--------DKL-LELMR 255
Query: 286 RLLAFDPKDRPSAEEI 301
++PK RP+ EI
Sbjct: 256 MCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 22 IGIGSYGVVASAIDTHTGEK---VAIKKMKEVFEH-VSDATRILREIKLLRMLKHPDIVE 77
+G G++G V + K VA+K +K+ EH + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 78 IKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA 136
+ + + +V EL L + +K ++ + +Q+ + Y+ S
Sbjct: 61 LIGVCKGE------PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 137 NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-------RWYRAP 189
+ HRDL +N+L + KI DFG++R + Y AT +WY AP
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS------DYYRATTAGRWPLKWY-AP 167
Query: 190 ELCGSFFSKYTPAIDIWSIGCIFAELLT 217
E C ++ K++ D+WS G E +
Sbjct: 168 E-CINYG-KFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 75/306 (24%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
Y + + + GS G V A + V +K + L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY-QLLRALKYIH 134
+ +K ++ + V SDL + P + Q+L L+Y+H
Sbjct: 120 IRMKDTLV---SGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
+ + HRD+K +NI N ++ I D G A+ P+ + V T APE+
Sbjct: 175 AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLAR 230
Query: 195 FFSKYTPAIDIWSIGCIFAELLT----------GRPLFPGRNV-AHQLDLVTDLLGTPSA 243
KY DIWS G + E+L P ++ +H L +++ L P
Sbjct: 231 --DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP-- 286
Query: 244 ESIAGIRNEKAKR---YLSSLRRKWAVPFSHKFPGADPLALR-----LLQRLLAFDPKDR 295
E + R +SL R+ P++ ++P + L L+ ++L FD R
Sbjct: 287 EEFPRDPGSRLVRGFIEYASLERQ---PYT-RYPCFQRVNLPIDGEFLVHKMLTFDAAMR 342
Query: 296 PSAEEI 301
PSAEEI
Sbjct: 343 PSAEEI 348
|
Length = 357 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 20 EIIGIGSYGVV--ASAIDTHTGE-KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
+IG G +G V + ID+ + A+K + + + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 77 EIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQF------FLYQLLRAL 130
+ I LP E + V+ + DL I+ + H+ F Q+ + +
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIR-----SETHNPTVKDLIGFGLQVAKGM 111
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
+Y+ S HRDL +N + + +K+ DFGLAR I+ +Y + + +
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAK 163
Query: 191 LCGSFFS-------KYTPAIDIWSIGCIFAELLT-GRPLFP 223
L + + K+T D+WS G + EL+T G P +P
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 50/285 (17%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
E IG G++G V S VA+K +E A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLI 59
Query: 80 HIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLR-------ALKY 132
+ C ++ + IY+V EL++ L E + + +L++ ++Y
Sbjct: 60 GV----CTQK-QPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+ S + HRDL +N L LKI DFG++R ++ + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
+ +Y+ D+WS G + E + LG A A + N+
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS--------------------LG---AVPYANLSNQ 203
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS 297
+ + + R +P P A RL++R +DP RPS
Sbjct: 204 QTREAIEQGVR---LPCPELCPDA---VYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
++G G +G V + TG+ A K++ K+ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 80 HIMLPPCRREFKD-IYVVFELMES-DLDQVI--KANDDLTPEHHQFFLYQLLRALKYIHS 135
+ E KD + +V +M DL I N E F+ ++L L+ +H
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
N +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPEVLNN- 175
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGR 225
+YT + D W +GC+ E++ G+ F GR
Sbjct: 176 -QRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 57/244 (23%), Positives = 103/244 (42%), Gaps = 51/244 (20%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEI 78
+++G G G V TG+ A+K + K+ + R+L E ++L L HP + +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 79 KHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDD--LTPEHHQFFLYQLLRALKY 132
F+ + +M+ +L ++++ L+ E +F+ ++L AL+Y
Sbjct: 67 YA--------SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT-------------- 178
+H + +RDLKP+NIL + + + DF L++ S P +
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPPPVSKALRKGSRRSSVNSIP 177
Query: 179 -------------DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222
+V T Y APE+ G + A+D W++G + E+L G F
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGTTPF 232
Query: 223 PGRN 226
G N
Sbjct: 233 KGSN 236
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLKHPDIVEIK 79
+G G+ GVV +G I K + + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSG---LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 80 HIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN- 137
+I + E M+ LDQV+K + E +LR L Y+ +
Sbjct: 70 GAFYSD-----GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-LCGSFF 196
+ HRD+KP NIL N+ ++K+CDFG++ D+ + +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMA----NSFVGTRSYMSPERLQGTHY 179
Query: 197 SKYTPAIDIWSIGCIFAELLTGR-PLFP 223
S + DIWS+G EL GR P+ P
Sbjct: 180 SVQS---DIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 73/309 (23%), Positives = 121/309 (39%), Gaps = 51/309 (16%)
Query: 15 QYEIQEIIGIGSYG--VVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
QY I + GS G V + +KV +K V+ REI +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKA-------VTGGKTPGREIDILKTISH 145
Query: 73 PDIVEIKH---------IMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFL 123
I+ + H +++P + D++ + + +T +
Sbjct: 146 RAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGP-----LPLEQAITIQR----- 192
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA--RVSFTDTPSAIFWTDYV 181
+LL AL Y+H + HRD+K +NI + + DFG A + DTP W+ +
Sbjct: 193 -RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTL 251
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV---AHQLDLVTDLL 238
T +PEL Y DIWS G + E+ G+ V + QL + +
Sbjct: 252 ET---NSPEL--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM 306
Query: 239 GTPSAESIAGIRNEKA------KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDP 292
E +N K+Y LR + +P + G L+ ++L FD
Sbjct: 307 QVHPLEF---PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ 363
Query: 293 KDRPSAEEI 301
+ RPSA++I
Sbjct: 364 EFRPSAQDI 372
|
Length = 392 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
+G G +G V T KVAIK +K L+E ++++ L+H +V + +
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLKP---GTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 82 MLPPCRREFKDIYVVFELM-ESDLDQVIKANDDLTPEHHQF--FLYQLLRALKYIHSANV 138
+ + IY+V E M + L +K D + Q Q+ + YI N
Sbjct: 70 V------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123
Query: 139 FHRDLKPKNILANADCKLKICDFGLARV----SFTDTPSAIFWTDYVATRWYRAPELCGS 194
HRDL+ NIL + KI DFGLAR+ +T A F +W APE +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-----PIKW-TAPE--AA 175
Query: 195 FFSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQLD 232
+ ++T D+WS G + EL+T GR +PG R V Q++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 19 QEIIGIGSYGVVA----SAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
++G G +G V+ + TGE VA+K +K + + +EI +L+ L H +
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK-KEINILKTLYHEN 67
Query: 75 IVEIKHIMLPPCRREF--KDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRAL 130
IV+ K C E K + ++ E + S D + K +L F Q+ +
Sbjct: 68 IVKYKG-----CCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLFAQQICEGM 120
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLA----------RVSFTDTPSAIFWTDY 180
Y+HS + HRDL +N+L + D +KI DFGLA RV D S +FW
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR-EDGDSPVFWY-- 177
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
A E K++ A D+WS G ELLT
Sbjct: 178 -------AVECLKEN--KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 12/215 (5%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV--SDATRILREIKLLRM 69
+A Y++ ++IG G++G V + + +KV K+ FE + SD+ E ++
Sbjct: 41 KAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRA 129
P +V+ L ++ K +Y+V E M + +N D+ + +F+ +++ A
Sbjct: 100 ANSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLA 154
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
L IHS + HRD+KP N+L + LK+ DFG D + V T Y +P
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK--MDETGMVRCDTAVGTPDYISP 212
Query: 190 ELCGSFFSK--YTPAIDIWSIGCIFAELLTGRPLF 222
E+ S Y D WS+G E+L G F
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 69/303 (22%), Positives = 128/303 (42%), Gaps = 55/303 (18%)
Query: 16 YEIQEIIGIGSYGVV-----ASAIDT------HTGEKVAIKKMKEVFEHVSDATRILREI 64
+E+ +++G G+YG V + DT +K A+ + + EH +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 65 KLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY 124
+ + P +V + + + YV M + L Q D+ + + +F+
Sbjct: 62 R-----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSG 112
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
+++ AL+++H + +RD+K +NIL +++ + + DFGL++ ++ + + T
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTI 170
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
Y APE+ + A+D WS+G + ELLTG F
Sbjct: 171 EYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGASPF---------------------- 207
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAE 299
++ G RN +++ L+ P P A LL +LL DPK R A
Sbjct: 208 TLEGERNTQSEVSRRILKCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGAS 262
Query: 300 EIR 302
EI+
Sbjct: 263 EIK 265
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLKHPDIVEI 78
+++G G++G V + TG A+K +K EV + L E ++L+ +HP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 79 KHIMLPPCRREFKDIY-----VVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
K+ R F Y + F L ++V + + +F+ +++ AL Y+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSR---ERV------FSEDRARFYGAEIVSALDYL 111
Query: 134 HSA-NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
HS NV +RDLK +N++ + D +KI DFGL + D + + T Y APE+
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVL 168
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQ 230
+ Y A+D W +G + E++ GR P N H+
Sbjct: 169 ED--NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
++G GS+G V A T E AIK +K +V D + E ++L + P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 80 HIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANV 138
H C + +Y V E + DL I+ F+ ++ L ++H +
Sbjct: 67 H----SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSK 198
+RDLK N++ +++ +KI DFG+ + D + + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCGTPDYIAPEIIA--YQP 177
Query: 199 YTPAIDIWSIGCIFAELLTGRPLFPGRN 226
Y ++D W+ G + E+L G+P F G +
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
+G G +G V + KVA+K +K V L E L++ L+H +V + +
Sbjct: 14 LGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLVRLYAV 69
Query: 82 MLPPCRREFKDIYVVFELM-ESDLDQVIKANDD---LTPEHHQFFLYQLLRALKYIHSAN 137
+ +E + IY++ E M + L +K+++ L P+ F Q+ + YI N
Sbjct: 70 V----TKE-EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-QIAEGMAYIERKN 123
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARV----SFTDTPSAIF---WTDYVATRWYRAPE 190
HRDL+ N+L + KI DFGLARV +T A F WT APE
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT---------APE 174
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN 226
F +T D+WS G + E++T G+ +PG +
Sbjct: 175 AIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 22 IGIGSYGVVASAI-DTHTGEK-VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
+G G++G V + EK VA+K +K + +LRE +++ L +P IV
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR-- 60
Query: 80 HIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANV 138
M+ C E + +V EL E L++ ++ N +T ++ ++Q+ +KY+ N
Sbjct: 61 --MIGIC--EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVSFTD-----TPSAIFWTDYVATRWYRAPELCG 193
HRDL +N+L KI DFGL++ D + W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 194 SFFSKYTPAIDIWSIGCIFAE 214
+++ K++ D+WS G + E
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 75/305 (24%), Positives = 123/305 (40%), Gaps = 51/305 (16%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEIKH 80
+G G +G V + TG+ A KK+ K+ + L E K+L + IV + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 81 IMLPPCRREFKDIYVVFELMES-DLD-QVIKANDDLTPEHHQ-FFLYQLLRALKYIHSAN 137
D+ +V LM DL + + PE F+ Q++ L+++H
Sbjct: 61 AFETK-----DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFS 197
+ +RDLKP+N+L + ++I D GLA + T Y APE+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA----VELKGGKKIKGRAGTPGYMAPEVLQG--E 169
Query: 198 KYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257
Y ++D +++GC E++ GR F R + E+ KR
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRK--------------------EKVEKEELKRR 209
Query: 258 LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAEEIR----FTEIVF 308
+ AV + KF P A L + LL DP+ R SA+E+R F ++ +
Sbjct: 210 TLEM----AVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262
Query: 309 NWLFL 313
L
Sbjct: 263 RRLEA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 22 IGIGSYG-VVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
+G GS+G V+ + VAIK+ K + E K+L + HP V +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL- 96
Query: 80 HIMLPPCRREFKD---IYVVFE-LMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
FKD +Y+V E ++ + ++ N + F+ Q++ +Y+ S
Sbjct: 97 -------YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
N+ +RDLKP+N+L + D +K+ DFG A+V T T + T Y APE+ +
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------LCGTPEYIAPEILLNV 203
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLF 222
+ A D W++G E+L G P F
Sbjct: 204 --GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 49/292 (16%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
++G G +G V + TG+ A KK+ K+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 80 HIMLPPCRREFKD-IYVVFELMES-DLDQVIK--ANDDLTPEHHQFFLYQLLRALKYIHS 135
+ E KD + +V LM DL I N E F+ ++ L+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
+ +RDLKP+NIL + ++I D GLA + P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKN- 175
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255
+YT + D W +GC+ E++ G+ F R ++ E+ +
Sbjct: 176 -ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK--------------------EKVKREEVE 214
Query: 256 RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAEEIR 302
R + + +++ FS A + ++LL DP R AEE++
Sbjct: 215 RRVKEDQEEYSEKFS-------EAARSICRQLLTKDPGFRLGCRGEGAEEVK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
++G GS+G V A T E AIK +K +V D + E ++L + P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL--- 63
Query: 80 HIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANV 138
L C + +Y V E + DL I+ H F+ ++ L ++HS +
Sbjct: 64 -TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVS-FTDTPSAIFWTDYVATRWYRAPELCGSFFS 197
+RDLK N++ +A+ +KI DFG+ + + F + F T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF----CGTPDYIAPEIIA--YQ 176
Query: 198 KYTPAIDIWSIGCIFAELLTGRPLFPG 224
Y ++D W+ G + E+L G+P F G
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRM-LKHPDIVEI 78
++G GS+G V A T E AIK +K +V D + E ++L + +HP + +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 79 KHIMLPPCRREFKD-IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA 136
C + K+ ++ V E + DL I+++ +F+ +++ L+++H
Sbjct: 62 F------CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115
Query: 137 NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFF 196
+ +RDLK N+L + D +KI DFG+ + + A + + T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG-- 170
Query: 197 SKYTPAIDIWSIGCIFAELLTGRPLFPG 224
KY ++D WS G + E+L G+ F G
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 13/210 (6%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLK-HPDIVE 77
++G GS+G V A +G A+K +K +V D + E ++L + + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 78 IKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA 136
+ P R ++ V E + DL I+ + +F+ ++ AL ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 137 NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFF 196
+ +RDLK N+L + + K+ DFG+ + + + + T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---GKTTSTFCGTPDYIAPEILQEML 172
Query: 197 SKYTPAIDIWSIGCIFAELLTGRPLFPGRN 226
Y P++D W++G + E+L G F N
Sbjct: 173 --YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
+E ++I G+YG V T ++ A+KK+ K+ + ++ E +L ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 73 PDIVEIKHIMLPPCRREFKD-IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRAL 130
P +V + C E K + +V E +E D ++K L + + + + + AL
Sbjct: 61 PFVVSMF------CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLAL 114
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF-WTDYVATRWYRAP 189
+Y+H+ + HRDLKP N+L + +K+ DFGL+++ + ++ TR +
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 190 ELCGS---------FFSKYTPAIDIWSIGCIFAELLTGRPLFPG 224
++CG+ Y +D W++G I E L G F G
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 74/307 (24%), Positives = 117/307 (38%), Gaps = 44/307 (14%)
Query: 25 GSYG-VVASAIDTHTGEKVAIKKMKEVFEHVSDATRIL---------------REIKLLR 68
G++G + A+ T E A + + + R++ EI L
Sbjct: 159 GAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG 218
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLR 128
L H +I++I+ I+ F+L D+ D + + + QLL
Sbjct: 219 RLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLC 278
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
A++YIH + HRD+K +NI N D K+ + DFG A + F + F +V T +
Sbjct: 279 AVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPF-EKEREAFDYGWVGTVATNS 336
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFP----GRNVAHQLDLVTDLLGTPSAE 244
PE+ Y DIWS G I ++L+ P G QL + D L E
Sbjct: 337 PEILAG--DGYCEITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKIIDSLSVCDEE 393
Query: 245 ----------SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD 294
I + A + L R +P ++P L ++L FD
Sbjct: 394 FPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP---------LVKMLTFDWHL 444
Query: 295 RPSAEEI 301
RP A E+
Sbjct: 445 RPGAAEL 451
|
Length = 501 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 80/291 (27%), Positives = 124/291 (42%), Gaps = 43/291 (14%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+EI +G G++G V A + TG A K ++ E + + EI++L HP I
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYI 71
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDD--LTPEHHQFFLYQLLRALKYI 133
V+ +L + K ++++ E I D LT Q Q+L AL+Y+
Sbjct: 72 VK----LLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
HS + HRDLK N+L D +K+ DFG VS + + ++ T ++ APE+
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 194 SFFSKYTP---AIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
K TP DIWS+G E+ P H+L+ + LL +E
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEP------PHHELNPMRVLLKIAKSEPPT--- 234
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
LS KW++ F F L+ L P+ RPSA ++
Sbjct: 235 -------LSQ-PSKWSMEF-RDF----------LKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 83/330 (25%), Positives = 138/330 (41%), Gaps = 76/330 (23%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGE-----KVAIKKMKEVFEHVSDATRILREIKLLR 68
++YE+ + IG G +G V T E ++ + +KE + ++++ E+ ++R
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-----REKSQLVIEVNVMR 67
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDL--TPEHHQF--FL 123
LKH +IV L + + +Y++ E ++ DL + I+ + E H
Sbjct: 68 ELKHKNIVRYIDRFL---NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 124 YQLLRALKYIHS-------ANVFHRDLKPKNILANADCK-----------------LKIC 159
QLL AL Y H+ V HRDLKP+NI + + KI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 160 DFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR 219
DFGL++ ++ + V T +Y +PEL Y D+W++GCI EL +G+
Sbjct: 185 DFGLSKNIGIESMAH----SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
Query: 220 PLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPL 279
F N QL +S L+R +P K + L
Sbjct: 241 TPFHKANNFSQL--------------------------ISELKRGPDLPIKGK---SKEL 271
Query: 280 ALRLLQRLLAFDPKDRPSAEEIRFTEIVFN 309
+ L++ LL K+RPSA + +I+ N
Sbjct: 272 NI-LIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 60/243 (24%), Positives = 104/243 (42%), Gaps = 37/243 (15%)
Query: 20 EIIGIGSYGVVASAIDTHTGEK---VAIKKMK-EVFEHVSDATRILREIKLLRMLKHPDI 75
+ +G GS+GVV + +G K VA+K +K + + D L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD--FLKEAAIMHSLDHENL 58
Query: 76 VEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEH--HQFFLYQLLRALK 131
+ + ++L + +V EL S LD++ K + + Q+ ++
Sbjct: 59 IRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV-QIANGMR 111
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR---- 187
Y+ S HRDL +NIL +D K+KI DFGL R + D+ +
Sbjct: 112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMR-------ALPQNEDHYVMEEHLKVPF 164
Query: 188 ---APELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN---VAHQLDLVTDLLGT 240
APE ++ A D+W G E+ T G + G + + ++D + L
Sbjct: 165 AWCAPESLR--TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER 222
Query: 241 PSA 243
P A
Sbjct: 223 PEA 225
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
A +E+ E++G G+YG V TG+ AIK M + + I +EI +L+ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSH 61
Query: 73 PDIVEIKHIML----PPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQFFLY 124
+ + PP + +++V E +DL + K N L E +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICR 118
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL-ARVSFTDTPSAIFWTDYVAT 183
++LR L ++H V HRD+K +N+L + ++K+ DFG+ A++ T F + T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----IGT 174
Query: 184 RWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGRP 220
++ APE+ + + Y D+WS+G E+ G P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 74/256 (28%), Positives = 117/256 (45%), Gaps = 65/256 (25%)
Query: 22 IGIGSYG--VVASAIDTHTGE-----KVAIKKMKEVFEHVSDATR-----ILREIKLLRM 69
+G G +G V+A AI + KVA+K +K SDAT ++ E+++++M
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK------SDATEKDLSDLISEMEMMKM 79
Query: 70 L-KHPDIVEIKHIMLPPCRREFKDIYVVFELM-ESDLDQVIKA----------NDDLTPE 117
+ KH +I+ +L C ++ +YV+ E + +L + ++A N PE
Sbjct: 80 IGKHKNIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 118 HHQFF------LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171
F YQ+ R ++Y+ S HRDL +N+L D +KI DFGLAR
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------ 188
Query: 172 PSAIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GRP 220
I DY + +W APE + F + YT D+WS G + E+ T G P
Sbjct: 189 --DIHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
Query: 221 LFPGRNVAHQLDLVTD 236
+PG V L+ +
Sbjct: 243 -YPGVPVEELFKLLKE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 44/286 (15%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
E++G G++G V VA+K KE + L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLI 58
Query: 80 HIMLPPCRREFKDIYVVFELMESD--LDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN 137
+ C + + IY+V EL+ L + K D+L + F + Y+ S N
Sbjct: 59 GV----CTQR-QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFS 197
HRDL +N L + LKI DFG++R D + + +W APE +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--YG 169
Query: 198 KYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256
+Y+ D+WS G + E + G +P G+ N++A+
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYP------------------------GMTNQQARE 205
Query: 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ + + + K P +++QR + P++RP E++
Sbjct: 206 ---QVEKGYRMSCPQKCPDD---VYKVMQRCWDYKPENRPKFSELQ 245
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81
+G G +G V T +VAIK +K L+E ++++ L+H +V++ +
Sbjct: 14 LGQGCFGEVWMGTWNGT-TRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 82 MLPPCRREFKDIYVVFELM-ESDLDQVIKANDDLTPEHHQF--FLYQLLRALKYIHSANV 138
+ + IY+V E M + L +K Q Q+ + Y+ N
Sbjct: 70 V------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 139 FHRDLKPKNILANADCKLKICDFGLARV----SFTDTPSAIFWTDYVATRWYRAPELCGS 194
HRDL+ NIL + K+ DFGLAR+ +T A F +W APE +
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-----PIKW-TAPE--AA 175
Query: 195 FFSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQLD 232
+ ++T D+WS G + EL T GR +PG R V Q++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 66/237 (27%), Positives = 102/237 (43%), Gaps = 49/237 (20%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM--------LKHP 73
IG G++G V + +G +A+K+++ +T +E K L M P
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIR--------STVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 74 DIVEIKHIMLPPCRREFK--DIYVVFELMESDLDQVIK----ANDDLTPEHHQFFL---- 123
IV+ + F+ D ++ ELM+ LD+ K + PE L
Sbjct: 64 YIVKFYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEE---ILGKIA 113
Query: 124 YQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLA---RVSFTDTPSAIFWTD 179
++AL Y+ + HRD+KP NIL + + +K+CDFG++ S T A
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA----- 168
Query: 180 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN-VAHQLDLV 234
R Y APE + S Y D+WS+G E+ TG+ +P N V QL V
Sbjct: 169 --GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV 223
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 44/280 (15%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
++G G +G V + TG+ A KK+ K+ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 80 HIMLPPCRREFKD-IYVVFELMES-DLD-QVIKANDDLTPEHHQ-FFLYQLLRALKYIHS 135
+ E KD + +V LM DL + + E F+ ++ L+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMAPEVVKN- 175
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255
+YT + D W++GC+ E++ G+ F R I+ E+ +
Sbjct: 176 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRK--------------------KKIKREEVE 214
Query: 256 RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR 295
R + ++ +++ FS P A L + LL DPK+R
Sbjct: 215 RLVKEVQEEYSEKFS-------PDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 24/233 (10%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLKHPDIVEIK 79
+G G+ GVV +G I K + + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVFKVSHKPSG---LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 80 HIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN- 137
+I + E M+ LDQV+K + + +++ L Y+ +
Sbjct: 70 GAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-LCGSFF 196
+ HRD+KP NIL N+ ++K+CDFG++ D+ + +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMA----NSFVGTRSYMSPERLQGTHY 179
Query: 197 SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLV--TDLLGTPSAESIA 247
S + DIWS+G E+ GR P + A +L+L+ + G P+ +
Sbjct: 180 SVQS---DIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 40/127 (31%), Positives = 66/127 (51%), Gaps = 6/127 (4%)
Query: 101 ESDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKI 158
+S++ ++ + + LT F YQ+ R ++++ S N HRDL +N+L +KI
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278
Query: 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT- 217
CDFGLAR D+ + ++ +W APE F + YT D+WS G + E+ +
Sbjct: 279 CDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLSDVWSYGILLWEIFSL 335
Query: 218 GRPLFPG 224
G +PG
Sbjct: 336 GGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+EI +G G++G V A + TG A K + E + + EI +L HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNI 64
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESD-LDQV-IKANDDLTPEHHQFFLYQLLRALKYI 133
V+ +L E +++++ E +D V ++ LT + Q L AL Y+
Sbjct: 65 VK----LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
H + HRDLK NIL D +K+ DFG VS +T + ++ T ++ APE+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 194 SFFSKYTP---AIDIWSIGCIFAELLTGRP 220
SK P D+WS+G E+ P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 17 EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
++ + IG G +G V + + G KVA+K +K + + A L E ++ L+H ++V
Sbjct: 9 KLLQTIGKGEFGDVM--LGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLV 62
Query: 77 EIKHIMLPPCRREFKDIYVVFELME--SDLDQV-IKANDDLTPEHHQFFLYQLLRALKYI 133
++ +++ E +Y+V E M S +D + + L + F + A++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
+ N HRDL +N+L + D K+ DFGL T S+ T + +W APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGL-----TKEASSTQDTGKLPVKW-TAPEALR 172
Query: 194 SFFSKYTPAIDIWSIGCIFAELLT-GRPLFP 223
K++ D+WS G + E+ + GR +P
Sbjct: 173 E--KKFSTKSDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 22/220 (10%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
A +E+ E++G G+YG V TG+ AIK M +V E + I EI +L+ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTE--DEEEEIKLEINMLKKYSH 71
Query: 73 PDIVEIKHIML----PPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQFFLY 124
+ + PP + +++V E +DL + K N L + +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDD--QLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICR 128
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL-ARVSFTDTPSAIFWTDYVAT 183
++LR L ++H+ V HRD+K +N+L + ++K+ DFG+ A++ T F + T
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----IGT 184
Query: 184 RWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGRP 220
++ APE+ + + Y DIWS+G E+ G P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV--SDATRILREIKLLRM 69
+A YE+ ++IG G++G V T + A+K + + FE + SD+ E ++
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSAFFWEERDIMAF 99
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRA 129
P +V++ + ++ + +Y+V E M + +N D+ + +F+ +++ A
Sbjct: 100 ANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA 154
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFG----LARVSFTDTPSAIFWTDYVATRW 185
L IHS HRD+KP N+L + LK+ DFG + + +A+ DY+
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI---- 210
Query: 186 YRAPELCGSFFSK--YTPAIDIWSIGCIFAELLTGRPLF 222
+PE+ S Y D WS+G E+L G F
Sbjct: 211 --SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 42/199 (21%)
Query: 42 VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME 101
VAIK +KE E +E +L+ L+HP+IV + L C +E + ++FE +
Sbjct: 38 VAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCL----LGVCTKE-QPTCMLFEYLA 91
Query: 102 -----------SDLDQVIKANDDLTPEH---HQFFL---YQLLRALKYIHSANVFHRDLK 144
S V + D T + FL Q+ ++Y+ S + HRDL
Sbjct: 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLA 151
Query: 145 PKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY--------VATRWYRAPELCGSFF 196
+N L +KI DFGL+R I+ DY + RW PE +
Sbjct: 152 ARNCLVGEGLTVKISDFGLSR--------DIYSADYYRVQSKSLLPVRWM-PPE--AILY 200
Query: 197 SKYTPAIDIWSIGCIFAEL 215
K+T DIWS G + E+
Sbjct: 201 GKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 37/209 (17%)
Query: 103 DLDQVIKA--NDDLTPEHHQ--FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKI 158
DL++ IK + L + ++ YQ++ AL +HS + HRDLK NI +K+
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
Query: 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 218
DFG ++ ++D+ S + + T +Y APEL +Y+ D+WS+G I ELLT
Sbjct: 211 GDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTL 267
Query: 219 RPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADP 278
F G PS I ++ L + P S
Sbjct: 268 HRPFKG----------------PSQREI-------MQQVLYGKYDPFPCPVSSGMKA--- 301
Query: 279 LALRLLQRLLAFDPKDRPSAEEIRFTEIV 307
LL LL+ +P RP+ +++ TE +
Sbjct: 302 ----LLDPLLSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 69/242 (28%), Positives = 111/242 (45%), Gaps = 27/242 (11%)
Query: 2 FDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRIL 61
F K+ T +A +Y I ++G G+ G V A GE A+K + +D R
Sbjct: 20 FAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ 79
Query: 62 REIKLLRMLKHPDIVEIKHIMLPPCRREF--KD---------IYVVFELMES-DLDQVIK 109
E+ L IV+ C +F KD I +V + + DL Q IK
Sbjct: 80 AEVCCLLNCDFFSIVK--------CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIK 131
Query: 110 ANDDLT---PEHHQFFLY-QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165
+ EH L+ Q+L A+ ++HS ++ HRD+K NIL ++ +K+ DFG ++
Sbjct: 132 SRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191
Query: 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR 225
+ + T S + T +Y APE+ Y+ D++S+G + ELLT + F G
Sbjct: 192 M-YAATVSDDVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGE 248
Query: 226 NV 227
N+
Sbjct: 249 NM 250
|
Length = 496 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRML-KHPDIVE 77
+++G GS+G V A T + AIK +K +V D + E ++L + +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 78 IKHIMLPPCRREFKD-IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
+ C + K+ ++ V E + DL I++ F+ +++ L+++HS
Sbjct: 61 LY------CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFT-DTPSAIFWTDYVATRWYRAPELCGS 194
+ +RDLK NIL + D +KI DFG+ + + D + F T Y APE+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEIL-- 168
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN 226
KY ++D WS G + E+L G+ F G +
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR-----ILREIK 65
G+ + + E G+ + + VA+K ++ +D T+ L+EIK
Sbjct: 16 GQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR------ADVTKTARNDFLKEIK 69
Query: 66 LLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVI----------KANDDL 114
++ LK+P+I+ +L C + + ++ E ME+ DL+Q + AN+ +
Sbjct: 70 IMSRLKNPNIIR----LLGVCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANN-I 123
Query: 115 TPEHHQFFLY---QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171
LY Q+ +KY+ S N HRDL +N L +KI DFG++R ++
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
I + RW + K+T A D+W+ G E+ T
Sbjct: 184 YYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 34/232 (14%)
Query: 21 IIGIGSYGVVASAIDTHTGEK-----VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+G G +G V A + VA+K +KE S+ +L E LL+ + HP +
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHV 65
Query: 76 VEI-----------------KHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEH 118
+++ K+ L RE + + + + + + N D
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 119 HQF---FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175
F +Q+ R ++Y+ + HRDL +N+L K+KI DFGL+R + +
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 176 FWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GRPLFPG 224
+ +W A E S F YT D+WS G + E++T G P +PG
Sbjct: 186 RSKGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 45/136 (33%), Positives = 66/136 (48%), Gaps = 20/136 (14%)
Query: 101 ESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICD 160
E D + + LT E + +Q+ R ++++ S HRDL +NIL + + +KICD
Sbjct: 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICD 216
Query: 161 FGLARVSFTDTPSAIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIF 212
FGLAR + D DYV +W APE S F K YT D+WS G +
Sbjct: 217 FGLARDIYKD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLL 265
Query: 213 AELLT-GRPLFPGRNV 227
E+ + G +PG +
Sbjct: 266 WEIFSLGASPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 6/130 (4%)
Query: 101 ESDLDQVIKANDDLTPEHHQF--FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKI 158
+ D+ I D+L + F YQ+ + + ++ S N HRDL +NIL KI
Sbjct: 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKI 255
Query: 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT- 217
CDFGLAR D+ + + +W APE F YT D+WS G + E+ +
Sbjct: 256 CDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFESDVWSYGILLWEIFSL 312
Query: 218 GRPLFPGRNV 227
G +PG V
Sbjct: 313 GSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 37/196 (18%)
Query: 42 VAIKKMKEVFEHVSDATR-----ILREIKLLRMLKHPDIVEIKHIML---PPCRREFKDI 93
VA+K ++E DA + L+EIK++ LK P+I+ + + + P C
Sbjct: 49 VAVKMLRE------DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLC------- 95
Query: 94 YVVFELMES-DLDQVI---KANDDLTPEHHQFFLY--------QLLRALKYIHSANVFHR 141
++ E ME+ DL+Q + + + Y Q+ +KY+ S N HR
Sbjct: 96 -MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHR 154
Query: 142 DLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTP 201
DL +N L + +KI DFG++R ++ I + RW + K+T
Sbjct: 155 DLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI---LLGKFTT 211
Query: 202 AIDIWSIGCIFAELLT 217
A D+W+ G E+LT
Sbjct: 212 ASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 93 IYVVFELMESDLDQVIKANDDL-----TPEHHQFFLYQLLRALKYIHSANVFHRDLKPKN 147
++ F+ S + DDL T E + +Q+ R ++++ S HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 148 ILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 206
IL + + +KICDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 207 SIGCIFAELLT-GRPLFPG 224
S G + E+ + G +PG
Sbjct: 261 SFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 18/222 (8%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDA---TRILREIKLLRMLKHPDIV 76
+++G G++G V I GE V I ++ + + E ++ + HP +V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 77 EIKHIMLPPCRREFKDIYVVFELMESD--LDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
+ + L P I +V +LM LD V + D++ + + Q+ + + Y+
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
+ HRDL +N+L + +KI DFGLAR+ D + +W L
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---ALECI 183
Query: 195 FFSKYTPAIDIWSIGCIFAELLT--GRPL--FPGRNVAHQLD 232
+ K+T D+WS G EL+T G+P P R + L+
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRML-KHPDIVE 77
+++G GS+G V A GE A+K +K +V D + E ++L + ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 78 IKHIMLPPCRREFKD-IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
+ C + K+ ++ V E + DL I+ F+ +++ L+++HS
Sbjct: 61 LY------CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVS-FTDTPSAIFWTDYVATRWYRAPELCGS 194
+ +RDLK N++ + D +KI DFG+ + + F D ++ F T Y APE+
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQG 170
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPG 224
KYT ++D WS G + E+L G+ F G
Sbjct: 171 L--KYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 9e-11
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+EI ++IG G++G VA V +K +VF A +IL + ++L+ +
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKLKNADKVF-----AMKILNKWEMLKRAETACF 48
Query: 76 VEIKHIM-------LPPCRREFKD---IYVVFEL-MESDLDQVIKANDDLTPEHH-QFFL 123
E + ++ + F+D +Y+V + + DL ++ +D PE +F+L
Sbjct: 49 REERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG----LARVSFTDTPSAIFWTD 179
+++ A+ +H + HRD+KP NIL + + +++ DFG L + A+ D
Sbjct: 109 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168
Query: 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222
Y++ +A E KY P D WS+G E+L G F
Sbjct: 169 YISPEILQAME---DGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 43/199 (21%)
Query: 42 VAIKKMKEVFEHVSDATRI--LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFEL 99
VA+K ++ SD R L+E+K+L L P+I + L C + + ++ E
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARL----LGVCTVD-PPLCMIMEY 100
Query: 100 ME-SDLDQVIKANDDLTPEH--------HQFFLY---QLLRALKYIHSANVFHRDLKPKN 147
ME DL+Q ++ + T LY Q+ ++Y+ S N HRDL +N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 148 ILANADCKLKICDFGLARVSFTDTPSAIFWTDY--------VATRWYRAPELCGSFF-SK 198
L + +KI DFG++R ++ +DY + RW A E S K
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYS--------SDYYRVQGRAPLPIRWM-AWE---SVLLGK 208
Query: 199 YTPAIDIWSIGCIFAELLT 217
+T D+W+ G E+LT
Sbjct: 209 FTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 22 IGIGSYGVVASAIDTHTGE-KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKH 80
+G G +GVV G+ VAIK +KE + + E K++ L H +V++
Sbjct: 12 LGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDE---FIEEAKVMMKLSHEKLVQLYG 66
Query: 81 IMLPPCRREFKDIYVVFELMESD--LDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANV 138
+ C ++ + IY+V E M + L+ + + P + + Y+ S
Sbjct: 67 V----CTKQ-RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSK 198
HRDL +N L + +K+ DFGL+R D ++ + + RW PE+ +SK
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW-SPPEVL--LYSK 177
Query: 199 YTPAIDIWSIGCIFAELLT 217
++ D+W+ G + E+ +
Sbjct: 178 FSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 42/200 (21%)
Query: 42 VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME 101
VA+K +KE E S RE +LL +L+H IV + C E + + +VFE M
Sbjct: 38 VAVKALKEASE--SARQDFQREAELLTVLQHQHIVRFYGV----CT-EGRPLLMVFEYMR 90
Query: 102 -SDLDQVIKAND---------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKP 145
DL++ ++++ LT Q+ + Y+ S + HRDL
Sbjct: 91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLAT 150
Query: 146 KNILANADCKLKICDFGLARVSFTDTPSAIFWTDY--------VATRWYRAPELCGSFFS 197
+N L +KI DFG++R I+ TDY + RW PE +
Sbjct: 151 RNCLVGQGLVVKIGDFGMSR--------DIYSTDYYRVGGRTMLPIRWM-PPE--SILYR 199
Query: 198 KYTPAIDIWSIGCIFAELLT 217
K+T DIWS G + E+ T
Sbjct: 200 KFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDA-TRILREIKLLRMLKHPD 74
+EI ++IG G++G VA HT E++ K+ +E + A T RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHT-ERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEH-HQFFLYQLLRA 129
I + F+D ++ +M+ DL ++ +D PE +F++ +++ A
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFG----LARVSFTDTPSAIFWTDYVATRW 185
+ IH + HRD+KP N+L + + +++ DFG + + + A+ DY++
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222
+A E KY P D WS+G E+L G F
Sbjct: 175 LQAME---DGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 66/245 (26%), Positives = 109/245 (44%), Gaps = 43/245 (17%)
Query: 22 IGIGSYGVVASA----IDTHTGEK---VAIKKMKEVFEHVSDATRILREIKLLRML-KHP 73
+G G +G V A ID K VA+K +K+ D + ++ E+++++M+ KH
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHK 78
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFEL-----------------MESDLDQVIKANDDLTP 116
+I+ +L C ++ +YV+ E M+ D + LT
Sbjct: 79 NIIN----LLGACTQD-GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 117 EHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176
+ YQ+ R ++Y+ S HRDL +N+L D +KI DFGLAR D + +
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDY 189
Query: 177 WTDYVATRW---YRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQL 231
+ R + APE + F + YT D+WS G + E+ T G +PG V
Sbjct: 190 YKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
Query: 232 DLVTD 236
L+ +
Sbjct: 247 KLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 74/318 (23%), Positives = 126/318 (39%), Gaps = 82/318 (25%)
Query: 18 IQEI--IGIGSYGVV----ASAIDTHTGEKVAIKKMKEVFEHVSDATRIL---REIKLLR 68
+QEI +G G +G V A I+ GE + + K + D RE+ + R
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRRELDMFR 63
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD---------LTPEH 118
L H ++V + L CR E + Y++ E + DL Q ++A L+ +
Sbjct: 64 KLSHKNVVRL----LGLCR-EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQ 118
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT 178
Q+ + ++ +A HRDL +N L ++ ++K+ L++ +
Sbjct: 119 KVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-------- 170
Query: 179 DY-------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPL-FPGRNVAHQ 230
+Y + RW APE ++ D+WS G + E+ T L F G
Sbjct: 171 EYYKLRNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG------ 221
Query: 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLAL-RLLQRLLA 289
++D E + ++ K + V P P L +L+ R A
Sbjct: 222 ---LSD------EEVLNRLQAGKL---------ELPV------PEGCPSRLYKLMTRCWA 257
Query: 290 FDPKDRPSAEEIRFTEIV 307
+PKDRPS F+E+V
Sbjct: 258 VNPKDRPS-----FSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 64/244 (26%), Positives = 103/244 (42%), Gaps = 47/244 (19%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+E ++IG G++G V TG A+K +++ +L + ++ + DI
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRK--------ADMLEKEQVAHIRAERDI 54
Query: 76 -VEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRAL 130
VE + F+D +Y++ E + D+ ++ D L+ E QF++ + + A+
Sbjct: 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAI 114
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLA-------RVSF----TDTPSAIF--- 176
IH HRD+KP N+L +A +K+ DFGL R F T P + F
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 177 ----------WT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 218
W V T Y APE+ + Y D WS+G I E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIG 232
Query: 219 RPLF 222
P F
Sbjct: 233 YPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 71/241 (29%), Positives = 107/241 (44%), Gaps = 41/241 (17%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKE-VFEHVSDATRILREIKLLRMLKHPD 74
Y+I +IG G G V A D +VA+KK++E + E+ R LRE K+ L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKA---NDDLTPEHHQ-----FFL-- 123
IV + I + +Y +E L ++K+ + L+ E + FL
Sbjct: 64 IVPVYSIC-----SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 124 -YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY-- 180
+++ ++Y+HS V HRDLKP NIL ++ I D+G A + + D
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD-IDVDE 177
Query: 181 --------------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR 225
V T Y APE L G S+ T DI+++G I ++LT FP R
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQMLTLS--FPYR 232
Query: 226 N 226
Sbjct: 233 R 233
|
Length = 932 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 6/115 (5%)
Query: 112 DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171
LT E + +Q+ + ++++ S HRDL +NIL + + +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 172 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GRPLFPG 224
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 34/216 (15%)
Query: 83 LPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHR 141
L C + +++V E + DL ++ L EH +F+ ++ AL ++H + +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 142 DLKPKNILANADCKLKICDFGLAR--VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKY 199
DLK N+L +AD +K+ D+G+ + + DT S + T Y APE+ +Y
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-----FCGTPNYIAPEILRG--EEY 173
Query: 200 TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLS 259
++D W++G + E++ GR F D++TD + + + + EK R
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF---------DIITDNPDMNTEDYLFQVILEKPIRIPR 224
Query: 260 SLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR 295
L K A +L+ L DPK+R
Sbjct: 225 FLSVK---------------ASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 74/322 (22%), Positives = 110/322 (34%), Gaps = 63/322 (19%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
I + +A T VA+KK+ D + +EI R L+H
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPT--NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH 58
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIKAN-DDLTPEHH-QFFLYQL 126
P+I+ + ++YVV LM DL +K + + PE F L +
Sbjct: 59 PNILPYVTSFI-----VDSELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIAFILKDV 110
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA----------RVSFTDTPSAIF 176
L AL YIHS HR +K +IL + D K+ + + RV S++
Sbjct: 111 LNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 177 ---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR-------- 225
W +PE+ Y DI+S+G EL G F
Sbjct: 171 NLPWL---------SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221
Query: 226 ----NVAHQLDLVT--DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPL 279
V LD T + S + R ++ F H+F
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHF-HQF------ 274
Query: 280 ALRLLQRLLAFDPKDRPSAEEI 301
LQR DP+ RPSA ++
Sbjct: 275 VELCLQR----DPESRPSASQL 292
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 3/126 (2%)
Query: 92 DIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151
D Y+ + D +I + L+ F YQ+ ++++ S N HRDL +N+L
Sbjct: 214 DQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273
Query: 152 ADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 211
+KICDFGLAR D+ + ++ +W APE F + YT D+WS G +
Sbjct: 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APE--SIFNNLYTTLSDVWSFGIL 330
Query: 212 FAELLT 217
E+ T
Sbjct: 331 LWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 45/246 (18%)
Query: 22 IGIGSYGVVASA----IDTHTGEK---VAIKKMKEVFEHVSDATRILREIKLLRML-KHP 73
+G G +G V A ID ++ VA+K +K+ D + ++ E+++++M+ KH
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 81
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELM-ESDLDQVIKANDDL----------TPEHHQFF 122
+I+ +L C ++ +YV+ E + +L + ++A P+ F
Sbjct: 82 NIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 123 ------LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176
YQ+ R ++Y+ S HRDL +N+L + +KI DFGLAR D + +
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDY 192
Query: 177 WTDYVATRW---YRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GRPLFPGRNVAHQ 230
+ R + APE + F + YT D+WS G + E+ T G P +PG V
Sbjct: 193 YKKTTNGRLPVKWMAPE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEEL 248
Query: 231 LDLVTD 236
L+ +
Sbjct: 249 FKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 47/244 (19%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+E ++IG G++G V TG A+K +++ +L + ++ + DI
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRK--------ADMLEKEQVGHIRAERDI 54
Query: 76 -VEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRAL 130
VE + + F+D +Y++ E + D+ ++ D LT E QF++ + + A+
Sbjct: 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAI 114
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLA-------RVSFTDTPSAIFWTDY--- 180
IH HRD+KP N+L ++ +K+ DFGL R F + +D+
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 181 ----------------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 218
V T Y APE+ + Y D WS+G I E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIG 232
Query: 219 RPLF 222
P F
Sbjct: 233 YPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 66/239 (27%), Positives = 111/239 (46%), Gaps = 55/239 (23%)
Query: 22 IGIGSYGVVASA----IDTHTGEK---VAIKKMKEVFEHVSDATRILREIKLLRML-KHP 73
+G G +G V A ID ++ VA+K +K+ D ++ E++L++++ KH
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHK 78
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELM-ESDLDQVIKANDDLTPEH-------HQFFL-- 123
+I+ +L C +E +YV+ E + +L + ++A P++ + L
Sbjct: 79 NIIN----LLGVCTQE-GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 124 -------YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176
YQ+ R ++Y+ S HRDL +N+L D +KI DFGLAR +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GVH 185
Query: 177 WTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GRPLFPG 224
DY + +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 186 DIDYYKKTSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 28/192 (14%)
Query: 42 VAIKKMKEVFEHVSDATR--ILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFEL 99
VA+K +K+ SD R RE +LL L+H IV+ + + E + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 100 ME-SDLDQVIKAN-------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKP 145
M+ DL++ ++A+ +LT Q+ + Y+ S + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 146 KNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 205
+N L + +KI DFG++R ++ + + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 206 WSIGCIFAELLT 217
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH---PDIV 76
IIG G +G V TG+ A+K + K+ + T L E +L ++ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 77 EIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
+ + P + F + +LM DL + + + + +F+ +++ L+++H+
Sbjct: 61 CMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQK- 169
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV--AHQLDLVT 235
+ Y + D +S+GC+ +LL G F H++D +T
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 68/250 (27%), Positives = 105/250 (42%), Gaps = 52/250 (20%)
Query: 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGE-KVAIKKMKEVFEHVSDATRILREIKLL 67
+GE + +I+G GS G +VA+K +++ + L+E L+
Sbjct: 7 AFGEVYEGTATDILGPGS------------GPIRVAVKTLRK-GATDQEKKEFLKEAHLM 53
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQL 126
HP+IV++ + L + Y++ ELME DL ++ L +L
Sbjct: 54 SNFNHPNIVKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108
Query: 127 L-------RALKYIHSANVFHRDLKPKNILA-----NADCKLKICDFGLARVSFTDTPSA 174
L + Y+ + HRDL +N L +AD +KI DFGLAR
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------D 160
Query: 175 IFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGR 225
I+ +DY + RW APE K+T D+WS G + E+LT G+ +P
Sbjct: 161 IYKSDYYRKEGEGLLPVRWM-APE--SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217
Query: 226 NVAHQLDLVT 235
N L VT
Sbjct: 218 NNQEVLQHVT 227
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 22 IGIGSYGVVASAIDTHTGEK--VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
+G G++G V + ++ VAIK +K E S ++RE +++ L +P IV
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVR-- 59
Query: 80 HIMLPPCRREFKDIYVVFELMESD-LDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSAN 137
M+ C E + +V E+ L++ + D++T + ++Q+ +KY+ N
Sbjct: 60 --MIGVCEAE--ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARV-----SFTDTPSAIFWTDYVATRWYRAPELC 192
HRDL +N+L KI DFGL++ S+ SA W +WY APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW----PLKWY-APECI 170
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLT 217
F K++ D+WS G E +
Sbjct: 171 N--FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 24/225 (10%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIK-------KMKEVFEHVSDATRILREIKLLRMLKHP 73
IIG G +G V TG+ A+K KMK+ E ++ RI+ + L+ P
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIM--LSLVSTGDCP 57
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
IV + + P + F + +LM DL + + + +F+ +++ L++
Sbjct: 58 FIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEH 112
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+H+ V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVL 167
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV--AHQLDLVT 235
+ Y + D +S+GC+ +LL G F H++D +T
Sbjct: 168 QKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 41/226 (18%)
Query: 22 IGIGSYGVV--ASAIDTHTGEK---VAIKKMKEVFEHVSDATR--ILREIKLLRMLKHPD 74
IG G++G V A A E VA+K +KE S + RE L+ HP+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASADMQADFQREAALMAEFDHPN 69
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKAND--------------------- 112
IV+ +L C K + ++FE M DL++ ++
Sbjct: 70 IVK----LLGVCA-VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 113 -DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171
L+ Q+ + Y+ HRDL +N L + +KI DFGL+R ++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
D + RW PE F+++YT D+W+ G + E+ +
Sbjct: 185 YYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 41/281 (14%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKH 80
+IG GSY V T A+K +K+ E V+D +I ++ KH H
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKK--ELVNDD----EDIDWVQTEKHVFEQASNH 55
Query: 81 ---IMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA 136
+ L C + ++ V E + DL ++ L EH +F+ ++ AL Y+H
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115
Query: 137 NVFHRDLKPKNILANADCKLKICDFGLARVSFT--DTPSAIFWTDYVATRWYRAPELCGS 194
+ +RDLK N+L +++ +K+ D+G+ + DT S + T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-----TFCGTPNYIAPEILRG 170
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254
Y ++D W++G + E++ GR F D++G+ +N +
Sbjct: 171 --EDYGFSVDWWALGVLMFEMMAGRSPF-------------DIVGSSDNPD----QNTED 211
Query: 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR 295
+ L ++ +P S A +L+ L DPK+R
Sbjct: 212 YLFQVILEKQIRIPRSLSVKAAS-----VLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 53/227 (23%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 21 IIGIGSYGVVASA---IDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVE 77
++G G +G V A + + +KVA+K +K SD LRE ++ HP++++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 78 IKHIMLPPCRREFKD----IYVVFELME-SDLDQVIKAND------DLTPEHHQFFLYQL 126
+ + L R K V+ M+ DL + + L + F+ +
Sbjct: 66 LIGVSL---RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY------ 180
++Y+ S N HRDL +N + N + + + DFGL++ I+ DY
Sbjct: 123 ASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQGCA 174
Query: 181 --VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG 224
+ +W L + YT D+W+ G E++T G+ + G
Sbjct: 175 SKLPVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEK----VAIKKMKEVFEHVSDATRILREIKLLRM 69
++++ +++G G++G V + GEK VAIK+++E ++ IL E ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMAS 65
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESD--LDQVIKANDDLTPEHHQFFLYQLL 127
+ +P + + I L + ++ +LM LD V + D++ ++ + Q+
Sbjct: 66 VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
+ + Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 188 APELCGSFFSKYTPAIDIWSIGCIFAELLT 217
+ YT D+WS G EL+T
Sbjct: 180 LESI---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRML-KHPDIVEI 78
+IG GSY V T A+K +K E+ D + E + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 79 KHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN 137
R ++ V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARVSFT--DTPSAIFWTDYVATRWYRAPELCGSF 195
+ +RDLK N+L +A+ +K+ D+G+ + DT S + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-----FCGTPNYIAPEILRG- 170
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLF 222
Y ++D W++G + E++ GR F
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEI-- 78
+G G +G V + +TG+ A KK+ K+ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 79 -----KHIMLPPCRREFKDI-YVVFELMES--DLDQVIKANDDLTPEHHQFFLYQLLRAL 130
H+ L D+ Y ++ + E ++++VI + Q+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI------------HYSAQITCGI 108
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
++HS ++ +RD+KP+N+L + ++ D GLA + T T Y APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA----VELKDGKTITQRAGTNGYMAPE 164
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222
+ Y+ +D +++GC E++ GR F
Sbjct: 165 ILKE--EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 20 EIIGIGSYGVVASAIDTHTGEK----VAIKKM-----KEVFEHVSDATRILREIKLLRM- 69
+++G G +G V I G+ VAIK + ++ F+ ++D +L M
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD--------HMLAMG 64
Query: 70 -LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLR 128
L H IV + I C + + S LD V + D L P+ + Q+ +
Sbjct: 65 SLDHAYIVRLLGI----CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
+ Y+ + HR+L +NIL +D ++I DFG+A + + D + +W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM-- 178
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLT 217
L F +YT D+WS G E+++
Sbjct: 179 -ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
++G G +G V + TG+ A KK+ K+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 80 HIMLPPCRREFKD-IYVVFELMES-DLDQVI--KANDDLTPEHHQFFLYQLLRALKYIHS 135
+ E KD + +V +M DL I N + F+ +L L+ +
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN- 175
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGR 225
KYT + D W +GC+ E++ G+ F R
Sbjct: 176 -EKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 20/222 (9%)
Query: 21 IIGIGSYGVVASAIDTHTGEK----VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
++G G++G V I GE VAIK ++E ++ IL E ++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAYVMAGVGSPYVC 72
Query: 77 EIKHIMLPPCRREFKDIYVVFELMESD--LDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
+ I L + +V +LM LD V + D + + + Q+ + + Y+
Sbjct: 73 RLLGICLT------STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
+ HRDL +N+L + +KI DFGLAR+ D V +W +
Sbjct: 127 EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI--- 183
Query: 195 FFSKYTPAIDIWSIGCIFAELLT--GRPL--FPGRNVAHQLD 232
++T D+WS G EL+T +P P R + L+
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV--SDATRILREIKLLRML 70
A +++ ++IG G++G V + + A+K + + FE + SD+ E ++
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHA 100
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRA 129
IV++ + K +Y+V E M DL ++ +N D+ + +F+ +++ A
Sbjct: 101 NSEWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLA 154
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFG----LARVSFTDTPSAIFWTDYVATRW 185
L IHS HRD+KP N+L + LK+ DFG + +A+ DY+
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI---- 210
Query: 186 YRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGRPLF 222
+PE+ S Y D WS+G E+L G F
Sbjct: 211 --SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 4/104 (3%)
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYV 181
F Q+ + + ++ S N HRD+ +N+L KICDFGLAR D+ + +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG 224
+W APE F YT D+WS G + E+ + G+ +PG
Sbjct: 277 PVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 39/200 (19%)
Query: 42 VAIKKMKEVFEHVSDATR-----ILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVV 96
VA+K ++ DA + L+E+K+L LK P+I+ +L C E + ++
Sbjct: 49 VAVKILR------PDANKNARNDFLKEVKILSRLKDPNIIR----LLGVCVDE-DPLCMI 97
Query: 97 FELMES-DLDQVIKA----------NDDLTPEH------HQFFLY---QLLRALKYIHSA 136
E ME+ DL+Q + + ND + P H + L+ Q+ +KY+ S
Sbjct: 98 TEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157
Query: 137 NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFF 196
N HRDL +N L + +KI DFG++R + I + RW A E
Sbjct: 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LM 214
Query: 197 SKYTPAIDIWSIGCIFAELL 216
K+T A D+W+ G E+L
Sbjct: 215 GKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 57/223 (25%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+EI ++IG G++G VA V +K +V+ A +IL + ++L+ +
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 76 VEIKHIMLPPCRR-------EFKD---IYVVFEL-MESDLDQVI-KANDDLTPEHHQFFL 123
E + +++ RR F+D +Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG----LARVSFTDTPSAIFWTD 179
+++ A+ +H HRD+KP N+L + + +++ DFG L + A+ D
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222
Y++ +A E +Y P D WS+G E+L G F
Sbjct: 169 YISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 35/111 (31%), Positives = 57/111 (51%), Gaps = 6/111 (5%)
Query: 116 PEHHQ-FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174
PE F+ Q++ L+++H + +RDLKP+N+L + D ++I D GLA V D S
Sbjct: 95 PEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSK 153
Query: 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR 225
Y T + APEL +Y ++D +++G E++ R F R
Sbjct: 154 T--KGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRAR 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 22 IGIGSYGVVASAIDTHTG---EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEI 78
IG G +G V + H G +V +K+++ + L+E++ R L HP++++
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQ- 59
Query: 79 KHIMLPPCRREFKDIYVVFELME-SDLDQVIKAND-----DLTPEHHQFFLYQLLRALKY 132
L C E +V E DL +++N + Q ++ L +
Sbjct: 60 ---CLGQCI-ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD---YVATRWYRAP 189
+H A+ H DL +N AD +KI D+GLA P + T V RW AP
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLA---LEQYPEDYYITKDCHAVPLRWL-AP 171
Query: 190 ELCGSFFS-----KYTPAIDIWSIGCIFAELLT 217
EL T +IWS+G EL T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 69/302 (22%), Positives = 111/302 (36%), Gaps = 64/302 (21%)
Query: 22 IGIGSYGVVASAIDTHTGE--KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
+G G +G V KVA+K MK S+ L E ++ HP+++ +
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 80 HIMLPPCRRE-FKDIYVVFELME-SDLDQVI---KANDD---LTPEHHQFFLYQLLRALK 131
+ L E + V+ M+ DL + + D L + F+ + ++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY--------VAT 183
Y+ S + HRDL +N + N + + + DFGL++ I+ DY +
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK--------KIYNGDYYRQGRIAKMPV 178
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPS 242
+W L YT D+WS G E+ T G+ +P
Sbjct: 179 KWIAIESLADRV---YTTKSDVWSFGVTMWEIATRGQTPYP------------------- 216
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPL--ALRLLQRLLAFDPKDRPSAEE 300
G+ N + YL R K P D L L+ +PKDRPS E
Sbjct: 217 -----GVENSEIYDYLRQGNRL-------KQP-PDCLDGLYSLMSSCWLLNPKDRPSFET 263
Query: 301 IR 302
+R
Sbjct: 264 LR 265
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 19 QEIIGIGSYGVVASAIDTHTGEKV--AIKKMKEVFEHVSDATRILREIKLL-RMLKHPDI 75
+++IG G++G V A+ G K+ AIK +KE F +D E+++L ++ HP+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNI 65
Query: 76 VEIKHIMLPPCR-REFKDIYVVFELMESDLD-----QVIKANDDLTPEH---HQFFLYQL 126
+ +L C R + I + + + LD +V++ + EH QL
Sbjct: 66 IN----LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 127 LR-------ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD 179
L+ ++Y+ HRDL +N+L + KI DFGL+R +
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM---G 178
Query: 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGRP 220
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 179 RLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 27/193 (13%)
Query: 42 VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME 101
VA+K +K+ ++ RE +LL L+H IV+ + + + +VFE M+
Sbjct: 38 VAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DGDPLIMVFEYMK 90
Query: 102 -SDLDQVIKA----------------NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLK 144
DL++ ++A +L Q+ + Y+ S + HRDL
Sbjct: 91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLA 150
Query: 145 PKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAID 204
+N L A+ +KI DFG++R ++ + + RW PE + K+T D
Sbjct: 151 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESD 207
Query: 205 IWSIGCIFAELLT 217
+WS G I E+ T
Sbjct: 208 VWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 64/264 (24%), Positives = 102/264 (38%), Gaps = 75/264 (28%)
Query: 14 SQYEIQEIIGIGSYGVV--ASAIDTHTGEKVAIKKMKEVFE-----HVSDATRILREIKL 66
S + + IGIG++G V +DT+ + + +V HV IL E
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD- 59
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKD---IYVVFEL-----MESDLDQVIKANDDLTPEH 118
+ +V++ + F+D +Y V + M S L ++ +DL
Sbjct: 60 -----NEWVVKLYY--------SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA--- 103
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL--------------- 163
+F++ +L A++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 104 -RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK 162
Query: 164 ---ARV---SFTDTPSAIFWTDY-------------------VATRWYRAPELCGSFFSK 198
R ++ S I V T Y APE+ +
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TG 220
Query: 199 YTPAIDIWSIGCIFAELLTGRPLF 222
YT D WS+G I E+L G+P F
Sbjct: 221 YTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 32/224 (14%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKV--AIKKMKEVFEHVSDATRILREIKLL-RML 70
+ + Q++IG G++G V A G ++ AIK+MKE + D E+++L ++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 65
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFE---------------LMESDLDQVIKANDDLT 115
HP+I+ +L C +Y+ E ++E+D I + T
Sbjct: 66 HHPNIIN----LLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 116 PEHHQF--FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173
Q F + R + Y+ HRDL +NIL + KI DFGL+R
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180
Query: 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
+ + RW L +S YT D+WS G + E+++
Sbjct: 181 TM---GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 56/248 (22%), Positives = 98/248 (39%), Gaps = 55/248 (22%)
Query: 22 IGIGSYGVV--ASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
+GIG++G V A +DTH + + K+V + + E +L + +V++
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR-NQVAHVKAERDILAEADNEWVVKLY 67
Query: 80 HIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEH-HQFFLYQLLRALKYIHSANV 138
+ ++ ++Y V + + + ++ PE +F++ +L A++ +H
Sbjct: 68 YSF-----QDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 139 FHRDLKPKNILANADCKLKICDFGL----------------ARVSFTDTPSAIFWTD--- 179
HRD+KP NIL + D +K+ DFGL + + + W D
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 180 -------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 214
V T Y APE+ YT D WS+G I E
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGVILFE 240
Query: 215 LLTGRPLF 222
+L G+P F
Sbjct: 241 MLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKV--AIKKMKEVFEHVSDATRILREIKLL-RMLKHPDIV 76
++IG G++G V A G ++ AIK+MKE + D E+++L ++ HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 77 EIKHIMLPPCR-REFKDIYVVFELMESDLD-----QVIKANDDLTPEH---HQFFLYQLL 127
+L C R + + + + + LD +V++ + + QLL
Sbjct: 60 N----LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 128 R-------ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
+ Y+ HRDL +NIL + KI DFGL+R +
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GR 172
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
+ RW L +S YT D+WS G + E+++
Sbjct: 173 LPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 36/93 (38%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG---LARVSFTDTPSAIFWTDYV 181
QLL A+ YIH + HRD+K +N+L N + + DFG AR S++ TP F
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-TP---FHYGIA 323
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 214
T APE+ YTP++DIWS G + E
Sbjct: 324 GTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 50/227 (22%), Positives = 88/227 (38%), Gaps = 35/227 (15%)
Query: 20 EIIGIGSYGVVASAI---DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
+I+G G +G V D + KVA+K MK S+ L E ++ HP+++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 77 EIKHIMLPPCRRE-FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLL------- 127
++ + + V+ M+ DL + + + Q L
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVDI 122
Query: 128 -RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY------ 180
++Y+ + N HRDL +N + D + + DFGL++ I+ DY
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQGRI 174
Query: 181 --VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG 224
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 175 AKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 38/118 (32%), Positives = 62/118 (52%), Gaps = 12/118 (10%)
Query: 103 DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN-ADCKLKICDF 161
DL ++K L+ + + QL+ AL +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 162 GLARVSFTDTPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTG 218
GL ++ TPS Y T Y +PE + G Y + D W++G + ELLTG
Sbjct: 155 GLCKI--IGTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 45/181 (24%), Positives = 80/181 (44%), Gaps = 18/181 (9%)
Query: 48 KEVFEHVSDA--TRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDL 104
K V +H S+ T +L+E LL L H +I+ I H+ C + + +V++ M +L
Sbjct: 41 KTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV----CIEDGEPPFVLYPYMNWGNL 96
Query: 105 DQVIK------ANDDLTPEHHQF--FLYQLLRALKYIHSANVFHRDLKPKNILANADCKL 156
++ AN+ Q Q+ + Y+H V H+D+ +N + + + ++
Sbjct: 97 KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQV 156
Query: 157 KICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 216
KI D L+R F + + +W L +S A D+WS G + EL+
Sbjct: 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELM 213
Query: 217 T 217
T
Sbjct: 214 T 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 34/215 (15%)
Query: 22 IGIGSYG-VVASAIDT-HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
IG G +G V+ +++ +T +V +K+++ V V + + L E + R L+H ++++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQ-- 59
Query: 80 HIMLPPCRREFKDIYVVFELME----SDLD---QVIKANDDLTPEHH--QFFLYQLLRAL 130
C + ++ +ME DL + + + +TP+ Q ++ L
Sbjct: 60 ------CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGL 113
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD----TPSAIFWTDYVATRWY 186
++H N H DL +N L AD +KI D+GL+ + + TP + +V RW
Sbjct: 114 LHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL----WVPLRWI 169
Query: 187 RAPELCGSFFSKY-----TPAIDIWSIGCIFAELL 216
APEL T ++WS+G EL
Sbjct: 170 -APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 18/191 (9%)
Query: 40 EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLP--PCRREFK-----D 92
+ VAIK +K+ E E + L+HP+IV + ++ P F D
Sbjct: 36 QAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD 94
Query: 93 IYVVFELMESDLDQVIKANDD------LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPK 146
++ F +M S V +DD L P + Q+ ++++ S +V H+DL +
Sbjct: 95 LHE-FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153
Query: 147 NILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 206
N+L +KI D GL R + + + RW +PE + K++ DIW
Sbjct: 154 NVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPE--AIMYGKFSIDSDIW 210
Query: 207 SIGCIFAELLT 217
S G + E+ +
Sbjct: 211 SYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 37/199 (18%)
Query: 42 VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM- 100
VAIK +K+ + +E L+ L HP+IV +L +E + + ++FE +
Sbjct: 37 VAIKTLKD-INNPQQWGEFQQEASLMAELHHPNIV----CLLGVVTQE-QPVCMLFEYLN 90
Query: 101 -------------------ESDLDQVIKANDDLTPEHHQFFLY---QLLRALKYIHSANV 138
SD D +K++ D H FL+ Q+ ++Y+ S
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD-----HGDFLHIAIQIAAGMEYLSSHFF 145
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSK 198
H+DL +NIL +KI D GL+R ++ + + RW PE + K
Sbjct: 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGK 202
Query: 199 YTPAIDIWSIGCIFAELLT 217
++ DIWS G + E+ +
Sbjct: 203 FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 40/148 (27%), Positives = 58/148 (39%), Gaps = 48/148 (32%)
Query: 120 QFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF--- 176
+F++ +L A++ +H HRD+KP NIL + D +K+ DFGL F T + +
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQS 162
Query: 177 --------------WTD----------------------------YVATRWYRAPELCGS 194
W D V T Y APE+
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-- 220
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLF 222
+ YT D WS+G I E+L G+P F
Sbjct: 221 LRTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 19 QEIIGIGSYG-VVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVE 77
QEI G G +G V+ S I T TG + K + + L++ R+L+HP+I++
Sbjct: 1 QEI-GNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 78 IKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLY----QLLRALKY 132
L C E +VFE E DL + L ++ + +
Sbjct: 60 C----LGQCV-EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH 114
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+H N H DL +N +D +K+ D+G+ + + V RW APEL
Sbjct: 115 MHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELV 173
Query: 193 GSFF-----SKYTPAIDIWSIGCIFAELL 216
G F ++ T ++W++G EL
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 25/160 (15%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-------KEVFEHVSDATRILREIKLLR 68
+ ++IG G++G V TG+ A+K + K+ HV +L E
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--- 59
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQFFLY 124
P +V + + F+D ++ +ME DL ++ D + + +F++
Sbjct: 60 ---SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164
+ + A++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 10/98 (10%)
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG-LARVSFTDTPSAIFWTDYVAT 183
+++ AL +H + RDL P NIL + +++ F + V + A+
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-------E 145
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPL 221
Y APE+ G S+ T A D WS+G I ELLTG+ L
Sbjct: 146 NMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 24/76 (31%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 93 IYVVFE-LMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151
+Y+V E L+ D+ ++ E ++ ++ AL Y+H + HRDLKP N+L +
Sbjct: 79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138
Query: 152 ADCKLKICDFGLARVS 167
+ +K+ DFGL++V+
Sbjct: 139 NEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 57/233 (24%), Positives = 88/233 (37%), Gaps = 45/233 (19%)
Query: 27 YGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86
G+ +VA+K + E D + L E ++ H +IV + +
Sbjct: 24 EGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82
Query: 87 RREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLR-------ALKYIHSANV 138
R +++ ELM DL ++ N + LL KY+ +
Sbjct: 83 PR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHF 137
Query: 139 FHRDLKPKNILANADCK-----LKICDFGLARVSFTDTPSAIFWTDY--------VATRW 185
HRD+ +N L CK KI DFG+AR I+ Y + +W
Sbjct: 138 IHRDIAARNCLLT--CKGPGRVAKIADFGMAR--------DIYRASYYRKGGRAMLPIKW 187
Query: 186 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVT 235
PE L G F SK D+WS G + E+ + G +PGR ++ VT
Sbjct: 188 M-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 22 IGIGSYGVVASAI-----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
+G GS+G+V I +VAIK + E + + L E +++ +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 77 EIKHIMLPPCRREFKDIYVVFELM-ESDLDQVIKA-------NDDLTPEHHQFFLY---Q 125
+ ++ + + V+ ELM DL +++ N P + + +
Sbjct: 73 RLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY----- 180
+ + Y+++ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKGG 179
Query: 181 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 23/184 (12%)
Query: 41 KVAIKKMKEVFEHVSDATRI-LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFEL 99
K M+ V + ++D I EI + L+HP+IV++ + CR E K Y++ E
Sbjct: 710 KSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKL----IGLCRSE-KGAYLIHEY 764
Query: 100 ME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH---SANVFHRDLKPKNILANADCK 155
+E +L +V++ +L+ E + + +AL+++H S V +L P+ I+ + +
Sbjct: 765 IEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE 821
Query: 156 LKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 215
+ L + TDT I + Y APE + T DI+ G I EL
Sbjct: 822 PHLR-LSLPGLLCTDTKCFI-------SSAYVAPETRET--KDITEKSDIYGFGLILIEL 871
Query: 216 LTGR 219
LTG+
Sbjct: 872 LTGK 875
|
Length = 968 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 18/42 (42%), Positives = 28/42 (66%)
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164
+ Q+L L+ +H + HRD+KP+N+L D ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 39/219 (17%)
Query: 22 IGIGSYGVVASAI--DTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRMLKHPDIVE 77
+G GS+G+V D GE +K V E S RI L E +++ +V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 78 IKHIMLPPCRREFKDIYVVFELM-ESDLDQVIKA------NDDLTPEHHQFFLYQLLR-- 128
+ ++ + + VV ELM DL +++ N+ P + Q+
Sbjct: 74 LLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 129 --ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY------ 180
+ Y+++ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYYRKGGK 180
Query: 181 --VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
+ RW L F+ + D+WS G + E+ +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 21/214 (9%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEK---VAIKKMKEVFEHVSDATR--ILREIKL 66
+ +I+ I+G G +G + ++ VAI ++ SD R L E
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA---GCSDKQRRGFLAEALT 59
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKAND-DLTPEHHQFFLY 124
L H +IV ++ ++ + +V E M + LD ++ ++ L L
Sbjct: 60 LGQFDHSNIVRLEGVI-----TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT-DYVAT 183
L +KY+ H+ L +L N+D KI F + D AI+ T +
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSP 171
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
+ APE + ++ A D+WS G + E+++
Sbjct: 172 VLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 26/75 (34%), Positives = 37/75 (49%), Gaps = 9/75 (12%)
Query: 120 QFFLYQLLRALKYIHSANVFHRDLKPKNIL-ANADCKLKICDFGLA---RVSFTDTPSAI 175
Q + Q+L AL +HS + HRD+KP+NI+ + KI D G A RV P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK-- 315
Query: 176 FWTDYVATRWYRAPE 190
+++ Y APE
Sbjct: 316 ---EFLLDPRYAAPE 327
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 506 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.87 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.15 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.12 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.99 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.97 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.93 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.76 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.62 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.61 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.6 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.4 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.35 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.33 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.3 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.25 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.22 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.15 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.94 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.66 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.62 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.52 | |
| PLN02236 | 344 | choline kinase | 96.49 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.4 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.22 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.15 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.05 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.72 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.1 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.57 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.24 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.23 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.0 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.91 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.1 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.82 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.44 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.37 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-83 Score=627.68 Aligned_cols=344 Identities=57% Similarity=0.939 Sum_probs=325.8
Q ss_pred cccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 6 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
|-+.|....+|..++.||+|+||+||.|.++.+|+.||||++.+.|.+...+++.+||+++|++++|+||+.+.+++.++
T Consensus 14 ~~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 14 FGELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP 93 (359)
T ss_pred eeeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence 34567888889889999999999999999999999999999999999999999999999999999999999999999997
Q ss_pred CcCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 86 CRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
..+.+.++|+|+|+|+.||+++|++++.|+++++++++||||+||+|+|++||+||||||.|+|+|.+|.+||||||+||
T Consensus 94 ~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred cccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence 77889999999999999999999999899999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
..... ....++|+||.|+||||||+++.. ..|+.++||||+||||+||++|+++|+|.+..+|++.|...+|+|+++.
T Consensus 174 ~~~~~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 174 YLDKF-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred ecccc-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 87655 555678999999999999999874 8999999999999999999999999999999999999999999999999
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
+..+.++.++.|+++++..++.+|...||++++.|+|||++||++||.+|+|++| ||+||||
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e------------------AL~hPYl 313 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE------------------ALAHPYL 313 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH------------------HhcChhh
Confidence 9999999999999999999999999999999999999999999999999999999 9999999
Q ss_pred CCCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCchhH
Q 044076 326 HGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHPHML 373 (506)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~~~~ 373 (506)
..++++++||++.+.... ++.. ++.++||+++|+|+++|+|...
T Consensus 314 ~~~hdp~dEP~~~~~~~~---~~~~-~~~~~~r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 314 APYHDPEDEPVCQPIFDS---FEHE-LTEEELRELIYKEILDFHPDVS 357 (359)
T ss_pred hhhcCCccCCCCCCCCcc---cccc-ccHHHHHHHHHHHHHhhCcccc
Confidence 999999999998875432 4555 9999999999999999999753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-64 Score=475.76 Aligned_cols=288 Identities=41% Similarity=0.669 Sum_probs=254.0
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
.+|..+++||+|.||+||+|+|..||+.||||+|+.......-....+|||+.|+.++|+||+.|+++|.. .+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-----~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-----KSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-----CCce
Confidence 68999999999999999999999999999999997543333345568899999999999999999999954 3789
Q ss_pred EEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
-||+|||+.||..+|+... .++..+++.++.++++||+|||+++|+||||||.|+|++++|.+||+|||+|+.......
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999999765 699999999999999999999999999999999999999999999999999998654433
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
. .+..|.|+||||||++.|. ..|+..+||||+|||++||+.|.|.|+|.++.+|+..|...+|+|.++.|+.+..-
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 3555999999999999884 89999999999999999999999999999999999999999999999999997653
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
. +|.+. ...+..+....|+.++++++||+.+||.+||.+|+|+.| ||+||||.....+
T Consensus 233 p--dY~~~-~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q------------------aL~~~yf~~~P~p 290 (318)
T KOG0659|consen 233 P--DYVKI-QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ------------------ALKHPYFKSLPLP 290 (318)
T ss_pred c--cHHHH-hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH------------------HhcchhhhcCCCC
Confidence 2 22221 133444556699999999999999999999999999999 9999999986543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-64 Score=505.16 Aligned_cols=291 Identities=39% Similarity=0.654 Sum_probs=259.8
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~ 89 (506)
...+||.++++||.|+||.||+|+...+|+.||||++++.+....++.. +||++.|++|+ |||||+|.+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~---- 81 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDN---- 81 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhcc----
Confidence 3467999999999999999999999999999999999988777666654 49999999999 99999999999653
Q ss_pred CCcEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
+..+|+|||||+.+|+++++.++ .+++..++.||+||++||+|+|++|++|||+||+|||+..+..+||+|||+||-..
T Consensus 82 ~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 82 DRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred CceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 34899999999999999998754 69999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
...+ +|+||.|+||||||+|+.. ..|+.++|||++|||++|+.+-+|+|||.+..+|+.+|+.++|+|..+.|..
T Consensus 162 SkpP----YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKPP----YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cCCC----cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 5544 5999999999999999874 7899999999999999999999999999999999999999999999988876
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
-.+ -+...--.++...+.++...+|++++++.+||.+||.|||.+||||+| ||+||||+.-
T Consensus 237 g~~-La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~------------------al~~pffq~~ 297 (538)
T KOG0661|consen 237 GYN-LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ------------------ALQHPFFQVG 297 (538)
T ss_pred HHH-HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH------------------HhcCcccccc
Confidence 311 112222245677788889999999999999999999999999999999 9999999864
Q ss_pred CC
Q 044076 329 AN 330 (506)
Q Consensus 329 ~~ 330 (506)
..
T Consensus 298 ~~ 299 (538)
T KOG0661|consen 298 RA 299 (538)
T ss_pred cc
Confidence 43
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-63 Score=476.72 Aligned_cols=287 Identities=38% Similarity=0.674 Sum_probs=250.8
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|+.+.++|+|+||+|++|+++.||+.||||++....++..-.+-.+|||++|++|+|||+|.|+++|.. ...+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-----krkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-----KRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-----ccee
Confidence 57999999999999999999999999999999998665666667778899999999999999999999954 3889
Q ss_pred EEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
++|||||+.++.+.+.... .++++.++.+++|++.|+.|+|++++|||||||+|||++.+|.+||||||+||....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--- 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--- 153 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC---
Confidence 9999999998777777654 699999999999999999999999999999999999999999999999999997543
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
.+..+|+||+|+||||||++.+. ..|++++||||+||+++||++|.|+|||.++.+|+..|...+|...+.-..-+...
T Consensus 154 pgd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CcchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 22346999999999999999884 89999999999999999999999999999999999999999999887665433221
Q ss_pred HHHHHHhhhh---ccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 253 KAKRYLSSLR---RKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 253 ~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.|+..+. .....+++..+|+++..++||+++||..||.+|+|.+| +|.||||.++.
T Consensus 233 ---~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~q------------------ll~H~yFd~~~ 291 (396)
T KOG0593|consen 233 ---PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQ------------------LLHHPYFDGFI 291 (396)
T ss_pred ---CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHH------------------HhcChHHHHHH
Confidence 1111111 12345677889999999999999999999999999999 89999997654
Q ss_pred C
Q 044076 330 N 330 (506)
Q Consensus 330 ~ 330 (506)
.
T Consensus 292 e 292 (396)
T KOG0593|consen 292 E 292 (396)
T ss_pred H
Confidence 4
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-62 Score=473.03 Aligned_cols=295 Identities=38% Similarity=0.601 Sum_probs=260.4
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
....+.|+.+..|++|+||+||+|+|+.|++.||+|+++...+.....-..+|||.+|.+++|||||.+.++.+-. +
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~ 148 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---N 148 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---c
Confidence 4456789999999999999999999999999999999986555555556678999999999999999999998654 3
Q ss_pred CCcEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
-+.+|||||||+.||..++...+ ++...+++.++.|+|+||+|||.++|+||||||+|+|++..|.+||+|||+||.+.
T Consensus 149 ~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 149 MDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred cceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 46799999999999999998765 89999999999999999999999999999999999999999999999999999764
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. ...+|..|.|.||||||++++. ..|+.++||||+|||++||++++|+|+|.+..+|+++|.+++|+|+...|++
T Consensus 229 sp---~k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 229 SP---LKPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred CC---cccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 43 2346889999999999999984 8899999999999999999999999999999999999999999999999999
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCC--CHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGA--DPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
+....+.+.+. ++..+...+...|+.. +....||+.+||.+||.+|.||+| +|.|+||.
T Consensus 305 ~~~lp~~k~~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~------------------~L~h~~F~ 365 (419)
T KOG0663|consen 305 YSELPAVKKMT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED------------------GLKHEYFR 365 (419)
T ss_pred ccccchhhccc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH------------------hhcccccc
Confidence 87766554322 3344445566677655 499999999999999999999999 99999999
Q ss_pred CCCC
Q 044076 327 GLAN 330 (506)
Q Consensus 327 ~~~~ 330 (506)
+...
T Consensus 366 e~P~ 369 (419)
T KOG0663|consen 366 ETPL 369 (419)
T ss_pred cCCC
Confidence 8543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-62 Score=494.62 Aligned_cols=288 Identities=37% Similarity=0.612 Sum_probs=252.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..+.|+.+++||+|+||.||+|++..||+.||+|++............+.|||.||++|.||||++|.++++.. ...
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~ 191 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSG 191 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCc
Confidence 35689999999999999999999999999999999976555666777888999999999999999999998764 236
Q ss_pred cEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|||||||+.||..++.+.+ .|++.+++.||+||+.||.|||++||+|||||..|||||.+|.+||+|||||+++...
T Consensus 192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 899999999999999998744 7999999999999999999999999999999999999999999999999999976544
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
... .+|..|.|+||||||+|++. ..|+.++|+||+||||+||+.|+|+|+|.+..+|+.+|.+++|.|+++.|....
T Consensus 272 ~~~--~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 272 GSA--PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCc--ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 332 36899999999999999984 899999999999999999999999999999999999999999999999998322
Q ss_pred hhHHHHHHhhhhc--cCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 251 NEKAKRYLSSLRR--KWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 251 ~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
-..+ ..++. .+...+.+.|...++.+++|+..||..||.+|.||.+ ||.|+||..
T Consensus 349 LP~~----~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~------------------aL~seyF~t 405 (560)
T KOG0600|consen 349 LPHA----TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS------------------ALQSEYFTT 405 (560)
T ss_pred CCcc----cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH------------------HhcCccccc
Confidence 2111 11111 1233455667889999999999999999999999999 999999954
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-59 Score=476.47 Aligned_cols=338 Identities=86% Similarity=1.400 Sum_probs=306.1
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||+|+||.||+|++..+|..||||++...........++.+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999975555555667789999999999999999999998766545556799
Q ss_pred EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCc
Q 044076 95 VVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~ 174 (506)
+||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999997644333333
Q ss_pred ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 175 ~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
......++|++|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+.+.+|.|..+.+..+.+...
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 33456789999999999865335789999999999999999999999999999999999999999999999999888888
Q ss_pred HHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCCCCC
Q 044076 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEE 334 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~~~~ 334 (506)
..++..+....+.++...+++.++++.+||.+||+.||.+|||++| +|+||||+++......
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e------------------~l~hp~f~~~~~~~~~ 302 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE------------------ALADPYFKGLAKVERE 302 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHH------------------HhcCchhhhcCccccc
Confidence 8888888887777788888999999999999999999999999999 8999999999988888
Q ss_pred CCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 335 PSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
+...+++...+.+++++++.++++..+++++++|||
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 303 PSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338 (338)
T ss_pred cccCccccccccHHHHhcCHHHHHHHHHHHHHhcCC
Confidence 889999999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-59 Score=456.95 Aligned_cols=295 Identities=39% Similarity=0.666 Sum_probs=252.0
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
.|+-.+++|.|+||+||.|....+++.||||++-. + .+.-.+|+.+|+.+.|||||+|..+|......+.-...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~---d---~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQ---D---KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecC---C---CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 58889999999999999999999999999999842 1 11224899999999999999999998776443334566
Q ss_pred EEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-CCEEEeecCCcccccC
Q 044076 95 VVFELMESDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLARVSFT 169 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~-~~lKL~DFGla~~~~~ 169 (506)
+|||||+.+|.++++. +..++.-+++.+++||++||+|||+.||+||||||.|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999999999985 5689999999999999999999999999999999999999976 9999999999998766
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
+.+. ..|..|+.|||||++.+ ...|+.++||||.||+++||+-|+|+|+|++..+|+..|.+++|+|+.+++..+
T Consensus 179 ~epn----iSYicSRyYRaPELifg-a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcC-ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 6554 67899999999999988 489999999999999999999999999999999999999999999999998887
Q ss_pred hhhHHHHHHhhhhccCCCCCCC-CCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSH-KFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
..... -..+++....++.. .++..++++.||+.++|+++|.+|.|+.| +|.||||+.+
T Consensus 254 n~~y~---~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~------------------~l~h~fFdel 312 (364)
T KOG0658|consen 254 NPNYT---EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE------------------ALAHPFFDEL 312 (364)
T ss_pred Ccccc---cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHH------------------HhcchhhHHh
Confidence 54322 11233344445544 55789999999999999999999999999 9999999999
Q ss_pred CCCCC-CCCCCCCc
Q 044076 329 ANLEE-EPSRKPIS 341 (506)
Q Consensus 329 ~~~~~-~~~~~~~~ 341 (506)
+++.- .|...+++
T Consensus 313 r~~~~~l~~g~~lp 326 (364)
T KOG0658|consen 313 RDPNTKLPNGRPLP 326 (364)
T ss_pred hCcCccCcCCCcCC
Confidence 98643 24444444
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-57 Score=451.51 Aligned_cols=264 Identities=35% Similarity=0.565 Sum_probs=222.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh-----hHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV-----SDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~-----~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
..+.|.+.+.||+|+||.|-+|.++.||+.||||++++..... .....+.+|+.+|++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 4578999999999999999999999999999999996532211 133457799999999999999999999944
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC---CCEEEeecC
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD---CKLKICDFG 162 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~---~~lKL~DFG 162 (506)
.+..|||||||+ |+|.+.+-.++.+.+...+.+++||+.||+|||+.||+||||||+|||++.+ +.+||+|||
T Consensus 248 ---~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 248 ---PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ---CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 477899999998 5999999999999999999999999999999999999999999999999876 889999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCc-hhhhhhhhHHHHHHHhCCCCCCCCCchh-hHHHHHhhcCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGRPLFPGRNVAH-QLDLVTDLLGT 240 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~-~~DIWSlG~il~eLl~G~~pF~~~~~~~-~l~~I~~~~g~ 240 (506)
+|+.... ..++.+.+||+.|.|||++.+....+.+ ++||||+||+||-+|+|.+||.+..... ..++|.+.--.
T Consensus 325 lAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 325 LAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred hhhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 9987532 3456889999999999999764444444 9999999999999999999998776544 44444221111
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
.. ...|..++.++++||.+||..||++|||++| ||
T Consensus 401 f~---------------------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~e------------------aL 435 (475)
T KOG0615|consen 401 FG---------------------------PLQWDRISEEALDLINWMLVVDPENRPSADE------------------AL 435 (475)
T ss_pred cc---------------------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHH------------------Hh
Confidence 11 1234568999999999999999999999999 99
Q ss_pred cCcccCCCC
Q 044076 321 ADPYFHGLA 329 (506)
Q Consensus 321 ~HP~f~~~~ 329 (506)
+||||+...
T Consensus 436 ~hpW~~~~~ 444 (475)
T KOG0615|consen 436 NHPWFKDAP 444 (475)
T ss_pred cChhhhccc
Confidence 999999654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=446.15 Aligned_cols=294 Identities=39% Similarity=0.660 Sum_probs=254.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC-cceeceeecCCCc-CCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD-IVEIKHIMLPPCR-REF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn-Iv~l~~v~~~~~~-~~~ 90 (506)
...|+.+++||+|+||+||+|+++.+|+.||+|+++-..+.+.-.....||+.+|+.|+|+| |+.|++++..... +..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 44588889999999999999999999999999999765444344556789999999999999 9999999866421 223
Q ss_pred CcEEEEEecCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 91 KDIYVVFELMESDLDQVIKAND----DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~~----~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..+|+||||++.||..++.... .++...++.+++||++||+|||++||+||||||.||||+++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 5799999999999999998755 588889999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
..-. ...++..++|.||+|||++++. ..|+..+||||+|||++||++++++|+|.+..+|+..|.+++|+|+.+.|
T Consensus 170 ~~ip---~~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIP---MRTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCC---cccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 4222 1235788999999999999984 67999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhHHHHHHhhhhccC-CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 247 AGIRNEKAKRYLSSLRRKW-AVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
+.+......+ ..++... +.++....++.++++.||+.+||++||.+|.||.. ||.||||
T Consensus 246 p~v~~~~~~k--~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~------------------al~h~yf 305 (323)
T KOG0594|consen 246 PGVSSLPDYK--APFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG------------------ALTHPYF 305 (323)
T ss_pred CCcccccccc--ccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH------------------HhcChhh
Confidence 9875432211 1334444 66777788888999999999999999999999999 9999999
Q ss_pred CCCCC
Q 044076 326 HGLAN 330 (506)
Q Consensus 326 ~~~~~ 330 (506)
..+..
T Consensus 306 ~~~~~ 310 (323)
T KOG0594|consen 306 SELPE 310 (323)
T ss_pred ccccc
Confidence 98754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-56 Score=459.74 Aligned_cols=255 Identities=33% Similarity=0.594 Sum_probs=229.5
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecc-cccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKE-VFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~-~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.+|+..+.||+|||+.||.+++..+|+.||+|+|.+ ........+++.+||+|.+.|+|||||+++++| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 679999999999999999999999999999999953 455667788899999999999999999999999 55699
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|||+|+|. ++|..++++++.++|.++++|++||+.||.|||++||+|||||..|||++++.++||+|||||.....+.
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999998 6999999999999999999999999999999999999999999999999999999999999998755432
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
.. -.+.+||+.|.|||++.. ...+..+||||+|||||.||.|+|||..++..+.+.+|...
T Consensus 173 Er---k~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------- 233 (592)
T KOG0575|consen 173 ER---KKTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------- 233 (592)
T ss_pred cc---cceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--------------
Confidence 22 256799999999999997 78999999999999999999999999999988888888431
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.+..| ..++.+|+|||.+||+.||.+|||+++ +|.|+||..
T Consensus 234 ------------~Y~~P-----~~ls~~A~dLI~~lL~~~P~~Rpsl~~------------------vL~h~Ff~~ 274 (592)
T KOG0575|consen 234 ------------EYSMP-----SHLSAEAKDLIRKLLRPNPSERPSLDE------------------VLDHPFFKS 274 (592)
T ss_pred ------------Ccccc-----cccCHHHHHHHHHHhcCCcccCCCHHH------------------HhcCHhhhC
Confidence 11111 258999999999999999999999999 899999954
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-56 Score=429.35 Aligned_cols=335 Identities=36% Similarity=0.656 Sum_probs=293.8
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC-
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC- 86 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~- 86 (506)
+.|.+..||.-+..+|.|+- .|..|.|..+++.||||++...+.+...+++..||+.++..+.|+||++++.+|.+..
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 34667889999999999999 8999999999999999999888888888999999999999999999999999998763
Q ss_pred cCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 87 RREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+++.++|+|||+|..+|.+++. -.+.-+.++++++|+++|++|||++||+||||||+||+++.+|.+||+|||+|+.
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 36678899999999999999998 4588889999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...+ ..++.|+.|+.|+|||++.+ ..|...+||||+|||++||++|+.+|+|.+..+|..+|.+.+|+|.+..+
T Consensus 168 e~~~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 168 EDTD----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cCcc----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 3222 45799999999999999998 56999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCC------------CHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHH
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGA------------DPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLY 314 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~ 314 (506)
.++. +.++.|+.+.++.....+...||+. +..+.||+.+||..||++|.++++
T Consensus 242 ~qL~-~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~d-------------- 306 (369)
T KOG0665|consen 242 KQLQ-PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDD-------------- 306 (369)
T ss_pred HHhh-HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHH--------------
Confidence 8864 4567787777776667777766642 356899999999999999999999
Q ss_pred hhhhhccCcccCCCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCch
Q 044076 315 FYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHPH 371 (506)
Q Consensus 315 ~~~~aL~HP~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~~ 371 (506)
||.||||+-+.+ .+++.+++...++..++.+..+.++||++|++|+.+|.+.
T Consensus 307 ----aL~HPY~~vw~~-~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~ 358 (369)
T KOG0665|consen 307 ----ALRHPYIKVWYD-PDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEF 358 (369)
T ss_pred ----HhcCCeeeeecc-cccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhccc
Confidence 999999995543 3344443333466677888888999999999999998874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=446.48 Aligned_cols=283 Identities=35% Similarity=0.624 Sum_probs=239.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CC-----CcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HP-----DIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-Hp-----nIv~l~~v~~~~~ 86 (506)
..||+|+++||+|+||+|.+|.|..|++.||||++++ +.....+...||++|..|+ |. |+|+++++|...
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr- 260 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR- 260 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-
Confidence 4599999999999999999999999999999999985 3455667788999999997 53 799999999765
Q ss_pred cCCCCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC--CCCEEEeecC
Q 044076 87 RREFKDIYVVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA--DCKLKICDFG 162 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~--~~~lKL~DFG 162 (506)
+++|||+|+++.+|+++|+.+. .++...++.|+.||+.||.+||+.||||+||||+|||+.. .+.+||+|||
T Consensus 261 ----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 ----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 8999999999999999999875 6999999999999999999999999999999999999975 4579999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
+|...... ...|+.++.|||||++++ ..|+.++||||||||++||++|.|+|+|.+..+|+..|++++|.|+
T Consensus 337 SSc~~~q~------vytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 337 SSCFESQR------VYTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred cccccCCc------ceeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 99753211 247899999999999999 8999999999999999999999999999999999999999999999
Q ss_pred hHHHhhhhhhHHHHHHhh----------------------------hhccCC-----CCCCCCCC-CCCHHHHHHHHHhh
Q 044076 243 AESIAGIRNEKAKRYLSS----------------------------LRRKWA-----VPFSHKFP-GADPLALRLLQRLL 288 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~----------------------------~~~~~~-----~~~~~~~~-~~s~~~~dLI~~mL 288 (506)
..++....+. ..|+.. ...... .++...++ .....++|||.+||
T Consensus 409 ~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 409 PKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred HHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 9988765432 222222 111111 11222333 23456799999999
Q ss_pred hcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 289 AFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 289 ~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
.+||.+|+|+.| ||+||||.+....
T Consensus 487 ~~dP~~R~tp~q------------------al~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 487 EWDPAERITPAQ------------------ALNHPFLTGTSLE 511 (586)
T ss_pred ccCchhcCCHHH------------------HhcCccccccccc
Confidence 999999999999 9999999986654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=417.56 Aligned_cols=293 Identities=41% Similarity=0.641 Sum_probs=243.8
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCc----EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGE----KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
...|++++.||+|.||.||+|..+.++. .+|||+++.......-....-|||.++|.++||||+.|..+|+..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--- 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--- 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---
Confidence 3579999999999999999997665543 689999975433223334567999999999999999999999753
Q ss_pred CCCcEEEEEecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC----CCEEEe
Q 044076 89 EFKDIYVVFELMESDLDQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD----CKLKIC 159 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~-----~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~----~~lKL~ 159 (506)
+..+++|+||.+.||+++|+-. ..++...++.+++||+.|++|||++.|+||||||.||||..+ |.+||+
T Consensus 100 -d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred -CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 4789999999999999999743 359999999999999999999999999999999999999988 899999
Q ss_pred ecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---------chhh
Q 044076 160 DFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN---------VAHQ 230 (506)
Q Consensus 160 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~---------~~~~ 230 (506)
|||+||.+.+.-..-......|.|.||||||++++- ..|++++|||++|||++|||+-+|+|.|.. ..+|
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999865433322233557899999999999884 899999999999999999999999998753 3689
Q ss_pred HHHHHhhcCCCChHHHhhhhhhH-HHHHHhhhhccCCCC-----CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhh
Q 044076 231 LDLVTDLLGTPSAESIAGIRNEK-AKRYLSSLRRKWAVP-----FSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFT 304 (506)
Q Consensus 231 l~~I~~~~g~p~~e~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~ 304 (506)
+.+|.+++|+|+.+.|+.+++-. ....+..++.....+ +.+....-++.+.+||.+||++||.+|+|+++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q---- 333 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ---- 333 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH----
Confidence 99999999999999999986543 334455555443333 12334556778999999999999999999999
Q ss_pred hhhhhHHHHHhhhhhccCcccCCC
Q 044076 305 EIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 305 ~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
||+|+||...
T Consensus 334 --------------Aleh~yF~~d 343 (438)
T KOG0666|consen 334 --------------ALEHPYFTED 343 (438)
T ss_pred --------------HhcccccccC
Confidence 9999999974
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=427.21 Aligned_cols=337 Identities=54% Similarity=0.952 Sum_probs=295.5
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
|...++|++.+.||.|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.....+.
T Consensus 1 ~~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred CccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 45678999999999999999999999999999999999765444455667889999999999999999999886654444
Q ss_pred CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 90 FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+..+|+|+||++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 56799999999999999999888899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. .....+.++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+....+..+....|.+..+.+..+
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 161 KG---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred Cc---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 21 223456789999999988652 45889999999999999999999999999999999999999999999888777
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.......+....+.....++...++++++++.+||.+||+.||.+|||++| +|+||||..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~e------------------ll~h~~~~~~~ 298 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEE------------------ALAHPYLASLH 298 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHH------------------HHcCcchhhhc
Confidence 777778887776666555556667889999999999999999999999999 89999999998
Q ss_pred CCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 330 NLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
+....+..+ ..+++.|+...+++++++++|+.|.+.|||
T Consensus 299 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 299 DPSDEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred CcccCccCC--CccchhhhhhhcCHHHHHHHHHHHHhhcCC
Confidence 888777765 357888898899999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=410.51 Aligned_cols=294 Identities=42% Similarity=0.703 Sum_probs=255.2
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+.+--+.||.|+||+||.+.|..+|+.||+|++.+.+.+....+++.||+++|..++|.||+..+++..++..+-+..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 44456789999999999999999999999999999999999999999999999999999999999999888777788899
Q ss_pred EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCc
Q 044076 95 VVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~ 174 (506)
+|+|+|..||+.+|-+-+.++.++++-|+|||++||+|||++||.||||||.|+|+|+||.+||||||+||....+. .
T Consensus 134 V~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~--~ 211 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD--R 211 (449)
T ss_pred HHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh--h
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999854443 3
Q ss_pred ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 175 ~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
..++.-+.|.+|+|||++.+. ..|+.++||||+||||+||+.++.+|...+..+|+++|.+++|+|+.|.+.......-
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 346788999999999999884 8899999999999999999999999999999999999999999999998876544332
Q ss_pred HHHHhhhhccCCCCCCCCC-C--CCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 255 KRYLSSLRRKWAVPFSHKF-P--GADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~-~--~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
...++.-.+.+..+.--.+ . ....++.+++.+||.+||++|++.++ |+.|+|+...+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~------------------A~~~~~~~e~R 350 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEE------------------ALQHRYLEEGR 350 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhh------------------hcccccccccc
Confidence 2233322222222211111 1 34457899999999999999999999 99999998754
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=421.90 Aligned_cols=334 Identities=42% Similarity=0.775 Sum_probs=282.7
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..|...++|++++.||.|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 34677899999999999999999999999999999999997544444456678899999999999999999998864422
Q ss_pred -CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 -REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 -~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.....+|+|+++++++|.++++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 89 IENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 33466899999999999988764 5699999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... ...+++|++|+|||++.+. ..++.++|||||||++|+|++|++||++.+..+.+..+....|.+..+.+
T Consensus 168 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 168 ADDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred cCCC------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4221 2456799999999998762 56899999999999999999999999999999999999999999999988
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
..+.......++..++......+...+.+.++.+.+||.+||+.||.+|||+.| +|.||||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e------------------ll~hp~~~ 302 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE------------------ALAHPYFS 302 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHH------------------HhcCcchh
Confidence 888777777777777666665666667788999999999999999999999999 89999999
Q ss_pred CCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 327 GLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
....+...+...+.. ..-+....+.++|++..+.+..++.|
T Consensus 303 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07878 303 QYHDPEDEPEAEPYD---ESPENKERTIEEWKELTYEEVSSFKP 343 (343)
T ss_pred ccCCCccccccCccc---cchhhhhccHHHHHHHHHHHHHhcCC
Confidence 987766555444432 22245566778999988888777655
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=410.29 Aligned_cols=259 Identities=28% Similarity=0.478 Sum_probs=222.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC-c
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK-D 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~-~ 92 (506)
.+.+.++.||+|..|+|++++++.|++.+|+|+|.. ..+....+++.||+++++..+||+||++|+.|... . .
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~ 152 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEE 152 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----Cce
Confidence 467888999999999999999999999999999942 34556778899999999999999999999999764 4 5
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
++|+||||+ |+|..+++..+.+++..+..++++|++||.|||. .+||||||||+|||+|..|.+||||||.++.....
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999998 5999999998999999999999999999999995 99999999999999999999999999999865443
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC--CchhhHHHHHhhcCCCChHHHhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR--NVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~--~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
....++||..|||||-+.+ ..|+.++||||||+.+.||.+|+.||+.. .....++.+..+.-.|++..
T Consensus 233 -----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l--- 302 (364)
T KOG0581|consen 233 -----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL--- 302 (364)
T ss_pred -----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC---
Confidence 2367899999999999998 79999999999999999999999999874 22333333333332222210
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCC-CCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFP-GADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
| . .+|+++.+||..||+.||.+|+|+.| +|+|||++.
T Consensus 303 -------------------P-----~~~fS~ef~~FV~~CL~Kdp~~R~s~~q------------------Ll~Hpfi~~ 340 (364)
T KOG0581|consen 303 -------------------P-----EGEFSPEFRSFVSCCLRKDPSERPSAKQ------------------LLQHPFIKK 340 (364)
T ss_pred -------------------C-----cccCCHHHHHHHHHHhcCCcccCCCHHH------------------HhcCHHHhh
Confidence 1 1 38999999999999999999999999 899999997
Q ss_pred CCC
Q 044076 328 LAN 330 (506)
Q Consensus 328 ~~~ 330 (506)
...
T Consensus 341 ~~~ 343 (364)
T KOG0581|consen 341 FED 343 (364)
T ss_pred ccc
Confidence 544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-53 Score=377.94 Aligned_cols=287 Identities=40% Similarity=0.641 Sum_probs=245.0
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
.+|.-.++||+|.||+|++|++..+++.||+|.++-...++......+|||.+|+.++|.|||+++++.. .+..+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCcee
Confidence 3567788999999999999999999999999999754445555677899999999999999999999973 34789
Q ss_pred EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
-+|+|||..+|..+..+ ++.+..+.++.+|.|+++||.++|++++.||||||.|+|+|.+|.+||+|||+|+...-.
T Consensus 77 tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip-- 154 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-- 154 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence 99999999999999976 678999999999999999999999999999999999999999999999999999864221
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
..-+...+.|.||++|.++.+ ..-|+..+||||.|||++|+.. |+|+|+|.+..+|+.+|...+|+|+.+.|+.+..
T Consensus 155 -vrcysaevvtlwyrppdvlfg-akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 155 -VRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred -eEeeeceeeeeeccCcceeee-eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 112355689999999999988 3789999999999999999997 9999999999999999999999999999988743
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
... |.---.-.....+..+.|+++...+||+.++|..+|..|++|++ ||+||||.+..
T Consensus 233 lpd--yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaea------------------alqhpyf~d~s 290 (292)
T KOG0662|consen 233 LPD--YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEA------------------ALQHPYFSDFS 290 (292)
T ss_pred CCC--CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHH------------------HhcCccccccC
Confidence 211 10000001122355666888888999999999999999999999 99999998754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-52 Score=408.10 Aligned_cols=261 Identities=30% Similarity=0.516 Sum_probs=228.2
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
....++|+++++||+|+||+|+.++.+.|++.+|+|++++. .-...+...+..|..||..++||+||+++..| +
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Q 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----Q 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----c
Confidence 34578999999999999999999999999999999999653 22335677889999999999999999999888 4
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
+.+++|+|+||+.| +|...|.+.+.++++.+++++.+|+.||.|||++|||||||||+|||++.+|+++|+|||+|+..
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 45899999999985 99999999999999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
...... ....+||+.|+|||++.+ ..|+.++|.||||+++|+|++|.+||.+.+.....+.|...-.
T Consensus 176 ~~~~~~---t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-------- 242 (357)
T KOG0598|consen 176 LKDGDA---TRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-------- 242 (357)
T ss_pred ccCCCc---cccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC--------
Confidence 433222 245799999999999998 7999999999999999999999999999998888777743210
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCC-CCHHHHHHHHHhhhcCCCCCC----CHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPG-ADPLALRLLQRLLAFDPKDRP----SAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLI~~mL~~DP~~Rp----Ta~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
...|. ++.+++|||+++|+.||++|. .+.+ +-.|
T Consensus 243 -----------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~------------------ik~H 281 (357)
T KOG0598|consen 243 -----------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEE------------------IKRH 281 (357)
T ss_pred -----------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHH------------------hhcC
Confidence 11233 899999999999999999996 5666 7899
Q ss_pred cccCCCC
Q 044076 323 PYFHGLA 329 (506)
Q Consensus 323 P~f~~~~ 329 (506)
|||.++.
T Consensus 282 pfF~~in 288 (357)
T KOG0598|consen 282 PFFKGIN 288 (357)
T ss_pred cccccCC
Confidence 9999865
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=418.23 Aligned_cols=329 Identities=43% Similarity=0.678 Sum_probs=264.9
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
.|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.......+..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999999976555555667889999999999999999999998765333345799
Q ss_pred EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCc
Q 044076 95 VVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~ 174 (506)
+|+||+.++|.+.+.....+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999976432221
Q ss_pred ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 175 ~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
...+..++|++|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+++..|.+.+|.|+.+.+..... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HH
Confidence 123456789999999998762 4589999999999999999999999999999999999999999999887765433 22
Q ss_pred HHHHhhhhccCCC--CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC--
Q 044076 255 KRYLSSLRRKWAV--PFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN-- 330 (506)
Q Consensus 255 ~~~~~~~~~~~~~--~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~-- 330 (506)
..++...+...+. ......+..++++.+||.+||++||.+|||+.| +|+||||.+..-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e------------------~l~hp~~~~~~~~~ 298 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD------------------ALAHPYLDEGRLRY 298 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHH------------------HhcCHhhCCCcchh
Confidence 3332222211111 011233457899999999999999999999999 899999987431
Q ss_pred ------------------CCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHh
Q 044076 331 ------------------LEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILE 367 (506)
Q Consensus 331 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~ 367 (506)
...+|.. ...+++.++....+..++++.++.++.+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (372)
T cd07853 299 HTCMCKCCYTTSGGRVYTSDFEPSA--NPPFDDEYEKNLTSVRQVKEELHQFILE 351 (372)
T ss_pred ccccccccccccccccCCcccCCCC--CCCCCcccccccCCHHHHHHHHHHHHHH
Confidence 1112211 1234556666667788889988888664
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=414.92 Aligned_cols=328 Identities=36% Similarity=0.639 Sum_probs=265.3
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC-cCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC-RRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~-~~~ 89 (506)
...++|++.+.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4568999999999999999999999999999999999765555566777889999999999999999999886542 234
Q ss_pred CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 90 FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
...+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 467899999999999988864 488999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. .....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...+|.|.++.+..+
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 179 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 21 1245678999999999987 78999999999999999999999999999999999999999999988776665
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCC------------CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKF------------PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~ 317 (506)
... ...+....+......+...+ ...+..+++||.+||+.||.+|||++|
T Consensus 253 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e----------------- 314 (364)
T cd07875 253 QPT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE----------------- 314 (364)
T ss_pred hHH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH-----------------
Confidence 332 23343333322222221111 124578999999999999999999999
Q ss_pred hhccCcccCCCCCCCCCCCCCC-CccchhhHHhhcCCHHHHHHHHHHHHHh
Q 044076 318 LALADPYFHGLANLEEEPSRKP-ISKLVFEFERRKLIKDDVRELIYREILE 367 (506)
Q Consensus 318 ~aL~HP~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~r~~~~~ei~~ 367 (506)
+|+||||..+.++...+...+ ++ ....+.+....++|++.++.|+++
T Consensus 315 -~L~hp~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 315 -ALQHPYINVWYDPSEAEAPPPKIP--DKQLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred -HhcCcccccccCcccCCCCCCCCC--CccchhhhccHHHHHHHHHHHHHc
Confidence 899999987766554433322 22 223445667788999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=421.51 Aligned_cols=263 Identities=32% Similarity=0.525 Sum_probs=228.8
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~ 89 (506)
-..+|.+++.||.|+|++|++|+++.+++.||||++.+. .-.+...+.+.+|-.+|.+| .||.|++|+..| .+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence 357899999999999999999999999999999999543 22344456678899999999 699999999998 44
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...+|+|+||++ |+|.++|+.-+.|++...++++.||+.||.|||++|||||||||+|||++.|+++||+|||.|+...
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 588999999998 6999999999999999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCC--------cc--cccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhc
Q 044076 169 TDTPS--------AI--FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 169 ~~~~~--------~~--~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~ 238 (506)
..... .. ....+|||..|++||+|.. ...++.+|||+||||+|+|+.|.|||.+.+.-..+++|+.+-
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 32111 01 1245899999999999988 788999999999999999999999999999988888886643
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVL 318 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~ 318 (506)
-.. -++.++.+.|||+++|..||.+|+|++|
T Consensus 304 y~f-------------------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~q------------------ 334 (604)
T KOG0592|consen 304 YEF-------------------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQ------------------ 334 (604)
T ss_pred ccC-------------------------------CCCCCHHHHHHHHHHHccCccccccHHH------------------
Confidence 221 1457899999999999999999999999
Q ss_pred hccCcccCCCCC
Q 044076 319 ALADPYFHGLAN 330 (506)
Q Consensus 319 aL~HP~f~~~~~ 330 (506)
+.+||||.++.-
T Consensus 335 Ik~HpFF~~Vdw 346 (604)
T KOG0592|consen 335 IKAHPFFEGVDW 346 (604)
T ss_pred HhhCcccccCCh
Confidence 799999988653
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=410.43 Aligned_cols=335 Identities=50% Similarity=0.847 Sum_probs=281.7
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
|...++|++.+.||+|+||.||+|.+..+|+.||||++... .......++.+|+.+++.++||||+++++++.......
T Consensus 1 ~~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred CccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 35678999999999999999999999999999999998632 23344566789999999999999999999886654455
Q ss_pred CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 90 FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
...+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 80 FNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred cceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 567999999999999988864 5799999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
............+|..|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+...++..+...++.|+.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 22222223456789999999987552 56889999999999999999999999999999999999999999999998888
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.....+.++...+.....++....++.++++.+||.+||+.||.+|||+.| ++.||||..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e------------------~l~hp~~~~~~ 299 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE------------------ALAHPYLEQYH 299 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH------------------HhcCccccccC
Confidence 877777887776666666666667788999999999999999999999999 89999999998
Q ss_pred CCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHH
Q 044076 330 NLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREIL 366 (506)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~ 366 (506)
+...+|..++...++++- -+.+.++..+++|+.||+
T Consensus 300 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 300 DPSDEPVAEEPFPFDFEL-FDDLPKEKLKELIFEEIM 335 (336)
T ss_pred CCCCcccCCCCCChhhcc-ccccCHHHHHHHHHHHhc
Confidence 876666554333333332 245668899999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=401.88 Aligned_cols=286 Identities=36% Similarity=0.659 Sum_probs=238.9
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
|+..++|++++.||.|+||.||+|.+..++..||+|+++... .......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 74 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHT----- 74 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----
Confidence 567789999999999999999999999999999999986432 22233457799999999999999999999843
Q ss_pred CCcEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+..|+||||++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 75 ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 36799999999999999987654 57999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ......+++.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+...+|.|..+.|..
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 155 VPTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CCCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 2211 12445789999999998652 5689999999999999999999999999999999999999999999998887
Q ss_pred hhhh-HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 249 IRNE-KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 249 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
+... ....+. .+.....+.....+.++++++|||++||++||.+|||++| +|+||||
T Consensus 231 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~------------------~l~hp~f 288 (288)
T cd07871 231 ITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA------------------ALRHSYF 288 (288)
T ss_pred cccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH------------------HhcCCCC
Confidence 6432 222111 1111222333345678999999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=410.06 Aligned_cols=327 Identities=38% Similarity=0.658 Sum_probs=258.0
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-CC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-RE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~~ 89 (506)
...++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45689999999999999999999999999999999997655555666778899999999999999999999865422 34
Q ss_pred CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 90 FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+..+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 457899999999999888753 588999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+++..+...+|.|..+.+...
T Consensus 176 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 NF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred Cc----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 21 1245678999999999987 78999999999999999999999999999999999999999999988776654
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCC------------CCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFP------------GADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~ 317 (506)
.. ....+....+......+...++ ..++.+.+||.+||+.||++|||+.|
T Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e----------------- 311 (359)
T cd07876 250 QP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE----------------- 311 (359)
T ss_pred HH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH-----------------
Confidence 32 2334443333332222222222 24678999999999999999999999
Q ss_pred hhccCcccCCCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHH
Q 044076 318 LALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREI 365 (506)
Q Consensus 318 ~aL~HP~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei 365 (506)
+|+||||....++.......+.. .....+.+....+.+++.|+..+
T Consensus 312 -~l~hp~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 357 (359)
T cd07876 312 -ALRHPYITVWYDPAEAEAPPPQI-YDAQLEEREHAIEEWKELIYKEV 357 (359)
T ss_pred -HhcCchhhhhcCcccccCCCccc-cccccccccccHHHHHHHHHHHh
Confidence 89999998765544332222211 11122344555566777666543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=400.56 Aligned_cols=260 Identities=33% Similarity=0.487 Sum_probs=223.5
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|.+.+.||+|+||+||+|+++.++..||||.|.+........+.+..||.+|+.++|||||.|+++... .
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-----~ 81 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-----D 81 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-----C
Confidence 45678999999999999999999999999999999997654466677788999999999999999999999844 4
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC------CCEEEeecCC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD------CKLKICDFGL 163 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~------~~lKL~DFGl 163 (506)
+.+|+|||||+ |||.++|++.+.+++..++.|+.||+.||++||+++||||||||+|||++.+ -.+||+|||+
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 89999999998 6999999999999999999999999999999999999999999999999865 4589999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
||....+. .....+|++.|||||++.. ..|+.++|+||+|+|+|+|++|++||...+..+.+..|.+.--.
T Consensus 162 AR~L~~~~----~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~--- 232 (429)
T KOG0595|consen 162 ARFLQPGS----MAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI--- 232 (429)
T ss_pred hhhCCchh----HHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc---
Confidence 99865332 3466789999999999976 79999999999999999999999999988877766544221100
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
. ..+ ...++...+|+..+|+.||.+|.+..+ -+.|
T Consensus 233 -----------------------~---~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~------------------~~~~ 268 (429)
T KOG0595|consen 233 -----------------------V---PVLPAELSNPLRELLISLLQRNPKDRISFED------------------FFDH 268 (429)
T ss_pred -----------------------c---CchhhhccCchhhhhhHHHhcCccccCchHH------------------hhhh
Confidence 0 011 124556779999999999999999999 7899
Q ss_pred cccCCC
Q 044076 323 PYFHGL 328 (506)
Q Consensus 323 P~f~~~ 328 (506)
+++..-
T Consensus 269 ~~l~~~ 274 (429)
T KOG0595|consen 269 PFLAAN 274 (429)
T ss_pred hhcccC
Confidence 988763
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=405.14 Aligned_cols=333 Identities=44% Similarity=0.811 Sum_probs=289.2
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR- 87 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~- 87 (506)
.+...++|++.+.||.|++|.||+|.+..+++.||||++............+.+|+.+++.+.||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 4567889999999999999999999999999999999986544444456678899999999999999999988755422
Q ss_pred CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 88 REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.....+|+|+||++++|.+++.. ..+++..++.++.||++||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 90 EDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 33456999999999999999875 46999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ...+.++.+|+|||++.+. ..++.++|||||||++|+|++|++||++.+..+.+..+.+..+.|.+..+.
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 169 DDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccc------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 222 2455789999999998652 467889999999999999999999999999999999999999999998888
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
++.......++...+......+...++..++.+.+||.+||+.||.+|||+.| +|+||||..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e------------------ll~h~~~~~ 303 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE------------------ALAHPYLAE 303 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH------------------HhcCCCccc
Confidence 88887778888777777666666677788999999999999999999999999 899999999
Q ss_pred CCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 328 LANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
.....+++..+ .++.+|++..+..++|+.++|.||++|.|
T Consensus 304 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 304 YHDPEDEPVAP---PYDQSFESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred cCCCccccccc---ccCcchhhhhcCHHHHHHHhHHHHHhccC
Confidence 88877666543 34567889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=404.75 Aligned_cols=328 Identities=36% Similarity=0.633 Sum_probs=258.2
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-CC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-RE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~~ 89 (506)
...++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... +.
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45689999999999999999999999999999999997655555667788899999999999999999999865422 34
Q ss_pred CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 90 FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
...+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred cceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 467899999999999888764 488999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...+|.|.++.+..+
T Consensus 172 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 172 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cc----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 1245678999999999987 68999999999999999999999999999999999999999999988877665
Q ss_pred hhhHHHHHHhhhhccCCCCCCC------------CCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSH------------KFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~ 317 (506)
.. ....+....+......+.. .....+.++.+||.+||+.||.+|||+.|
T Consensus 246 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~e----------------- 307 (355)
T cd07874 246 QP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE----------------- 307 (355)
T ss_pred cH-HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHH-----------------
Confidence 43 2333433322211111111 11234678899999999999999999999
Q ss_pred hhccCcccCCCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHH
Q 044076 318 LALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREIL 366 (506)
Q Consensus 318 ~aL~HP~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~ 366 (506)
+|+||||....+........+ ..+...-+.+..+.++|++.++.+++
T Consensus 308 -ll~hp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T cd07874 308 -ALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVM 354 (355)
T ss_pred -HhcCcchhcccChhhccCCCc-cccccchhhhhccHHHHHHHHHHHhh
Confidence 899999987654322211111 11111122344566788888887764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=404.30 Aligned_cols=330 Identities=50% Similarity=0.882 Sum_probs=283.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 2 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 80 (334)
T cd07855 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADF 80 (334)
T ss_pred chhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCC
Confidence 3458999999999999999999999999999999999754444455677889999999999999999999876543 334
Q ss_pred CcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 91 KDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
..+|+||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 81 KDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred ceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 67999999999999999988888999999999999999999999999999999999999999999999999999764322
Q ss_pred CC-CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~-~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. ........+++.+|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+...++..+...+|.|+.+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 21 11222456789999999998652 46889999999999999999999999999999999999999999999988887
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.......+....+.....++...++..++++.+||.+||+.||.+|||+.+ +|.||||.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~------------------~l~~~~~~~~~ 301 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ------------------ALQHPFLAQYH 301 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHH------------------HHhChhhhhcc
Confidence 777777777777666666666777889999999999999999999999999 89999999999
Q ss_pred CCCCCCCCCCCccchhhHHhhcCCHHHHHHHHH
Q 044076 330 NLEEEPSRKPISKLVFEFERRKLIKDDVRELIY 362 (506)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~ 362 (506)
.+..++.+. ..+++.|+...++.+.+.+.|.
T Consensus 302 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 332 (334)
T cd07855 302 DPDDEPTCP--PPFDFDFEAIELSREQLKEAIV 332 (334)
T ss_pred CCcccccCC--CCCCCChhhhhcChhhHHHHhh
Confidence 888877653 4577888888888877776654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=402.43 Aligned_cols=329 Identities=57% Similarity=0.949 Sum_probs=287.9
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||.|++|.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999976554455667789999999999999999999998665334456899
Q ss_pred EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCc
Q 044076 95 VVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~ 174 (506)
+||||++++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999997644332111
Q ss_pred ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 175 ~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
.......++.+|+|||++.+. ..++.++|+||+||++|+|++|++||.+.+..+++..+....|.|..+.+........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223456789999999999872 3789999999999999999999999999999999999999999999998887777788
Q ss_pred HHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCCCCC
Q 044076 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEE 334 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~~~~ 334 (506)
..++...+.....++...++++++.+.+||.+||+.||.+|||+++ +|.||||+++.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~------------------ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE------------------ALAHPYLAQLHDPEDE 301 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHH------------------HHhCccHHhhcccccC
Confidence 8888887777777788888899999999999999999999999999 8999999999988777
Q ss_pred CCCCCCccchh-hHHhhcCCHHHHHHHHHHH
Q 044076 335 PSRKPISKLVF-EFERRKLIKDDVRELIYRE 364 (506)
Q Consensus 335 ~~~~~~~~~~~-~~~~~~~~~~~~r~~~~~e 364 (506)
+...... ++ .|+...+++++.+++|+.|
T Consensus 302 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 330 (330)
T cd07834 302 PVAKPPF--DFDFFDDDELTEEELKELIYEE 330 (330)
T ss_pred CCCCCcc--cccccchhhcCHHHHhHHhhcC
Confidence 6665433 33 5788899999999998864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=408.18 Aligned_cols=267 Identities=27% Similarity=0.439 Sum_probs=226.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
-.++|+++++||+|+||.||+|+.+.||+.+|+|++++. .........+..|-.+|....+|+||+|+-.| .+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 357899999999999999999999999999999999753 23445677888999999999999999999998 445
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+++||||||++ ||+..+|...+.|+++++++++.+++.|+..||+.|+|||||||+|+||+.+|++||+|||||.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 89999999998 59999999999999999999999999999999999999999999999999999999999999954211
Q ss_pred C--------------------CCCcc------------------------cccccccCCcccCcccccccCCCCCchhhh
Q 044076 170 D--------------------TPSAI------------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDI 205 (506)
Q Consensus 170 ~--------------------~~~~~------------------------~~~~~vgt~~Y~APE~l~~~~~~~s~~~DI 205 (506)
. ..... .....||||.|+|||++.+ ..|+..+|.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0 00000 0113589999999999999 789999999
Q ss_pred hhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHH
Q 044076 206 WSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQ 285 (506)
Q Consensus 206 WSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~ 285 (506)
||||||+||||.|.|||.+.+..+...+|++.-- .+.... -..++++|+|||.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------------------~l~fP~-------~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE--------------------TLKFPE-------EVDLSDEAKDLIT 424 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------------------hccCCC-------cCcccHHHHHHHH
Confidence 9999999999999999999999988888854211 010000 0236799999999
Q ss_pred HhhhcCCCCCCC---HhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 286 RLLAFDPKDRPS---AEEIRFTEIVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 286 ~mL~~DP~~RpT---a~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
+||. ||.+|.. ++| +.+||||+++.-.
T Consensus 425 rll~-d~~~RLG~~G~~E------------------IK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEE------------------IKKHPFFKGVDWD 454 (550)
T ss_pred HHhc-CHHHhcCcccHHH------------------HhcCCccccCCcc
Confidence 9999 9999986 888 8999999998753
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=396.60 Aligned_cols=291 Identities=34% Similarity=0.585 Sum_probs=231.6
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
||..++|++.+.||.|+||.||+|.+..+++.||||+++.... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHT----- 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEec-----
Confidence 6889999999999999999999999999999999999864322 2233457789999999999999999999843
Q ss_pred CCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
....|+||||++++|.+.+... +.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 4789999999999999888764 569999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-chhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN-VAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~-~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... .......+|+.|+|||++.+. ..++.++||||+||++|+|++|.+||.+.. ..+++..+...+|.|....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 211 112445689999999998652 568899999999999999999999998754 457788888888988877765
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFP--GADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
......... ...+....+..+...+. ..++.+.|||.+||+.||++|||++| +|+||||
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~------------------~l~h~~f 291 (303)
T cd07869 231 GVHSLPHFK-PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA------------------ALSHEYF 291 (303)
T ss_pred chhhccccc-cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHH------------------HhcCccc
Confidence 543210000 00000000111111111 25678999999999999999999999 8999999
Q ss_pred CCCC
Q 044076 326 HGLA 329 (506)
Q Consensus 326 ~~~~ 329 (506)
+++.
T Consensus 292 ~~~~ 295 (303)
T cd07869 292 SDLP 295 (303)
T ss_pred ccCC
Confidence 8764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=413.51 Aligned_cols=288 Identities=35% Similarity=0.612 Sum_probs=233.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC---
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR--- 88 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~--- 88 (506)
..++|++++.||+|+||+||+|.+..+++.||||++... .....+|+.+|+.++||||+++++++...+..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 356899999999999999999999999999999998531 12245799999999999999999987654321
Q ss_pred CCCcEEEEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-CEEEeecCC
Q 044076 89 EFKDIYVVFELMESDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-KLKICDFGL 163 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-~lKL~DFGl 163 (506)
....+++||||++++|.+++.. ...+++..++.+++||+.||+|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 2235779999999998887753 45799999999999999999999999999999999999999665 699999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
|+....... ...+++|+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|...+|+|..
T Consensus 218 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred chhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 976433221 2456789999999998652 57899999999999999999999999999999999999999999988
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCC-CCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP-GADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
+.+..+.... ..+ .++.....++...+| ..++++++||.+||++||.+|||+.| +|+|
T Consensus 293 ~~~~~~~~~~-~~~--~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e------------------~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNY-ADI--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE------------------ALAD 351 (440)
T ss_pred HHHHHhchhh-hcc--cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHH------------------HhCC
Confidence 7765442211 000 011111222223333 47889999999999999999999999 8999
Q ss_pred cccCCCCCC
Q 044076 323 PYFHGLANL 331 (506)
Q Consensus 323 P~f~~~~~~ 331 (506)
|||..+.+.
T Consensus 352 p~f~~~~~~ 360 (440)
T PTZ00036 352 PFFDDLRDP 360 (440)
T ss_pred hhHHhhhcc
Confidence 999988764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=405.20 Aligned_cols=258 Identities=33% Similarity=0.530 Sum_probs=220.7
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc--C-hhHHHHHHHHHHHHHhCC-CCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE--H-VSDATRILREIKLLRMLK-HPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~--~-~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~ 86 (506)
...++|++++.||+|+||.|+.|.+..++..||||++.+... . ......+.||+.+++.++ ||||+++++++..+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 456799999999999999999999999999999998765311 1 134556779999999999 99999999999554
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-CCEEEeecCCc
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLA 164 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~-~~lKL~DFGla 164 (506)
..+|+||||+.| +|++.|...+.+.+.+++.+++||+.|++|||+.||+||||||+|||++.+ +++||+|||++
T Consensus 93 ----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 ----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred ----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 669999999985 999999998999999999999999999999999999999999999999999 99999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCC-C-CchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSK-Y-TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~-~-s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
.... .......+.+||+.|+|||++.+ .. | +.++||||+|++||.|++|+.||...+.......|...
T Consensus 169 ~~~~---~~~~~l~t~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~----- 238 (370)
T KOG0583|consen 169 AISP---GEDGLLKTFCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG----- 238 (370)
T ss_pred cccC---CCCCcccCCCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-----
Confidence 8753 12224577899999999999988 34 6 48999999999999999999999987766665554221
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCC-CHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGA-DPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
. ..+. ..+ ++++.+||++||..||.+|+|+.+ ++.
T Consensus 239 ---------------------~--~~~p---~~~~S~~~~~Li~~mL~~~P~~R~t~~~------------------i~~ 274 (370)
T KOG0583|consen 239 ---------------------E--FKIP---SYLLSPEARSLIEKMLVPDPSTRITLLE------------------ILE 274 (370)
T ss_pred ---------------------C--ccCC---CCcCCHHHHHHHHHHcCCCcccCCCHHH------------------Hhh
Confidence 0 1111 124 999999999999999999999999 789
Q ss_pred CcccCC
Q 044076 322 DPYFHG 327 (506)
Q Consensus 322 HP~f~~ 327 (506)
||||+.
T Consensus 275 h~w~~~ 280 (370)
T KOG0583|consen 275 HPWFQK 280 (370)
T ss_pred Chhhcc
Confidence 999996
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=395.25 Aligned_cols=334 Identities=41% Similarity=0.740 Sum_probs=282.8
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
+.|...++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34667899999999999999999999999999999999986543344445678899999999999999999999865421
Q ss_pred -CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 -REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 -~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.....+|+||||++++|.+++.. ..+++..++.++.||++||.|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 89 LDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 22346799999998899988864 5799999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... .....++++|+|||.+.+. ..++.++|+||+||++|+|++|++||.+.+....+..+....+.+..+..
T Consensus 168 ~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 168 TDSE------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred cccC------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 3221 1345678999999998652 45889999999999999999999999999888888899888888888877
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
..+.......+...++......+....+++++++.+||.+||+.||.+|||+.+ ++.||||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~------------------~l~~~~~~ 302 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE------------------ALAHPYFE 302 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHH------------------HhcCccHh
Confidence 777777777777766655555555566789999999999999999999999999 89999999
Q ss_pred CCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 327 GLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
.......++...+ +...++....+.++|+.+.+.||++|+|
T Consensus 303 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 303 EFHDPEDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred hhcCcccccCCCC---ccccHHhhccchHHHHHHHHHHHHhcCC
Confidence 9887666554443 5556788888999999999999999886
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=389.33 Aligned_cols=284 Identities=36% Similarity=0.585 Sum_probs=232.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECC-CCcEEEEEEecccccChhHHHHHHHHHHHHHhC---CCCCcceeceeecCCCcCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTH-TGEKVAIKKMKEVFEHVSDATRILREIKLLRML---KHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~-t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l---~HpnIv~l~~v~~~~~~~~ 89 (506)
++|++++.||+|+||+||+|.+.. ++..||||+++.............+|+.+++.+ .||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 489999999999999999999865 468899999865433333344566788887766 5999999999986543344
Q ss_pred CCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELMESDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
...+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999998764 35899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ......+|..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|.+..|.|.++.+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3221 1234568999999999977 678999999999999999999999999999999999999999988877665
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
....... ..+......++....+.+++.+.+||.+||+.||++|||+.| +|+||||
T Consensus 235 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~------------------~l~hp~f 290 (290)
T cd07862 235 RDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS------------------ALSHPYF 290 (290)
T ss_pred hhhcccc----hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH------------------HhcCCCC
Confidence 4221110 111222333444556778999999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=381.95 Aligned_cols=263 Identities=30% Similarity=0.492 Sum_probs=227.0
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.....+.|++.++||+|.|++|+++.+..||+.+|+|+++.......+.+.+.||++|-+.|+||||++|.+.+ .
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~ 80 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----Q 80 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----c
Confidence 34456789999999999999999999999999999999964333445778899999999999999999999987 4
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC---CCCEEEeecCCc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA---DCKLKICDFGLA 164 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~---~~~lKL~DFGla 164 (506)
+.+..|||||+|+| +|..-|-.+.-+++..+..+++|||++|.|+|.+||||||+||+|+++-+ ...+||||||+|
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceE
Confidence 45889999999986 88777766677899999999999999999999999999999999999864 345999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
.... .+..+.+.+||+.|+|||++.. ..|+..+|||+.|+|||.||.|++||.+.+.....+.|...--..+
T Consensus 161 i~l~----~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~-- 232 (355)
T KOG0033|consen 161 IEVN----DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP-- 232 (355)
T ss_pred EEeC----CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC--
Confidence 7644 2334678899999999999988 8999999999999999999999999999888777777743211111
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
...|+++++++++||++||..||.+|+|+.| ||.|||
T Consensus 233 -------------------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~E------------------AL~HpW 269 (355)
T KOG0033|consen 233 -------------------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADE------------------ALKHPW 269 (355)
T ss_pred -------------------------CcccCcCCHHHHHHHHHHhccChhhhccHHH------------------HhCCch
Confidence 1357889999999999999999999999999 999999
Q ss_pred cCC
Q 044076 325 FHG 327 (506)
Q Consensus 325 f~~ 327 (506)
+.+
T Consensus 270 i~~ 272 (355)
T KOG0033|consen 270 ICN 272 (355)
T ss_pred hcc
Confidence 976
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=384.33 Aligned_cols=304 Identities=33% Similarity=0.514 Sum_probs=254.6
Q ss_pred ccccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecC
Q 044076 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLP 84 (506)
Q Consensus 5 ~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~ 84 (506)
-++......+.|+-...||+|.||.||+|+...+|+.||+|++-..-+........+||+++|..|+|+|++.+++++..
T Consensus 8 ~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 8 MYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred ccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 35566677899999999999999999999999999999999885433444555667899999999999999999998754
Q ss_pred CCc---CCCCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEee
Q 044076 85 PCR---REFKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICD 160 (506)
Q Consensus 85 ~~~---~~~~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~D 160 (506)
... .+...+|+||.+|+.||..++... ..++..+++.+|.+++.||.|+|++.|+|||+|+.|+||+.+|.+||+|
T Consensus 88 k~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeec
Confidence 322 334569999999999999999765 5799999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCC-CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcC
Q 044076 161 FGLARVSFTD-TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 161 FGla~~~~~~-~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g 239 (506)
||+||..... ......++..+.|.||++||.+++. ..|++++|||+.|||++||++|.|+|.|.+..+|+..|..++|
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 9999764332 2223346888999999999999984 8999999999999999999999999999999999999999999
Q ss_pred CCChHHHhhhhhhHHHHHHhhh--hccCCCCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSL--RRKWAVPFSHKFP--GADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYF 315 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~ 315 (506)
.-+.+.|+.+.+-...+-++.- ++........... .-++++.||+.+||.+||.+|+++++
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~--------------- 311 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ--------------- 311 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh---------------
Confidence 9999999998776554443221 1111111111111 23679999999999999999999999
Q ss_pred hhhhccCcccCC
Q 044076 316 YVLALADPYFHG 327 (506)
Q Consensus 316 ~~~aL~HP~f~~ 327 (506)
||.|.||..
T Consensus 312 ---alnh~~F~k 320 (376)
T KOG0669|consen 312 ---ALNHDFFWK 320 (376)
T ss_pred ---hhchhhhhc
Confidence 999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-50 Score=408.46 Aligned_cols=258 Identities=35% Similarity=0.567 Sum_probs=230.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|.+.+.||+|+||+||+|+.+.|.+.||||.+.+......+.+.+.+|++|++.++|||||.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 689999999999999999999999999999999987777788889999999999999999999999998 555899
Q ss_pred EEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 94 YVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
|+|+||+.|+|+.++...+.++++.++.|.+|++.||.|||+++|+|||+||.|||+..+|.+|+||||+|+......
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999764433
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhH
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~ 253 (506)
...+..-||+.|||||++.+ ..|+..+|+||||||+|||+.|+|||...+..+....|..- |
T Consensus 155 -~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~------------ 216 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---P------------ 216 (808)
T ss_pred -eeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---C------------
Confidence 23567789999999999987 89999999999999999999999999887766555555321 1
Q ss_pred HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
.. ..+.++..+++||..+|..||.+|+|-.+ ++.|||.++-..
T Consensus 217 ------------v~----~p~~~S~~f~nfl~gLL~kdP~~RltW~~------------------Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 217 ------------VK----PPSTASSSFVNFLQGLLIKDPAQRLTWTD------------------LLGHPFWKGKIN 259 (808)
T ss_pred ------------CC----CcccccHHHHHHHHHHhhcChhhcccHHH------------------HhcChHHhhhhh
Confidence 00 11258999999999999999999999999 799999987444
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=392.06 Aligned_cols=332 Identities=44% Similarity=0.808 Sum_probs=284.0
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC-cC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC-RR 88 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~-~~ 88 (506)
+...++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.... ..
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 56789999999999999999999999999999999999754444445667889999999999999999999885432 12
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
....+|+|+++++++|.++++. ..+++..++.++.||++||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3456899999999999888765 469999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. ...+.++.+|+|||++.+. ..++.++||||+||++|+|++|++||++.+....+..+....+.+.+..+..
T Consensus 172 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 172 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cc------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 21 2345789999999998652 5688899999999999999999999999988888999999999999888888
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+.....+.++..++......+...+...++++.+||.+||+.||.+|||+.+ +|.||||.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e------------------~l~h~~f~~~ 306 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ------------------ALAHAYFAQY 306 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHH------------------HhcChhhhhc
Confidence 7777777777777666666666666678999999999999999999999999 8999999998
Q ss_pred CCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 329 ANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
..+..+|...+ +...+..+.+..++|....|.|+..|-|
T Consensus 307 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 307 HDPDDEPVADP---YDQSFESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred CCCCccccCCC---ccCcchhcccCHHHHHHHHHHHHHhcCC
Confidence 88777776543 5666777788889999999999988865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=389.49 Aligned_cols=292 Identities=37% Similarity=0.651 Sum_probs=242.8
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
|+..++|++++.||+|+||.||+|++..+++.||||+++.... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 75 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHT----- 75 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEee-----
Confidence 6778899999999999999999999999999999999864322 2233457789999999999999999999843
Q ss_pred CCcEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+..|+||||++++|.+.+...+ .++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 37899999999999999887644 58999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ......+|..|+|||++.+. ..++.++||||+||++|+|++|++||++.+..+.+..+...+|.|..+.|..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2211 12345689999999998652 5688999999999999999999999999999999999999999999988877
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+........ ...+.....++....+.+++++.+||.+||+.||.+|||+.| +|+||||+.+
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e------------------~l~h~~~~~~ 292 (309)
T cd07872 232 ISSNDEFKN-YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE------------------AMKHAYFRSL 292 (309)
T ss_pred hcchhhhhh-hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH------------------HhcChhhhhc
Confidence 644321111 112222233333455678999999999999999999999999 8999999987
Q ss_pred CC
Q 044076 329 AN 330 (506)
Q Consensus 329 ~~ 330 (506)
..
T Consensus 293 ~~ 294 (309)
T cd07872 293 GT 294 (309)
T ss_pred cc
Confidence 64
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=409.86 Aligned_cols=263 Identities=29% Similarity=0.485 Sum_probs=231.0
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
...+-|++++.||.|+.|.|..|.+..||+.+|||+|.+. .........+.+||-||+.+.||||+.|++++ ++
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----EN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----cc
Confidence 3456799999999999999999999999999999999654 33445567789999999999999999999999 55
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..++|+|.||++ |.|++++...+++++.++..+++||+.|+.|||..||+||||||+|+|++..+++||+|||+|....
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 589999999998 5999999999999999999999999999999999999999999999999999999999999998733
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.+ ..+.+.+|++.|.|||++.+ ..| +.++||||.|||||.||+|+.||.+.|....|.++.....
T Consensus 164 ~g----klLeTSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-------- 229 (786)
T KOG0588|consen 164 PG----KLLETSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-------- 229 (786)
T ss_pred CC----ccccccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--------
Confidence 32 34578899999999999998 555 6799999999999999999999998887777777643111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
+.-.+++++|.|||.+||.+||.+|+|.+| +++|||+.+
T Consensus 230 -----------------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~e------------------I~kHP~l~g 268 (786)
T KOG0588|consen 230 -----------------------EMPSNISSEAQDLLRRMLDVDPSTRITTEE------------------ILKHPFLSG 268 (786)
T ss_pred -----------------------cCCCcCCHHHHHHHHHHhccCccccccHHH------------------HhhCchhhc
Confidence 222469999999999999999999999999 899999998
Q ss_pred CCCCCC
Q 044076 328 LANLEE 333 (506)
Q Consensus 328 ~~~~~~ 333 (506)
......
T Consensus 269 ~~~~~~ 274 (786)
T KOG0588|consen 269 YTSLPS 274 (786)
T ss_pred CCCCCh
Confidence 776443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=386.14 Aligned_cols=284 Identities=36% Similarity=0.637 Sum_probs=228.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++.+.||+|+||.||+|++..+++.||||+++...........+.+|+.+++.++||||+++++++. ..+.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEE
Confidence 5799999999999999999999999999999999754333444567889999999999999999999883 34789
Q ss_pred EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||+++++.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999876666554 45799999999999999999999999999999999999999999999999999976432211
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
.......+|+.|+|||++.+ ..++.++||||+||++|+|++|++||++.+..+.+..+....|..+.+.+......
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 --ANYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred --ccccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 11234678999999999977 67899999999999999999999999999988888888888888776655432211
Q ss_pred HHHHHHhhhhc-cCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 253 KAKRYLSSLRR-KWAVPF-SHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 253 ~~~~~~~~~~~-~~~~~~-~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
....-. ..+. ...... ......+++++.+||++||++||++|||++| +|+||||
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~------------------~l~hp~f 287 (287)
T cd07848 232 PRFHGL-RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ------------------CLNHPAF 287 (287)
T ss_pred chhccc-ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH------------------HhcCCCC
Confidence 000000 0000 000000 1122347889999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=393.57 Aligned_cols=328 Identities=37% Similarity=0.663 Sum_probs=262.2
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC-cC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC-RR 88 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~-~~ 88 (506)
|...++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... .+
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 45678999999999999999999999999999999998755555556677889999999999999999999986542 23
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
+....|+||||+.++|.+.+... +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 44678999999999999988754 8999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||++.+...+...+...+|.|..+.+..
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 170 TSFM----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CCCC----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 2211 234568899999999987 7899999999999999999999999999999999999999999998876655
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCC-------------CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKF-------------PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYF 315 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~ 315 (506)
+... ...+....+.....++...+ ...++.+.+||.+||+.||.+|||+.|
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e--------------- 307 (353)
T cd07850 244 LQPT-VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD--------------- 307 (353)
T ss_pred hhhh-hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH---------------
Confidence 4322 22233222222222222222 134667899999999999999999999
Q ss_pred hhhhccCcccCCCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHH
Q 044076 316 YVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREI 365 (506)
Q Consensus 316 ~~~aL~HP~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei 365 (506)
+|.||||+.+-...+.....| ...+...+.+..+.++|++.+|.|+
T Consensus 308 ---iL~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (353)
T cd07850 308 ---ALQHPYINVWYDPSEVEAPPP-APYDHSIDEREHTVEEWKELIYKEV 353 (353)
T ss_pred ---HhcChhHhhccCCccCCCCCC-CccccccccccccHHHHHHHHHhhC
Confidence 899999987665444333222 1233344566778899999888763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=384.16 Aligned_cols=283 Identities=35% Similarity=0.592 Sum_probs=231.1
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC---CCCCcceeceeecCCCcCCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML---KHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l---~HpnIv~l~~v~~~~~~~~~~ 91 (506)
+|++++.||+|+||+||+|.+..+++.||||.++...........+.+|+.+++.+ +||||+++++++.....+...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999865332222333456777777665 699999999998654334456
Q ss_pred cEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELMESDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+++||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 79999999999999988764 3589999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... .....+|..|+|||++.+ ..++.++||||+||++|+|++|+++|.+.+..+.+..+....|.|....|...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccc----CCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 211 234568999999999977 67999999999999999999999999999999999999999988877665432
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..... ..+......+.....+.++..+.+||.+||+.||.+|||+.| +|.||||
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~------------------~l~hp~f 288 (288)
T cd07863 235 VTLPR----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR------------------ALQHPFF 288 (288)
T ss_pred ccccc----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH------------------HhcCCCC
Confidence 11100 011112223334555778999999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=373.75 Aligned_cols=254 Identities=27% Similarity=0.477 Sum_probs=223.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||.|+||.|.+++++.+|..+|+|++++. .-.....+...+|..+|+.+.||+++++.+.+. +.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-----d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-----DNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-----cCC
Confidence 46899999999999999999999999999999999642 123455677889999999999999999999884 458
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+||||||.+| .|..++++.+++++.++++++.||+.||.|||+++|++|||||+|||++.+|.+||+|||+|+.....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999985 99999999999999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
..+.+||+.|+|||++.. ..|+.++|.||||+++|||+.|.+||.+.+.....++|...--
T Consensus 198 ------T~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v----------- 258 (355)
T KOG0616|consen 198 ------TWTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV----------- 258 (355)
T ss_pred ------EEEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-----------
Confidence 246789999999999988 8999999999999999999999999999998888888754211
Q ss_pred hhHHHHHHhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
.| +..+++++|||+++|+.|-.+|. ...+ +..|||
T Consensus 259 ---------------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~d------------------Ik~H~w 299 (355)
T KOG0616|consen 259 ---------------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVED------------------IKNHPW 299 (355)
T ss_pred ---------------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccc------------------cccCcc
Confidence 12 24799999999999999999994 4556 799999
Q ss_pred cCCCC
Q 044076 325 FHGLA 329 (506)
Q Consensus 325 f~~~~ 329 (506)
|+++.
T Consensus 300 F~~v~ 304 (355)
T KOG0616|consen 300 FKGVD 304 (355)
T ss_pred ccccc
Confidence 99764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=389.30 Aligned_cols=331 Identities=40% Similarity=0.733 Sum_probs=275.6
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-C
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-R 88 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~ 88 (506)
|...++|.+.+.||.|+||.||+|++..+|+.||||++............+.+|+.+++.+.||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 556789999999999999999999999999999999997543333445567899999999999999999998864421 2
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
....+|+|+||+..+|..++. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 335689999999988887653 468999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. ...+.++.+|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....|.+.++.+..
T Consensus 169 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 169 AE------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CC------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 21 2345688999999998652 4688999999999999999999999999998889999999999998888777
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+.......+....+......+...++..++.+.+||.+||+.||.+|||+++ +|.||||..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e------------------~l~h~~f~~~ 303 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATE------------------ALEHPYFDSF 303 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHH------------------HhcCcchhhc
Confidence 7665556665555555555666667889999999999999999999999999 8999999999
Q ss_pred CCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 329 ANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
++...++...+ +...-+...+..+++...||.|+-++.|
T Consensus 304 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (342)
T cd07879 304 RDADEETEQQP---YDDSLENEKLSVDEWKKHIYKEVKSFSP 342 (342)
T ss_pred ccccccCCCCc---ccchhhhhhCCHHHHHHHhhhhhhccCC
Confidence 87655554333 4455566677789999999999776654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=398.51 Aligned_cols=284 Identities=25% Similarity=0.345 Sum_probs=225.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||.||+|.+..+++.||||+.. ...+.+|+.+|+.++||||+++++++.. ...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCe
Confidence 368999999999999999999999999999999753 2346799999999999999999999843 367
Q ss_pred EEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 93 IYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
.|+|+|++.++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 158 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 158 TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred eEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 89999999999999998888899999999999999999999999999999999999999999999999999975322111
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-------CchhhHHHHHhhcCCCChHH
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR-------NVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~-------~~~~~l~~I~~~~g~p~~e~ 245 (506)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+. +...++..|...+|.++.+.
T Consensus 238 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 --NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred --cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 11245679999999999987 68999999999999999999999776443 23567888888888776543
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCC----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPF----SHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
...........+..........+. ......++.++.+||.+||++||.+||||+| +|.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e------------------lL~ 375 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA------------------LLD 375 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH------------------Hhc
Confidence 221111111112111111111111 1111245778999999999999999999999 899
Q ss_pred CcccCCCCCC
Q 044076 322 DPYFHGLANL 331 (506)
Q Consensus 322 HP~f~~~~~~ 331 (506)
||||+.+..+
T Consensus 376 hp~f~~~~~~ 385 (391)
T PHA03212 376 FAAFQDIPDP 385 (391)
T ss_pred ChhhccCCCC
Confidence 9999986553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=376.93 Aligned_cols=249 Identities=31% Similarity=0.451 Sum_probs=213.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
...|+|.++||+|+||.||++++..+|..||.|+++-..-+......+..||.+|++|+|||||+.++.-.. ++..-
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence 346999999999999999999999999999999997433455667778899999999999999999883222 23345
Q ss_pred EEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--eeecCCCCCcEEECCCCCEEEeecCC
Q 044076 93 IYVVFELME-SDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHS--AN--VFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~--~g--IvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
++||||||+ |||.+.|+. ...+++..++.++.|+++||..||+ .+ |+||||||.||+++.+|.+||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 999999998 699999974 3469999999999999999999999 45 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
++..... ..+...+|||+.||+||++.+ ..|+.++||||+||++|||..-++||.|++..+...+|.+.--.|-+
T Consensus 175 ~r~l~s~---~tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 175 GRFLSSK---TTFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred HhHhcch---hHHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 9986443 335678999999999999998 89999999999999999999999999999888888888654222211
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa 298 (506)
. ...|.++..||..|+..||+.||+.
T Consensus 250 ~-----------------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 D-----------------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred H-----------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 1 1267889999999999999999984
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=384.04 Aligned_cols=328 Identities=48% Similarity=0.793 Sum_probs=273.3
Q ss_pred CEEEeEEEeecCceEEEEEEECCC--CcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHT--GEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t--~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~ 91 (506)
+|++.+.||.|+||.||+|.+..+ +..||||++..........+.+.+|+.+++++. ||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999888 899999998754444445667889999999995 999999998653321 2346
Q ss_pred cEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 92 DIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.+|++++|++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999997543221
Q ss_pred C-CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 172 P-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 172 ~-~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. ........++|..|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+...+|.|..+.+..+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 1 11122446789999999987652 568899999999999999999999999999999999999999999998888877
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
......+...+......++....+..+..+.+||.+||+.||.+|||+.+ ++.||||+.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~------------------ll~~~~~~~~~~ 300 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEE------------------ALEHPYLAIWHD 300 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHH------------------HhcChhhhhhcC
Confidence 77666666666666666666777888999999999999999999999999 899999999998
Q ss_pred CCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHH
Q 044076 331 LEEEPSRKPISKLVFEFERRKLIKDDVRELIYREI 365 (506)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei 365 (506)
+...+.|.... .+.|+. +-+.+++|++|..|+
T Consensus 301 ~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~ 332 (332)
T cd07857 301 PDDEPVCQKPF--DFSFES-EDSMEELRDMIIEEV 332 (332)
T ss_pred ccccccccccc--cCCccc-cccHHHHHHHHhhcC
Confidence 87777775332 333433 335678888887653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=403.28 Aligned_cols=285 Identities=26% Similarity=0.400 Sum_probs=226.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCC------CCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH------PDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~H------pnIv~l~~v~~~~~ 86 (506)
.++|++++.||+|+||+||+|.+..+++.||||+++.. ........+|+.+++.+.| .+|+.+++++..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-- 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-- 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc--
Confidence 57899999999999999999999999999999999642 1223345567777777754 457888887743
Q ss_pred cCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCC-----------
Q 044076 87 RREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADC----------- 154 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~----------- 154 (506)
+..++|+|||+++++|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 --~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 --ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred --CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 23679999999999999999888889999999999999999999998 5999999999999998765
Q ss_pred -----CEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchh
Q 044076 155 -----KLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAH 229 (506)
Q Consensus 155 -----~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~ 229 (506)
.+||+|||++..... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998854211 1245689999999999987 789999999999999999999999999999999
Q ss_pred hHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCC----CCC-----CCCC--CCCHHHHHHHHHhhhcCCCCCCCH
Q 044076 230 QLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAV----PFS-----HKFP--GADPLALRLLQRLLAFDPKDRPSA 298 (506)
Q Consensus 230 ~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~----~~~-----~~~~--~~s~~~~dLI~~mL~~DP~~RpTa 298 (506)
++..|...+|.++.+..........+.+........+. .+. ..+. ..++.+.|||.+||++||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 99999999999877655443333333333222111000 000 0000 125678999999999999999999
Q ss_pred hhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 299 EEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 299 ~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
+| +|.||||.....
T Consensus 433 ~e------------------~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQ------------------MTTHPYVLKYYP 446 (467)
T ss_pred HH------------------HhcCccccccCC
Confidence 99 899999987543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=379.93 Aligned_cols=281 Identities=36% Similarity=0.600 Sum_probs=218.5
Q ss_pred eEEEeecCceEEEEEEEC--CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEE
Q 044076 19 QEIIGIGSYGVVASAIDT--HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~--~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
.++||+|+||+||+|.+. .+++.||+|.+... .....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEE
Confidence 468999999999999965 46789999998642 1223467999999999999999999988543 23678999
Q ss_pred EecCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE----CCCCCEEEeecCC
Q 044076 97 FELMESDLDQVIKAN---------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA----NADCKLKICDFGL 163 (506)
Q Consensus 97 ~E~~~~~L~~~i~~~---------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv----~~~~~lKL~DFGl 163 (506)
|||++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999999988632 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc---------hhhHHHH
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV---------AHQLDLV 234 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~---------~~~l~~I 234 (506)
|+...............++|+.|+|||++.+. ..++.++||||+||++|+|++|++||.+... .+++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 97643322222223456789999999998762 5689999999999999999999999976543 4678899
Q ss_pred HhhcCCCChHHHhhhhhhH-HHHHHhhhhccCC--CC----CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhh
Q 044076 235 TDLLGTPSAESIAGIRNEK-AKRYLSSLRRKWA--VP----FSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIV 307 (506)
Q Consensus 235 ~~~~g~p~~e~~~~~~~~~-~~~~~~~~~~~~~--~~----~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~ 307 (506)
...+|.|....|..+.... .......+..... .. +.......+..+.|||.+||++||.+|||++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e------- 310 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ------- 310 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHH-------
Confidence 9999999988877653211 1111111111100 00 11111235678999999999999999999999
Q ss_pred hhHHHHHhhhhhccCccc
Q 044076 308 FNWLFLYFYVLALADPYF 325 (506)
Q Consensus 308 ~~~~~~~~~~~aL~HP~f 325 (506)
+|+||||
T Consensus 311 -----------~l~hp~f 317 (317)
T cd07868 311 -----------AMQDPYF 317 (317)
T ss_pred -----------HhcCCCC
Confidence 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=378.22 Aligned_cols=277 Identities=28% Similarity=0.442 Sum_probs=230.9
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...+.|++.++||.|..++||+|+...+++.||||++.-. ....+...+.+|+..|+.++||||++++..|...
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE-kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~----- 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE-KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD----- 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh-hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-----
Confidence 4578999999999999999999999999999999999632 2334467899999999999999999999999654
Q ss_pred CcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 91 KDIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
..+|+||+||. |++.++++.. ..+.|..+..|++++++||.|||.+|-||||||+.||||+.+|.+||+|||.+...
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 78999999998 6999999874 35999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccc-cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~-~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.......... ...+||++|+|||++...-..|+.++||||||++..||.+|..||........| +.++-|.|+.-..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCccc
Confidence 5444332222 678999999999997665588999999999999999999999999877665544 3445566653222
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.....+.. ...+..++.+|..||+.||.+||||++ +|+|+||+
T Consensus 255 ~~~~~d~~-------------------k~~~ksf~e~i~~CL~kDP~kRptAsk------------------Llkh~FFk 297 (516)
T KOG0582|consen 255 SGLDKDED-------------------KKFSKSFREMIALCLVKDPSKRPTASK------------------LLKHAFFK 297 (516)
T ss_pred ccCChHHh-------------------hhhcHHHHHHHHHHhhcCcccCCCHHH------------------HhccHHHh
Confidence 22211111 225668999999999999999999999 89999999
Q ss_pred CCCCCC
Q 044076 327 GLANLE 332 (506)
Q Consensus 327 ~~~~~~ 332 (506)
......
T Consensus 298 ~~k~~~ 303 (516)
T KOG0582|consen 298 KAKSKE 303 (516)
T ss_pred hccchh
Confidence 876543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=379.03 Aligned_cols=325 Identities=46% Similarity=0.822 Sum_probs=276.4
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
+-+...++|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++.+++...
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 81 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-- 81 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC--
Confidence 346778999999999999999999999999999999999864333334456688999999999999999999987432
Q ss_pred CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 88 REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
....|+|+||++++|.++++. ..+++..+..++.||+.||+|||+.||+||||+|.||+++.++.+||+|||+++..
T Consensus 82 --~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 82 --LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred --CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 357899999999999988764 46889999999999999999999999999999999999999999999999999743
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ...++++..|+|||.+.+ ...++.++|+||+||++|+|++|++||++.........+.+.+|.|+.+.+.
T Consensus 159 ~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 159 DPQ------MTGYVSTRYYRAPEIMLT-WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred CCC------cCCCcccccccCceeeec-cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 211 134567889999998754 2568999999999999999999999999999888888999999999988877
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.+.......+....+.....+....++++++.+.++|.+||+.||.+|||+++ ++.||||..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e------------------ll~~~~~~~ 293 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE------------------ALAHPYLAP 293 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH------------------HhcCCcccc
Confidence 76655556666666665666666677789999999999999999999999999 899999999
Q ss_pred CCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHH
Q 044076 328 LANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364 (506)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~e 364 (506)
.+.+..+|... ..+++.|+...+..+.|+-++|.|
T Consensus 294 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 328 (328)
T cd07856 294 YHDPTDEPVAE--EKFDWSFNDADLPVDTWKVMMYSE 328 (328)
T ss_pred ccCCccccCch--hhcCCchhcccCCHHHHHHHhcCC
Confidence 88877666543 478888899999999999887743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=383.40 Aligned_cols=331 Identities=45% Similarity=0.754 Sum_probs=273.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~ 89 (506)
...++|++.+.||.|+||.||+|.+..+++.||||++...+........+.+|+.+++.+ +||||+++++++... +
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~ 80 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---N 80 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---C
Confidence 346789999999999999999999999999999999865444445566778999999999 899999999987432 2
Q ss_pred CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 90 FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
....|+||||++++|.+++..+ .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred CceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 3568999999999999998876 789999999999999999999999999999999999999999999999999976433
Q ss_pred CCCC--cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 170 DTPS--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 170 ~~~~--~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ......+++|.+|+|||++.+. ..++.++|+||+||++|+|++|++||++....+.+..+....|.+..+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred ccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 2211 1223457799999999988652 567889999999999999999999999999999999999999999888887
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.+........+.........+....+++++.++.+||.+||+.||.+|||+.+ ++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~------------------il~~~~~~~ 300 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE------------------ALEHPYVAQ 300 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHH------------------HhhChhhhh
Confidence 77666666666655555555566677789999999999999999999999999 899999999
Q ss_pred CCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHH
Q 044076 328 LANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREI 365 (506)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei 365 (506)
+.....++........-+. +.+++...+.|..+|.||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07852 301 FHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337 (337)
T ss_pred hccCCCCCCCCCCccCCcc-ccceeeHHHHHhhhhhcC
Confidence 8776666543221111111 356778888888888875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=375.82 Aligned_cols=292 Identities=37% Similarity=0.652 Sum_probs=237.7
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
|+..++|++++.||.|+||.||+|.+..+++.||+|.++.... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----- 75 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT----- 75 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEec-----
Confidence 5677899999999999999999999999999999999864322 2233457789999999999999999999843
Q ss_pred CCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
....|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 76 EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 3789999999999999988764 468999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.|....|..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2111 12344678999999998652 5688899999999999999999999999999999999999999998887765
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+....... ....+......+....+.+++.+.+||.+||+.||.+|||++| +|+||||+.+
T Consensus 232 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~e------------------il~h~~f~~~ 292 (301)
T cd07873 232 ILSNEEFK-SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE------------------AMKHPYFHCL 292 (301)
T ss_pred hhcccccc-ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHH------------------HhcCcccccc
Confidence 43221100 0001111111112233568899999999999999999999999 8999999887
Q ss_pred CC
Q 044076 329 AN 330 (506)
Q Consensus 329 ~~ 330 (506)
..
T Consensus 293 ~~ 294 (301)
T cd07873 293 GE 294 (301)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=377.62 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=214.8
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence 47999999999999999999999999999999986321 12234566889999999999999999998874 3478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||+. ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999997 5999999988899999999999999999999999999999999999999999999999999997542211
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....|... .
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~----------- 214 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--K----------- 214 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C-----------
Confidence 23568999999999987 67899999999999999999999999887765544444210 0
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
. ......++.+.+||++||+.||.+|++ +++ ++.||||.
T Consensus 215 ---------------~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~------------------~l~h~~~~ 258 (291)
T cd05612 215 ---------------L---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADD------------------VKNHRWFK 258 (291)
T ss_pred ---------------c---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHH------------------HhcCcccc
Confidence 0 011246889999999999999999995 999 89999998
Q ss_pred CCC
Q 044076 327 GLA 329 (506)
Q Consensus 327 ~~~ 329 (506)
.+.
T Consensus 259 ~~~ 261 (291)
T cd05612 259 SVD 261 (291)
T ss_pred CCC
Confidence 654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=386.01 Aligned_cols=264 Identities=32% Similarity=0.505 Sum_probs=227.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~ 88 (506)
.....|++.+.||.|.||+||.|+++.||+.+|+|++.+... ...+...+.+|+.+|++++ |||||.++++|.
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e----- 106 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE----- 106 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE-----
Confidence 345689999999999999999999999999999999965332 2335567899999999999 999999999994
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC----CCEEEeecCC
Q 044076 89 EFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD----CKLKICDFGL 163 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~----~~lKL~DFGl 163 (506)
+...+|+|||++. |+|.+.|... .+++..+..++.||+.+++|||+.||+||||||+|+|+... +.+|++|||+
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 4479999999998 5999998876 49999999999999999999999999999999999998643 5799999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
|..... .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......|.. |.+
T Consensus 186 a~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~--~~~-- 255 (382)
T KOG0032|consen 186 AKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR--GDF-- 255 (382)
T ss_pred ceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc--CCC--
Confidence 987543 223577899999999999987 7999999999999999999999999999987776665533 211
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
.--...|++++..|++||++||..||.+|+|+.+ +|+||
T Consensus 256 -----------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~------------------~L~Hp 294 (382)
T KOG0032|consen 256 -----------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQ------------------ALQHP 294 (382)
T ss_pred -----------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHH------------------HhcCc
Confidence 1123567889999999999999999999999999 99999
Q ss_pred ccCCCCCC
Q 044076 324 YFHGLANL 331 (506)
Q Consensus 324 ~f~~~~~~ 331 (506)
|+++....
T Consensus 295 Wi~~~~~~ 302 (382)
T KOG0032|consen 295 WIKSIGEA 302 (382)
T ss_pred cccCCccc
Confidence 99886443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=376.09 Aligned_cols=265 Identities=29% Similarity=0.446 Sum_probs=213.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
..+|..++.||+|+||.||++.+..+|+..|||.+... +....+.+.+|+.+|..++|||||+.++..... ++ ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~~-~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--EN-DE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--cC-ee
Confidence 56788999999999999999999999999999999643 222266789999999999999999999864322 11 47
Q ss_pred EEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-CCCEEEeecCCcccccC
Q 044076 93 IYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-~~~lKL~DFGla~~~~~ 169 (506)
+++.|||+. |+|.++++..+ .|++..++.+..||++||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999998 59999999877 7999999999999999999999999999999999999999 79999999999976443
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-CchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR-NVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~-~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
............||+.|||||++.. .....+++|||||||++.||++|++||... .....+-.|
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i-------------- 235 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI-------------- 235 (313)
T ss_pred ccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH--------------
Confidence 1122222345789999999999985 133446999999999999999999999763 211111111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
......| .+...+++++.+||.+||..||.+||||++ +|.|||..+.
T Consensus 236 -------------g~~~~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~e------------------LL~hpf~~~~ 282 (313)
T KOG0198|consen 236 -------------GREDSLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEE------------------LLEHPFLKQN 282 (313)
T ss_pred -------------hccCCCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHH------------------HhhChhhhcc
Confidence 0011111 333468999999999999999999999999 8999999874
Q ss_pred CC
Q 044076 329 AN 330 (506)
Q Consensus 329 ~~ 330 (506)
..
T Consensus 283 ~~ 284 (313)
T KOG0198|consen 283 SI 284 (313)
T ss_pred cc
Confidence 43
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=381.47 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=214.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++.+.||+|+||.||+|.+..+++.||||+++... ........+.+|+.+|+.++||||+++++++.. .+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----EN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CC
Confidence 578999999999999999999999999999999996421 223345668899999999999999999999843 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+||||+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 8999999997 599999998889999999999999999999999999999999999999999999999999999764221
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. ....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......|.. |.
T Consensus 172 ~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~--~~---------- 231 (329)
T PTZ00263 172 T------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA--GR---------- 231 (329)
T ss_pred c------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CC----------
Confidence 1 23568999999999987 6789999999999999999999999987765544444321 00
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.. ....+++.+.+||.+||+.||.+|++ +++ ++.||||
T Consensus 232 ----------------~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~------------------ll~hp~f 274 (329)
T PTZ00263 232 ----------------LK---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVAD------------------VKNHPYF 274 (329)
T ss_pred ----------------cC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHH------------------HhcCCcc
Confidence 00 01237888999999999999999997 688 8999999
Q ss_pred CC
Q 044076 326 HG 327 (506)
Q Consensus 326 ~~ 327 (506)
.+
T Consensus 275 ~~ 276 (329)
T PTZ00263 275 HG 276 (329)
T ss_pred CC
Confidence 86
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=390.41 Aligned_cols=258 Identities=31% Similarity=0.500 Sum_probs=224.2
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
....+|...+.||+|+.|.||.|....+++.||||.+.. ......+-+++|+.+|+..+|+|||.+++.|+..
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l--~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~----- 342 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDL--RKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG----- 342 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEe--ccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----
Confidence 445689999999999999999999999999999999964 2334456688999999999999999999988654
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+.+|+|||||+| +|.+++... .++|..+..|+++++.||+|||..||+|||||.+|||+..+|.+||+|||+|.....
T Consensus 343 deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred ceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 789999999985 888888754 599999999999999999999999999999999999999999999999999987554
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... .....|||++|||||+... ..|++++||||||++++||+-|+|||-..+....+.+|.. -|+|..
T Consensus 422 ~~~---KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l------ 489 (550)
T KOG0578|consen 422 EQS---KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL------ 489 (550)
T ss_pred ccC---ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc------
Confidence 433 2367899999999999987 8999999999999999999999999988887777777643 233322
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.....+|++++|||.+||+.|+.+|+||.| +|+||||+.
T Consensus 490 ---------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~e------------------LL~HpFl~~ 528 (550)
T KOG0578|consen 490 ---------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKE------------------LLEHPFLKM 528 (550)
T ss_pred ---------------------CCccccCHHHHHHHHHHhhcchhcCCCHHH------------------HhcChhhhh
Confidence 122458999999999999999999999999 899999953
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=380.79 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=210.4
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEe
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFE 98 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E 98 (506)
+.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.+++.++||||+++++++.. .+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence 47999999999999999999999999996432 233445667899999999999999999998843 478999999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccc
Q 044076 99 LME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177 (506)
Q Consensus 99 ~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 177 (506)
|++ ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 998 48999998888999999999999999999999999999999999999999999999999999975322111 12
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~ 257 (506)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~----------------- 211 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--E----------------- 211 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--C-----------------
Confidence 45679999999999987 68999999999999999999999999877655444433210 0
Q ss_pred HhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 258 LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
. .....+++++.+||++||+.||++|| ++.+ +++||||.++
T Consensus 212 -------~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~------------------ll~h~~f~~~ 257 (323)
T cd05571 212 -------I-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE------------------IMEHRFFASI 257 (323)
T ss_pred -------C-----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHH------------------HHcCCCcCCC
Confidence 0 11135789999999999999999999 8999 8999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=365.37 Aligned_cols=282 Identities=36% Similarity=0.623 Sum_probs=232.0
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++++.||.|++|.||+|.+..++..||||+++...........+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 5899999999999999999999999999999986533333445667899999999999999999999854 37899
Q ss_pred EEEecCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 95 VVFELMESDLDQVIKAN---DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~~---~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998888653 468999999999999999999999999999999999999999999999999997532211
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
.......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...+|.+....|.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 112334678999999988652 4678899999999999999999999999988888888888888887777765432
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
. ..+....+......+....+.+++++.+||.+||+.||.+|||+.+ ++.||||
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~------------------ll~~~~~ 285 (285)
T cd07861 232 L--PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK------------------ALNHPYF 285 (285)
T ss_pred h--HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH------------------HhcCCCC
Confidence 2 2222222222222223344568999999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=377.75 Aligned_cols=262 Identities=26% Similarity=0.456 Sum_probs=219.2
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.+++.++||||+++++++. +.+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 47999999999999999999999999999999996432 22334566889999999999999999999884 3478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999997 59999999888899999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+........
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------- 218 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------- 218 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------
Confidence 1245679999999999987 6899999999999999999999999988776665554432111000
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
. .........+++++.+||.+||..+|.+|||+++ ++.||||.+..
T Consensus 219 -----------~---~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~------------------ll~h~~~~~~~ 264 (333)
T cd05600 219 -----------R---PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLED------------------IKNHPFFKEVD 264 (333)
T ss_pred -----------C---CCCCccccccCHHHHHHHHHHhhChhhhcCCHHH------------------HHhCcccCCCC
Confidence 0 0000111357899999999999999999999999 89999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=374.60 Aligned_cols=247 Identities=30% Similarity=0.546 Sum_probs=220.9
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecc-cccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKE-VFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~-~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
...-||++.+.||+|.||.|-+|++...|+.||||.|++ ...+..+.-++.|||.||..|+||||+.++++| ++
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----EN 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----EN 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cC
Confidence 455799999999999999999999999999999999954 456777888899999999999999999999999 55
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+.+.|||||.. |+|+++|...+.|++.+++.|++||..|+.|+|.++++|||||.+|||++.||++||+|||++..+.
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 689999999997 6999999999999999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.+ .+++.++|++.|.+||++.+ ..| ++.+|.||||++||.|+.|..||.|.+......+|....-
T Consensus 205 ~~----kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY-------- 270 (668)
T KOG0611|consen 205 DK----KFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY-------- 270 (668)
T ss_pred cc----cHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc--------
Confidence 33 36788999999999999998 566 6899999999999999999999999998777776633110
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
.-|.-+.++.-||+.||..||++|.|+++
T Consensus 271 ------------------------rEP~~PSdA~gLIRwmLmVNP~RRATieD 299 (668)
T KOG0611|consen 271 ------------------------REPETPSDASGLIRWMLMVNPERRATIED 299 (668)
T ss_pred ------------------------cCCCCCchHHHHHHHHHhcCcccchhHHH
Confidence 11446678999999999999999999999
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=384.76 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=214.2
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|+++++||+|+||+||+|++..+++.||||++.... ........+.+|+.+++.+.||||+++++.+.. .+.
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCE
Confidence 46999999999999999999999999999999996421 123345678899999999999999999999843 478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CcccccccccCCcccCcccccccCCCCCchhhhhh
Q 044076 172 P--------------------------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 207 (506)
Q Consensus 172 ~--------------------------------------------~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWS 207 (506)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123579999999999987 68999999999
Q ss_pred hhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHh
Q 044076 208 IGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRL 287 (506)
Q Consensus 208 lG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~m 287 (506)
|||++|||++|++||.+.+..+....+....... .. .....+++++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------~~---p~~~~~s~~~~~li~~l 286 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL------------------------HI---PPQAKLSPEASDLIIKL 286 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc------------------------CC---CCcccCCHHHHHHHHHH
Confidence 9999999999999998877655444443211100 00 11235789999999998
Q ss_pred hhcCCCCCCC---HhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 288 LAFDPKDRPS---AEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 288 L~~DP~~RpT---a~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
+ .||.+|++ ++| ++.||||.++.
T Consensus 287 ~-~~p~~R~~~~~~~e------------------i~~hp~f~~~~ 312 (382)
T cd05625 287 C-RGPEDRLGKNGADE------------------IKAHPFFKTID 312 (382)
T ss_pred c-cCHhHcCCCCCHHH------------------HhcCCCcCCcC
Confidence 7 59999998 999 89999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=382.02 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=215.0
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++.+.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 47999999999999999999999999999999996421 223345567889999999999999999999844 478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999997 5999999988889999999999999999999999999999999999999999999999999986532211
Q ss_pred CCc-----------------------------------ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHH
Q 044076 172 PSA-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 216 (506)
Q Consensus 172 ~~~-----------------------------------~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl 216 (506)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 00113469999999999977 68999999999999999999
Q ss_pred hCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 044076 217 TGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP 296 (506)
Q Consensus 217 ~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp 296 (506)
+|.+||.+.+..+.+..+..... ...+. ....+++++.+||.+||. ||.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~--------------------------~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKE--------------------------TLQFP-DEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCC--------------------------ccCCC-CCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 99999988776555444422100 00000 012478999999999997 999999
Q ss_pred C---HhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 297 S---AEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 297 T---a~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+ ++| +|.||||++.
T Consensus 286 ~~~~~~~------------------ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNE------------------IKSHPFFKGV 302 (364)
T ss_pred CCCCHHH------------------HhcCCCcCCC
Confidence 8 999 8999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=377.50 Aligned_cols=268 Identities=28% Similarity=0.410 Sum_probs=218.7
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-------c-----ChhHHHHHHHHHHHHHhCCCCCcce
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-------E-----HVSDATRILREIKLLRMLKHPDIVE 77 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-------~-----~~~~~~~~~rEi~iL~~l~HpnIv~ 77 (506)
....++|++++.||+|.||.|-+|++..+++.||||++.+.. . .....+++.+||.||+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345689999999999999999999999999999999995421 1 1122457899999999999999999
Q ss_pred eceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC
Q 044076 78 IKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK 155 (506)
Q Consensus 78 l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~-ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~ 155 (506)
|+++.-++ ..+.+|||+|||.. .+.. ...... +++.+++.+++.++.||.|||.+|||||||||+|+|++++|+
T Consensus 173 LiEvLDDP---~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDP---ESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCc---ccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99998654 34889999999984 4433 233334 999999999999999999999999999999999999999999
Q ss_pred EEEeecCCcccccCC--CCCcccccccccCCcccCcccccccC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhH
Q 044076 156 LKICDFGLARVSFTD--TPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL 231 (506)
Q Consensus 156 lKL~DFGla~~~~~~--~~~~~~~~~~vgt~~Y~APE~l~~~~--~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l 231 (506)
+||+|||.+.....+ ......+...+||+.|+|||++.+.. ...+.+.||||+||+||.|+.|+.||-+....+..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999999753221 11112234578999999999986621 33577999999999999999999999998888888
Q ss_pred HHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHH
Q 044076 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWL 311 (506)
Q Consensus 232 ~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~ 311 (506)
.+|++.--. ....|.+.++++|||.+||..||.+|++..+
T Consensus 329 ~KIvn~pL~-----------------------------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~----------- 368 (576)
T KOG0585|consen 329 DKIVNDPLE-----------------------------FPENPEINEDLKDLIKRLLEKDPEQRITLPD----------- 368 (576)
T ss_pred HHHhcCccc-----------------------------CCCcccccHHHHHHHHHHhhcChhheeehhh-----------
Confidence 887542111 1123457899999999999999999999999
Q ss_pred HHHhhhhhccCcccCCC
Q 044076 312 FLYFYVLALADPYFHGL 328 (506)
Q Consensus 312 ~~~~~~~aL~HP~f~~~ 328 (506)
+..|||...-
T Consensus 369 -------ik~Hpwvt~~ 378 (576)
T KOG0585|consen 369 -------IKLHPWVTRD 378 (576)
T ss_pred -------heecceeccC
Confidence 7999999764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=380.25 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=214.3
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||+||+|.+..+++.||||+++.... .......+.+|+.+++.++||||+++++.+. +...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-----DKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCe
Confidence 479999999999999999999999999999999964221 2233456788999999999999999999984 3478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999997 4999999988899999999999999999999999999999999999999999999999999987532111
Q ss_pred CC--------------------------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCC
Q 044076 172 PS--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR 219 (506)
Q Consensus 172 ~~--------------------------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~ 219 (506)
.. .......+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001124579999999999987 68999999999999999999999
Q ss_pred CCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC---CC
Q 044076 220 PLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD---RP 296 (506)
Q Consensus 220 ~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~---Rp 296 (506)
+||.+.+..+....|....... .+.. ...+++++++||.+|+. +|.+ ||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~--------------------------~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKETL--------------------------IFPP-EVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCcc--------------------------cCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 9998877666655553311110 0000 12478999999999886 5554 58
Q ss_pred CHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 297 SAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 297 Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
+++| +++||||+++.
T Consensus 286 ~~~e------------------i~~hp~f~~~~ 300 (363)
T cd05628 286 GVEE------------------IKTNPFFEGVD 300 (363)
T ss_pred CHHH------------------HhCCCCCCCCC
Confidence 9999 89999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=366.28 Aligned_cols=282 Identities=39% Similarity=0.621 Sum_probs=228.7
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||.|+||.||+|.+..+|+.||+|.++...........+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence 6999999999999999999999999999999996432233334557789999999999999999999843 47899
Q ss_pred EEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 95 VVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
+|+||++++|.+.+.. .+.+++..++.++.||++||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999998875 46799999999999999999999999999999999999999999999999999975322111
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCC-CCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPL-FPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~p-F~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
......++..|+|||++.+. ..++.++||||+||++|+|++|..| |++.+..+++..+...++.+....+..+...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345678999999998662 4578999999999999999997655 6788888899999999998887776554321
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
....... .......+....+.+++++.+||.+||+.||.+|||+++ +|.||||
T Consensus 232 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~------------------il~h~~f 284 (284)
T cd07839 232 PDYKPYP--MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE------------------ALQHPYF 284 (284)
T ss_pred ccccccC--CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH------------------HhcCCCC
Confidence 1100000 000111223445678999999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=362.20 Aligned_cols=263 Identities=30% Similarity=0.470 Sum_probs=221.6
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-----Chh-HHHHHHHHHHHHHhCC-CCCcceeceeecCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-----HVS-DATRILREIKLLRMLK-HPDIVEIKHIMLPPC 86 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-----~~~-~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~ 86 (506)
+.|.-.+.||+|..++|.++.++.+|..+|+|++..... ... -.+...+|+.||+++. ||+|++|.++|.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye--- 93 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE--- 93 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc---
Confidence 467778999999999999999999999999999953221 111 1234557999999996 999999999994
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
....+++|+|+|. |.|.+++.+.-.+++...+.+|+||++|+.|||..+||||||||+|||++++.++||+|||+|.
T Consensus 94 --s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 94 --SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred --CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 4477999999998 7999999988899999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCccccccc----CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~----~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
....+ ..+.+.+||+.|.|||.+... ...|+..+|+|++|+|||.||.|.|||-.....-++.+|+..--..
T Consensus 172 ~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF 247 (411)
T KOG0599|consen 172 QLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF 247 (411)
T ss_pred ccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence 64433 346788999999999997431 2568999999999999999999999997766666666664422222
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
.. ..|.+++..++|||++||+.||.+|+|++| +|+
T Consensus 248 ~s---------------------------peWadis~~~KdLIsrlLqVdp~~Ritake------------------~La 282 (411)
T KOG0599|consen 248 RS---------------------------PEWADISATVKDLISRLLQVDPTKRITAKE------------------ALA 282 (411)
T ss_pred CC---------------------------cchhhccccHHHHHHHHHeeCchhcccHHH------------------Hhc
Confidence 22 345678899999999999999999999999 999
Q ss_pred CcccCCCCC
Q 044076 322 DPYFHGLAN 330 (506)
Q Consensus 322 HP~f~~~~~ 330 (506)
||||..+..
T Consensus 283 Hpff~q~~~ 291 (411)
T KOG0599|consen 283 HPFFIQIAQ 291 (411)
T ss_pred ChHHHHHHH
Confidence 999976654
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=383.00 Aligned_cols=264 Identities=24% Similarity=0.358 Sum_probs=213.2
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
..|++++.||+|+||+||+|++..+++.||||++... .........+.+|+.+|+.++||||+++++.+.. .+.
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCE
Confidence 3699999999999999999999999999999999642 2233445678899999999999999999999843 478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999997 5999999988889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CcccccccccCCcccCcccccccCCCCCchhhhhh
Q 044076 172 P--------------------------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 207 (506)
Q Consensus 172 ~--------------------------------------------~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWS 207 (506)
. ........+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceee
Confidence 0 0000124579999999999987 67999999999
Q ss_pred hhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHh
Q 044076 208 IGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRL 287 (506)
Q Consensus 208 lG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~m 287 (506)
|||++|||++|++||.+.+..+....+....+.. .. .....+++++.+||.+|
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------~~---~~~~~~s~~~~dli~~l 286 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTL------------------------HI---PPQVKLSPEAVDLITKL 286 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc------------------------CC---CCCCCCCHHHHHHHHHH
Confidence 9999999999999998876554444442211110 00 11134789999999997
Q ss_pred hhcC--CCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 288 LAFD--PKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 288 L~~D--P~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
|..+ |..|+|+++ ++.||||.++.
T Consensus 287 l~~~~~~~~R~~~~~------------------~l~hp~f~~~~ 312 (381)
T cd05626 287 CCSAEERLGRNGADD------------------IKAHPFFSEVD 312 (381)
T ss_pred ccCcccccCCCCHHH------------------HhcCcccCCCC
Confidence 7554 445999999 89999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=366.68 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=211.1
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
.|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++|+||+++++++.. .+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeE
Confidence 3889999999999999999999999999999986422 222334457799999999999999999998843 4689
Q ss_pred EEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 94 YVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
|+||||++ ++|...+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998 5898877543 36899999999999999999999999999999999999999999999999999763222
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. .....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~---------- 219 (285)
T cd05631 156 E----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE---------- 219 (285)
T ss_pred C----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc----------
Confidence 1 1234578999999999987 78999999999999999999999999876643332222111100
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
........+++++.+||++||+.||.+||| +++ +++||||
T Consensus 220 -----------------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~------------------~~~h~~~ 264 (285)
T cd05631 220 -----------------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAG------------------VKQHPIF 264 (285)
T ss_pred -----------------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHH------------------HhcCHhh
Confidence 001122457899999999999999999997 788 8999999
Q ss_pred CCCC
Q 044076 326 HGLA 329 (506)
Q Consensus 326 ~~~~ 329 (506)
.++.
T Consensus 265 ~~~~ 268 (285)
T cd05631 265 KNIN 268 (285)
T ss_pred cCCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=372.34 Aligned_cols=281 Identities=33% Similarity=0.581 Sum_probs=227.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC--CCC----cceeceeecCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK--HPD----IVEIKHIMLPP 85 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~--Hpn----Iv~l~~v~~~~ 85 (506)
..+||+++..+|+|.||.|..+.|..++..||||+++.+ .. ..+..+-||.+|.++. -|+ ++.+.++|
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--- 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DK--YREAALIEIEVLQKINESDPNGKFRCVQMRDWF--- 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HH--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh---
Confidence 478999999999999999999999999999999999754 12 2223456999999995 233 55565555
Q ss_pred CcCCCCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-----------
Q 044076 86 CRREFKDIYVVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA----------- 152 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~----------- 152 (506)
+-.+++|||+|.|+-++.++++.+. +++..+++.+.+||++++++||+.+++|.||||+|||+.+
T Consensus 161 --dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 161 --DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred --hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 5568999999999999999999876 6899999999999999999999999999999999999643
Q ss_pred ---------CCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCC
Q 044076 153 ---------DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFP 223 (506)
Q Consensus 153 ---------~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~ 223 (506)
+..+||+|||.|+...... +..|.|+.|||||++++ ..|+..+||||+||||+||.+|..+|+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceecc
Confidence 2458999999998643332 55789999999999999 799999999999999999999999999
Q ss_pred CCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccC---------------CCCCCCCCCCCCH---HHHHHHH
Q 044076 224 GRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKW---------------AVPFSHKFPGADP---LALRLLQ 285 (506)
Q Consensus 224 ~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~s~---~~~dLI~ 285 (506)
+.++.++|.++..++|.++..++.+.. ..+|+...+-.+ +.++.......+. .+.|||+
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 999999999999999977776665543 233333222111 2222222222233 4789999
Q ss_pred HhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 286 RLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 286 ~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
+||.+||.+|+|+.| ||.||||+.+.
T Consensus 388 ~mL~fDP~~RiTl~E------------------AL~HpFF~~~~ 413 (415)
T KOG0671|consen 388 RMLEFDPARRITLRE------------------ALSHPFFARLT 413 (415)
T ss_pred HHHccCccccccHHH------------------HhcCHHhhcCC
Confidence 999999999999999 99999999764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=377.68 Aligned_cols=263 Identities=30% Similarity=0.487 Sum_probs=217.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||+||+|.+..+++.||||+++.... .......+.+|+.+++.++||||+++++++. +.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 579999999999999999999999999999999964321 2234566889999999999999999999884 3478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999997643322
Q ss_pred --------------------------CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Q 044076 172 --------------------------PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR 225 (506)
Q Consensus 172 --------------------------~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~ 225 (506)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 00011234679999999999987 68999999999999999999999999887
Q ss_pred CchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-Hhhhhhh
Q 044076 226 NVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-AEEIRFT 304 (506)
Q Consensus 226 ~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-a~eL~~~ 304 (506)
+.......|....... ..+ ..+.+++++.+||.+||. ||.+|++ +++
T Consensus 234 ~~~~~~~~i~~~~~~~------------------------~~p---~~~~~~~~~~~li~~ll~-dp~~R~~s~~~---- 281 (350)
T cd05573 234 TLQETYNKIINWKESL------------------------RFP---PDPPVSPEAIDLICRLLC-DPEDRLGSFEE---- 281 (350)
T ss_pred CHHHHHHHHhccCCcc------------------------cCC---CCCCCCHHHHHHHHHHcc-ChhhcCCCHHH----
Confidence 7655554443211100 001 112378999999999998 9999999 999
Q ss_pred hhhhhHHHHHhhhhhccCcccCCCC
Q 044076 305 EIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 305 ~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
+|+||||.++.
T Consensus 282 --------------ll~hp~~~~~~ 292 (350)
T cd05573 282 --------------IKSHPFFKGID 292 (350)
T ss_pred --------------HhcCCCcCCCC
Confidence 89999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=383.18 Aligned_cols=262 Identities=25% Similarity=0.401 Sum_probs=212.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence 47999999999999999999999999999999985421 122345668899999999999999999999843 478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999996321100
Q ss_pred CC------------c--------------------------------ccccccccCCcccCcccccccCCCCCchhhhhh
Q 044076 172 PS------------A--------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 207 (506)
Q Consensus 172 ~~------------~--------------------------------~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWS 207 (506)
.. . ......+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00012469999999999977 68999999999
Q ss_pred hhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHh
Q 044076 208 IGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRL 287 (506)
Q Consensus 208 lG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~m 287 (506)
|||++|||++|.+||.+.+..+.+..|...... ..+ .....+++++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------------------~~~-p~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRET--------------------------LYF-PDDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc--------------------------cCC-CCCCCCCHHHHHHHHHH
Confidence 999999999999999887766555554321100 000 01124789999999999
Q ss_pred hhcCCCCC---CCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 288 LAFDPKDR---PSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 288 L~~DP~~R---pTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
|. +|.+| +|+.| ++.||||++.
T Consensus 287 L~-~~~~r~~r~~~~~------------------~l~hp~~~~~ 311 (377)
T cd05629 287 IT-NAENRLGRGGAHE------------------IKSHPFFRGV 311 (377)
T ss_pred hc-CHhhcCCCCCHHH------------------HhcCCCcCCC
Confidence 98 77775 59999 8999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=377.59 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=215.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCC-cEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTG-EKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~-~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
..++|++++.||+|+||.||+|.+..++ ..||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----- 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD----- 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----
Confidence 3468999999999999999999876655 689999985321 223345668899999999999999999999843
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...+|+||||+. ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 378999999996 5999999988899999999999999999999999999999999999999999999999999997642
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. .....||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......|.....
T Consensus 183 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--------- 245 (340)
T PTZ00426 183 TR------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--------- 245 (340)
T ss_pred CC------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 21 134579999999999987 6789999999999999999999999988766544444422100
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
...+.+++.+.+||++||+.||.+|+ |+++ +++||
T Consensus 246 ----------------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~------------------~~~hp 285 (340)
T PTZ00426 246 ----------------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQN------------------VKEHP 285 (340)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHH------------------HHcCC
Confidence 01134788999999999999999996 8999 89999
Q ss_pred ccCCCC
Q 044076 324 YFHGLA 329 (506)
Q Consensus 324 ~f~~~~ 329 (506)
||.++.
T Consensus 286 ~f~~~~ 291 (340)
T PTZ00426 286 WFGNID 291 (340)
T ss_pred CcCCCC
Confidence 998754
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=366.78 Aligned_cols=295 Identities=40% Similarity=0.627 Sum_probs=237.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++.+.||.|+||.||+|.+..+|+.||||+++...........+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HL 80 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CC
Confidence 356789999999999999999999999999999999864322222233466899999999999999999998542 23
Q ss_pred CcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+.+|+||||++++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 81 DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred CeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 568999999999999988763 5799999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... ..+...++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+++..+...+|.|....+..+
T Consensus 161 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAK---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccC---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 211 12344568899999998652 56889999999999999999999999999999999999999999888776554
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.......-. .........+...++..++.+.+||.+||++||++|||++| +|.||||++..
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~------------------il~h~~f~~~~ 297 (309)
T cd07845 237 SDLPLVGKF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE------------------ALESSYFKEKP 297 (309)
T ss_pred hcccccccc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHH------------------HhcChhhccCC
Confidence 321110000 00111111222334557899999999999999999999999 89999998755
Q ss_pred CC
Q 044076 330 NL 331 (506)
Q Consensus 330 ~~ 331 (506)
-+
T Consensus 298 ~~ 299 (309)
T cd07845 298 LP 299 (309)
T ss_pred CC
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=381.59 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=213.3
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++.+.. .+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-----KDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCE
Confidence 47999999999999999999999999999999985421 122345667899999999999999999999843 478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999997 5999999988889999999999999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------CcccccccccCCcccCcccccccCCCCCchhhhhhhhHH
Q 044076 172 P----------------------------------------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 211 (506)
Q Consensus 172 ~----------------------------------------~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~i 211 (506)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999987 688999999999999
Q ss_pred HHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 044076 212 FAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFD 291 (506)
Q Consensus 212 l~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~D 291 (506)
+|+|++|++||.+.+..+....+...... ... .....+++++.+||.+|+ .|
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~------------------------~~~---~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWETT------------------------LHI---PSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCcc------------------------ccC---CCCCCCCHHHHHHHHHHh-cC
Confidence 99999999999887765544443211000 000 112357899999999987 59
Q ss_pred CCCCC---CHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 292 PKDRP---SAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 292 P~~Rp---Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
|.+|+ |+.| +++||||.++
T Consensus 286 p~~R~~~~t~~e------------------ll~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADE------------------IKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHH------------------HhCCCCcCCC
Confidence 99999 9999 8999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=370.98 Aligned_cols=248 Identities=31% Similarity=0.490 Sum_probs=208.1
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecC
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 100 (506)
||+|+||.||+|.+..+++.||||+++... ........+.+|+.+|+.++||||+++++++.. .+.+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence 699999999999999999999999996422 233455678899999999999999999998843 47899999999
Q ss_pred C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccc
Q 044076 101 E-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD 179 (506)
Q Consensus 101 ~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 179 (506)
+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 7 59999998888899999999999999999999999999999999999999999999999999975322221 1245
Q ss_pred cccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHh
Q 044076 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLS 259 (506)
Q Consensus 180 ~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~ 259 (506)
.+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+....+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 679999999999987 7899999999999999999999999987765544433321
Q ss_pred hhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC---CHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 260 SLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP---SAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 260 ~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp---Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.. . .....+++++.+||.+||+.||.+|| ++.| +|.||||...
T Consensus 208 ---~~--~---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e------------------~l~hp~~~~~ 253 (312)
T cd05585 208 ---EP--L---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE------------------IKNHPFFSQL 253 (312)
T ss_pred ---CC--C---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH------------------HHcCCCcCCC
Confidence 00 0 11135789999999999999999997 4788 8999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=359.39 Aligned_cols=285 Identities=42% Similarity=0.694 Sum_probs=236.9
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.. ....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 6999999999999999999999999999999996543333445678899999999999999999999844 47899
Q ss_pred EEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 95 VVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
+|+||++++|.+++.. ...+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999997799999865 45699999999999999999999999999999999999999999999999999976433221
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhH
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~ 253 (506)
.......++.+|+|||.+.+. ..++.++||||+||++++|++|.++|.+.+....+..+...++.|....+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112345689999999998652 557899999999999999999999999999999999999999999887776543211
Q ss_pred HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.... ...+.....++...+++.+.++.+||.+||+.||.+|||+++ +|.||||.
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~------------------~l~h~~~~ 286 (286)
T cd07832 233 DYNK-ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE------------------ALRHPYFT 286 (286)
T ss_pred hhhc-ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH------------------HhhCcCcC
Confidence 1100 111222333344556778899999999999999999999999 89999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=359.24 Aligned_cols=282 Identities=39% Similarity=0.642 Sum_probs=233.1
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
.|++++.||.|++|.||+|.+..+++.||||+++...........+.+|+.+++.++||||+++++++. +.+..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 489999999999999999999999999999998643333334456889999999999999999999874 347899
Q ss_pred EEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 95 VVFELMESDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
+||||+.++|..++.. ...+++..+..++.||+.||+|||+.|++||||+|+||+++.++.+||+|||+++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999899998865 34689999999999999999999999999999999999999999999999999875322211
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...+|.|....+..+...
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 12334578899999988652 44688999999999999999999999999988899999999999887766544321
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..+...++......+....+.+++++.+||.+||+.||.+|||+++ +|.||||
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~------------------~l~~~~f 284 (284)
T cd07860 232 --PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKA------------------ALAHPFF 284 (284)
T ss_pred --HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHH------------------HhcCCCC
Confidence 2222233333333344455678999999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=386.40 Aligned_cols=256 Identities=24% Similarity=0.446 Sum_probs=221.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~ 90 (506)
.++|.++++||+|+||+|++|..+.+++.+|||++++. .....+.+.++.|-+|+...+ ||.++.|+..|.. .
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-----~ 441 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-----K 441 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-----C
Confidence 46899999999999999999999999999999999653 234456777889999998887 9999999998854 4
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+++|+||||+.| | .-.+...+.+++..+++|+..|+.||+|||++|||+||||.+|||++.+|.+||+|||+++-.-.
T Consensus 442 ~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 899999999985 6 44445557899999999999999999999999999999999999999999999999999975332
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... ..++++||+.|+|||++.+ ..|+.++|.|||||+|||||.|.+||+|.+..+..+.|..--
T Consensus 521 ~g~---~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~----------- 584 (694)
T KOG0694|consen 521 QGD---RTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE----------- 584 (694)
T ss_pred CCC---ccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 221 2367899999999999998 899999999999999999999999999999999888884311
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCH-----hhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSA-----EEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~RpTa-----~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
..+ -.++.++.+++++||+.||++|..+ ++ +..||
T Consensus 585 ---------------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~------------------i~~hp 625 (694)
T KOG0694|consen 585 ---------------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAED------------------IKKHP 625 (694)
T ss_pred ---------------------CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchh------------------hhhCC
Confidence 111 2489999999999999999999976 44 89999
Q ss_pred ccCCCC
Q 044076 324 YFHGLA 329 (506)
Q Consensus 324 ~f~~~~ 329 (506)
||+.+.
T Consensus 626 FFr~i~ 631 (694)
T KOG0694|consen 626 FFRSID 631 (694)
T ss_pred ccccCC
Confidence 999865
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=364.80 Aligned_cols=281 Identities=36% Similarity=0.593 Sum_probs=216.1
Q ss_pred eEEEeecCceEEEEEEECC--CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEE
Q 044076 19 QEIIGIGSYGVVASAIDTH--TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~--t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
..+||+|+||.||+|.+.. ++..||+|.+... .....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEE
Confidence 3689999999999998654 6689999998642 1233467999999999999999999988543 23678999
Q ss_pred EecCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE----CCCCCEEEeecCC
Q 044076 97 FELMESDLDQVIKAN---------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA----NADCKLKICDFGL 163 (506)
Q Consensus 97 ~E~~~~~L~~~i~~~---------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv----~~~~~lKL~DFGl 163 (506)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999999888532 248899999999999999999999999999999999999 5667899999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc---------hhhHHHH
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV---------AHQLDLV 234 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~---------~~~l~~I 234 (506)
++...............++|..|+|||++.+. ..++.++||||+||++|+|++|++||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98643322222223456789999999998662 5689999999999999999999999976542 4677888
Q ss_pred HhhcCCCChHHHhhhhhhH-HHHHHhhhhccC--CCC----CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhh
Q 044076 235 TDLLGTPSAESIAGIRNEK-AKRYLSSLRRKW--AVP----FSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIV 307 (506)
Q Consensus 235 ~~~~g~p~~e~~~~~~~~~-~~~~~~~~~~~~--~~~----~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~ 307 (506)
...+|.+..+.|..+.... ............ ... +.......+..+.+||.+||+.||.+|||++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e------- 310 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ------- 310 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHH-------
Confidence 8999998888776643211 001000000000 000 01111235678999999999999999999999
Q ss_pred hhHHHHHhhhhhccCccc
Q 044076 308 FNWLFLYFYVLALADPYF 325 (506)
Q Consensus 308 ~~~~~~~~~~~aL~HP~f 325 (506)
+|+||||
T Consensus 311 -----------~l~hp~f 317 (317)
T cd07867 311 -----------ALQDPYF 317 (317)
T ss_pred -----------HhcCCCC
Confidence 8999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=371.33 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=209.3
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEe
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFE 98 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E 98 (506)
+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.+.||||+++++++. ..+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence 46999999999999999999999999996432 23345567889999999999999999998884 3478999999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccc
Q 044076 99 LME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177 (506)
Q Consensus 99 ~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 177 (506)
|++ ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 997 48999988888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~ 257 (506)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.. +
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~------------------ 210 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--E------------------ 210 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--C------------------
Confidence 34679999999999987 6789999999999999999999999987665544433311 0
Q ss_pred HhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 258 LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.. ...+.+++++.+||++||+.||.+|+ ++.| +++||||.+.
T Consensus 211 ------~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~------------------il~h~~~~~~ 257 (328)
T cd05593 211 ------DI-----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE------------------IMRHSFFTGV 257 (328)
T ss_pred ------Cc-----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH------------------HhcCCCcCCC
Confidence 00 11135789999999999999999997 8999 8999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=370.10 Aligned_cols=251 Identities=26% Similarity=0.445 Sum_probs=209.8
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEe
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFE 98 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E 98 (506)
+.||+|+||.||+|.+..+|+.||+|+++... ........+.+|+.+++.++||||+++++.+.. .+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 47999999999999999999999999996432 123345567789999999999999999998843 378999999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccc
Q 044076 99 LME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177 (506)
Q Consensus 99 ~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 177 (506)
|++ ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 58999998888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~ 257 (506)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-------------------- 210 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------- 210 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------------
Confidence 34679999999999977 68899999999999999999999999877655444443210
Q ss_pred HhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 258 LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.. .....+++++.+||.+||+.||.+|+ ++.+ +++||||.+..
T Consensus 211 ------~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~------------------~l~h~~~~~~~ 258 (323)
T cd05595 211 ------EI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE------------------VMEHRFFLSIN 258 (323)
T ss_pred ------CC-----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH------------------HHcCCCcCCCC
Confidence 00 01134789999999999999999998 8999 89999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=367.72 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=212.6
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCC-CcceeceeecCCCcCCCCc
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHP-DIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~Hp-nIv~l~~v~~~~~~~~~~~ 92 (506)
+|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.++..+.|+ +|+.+++++.. .+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 5899999999999999999999999999999996432 2234456678899999999865 57788888743 378
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999986432211
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. .....+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..|.....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------ 218 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------ 218 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 1 1234579999999999987 6789999999999999999999999988776655555432110
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----hhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA-----EEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa-----~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.....+++++.+||.+||..||.+|+++ ++ +++||||.
T Consensus 219 -------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~------------------~~~hp~~~ 261 (324)
T cd05587 219 -------------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERD------------------IREHAFFR 261 (324)
T ss_pred -------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHH------------------HhcCCCcC
Confidence 1113478899999999999999999987 67 89999998
Q ss_pred CC
Q 044076 327 GL 328 (506)
Q Consensus 327 ~~ 328 (506)
.+
T Consensus 262 ~~ 263 (324)
T cd05587 262 RI 263 (324)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=358.31 Aligned_cols=287 Identities=37% Similarity=0.657 Sum_probs=229.9
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
|+..++|++++.||.|++|.||+|.+..+++.||||.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 74 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT----- 74 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec-----
Confidence 57789999999999999999999999999999999998643222 122346789999999999999999999843
Q ss_pred CCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
....|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 75 KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 4789999999999999988764 468999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-chhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN-VAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~-~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ......++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.. ..+++..+.+.++.|..+.+.
T Consensus 155 ~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 2111 11233567889999998652 568889999999999999999999998776 677888888999998888776
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCC--HHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGAD--PLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.+.......- ...+.....++...++.++ .++.+||.+||+.||.+|||+.| +|.||||
T Consensus 231 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e------------------~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFKP-YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE------------------AMKHPYF 291 (291)
T ss_pred hhhhcccccc-ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH------------------HhcCCCC
Confidence 5432110000 0011111122223334455 88999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=370.43 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=215.2
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++.+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.+++.+.||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 479999999999999999999999999999999974322 22345567889999999999999999998843 478
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999997 5999999876 67999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCCcccCccccccc----CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~----~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
... ......+|+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+....+..|.....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~------- 226 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR------- 226 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 211 12345689999999998631 14678899999999999999999999988776555544432100
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
...+ ...+.+++++.+||.+||+ ||.+|||+++ ++.||||.
T Consensus 227 -------------------~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~------------------l~~h~~~~ 267 (330)
T cd05601 227 -------------------FLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEG------------------LCCHPFFS 267 (330)
T ss_pred -------------------ccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHH------------------HhCCCCcC
Confidence 0000 1124578999999999998 9999999999 89999998
Q ss_pred CC
Q 044076 327 GL 328 (506)
Q Consensus 327 ~~ 328 (506)
.+
T Consensus 268 ~~ 269 (330)
T cd05601 268 KI 269 (330)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=359.10 Aligned_cols=287 Identities=42% Similarity=0.658 Sum_probs=236.4
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC---hhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH---VSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~---~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
+|++++.||.|+||.||+|.+..+++.||||+++..... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 589999999999999999999999999999999643222 2234557789999999999999999999844 37
Q ss_pred cEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+||||+.++|.+++.... .+++..+..++.||++||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 899999999889999998776 7999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. ......++..|+|||.+.+. ..++.++|+||+||++++|++|.++|.+.+..+.+..+...++.|....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 12334578899999988552 567899999999999999999999999999888888888888888777665432
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
... .+. ........+....++..+..+.+||.+||+.||.+|||+.| +|.||||++...
T Consensus 232 ~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e------------------~l~~~~~~~~~~ 290 (298)
T cd07841 232 SLP--DYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ------------------ALEHPYFSNDPA 290 (298)
T ss_pred ccc--ccc-cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH------------------HhhCccccCCCC
Confidence 211 111 11122233344556778899999999999999999999999 899999998665
Q ss_pred C
Q 044076 331 L 331 (506)
Q Consensus 331 ~ 331 (506)
+
T Consensus 291 ~ 291 (298)
T cd07841 291 P 291 (298)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=368.76 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=209.5
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||+||+|.+..+++.||||+++... ........+.+|+.++..+ .||||+++++++.. .+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999986422 2233455677899998877 59999999999843 47899999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||++ ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----------------- 213 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------------- 213 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----------------
Confidence 234579999999999987 6889999999999999999999999998876665555422100
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------hhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA------EEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa------~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
...+.+++++.+||++||+.||.+||++ ++ ++.||||.++.
T Consensus 214 --------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~------------------~~~h~~f~~~~ 260 (320)
T cd05590 214 --------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEA------------------ILRHPFFKELD 260 (320)
T ss_pred --------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHH------------------HHcCCCcCCCC
Confidence 0112478899999999999999999998 77 89999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=367.09 Aligned_cols=305 Identities=40% Similarity=0.662 Sum_probs=236.7
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc--
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-- 87 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-- 87 (506)
|...++|++.+.||.|+||.||+|.+..+|+.||+|++... +....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CCcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC--CCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 34578999999999999999999999999999999998542 22445668899999999999999999988754321
Q ss_pred -------CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-CCCEEEe
Q 044076 88 -------REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKIC 159 (506)
Q Consensus 88 -------~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-~~~lKL~ 159 (506)
.+....|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 12246899999999999988764 46999999999999999999999999999999999999974 5678999
Q ss_pred ecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcC
Q 044076 160 DFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 160 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g 239 (506)
|||+++................++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999997542221111112334678999999987542 5688899999999999999999999999888877777776666
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLA 319 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~a 319 (506)
.+..+......+..... ..........++....+..+.++.+||.+||+.||.+|||+.| +
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------------------l 297 (342)
T cd07854 237 VVREEDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE------------------A 297 (342)
T ss_pred CCChHHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHH------------------H
Confidence 55554443332221111 1111122223334455678999999999999999999999999 8
Q ss_pred ccCcccCCCCCCCCCCCC
Q 044076 320 LADPYFHGLANLEEEPSR 337 (506)
Q Consensus 320 L~HP~f~~~~~~~~~~~~ 337 (506)
|.||||+.+..+...|..
T Consensus 298 l~h~~~~~~~~~~~~~~~ 315 (342)
T cd07854 298 LMHPYMSCYSCPFDEPVS 315 (342)
T ss_pred hCCCccccccCCccccCC
Confidence 999999987665544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.36 Aligned_cols=251 Identities=27% Similarity=0.459 Sum_probs=209.1
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEe
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFE 98 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E 98 (506)
+.||+|+||.||+|.+..+|+.||+|+++... ........+.+|+++++.++||||+++++++.. .+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 46999999999999999999999999996432 233345667889999999999999999998843 478999999
Q ss_pred cCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 99 LMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 99 ~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
|+++ +|...+.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 9984 899988888889999999999999999999997 7999999999999999999999999999875322211 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~---------------- 212 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--E---------------- 212 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--C----------------
Confidence 234579999999999977 68899999999999999999999999887655444433110 0
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
. ..-..+++++.+||.+||+.||.+|+ ++.+ +|+||||.+..
T Consensus 213 ----------~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~------------------il~h~~~~~~~ 259 (325)
T cd05594 213 ----------I---RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKE------------------IMQHKFFAGIV 259 (325)
T ss_pred ----------C---CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHH------------------HhcCCCcCCCC
Confidence 0 01124789999999999999999997 8999 89999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=363.79 Aligned_cols=279 Identities=24% Similarity=0.368 Sum_probs=217.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||.||+|++..++..||+|.+... ........+.+|+.+|+.++||||+++++++.. .+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 57999999999999999999999999999999998642 123345678899999999999999999999844 368
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||+++ +|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999985 9999999888899999999999999999999986 6999999999999999999999999999754222
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH----H
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES----I 246 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~----~ 246 (506)
. .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.... ++.+.... .
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCc
Confidence 1 234579999999999987 6799999999999999999999999987665443222 22211000 0
Q ss_pred hhh-------------------hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhh
Q 044076 247 AGI-------------------RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIV 307 (506)
Q Consensus 247 ~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~ 307 (506)
... ...........+....... ......++++.+||.+||++||++|||++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~e------- 297 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKM------- 297 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHH-------
Confidence 000 0000011111111111100 011247889999999999999999999999
Q ss_pred hhHHHHHhhhhhccCcccCCC
Q 044076 308 FNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 308 ~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+|+||||+..
T Consensus 298 -----------ll~h~~~~~~ 307 (331)
T cd06649 298 -----------LMNHTFIKRS 307 (331)
T ss_pred -----------HhcChHHhhc
Confidence 8999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=355.93 Aligned_cols=282 Identities=39% Similarity=0.670 Sum_probs=222.2
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence 57999999999999999999999999999999986432233334557899999999999999999999843 3789
Q ss_pred EEEEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESD-LDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~-L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||+++. |..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999999974 555555556799999999999999999999999999999999999999999999999999976433221
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
......++.+|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+...++............
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST- 230 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc-
Confidence 12345688999999998652 5688999999999999999999999999888888877776666543322111100
Q ss_pred HHHHHHhhhhcc---CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 253 KAKRYLSSLRRK---WAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 253 ~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..+...+... ...++...+++++..+.+||.+||+.||.+|||+.| ++.||||
T Consensus 231 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e------------------il~~~~f 286 (286)
T cd07847 231 --NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE------------------LLEHPYF 286 (286)
T ss_pred --ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH------------------HhcCCCC
Confidence 0011111100 111122335678899999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=372.76 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=214.6
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+.|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.++..++||||+++++.+. +.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 47999999999999999999999999999999996421 12334567888999999999999999999884 3478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999986432111
Q ss_pred CC--------------------------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCC
Q 044076 172 PS--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR 219 (506)
Q Consensus 172 ~~--------------------------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~ 219 (506)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000123579999999999987 78999999999999999999999
Q ss_pred CCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC--
Q 044076 220 PLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-- 297 (506)
Q Consensus 220 ~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-- 297 (506)
+||.+.+.......|..... ...+.. ...+++++.+||.+|+. ||.+|++
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~--------------------------~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNWKE--------------------------TLVFPP-EVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcCCC--------------------------ceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 99988776655554432100 000000 12378999999999875 9999995
Q ss_pred -HhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 298 -AEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 298 -a~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
++| +++||||.++.
T Consensus 286 ~~~e------------------i~~hp~f~~~~ 300 (360)
T cd05627 286 GVEE------------------IKSHPFFEGVD 300 (360)
T ss_pred CHHH------------------HhcCCCCCCCC
Confidence 788 89999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=352.84 Aligned_cols=268 Identities=29% Similarity=0.461 Sum_probs=221.8
Q ss_pred cccCCCCCEEEe-EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCC
Q 044076 8 TEYGEASQYEIQ-EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPP 85 (506)
Q Consensus 8 ~~~~~~~rY~i~-~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~ 85 (506)
.++.+.++|.|- ++||-|-.|.|..|.++.||+++|+|++. +..+..||+.+.-..+ |||||.++++|...
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------DSPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------cCHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 677888999995 79999999999999999999999999985 3455679999987775 99999999998543
Q ss_pred CcCCCCcEEEEEecCCC-CHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC---CCCEEEe
Q 044076 86 CRREFKDIYVVFELMES-DLDQVIKANDD--LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA---DCKLKIC 159 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~-~L~~~i~~~~~--ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~---~~~lKL~ 159 (506)
..+...+.+|||.|+| +|+.-|..++. +++.++..|++||..|+.|||+.+|.||||||+|+|... |+.+||+
T Consensus 128 -~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 128 -YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred -ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 3445778999999985 99999988765 999999999999999999999999999999999999864 5779999
Q ss_pred ecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch----hhHHHHH
Q 044076 160 DFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA----HQLDLVT 235 (506)
Q Consensus 160 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~----~~l~~I~ 235 (506)
|||+|+.... ...+...+.|++|.|||++.. ..|+...|+||+|||+|.||+|.|||...... .+-.+|.
T Consensus 207 DfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~ 280 (400)
T KOG0604|consen 207 DFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR 280 (400)
T ss_pred ccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh
Confidence 9999986332 123466789999999999988 78999999999999999999999999775532 1222222
Q ss_pred hhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHh
Q 044076 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYF 315 (506)
Q Consensus 236 ~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~ 315 (506)
...-.++ ...|..+|.+++|||++||..+|.+|.|++|
T Consensus 281 ~gqy~FP---------------------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~--------------- 318 (400)
T KOG0604|consen 281 TGQYEFP---------------------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEE--------------- 318 (400)
T ss_pred ccCccCC---------------------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHH---------------
Confidence 2111222 2344568999999999999999999999999
Q ss_pred hhhhccCcccCCCCCCCCC
Q 044076 316 YVLALADPYFHGLANLEEE 334 (506)
Q Consensus 316 ~~~aL~HP~f~~~~~~~~~ 334 (506)
.+.|||+.+.......
T Consensus 319 ---~m~hpwi~~~~~vp~t 334 (400)
T KOG0604|consen 319 ---VMDHPWINQYEAVPQT 334 (400)
T ss_pred ---hhcCchhcccccCCCC
Confidence 8999999986654433
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=366.40 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=209.3
Q ss_pred CEEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccc--cChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVF--EHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~ 88 (506)
+|++++.||+|+||+||+|++. .+++.||+|++.+.. ........+.+|+.+++.++ ||||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ----- 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence 5899999999999999998864 578999999986421 22334566789999999995 999999998884
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
..+.+|+||||+++ +|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 34789999999984 99999988888999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+..
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----------- 221 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----------- 221 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH-----------
Confidence 322211 12346799999999998762 4578899999999999999999999975443222111110
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
.. ..... ...+.+++.+.+||.+||+.||.+|| ++++ +++|
T Consensus 222 --------~~---~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~------------------~l~h 267 (332)
T cd05614 222 --------RI---LKCDP-----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE------------------IKEH 267 (332)
T ss_pred --------HH---hcCCC-----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH------------------HHcC
Confidence 00 00011 11135789999999999999999999 7788 8999
Q ss_pred cccCCC
Q 044076 323 PYFHGL 328 (506)
Q Consensus 323 P~f~~~ 328 (506)
|||++.
T Consensus 268 ~~~~~~ 273 (332)
T cd05614 268 PFFKGL 273 (332)
T ss_pred CCcCCC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=365.10 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=208.1
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHH---HhCCCCCcceeceeecCCCcCCCC
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLL---RMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL---~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.++ +.++||||+++++++.. ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence 789999999999999999999999999999996432 1223455677777665 45679999999999843 47
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+||||+++ +|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 89999999985 88877754 57999999999999999999999999999999999999999999999999998643221
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~----------- 218 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV----------- 218 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 11 1245679999999999987 6889999999999999999999999988776655544422100
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...+.+++.+.+||.+||+.||.+|| ++.+ +++||||
T Consensus 219 --------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~------------------l~~~~~f 260 (324)
T cd05589 219 --------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAED------------------VKKQPFF 260 (324)
T ss_pred --------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH------------------HhhCCCc
Confidence 01134789999999999999999999 5777 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
.++
T Consensus 261 ~~~ 263 (324)
T cd05589 261 RDI 263 (324)
T ss_pred CCC
Confidence 874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=356.02 Aligned_cols=288 Identities=38% Similarity=0.611 Sum_probs=231.3
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.+. ||||+++++++.....+....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998654333334456789999999996 699999999885542222345
Q ss_pred EEEEEecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-CCCEEEeecCCccc
Q 044076 93 IYVVFELMESDLDQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLARV 166 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~~-----~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-~~~lKL~DFGla~~ 166 (506)
.|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999999988653 35899999999999999999999999999999999999998 89999999999975
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...... ..+...++++|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+....+..+...++.|....+
T Consensus 161 ~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK---SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc---ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 322111 11334578899999988652 56789999999999999999999999999998888889888888887766
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
......... . ..+...........+.+++.+.+||.+||..||.+|||+.| +|.||||+
T Consensus 237 ~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e------------------il~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDW--H-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA------------------ALTHPYFD 295 (295)
T ss_pred cchhhccch--h-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHH------------------HhcCCCcC
Confidence 543221110 0 01111222233344678999999999999999999999999 89999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=364.25 Aligned_cols=256 Identities=22% Similarity=0.380 Sum_probs=213.2
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCc
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+|++++.||+|+||.||+|.+..+++.||||+++... ...........|..++..+. |++|+.+++++.. .+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence 5899999999999999999999999999999996432 12234455678888888875 8899999988743 478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ ++|...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999997532211
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|.....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------ 218 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------ 218 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 1 1234678999999999987 7899999999999999999999999988876666555532110
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----hhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA-----EEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa-----~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.....+++++.+||.+||+.||.+|+++ .+ ++.||||+
T Consensus 219 -------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~------------------i~~h~~~~ 261 (323)
T cd05616 219 -------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERD------------------IKEHAFFR 261 (323)
T ss_pred -------------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHH------------------HhcCCCcC
Confidence 0112478999999999999999999985 56 79999998
Q ss_pred CCC
Q 044076 327 GLA 329 (506)
Q Consensus 327 ~~~ 329 (506)
.+.
T Consensus 262 ~~~ 264 (323)
T cd05616 262 YID 264 (323)
T ss_pred CCC
Confidence 643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=365.77 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=209.2
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
++||+|+||.||+|.+..+++.||||+++... ........+..|+.++..+ +||||+++++++.. .+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 46999999999999999999999999996421 2234455677899999876 69999999999843 37899999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||++ ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 49999998888899999999999999999999999999999999999999999999999999975322221 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~------------------ 212 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD------------------ 212 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 245679999999999977 689999999999999999999999999887766655553210
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-------CHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-------SAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-------Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
. .....+++++.+||.+||+.||.+|+ ++++ +++||||..+
T Consensus 213 --------~-----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~------------------~~~hp~~~~~ 260 (321)
T cd05591 213 --------V-----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDA------------------IKQHPFFKEI 260 (321)
T ss_pred --------C-----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHH------------------HhcCCccCCC
Confidence 0 00123688999999999999999999 8888 8999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.35 Aligned_cols=298 Identities=35% Similarity=0.527 Sum_probs=232.3
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
......++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred cccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 34456678999999999999999999999999999999986433333334456789999999999999999998765421
Q ss_pred ---CCCCcEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCC
Q 044076 88 ---REFKDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 88 ---~~~~~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
......|+||||++++|.+.+.... .+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred cccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 2235679999999999998887653 689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC-cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 164 ARVSFTDTPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 164 a~~~~~~~~~-~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
+......... ........++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.+...++..+..+.|..+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9754322211 1112345678999999988652 4578899999999999999999999999998889999999988887
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCC-C-CCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSH-K-FPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
.+.++............ ++......... . ....++.+.+||.+||..||.+|||++| +|
T Consensus 245 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e------------------~l 305 (310)
T cd07865 245 PEVWPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT------------------AL 305 (310)
T ss_pred hhhcccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH------------------Hh
Confidence 77665542221111100 01100000000 0 0124678899999999999999999999 89
Q ss_pred cCccc
Q 044076 321 ADPYF 325 (506)
Q Consensus 321 ~HP~f 325 (506)
+||||
T Consensus 306 ~h~~f 310 (310)
T cd07865 306 NHDFF 310 (310)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=366.49 Aligned_cols=260 Identities=29% Similarity=0.502 Sum_probs=228.3
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
.+++=|.+.+.||+|-|.+|-+|++..||+.||||+|.+...+......+..|++.|+.++|||||+||++. +..
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence 356779999999999999999999999999999999977655666667799999999999999999999998 344
Q ss_pred CcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE-CCCCCEEEeecCCcccc
Q 044076 91 KDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA-NADCKLKICDFGLARVS 167 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv-~~~~~lKL~DFGla~~~ 167 (506)
..+|||+|+-++ ||+++|..+ ..+.++..+.++.||+.|+.|+|+.++|||||||+|+.+ .+-|-+||+|||++..+
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 789999999974 999999765 469999999999999999999999999999999999865 56689999999999765
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
..+. .++..+|+..|.|||++++ ..| .+++||||||||||-|++|++||..-++-+.|.+|++.--+-
T Consensus 170 ~PG~----kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv----- 238 (864)
T KOG4717|consen 170 QPGK----KLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV----- 238 (864)
T ss_pred CCcc----hhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC-----
Confidence 4443 3577899999999999998 566 479999999999999999999999999999999996643221
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
| ..++.+++|||..||+.||++|.|.+| +..|+|++
T Consensus 239 ---------------------P-----shvS~eCrdLI~sMLvRdPkkRAslEe------------------I~s~~Wlq 274 (864)
T KOG4717|consen 239 ---------------------P-----SHVSKECRDLIQSMLVRDPKKRASLEE------------------IVSTSWLQ 274 (864)
T ss_pred ---------------------c-----hhhhHHHHHHHHHHHhcCchhhccHHH------------------Hhcccccc
Confidence 1 347899999999999999999999999 89999999
Q ss_pred CCCC
Q 044076 327 GLAN 330 (506)
Q Consensus 327 ~~~~ 330 (506)
....
T Consensus 275 ~~D~ 278 (864)
T KOG4717|consen 275 AGDR 278 (864)
T ss_pred CCCC
Confidence 8643
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=364.56 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=206.2
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHH-HHHhCCCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIK-LLRMLKHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~-iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||+||+|.+..+|+.||||++.... ........+.+|.. +++.++||||+++++.+.. .+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 47999999999999999999999999996421 22233455666665 4678999999999998843 47899999
Q ss_pred ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||+.+ +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 99985 9999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------------- 211 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK------------------- 211 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 244579999999999987 67999999999999999999999999887655544443210
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh----hhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE----EIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~----eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
. ....+++++.+.+||.+||+.||.+||++. + ++.||||..+
T Consensus 212 ---------~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~------------------il~~~~~~~~ 257 (323)
T cd05575 212 ---------P---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLE------------------IKNHVFFSSI 257 (323)
T ss_pred ---------C---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHH------------------HHcCCCcCCC
Confidence 0 012356789999999999999999999984 6 8999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=358.87 Aligned_cols=265 Identities=26% Similarity=0.384 Sum_probs=224.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.+.+++++.||+|.-|+||+|....++..+|+|++.+.. .......++..|-.||..+.||.+..||+.| +...
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence 457889999999999999999999999999999996532 3345567788899999999999999999999 4458
Q ss_pred cEEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..|+|||||.| +|+.+.+++. .++++.+++++.+|+.||.|||-.|||.|||||+||||.++|++.|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 89999999985 9999988754 69999999999999999999999999999999999999999999999999974321
Q ss_pred CC----------------------------------C-------------------CCcccccccccCCcccCccccccc
Q 044076 169 TD----------------------------------T-------------------PSAIFWTDYVATRWYRAPELCGSF 195 (506)
Q Consensus 169 ~~----------------------------------~-------------------~~~~~~~~~vgt~~Y~APE~l~~~ 195 (506)
.. . +.......+|||-.|.|||++.+
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 10 0 00011124689999999999998
Q ss_pred CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCC
Q 044076 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPG 275 (506)
Q Consensus 196 ~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (506)
...+.++|.|+||+.+||||.|..||.|.+..+.+..|+..--. | ...+.
T Consensus 310 -~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~----------------------------F-p~~~~ 359 (459)
T KOG0610|consen 310 -EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK----------------------------F-PEEPE 359 (459)
T ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc----------------------------C-CCCCc
Confidence 78889999999999999999999999999999888877431110 0 01135
Q ss_pred CCHHHHHHHHHhhhcCCCCCCC----HhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 276 ADPLALRLLQRLLAFDPKDRPS----AEEIRFTEIVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 276 ~s~~~~dLI~~mL~~DP~~RpT----a~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
++.+++|||+++|..||.+|+. |.| +-+||||+++...
T Consensus 360 vs~~akDLIr~LLvKdP~kRlg~~rGA~e------------------IK~HpFF~gVnWa 401 (459)
T KOG0610|consen 360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAE------------------IKRHPFFEGVNWA 401 (459)
T ss_pred chhHHHHHHHHHhccChhhhhccccchHH------------------hhcCccccCCChh
Confidence 7799999999999999999999 999 8999999998764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=371.15 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=214.8
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++. +.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----DD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 4578999999999999999999999999999999996421 22234455778999999999999999999884 34
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+||||++ ++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 78999999997 589998865 4689999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccCccccccc--CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~--~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+.+.......|......
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------- 265 (370)
T cd05596 195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS------- 265 (370)
T ss_pred CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc-------
Confidence 211 112345799999999998652 134789999999999999999999999887765555544321110
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD--RPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..+ ...+.++.++.+||.+||+.+|.+ |+|++| ++.||||
T Consensus 266 -------------------~~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~e------------------ll~h~~~ 307 (370)
T cd05596 266 -------------------LTF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDE------------------IKSHPFF 307 (370)
T ss_pred -------------------CCC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHH------------------HhcCccc
Confidence 000 112357899999999999999988 999999 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
++.
T Consensus 308 ~~~ 310 (370)
T cd05596 308 KND 310 (370)
T ss_pred CCC
Confidence 863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=341.31 Aligned_cols=292 Identities=32% Similarity=0.600 Sum_probs=240.3
Q ss_pred cccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecC
Q 044076 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLP 84 (506)
Q Consensus 6 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~ 84 (506)
....||..++|++.+++|+|.|+.|+.|++..++++++||+++. ...+++.|||+||+.|. ||||++|+++..+
T Consensus 30 ~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 30 LVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred eeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 45679999999999999999999999999999999999999974 46677999999999998 9999999999977
Q ss_pred CCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-CCEEEeecC
Q 044076 85 PCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFG 162 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~-~~lKL~DFG 162 (506)
+.. ....+||||.+. |...+.. .|+.-.++++++||+.||.|||+.||+|||+||.|++++.. -.++|+|+|
T Consensus 105 p~S---ktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 105 PES---KTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred ccc---cCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecc
Confidence 633 556799999986 6655543 58899999999999999999999999999999999999964 569999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCC-CCCCCCCchhhHHHHHhhcCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR-PLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~-~pF~~~~~~~~l~~I~~~~g~p 241 (506)
+|..+..+.. ..-.++++.|.-||++.. ...|+..-|||||||+|+.|+..+ |.|.|.++.+|+-+|.+++|+.
T Consensus 179 LAEFYHp~~e----YnVRVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~ 253 (338)
T KOG0668|consen 179 LAEFYHPGKE----YNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD 253 (338)
T ss_pred hHhhcCCCce----eeeeeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence 9987544322 345689999999999987 378999999999999999999965 6668999999999999999985
Q ss_pred ChHHH-hhhhhhHHHHHHhhhhccCCCCCCCCCC-----CCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHh
Q 044076 242 SAESI-AGIRNEKAKRYLSSLRRKWAVPFSHKFP-----GADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYF 315 (506)
Q Consensus 242 ~~e~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~ 315 (506)
....+ .+..-.-..+|-..+..-.+.+|....+ -++++++|||.++|.+|-.+|+||.|
T Consensus 254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE--------------- 318 (338)
T KOG0668|consen 254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE--------------- 318 (338)
T ss_pred HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH---------------
Confidence 44322 1111112233444444444555544332 25799999999999999999999999
Q ss_pred hhhhccCcccCCCCCC
Q 044076 316 YVLALADPYFHGLANL 331 (506)
Q Consensus 316 ~~~aL~HP~f~~~~~~ 331 (506)
|+.||||..+...
T Consensus 319 ---am~HpyF~~~~~~ 331 (338)
T KOG0668|consen 319 ---AMAHPYFAPVREA 331 (338)
T ss_pred ---HhcCchHHHHHHH
Confidence 9999999876653
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=363.91 Aligned_cols=251 Identities=29% Similarity=0.469 Sum_probs=208.4
Q ss_pred eEEEeecCceEEEEEEEC---CCCcEEEEEEecccc--cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 19 QEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVF--EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++.||+|+||.||+|.+. .+++.||||+++... ........+.+|+.+|+.++||||+++++++.. .+.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence 468999999999999864 578899999986421 222344567789999999999999999999843 3789
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||+.+ +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999985 9999998888899999999999999999999999999999999999999999999999999874322211
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+... .
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~------------ 216 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--K------------ 216 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C------------
Confidence 1234579999999999987 67889999999999999999999999887765544444211 0
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
. ...+.+++++.+||.+||+.||.+|| ++++ ++.||||..
T Consensus 217 ------------~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~------------------l~~h~~~~~ 261 (323)
T cd05584 217 ------------L-----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAE------------------VQSHPFFRH 261 (323)
T ss_pred ------------C-----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHH------------------HhcCCCcCC
Confidence 0 11235789999999999999999999 8999 899999986
Q ss_pred C
Q 044076 328 L 328 (506)
Q Consensus 328 ~ 328 (506)
.
T Consensus 262 ~ 262 (323)
T cd05584 262 V 262 (323)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=371.64 Aligned_cols=264 Identities=25% Similarity=0.356 Sum_probs=213.8
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++.. .
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-----D 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence 3578999999999999999999999999999999986421 223344567899999999999999999999843 4
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+||||++ ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 78999999997 5999988654 689999999999999999999999999999999999999999999999999976422
Q ss_pred CCCCcccccccccCCcccCcccccccC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~--~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.. .......+||+.|+|||++.+.. ..++.++||||+||++|+|++|++||.+.+....+..|......+
T Consensus 195 ~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------ 266 (370)
T cd05621 195 TG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL------ 266 (370)
T ss_pred CC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc------
Confidence 21 11123567999999999986521 237889999999999999999999998887666555553321111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD--RPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.+. ....+++.+++||.+||+.++.+ |+|++| +++||||
T Consensus 267 --------------------~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e------------------~l~hp~~ 307 (370)
T cd05621 267 --------------------NFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEE------------------IKQHPFF 307 (370)
T ss_pred --------------------CCC-CcccCCHHHHHHHHHHccCchhccCCCCHHH------------------HhcCccc
Confidence 000 01246899999999999865544 889999 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
+..
T Consensus 308 ~~~ 310 (370)
T cd05621 308 KND 310 (370)
T ss_pred CCC
Confidence 873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=372.64 Aligned_cols=281 Identities=25% Similarity=0.307 Sum_probs=220.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC--CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT--HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~--~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..+|++++.||.|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++. ..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~-----~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYR-----WK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEe-----eC
Confidence 457999999999999999999754 45678999988531 23458999999999999999999884 34
Q ss_pred CcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 91 KDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
..+|+|||++.++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 78999999999999999987788999999999999999999999999999999999999999999999999999754332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---chhhHHHHHhhcCCCChHHHh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN---VAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~---~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.. ...++..|...++..+.+...
T Consensus 239 ~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PD-TPQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cc-cccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 21 112235679999999999987 689999999999999999999999997765 356677777777765443222
Q ss_pred hhhhh---HHHHHHhhhhccCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 248 GIRNE---KAKRYLSSLRRKWAVPFSHKF--PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 248 ~~~~~---~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
..... ....+....+. .......+ ...+.++.+||.+||++||.+|||+.| +|.|
T Consensus 316 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e------------------~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRP--PYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD------------------ILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccC--CccccchhhccCcchhHHHHHHHHhccChhhCCCHHH------------------HhhC
Confidence 11111 11111111111 11111111 245778999999999999999999999 8999
Q ss_pred cccCCC
Q 044076 323 PYFHGL 328 (506)
Q Consensus 323 P~f~~~ 328 (506)
|||...
T Consensus 376 p~f~~~ 381 (392)
T PHA03207 376 PLFTKE 381 (392)
T ss_pred chhhcc
Confidence 999763
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=354.89 Aligned_cols=288 Identities=38% Similarity=0.657 Sum_probs=234.0
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++.+.||.|++|.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 57999999999999999999999999999999986433333334567899999999999999999999843 3789
Q ss_pred EEEEecCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-CCCEEEeecCCcccccCC
Q 044076 94 YVVFELMESDLDQVIKANDD--LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLARVSFTD 170 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~~~~~--ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-~~~lKL~DFGla~~~~~~ 170 (506)
|+||||++++|.+.+..... +++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||+++.....
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999998876543 578889999999999999999999999999999999985 567999999999753222
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. ...+..+++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+....+.|....|....
T Consensus 157 ~---~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V---RTFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred c---cccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 1 112445678999999988652 468899999999999999999999999988888888888899998877776432
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
.. ..+....+...........++.++++.++|.+||+.||++|||+.+ +|.||||.++..
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~------------------~l~~~~~~~~~~ 292 (294)
T PLN00009 233 SL--PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA------------------ALEHEYFKDLGD 292 (294)
T ss_pred cc--hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHH------------------HhcCchHhHHhc
Confidence 21 1222222222222333345678999999999999999999999999 899999997653
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.21 Aligned_cols=278 Identities=24% Similarity=0.339 Sum_probs=213.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
...|++++.||+|+||.||+|.+..+++.||+|+.... ...+|+.+++.++||||+++++++.. ...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEe-----CCe
Confidence 45799999999999999999999999999999985421 23579999999999999999999854 367
Q ss_pred EEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.|+|||++.++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 899999999999998865 4579999999999999999999999999999999999999999999999999997532211
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCc---------hhhHHHHHhhcCCC
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNV---------AHQLDLVTDLLGTP 241 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~---------~~~l~~I~~~~g~p 241 (506)
......||..|+|||++.+ ..++.++|||||||++|||++ +.++|.+... ..++..+...+|..
T Consensus 212 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 212 ----AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ----ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1234569999999999987 679999999999999999998 4556554321 23444555555544
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCC----CCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhh
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSH----KFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~ 317 (506)
+.+............++... .....++.. ...+++.++.+||.+||++||.+||||.|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e----------------- 347 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYA-SLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEE----------------- 347 (357)
T ss_pred hhhcCCCCccHHHHHHHhhc-ccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHH-----------------
Confidence 33322111111112222110 111111110 11356788999999999999999999999
Q ss_pred hhccCcccCCC
Q 044076 318 LALADPYFHGL 328 (506)
Q Consensus 318 ~aL~HP~f~~~ 328 (506)
+|+||||+.+
T Consensus 348 -~l~hp~f~~~ 357 (357)
T PHA03209 348 -ILNYPMFAQL 357 (357)
T ss_pred -HhcCchhccC
Confidence 8999999864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.74 Aligned_cols=281 Identities=38% Similarity=0.681 Sum_probs=231.7
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||.|++|.||+|.+..+|+.||||+++.... ......+.+|+.+++.++||||+++++.+.. .+..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEE
Confidence 58999999999999999999999999999999864322 2234567789999999999999999999844 37789
Q ss_pred EEEecCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 95 VVFELMESDLDQVIKAND---DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~~~---~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+||||++++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||++++++.+||+|||+++......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 999999999999887643 58999999999999999999999999999999999999999999999999997532211
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......++..|++||++.+. ..++.++|+||+||++|+|++|++||.+.+..+++..+....+.|....+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12345678899999988652 4678899999999999999999999999999999999999999998887766542
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
. ..+....+..........++..++.+.++|.+||+.||.+|||+.| +++||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~------------------~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD------------------ALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH------------------HhcCCCC
Confidence 1 1121222222222223345667899999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=356.50 Aligned_cols=287 Identities=40% Similarity=0.658 Sum_probs=234.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.+.|++.+.||.|+||.||+|.+..+++.||||.++...........+.+|+.+++.++||||+++++++... +...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCc
Confidence 4679999999999999999999999999999999974433333344567899999999999999999987543 2378
Q ss_pred EEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.|+|+||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999999999999987644 59999999999999999999999999999999999999999999999999997643321
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......++..|+|||.+.+. ..++.++||||+||++++|++|.+||.+.+..+.+..+....|.|....|..+..
T Consensus 161 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 K---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1 12345678899999998652 4578899999999999999999999999999999999999999998887765432
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCC--CHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGA--DPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.....- ..........+...++.. ++.+.+||.+||+.||++|||+.| +|.||||
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~e------------------ll~~~~f 293 (293)
T cd07843 237 LPGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED------------------ALKHPYF 293 (293)
T ss_pred cchhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHH------------------HhcCCCC
Confidence 111100 011111122233445554 899999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=361.82 Aligned_cols=264 Identities=23% Similarity=0.396 Sum_probs=213.0
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||+||+|.+..+++.||||++.+. .........+.+|+.++..++|+||+++++++. +.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence 5799999999999999999999999999999998642 122334556788999999999999999999884 3478
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 599999976 457999999999999999999999999999999999999999999999999998653322
Q ss_pred CCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... .....+||+.|+|||++... ...++.++||||+||++|+|++|+.||.+.+..+....|....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------- 224 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC---------
Confidence 211 11234689999999998631 1457889999999999999999999998877655555443211
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD--RPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
....+....+.+++++.+||++||..++.+ |+++++ +|.||||
T Consensus 225 -----------------~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~------------------~l~hp~~ 269 (331)
T cd05597 225 -----------------EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQD------------------FKDHPFF 269 (331)
T ss_pred -----------------CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHH------------------HhcCCCC
Confidence 111122233458999999999999765544 789999 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
.++
T Consensus 270 ~~~ 272 (331)
T cd05597 270 EGI 272 (331)
T ss_pred CCC
Confidence 874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.89 Aligned_cols=281 Identities=41% Similarity=0.683 Sum_probs=233.2
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
|++++.||.|++|.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.. ....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence 678999999999999999999999999999986433233334567889999999999999999999843 378999
Q ss_pred EEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 96 VFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 96 V~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
||||++++|.+++.... .+++..+..++.||++||+|||+.|++||||+|+||+++.++.++|+|||+++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999999999998765 799999999999999999999999999999999999999999999999999975322111
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhH
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~ 253 (506)
......++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+.+..++|....|..+...
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL- 230 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc-
Confidence 11334568899999988652 45788999999999999999999999999988888899999999988877554221
Q ss_pred HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..+...++...........+++++.+.+||.+||+.||.+|||++| ++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~------------------il~~~~~ 283 (283)
T cd07835 231 -PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA------------------ALQHPYF 283 (283)
T ss_pred -hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH------------------HhcCCCC
Confidence 1222233333333334456778999999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=341.15 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=223.2
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
...++|++++.||+|-||.||.|+.+.++..||+|++.+. .........+.||+.|...|+||||++++++|.+.
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~---- 94 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS---- 94 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc----
Confidence 4568999999999999999999999999999999999532 22334456788999999999999999999999554
Q ss_pred CCcEEEEEecCC-CCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 90 FKDIYVVFELME-SDLDQVIK--ANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~--~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..+|+++||.. |+|...+. ....+++.....+++|++.||.|+|..+|+||||||+|+|++.++.+||+|||-+..
T Consensus 95 -~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 95 -KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred -ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 88999999997 69999998 556799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... .....+||..|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+....|.+.--.
T Consensus 174 ~p~~-----kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~------ 240 (281)
T KOG0580|consen 174 APSN-----KRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK------ 240 (281)
T ss_pred cCCC-----CceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc------
Confidence 4321 1256789999999999988 78999999999999999999999999988877777666432111
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.| +.++.++.|||.+||..+|.+|.+..| ++.|||..
T Consensus 241 --------------------~p-----~~is~~a~dlI~~ll~~~p~~r~~l~~------------------v~~hpwI~ 277 (281)
T KOG0580|consen 241 --------------------FP-----STISGGAADLISRLLVKNPIERLALTE------------------VMDHPWIV 277 (281)
T ss_pred --------------------CC-----cccChhHHHHHHHHhccCccccccHHH------------------HhhhHHHH
Confidence 11 468999999999999999999999999 89999986
Q ss_pred CC
Q 044076 327 GL 328 (506)
Q Consensus 327 ~~ 328 (506)
..
T Consensus 278 a~ 279 (281)
T KOG0580|consen 278 AN 279 (281)
T ss_pred hc
Confidence 53
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=350.54 Aligned_cols=258 Identities=35% Similarity=0.578 Sum_probs=213.7
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.+++.++||||+++++++.. ...+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999997543333334445679999999999999999999854 478999
Q ss_pred EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCc
Q 044076 96 VFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174 (506)
Q Consensus 96 V~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~ 174 (506)
|||++.+ +|.+++.....+++..+..++.||++||++||++||+|+||||+||+++.++.++|+|||.+..... ..
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---~~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---NN 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc
Confidence 9999997 9999999778899999999999999999999999999999999999999999999999999975311 11
Q ss_pred ccccccccCCcccCccccc-ccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhH
Q 044076 175 IFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253 (506)
Q Consensus 175 ~~~~~~vgt~~Y~APE~l~-~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~ 253 (506)
.......++..|+|||++. + ..++.++|+|||||++++|++|..||...+..+....+.............
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------ 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc------
Confidence 1235667899999999987 4 688999999999999999999999998875555555553332221111100
Q ss_pred HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.....++.+.+||.+||+.||++|||+.+ +++||||
T Consensus 225 ------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~------------------l~~~~~~ 260 (260)
T PF00069_consen 225 ------------------QSREKSEELRDLIKKMLSKDPEQRPSAEE------------------LLKHPWF 260 (260)
T ss_dssp ------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHH------------------HHTSGGG
T ss_pred ------------------ccchhHHHHHHHHHHHccCChhHCcCHHH------------------HhcCCCC
Confidence 00112378999999999999999999999 8999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=356.95 Aligned_cols=296 Identities=36% Similarity=0.611 Sum_probs=233.4
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc--
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-- 87 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-- 87 (506)
....++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 345689999999999999999999999999999999985432222233456789999999999999999998765421
Q ss_pred -CCCCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 -REFKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 -~~~~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.....+|+|+||++++|...+... ..+++..++.++.||++||.|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 84 ~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 84 KRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 234568999999999998887653 479999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCC--------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhh
Q 044076 166 VSFTDTPS--------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDL 237 (506)
Q Consensus 166 ~~~~~~~~--------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~ 237 (506)
........ ....+..+++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.+....+..+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 64322211 1122445678999999988652 56889999999999999999999999999999999999999
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~ 317 (506)
.+.+.+..+..........- .......+..+...+...++.+.+||.+||+.||.+|||+.|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e----------------- 304 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD----------------- 304 (311)
T ss_pred hCCCChhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH-----------------
Confidence 99887766544221110000 000011111222344567788999999999999999999999
Q ss_pred hhccCccc
Q 044076 318 LALADPYF 325 (506)
Q Consensus 318 ~aL~HP~f 325 (506)
++.||||
T Consensus 305 -ll~~~~f 311 (311)
T cd07866 305 -ALEHPYF 311 (311)
T ss_pred -HhcCCCC
Confidence 8999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=352.94 Aligned_cols=285 Identities=37% Similarity=0.641 Sum_probs=225.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++.+.||.|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++. +....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence 4799999999999999999999999999999998653333334556789999999999999999999984 34789
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+|+||+++ .|..+......+++..++.++.||+.||+|||+.||+||||+|+||++++++.+||+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999996 566665555679999999999999999999999999999999999999999999999999997643322
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
...+.+.++.+|+|||++.+. ..++.++||||+||++|+|++|++||++.+..+.+..+....+.............
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 123456789999999998652 45788999999999999999999999998888888888777776543322111110
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...............+....+++++..+.+|+.+||+.||.+|||+.+ +|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~------------------il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ------------------LLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH------------------HhcCCCC
Confidence 000000000001111222345678999999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=362.25 Aligned_cols=250 Identities=25% Similarity=0.423 Sum_probs=206.1
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||.||+|.+..+|+.||+|+++.... .........+|+.++..+ .||||+++++++. +.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence 479999999999999999999999999964321 123445567788888765 7999999999984 347899999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||+. ++|...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---R 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---c
Confidence 9997 49999998888899999999999999999999999999999999999999999999999999864221111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+.. +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~--------------- 213 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTP--------------- 213 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCC---------------
Confidence 245679999999999987 6899999999999999999999999988776544444321 000
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh-hhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE-EIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~-eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.....+++++.+||.+||+.||.+|||+. + ++.||||...
T Consensus 214 --------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~------------------~~~h~~f~~~ 254 (316)
T cd05620 214 --------------HYPRWITKESKDILEKLFERDPTRRLGVVGN------------------IRGHPFFKTI 254 (316)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHH------------------HHcCCCcCCC
Confidence 01123788999999999999999999985 6 7899999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=361.70 Aligned_cols=250 Identities=26% Similarity=0.437 Sum_probs=205.9
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
++||+|+||+||+|.+..+++.||||+++... ..........+|..++..+ .||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 47999999999999999999999999996432 1223444566777777654 79999999998843 47899999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||++ ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---K 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---c
Confidence 9997 59999998888899999999999999999999999999999999999999999999999999975322221 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~---------------- 212 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--R---------------- 212 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C----------------
Confidence 244579999999999987 67899999999999999999999999987765555444211 0
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh-hhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE-EIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~-eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
. ..-..+++++.+||.+||+.||.+||++. + ++.||||..+
T Consensus 213 --------~-----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~------------------l~~h~~~~~~ 254 (316)
T cd05592 213 --------P-----HFPRWISKEAKDCLSKLFERDPTKRLGVDGD------------------IRQHPFFRGI 254 (316)
T ss_pred --------C-----CCCCCCCHHHHHHHHHHccCCHHHcCCChHH------------------HHcCcccCCC
Confidence 0 01124788999999999999999999875 5 7899999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=361.32 Aligned_cols=250 Identities=24% Similarity=0.429 Sum_probs=208.3
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||+||+|.+..+++.||||+++... ........+.+|+.+++.+ .||||+++++++.. .+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999996432 2233455677899999888 59999999999843 37899999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||+. ++|...+...+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9997 59999998888899999999999999999999999999999999999999999999999999964222111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~------------------- 211 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED------------------- 211 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 234568999999999987 78999999999999999999999999887755444433210
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----hhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA-----EEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa-----~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.. .....+++.+.+||.+||+.||.+|||+ .+ ++.||||...
T Consensus 212 -------~~-----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~------------------ll~~~~~~~~ 258 (318)
T cd05570 212 -------EV-----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQD------------------IKGHPFFREI 258 (318)
T ss_pred -------CC-----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHH------------------HhcCCCcCCC
Confidence 00 0112478899999999999999999999 88 8999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=363.90 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=208.8
Q ss_pred eEEEeecCceEEEEEEE---CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 19 QEIIGIGSYGVVASAID---THTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d---~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
++.||+|+||.||++.+ ..+|+.||+|++............+.+|+.+|+.++||||+++++++.. .+.+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEE
Confidence 36899999999999986 3578999999997543333445567789999999999999999999843 478999
Q ss_pred EEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCc
Q 044076 96 VFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174 (506)
Q Consensus 96 V~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~ 174 (506)
||||++ ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999997 59999998888899999999999999999999999999999999999999999999999999975432211
Q ss_pred ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 175 ~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------------- 214 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------------- 214 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 1234578999999999987 678899999999999999999999998877655554442210
Q ss_pred HHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
. ...+.+++.+.+||++||+.||.+|||+.++. ...++.||||..+
T Consensus 215 ----------~-----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~-------------~~~~~~~~~~~~~ 260 (318)
T cd05582 215 ----------L-----GMPQFLSPEAQSLLRALFKRNPANRLGAGPDG-------------VEEIKRHPFFSTI 260 (318)
T ss_pred ----------C-----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCC-------------HHHHhCCCCcCCC
Confidence 0 11134788999999999999999999944310 0118999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=361.70 Aligned_cols=258 Identities=24% Similarity=0.429 Sum_probs=204.6
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
++||+|+||.||+|.+..+++.||||+++... ........+.+|+.+++.+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence 47999999999999999999999999997532 2334456688999999998 59999999999843 47899999
Q ss_pred ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||+++ +|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 99975 9999988888999999999999999999999999999999999999999999999999999964222111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+||..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+ .|.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~---------~~ 211 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNT---------ED 211 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccc---------hH
Confidence 245679999999999987 688999999999999999999999996432110 000000 00
Q ss_pred H-HhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC------HhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 Y-LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS------AEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~-~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT------a~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+ .+.+... .. ..-..+++.+.+||.+||+.||.+|+| +++ ++.||||..+
T Consensus 212 ~~~~~~~~~-~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~------------------i~~hp~~~~~ 268 (329)
T cd05588 212 YLFQVILEK-QI---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRD------------------IKSHPFFRNI 268 (329)
T ss_pred HHHHHHHcC-CC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHH------------------HhcCCCCCCC
Confidence 0 0000010 01 111357899999999999999999998 678 8999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=349.32 Aligned_cols=280 Identities=39% Similarity=0.716 Sum_probs=223.8
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCcEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
|++++.||.|+||.||+|.+..+++.||+|+++........ ....+|+.+++++. |+||+++++++... ..+.+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 78899999999999999999999999999998754333222 33458999999886 99999999998542 226789
Q ss_pred EEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 95 VVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
+||||++++|.+.+... ..+++..+..++.||+.||.|||+.||+||||+|+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999999988764 47899999999999999999999999999999999999999 9999999999976433222
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhH
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~ 253 (506)
...+.++.+|+|||++.+. ..++.++||||+||++|+|++|.+||++.+..+.+..+...+|.+............
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2345689999999987542 457889999999999999999999999999989999999999988775532221111
Q ss_pred HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...+ ..+......+....+.++.++.+||.+||+.||.+|||+++ +|+||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~------------------~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ------------------ALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHH------------------HhhCCCC
Confidence 0000 00000111111223467899999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=358.90 Aligned_cols=256 Identities=22% Similarity=0.387 Sum_probs=211.5
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCc
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.+. |++|+++++++.. .+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 4788999999999999999999999999999996432 12334556778999998887 5778888888743 368
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999997532221
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+.......|.....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------ 218 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------ 218 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 1 1234568999999999987 6789999999999999999999999988776555554432100
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----hhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA-----EEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa-----~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
...+.+++++.+|+.+||+.||.+|+++ ++ +++||||.
T Consensus 219 -------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~------------------i~~h~~f~ 261 (323)
T cd05615 219 -------------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERD------------------IREHAFFR 261 (323)
T ss_pred -------------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHH------------------HhcCcccC
Confidence 1113478899999999999999999985 45 79999998
Q ss_pred CCC
Q 044076 327 GLA 329 (506)
Q Consensus 327 ~~~ 329 (506)
.+.
T Consensus 262 ~~~ 264 (323)
T cd05615 262 RID 264 (323)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.74 Aligned_cols=254 Identities=29% Similarity=0.483 Sum_probs=206.1
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHH-HHHhCCCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIK-LLRMLKHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~-iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||+||+|.+..+|+.||||++.... ........+.+|.. +++.++||||+++++.+.. .+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence 46999999999999999999999999996421 22234455666665 4677899999999998843 47899999
Q ss_pred ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||+.+ +|...+.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 99985 8999998888999999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~------------------- 211 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK------------------- 211 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999987 67899999999999999999999999887655444433210
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
. ....++.+..+.+||.+||+.||.+||++.+. +..++.||||...
T Consensus 212 ---------~---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~--------------~~~i~~h~~f~~~ 257 (325)
T cd05604 212 ---------P---LVLRPGASLTAWSILEELLEKDRQRRLGAKED--------------FLEIQEHPFFESL 257 (325)
T ss_pred ---------C---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCC--------------HHHHhcCCCcCCC
Confidence 0 01225688999999999999999999988520 0018999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=351.33 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=210.0
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
.|++.+.||+|+||.||++.+..+++.||||++.... ........+.+|+.+++.++||||+++++.+.. .+.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence 4899999999999999999999999999999986421 222233456789999999999999999998843 3689
Q ss_pred EEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 94 YVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
|+||||++ ++|...+... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999997 5898887653 36999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. ....+|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...+.
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~----------- 218 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK----------- 218 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh-----------
Confidence 11 133468999999999977 6789999999999999999999999987665433322211100
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.. . ....+.+++.+.+||.+||..||.+|| ++++ ++.||||
T Consensus 219 ------------~~-~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~------------------l~~~~~~ 264 (285)
T cd05605 219 ------------ED-Q---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEE------------------VKAHPFF 264 (285)
T ss_pred ------------hc-c---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHH------------------HhcCcCc
Confidence 00 0 011234788999999999999999999 8999 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
...
T Consensus 265 ~~~ 267 (285)
T cd05605 265 RTA 267 (285)
T ss_pred cCC
Confidence 863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=351.05 Aligned_cols=286 Identities=39% Similarity=0.674 Sum_probs=227.2
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++.+.||.|+||.||+|.+..+++.||||+++...........+.+|+.+++.++|+||+++++++.. .+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 47999999999999999999999999999999986543344455678899999999999999999999854 3679
Q ss_pred EEEEecCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESDLDQVI-KANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~L~~~i-~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||+++++...+ .....+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 999999998665554 4456799999999999999999999999999999999999999999999999999976433322
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
.....++++.+|+|||++.+. ..++.++|+||+||++|+|++|++||.+.+..+.+..+...+|...+.........
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122456789999999999772 37889999999999999999999999999888888888888887666544332111
Q ss_pred HHHHHHhhhhccCCCCCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPG-ADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
....-...........+...++. +++++.+||.+||..||.+|||+++ +++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------------------il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE------------------LLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH------------------HhcCCCC
Confidence 00000000000001111122333 4889999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=358.87 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=206.5
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||+||+|.+..+++.||||+++.... .........+|..++..+ .||||+++++++.. .+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 479999999999999999999999999964321 123345566788888764 79999999999843 37899999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||++ ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9997 59999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
.....||..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+.. +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~--------------- 213 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNP--------------- 213 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCC---------------
Confidence 234568999999999987 6799999999999999999999999988776554444311 000
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh-hhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE-EIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~-eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.....++.++.+||.+||+.||.+||++. + +++||||..+.
T Consensus 214 --------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~------------------l~~h~~~~~~~ 255 (316)
T cd05619 214 --------------CYPRWLTREAKDILVKLFVREPERRLGVKGD------------------IRQHPFFREID 255 (316)
T ss_pred --------------CCCccCCHHHHHHHHHHhccCHhhcCCChHH------------------HHcCcccCCCC
Confidence 00123788999999999999999999997 7 79999998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=359.23 Aligned_cols=265 Identities=23% Similarity=0.391 Sum_probs=213.7
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|+++++||+|+||.||++.+..+++.||+|++.+. .........+.+|+.++..+.|+||+++++.+. +...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence 4799999999999999999999999999999998532 112233445778999999999999999999884 3478
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999997 599999976 457999999999999999999999999999999999999999999999999999653222
Q ss_pred CCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.. ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.+..|....
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (332)
T cd05623 156 GT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------- 224 (332)
T ss_pred Cc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---------
Confidence 21 112345799999999998531 2468899999999999999999999998877666555543211
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD--RPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...++......+++++.+||++||..++.+ |+|++| +++||||
T Consensus 225 -----------------~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~------------------~~~h~~f 269 (332)
T cd05623 225 -----------------ERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIED------------------FKQHPFF 269 (332)
T ss_pred -----------------ccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHH------------------HhCCCCc
Confidence 111122233468999999999999765554 689999 8999999
Q ss_pred CCCC
Q 044076 326 HGLA 329 (506)
Q Consensus 326 ~~~~ 329 (506)
.++.
T Consensus 270 ~~~~ 273 (332)
T cd05623 270 TGID 273 (332)
T ss_pred CCCC
Confidence 8753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=342.34 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=211.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC---hhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH---VSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~---~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
+.|++.+.||.|++|.||.|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-----D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-----C
Confidence 5799999999999999999999999999999998643221 1234568899999999999999999999843 3
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+|+||+++ +|.+.+...+.+++..++.+++||+.||.|||+.||+||||+|+||+++.++.++|+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 689999999974 8999998888899999999999999999999999999999999999999999999999999975332
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
............++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 224 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT---------- 224 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC----------
Confidence 2111111134568889999999987 5689999999999999999999999976544332222211000
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
. ......+++.+.+||.+||..||.+|||+.+ +|+||||
T Consensus 225 ----------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~------------------ll~~~~~ 263 (263)
T cd06625 225 ----------------N---PQLPSHVSPDARNFLRRTFVENAKKRPSAEE------------------LLRHFFV 263 (263)
T ss_pred ----------------C---CCCCccCCHHHHHHHHHHhhcCcccCCCHHH------------------HhhCCCC
Confidence 0 0112357889999999999999999999999 8999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=347.35 Aligned_cols=286 Identities=36% Similarity=0.617 Sum_probs=224.0
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
|+..++|++++.||+|+||.||+|.+..+|+.||||.+..... ......+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----- 74 (291)
T cd07870 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT----- 74 (291)
T ss_pred CCccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----
Confidence 4677899999999999999999999999999999999864221 2223456789999999999999999999843
Q ss_pred CCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
....|+||||+.++|.+.+... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 75 KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 3679999999999988877653 468899999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-chhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN-VAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~-~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ......++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+ ..+++..+...+|.|....+.
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 155 IPSQ---TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCCC---CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 2111 11334578899999998652 457889999999999999999999997655 456777788888888777655
Q ss_pred hhhhhHHHHHHhh-hhccCCCCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 248 GIRNEKAKRYLSS-LRRKWAVPFSHKFP--GADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 248 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
...... .+... .....+..+...+. ..++.+.+||.+||..||.+|||+.| +|.|||
T Consensus 231 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~------------------~l~h~~ 290 (291)
T cd07870 231 GVSKLP--NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQD------------------ALLHPY 290 (291)
T ss_pred hhhhcc--cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHH------------------HhcCCC
Confidence 442210 00000 01111111111111 13678999999999999999999999 899999
Q ss_pred c
Q 044076 325 F 325 (506)
Q Consensus 325 f 325 (506)
|
T Consensus 291 ~ 291 (291)
T cd07870 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=351.25 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=203.2
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecC
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 100 (506)
||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++.+++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence 699999999999999999999999986421 222334567789999999999999999988843 47799999999
Q ss_pred C-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcc
Q 044076 101 E-SDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175 (506)
Q Consensus 101 ~-~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 175 (506)
+ ++|...+.. +..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--- 152 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--- 152 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---
Confidence 7 588877743 34699999999999999999999999999999999999999999999999999975433221
Q ss_pred cccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHH
Q 044076 176 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255 (506)
Q Consensus 176 ~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~ 255 (506)
......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.........+....
T Consensus 153 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~----------------- 213 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI----------------- 213 (280)
T ss_pred cccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh-----------------
Confidence 1234578999999999987 688999999999999999999999997654322111111000
Q ss_pred HHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 256 RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
... . ....+.+++++.+|+.+||+.||.+|| |+++ ++.||||+++..
T Consensus 214 -----~~~--~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~------------------~l~h~~~~~~~~ 265 (280)
T cd05608 214 -----LND--S---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDG------------------LRTHPLFRDLNW 265 (280)
T ss_pred -----ccc--C---CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH------------------HhcChhhhcCCH
Confidence 000 0 011235789999999999999999999 7788 899999988543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=364.89 Aligned_cols=264 Identities=24% Similarity=0.354 Sum_probs=212.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .........+.+|+.+++.++||||+++++.+.. .
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----D 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----C
Confidence 358999999999999999999999999999999998542 1223344567789999999999999999998843 4
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+||||++ ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 78999999997 5899988754 589999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~--~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|++||.+.+.......|......
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------- 265 (371)
T cd05622 195 EGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS------- 265 (371)
T ss_pred CCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc-------
Confidence 211 1123567999999999986521 23889999999999999999999999887765555554321111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD--RPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..+ ...+.+++.+.+||.+||+.++.+ |++++| +++||||
T Consensus 266 -------------------~~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~e------------------i~~h~~~ 307 (371)
T cd05622 266 -------------------LTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEE------------------IKRHLFF 307 (371)
T ss_pred -------------------ccC-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHH------------------HhcCccc
Confidence 011 112458999999999999844433 789999 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
.+.
T Consensus 308 ~~~ 310 (371)
T cd05622 308 KND 310 (371)
T ss_pred CCC
Confidence 873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=372.88 Aligned_cols=281 Identities=26% Similarity=0.332 Sum_probs=212.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|+.++||||+++++++.. .+.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence 457999999999999999999999999999999643 1235689999999999999999998743 367
Q ss_pred EEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.|+|||++.++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 235 ~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 235 TCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 8999999999999988764 469999999999999999999999999999999999999999999999999997643221
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCC-CCCCCC------chhhHHHHHhhcCCCChH
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRP-LFPGRN------VAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~-pF~~~~------~~~~l~~I~~~~g~p~~e 244 (506)
. ........||..|+|||++.+ ..++.++|||||||++|||++|.. +|.... ...++..+....+....+
T Consensus 315 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 S-TPFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred c-cccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1 111234579999999999987 679999999999999999999764 444322 234455555544432221
Q ss_pred HHhhhhhhHHHHHHhhhhcc----CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 245 SIAGIRNEKAKRYLSSLRRK----WAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
.-..........+....... ...+.-..+...++++.+||.+||++||.+|||+.| +|
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~e------------------lL 453 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAE------------------LL 453 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHH------------------Hh
Confidence 11111111111111111111 111111122356789999999999999999999999 89
Q ss_pred cCcccCC
Q 044076 321 ADPYFHG 327 (506)
Q Consensus 321 ~HP~f~~ 327 (506)
+||||+.
T Consensus 454 ~hp~f~~ 460 (461)
T PHA03211 454 RLPLFQS 460 (461)
T ss_pred hCcccCC
Confidence 9999974
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=352.48 Aligned_cols=288 Identities=40% Similarity=0.638 Sum_probs=223.5
Q ss_pred CEEEeEEEeecCceEEEEEEECC--CCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTH--TGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~--t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
+|++.+.||+|+||.||+|.+.. +++.||||.+.... ........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 68999999999999999999988 89999999996522 1223345678899999999999999999998543 236
Q ss_pred cEEEEEecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC----CCCEEEeecC
Q 044076 92 DIYVVFELMESDLDQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA----DCKLKICDFG 162 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~-----~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~----~~~lKL~DFG 162 (506)
.+|+||||++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 79999999999988887532 26899999999999999999999999999999999999999 8999999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch---------hhHHH
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA---------HQLDL 233 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~---------~~l~~ 233 (506)
+++................++.+|+|||++.+. ..++.++|||||||++++|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 997643322211122345688999999988652 56889999999999999999999999876543 46777
Q ss_pred HHhhcCCCChHHHhhhhhhH-HHHHHhhhhccCCCC------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhh
Q 044076 234 VTDLLGTPSAESIAGIRNEK-AKRYLSSLRRKWAVP------FSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEI 306 (506)
Q Consensus 234 I~~~~g~p~~e~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~ 306 (506)
+...++.+....+....... .....+... ....+ ....+...+..+.++|.+||+.||.+|||+.|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e------ 309 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFK-TKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE------ 309 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhcc-CCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH------
Confidence 78888888776665432221 111100000 00000 00111257889999999999999999999999
Q ss_pred hhhHHHHHhhhhhccCccc
Q 044076 307 VFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 307 ~~~~~~~~~~~~aL~HP~f 325 (506)
++.||||
T Consensus 310 ------------il~~~~f 316 (316)
T cd07842 310 ------------ALEHPYF 316 (316)
T ss_pred ------------HhcCCCC
Confidence 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=359.09 Aligned_cols=259 Identities=24% Similarity=0.415 Sum_probs=203.8
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||.||+|.+..+++.||+|+++... ........+.+|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 47999999999999999999999999997532 2334456678899998877 69999999998843 47899999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||++ ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9998 58999888888899999999999999999999999999999999999999999999999999975322111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
.....||..|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~~---------~~~ 211 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQN---------TED 211 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcC----------Ccccc---------cHH
Confidence 234578999999999987 788999999999999999999999995321100 00000 000
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------hhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA------EEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa------~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
++......... ......+..+.+||.+||+.||.+|||+ .+ ++.||||.+.
T Consensus 212 ~~~~~i~~~~~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~------------------i~~hp~f~~~ 268 (329)
T cd05618 212 YLFQVILEKQI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFAD------------------IQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcCCC---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHH------------------HhcCCCCCCC
Confidence 00000000000 1123578999999999999999999995 57 8999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=358.27 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=205.7
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHH-HHHhCCCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIK-LLRMLKHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~-iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||+||+|++..+++.||+|++.... ........+.+|.. +++.++||||+++++++.. .+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence 47999999999999999999999999986421 11223334555554 5678899999999998843 47899999
Q ss_pred ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 99985 9999998888899999999999999999999999999999999999999999999999999975322111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------------------- 211 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------------------- 211 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 245679999999999987 68999999999999999999999999887765554444210
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
. ....+++++.+.+||.+||+.||.+|+++.+. +..+++|+||..+
T Consensus 212 ---------~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~--------------~~~i~~~~~~~~~ 257 (325)
T cd05602 212 ---------P---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD--------------FMEIKNHIFFSPI 257 (325)
T ss_pred ---------C---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC--------------HHHHhcCcccCCC
Confidence 0 01235689999999999999999999998741 1117899999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=367.17 Aligned_cols=250 Identities=30% Similarity=0.472 Sum_probs=222.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++++|+|+||.++.++++..+..|++|+|.-............+|+.++.++.|||||.+++.|... +
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-----~ 76 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-----G 76 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-----C
Confidence 35789999999999999999999999999999999975545555555788999999999999999999998543 5
Q ss_pred c-EEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 92 D-IYVVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 92 ~-~ylV~E~~~~-~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
. ++|||+|++| +|.+.|+... .++++.+..++.||+.|+.|||+++|+|||||+.|||++.++.+||+|||+|+..
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence 5 9999999985 9999997654 6999999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
..... +...++||+.|++||++.+ .+|+.++|||||||++|||++-++.|.+.+-.....+|......|-+.
T Consensus 157 ~~~~~---~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~--- 228 (426)
T KOG0589|consen 157 NPEDS---LASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPS--- 228 (426)
T ss_pred CCchh---hhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCc---
Confidence 54431 3467899999999999998 899999999999999999999999999999998888887766555432
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+.+++.||+.||..+|..||+|.+|
T Consensus 229 ---------------------------~ys~el~~lv~~~l~~~P~~RPsa~~L 255 (426)
T KOG0589|consen 229 ---------------------------MYSSELRSLVKSMLRKNPEHRPSALEL 255 (426)
T ss_pred ---------------------------cccHHHHHHHHHHhhcCCccCCCHHHH
Confidence 378899999999999999999999993
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=375.64 Aligned_cols=267 Identities=26% Similarity=0.383 Sum_probs=217.8
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc---
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR--- 87 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~--- 87 (506)
...++|++.+.||+|+||+||+|.+..+|+.||||++............+.+|+.++..++|+||+++++.+.....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34589999999999999999999999999999999996544445566778899999999999999999887654311
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecC
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN----DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG 162 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~----~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFG 162 (506)
.....+++||||+. |+|.++++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 11224789999998 5999988653 468999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
+++........ .......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.. +.
T Consensus 189 ls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~--~~-- 261 (496)
T PTZ00283 189 FSKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA--GR-- 261 (496)
T ss_pred cCeeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CC--
Confidence 99764322111 11234679999999999987 6799999999999999999999999988765554444321 00
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
.....+.+++++.+||.+||+.||.+|||+.+ +|.|
T Consensus 262 --------------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~e------------------ll~~ 297 (496)
T PTZ00283 262 --------------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSK------------------LLNM 297 (496)
T ss_pred --------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHH------------------HHhC
Confidence 00122457899999999999999999999999 7888
Q ss_pred cccCCC
Q 044076 323 PYFHGL 328 (506)
Q Consensus 323 P~f~~~ 328 (506)
||++.+
T Consensus 298 p~~~~~ 303 (496)
T PTZ00283 298 PICKLF 303 (496)
T ss_pred HHHHHh
Confidence 887654
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=356.97 Aligned_cols=250 Identities=27% Similarity=0.445 Sum_probs=203.9
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHH-HHHhCCCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIK-LLRMLKHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~-iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
++||+|+||.||+|++..+++.||||++.... ........+.+|+. +++.++||||+++++++.. .+.+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence 47999999999999999999999999986421 12233445556655 5788999999999998843 47899999
Q ss_pred ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||+++ +|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 99985 8998888888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~---------------- 211 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH---K---------------- 211 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc---C----------------
Confidence 244678999999999977 6789999999999999999999999988765444433311 0
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh----hhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE----EIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~----eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.. ...+..+.++.+||.+||+.||.+|+++. + ++.||||..+
T Consensus 212 ---------~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~------------------~~~~~~~~~~ 257 (321)
T cd05603 212 ---------PL---QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLE------------------IKNHVFFSPI 257 (321)
T ss_pred ---------CC---CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHH------------------HhCCCCcCCC
Confidence 00 11245788999999999999999999875 5 8999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=346.25 Aligned_cols=282 Identities=46% Similarity=0.754 Sum_probs=236.4
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
|++.+.||.|++|.||+|.+..+++.+++|.++...........+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence 678899999999999999999999999999987544444456678899999999999999999998844 378999
Q ss_pred EEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCc
Q 044076 96 VFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174 (506)
Q Consensus 96 V~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~ 174 (506)
|+||++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 9999999999988764 579999999999999999999999999999999999999999999999999997643322
Q ss_pred ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 175 ~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
.......++.+|+|||.+.+. ..++.++|+|||||++|+|++|+++|++.+..+++..+...+|.+..+.+..+... .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-A 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-h
Confidence 122445688999999998762 47899999999999999999999999999999999999999999888777665431 1
Q ss_pred HHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.......+...........++++.++.+||.+||+.||.+||++.+ ++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~------------------ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ------------------ALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH------------------HhhCCCC
Confidence 1111222333333334455678999999999999999999999999 8999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=356.86 Aligned_cols=295 Identities=38% Similarity=0.560 Sum_probs=236.0
Q ss_pred cCCCCCEEEe-EEEeecCceEEEEEEECCCCcEEEEEEecccccChh------------HHHHHHHHHHHHHhCCCCCcc
Q 044076 10 YGEASQYEIQ-EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVS------------DATRILREIKLLRMLKHPDIV 76 (506)
Q Consensus 10 ~~~~~rY~i~-~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~------------~~~~~~rEi~iL~~l~HpnIv 76 (506)
+...+||..+ +.||.|+||+||+|.+..+++.||||+++....... ....+.+|+.+++.++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 4667899764 779999999999999999999999999864322110 012467999999999999999
Q ss_pred eeceeecCCCcCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCE
Q 044076 77 EIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKL 156 (506)
Q Consensus 77 ~l~~v~~~~~~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~l 156 (506)
++++++.. .+..|+||||+.++|.+++.....+++..+..++.||+.||+|||+.||+||||+|+||+++.++.+
T Consensus 84 ~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYVE-----GDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEec-----CCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 99999843 3789999999999999999888889999999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCC-----------CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Q 044076 157 KICDFGLARVSFTDT-----------PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR 225 (506)
Q Consensus 157 KL~DFGla~~~~~~~-----------~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~ 225 (506)
||+|||+++...... ..........++..|+|||.+.+. ..++.++|+|||||++|+|++|++||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999997543111 001112334578899999998762 45789999999999999999999999999
Q ss_pred CchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhh
Q 044076 226 NVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305 (506)
Q Consensus 226 ~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~ 305 (506)
+..+++..+...++.|....|....... .+. ......+..+...++..+..+.+||.+||+.||.+|||++|
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~----- 309 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLP--LYT-EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE----- 309 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcc--ccc-ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH-----
Confidence 9999999999999998876655432110 000 00011112223345667899999999999999999999999
Q ss_pred hhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 306 IVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 306 ~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
+|.||||++....
T Consensus 310 -------------~l~~~~~~~~~~~ 322 (335)
T PTZ00024 310 -------------ALKHEYFKSDPLP 322 (335)
T ss_pred -------------HhcCcccCCCCCC
Confidence 8999999976543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=357.84 Aligned_cols=283 Identities=22% Similarity=0.349 Sum_probs=215.8
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+++++.++||||+++++++.. .+.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCE
Confidence 578999999999999999999999999999999886432 23345678899999999999999999999854 378
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999997 59999999888899999999999999999999975 7999999999999999999999999999753222
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHH-hhcCCCChHHHhh-
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVT-DLLGTPSAESIAG- 248 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~-~~~g~p~~e~~~~- 248 (506)
. .....+|..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+....+. ...|.+.......
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 134568999999999987 678999999999999999999999998765433322221 1111111110000
Q ss_pred hhh---------------hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHH
Q 044076 249 IRN---------------EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFL 313 (506)
Q Consensus 249 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~ 313 (506)
... .................+ .....++++.+||.+||++||.+|||+.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~e------------- 295 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQ------------- 295 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHH-------------
Confidence 000 000000000101100000 01236788999999999999999999999
Q ss_pred HhhhhhccCcccCCC
Q 044076 314 YFYVLALADPYFHGL 328 (506)
Q Consensus 314 ~~~~~aL~HP~f~~~ 328 (506)
+|.||||+..
T Consensus 296 -----ll~h~~~~~~ 305 (333)
T cd06650 296 -----LMVHAFIKRS 305 (333)
T ss_pred -----HhhCHHHhcC
Confidence 8999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=362.92 Aligned_cols=259 Identities=26% Similarity=0.327 Sum_probs=204.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||.||+|.+..+++.||||++... ........+.+|+.+++.++|+||+++++++. ..+.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVNHPNVVKCHDMFD-----HNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC-CcHHHHHHHHHHHHHHHhCCCCCcceeeeEec-----cCCe
Confidence 46788999999999999999999999999999998542 22334567889999999999999999999984 3478
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||+++ +|.. .....+..+..+++||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999999985 6643 2346788889999999999999999999999999999999999999999999997643221
Q ss_pred CCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
. .....+||..|+|||++... ...++.++|||||||++|+|++|+.||......+....+...
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----------- 288 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----------- 288 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-----------
Confidence 1 12345799999999987431 123456899999999999999999999743322211111100
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.... .....+.+++++.+||.+||+.||.+|||+.| +|+||||.+-
T Consensus 289 -------------~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e------------------ll~hp~~~~~ 334 (353)
T PLN00034 289 -------------CMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQ------------------LLQHPFILRA 334 (353)
T ss_pred -------------hccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHH------------------HhcCcccccC
Confidence 0000 01122457899999999999999999999999 8999999875
Q ss_pred C
Q 044076 329 A 329 (506)
Q Consensus 329 ~ 329 (506)
.
T Consensus 335 ~ 335 (353)
T PLN00034 335 Q 335 (353)
T ss_pred C
Confidence 3
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=360.85 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=202.5
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhC---CCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRML---KHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l---~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
||+|+||+||+|.+..+++.||||++... ...........+|..++..+ .||||+++++++.. ...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence 69999999999999999999999998532 11223344556677777665 69999999998843 47899999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||+. ++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9997 59999998888999999999999999999999999999999999999999999999999999975322221 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+||..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....|.. +.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~--~~---------------- 213 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF--GK---------------- 213 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--CC----------------
Confidence 2456799999999998652 4588999999999999999999999988765544444321 00
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC----CHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP----SAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
...+ ...+++++.+||.+||+.||.+|| ++++ ++.||||...
T Consensus 214 --------~~~~----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~------------------ll~h~~~~~~ 259 (330)
T cd05586 214 --------VRFP----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVE------------------LKEHPFFADI 259 (330)
T ss_pred --------CCCC----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHH------------------HhcCccccCC
Confidence 0000 123688999999999999999998 6788 8999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.50 Aligned_cols=264 Identities=23% Similarity=0.381 Sum_probs=212.7
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||.||++.+..+++.||+|++... .........+.+|+.+++.+.|+||+.+++++. +.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 5799999999999999999999999999999998642 122233455778999999999999999999884 3478
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999997 599999987 467999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ......||+.|+|||++.+. ...++.++||||+||++|+|++|+.||.+.+..+.+..|....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (331)
T cd05624 156 GTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE--------- 224 (331)
T ss_pred Cce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC---------
Confidence 211 11235699999999998641 1357889999999999999999999998877655554442211
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD--RPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...++...+.++++++.+||.+||..++++ |+++++ ++.||||
T Consensus 225 -----------------~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~------------------~~~h~~f 269 (331)
T cd05624 225 -----------------ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIED------------------FKKHAFF 269 (331)
T ss_pred -----------------CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHH------------------HhcCCCc
Confidence 111222334567899999999999976654 568999 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
.++
T Consensus 270 ~~~ 272 (331)
T cd05624 270 EGI 272 (331)
T ss_pred CCC
Confidence 863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=345.54 Aligned_cols=281 Identities=43% Similarity=0.718 Sum_probs=237.1
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++.. .+..|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence 678899999999999999999999999999997544334445667899999999999999999998843 378999
Q ss_pred EEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCc
Q 044076 96 VFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174 (506)
Q Consensus 96 V~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~ 174 (506)
|+||++++|.+++... ..+++..+..++.||+.||+|||+.||+||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999976432211
Q ss_pred ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 175 ~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
......++.+|+|||.+.+. ..++.++|||||||++++|++|++||.+.+..+.+..+...++.+....|..+.+..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334567889999998762 478899999999999999999999999999999999999999999988877654432
Q ss_pred HHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.+...++..........++..+..+.++|.+||..||.+|||+++ ++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~------------------~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE------------------ALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH------------------HhhCcCC
Confidence 112222333333444556778999999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.34 Aligned_cols=286 Identities=25% Similarity=0.392 Sum_probs=221.7
Q ss_pred EEE-eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCcE
Q 044076 16 YEI-QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 16 Y~i-~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
|++ .+.||+|+|+.|--|....+|..||||+|.+. ......++.||+.++.+.+ |+||+.|+++| +++..+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceE
Confidence 444 47899999999999999999999999999764 3446778999999999997 99999999999 666899
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC---CCEEEeecCCcccccC
Q 044076 94 YVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD---CKLKICDFGLARVSFT 169 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~---~~lKL~DFGla~~~~~ 169 (506)
|||||-|. |.|...|..+..+++.++..++..|+.||+|||.+||.||||||+|||.... +.+|||||.++.....
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999997 5999999999999999999999999999999999999999999999998654 4589999999854222
Q ss_pred CC----CCcccccccccCCcccCcccc---cccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 170 DT----PSAIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 170 ~~----~~~~~~~~~vgt~~Y~APE~l---~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
.. .....+...+|+..|||||+. .+....|++..|.||||+|+|.||+|++||.|....+--.. -|.+-
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd----rGe~C 307 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD----RGEVC 307 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc----CCCcc
Confidence 21 122334567899999999985 33346799999999999999999999999988653220000 00000
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
.. . -...+.++...+-.--.+.|..+|.+++|||+.+|..|+..|.++.+ .++|
T Consensus 308 r~----C----Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~------------------vlnh 361 (463)
T KOG0607|consen 308 RV----C----QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQ------------------VLNH 361 (463)
T ss_pred HH----H----HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhh------------------ccCC
Confidence 00 0 01112222221111112344568999999999999999999999999 8999
Q ss_pred cccCCCCCCCCCCCCC
Q 044076 323 PYFHGLANLEEEPSRK 338 (506)
Q Consensus 323 P~f~~~~~~~~~~~~~ 338 (506)
||++........|...
T Consensus 362 Pw~~~~~~ekalptp~ 377 (463)
T KOG0607|consen 362 PWVQRCAPEKALPTPQ 377 (463)
T ss_pred ccccccchhccCCCCc
Confidence 9999877654444443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=358.27 Aligned_cols=251 Identities=30% Similarity=0.420 Sum_probs=206.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcE-EEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEK-VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~-vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.....+.+.||.|+||+||+|.. .|.. ||||++.....+......+.+|+.+|.+++|||||++++++..+ ..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~ 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PG 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CC
Confidence 44556667799999999999965 4556 99999976444444477899999999999999999999998544 12
Q ss_pred cEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCCCcEEECCCC-CEEEeecCCccc
Q 044076 92 DIYVVFELME-SDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSAN-VFHRDLKPKNILANADC-KLKICDFGLARV 166 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~g-IvHrDLKp~NILv~~~~-~lKL~DFGla~~ 166 (506)
.++||||||+ |+|.+++.. ...++...+..++.||++||.|||+++ ||||||||+|||++.++ .+||||||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 6899999998 699999987 578999999999999999999999999 99999999999999998 999999999987
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
..... ...+...||..|||||++.+....|+.++||||+|+++|||++|+.||.+.........+....-+|.
T Consensus 194 ~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~---- 266 (362)
T KOG0192|consen 194 KVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP---- 266 (362)
T ss_pred ecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence 43321 12345679999999999984116899999999999999999999999998887444333322211111
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+ ...++.+..|+.+||..||.+||+..+|
T Consensus 267 --------------------~p-----~~~~~~l~~l~~~CW~~dp~~RP~f~ei 296 (362)
T KOG0192|consen 267 --------------------IP-----KECPPHLSSLMERCWLVDPSRRPSFLEI 296 (362)
T ss_pred --------------------CC-----ccCCHHHHHHHHHhCCCCCCcCCCHHHH
Confidence 11 1278899999999999999999999996
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=363.24 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=220.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
....|..++.||+|+||.||+|.|..+++.||||++.- .....+...+.+|+.+|..++++||.+.++.|+.. .
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~L-e~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~ 84 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDL-EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----T 84 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEech-hhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----c
Confidence 35678899999999999999999999999999999963 23445667799999999999999999999998765 7
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.++++||||. |++.++++....+.+.++..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+......
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 7999999998 599999998888899999999999999999999999999999999999999999999999999764333
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. ...+++||+.|||||++.+ ..|+.++||||||++.+||.+|.||+........+..|
T Consensus 165 ~~---rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------------- 223 (467)
T KOG0201|consen 165 VK---RRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------------- 223 (467)
T ss_pred hh---ccccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------
Confidence 22 2257899999999999997 89999999999999999999999999776654333333
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
++..+-.+. ...++.+++|+..||..||+.||||.+ +|+|+|++.
T Consensus 224 -----------pk~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~------------------LLKh~FIk~ 268 (467)
T KOG0201|consen 224 -----------PKSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKE------------------LLKHKFIKR 268 (467)
T ss_pred -----------cCCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHH------------------HhhhHHHHh
Confidence 222222222 257899999999999999999999999 899999986
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.28 Aligned_cols=258 Identities=22% Similarity=0.381 Sum_probs=204.8
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||.||+|.+..+++.||+|+++... ........+.+|+.++..+ .||||+.+++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 47999999999999999999999999996532 2334456688999999888 49999999998843 47899999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||++ ++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9997 59999998888899999999999999999999999999999999999999999999999999974222111 1
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~---------~~~~----------- 210 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN---------TEDY----------- 210 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc---------cHHH-----------
Confidence 234679999999999987 788999999999999999999999996433211000 0000
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------hhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA------EEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa------~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
....... .+.. ....+++.+.+||.+||+.||.+|+++ ++ ++.||||..+.
T Consensus 211 ~~~~~~~-~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~------------------i~~h~~f~~~~ 267 (327)
T cd05617 211 LFQVILE-KPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSD------------------IKSHTFFRSID 267 (327)
T ss_pred HHHHHHh-CCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHH------------------HHcCCCCCCCC
Confidence 0000000 0111 113478999999999999999999986 46 89999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=345.41 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=207.5
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
.|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++|+||+.+++.+.. .+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence 4889999999999999999999999999999985422 222334557789999999999999999988743 3689
Q ss_pred EEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 94 YVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999997 5898888653 35899999999999999999999999999999999999999999999999999753222
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. .....|+..|+|||++.+ ..++.++||||+||++|+|++|++||.+...........
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~--------------- 214 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------------- 214 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---------------
Confidence 11 133468999999999987 679999999999999999999999997643221111110
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
........ .....+++++.+||.+||+.||.+||| ++| +++||||
T Consensus 215 -----~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~------------------~~~h~~~ 264 (285)
T cd05630 215 -----RLVKEVQE-------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGARE------------------VKEHPLF 264 (285)
T ss_pred -----hhhhhhhh-------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHH------------------HHcChhh
Confidence 00000000 112357889999999999999999999 889 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
.++
T Consensus 265 ~~~ 267 (285)
T cd05630 265 KQI 267 (285)
T ss_pred hcc
Confidence 874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=347.19 Aligned_cols=292 Identities=36% Similarity=0.600 Sum_probs=231.8
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC-----
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC----- 86 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~----- 86 (506)
..++|++.+.||.|+||.||+|.+..+|+.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 357899999999999999999999999999999999643333333455778999999999999999999886542
Q ss_pred cCCCCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 87 RREFKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
..+...+|+|+||++++|...+... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 1123479999999999998888764 369999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
........ ......++..|+|||.+.+. ..++.++||||+||++++|++|++||...+..+.+..+....|.+....
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 165 LYNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred cccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 64332211 11233467889999988652 4578899999999999999999999999999999999999999888776
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
++.+............ ..........+..+++.+.+||.+||+.||.+|||+.+ ++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~------------------il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPK-KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE------------------ALNSPWL 302 (302)
T ss_pred cccccccccccccccc-cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH------------------HhcCCCC
Confidence 6544321110000000 00011122334557899999999999999999999999 8999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=342.23 Aligned_cols=283 Identities=41% Similarity=0.682 Sum_probs=230.4
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
|++.+.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.+.||||+++++++... ..+..|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 7899999999999999999999999999999975433344456688999999999999999999998432 1368999
Q ss_pred EEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCc
Q 044076 96 VFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174 (506)
Q Consensus 96 V~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~ 174 (506)
|+||++++|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999998765 5799999999999999999999999999999999999999999999999999976433221
Q ss_pred ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 175 ~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
...+...++..|+|||.+.+. ..++.++|||||||++++|++|++||.+.+....+..+....+.+....+..+....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP- 233 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch-
Confidence 112344678899999987652 568899999999999999999999999999989999999999988877765543221
Q ss_pred HHHHhhhhccC--CCCCCCCCCCC-CHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 255 KRYLSSLRRKW--AVPFSHKFPGA-DPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 255 ~~~~~~~~~~~--~~~~~~~~~~~-s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
+........ ...+...+... ++.+.++|.+||+.||.+|||+.+ ++.||||
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~------------------~l~~~~~ 287 (287)
T cd07840 234 --WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ------------------ALQHEYF 287 (287)
T ss_pred --hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH------------------HhhCcCC
Confidence 011111100 01111233343 889999999999999999999999 8999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.15 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=209.9
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
.|++++.||+|++|.||++.+..+++.||+|++............+.+|+.+++.++|+||+++++.+.. ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 5999999999999999999999999999999996533344455678899999999999999999887632 234689
Q ss_pred EEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 95 VVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+||||++ ++|.+.+... ..+++..++.++.||+.||.+||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999997 5899988763 458999999999999999999999999999999999999999999999999997643221
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......++..|+|||++.+ ..++.++|+||+||++++|++|+.||.+.+.......+.. |..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--~~~---------- 219 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--GKL---------- 219 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cCC----------
Confidence 1 1234568899999999987 6788999999999999999999999987664443333211 000
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...-...++.+.+||.+||+.||.+|||+.+ ++.||||
T Consensus 220 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------~l~~~~~ 257 (257)
T cd08223 220 ------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKS------------------ILRQPYI 257 (257)
T ss_pred ------------------CCCccccCHHHHHHHHHHhccCcccCCCHHH------------------HhcCCCC
Confidence 0111347889999999999999999999999 8999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=368.35 Aligned_cols=257 Identities=25% Similarity=0.322 Sum_probs=211.3
Q ss_pred CCEEEeEEEeecCceEEEEEEECCC-CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHT-GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t-~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
..|.+.+.||+|++|.||+|.+..+ ++.||+|++.. ........+.+|+.+|+.++||||+++++++.. .+.
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCE
Confidence 3499999999999999999998888 78899997742 334445667889999999999999999999843 478
Q ss_pred EEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 93 IYVVFELME-SDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
+||||||++ ++|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999997 599887753 346899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.. |..
T Consensus 220 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~--~~~------ 288 (478)
T PTZ00267 220 SDSVS-LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY--GKY------ 288 (478)
T ss_pred CCccc-cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCC------
Confidence 32211 111245679999999999987 6899999999999999999999999987766555444422 110
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
. .....+++++.+||.+||..||.+|||+.+ +|.|||++.
T Consensus 289 -------------------~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~------------------~l~~~~~~~ 328 (478)
T PTZ00267 289 -------------------D---PFPCPVSSGMKALLDPLLSKNPALRPTTQQ------------------LLHTEFLKY 328 (478)
T ss_pred -------------------C---CCCccCCHHHHHHHHHHhccChhhCcCHHH------------------HHhCHHHHH
Confidence 0 011247889999999999999999999999 778888765
Q ss_pred C
Q 044076 328 L 328 (506)
Q Consensus 328 ~ 328 (506)
+
T Consensus 329 ~ 329 (478)
T PTZ00267 329 V 329 (478)
T ss_pred H
Confidence 3
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=339.53 Aligned_cols=282 Identities=40% Similarity=0.630 Sum_probs=226.3
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC---CCCCcceeceeecCCCcCCCCc
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML---KHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l---~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
|++++.||.|+||.||+|.+..+++.||||+++...........+.+|+.+++++ .||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999998999999999974333333344566788887766 5999999999986553222335
Q ss_pred EEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||+.++|.+++.... .+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999999999887643 5899999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. .....++..|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+..+.+..+....+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 133457889999999987 678899999999999999999999999999999898888877776554443221
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..... ..+...........+.+++.+.+||.+||+.||.+|||+.| ++.||||
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~------------------il~~~~~ 287 (287)
T cd07838 235 SLPRS----SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE------------------ALQHPYF 287 (287)
T ss_pred ccchh----hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHH------------------HhcCcCC
Confidence 11000 11122222334445667889999999999999999999999 8999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=341.89 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=200.7
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecC
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 100 (506)
||+|+||.||++.+..+|+.||+|++..... .......+..|+.+++.++||||+++++++. ....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence 6999999999999999999999999854211 2223344567999999999999999999884 347899999999
Q ss_pred C-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccc
Q 044076 101 E-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177 (506)
Q Consensus 101 ~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 177 (506)
. ++|..++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........ .
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----I 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----e
Confidence 7 58988876543 588999999999999999999999999999999999999999999999999975432211 2
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~ 257 (506)
....++..|+|||++.+ ..++.++|+||+||++|+|++|+.||.+.........+.. .
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~-------------------~- 209 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR-------------------R- 209 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH-------------------H-
Confidence 34568999999999987 5699999999999999999999999976432111111100 0
Q ss_pred HhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 258 LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.... ........+++++.+||.+||+.||.+|||+.|+..+ ++.||||+++.
T Consensus 210 --~~~~----~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~--------------~~~h~~f~~~~ 261 (277)
T cd05607 210 --TLED----EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD--------------PRKHEFFKTIN 261 (277)
T ss_pred --hhcc----ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhh--------------hhcChhhcCCC
Confidence 0000 0011123578999999999999999999999552111 78999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=357.90 Aligned_cols=262 Identities=29% Similarity=0.428 Sum_probs=208.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~ 90 (506)
....|+++++||+||.+.||++.. .....||+|++.....+......+.+||.+|.+|+ |.+||+|+|+-+. +
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d 432 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----D 432 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----C
Confidence 356799999999999999999975 34566888888665567777888999999999997 9999999998654 4
Q ss_pred CcEEEEEecCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMESDLDQVIKANDD-LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~~~-ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+.+|||||+-+.||..+|+.... +..-.++++.+|||.|++++|.+||||-||||.|+|+- .|.+||+|||.|.....
T Consensus 433 ~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 433 GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 88999999999999999988654 44458999999999999999999999999999999874 68999999999987655
Q ss_pred CCCCcccccccccCCcccCcccccccCC---------CCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCC
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFS---------KYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~---------~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~ 240 (506)
+... ..-...+||..||+||.+..... +.+.++||||||||||+|+.|++||..-. .++.++..+ -.
T Consensus 512 DTTs-I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI-~~ 587 (677)
T KOG0596|consen 512 DTTS-IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI-TD 587 (677)
T ss_pred cccc-eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh-cC
Confidence 5433 23356789999999999854211 25779999999999999999999994321 122222111 11
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCC--HHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhh
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGAD--PLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVL 318 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~ 318 (506)
|. .. -.||.++ .+++++++.||..||++|||+.|
T Consensus 588 P~----------------------~~----Iefp~~~~~~~li~~mK~CL~rdPkkR~si~e------------------ 623 (677)
T KOG0596|consen 588 PN----------------------HE----IEFPDIPENDELIDVMKCCLARDPKKRWSIPE------------------ 623 (677)
T ss_pred CC----------------------cc----ccccCCCCchHHHHHHHHHHhcCcccCCCcHH------------------
Confidence 11 11 1233332 23999999999999999999999
Q ss_pred hccCcccCCC
Q 044076 319 ALADPYFHGL 328 (506)
Q Consensus 319 aL~HP~f~~~ 328 (506)
+|+|||++..
T Consensus 624 LLqhpFl~~~ 633 (677)
T KOG0596|consen 624 LLQHPFLQIQ 633 (677)
T ss_pred HhcCcccccc
Confidence 8999999863
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.54 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=210.5
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
.|++.+.||.|+||+||+|.+..+++.||+|++... .........+.+|+.+|+.++|+||+.+.+.+.. .+.+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEE
Confidence 488899999999999999999999999999998542 2222334557789999999999999999988843 3689
Q ss_pred EEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 94 YVVFELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
|+||||+.+ +|...+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999985 888877643 36999999999999999999999999999999999999999999999999999653222
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. .....|+..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.........+.......
T Consensus 156 ~~----~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--------- 220 (285)
T cd05632 156 ES----IRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--------- 220 (285)
T ss_pred Cc----ccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc---------
Confidence 11 234568999999999977 678999999999999999999999998766543333331111000
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.....+.+++++.+|+.+||+.||.+||| +.+ ++.||||
T Consensus 221 ------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~------------------l~~~~~~ 264 (285)
T cd05632 221 ------------------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGE------------------VKRHPFF 264 (285)
T ss_pred ------------------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHH------------------HHcChhh
Confidence 00122457889999999999999999999 777 8999999
Q ss_pred CCCC
Q 044076 326 HGLA 329 (506)
Q Consensus 326 ~~~~ 329 (506)
+...
T Consensus 265 ~~~~ 268 (285)
T cd05632 265 RNMN 268 (285)
T ss_pred hcCC
Confidence 9864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.03 Aligned_cols=260 Identities=26% Similarity=0.403 Sum_probs=207.5
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc---ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE---HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 579999999999999999999999999999999864322 223456688999999999999999999987532 23
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+|+||+++ +|.+.+...+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 678999999974 8999998888899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
............++..|+|||.+.+ ..++.++|+||+||++|+|++|++||...........+ ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~---~~~~~------- 226 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI---ATQPT------- 226 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH---hcCCC-------
Confidence 1111111123458889999999877 67899999999999999999999999765433222221 11100
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.. ..-..+++.+.+|| +||..||.+|||++| ++.||||+
T Consensus 227 --------------~~-----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~e------------------il~hp~~~ 265 (266)
T cd06651 227 --------------NP-----QLPSHISEHARDFL-GCIFVEARHRPSAEE------------------LLRHPFAQ 265 (266)
T ss_pred --------------CC-----CCchhcCHHHHHHH-HHhcCChhhCcCHHH------------------HhcCcccc
Confidence 00 01123678889999 577789999999999 89999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=382.03 Aligned_cols=270 Identities=28% Similarity=0.385 Sum_probs=217.2
Q ss_pred cccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 6 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
|.+.-...++|++++.||.|+||+||+|.+..++..||+|++............+.+|+.+|+.|+||||++++++|...
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 44444556899999999999999999999999999999999975444455667789999999999999999999988543
Q ss_pred CcCCCCcEEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CeeecCCCCCcEEECC-
Q 044076 86 CRREFKDIYVVFELME-SDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSA-------NVFHRDLKPKNILANA- 152 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~-~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~-------gIvHrDLKp~NILv~~- 152 (506)
....+||||||++ ++|.++|.. ...+++..++.|+.||+.||.|||+. +||||||||+|||++.
T Consensus 85 ---~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 85 ---ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred ---CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 2357999999998 599998865 35799999999999999999999985 4999999999999964
Q ss_pred ----------------CCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHH
Q 044076 153 ----------------DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 216 (506)
Q Consensus 153 ----------------~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl 216 (506)
.+.+||+|||++........ ....++|+.|+|||++.+....++.++||||||||||+|+
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 23589999999975422211 2345799999999998653356899999999999999999
Q ss_pred hCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 044076 217 TGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP 296 (506)
Q Consensus 217 ~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp 296 (506)
+|..||...+...++..+.. ..+. ..++..++++.+||.+||+.||.+||
T Consensus 238 TGk~PF~~~~~~~qli~~lk--------------------------~~p~----lpi~~~S~eL~dLI~~~L~~dPeeRP 287 (1021)
T PTZ00266 238 SGKTPFHKANNFSQLISELK--------------------------RGPD----LPIKGKSKELNILIKNLLNLSAKERP 287 (1021)
T ss_pred HCCCCCCcCCcHHHHHHHHh--------------------------cCCC----CCcCCCCHHHHHHHHHHhcCChhHCc
Confidence 99999976654433322211 0011 11235688999999999999999999
Q ss_pred CHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 297 SAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 297 Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
|+.| +|.||||..+..
T Consensus 288 Sa~Q------------------lL~h~~ik~i~~ 303 (1021)
T PTZ00266 288 SALQ------------------CLGYQIIKNVGP 303 (1021)
T ss_pred CHHH------------------HhccHHHhhcCC
Confidence 9999 899999986644
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.33 Aligned_cols=280 Identities=41% Similarity=0.694 Sum_probs=228.9
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCcEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
|++.+.||.|++|+||+|.+..+++.||||++...... .......+|+..++.++ ||||+++++++.. .+..|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEE
Confidence 78899999999999999999999999999998654332 22334567999999999 9999999998844 47899
Q ss_pred EEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 95 VVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
+||||++++|.+.+.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999999999998764 789999999999999999999999999999999999999999999999999975433221
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
.....++..|+|||++.+. ..++.++|+|||||++++|++|++||++.+..+++..+...+|.|....+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2456789999999988552 56889999999999999999999999999999999999999999887765442111
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
. ...-..++..........++..++++.+||++||+.||.+|||++| ++.||||
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e------------------i~~~~~~ 283 (283)
T cd07830 230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ------------------ALQHPYF 283 (283)
T ss_pred h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH------------------HhhCCCC
Confidence 0 0000011111122223344566889999999999999999999999 8999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=331.00 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=211.2
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
.|.+.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++.+.. .+..|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence 4889999999999999999999999999999986433345566778899999999999999999998843 37899
Q ss_pred EEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 95 VVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999997 5999999774 578999999999999999999999999999999999999999999999999997643321
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......++.+|+|||++.+ ..++.++|+|||||++++|++|+.||...+.......+.....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 218 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------ 218 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 1 1234568899999999987 6788999999999999999999999987765443333321100
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
......+++.+.++|.+||+.||++||++.+ ++.|||+
T Consensus 219 ------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~------------------ll~~~~~ 256 (256)
T cd08529 219 ------------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQ------------------LLRNPSL 256 (256)
T ss_pred ------------------CCCccccCHHHHHHHHHHccCCcccCcCHHH------------------HhhCCCC
Confidence 0111146788999999999999999999999 7999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=349.96 Aligned_cols=287 Identities=22% Similarity=0.274 Sum_probs=208.3
Q ss_pred EeEEEeec--CceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 18 IQEIIGIG--SYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 18 i~~~LG~G--~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
++++||+| +|++||++.+..+|+.||||+++...........+.+|+.+++.++||||+++++++.. .+..|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence 57889999 78899999999999999999996543334445667889999999999999999999854 378999
Q ss_pred EEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 96 VFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 96 V~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999998 5899998653 4589999999999999999999999999999999999999999999999987643221111
Q ss_pred Cc----ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChH-HHh
Q 044076 173 SA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE-SIA 247 (506)
Q Consensus 173 ~~----~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e-~~~ 247 (506)
.. .......++..|+|||++.+....|+.++||||+||++|+|++|+.||.+........... .+..+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCcccccccc
Confidence 00 0112235677899999987532468999999999999999999999998765443332221 1211100 000
Q ss_pred hhhhhHHHH----------HHhhh------hccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHH
Q 044076 248 GIRNEKAKR----------YLSSL------RRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWL 311 (506)
Q Consensus 248 ~~~~~~~~~----------~~~~~------~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~ 311 (506)
.+....... +.... +.............+++.+.+||.+||++||.+|||++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e----------- 303 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAST----------- 303 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHH-----------
Confidence 000000000 00000 000000001122346789999999999999999999999
Q ss_pred HHHhhhhhccCcccCCCC
Q 044076 312 FLYFYVLALADPYFHGLA 329 (506)
Q Consensus 312 ~~~~~~~aL~HP~f~~~~ 329 (506)
+|+||||+.+.
T Consensus 304 -------ll~~p~f~~~~ 314 (327)
T cd08227 304 -------LLNHSFFKQIK 314 (327)
T ss_pred -------HhcChhhhhcc
Confidence 89999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=342.06 Aligned_cols=284 Identities=25% Similarity=0.371 Sum_probs=214.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++.. .+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEE
Confidence 47999999999999999999999999999999986422 23345568899999999999999999999844 4789
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
|+||||+++ +|.++++..+.+++..+..++.||+.||.|||+ .|++||||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999985 999999888889999999999999999999997 699999999999999999999999999986532221
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH-----
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI----- 246 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~----- 246 (506)
....+++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+............
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 134578999999999876 67889999999999999999999999876633322222111000000000
Q ss_pred ----hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 247 ----AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 247 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
.................... + ......+++++.+||.+||..||.+|||+.| ++.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~------------------ll~~ 287 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPP-P-KLPSGAFSDEFQDFVDKCLKKNPKERADLKE------------------LTKH 287 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCC-c-cCcCcccCHHHHHHHHHHccCChhhCcCHHH------------------HhcC
Confidence 00000000000111100000 0 0011236889999999999999999999999 8999
Q ss_pred cccCCCCC
Q 044076 323 PYFHGLAN 330 (506)
Q Consensus 323 P~f~~~~~ 330 (506)
|||.....
T Consensus 288 ~~~~~~~~ 295 (308)
T cd06615 288 PFIKRAEL 295 (308)
T ss_pred hhhhhccc
Confidence 99987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=339.20 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=214.3
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+.||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence 47999999999999999999999999999999986421 223445678899999999999999999999843 478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||+|.||+++.++.+||+|||+++.....
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999995 699999998889999999999999999999999999999999999999999999999999999764332
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+.. +.+
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~---------- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKV---------- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCc----------
Confidence 133468899999999876 5788999999999999999999999987664433333321 100
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
..-+..++.+.++|.+||+.||.+|+ +++| ++.||||.
T Consensus 216 -------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~------------------l~~~~~~~ 258 (290)
T cd05580 216 -------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVND------------------IKNHPWFA 258 (290)
T ss_pred -------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHH------------------HHcCcccc
Confidence 01124688999999999999999999 8999 89999998
Q ss_pred CCC
Q 044076 327 GLA 329 (506)
Q Consensus 327 ~~~ 329 (506)
.+.
T Consensus 259 ~~~ 261 (290)
T cd05580 259 GID 261 (290)
T ss_pred cCC
Confidence 754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=349.16 Aligned_cols=252 Identities=26% Similarity=0.448 Sum_probs=198.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEE-----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d-----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ........+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 46899999999999999999975 245578999998642 2233456788999999999 799999999987432
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhC------------------------------------------------------
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAN------------------------------------------------------ 111 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~------------------------------------------------------ 111 (506)
...+|+||||++ |+|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 356899999998 5999988753
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccC
Q 044076 112 --------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT 183 (506)
Q Consensus 112 --------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt 183 (506)
..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........ .......++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCC
Confidence 24778889999999999999999999999999999999999999999999999754322111 111223456
Q ss_pred CcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhh
Q 044076 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLR 262 (506)
Q Consensus 184 ~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~ 262 (506)
..|+|||++.+ ..++.++|||||||++|||++ |.+||++....+.+.....
T Consensus 240 ~~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-------------------------- 291 (338)
T cd05102 240 LKWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK-------------------------- 291 (338)
T ss_pred ccccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh--------------------------
Confidence 78999999977 678999999999999999997 9999987654332221110
Q ss_pred ccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 263 RKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 263 ~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..... ......++++.+||.+||+.||.+|||+.||
T Consensus 292 ~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~el 327 (338)
T cd05102 292 DGTRM---RAPENATPEIYRIMLACWQGDPKERPTFSAL 327 (338)
T ss_pred cCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00000 1113578899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=338.01 Aligned_cols=266 Identities=25% Similarity=0.394 Sum_probs=213.6
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.....+.|++++.||.|+||.||+|.+..++..||+|.+.. ........+.+|+.+++.++||||+++++.+..
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGAFYW---- 80 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe----
Confidence 34556889999999999999999999999999999999864 234456678899999999999999999998843
Q ss_pred CCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
....|+||||+++ +|..++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 81 -~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 81 -DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred -CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 3689999999985 77777654 45689999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
...... ......++..|+|||++.+. ...++.++|+|||||++|+|++|.+||.+.+.......+... .+
T Consensus 160 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~-- 232 (292)
T cd06644 160 NVKTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EP-- 232 (292)
T ss_pred cccccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CC--
Confidence 322111 12345688899999998531 245788999999999999999999999765543322222110 00
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
+.......++.++.+||.+||..||.+|||+++ ++.||
T Consensus 233 ------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------il~~~ 270 (292)
T cd06644 233 ------------------------PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQ------------------LLEHP 270 (292)
T ss_pred ------------------------ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHH------------------HhcCc
Confidence 000112357788999999999999999999999 89999
Q ss_pred ccCCCCC
Q 044076 324 YFHGLAN 330 (506)
Q Consensus 324 ~f~~~~~ 330 (506)
||..+..
T Consensus 271 ~~~~~~~ 277 (292)
T cd06644 271 FVSSVTS 277 (292)
T ss_pred ccccccc
Confidence 9987654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=340.42 Aligned_cols=263 Identities=26% Similarity=0.422 Sum_probs=215.3
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++.+.||.|+||.||+|.+..+++.||||.+..... .......+.+|+.+++.+.||||+++++.+. +...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 479999999999999999999999999999999964322 2235667889999999999999999999884 3478
Q ss_pred EEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999975 999998764 4699999999999999999999999999999999999999999999999999865322
Q ss_pred CCCC--------------------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCC
Q 044076 170 DTPS--------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFP 223 (506)
Q Consensus 170 ~~~~--------------------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~ 223 (506)
.... .......+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 1110 001123578899999999987 678999999999999999999999998
Q ss_pred CCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC----Hh
Q 044076 224 GRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS----AE 299 (506)
Q Consensus 224 ~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT----a~ 299 (506)
+.+....+..+... .. .+ .....+++.+.+||.+||..||.+||| ++
T Consensus 234 ~~~~~~~~~~~~~~--------------------------~~--~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILKK--------------------------EV--TF-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhcC--------------------------Cc--cC-CCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 87765544433210 00 00 011226889999999999999999999 99
Q ss_pred hhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 300 EIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 300 eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
| +|.||||++...
T Consensus 285 ~------------------ll~~~~~~~~~~ 297 (316)
T cd05574 285 E------------------IKQHPFFRGVNW 297 (316)
T ss_pred H------------------HHcCchhhcCCh
Confidence 9 899999998654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=354.11 Aligned_cols=283 Identities=30% Similarity=0.503 Sum_probs=230.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCC------CCcceeceeecCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH------PDIVEIKHIMLPP 85 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~H------pnIv~l~~v~~~~ 85 (506)
..++|.+....|+|-||+|..|.|...|..||||+|.+ ++.-.+.-++|+.||++|+. -++++|+..|...
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 35799999999999999999999999999999999964 33344556789999999952 3688888777554
Q ss_pred CcCCCCcEEEEEecCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-CCEEEeec
Q 044076 86 CRREFKDIYVVFELMESDLDQVIKAND---DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDF 161 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~~L~~~i~~~~---~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~-~~lKL~DF 161 (506)
.++|||||.+.-+|.++++.-+ .|....++.+++||+-||+.|-.+||+|.||||+|||||+. ..+|||||
T Consensus 507 -----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 507 -----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred -----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 8999999999999999998754 58899999999999999999999999999999999999975 56899999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
|.|....... .+.|..++.|+|||+++| ..|++.+|+||+||+||||.+|+.+|||..+.++|...+++-|..
T Consensus 582 GSA~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 582 GSASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred cccccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 9997543322 478899999999999999 799999999999999999999999999999999999999999999
Q ss_pred ChHHHhhh--hhhHHHH---H-------------HhhhhccCC-CCCCCC------CCCC----CHHHHHHHHHhhhcCC
Q 044076 242 SAESIAGI--RNEKAKR---Y-------------LSSLRRKWA-VPFSHK------FPGA----DPLALRLLQRLLAFDP 292 (506)
Q Consensus 242 ~~e~~~~~--~~~~~~~---~-------------~~~~~~~~~-~~~~~~------~~~~----s~~~~dLI~~mL~~DP 292 (506)
+..++.+- ....+.. | ..-+....+ .++... +|.- -..+.|||.+||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 88876542 1111100 0 000111111 111111 1211 1357899999999999
Q ss_pred CCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 293 KDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 293 ~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.+|+|+.+ ||.||||++
T Consensus 735 ~KRit~nq------------------AL~HpFi~~ 751 (752)
T KOG0670|consen 735 EKRITVNQ------------------ALKHPFITE 751 (752)
T ss_pred hhcCCHHH------------------HhcCCcccC
Confidence 99999999 999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.57 Aligned_cols=287 Identities=28% Similarity=0.448 Sum_probs=223.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-----C---CCcceeceeecC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-----H---PDIVEIKHIMLP 84 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-----H---pnIv~l~~v~~~ 84 (506)
.+||.++++||.|-|++||+|.|..+.+.||+|+++.. ....+..+.||++|+.++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 48999999999999999999999999999999999742 334455778999999984 2 259999999987
Q ss_pred CCcCCCCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCC--------
Q 044076 85 PCRREFKDIYVVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANAD-------- 153 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~-------- 153 (506)
... +..++|||+|+++.+|..+|+... .++...++.|++|||.||.|||. +||||.||||+|||+..+
T Consensus 154 sGp-NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 154 SGP-NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred cCC-CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 643 458999999999999999998753 69999999999999999999995 699999999999995322
Q ss_pred ---C----------------------------------------------------------------------------
Q 044076 154 ---C---------------------------------------------------------------------------- 154 (506)
Q Consensus 154 ---~---------------------------------------------------------------------------- 154 (506)
+
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence 0
Q ss_pred -------------------------------------------------------------------------------C
Q 044076 155 -------------------------------------------------------------------------------K 155 (506)
Q Consensus 155 -------------------------------------------------------------------------------~ 155 (506)
+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 0
Q ss_pred EEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC------chh
Q 044076 156 LKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN------VAH 229 (506)
Q Consensus 156 lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~------~~~ 229 (506)
+||+|||.|.... ..+|.-+.|+.|||||++++ ..|++.+||||++|+++||.||..+|...+ +.+
T Consensus 393 vKIaDlGNACW~~------khFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 393 VKIADLGNACWVH------KHFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred EEEeeccchhhhh------hhhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 2333333332110 11345578999999999999 899999999999999999999999996543 678
Q ss_pred hHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCC---------CC----CHHHHHHHHHhhhcCCCCCC
Q 044076 230 QLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP---------GA----DPLALRLLQRLLAFDPKDRP 296 (506)
Q Consensus 230 ~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~----s~~~~dLI~~mL~~DP~~Rp 296 (506)
.+..|+.++|.-+......- ..-++|+..-..-..+.--+.|| .. ..++.|||.-||+++|++||
T Consensus 465 HiA~i~ELLG~iPr~ia~~G--k~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~ 542 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGG--KYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP 542 (590)
T ss_pred HHHHHHHHHhhccHHHHhcC--cchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence 99999999998877665332 22245544332221111111121 12 34678999999999999999
Q ss_pred CHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 297 SAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 297 Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
||.+ +|+|||+..+..+
T Consensus 543 tA~~------------------cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 543 TAAQ------------------CLKHPWLNPVAGP 559 (590)
T ss_pred cHHH------------------HhcCccccCCCCC
Confidence 9999 9999999988765
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=331.81 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=208.6
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh-------hHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV-------SDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~-------~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
+|.+.+.||.|++|.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 5788999999999999999999999999999886432211 123567899999999999999999998743
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 REFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
....++||||+++ +|.+++...+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.+||+|||.++.
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 3788999999975 9999998888899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCc---ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 167 SFTDTPSA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 167 ~~~~~~~~---~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
........ .......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN------ 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc------
Confidence 43221110 11123457889999999877 67889999999999999999999999775543322222110
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
.........+..+.+||.+||+.||.+|||+.| +++||
T Consensus 228 ------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------il~~~ 265 (267)
T cd06628 228 ------------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAE------------------LLKHP 265 (267)
T ss_pred ------------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHH------------------HhhCC
Confidence 000111347889999999999999999999999 89999
Q ss_pred cc
Q 044076 324 YF 325 (506)
Q Consensus 324 ~f 325 (506)
||
T Consensus 266 ~~ 267 (267)
T cd06628 266 FL 267 (267)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=366.97 Aligned_cols=287 Identities=25% Similarity=0.307 Sum_probs=207.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCC-cEEEEEE--------------e-cccccChhHHHHHHHHHHHHHhCCCCCcc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTG-EKVAIKK--------------M-KEVFEHVSDATRILREIKLLRMLKHPDIV 76 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~-~~vAIK~--------------i-~~~~~~~~~~~~~~rEi~iL~~l~HpnIv 76 (506)
.++|++++.||+|+||.||+|..+... ..+++|. + +...........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998764332 2222221 1 11111223455678999999999999999
Q ss_pred eeceeecCCCcCCCCcEEEEEecCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC
Q 044076 77 EIKHIMLPPCRREFKDIYVVFELMESDLDQVIKAND-----DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151 (506)
Q Consensus 77 ~l~~v~~~~~~~~~~~~ylV~E~~~~~L~~~i~~~~-----~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~ 151 (506)
++++++.. .+..|+|++++.++|..++.... ......++.++.||+.||+|||++||+||||||+|||++
T Consensus 227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 99999843 36789999999999988876432 244667889999999999999999999999999999999
Q ss_pred CCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCC-CCC--CCch
Q 044076 152 ADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPL-FPG--RNVA 228 (506)
Q Consensus 152 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~p-F~~--~~~~ 228 (506)
.++.+||+|||+++....... ......+||..|+|||++.+ ..|+.++|||||||++|||++|..+ |.+ .+..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999976433211 11234679999999999987 6899999999999999999998754 432 2344
Q ss_pred hhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhcc-CCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhh
Q 044076 229 HQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRK-WAVPFSHKF--PGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305 (506)
Q Consensus 229 ~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~ 305 (506)
.++..+...++.+..+. .... .....++....-. ....+...+ ..++.++.++|.+||++||.+|||+.|
T Consensus 378 ~~~~~~~~~~~~~~~~~-p~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~e----- 450 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEF-PDPP-CKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAE----- 450 (501)
T ss_pred HHHHHHHHhcccChhhc-CCcH-HHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHH-----
Confidence 56666666666543321 1110 1112222211100 000111111 236778999999999999999999999
Q ss_pred hhhhHHHHHhhhhhccCcccCCC
Q 044076 306 IVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 306 ~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+|.||||...
T Consensus 451 -------------lL~hp~f~~~ 460 (501)
T PHA03210 451 -------------LLALPLFSAE 460 (501)
T ss_pred -------------HhhChhhhcC
Confidence 8999999763
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=337.64 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=212.4
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+.|++++.||.|+||.||++.+..+++.||||.+..... .......+.+|+.+++.++||||+++++.+. ..+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 479999999999999999999999999999999864321 2234567889999999999999999999884 3478
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||+++ +|.++++..+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999985 999999888889999999999999999999999999999999999999999999999999987421111
Q ss_pred CC------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcC
Q 044076 172 PS------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 172 ~~------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g 239 (506)
.. ........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~ 233 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 233 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 00 001123457888999999877 6789999999999999999999999987665443333321100
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HhhhhhhhhhhhHHHHHhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS---AEEIRFTEIVFNWLFLYFY 316 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT---a~eL~~~~~~~~~~~~~~~ 316 (506)
......+.+++++.+||.+||+.||.+||| +.+
T Consensus 234 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~---------------- 269 (305)
T cd05609 234 ----------------------------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFE---------------- 269 (305)
T ss_pred ----------------------------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHH----------------
Confidence 000111247889999999999999999998 677
Q ss_pred hhhccCcccCCCC
Q 044076 317 VLALADPYFHGLA 329 (506)
Q Consensus 317 ~~aL~HP~f~~~~ 329 (506)
+|+||||....
T Consensus 270 --ll~~~~~~~~~ 280 (305)
T cd05609 270 --VKQHRFFLGLD 280 (305)
T ss_pred --HHhCccccCCC
Confidence 79999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=335.92 Aligned_cols=261 Identities=25% Similarity=0.438 Sum_probs=210.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++++.||+|+||.||+|.+..++..||+|.++... .......+.+|+.+++.++||||+++++.+.. .+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeE
Confidence 47999999999999999999999999999999986432 33345678899999999999999999998744 3789
Q ss_pred EEEEecCCC-CHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 94 YVVFELMES-DLDQVIKAN---DDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~---~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
|+||||+++ +|..++... ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999985 898888763 379999999999999999999996 599999999999999999999999999996532
Q ss_pred CCCCCcccccccccCCcccCccccccc----CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~----~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
... .....++..|+|||.+.+. ...++.++|+||+||++|+|++|+.||...........+......+
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--- 226 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD--- 226 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC---
Confidence 211 1334578889999998542 1246889999999999999999999997654433222221111100
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
.....+.+++++.+||.+||+.||.+|||+++ ++.|||
T Consensus 227 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------l~~~~~ 264 (286)
T cd06622 227 ------------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQ------------------LLEHPW 264 (286)
T ss_pred ------------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHH------------------HhcChh
Confidence 11223458899999999999999999999999 899999
Q ss_pred cCCCCC
Q 044076 325 FHGLAN 330 (506)
Q Consensus 325 f~~~~~ 330 (506)
|.....
T Consensus 265 ~~~~~~ 270 (286)
T cd06622 265 LVKYKN 270 (286)
T ss_pred hhhccC
Confidence 987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=327.52 Aligned_cols=253 Identities=27% Similarity=0.470 Sum_probs=214.0
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++++.||.|+||.|+.+.+..+++.|++|++............+.+|+.+++.++|+||+++++++.. .+.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 6999999999999999999999999999999986544445556678899999999999999999999844 37899
Q ss_pred EEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 95 VVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+||||++ ++|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999997 5999999765 468999999999999999999999999999999999999999999999999997643322
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+..+....+.. |.+.
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~--------- 219 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYT--------- 219 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCC---------
Confidence 1 1244568999999999887 5688899999999999999999999987665554444421 1111
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...+.++.++.++|.+||..||.+|||+.+ +|+|||+
T Consensus 220 -------------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~------------------ll~~~~l 256 (256)
T cd08221 220 -------------------PVVSVYSSELISLVHSLLQQDPEKRPTADE------------------VLDQPLL 256 (256)
T ss_pred -------------------CCccccCHHHHHHHHHHcccCcccCCCHHH------------------HhhCcCC
Confidence 111457889999999999999999999999 8999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=329.04 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=212.0
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++++.||.|+||+||+|.+..++..||+|++...... .....+.+|+.+++.++|+||+++++.+.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ-TSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc-hHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEE
Confidence 4799999999999999999999889999999998643222 256778999999999999999999998743 3789
Q ss_pred EEEEecCCC-CHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 94 YVVFELMES-DLDQVIKAN---DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~---~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
|+|+|++++ +|.+++... ..+++..+..++.||+.||.|||++||+||||+|+||++++++.+||+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999975 899998764 4589999999999999999999999999999999999999999999999999976443
Q ss_pred CCCCc-ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~-~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
..... ......+++..|+|||.+... ..++.++|+|||||++++|++|+.||...+....+..+... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~------- 224 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DP------- 224 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CC-------
Confidence 32211 112344688999999998762 47889999999999999999999999766554333332111 00
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...+....+..+++.+.+||.+||..||.+|||+.+ ++.||||
T Consensus 225 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------ll~~p~~ 267 (267)
T cd06610 225 ----------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE------------------LLKHKFF 267 (267)
T ss_pred ----------------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHH------------------HhhCCCC
Confidence 001111113467899999999999999999999999 8999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=338.45 Aligned_cols=261 Identities=31% Similarity=0.478 Sum_probs=213.9
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
+...+|++++.||.|+||.||+|.+..+++.||||.+... .......+.+|+.+++.++||||+++++.+.. .
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~ 88 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLV-----G 88 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 4458999999999999999999999999999999998642 23344667899999999999999999999843 3
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+..|+||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 789999999975 89988865 4689999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|++||.+.+....+..+.. .+.|..
T Consensus 168 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~------ 235 (297)
T cd06656 168 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL------ 235 (297)
T ss_pred Ccc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCCC------
Confidence 211 1234568899999999977 6789999999999999999999999977654333222211 111110
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.....+++.+.+||.+||..||.+|||+.+ +|.||||....
T Consensus 236 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------------------il~~~~~~~~~ 276 (297)
T cd06656 236 ---------------------QNPERLSAVFRDFLNRCLEMDVDRRGSAKE------------------LLQHPFLKLAK 276 (297)
T ss_pred ---------------------CCccccCHHHHHHHHHHccCChhhCcCHHH------------------HhcCchhcccc
Confidence 111346788999999999999999999999 89999998755
Q ss_pred C
Q 044076 330 N 330 (506)
Q Consensus 330 ~ 330 (506)
.
T Consensus 277 ~ 277 (297)
T cd06656 277 P 277 (297)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=336.87 Aligned_cols=262 Identities=29% Similarity=0.464 Sum_probs=214.0
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
+.-+...+|++++.||.|+||.||+|.+..++..||||.+... .......+.+|+.+++.+.||||+++++.+..
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--- 88 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLV--- 88 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecC--CcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe---
Confidence 3345568999999999999999999999999999999998642 23345668899999999999999999998854
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 REFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
....|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 89 --~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 89 --GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred --CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 368999999997 489998864 4689999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...... ......++..|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+....+..+.. .+.+.
T Consensus 166 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~---- 235 (296)
T cd06654 166 ITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE---- 235 (296)
T ss_pred cccccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC----
Confidence 322211 1233468899999999877 6788999999999999999999999977654333222211 01100
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
....+.+++.+.+||.+||..||.+|||+.+ ++.||||.
T Consensus 236 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e------------------il~~~~~~ 274 (296)
T cd06654 236 -----------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE------------------LLQHQFLK 274 (296)
T ss_pred -----------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHH------------------HhhChhhh
Confidence 0111347788999999999999999999999 89999998
Q ss_pred CC
Q 044076 327 GL 328 (506)
Q Consensus 327 ~~ 328 (506)
..
T Consensus 275 ~~ 276 (296)
T cd06654 275 IA 276 (296)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=332.46 Aligned_cols=261 Identities=24% Similarity=0.387 Sum_probs=207.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcC-C
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRR-E 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~-~ 89 (506)
..++|++.+.||.|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ .||||+++++++...... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 3568999999999999999999999999999999986422 2345678999999998 599999999998654221 2
Q ss_pred CCcEEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
...+|+||||+.+ +|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 3568999999984 999988863 3689999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
...... ......|+..|+|||++.+. ...++.++||||+||++|+|++|+.||...........+..
T Consensus 161 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~------- 230 (272)
T cd06637 161 LDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------- 230 (272)
T ss_pred cccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-------
Confidence 322111 12345688999999998531 24688899999999999999999999965443222211100
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
.... ......++.++.+||.+||..||.+|||+.+ ++.||
T Consensus 231 --------------------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~------------------il~~~ 270 (272)
T cd06637 231 --------------------NPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQ------------------LMKHP 270 (272)
T ss_pred --------------------CCCC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHH------------------HhhCC
Confidence 0000 0111346789999999999999999999999 89999
Q ss_pred cc
Q 044076 324 YF 325 (506)
Q Consensus 324 ~f 325 (506)
||
T Consensus 271 ~~ 272 (272)
T cd06637 271 FI 272 (272)
T ss_pred CC
Confidence 97
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.57 Aligned_cols=261 Identities=26% Similarity=0.432 Sum_probs=208.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc---ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE---HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
+..|++.+.||+|+||.||.|.+..++..||||++..... .......+.+|+.+++.+.||||+++++++... .
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 77 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---M 77 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---C
Confidence 3679999999999999999999999999999998853211 123456788999999999999999999987432 1
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++...
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 256889999997 4999999887789999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.............++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+ ...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~------ 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQPT------ 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH---hcCCC------
Confidence 21111111233468889999999877 67899999999999999999999999765433322221 11110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
. ....+..+..+.++|.+||. +|.+|||++| +++|||+.
T Consensus 227 ------------------~--~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~------------------il~~~~~~ 265 (265)
T cd06652 227 ------------------N--PVLPPHVSDHCRDFLKRIFV-EAKLRPSADE------------------LLRHTFVH 265 (265)
T ss_pred ------------------C--CCCchhhCHHHHHHHHHHhc-ChhhCCCHHH------------------HhcCcccC
Confidence 0 01113467889999999994 9999999999 89999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=333.39 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=208.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||.|+||.||+|.+..+++.||+|.++.. .......+.+|+.+++.++||||+++++.+.. .+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~ 79 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RD 79 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CC
Confidence 356899999999999999999999999999999998642 22344567889999999999999999998843 37
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+||||+++ +|.+++...+.+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 89999999985 99999988889999999999999999999999999999999999999999999999999998653221
Q ss_pred CCCcccccccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. ......++..|+|||++.. ....++.++|+|||||++|+|++|.+||........+..+.. +..
T Consensus 160 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~~~-------- 226 (267)
T cd06645 160 IA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--SNF-------- 226 (267)
T ss_pred cc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--cCC--------
Confidence 11 1234578999999999742 124688899999999999999999999865443322221111 000
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
.. +.......++..+.+||.+||+.||++|||+++ ++.|||
T Consensus 227 ---------------~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~------------------ll~~~~ 267 (267)
T cd06645 227 ---------------QP-PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEK------------------LLQHPF 267 (267)
T ss_pred ---------------CC-CcccccCCCCHHHHHHHHHHccCCchhCcCHHH------------------HhcCCC
Confidence 00 000111246788999999999999999999999 899998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.42 Aligned_cols=260 Identities=30% Similarity=0.505 Sum_probs=214.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
...+|++++.||.|+||.||+|.+..+++.||||.+... .......+.+|+.+++.++||||+++++.+.. ..
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 89 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GD 89 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----Cc
Confidence 346899999999999999999999999999999998642 23345668899999999999999999999843 37
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+|+||+.+ +|..++.. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 89999999975 88888765 46899999999999999999999999999999999999999999999999998753322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+....+..+... +.+.
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~-------- 234 (296)
T cd06655 169 QSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE-------- 234 (296)
T ss_pred ccc---CCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc--------
Confidence 211 133468889999999877 67889999999999999999999999877654443333110 1100
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
......+++.+.+||.+||..||.+|||+.+ ++.||||+...+
T Consensus 235 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~------------------il~~~~~~~~~~ 277 (296)
T cd06655 235 -------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKE------------------LLQHPFLKLAKP 277 (296)
T ss_pred -------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHH------------------HhhChHhhhccc
Confidence 0112357889999999999999999999999 899999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=329.03 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=207.9
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc----ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE----HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~----~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
+|++.+.||.|+||.||+|.+ .+++.+|||.+..... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 588999999999999999986 5888999999863221 12334568899999999999999999999843 3
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+..|+|+||+.+ +|.+++.+...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 789999999975 9999998878899999999999999999999999999999999999999999999999999875321
Q ss_pred C---CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 170 D---TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 170 ~---~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
. ...........++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG------- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC-------
Confidence 1 111112234568999999999987 6788999999999999999999999976543332222211100
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
......+.++.++.+||.+||..||.+|||+.| +|.||||
T Consensus 226 ---------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~------------------~l~~~~~ 265 (265)
T cd06631 226 ---------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQ------------------LLRHDFL 265 (265)
T ss_pred ---------------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHH------------------HhcCCCC
Confidence 001122357889999999999999999999999 8999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=331.99 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=208.8
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++.+.||.|+||.||+|.+..+++.||+|.+... ......+.+|+.+++.+ +||||+++++++........
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 367899999999999999999999999999999998642 12345577899999999 69999999999865432334
Q ss_pred CcEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 91 KDIYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
...|+||||+++ +|.++++. ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 579999999975 89888753 4578999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccC---CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~---~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
........ .....++..|+|||++.... ..++.++||||+||++|+|++|++||...+....+..+... +
T Consensus 177 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~- 249 (291)
T cd06639 177 QLTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---P- 249 (291)
T ss_pred hccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---C-
Confidence 54322111 12346888999999975421 23688999999999999999999999776544333322110 0
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
...+ ......+..+.+||.+||+.||.+|||+.| +|+|
T Consensus 250 -----------------------~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~------------------il~~ 287 (291)
T cd06639 250 -----------------------PPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTH------------------LLEH 287 (291)
T ss_pred -----------------------CCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHH------------------HhcC
Confidence 0000 011246678999999999999999999999 8999
Q ss_pred cccC
Q 044076 323 PYFH 326 (506)
Q Consensus 323 P~f~ 326 (506)
|||+
T Consensus 288 ~~~~ 291 (291)
T cd06639 288 PFIK 291 (291)
T ss_pred cccC
Confidence 9995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.31 Aligned_cols=255 Identities=33% Similarity=0.515 Sum_probs=212.0
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++++.||.|+||.||+|.+..++..||+|.+...........++.+|+.+++.++||||+++++.+... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999865434455667788999999999999999999987543 235689
Q ss_pred EEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 95 VVFELME-SDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIH-----SANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH-----~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
+||||++ ++|.+++.. ...+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999997 489999875 357999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
........ ......++..|+|||.+.+ ..++.++|+|||||++++|++|+.||.+.+.......+...
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------- 225 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG------- 225 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-------
Confidence 76433221 1244578999999999977 67889999999999999999999999876644333322110
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
.+...-+..+..+.+|+.+||+.||.+|||+.+ +|+|||
T Consensus 226 -----------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~------------------il~~~~ 264 (265)
T cd08217 226 -----------------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE------------------LLQLPL 264 (265)
T ss_pred -----------------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHH------------------HhhCCC
Confidence 001112357789999999999999999999999 899999
Q ss_pred c
Q 044076 325 F 325 (506)
Q Consensus 325 f 325 (506)
+
T Consensus 265 ~ 265 (265)
T cd08217 265 I 265 (265)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=333.88 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=208.1
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
|++++.||.|+||.||+|.+..++..+++|.+.. ........+.+|+.+++.+.||||+++++++.. ....|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC--CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEE
Confidence 7889999999999999999999999999999853 233456678899999999999999999998854 367899
Q ss_pred EEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 96 VFELMES-DLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 96 V~E~~~~-~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
|+||+++ +|..++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999985 77777654 45799999999999999999999999999999999999999999999999999965322111
Q ss_pred cccccccccCCcccCcccccc---cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 174 AIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~---~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
......++..|+|||++.. ....++.++||||+||++|+|++|++||.+.+.......+..... .
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~-------- 226 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--P-------- 226 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC--C--------
Confidence 1234568899999999842 124578899999999999999999999987665444333321100 0
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
. ......++.++.+||.+||+.||.+|||+++ +++||||...
T Consensus 227 ---------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------il~~~~~~~~ 268 (282)
T cd06643 227 ---------------T---LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQ------------------LLQHPFVTVN 268 (282)
T ss_pred ---------------C---CCCccccCHHHHHHHHHHccCChhhCcCHHH------------------HhcCCCEecc
Confidence 0 0111246789999999999999999999999 8999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.63 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=209.1
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||.|+||.||+|.+..+++.||||.+............+.+|+.+++.++||||+++++.+.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 6999999999999999999999999999999996543344556778899999999999999999998743 37899
Q ss_pred EEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-CEEEeecCCcccccCC
Q 044076 95 VVFELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-KLKICDFGLARVSFTD 170 (506)
Q Consensus 95 lV~E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-~lKL~DFGla~~~~~~ 170 (506)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||++||+||||+|+||+++.++ .+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999975 999999764 3589999999999999999999999999999999999998654 5899999999764332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. .....++..|+|||.+.+ ..++.++||||+||++++|++|+.||.+.+.......+....
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~------------ 217 (256)
T cd08220 156 SK----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT------------ 217 (256)
T ss_pred cc----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC------------
Confidence 21 123568889999999977 678899999999999999999999998766544433331100
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.......+++.+.+||.+||..||.+|||+.| +|+||||
T Consensus 218 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~------------------ll~~p~~ 256 (256)
T cd08220 218 ------------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQ------------------IMAQPIC 256 (256)
T ss_pred ------------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHH------------------HhhCCCC
Confidence 00111347889999999999999999999999 8999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=330.85 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=202.0
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
+..++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+.. .
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~ 78 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----R 78 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----C
Confidence 3456899999999999999999999999999999998632 22344567899999999999999999998843 3
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+||||+++ +|.+++.....+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 689999999984 8999998888899999999999999999999999999999999999999999999999999975422
Q ss_pred CCCCcccccccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... ......++..|+|||.+.. ....++.++|+||+||++|+|++|++||...+..+....+....
T Consensus 159 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~---------- 225 (267)
T cd06646 159 TIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN---------- 225 (267)
T ss_pred ccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC----------
Confidence 111 1134568889999998743 12457889999999999999999999986543322111110000
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
...+.......++..+.+||++||+.||.+|||+++
T Consensus 226 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 226 ----------------FQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred ----------------CCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 000000111246889999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=326.88 Aligned_cols=253 Identities=26% Similarity=0.453 Sum_probs=209.9
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||.|+||.||.+.+..+|+.||||.+............+.+|+.+++.++||||+++++.+. +.+..|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence 699999999999999999999999999999998643223445567889999999999999999999883 347899
Q ss_pred EEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 95 VVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||+. ++|.+.+.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999997 49999887643 58899999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
.. .....++..|+|||++.+ ..++.++|+||+||++++|++|+.||...+..+....+.. |..+
T Consensus 156 ~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~--------- 219 (256)
T cd08218 156 EL---ARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSYP--------- 219 (256)
T ss_pred hh---hhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCCC---------
Confidence 11 123457888999999877 6788899999999999999999999976655444433311 1100
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
......+.++.++|.+||+.||.+||++.+ +|+||||
T Consensus 220 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------vl~~~~~ 256 (256)
T cd08218 220 -------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNS------------------ILEKNFI 256 (256)
T ss_pred -------------------CCcccCCHHHHHHHHHHhhCChhhCcCHHH------------------HhhCcCC
Confidence 111346888999999999999999999999 8999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=330.28 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=209.4
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC----hhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH----VSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~----~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
+|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-----D 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-----C
Confidence 488899999999999999999999999999998642211 1235678899999999999999999999843 4
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-CEEEeecCCccccc
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-KLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-~lKL~DFGla~~~~ 168 (506)
+..++|+||+.+ +|.++++..+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||.+....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 789999999985 9999998888899999999999999999999999999999999999998776 59999999997643
Q ss_pred CCCCCc-ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~-~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
...... .......++..|+|||.+.+ ..++.++|+||+||++++|++|..||...........+....-
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 225 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-------- 225 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc--------
Confidence 321111 11123467889999999876 6788999999999999999999999975543332222211100
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
. .......+..++++.++|.+||..||.+|||+.+ ++.||||+
T Consensus 226 ---------------~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~------------------ll~~~~~~ 268 (268)
T cd06630 226 ---------------A---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRE------------------LLKHPVFR 268 (268)
T ss_pred ---------------c---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHH------------------HhcCcccC
Confidence 0 0001111347889999999999999999999999 89999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=329.73 Aligned_cols=254 Identities=27% Similarity=0.444 Sum_probs=209.7
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++.+. +....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence 59999999999999999999999999999999964322 2245677889999999999999999998873 34789
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+|+||+.+ +|.+.+.....+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 999999975 9999998877899999999999999999999999999999999999999999999999999976433211
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+... ...+..
T Consensus 156 ----~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~---------------- 212 (258)
T cd05578 156 ----TTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQIRA---------------- 212 (258)
T ss_pred ----ccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHHHH----------------
Confidence 233457889999999977 568999999999999999999999998766421 111100
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH--hhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA--EEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa--~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.... ......+..++.+.++|.+||+.||.+||++ +| ++.||||
T Consensus 213 -------~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~------------------l~~~~~~ 258 (258)
T cd05578 213 -------KQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKD------------------LKNHPYF 258 (258)
T ss_pred -------Hhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHH------------------HhcCCCC
Confidence 0000 0001113467899999999999999999999 99 8999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.84 Aligned_cols=261 Identities=28% Similarity=0.504 Sum_probs=217.6
Q ss_pred CCCCCEEEe--EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 11 GEASQYEIQ--EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 11 ~~~~rY~i~--~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.+..-|+|. ++||+|-||+||-|.++++|+.||||+|.+..-.......+.+|+.||+.+.||.||.|.-.|.
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E----- 633 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE----- 633 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec-----
Confidence 334456664 7999999999999999999999999999765444444577889999999999999999988884
Q ss_pred CCCcEEEEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC---CCEEEeecCC
Q 044076 89 EFKDIYVVFELMESDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD---CKLKICDFGL 163 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~---~~lKL~DFGl 163 (506)
..+.+++|||-+.||+.+.|.+ .+.|++...++++.|||.||.|||-+||+|.||||+|||+.+. .++||||||+
T Consensus 634 T~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 634 TPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred CCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccc
Confidence 4489999999999999998865 4589999999999999999999999999999999999999765 4699999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
||+..+.. |....+||+.|.|||++.. ..|+..-||||+|+|+|--|+|..||....+ .-++|.+...-.++
T Consensus 714 ARiIgEks----FRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp 785 (888)
T KOG4236|consen 714 ARIIGEKS----FRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPP 785 (888)
T ss_pred eeecchhh----hhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCC
Confidence 99864432 3467899999999999988 8999999999999999999999999954322 22223221111111
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
..|..++++|+|||..+|+..-++|.|++. +|.||
T Consensus 786 ---------------------------~PW~eis~~AidlIn~LLqVkm~kRysvdk------------------~lsh~ 820 (888)
T KOG4236|consen 786 ---------------------------NPWSEISPEAIDLINNLLQVKMRKRYSVDK------------------SLSHP 820 (888)
T ss_pred ---------------------------CchhhcCHHHHHHHHHHHHHHHHHhcchHh------------------hccch
Confidence 224568999999999999999999999999 99999
Q ss_pred ccCCCC
Q 044076 324 YFHGLA 329 (506)
Q Consensus 324 ~f~~~~ 329 (506)
|+++..
T Consensus 821 Wlq~yq 826 (888)
T KOG4236|consen 821 WLQDYQ 826 (888)
T ss_pred hhhcch
Confidence 998743
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=332.24 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=212.3
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeE
Confidence 57999999999999999999999999999999986432 23445668899999999999999999998743 3789
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+|+||+++ +|.+++... .+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999985 899998765 799999999999999999999999999999999999999999999999999976433211
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
......++..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+...
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 213 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--------------- 213 (274)
T ss_pred ---ccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---------------
Confidence 1234568889999999987 56999999999999999999999999765543333222110
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
....+ ...++++++.++|.+||..||.+|||+++ +++||||.....
T Consensus 214 ------------~~~~~--~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~------------------il~~~~~~~~~~ 259 (274)
T cd06609 214 ------------NPPSL--EGNKFSKPFKDFVSLCLNKDPKERPSAKE------------------LLKHKFIKKAKK 259 (274)
T ss_pred ------------CCCCC--cccccCHHHHHHHHHHhhCChhhCcCHHH------------------HhhChhhcCCCc
Confidence 00000 00126888999999999999999999999 899999987443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=334.64 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=212.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||.|+||.||+|.+..++..||+|.+.. ........+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 75 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----EN 75 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CC
Confidence 35689999999999999999999999999999999863 344456678899999999999999999999854 36
Q ss_pred cEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 89999999985 898888764 4799999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
... ......++..|+|||++... ...++.++|+||+||++|+|++|++||.+.+....+..+.. +.+
T Consensus 156 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~----- 225 (280)
T cd06611 156 TLQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--SEP----- 225 (280)
T ss_pred ccc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--CCC-----
Confidence 211 11345688899999997521 14577899999999999999999999987654433332211 000
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
+....-..++.++.+||.+||+.||.+|||+.+ +|+||||.
T Consensus 226 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------------------il~~~~~~ 266 (280)
T cd06611 226 ---------------------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAE------------------LLKHPFVS 266 (280)
T ss_pred ---------------------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHH------------------HhcChhhc
Confidence 000111346889999999999999999999999 89999998
Q ss_pred CC
Q 044076 327 GL 328 (506)
Q Consensus 327 ~~ 328 (506)
..
T Consensus 267 ~~ 268 (280)
T cd06611 267 DQ 268 (280)
T ss_pred cc
Confidence 75
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.06 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=203.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHH-HHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKL-LRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~i-L~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||.||+|.+..+|+.||||.++...... ....+.+|+.+ ++.+.||||+++++.+.. ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCc
Confidence 47999999999999999999999999999999986543322 33456667665 666789999999999843 367
Q ss_pred EEEEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 93 IYVVFELMESDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
+|+||||++++|.+++.. ...+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999888764 24689999999999999999999997 9999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCCcccCccccccc--CCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-chhhHHHHHhhcCCCChH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGRPLFPGRN-VAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~--~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~-~~~~l~~I~~~~g~p~~e 244 (506)
..... .+...++..|+|||.+.+. ...++.++|+||+||++|+|++|+.||.... ..+.+..+.. +.
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~---- 224 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EP---- 224 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cC----
Confidence 22211 1334688899999988541 1357889999999999999999999996422 1222221110 00
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
. .. .....++.++.+||.+||..||.+|||+++ ++.|||
T Consensus 225 -----------------~--~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~------------------il~~~~ 263 (283)
T cd06617 225 -----------------S--PQ----LPAEKFSPEFQDFVNKCLKKNYKERPNYPE------------------LLQHPF 263 (283)
T ss_pred -----------------C--CC----CCccccCHHHHHHHHHHccCChhhCcCHHH------------------HhcCch
Confidence 0 00 001236889999999999999999999999 899999
Q ss_pred cCCCC
Q 044076 325 FHGLA 329 (506)
Q Consensus 325 f~~~~ 329 (506)
|....
T Consensus 264 ~~~~~ 268 (283)
T cd06617 264 FELHL 268 (283)
T ss_pred hhhcc
Confidence 98743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.73 Aligned_cols=258 Identities=25% Similarity=0.387 Sum_probs=204.3
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++++.||+|+||.||+|.+..+++.||||.+... ........+.+|+.+++.++||||+++++.+.. ....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC-CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEE
Confidence 4689999999999999999999999999999998642 223345668899999999999999999999854 3678
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
++||||+++ +|... ..+++..+..++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999986 55433 357899999999999999999999999999999999999999999999999997542221
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
....++|..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+.. +.....
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---------~~~~~~------ 208 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS---------LMPLQL------ 208 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc---------cchHHH------
Confidence 234578999999999987 67899999999999999999999999653221100 000000
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
........ +........++++.+||.+||+.||.+||+++| ++.||||...
T Consensus 209 -----~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~e------------------il~~~~~~~~ 259 (279)
T cd06619 209 -----LQCIVDED--PPVLPVGQFSEKFVHFITQCMRKQPKERPAPEN------------------LMDHPFIVQY 259 (279)
T ss_pred -----HHHHhccC--CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHH------------------HhcCcccccc
Confidence 00000000 000112347889999999999999999999999 8999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=323.83 Aligned_cols=254 Identities=27% Similarity=0.467 Sum_probs=209.1
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc---ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE---HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
+|+..+.||+|+||+||+|.+..+++.|+||.+..... .....+.+.+|+.+++.++|+||+++++++. +..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 68889999999999999999998999999999854221 1234567889999999999999999999874 347
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+|+||+++ +|.+++.....+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 89999999975 99999988888999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. ......++..|+|||.+... ..++.++|+||+||++|+|++|++||...........+...
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------- 217 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------------- 217 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-------------
Confidence 2 12345688999999998762 23889999999999999999999999765533322222110
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.......+.+++.+.+||.+||+.||.+|||+.+ +|.|||+
T Consensus 218 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------~l~~~~~ 258 (258)
T cd06632 218 ----------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAE------------------LLEHPFV 258 (258)
T ss_pred ----------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHH------------------HhcCCCC
Confidence 0011222457899999999999999999999999 8999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=324.66 Aligned_cols=258 Identities=29% Similarity=0.438 Sum_probs=209.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++.+.||.|+||.||+|.+..+++.+|+|++... .......+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCE
Confidence 46899999999999999999999999999999998642 22356778899999999999999999998743 478
Q ss_pred EEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||+++ +|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999985 899888776 68999999999999999999999999999999999999999999999999999753322
Q ss_pred CCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. ......++..|+|||.+.+. ...++.++|+||+||++|+|++|++||.+.+.......+....-.+
T Consensus 155 ~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 223 (262)
T cd06613 155 IA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-------- 223 (262)
T ss_pred hh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------
Confidence 11 11345688899999998651 1278889999999999999999999998766544333221100000
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
+.....+..+.++.+||++||..||..|||+.+ ++.|||
T Consensus 224 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~------------------il~~~~ 262 (262)
T cd06613 224 ------------------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATK------------------LLQHPF 262 (262)
T ss_pred ------------------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHH------------------HhcCCC
Confidence 000011235678999999999999999999999 899998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=327.05 Aligned_cols=262 Identities=26% Similarity=0.426 Sum_probs=209.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCc-CC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCR-RE 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~-~~ 89 (506)
..++|++.+.||.|++|.||+|.+..+++.|++|++... ......+.+|+.+++.+ .|+||+++++++..... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 458999999999999999999999999999999998642 22345688999999999 59999999999866432 23
Q ss_pred CCcEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 90 FKDIYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
...+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 4678999999985 88888764 357999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
........ ......++..|+|||++... ...++.++|||||||++|+|++|++||.+.+....+..+... +
T Consensus 161 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~ 234 (275)
T cd06608 161 AQLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---P 234 (275)
T ss_pred eecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---C
Confidence 75322211 12345688999999987531 145788999999999999999999999765443333332110 0
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
. .. .......+.++.+||.+||..||.+|||+.+ +++
T Consensus 235 ~------------------------~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~------------------ll~ 271 (275)
T cd06608 235 P------------------------PT-LKSPENWSKKFNDFISECLIKNYEQRPFMEE------------------LLE 271 (275)
T ss_pred C------------------------CC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHH------------------Hhc
Confidence 0 00 0001236788999999999999999999999 899
Q ss_pred Cccc
Q 044076 322 DPYF 325 (506)
Q Consensus 322 HP~f 325 (506)
|||+
T Consensus 272 ~~~~ 275 (275)
T cd06608 272 HPFI 275 (275)
T ss_pred CCCC
Confidence 9996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=323.04 Aligned_cols=261 Identities=28% Similarity=0.448 Sum_probs=210.6
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
||++.+.||+|+||.||+|.+..+++.||+|.++...........+.+|+.+++.++|+||++++++... ...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence 6999999999999999999999999999999997543334567789999999999999999999998743 37799
Q ss_pred EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 95 VVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
+|+||++ ++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 599999988778999999999999999999999999999999999999999999999999999764332221
Q ss_pred ccc-ccccccCCcccCcccccccC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 174 AIF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 174 ~~~-~~~~vgt~~Y~APE~l~~~~-~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
... .....++..|+|||++.+.. ..++.++||||+||++++|++|+.||.+.+........... +.+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~---------- 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK---------- 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC----------
Confidence 111 12356788999999987621 23888999999999999999999999765422221111000 100
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.. ......+++.+.+||.+||+.||.+|||+.+ ++.|||+
T Consensus 225 -------------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~------------------i~~~~~~ 264 (264)
T cd06626 225 -------------PP---IPDSLQLSPEGKDFLDRCLESDPKKRPTASE------------------LLQHPFV 264 (264)
T ss_pred -------------CC---CCcccccCHHHHHHHHHHccCCcccCCCHHH------------------HhcCCCC
Confidence 00 0112345889999999999999999999999 8999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=329.82 Aligned_cols=266 Identities=24% Similarity=0.396 Sum_probs=209.1
Q ss_pred ccccC-CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecC
Q 044076 7 FTEYG-EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLP 84 (506)
Q Consensus 7 ~~~~~-~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~ 84 (506)
++.+. ..++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44444 568999999999999999999999999999999987532 12234577899999999 59999999998764
Q ss_pred CCcCCCCcEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEe
Q 044076 85 PCRREFKDIYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKIC 159 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~ 159 (506)
.........|+||||+++ +|.+++.. ...+++..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 433344679999999974 89888753 3468899999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 044076 160 DFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD 236 (506)
Q Consensus 160 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~ 236 (506)
|||+++....... ......++..|+|||++... ...++.++||||+||++|+|++|+.||.+.+....+..+..
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 167 DFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred cCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 9999975432211 12334689999999997531 14588899999999999999999999976544332221100
Q ss_pred hcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHh
Q 044076 237 LLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYF 315 (506)
Q Consensus 237 ~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~ 315 (506)
.. ...... ...+..+.+||.+||+.||.+|||+.|
T Consensus 244 ---~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e--------------- 279 (286)
T cd06638 244 ---NP--------------------------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSD--------------- 279 (286)
T ss_pred ---cC--------------------------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHH---------------
Confidence 00 000001 125778999999999999999999999
Q ss_pred hhhhccCccc
Q 044076 316 YVLALADPYF 325 (506)
Q Consensus 316 ~~~aL~HP~f 325 (506)
+|.||||
T Consensus 280 ---ll~~~~~ 286 (286)
T cd06638 280 ---LLQHVFI 286 (286)
T ss_pred ---HhhcccC
Confidence 8999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=327.11 Aligned_cols=261 Identities=27% Similarity=0.472 Sum_probs=207.9
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC--------hhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH--------VSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~--------~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
+|.+.+.||.|+||.||+|.+..+|+.||||.++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 689999999999999999999999999999988532111 1123457789999999999999999998743
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
...+++||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 80 ---EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ---CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 478999999997 5999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
....... ........++..|+|||.+......++.++|+|||||++++|++|..||...+....+..+..
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 226 (272)
T cd06629 157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--------- 226 (272)
T ss_pred ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---------
Confidence 5322111 111234568889999999876323488999999999999999999999965443322221100
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPF-SHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
......+ ....+.++.++.+||.+||..||.+|||+++ +|+|||
T Consensus 227 -----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------------------il~~~~ 271 (272)
T cd06629 227 -----------------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE------------------LLQHPF 271 (272)
T ss_pred -----------------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHH------------------HhhCCC
Confidence 0000011 1223567899999999999999999999999 899999
Q ss_pred c
Q 044076 325 F 325 (506)
Q Consensus 325 f 325 (506)
|
T Consensus 272 ~ 272 (272)
T cd06629 272 I 272 (272)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=324.86 Aligned_cols=253 Identities=30% Similarity=0.495 Sum_probs=208.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++.+.||.|+||.||+|.+..++..|++|.+... .....+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~ 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTD 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCc
Confidence 46899999999999999999999988999999998642 226678899999999999999999998854 378
Q ss_pred EEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELMES-DLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+|+||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999985 99999875 457899999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. ......++..|+|||++.+ ..++.++||||+||++++|++|++||...+.......+..
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 213 (256)
T cd06612 153 MA---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------- 213 (256)
T ss_pred cc---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc--------------
Confidence 21 1133457889999999877 6789999999999999999999999976554332222110
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
... +.....+.++..+.+||.+||+.||.+|||+.| +|.||||
T Consensus 214 -------------~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~------------------il~~~~~ 256 (256)
T cd06612 214 -------------KPP-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ------------------LLQHPFI 256 (256)
T ss_pred -------------CCC-CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHH------------------HhcCCCC
Confidence 000 000111346788999999999999999999999 8999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=335.70 Aligned_cols=261 Identities=26% Similarity=0.472 Sum_probs=212.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.+.|.....||.|+||.||++.+..++..||||++.. ........+.+|+.+++.++||||+++++.+.. .+.
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~ 93 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL--RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDE 93 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec--chHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCe
Confidence 3566667889999999999999999999999999854 223445668899999999999999999998743 378
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.|+||||+++ +|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999985 78877654 569999999999999999999999999999999999999999999999999986532222
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
.. .....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+....+..+......
T Consensus 173 ~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 236 (292)
T cd06658 173 PK---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP----------- 236 (292)
T ss_pred cc---CceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----------
Confidence 11 134568999999999876 67899999999999999999999999876654433332211100
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
........+..+.+||.+||..||.+|||++| +|+||||.....+
T Consensus 237 -----------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~------------------il~~~~~~~~~~~ 281 (292)
T cd06658 237 -----------------RVKDSHKVSSVLRGFLDLMLVREPSQRATAQE------------------LLQHPFLKLAGPP 281 (292)
T ss_pred -----------------ccccccccCHHHHHHHHHHccCChhHCcCHHH------------------HhhChhhhccCCc
Confidence 00011246888999999999999999999999 8999999976654
Q ss_pred C
Q 044076 332 E 332 (506)
Q Consensus 332 ~ 332 (506)
.
T Consensus 282 ~ 282 (292)
T cd06658 282 S 282 (292)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.82 Aligned_cols=261 Identities=28% Similarity=0.477 Sum_probs=225.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..+-|.+.+.||+|.|++|.+|++..|+..||||.+.+...+......+.||+++|+.|+|||||+++.++.. ..
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-----~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-----EA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-----cc
Confidence 4568999999999999999999999999999999998877777777779999999999999999999999854 37
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+||||+. |.+++++.+++.+.+..++.++.|++.|++|||+++|||||||++|||++.+..+||+|||++......
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 8999999986 699999999999999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. ....++|++.|.|||++.+. ...++.+|+||+|+++|.|++|..||.|.+....-...
T Consensus 209 ~----~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------- 267 (596)
T KOG0586|consen 209 L----MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------- 267 (596)
T ss_pred c----cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchh----------------
Confidence 2 34678999999999999884 45578999999999999999999999987754322111
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
+..+.++++. ++-++.+||++||..+|.+|++.++ ++.|.|......
T Consensus 268 ----------l~gk~rIp~~-----ms~dce~lLrk~lvl~Pskr~~~dq------------------im~~~W~n~~~~ 314 (596)
T KOG0586|consen 268 ----------LRGKYRIPFY-----MSCDCEDLLRKFLVLNPSKRGPCDQ------------------IMKDRWRNDLLE 314 (596)
T ss_pred ----------eeeeecccce-----eechhHHHHHHhhccCccccCCHHH------------------hhhhcccchhhh
Confidence 1122233322 7888999999999999999999999 788888876554
Q ss_pred C
Q 044076 331 L 331 (506)
Q Consensus 331 ~ 331 (506)
.
T Consensus 315 ~ 315 (596)
T KOG0586|consen 315 A 315 (596)
T ss_pred h
Confidence 3
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=328.34 Aligned_cols=262 Identities=24% Similarity=0.400 Sum_probs=208.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCc-C
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCR-R 88 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~-~ 88 (506)
...++|++.+.||.|+||.||+|.+..+++.||+|.+.. .......+.+|+.+++.+ .||||+++++++..... .
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~---~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV---TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec---ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 456799999999999999999999999999999999853 223445678899999998 59999999998865322 2
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
....+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 34679999999985 899988763 358899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
....... ......++..|+|||++... ...++.++|+|||||++|+|++|.+||........+..+..
T Consensus 170 ~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~------ 240 (282)
T cd06636 170 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------ 240 (282)
T ss_pred hhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh------
Confidence 5322111 12345688999999998521 24688899999999999999999999966543322221100
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
. .........+++++.+||.+||+.||.+|||+.| +|.|
T Consensus 241 ---------------------~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e------------------ll~~ 279 (282)
T cd06636 241 ---------------------N--PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ------------------LLKH 279 (282)
T ss_pred ---------------------C--CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHH------------------HhcC
Confidence 0 0000111347889999999999999999999999 8999
Q ss_pred ccc
Q 044076 323 PYF 325 (506)
Q Consensus 323 P~f 325 (506)
|||
T Consensus 280 ~~~ 282 (282)
T cd06636 280 PFI 282 (282)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=331.42 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=222.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|..+++||+|.||.|.+++.+.+++.+|||++++.. -...+....+.|-++|+..+||.+..|.-.|. ..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ-----t~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ-----TQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc-----cCc
Confidence 467888999999999999999999999999999997532 23345566778999999999999999988774 348
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
++|+||||.. |.|.-.+.+...+++...+++-..|+.||.|||+.+||.||||.+|+|++++|++||+|||+++-....
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999997 489888888888999999999999999999999999999999999999999999999999999753332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. .....++||+.|.|||++.. ..|+.++|.|.+|+++|||++|+.||...+.......|... .
T Consensus 322 g---~t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------d----- 384 (516)
T KOG0690|consen 322 G---DTTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------D----- 384 (516)
T ss_pred c---ceeccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------h-----
Confidence 2 22467899999999999988 79999999999999999999999999999988887777321 0
Q ss_pred hhHHHHHHhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
-.| ..++++|+.||..+|..||.+|.. |.| +.+|+|
T Consensus 385 --------------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakE------------------i~~h~F 426 (516)
T KOG0690|consen 385 --------------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKE------------------IMRHRF 426 (516)
T ss_pred --------------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHH------------------HHhhhh
Confidence 112 258999999999999999999985 667 789999
Q ss_pred cCCCC
Q 044076 325 FHGLA 329 (506)
Q Consensus 325 f~~~~ 329 (506)
|.++.
T Consensus 427 F~~v~ 431 (516)
T KOG0690|consen 427 FASVD 431 (516)
T ss_pred hccCC
Confidence 99865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.21 Aligned_cols=245 Identities=29% Similarity=0.443 Sum_probs=205.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
+.+++++.||+|-||.||.|... ....||+|.++.. .-....+.+|+++|++|+|+|||++++++.. .+.+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCce
Confidence 45567889999999999999763 2348999999753 2334557799999999999999999999843 2579
Q ss_pred EEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 94 YVVFELME-SDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
|||||||. |+|.++++. +..+.......|+.||++|++||+++++|||||-..||||++++.+||+|||||+....+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999998 799999997 457999999999999999999999999999999999999999999999999999954333
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.... ..+.--+.-|.|||.+.. ..++.++||||||++|+||+| |+.||++.++.+.++.+.+..--|.+
T Consensus 357 ~Y~~--~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P------ 426 (468)
T KOG0197|consen 357 EYTA--SEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP------ 426 (468)
T ss_pred ceee--cCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC------
Confidence 2211 122234456899999987 789999999999999999999 99999999999888888553332222
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+++++++.+|+..||..+|++|||++.|
T Consensus 427 ------------------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L 454 (468)
T KOG0197|consen 427 ------------------------EGCPDEVYELMKSCWHEDPEDRPTFETL 454 (468)
T ss_pred ------------------------CCCCHHHHHHHHHHhhCCcccCCCHHHH
Confidence 4589999999999999999999999985
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=330.62 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=198.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECC----------------CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCc
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTH----------------TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~----------------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnI 75 (506)
..++|++.+.||+|+||.||+|.+.. ++..||||.+... ........+.+|+.+|+.++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCe
Confidence 35789999999999999999997532 3447999998643 223345668899999999999999
Q ss_pred ceeceeecCCCcCCCCcEEEEEecCC-CCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHh
Q 044076 76 VEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKAND-------------------DLTPEHHQFFLYQLLRALKYIHS 135 (506)
Q Consensus 76 v~l~~v~~~~~~~~~~~~ylV~E~~~-~~L~~~i~~~~-------------------~ls~~~~~~i~~QIl~gL~yLH~ 135 (506)
+++++++.. .+..|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+
T Consensus 82 v~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 82 IRLLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred eEEEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999854 367899999997 59999886532 36778899999999999999999
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHH
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 215 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eL 215 (506)
.||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|
T Consensus 157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CCccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHH
Confidence 99999999999999999999999999999754322211 11123345788999999876 6799999999999999999
Q ss_pred Hh--CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 044076 216 LT--GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPK 293 (506)
Q Consensus 216 l~--G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~ 293 (506)
++ +..||.+.+..+.+..+... .... .........+.+++.+.+||.+||+.||.
T Consensus 234 ~~~~~~~p~~~~~~~~~~~~~~~~--------------------~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 290 (304)
T cd05096 234 LMLCKEQPYGELTDEQVIENAGEF--------------------FRDQ---GRQVYLFRPPPCPQGLYELMLQCWSRDCR 290 (304)
T ss_pred HHccCCCCCCcCCHHHHHHHHHHH--------------------hhhc---cccccccCCCCCCHHHHHHHHHHccCCch
Confidence 87 56777766554433332111 0000 00001112245788999999999999999
Q ss_pred CCCCHhhh
Q 044076 294 DRPSAEEI 301 (506)
Q Consensus 294 ~RpTa~eL 301 (506)
+|||+.+|
T Consensus 291 ~RPs~~~i 298 (304)
T cd05096 291 ERPSFSDI 298 (304)
T ss_pred hCcCHHHH
Confidence 99999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=326.61 Aligned_cols=258 Identities=29% Similarity=0.481 Sum_probs=209.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+.||||+++++.+... ...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEE
Confidence 468899999999999999999999999999999865322 24556788999999999999999999988543 789
Q ss_pred EEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 94 YVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
|+|+||++ ++|.+++... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.+||+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 5999999876 789999999999999999999999 99999999999999999999999999998654222
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc--hhhHHHHHhhcCCCChHHHhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV--AHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~--~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. ....++..|+|||.+.+ ..++.++||||+||++++|++|..||...+. ......+.....
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 218 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN--------- 218 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---------
Confidence 11 12568888999999977 6889999999999999999999999965431 111111110000
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPG-ADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.... ..... +++++.+||.+||..||.+|||+.+ ++.||||+.
T Consensus 219 ---------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~------------------ll~~~~~~~ 262 (265)
T cd06605 219 ---------------EPPP---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKE------------------LLEHPFIKK 262 (265)
T ss_pred ---------------CCCC---CCChhhcCHHHHHHHHHHcCCCchhCcCHHH------------------HhhCchhhc
Confidence 0000 01111 7888999999999999999999999 899999986
Q ss_pred CC
Q 044076 328 LA 329 (506)
Q Consensus 328 ~~ 329 (506)
..
T Consensus 263 ~~ 264 (265)
T cd06605 263 YE 264 (265)
T ss_pred cc
Confidence 53
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=323.89 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=205.5
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecC
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 100 (506)
||.|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++.+.. ...+|+|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence 699999999999999999999999996432 233455678899999999999999999998743 47899999999
Q ss_pred C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccc
Q 044076 101 E-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD 179 (506)
Q Consensus 101 ~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 179 (506)
+ ++|.+++.....+++..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 7 5999999888889999999999999999999999999999999999999999999999999997643322 1133
Q ss_pred cccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--chhhHHHHHhhcCCCChHHHhhhhhhHHHHH
Q 044076 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN--VAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257 (506)
Q Consensus 180 ~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~--~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~ 257 (506)
..++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.... ..+....+...
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 209 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG-------------------- 209 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc--------------------
Confidence 468889999999876 678999999999999999999999997665 22222222110
Q ss_pred HhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 258 LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.... ..-...++++.++|.+||+.||.+||| ++| +++||||+++.
T Consensus 210 ------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~------------------l~~~~~~~~~~ 259 (262)
T cd05572 210 ------NGKL---EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKD------------------IKKHKWFNGFD 259 (262)
T ss_pred ------CCCC---CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHH------------------HhcChhhhCCC
Confidence 0000 011234788999999999999999999 999 89999999763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=314.54 Aligned_cols=265 Identities=24% Similarity=0.379 Sum_probs=209.0
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
+.+.+.+||+|.+.||+|||+-|+++....++..||+|++.. ....+.+..++||...++++||||+++++..+....
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c--~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC--HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeec--cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 456778999999999999999999999999999999999964 345778889999999999999999999988776544
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECCCCCEEEee
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN----DDLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANADCKLKICD 160 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~----~~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~~~~lKL~D 160 (506)
+.....|||++|.. |+|.+.|... ..+++..+..++.+|++||++||+.. .+||||||.|||+.+++.++|+|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 45577999999886 7899998652 36999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccCCCCC------cccccccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHH
Q 044076 161 FGLARVSFTDTPS------AIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233 (506)
Q Consensus 161 FGla~~~~~~~~~------~~~~~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~ 233 (506)
||.++...-.... -..+..-..|..|+|||++.- .....+.++|||||||+||.|+.|..||.-
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~--------- 243 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER--------- 243 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------
Confidence 9999653221111 112334568899999999743 224578899999999999999999999931
Q ss_pred HHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 234 I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+..-.|.-... +.+ ....+... +.++..+.+||+.||+.||.+||++.+|
T Consensus 244 ~~~~GgSlaLA----v~n-------------~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~l 293 (302)
T KOG2345|consen 244 IYQQGGSLALA----VQN-------------AQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPEL 293 (302)
T ss_pred HhhcCCeEEEe----eec-------------cccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHH
Confidence 21111110000 000 00111111 2378899999999999999999999995
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=321.10 Aligned_cols=259 Identities=29% Similarity=0.438 Sum_probs=213.5
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
+.|++.+.||.|++|.||+|.+..+++.|+||++...... .....+.+|+..+..++|+||+++++++... ...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeE
Confidence 4689999999999999999999999999999998643222 4566788999999999999999999998543 789
Q ss_pred EEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 94 YVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
|+||||++ ++|.+++.....+++..+..++.||++||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999998 6999999888889999999999999999999999 999999999999999999999999999997643322
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.........+.+....
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 216 (264)
T cd06623 155 DQ---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------- 216 (264)
T ss_pred Cc---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-------------
Confidence 21 134568889999999877 688999999999999999999999997664211111111110
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPG-ADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.... ...... ++..+.++|.+||..+|.+|||+.| +++||||+..
T Consensus 217 -----------~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~------------------ll~~~~~~~~ 262 (264)
T cd06623 217 -----------DGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAE------------------LLQHPFIKKA 262 (264)
T ss_pred -----------cCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHH------------------HHhCHHHHhc
Confidence 0000 111123 6889999999999999999999999 8999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=373.61 Aligned_cols=266 Identities=25% Similarity=0.386 Sum_probs=225.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
.+++|+|+++||+|+||.|..++.+.|++.||+|++++. .....+..-+..|-.+|..-+.+-|+.|+-.| .+.
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence 357899999999999999999999999999999999752 12334455577889999988899999999888 556
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.++|+|||||. |||..++..-+.++++.+++++..|+.||.-||+.|+|||||||+|||++..|++||+|||.|-....
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999997 59999999888999999999999999999999999999999999999999999999999999966543
Q ss_pred CCCCcccccccccCCcccCccccccc--C-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSF--F-SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~--~-~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
++. ......||||.|++||+|... . ..|++.+|.||+||++|||+.|..||...+..+...+|++.
T Consensus 228 dG~--V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--------- 296 (1317)
T KOG0612|consen 228 DGT--VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--------- 296 (1317)
T ss_pred CCc--EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch---------
Confidence 332 234667999999999998432 2 57999999999999999999999999999988888777653
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS---AEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT---a~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
+....|.. -..+|++++|||+++|. +|..|.. +++ +-.||
T Consensus 297 -----------------k~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngied------------------ik~Hp 339 (1317)
T KOG0612|consen 297 -----------------KESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIED------------------IKNHP 339 (1317)
T ss_pred -----------------hhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHH------------------HHhCc
Confidence 11112221 12489999999999996 7899999 999 79999
Q ss_pred ccCCCCC
Q 044076 324 YFHGLAN 330 (506)
Q Consensus 324 ~f~~~~~ 330 (506)
||.++..
T Consensus 340 FF~g~~W 346 (1317)
T KOG0612|consen 340 FFEGIDW 346 (1317)
T ss_pred cccCCCh
Confidence 9998765
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=326.65 Aligned_cols=258 Identities=29% Similarity=0.501 Sum_probs=211.7
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
..|...+.||.|++|.||+|.+..+++.|+||++.. ........+.+|+.+++.+.||||+++++.+.. .+..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL--RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec--cchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeE
Confidence 456677899999999999999999999999999853 223345568899999999999999999998854 3778
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+|+||+.+ +|.+++.. ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||.+........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 999999974 99998877 6799999999999999999999999999999999999999999999999998865332221
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
. .....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+....+..+... .
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~------------- 231 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-L------------- 231 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-C-------------
Confidence 1 133568899999999877 67899999999999999999999999776554444333211 0
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
.+.....+.+++.+.+||.+||+.||.+|||+.+ +++||||....+
T Consensus 232 --------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~------------------il~~~~~~~~~~ 277 (285)
T cd06648 232 --------------PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAE------------------LLNHPFLAKAGP 277 (285)
T ss_pred --------------CCCCcccccCCHHHHHHHHHHcccChhhCcCHHH------------------HccCcccccCCC
Confidence 0000111237789999999999999999999999 899999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=320.32 Aligned_cols=246 Identities=29% Similarity=0.458 Sum_probs=203.9
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||.|+||.||++.+..+++.||+|.++.. ......+.+.+|+.+++.++||||+++++.+. +.+.+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP-KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcC-cchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEE
Confidence 589999999999999999999999999999998642 22345667889999999999999999999984 347899
Q ss_pred EEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 95 VVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+||||++ ++|.+.+... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999997 5899888653 458999999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......++..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......+.. +.
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--~~----------- 216 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--GS----------- 216 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc--CC-----------
Confidence 1 1234678899999999877 6789999999999999999999999987665444333321 10
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ......++..+.+||.+||+.||.+|||+.+|
T Consensus 217 --------------~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 249 (255)
T cd08219 217 --------------Y---KPLPSHYSYELRSLIKQMFKRNPRSRPSATTI 249 (255)
T ss_pred --------------C---CCCCcccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence 0 01113467889999999999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=324.63 Aligned_cols=256 Identities=31% Similarity=0.546 Sum_probs=212.0
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~ 91 (506)
++|++.+.||.|+||.||+|.+..+++.||||++... .........+.+|+.+++.+. ||||+++++++.. .+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cc
Confidence 4799999999999999999999999999999998642 223344567889999999999 9999999998743 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
..|+|||+++ ++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 8999999995 699999998888999999999999999999999999999999999999999999999999999764332
Q ss_pred CCC-----------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHH
Q 044076 171 TPS-----------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233 (506)
Q Consensus 171 ~~~-----------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~ 233 (506)
... ........++..|+|||++.. ..++.++|+|||||++++|++|+.||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 210 011123457889999999877 5688999999999999999999999987664333333
Q ss_pred HHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----hhhhhhhhhhh
Q 044076 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA----EEIRFTEIVFN 309 (506)
Q Consensus 234 I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa----~eL~~~~~~~~ 309 (506)
+.. ... ...+.+++.+.+||.+||+.||.+|||+ ++
T Consensus 234 ~~~--------------------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~--------- 273 (280)
T cd05581 234 ILK--------------------------LEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE--------- 273 (280)
T ss_pred HHh--------------------------cCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHH---------
Confidence 211 000 1113468899999999999999999999 99
Q ss_pred HHHHHhhhhhccCccc
Q 044076 310 WLFLYFYVLALADPYF 325 (506)
Q Consensus 310 ~~~~~~~~~aL~HP~f 325 (506)
+|+||||
T Consensus 274 ---------ll~~~~~ 280 (280)
T cd05581 274 ---------LKAHPFF 280 (280)
T ss_pred ---------HhcCCCC
Confidence 8999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=319.74 Aligned_cols=253 Identities=29% Similarity=0.476 Sum_probs=207.9
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||.|+||.||+|.+..+|..||+|.+............+.+|+.+++.++|+||+++++.+. .....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence 689999999999999999999999999999998643223344566789999999999999999999874 347899
Q ss_pred EEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC-EEEeecCCcccccCC
Q 044076 95 VVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK-LKICDFGLARVSFTD 170 (506)
Q Consensus 95 lV~E~~~~-~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~-lKL~DFGla~~~~~~ 170 (506)
+|+||+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||++++++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999974 9999887643 4799999999999999999999999999999999999998865 699999999764322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. ......++..|+|||++.+ ..++.++|+||+||++++|++|..||.+.+..+....+..
T Consensus 156 ~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 ME---LAYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred cc---cccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 21 1123468889999999876 6788999999999999999999999976654433322211
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..+....+..+.++.++|.+||..||.+|||+.| ++.||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~------------------ll~~~~~ 257 (257)
T cd08225 217 ----------------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITS------------------ILKRPFL 257 (257)
T ss_pred ----------------ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHH------------------HhhCCCC
Confidence 0011223457889999999999999999999999 8999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=327.89 Aligned_cols=250 Identities=19% Similarity=0.234 Sum_probs=201.8
Q ss_pred CCEEEe--EEEeecCceEEEEEEECCCCcEEEEEEecccccCh-hHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 14 SQYEIQ--EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV-SDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 14 ~rY~i~--~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~-~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
++++.. ..||+|++|.||+|.. +|+.||||+++...... ...+.+.+|+.+|++++||||+++++++.... +..
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~ 94 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDL 94 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCC
Confidence 344444 6799999999999976 78999999997543222 22466779999999999999999999885411 223
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..+++||||+.+ +|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 578999999985 899999988889999999999999999999998 599999999999999999999999999997542
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... ...+++..|+|||++.+....++.++|||||||++|||++|+.||.+.+..+....+......+
T Consensus 175 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------- 241 (283)
T PHA02988 175 SPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL------- 241 (283)
T ss_pred ccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-------
Confidence 211 2346888999999986533578999999999999999999999998876655544442211111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+ .....++.+.+||.+||+.||.+|||++||
T Consensus 242 -------------------~---~~~~~~~~l~~li~~cl~~dp~~Rps~~el 272 (283)
T PHA02988 242 -------------------K---LPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272 (283)
T ss_pred -------------------C---CCCcCcHHHHHHHHHHhcCCcccCcCHHHH
Confidence 0 012578899999999999999999999995
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=329.85 Aligned_cols=262 Identities=27% Similarity=0.382 Sum_probs=213.1
Q ss_pred ccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 7 FTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 7 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
+.......+|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~- 86 (307)
T cd06607 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR- 86 (307)
T ss_pred hcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-
Confidence 344456678999999999999999999999999999999985432 233345678899999999999999999999854
Q ss_pred CcCCCCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 86 CRREFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
.+..|+|+||+.++|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++
T Consensus 87 ----~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 87 ----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred ----CCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcc
Confidence 367899999999999888764 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
...... ....++..|+|||++.+. ...++.++||||+||++|+|++|++||.+.+....+..+... .+
T Consensus 163 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~-- 231 (307)
T cd06607 163 SLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS-- 231 (307)
T ss_pred eecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC--
Confidence 753221 234578889999987531 256888999999999999999999999776544333222110 00
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
. .......+..+.+||.+||+.||.+|||+.+ ++.||
T Consensus 232 ---------------------~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------il~~~ 268 (307)
T cd06607 232 ---------------------P----TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEE------------------LLKHR 268 (307)
T ss_pred ---------------------C----CCCchhhCHHHHHHHHHHhcCChhhCcCHHH------------------HhcCh
Confidence 0 0001235778999999999999999999999 89999
Q ss_pred ccCC
Q 044076 324 YFHG 327 (506)
Q Consensus 324 ~f~~ 327 (506)
||..
T Consensus 269 ~~~~ 272 (307)
T cd06607 269 FVLR 272 (307)
T ss_pred hhcc
Confidence 9986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=319.44 Aligned_cols=260 Identities=26% Similarity=0.437 Sum_probs=209.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc---cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF---EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~---~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
+.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++.+... +
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~ 77 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---E 77 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---C
Confidence 357999999999999999999999999999999874211 1233456788999999999999999999987442 2
Q ss_pred CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...+++|+||+++ +|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++...
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 3568999999974 899999887789999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.........+...++..|+|||++.+ ..++.++|+|||||++++|++|++||.+.........+ ...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~----- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTK----- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCCC-----
Confidence 21111111234568899999999987 67889999999999999999999999765433322221 111110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
....+.+++.+.++|.+||+ +|..|||+.+ +|.|||.
T Consensus 228 ---------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~------------------~~~~~~~ 264 (264)
T cd06653 228 ---------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEF------------------LLRHPFV 264 (264)
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHH------------------HhcCCCC
Confidence 01123578899999999999 5799999999 7999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=328.86 Aligned_cols=263 Identities=24% Similarity=0.412 Sum_probs=205.4
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|+..+.||+|+||.||++.+..+++.||||++...... .....+.+|+.++.++. ||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCc
Confidence 4677788999999999999999999999999998643222 44567889999999996 9999999998743 367
Q ss_pred EEEEEecCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 93 IYVVFELMESDLDQVIK-----ANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~-----~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.++||||++.++.++.. ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 89999999987655432 23579999999999999999999997 4999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCCcccCcccccccC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~-~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
...... .....++..|+|||++.+.. ..++.++||||+||++|+|++|++||...+. ....+........
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~--- 228 (288)
T cd06616 158 LVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP--- 228 (288)
T ss_pred hccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC---
Confidence 332211 12345888999999987611 3689999999999999999999999976541 1122211111000
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
+..+ ......+++++.+||.+||+.||.+|||+++ ++.||||
T Consensus 229 -------------------~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~------------------i~~~~~~ 270 (288)
T cd06616 229 -------------------PILS-NSEEREFSPSFVNFINLCLIKDESKRPKYKE------------------LLEHPFI 270 (288)
T ss_pred -------------------CcCC-CcCCCccCHHHHHHHHHHccCChhhCcCHHH------------------HhcChhh
Confidence 0000 0111357889999999999999999999999 8999999
Q ss_pred CCCC
Q 044076 326 HGLA 329 (506)
Q Consensus 326 ~~~~ 329 (506)
+...
T Consensus 271 ~~~~ 274 (288)
T cd06616 271 KDYE 274 (288)
T ss_pred hchh
Confidence 8643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=323.41 Aligned_cols=249 Identities=20% Similarity=0.296 Sum_probs=200.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR----- 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----
Confidence 467999999999999999999765 456789999987532 22334568899999999999999999999843
Q ss_pred CCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
....|+||||+++ +|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+|++|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 3679999999985 898888764 47899999999999999999999999999999999999999999999999987642
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...... ......++..|+|||++.+ ..++.++||||+||++|+|++ |++||.+.+..+.+..+.+....|
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----- 228 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP----- 228 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-----
Confidence 211110 0112234578999999877 789999999999999999775 999998877655554442211111
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+.++..+.+++.+||+.||.+|||+++|
T Consensus 229 -------------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i 258 (266)
T cd05064 229 -------------------------APRNCPNLLHQLMLDCWQKERGERPRFSQI 258 (266)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 123477889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=326.57 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=196.8
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEecccccC-hhHHHHHHHHHHHHHh---CCCCCcceeceeecCCCcCCCCcEEEE
Q 044076 21 IIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH-VSDATRILREIKLLRM---LKHPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~---l~HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
.||+|+||.||+|.+..+++.||||.+...... ........+|..+++. ..||||+.+++.+.. .+..|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 489999999999999999999999998643222 2222233455544443 469999999998843 3679999
Q ss_pred EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcc
Q 044076 97 FELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175 (506)
Q Consensus 97 ~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 175 (506)
|||+. ++|.+++..++.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99998 5999999888889999999999999999999999999999999999999999999999999986432211
Q ss_pred cccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHH
Q 044076 176 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255 (506)
Q Consensus 176 ~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~ 255 (506)
.....++..|+|||.+.+ ...++.++|+||+||++|+|++|..||.+....... .+...
T Consensus 152 -~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~------------------ 210 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRM------------------ 210 (279)
T ss_pred -ccCcCCCcCccCHHHhcC-CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHH------------------
Confidence 123468999999999864 156889999999999999999999999764322111 01000
Q ss_pred HHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 256 RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
..... ....+.+++++.+||.+||..||.+|+ |++| +++||||+++.
T Consensus 211 ------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~------------------~~~h~~~~~~~ 262 (279)
T cd05633 211 ------TLTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQE------------------VKEHVFFKGID 262 (279)
T ss_pred ------hhcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHH------------------HHhCccccCCC
Confidence 00000 012245789999999999999999999 5999 89999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=345.70 Aligned_cols=258 Identities=27% Similarity=0.398 Sum_probs=215.9
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.....|.-++.||.|+||.||-|+|..+.+.||||++.-.. +.......++.|++.|+.++|||+|.+.+.|+..
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre---- 98 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE---- 98 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc----
Confidence 34456778899999999999999999999999999996433 2445567899999999999999999999999754
Q ss_pred CCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...|||||||-|+..+++.- ..++.+.++..|+.+.|.||+|||+.+.||||||..|||+.+.|.|||+|||.|....
T Consensus 99 -~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 99 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred -chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 67899999998866666543 3579999999999999999999999999999999999999999999999999997642
Q ss_pred CCCCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
. ...+|||++|||||+++.. .+.|+-++||||||++..||.-++||+-..+....|.-|...-. |
T Consensus 178 P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-P------ 243 (948)
T KOG0577|consen 178 P-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P------ 243 (948)
T ss_pred c-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-C------
Confidence 2 2467999999999998541 26799999999999999999999999877776666655532110 0
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.. .-+..+..+..|+..||+.=|.+|||.++ +|.|+|...
T Consensus 244 ------------------tL----qs~eWS~~F~~Fvd~CLqKipqeRptse~------------------ll~H~fv~R 283 (948)
T KOG0577|consen 244 ------------------TL----QSNEWSDYFRNFVDSCLQKIPQERPTSEE------------------LLKHRFVLR 283 (948)
T ss_pred ------------------CC----CCchhHHHHHHHHHHHHhhCcccCCcHHH------------------Hhhcchhcc
Confidence 00 01346888999999999999999999999 899999875
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=317.14 Aligned_cols=253 Identities=30% Similarity=0.497 Sum_probs=212.2
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||.|+||.||++.+..++..||+|++............+.+|+.+++.++|||++++.+.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 69999999999999999999999999999999975444456677788999999999999999999988543 7899
Q ss_pred EEEecCCC-CHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 95 VVFELMES-DLDQVIKAN----DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 95 lV~E~~~~-~L~~~i~~~----~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+|+|++++ +|.+.+... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999985 999998764 6799999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. .......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+....
T Consensus 156 ~~---~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 219 (258)
T cd08215 156 TV---DLAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----------- 219 (258)
T ss_pred Cc---ceecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----------
Confidence 22 11234568889999999877 678899999999999999999999997665433332221100
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
....-...+..+.++|.+||..||.+|||+.+ +|+||||
T Consensus 220 -------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~------------------ll~~~~~ 258 (258)
T cd08215 220 -------------------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQ------------------ILQSPFI 258 (258)
T ss_pred -------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH------------------HhcCCCC
Confidence 00111257789999999999999999999999 8999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=326.13 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=202.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCC-----cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTG-----EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~-----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++|++.+.||+|+||.||+|.+...+ ..||+|.++.. ........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--- 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--- 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC---
Confidence 357999999999999999999876655 68999998642 223345568899999999999999999998843
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA 150 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv 150 (506)
....|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 80 --~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 80 --EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 367899999997 5999999764 457889999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchh
Q 044076 151 NADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAH 229 (506)
Q Consensus 151 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~ 229 (506)
+.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred cCCCcEEECCCcceeeccccccc-cccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999753322111 11234456888999999876 678999999999999999998 999998876554
Q ss_pred hHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 230 QLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 230 ~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....|... ... .....+++++.+|+.+||+.||.+|||+.||
T Consensus 235 ~~~~i~~~---------------------------~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i 276 (283)
T cd05048 235 VIEMIRSR---------------------------QLL---PCPEDCPARVYALMIECWNEIPARRPRFKDI 276 (283)
T ss_pred HHHHHHcC---------------------------CcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 44333210 000 1113578999999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=325.29 Aligned_cols=252 Identities=27% Similarity=0.363 Sum_probs=202.6
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecC
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 100 (506)
||.|+||+||+|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++. ..+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence 6899999999999999999999999854221 2233455678999999999999999999884 347899999999
Q ss_pred C-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccc
Q 044076 101 E-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177 (506)
Q Consensus 101 ~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 177 (506)
+ ++|.+.+.... .+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||.+....... ..
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KI 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cc
Confidence 8 59999987765 79999999999999999999999999999999999999999999999999987532211 12
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~ 257 (506)
....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.........+....
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 210 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT------------------- 210 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-------------------
Confidence 34567889999999877 568999999999999999999999997655422111111000
Q ss_pred HhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 258 LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.... ....+..++.+.+||.+||+.||.+|| ++.+ ++.||||..+.
T Consensus 211 -----~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~------------------ll~h~~~~~~~ 261 (277)
T cd05577 211 -----LEMA---VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADE------------------VREHPLFKDLN 261 (277)
T ss_pred -----cccc---ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHH------------------HHhChhhhcCC
Confidence 0000 012235789999999999999999999 8888 89999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.35 Aligned_cols=259 Identities=31% Similarity=0.496 Sum_probs=211.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++.+.||.|+||.||++.+..++..||+|.+.. ........+.+|+.+++.++||||+++++++.. ...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL--QQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecc--ccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCc
Confidence 4799999999999999999999999999999999853 233345668899999999999999999998844 367
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.|+|+||++ ++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999997 4999988754 58899999999999999999999999999999999999999999999999986532221
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......++..|+|||.+.+ ..++.++|+||+||++|+|++|++||.+.+...++..+.. .+.+.
T Consensus 170 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------- 234 (293)
T cd06647 170 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------- 234 (293)
T ss_pred c---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------
Confidence 1 1233468889999999876 6789999999999999999999999987665433322210 01100
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
......++..+.+||.+||..||.+|||+.+ ++.||||+....
T Consensus 235 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~------------------il~h~~~~~~~~ 277 (293)
T cd06647 235 ------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE------------------LLQHPFLKIAKP 277 (293)
T ss_pred ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHH------------------HhcCHHHhcCcc
Confidence 0111236788999999999999999999999 899999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=348.30 Aligned_cols=252 Identities=32% Similarity=0.528 Sum_probs=205.4
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecC
Q 044076 21 IIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 100 (506)
+||+|.||+||.|+|..|...+|||.|.. .+....+-+..||.+.++|+|.|||+.++.+ .+.+.+-|.||-.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecC
Confidence 79999999999999999999999999953 3445566788999999999999999999986 3347788999998
Q ss_pred C-CCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-CCCEEEeecCCcccccCCCCCcc
Q 044076 101 E-SDLDQVIKAN-DDL--TPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLARVSFTDTPSAI 175 (506)
Q Consensus 101 ~-~~L~~~i~~~-~~l--s~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-~~~lKL~DFGla~~~~~~~~~~~ 175 (506)
+ |+|..++++. +++ ++..+.++.+||++||+|||++.|||||||-+|+|||. .|.+||.|||-++....-.+..
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T- 733 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT- 733 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc-
Confidence 7 5999999874 677 89999999999999999999999999999999999985 6899999999997643333322
Q ss_pred cccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHH
Q 044076 176 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255 (506)
Q Consensus 176 ~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~ 255 (506)
..+.||..|||||++......|++++|||||||++.||.||+|||.. +|.|...+..
T Consensus 734 --ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E-------------lgspqAAMFk-------- 790 (1226)
T KOG4279|consen 734 --ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE-------------LGSPQAAMFK-------- 790 (1226)
T ss_pred --cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee-------------cCChhHhhhh--------
Confidence 45679999999999977668899999999999999999999999954 3333322211
Q ss_pred HHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 256 RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+..++.-+++| ..++.+++.||.+|+.+||.+||+|.+ +|.+||++.-
T Consensus 791 --VGmyKvHP~iP-----eelsaeak~FilrcFepd~~~R~sA~~------------------LL~DpFlq~~ 838 (1226)
T KOG4279|consen 791 --VGMYKVHPPIP-----EELSAEAKNFILRCFEPDPCDRPSAKD------------------LLQDPFLQHN 838 (1226)
T ss_pred --hcceecCCCCc-----HHHHHHHHHHHHHHcCCCcccCccHHH------------------hccCcccccC
Confidence 00111111111 236778999999999999999999999 6888888653
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=323.81 Aligned_cols=267 Identities=24% Similarity=0.372 Sum_probs=207.8
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|+..+.||.|++|.||+|.+..+++.||+|.+... .......++.+|+.+++.++||||+++++++... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC-CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence 4799999999999999999999999999999998642 2224556788999999999999999999988542 23578
Q ss_pred EEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 94 YVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
|+||||+++ +|.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999975 88877643 3468999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc--hhhHHHHHhhcCCCChHHH
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV--AHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~--~~~l~~I~~~~g~p~~e~~ 246 (506)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+...
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 218 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----------- 218 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-----------
Confidence 2211 23457889999999877 6789999999999999999999999976532 11111110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
++..............-...++.+.+||.+||..||.+|||+.| ++.||||.
T Consensus 219 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e------------------il~~~~~~ 270 (287)
T cd06621 219 ----------YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD------------------MLEHPWIK 270 (287)
T ss_pred ----------HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHH------------------HHhCcccc
Confidence 00000000000000000124678999999999999999999999 89999997
Q ss_pred CCCC
Q 044076 327 GLAN 330 (506)
Q Consensus 327 ~~~~ 330 (506)
....
T Consensus 271 ~~~~ 274 (287)
T cd06621 271 AQMK 274 (287)
T ss_pred cccc
Confidence 6443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.58 Aligned_cols=253 Identities=30% Similarity=0.509 Sum_probs=206.3
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecC
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 100 (506)
||.|+||.||+|.+..+|+.|++|.+.... ........+.+|+.+++.++||||+++++.+. .....|+|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence 689999999999999999999999986421 22345667889999999999999999998873 347899999999
Q ss_pred CC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC-----c
Q 044076 101 ES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS-----A 174 (506)
Q Consensus 101 ~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~-----~ 174 (506)
.+ +|.+++.+.+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 74 99999988778999999999999999999999999999999999999999999999999999764332110 1
Q ss_pred ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 175 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 175 ~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
.......++..|+|||.+.. ..++.++|+|||||++|+|++|..||......+....+.. +..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~------------- 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKI------------- 218 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCc-------------
Confidence 11234567889999999877 5688899999999999999999999987665544433321 100
Q ss_pred HHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH---hhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA---EEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa---~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.+.. ....++.+.+||.+||+.||.+|||+ .+ +|.||||+++
T Consensus 219 -------------~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~------------------~l~~~~~~~~ 263 (265)
T cd05579 219 -------------EWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEE------------------IKNHPFFKGI 263 (265)
T ss_pred -------------CCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHH------------------HhcCccccCC
Confidence 0000 01248899999999999999999999 88 8999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=325.08 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=210.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
...|+.++.||.|+||.||.|.+..++..||||.+... ........+.+|+.+++.+.||||+++++++.. ...
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTK 76 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCE
Confidence 35688899999999999999999999999999998632 223456678899999999999999999999843 478
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.|+||||+++ +|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999975 89988865 578999999999999999999999999999999999999999999999999997643222
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+.. +.
T Consensus 156 ~---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~----------- 217 (277)
T cd06640 156 I---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NN----------- 217 (277)
T ss_pred c---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CC-----------
Confidence 1 1133467889999999876 6789999999999999999999999976554332222100 00
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.......++..+.+||.+||..||.+|||+.+ ++.||||....
T Consensus 218 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------il~~~~~~~~~ 260 (277)
T cd06640 218 -----------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKE------------------LLKHKFIVKNA 260 (277)
T ss_pred -----------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHH------------------HHhChHhhhcc
Confidence 00112346778999999999999999999999 89999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=325.76 Aligned_cols=267 Identities=25% Similarity=0.371 Sum_probs=211.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++.+... ..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec-CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CE
Confidence 46899999999999999999999999999999988642 2234456788999999999999999999998543 78
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||+++ +|.+++...+.+++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999985 899998887889999999999999999999997 69999999999999999999999999998653221
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. ....+++..|+|||++.+ ..++.++|+||+||++|+|++|+.||...+...... ....
T Consensus 158 ~-----~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~--------~~~~------ 216 (284)
T cd06620 158 I-----ADTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ--------DDPM------ 216 (284)
T ss_pred c-----cCccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh--------hhhh------
Confidence 1 123468999999999876 688899999999999999999999997655321100 0000
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.....+..........+ ....++.++.+||.+||+.||.+|||+.| +++||||..-
T Consensus 217 --~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e------------------~~~~~~~~~~ 272 (284)
T cd06620 217 --GILDLLQQIVQEPPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQ------------------LCAMPPFIQA 272 (284)
T ss_pred --HHHHHHHHHhhccCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHH------------------HhcCcccccc
Confidence 00011111111111110 01126788999999999999999999999 8999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=329.70 Aligned_cols=259 Identities=28% Similarity=0.499 Sum_probs=210.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
..-|.....||.|+||.||+|.+..+++.||||.+... .......+.+|+.+++.+.||||+++++.+.. .+.
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~ 92 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEE 92 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCe
Confidence 34556667899999999999999999999999998532 22345568899999999999999999998843 378
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.|+|+||+++ +|..++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 9999999985 88887654 568999999999999999999999999999999999999999999999999986532221
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......++..|+|||++.+ ..++.++||||+||++++|++|++||...+..+.+..+.. .+
T Consensus 172 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~---------- 233 (297)
T cd06659 172 P---KRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SP---------- 233 (297)
T ss_pred c---cccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cC----------
Confidence 1 1234568999999999977 6789999999999999999999999977665444433311 00
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
.+.......+++.+.++|.+||+.||.+|||+++ +++||||.....
T Consensus 234 ---------------~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~------------------ll~~~~~~~~~~ 279 (297)
T cd06659 234 ---------------PPKLKNAHKISPVLRDFLERMLTREPQERATAQE------------------LLDHPFLLQTGL 279 (297)
T ss_pred ---------------CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHH------------------HhhChhhccCCC
Confidence 0111223457889999999999999999999999 899999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=319.06 Aligned_cols=247 Identities=25% Similarity=0.465 Sum_probs=201.8
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
...|.+.+.||.|+||.||+|.+..+++.||+|++.. +......+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 76 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecC---CchHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCC
Confidence 4569999999999999999999999999999999863 23345668899999999999999999998843 367
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+++||||++ ++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 899999997 5999998764 3589999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||++.+..+....+....
T Consensus 157 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 222 (263)
T cd05052 157 DTYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---------- 222 (263)
T ss_pred ceeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC----------
Confidence 22111 112224567999999876 678999999999999999998 999998876544433331100
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ...+.+++++.+||.+||+.||.+|||+.+|
T Consensus 223 -----------------~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 255 (263)
T cd05052 223 -----------------RM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255 (263)
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 00 1113578999999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=318.06 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=199.1
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEe
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFE 98 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E 98 (506)
...||+|+||.||+|.+..++..||+|.+.. ........+.+|+.+++.++|+||+++++++.. .+..|+|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecC--CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEEEEEEe
Confidence 3589999999999999999999999998864 233456678899999999999999999998743 378999999
Q ss_pred cCC-CCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-CCCEEEeecCCcccccCCCCC
Q 044076 99 LME-SDLDQVIKAN-DDL--TPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 99 ~~~-~~L~~~i~~~-~~l--s~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-~~~lKL~DFGla~~~~~~~~~ 173 (506)
|+. ++|.+++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 997 5999998764 455 88889999999999999999999999999999999986 67999999999975432221
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhH
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~ 253 (506)
......++..|+|||++.+....++.++|+||+||++|+|++|++||.............
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~------------------ 224 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV------------------ 224 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh------------------
Confidence 123345788999999986532458899999999999999999999996533211100000
Q ss_pred HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...... ......+++++.+|+.+||+.+|.+|||+.| ++.||||
T Consensus 225 -----~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~------------------ll~~~~~ 268 (268)
T cd06624 225 -----GMFKIH-----PEIPESLSAEAKNFILRCFEPDPDKRASAHD------------------LLQDPFL 268 (268)
T ss_pred -----hhhccC-----CCCCcccCHHHHHHHHHHcCCCchhCCCHHH------------------HHhCCCC
Confidence 000000 0112357889999999999999999999999 8999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=313.33 Aligned_cols=253 Identities=32% Similarity=0.527 Sum_probs=212.2
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++|||++++++++.. ....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 6899999999999999999999999999999997654444566788999999999999999999998743 37899
Q ss_pred EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 95 VVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 95 lV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
+||||+++ +|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999985 99999988888999999999999999999999999999999999999999999999999999764332221
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhH
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~ 253 (506)
.....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+..
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------- 213 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ----------------- 213 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-----------------
Confidence 133457889999999877 5588999999999999999999999976553322222110
Q ss_pred HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
. ......+.+++.+.++|.+||..||++|||+.+ ++.||||
T Consensus 214 ----------~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~------------------~l~~~~~ 254 (254)
T cd06627 214 ----------D---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQ------------------LLKHPWI 254 (254)
T ss_pred ----------c---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHH------------------HhcCCCC
Confidence 0 001122457889999999999999999999999 8999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=318.55 Aligned_cols=251 Identities=27% Similarity=0.430 Sum_probs=200.4
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHH-HhCCCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLL-RMLKHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL-~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||.|+||.||+|.+..+++.||||.+..... .......+..|..++ ..+.|+||+++++++. ..+.+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 679999999999999999999999999864221 112223344555544 4457999999999984 347899999
Q ss_pred ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||+++ +|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 99975 9999998888899999999999999999999999999999999999999999999999999875322
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
.....++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+.......+.....
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 210 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI----------------- 210 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-----------------
Confidence 123458889999999877 5589999999999999999999999987665443333311000
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH---hhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA---EEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa---~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.. .....+.+++.+.++|.+||+.||.+|||+ +| +|.||||..+.
T Consensus 211 -------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~------------------~l~~~~~~~~~ 258 (260)
T cd05611 211 -------NW---PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE------------------IKSHPFFKSIN 258 (260)
T ss_pred -------CC---CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH------------------HHcChHhhcCC
Confidence 00 001123578999999999999999999966 57 89999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=334.43 Aligned_cols=288 Identities=20% Similarity=0.236 Sum_probs=206.0
Q ss_pred EEEeec--CceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIG--SYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G--~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
..||+| +||+||.|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++.. .+..|+|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence 456666 99999999999999999999986443344456778899999999999999999999854 36789999
Q ss_pred ecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCc
Q 044076 98 ELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA 174 (506)
Q Consensus 98 E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~ 174 (506)
||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99984 999988764 358999999999999999999999999999999999999999999999998664322111110
Q ss_pred c----cccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 175 I----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 175 ~----~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. ......++..|+|||++.+....++.++||||+||++|+|++|++||.+......+..+.......+........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0 001123456799999987633457899999999999999999999998876554443332211111110000000
Q ss_pred hh-H----HHHHHhhhhcc-----C--CC---CCC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHH
Q 044076 251 NE-K----AKRYLSSLRRK-----W--AV---PFS-HKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLY 314 (506)
Q Consensus 251 ~~-~----~~~~~~~~~~~-----~--~~---~~~-~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~ 314 (506)
.. . ...+...+... . .. .+. ......++.+.+||++||+.||.+|||+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e-------------- 304 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASS-------------- 304 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHH--------------
Confidence 00 0 00000000000 0 00 000 011235778999999999999999999999
Q ss_pred hhhhhccCcccCCCCC
Q 044076 315 FYVLALADPYFHGLAN 330 (506)
Q Consensus 315 ~~~~aL~HP~f~~~~~ 330 (506)
+|+||||..+..
T Consensus 305 ----~l~~~~~~~~~~ 316 (328)
T cd08226 305 ----LLSHAFFKQVKE 316 (328)
T ss_pred ----HhhCHHHHHHHH
Confidence 899999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=322.36 Aligned_cols=266 Identities=21% Similarity=0.326 Sum_probs=204.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECC-----CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTH-----TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~-----t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
..++|++.+.||+|+||.||+|.++. .+..||+|.++.. ........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-ASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 46799999999999999999997542 3458999988643 223344567899999999999999999998743
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAN----------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK 155 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~----------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~ 155 (506)
....|+||||+. ++|.++++.. ..++...+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 81 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 ---GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred ---CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc
Confidence 367899999997 6999999753 23466788999999999999999999999999999999999999
Q ss_pred EEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHH
Q 044076 156 LKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLV 234 (506)
Q Consensus 156 lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I 234 (506)
+||+|||+++........ .......++..|+|||.+.+ ..++.++|+||+||++|+|++ |.+||.+.+..+.+..+
T Consensus 158 ~~L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 158 VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred EEECcCCccccccccccc-cccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999754322111 11122235677999999876 678999999999999999998 78999876654444333
Q ss_pred HhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHH
Q 044076 235 TDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLY 314 (506)
Q Consensus 235 ~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~ 314 (506)
... +. .......++.+.+++.+||+.||.+|||+.+|+.
T Consensus 235 ~~~-~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~----------- 273 (288)
T cd05061 235 MDG-GY-----------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN----------- 273 (288)
T ss_pred HcC-CC-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH-----------
Confidence 210 00 0011235788999999999999999999999521
Q ss_pred hhhhhccCcccCCC
Q 044076 315 FYVLALADPYFHGL 328 (506)
Q Consensus 315 ~~~~aL~HP~f~~~ 328 (506)
...-+.||||.++
T Consensus 274 -~l~~~~~~~~~~~ 286 (288)
T cd05061 274 -LLKDDLHPSFPEV 286 (288)
T ss_pred -HHHhhcCCCCCCC
Confidence 0001249999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=321.36 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=199.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
..++|++.+.||+|+||+||+|.+. .++..||||++... ........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 5678999999999999999999864 24568999998542 23344566889999999999999999999883
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND----------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK 155 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~----------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~ 155 (506)
+....++||||+. ++|.+++.... .++...+..++.||+.||.|||+.|++||||||+||+++.++.
T Consensus 80 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 --QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred --CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 3467999999998 59999987532 3577888999999999999999999999999999999999999
Q ss_pred EEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHH
Q 044076 156 LKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLV 234 (506)
Q Consensus 156 lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I 234 (506)
+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+
T Consensus 158 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred EEECCCCCccccCCccee-ecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999998753222111 01122345778999999876 678999999999999999998 78999877655444433
Q ss_pred HhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 235 TDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 235 ~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..... . ......++.+.+||.+||+.||.+|||+.|+
T Consensus 235 ~~~~~---------------------------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 271 (277)
T cd05062 235 MEGGL---------------------------L---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271 (277)
T ss_pred HcCCc---------------------------C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 22100 0 0112467889999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=322.22 Aligned_cols=252 Identities=27% Similarity=0.363 Sum_probs=196.4
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEecccccC-hhHHHHHHHH---HHHHHhCCCCCcceeceeecCCCcCCCCcEEEE
Q 044076 21 IIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH-VSDATRILRE---IKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~-~~~~~~~~rE---i~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
.||+|+||.||+|.+..+++.||||++...... .........| +.+++...||||+.+++.+.. .+.+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence 489999999999999999999999998643221 1111223333 344555679999999998843 4789999
Q ss_pred EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcc
Q 044076 97 FELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175 (506)
Q Consensus 97 ~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 175 (506)
|||+. ++|..++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99997 4899999888889999999999999999999999999999999999999999999999999986532211
Q ss_pred cccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHH
Q 044076 176 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255 (506)
Q Consensus 176 ~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~ 255 (506)
.....|+..|+|||++.+. ..++.++||||+||++|+|++|+.||.+.............
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 211 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------------ 211 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh------------------
Confidence 1234689999999998751 46889999999999999999999999765322111100000
Q ss_pred HHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 256 RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
..... ...+..++.+.+||.+||..||.+|| ++.+ +++||||+...
T Consensus 212 -------~~~~~---~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~------------------ll~~~~~~~~~ 262 (278)
T cd05606 212 -------LTMAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE------------------VKEHPFFRSLD 262 (278)
T ss_pred -------hccCC---CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHH------------------HHhCccccCCC
Confidence 00000 11124689999999999999999999 9999 89999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=314.27 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=209.4
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|++.+.||.|+||.||++.+..+++.+|+|++............+.+|+.+++.++|+||+++++++.. ....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence 5899999999999999999999999999999997544444556678899999999999999999998854 37899
Q ss_pred EEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 95 VVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 95 lV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+|+||+++ +|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999975 89998866 35689999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. .....++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+.......+....
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 217 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK----------- 217 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 31 123457889999999977 678899999999999999999999997766443322221100
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
+...-...+.++.++|.+||+.||.+|||+.+ +|+||++
T Consensus 218 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------~l~~p~~ 256 (256)
T cd08530 218 -------------------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDK------------------ILASPAV 256 (256)
T ss_pred -------------------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHH------------------HhcCCCC
Confidence 00111246788999999999999999999999 8999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=322.52 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=201.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++|.+.+.||+|+||.||+|.+. .++..||||+++... .......+.+|+.+|+.+.||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTE--- 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEec---
Confidence 467999999999999999999874 346789999986432 22345678899999999999999999999854
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAND--------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA 152 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~--------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~ 152 (506)
....|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||+++.
T Consensus 80 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 80 --GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred --CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 377999999997 59999997642 4788999999999999999999999999999999999999
Q ss_pred CCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhH
Q 044076 153 DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQL 231 (506)
Q Consensus 153 ~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l 231 (506)
++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999753222111 11123346788999999977 689999999999999999998 99999877655544
Q ss_pred HHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 232 ~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+..... .......+..+.+||.+||+.||.+|||+.||
T Consensus 235 ~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 235 ECITQGRL------------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred HHHHcCCc------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 44321000 01113478899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=330.36 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=213.6
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
-|.++++||+|+||.|++|.++.+|..||||++.. ..+.+.+.+||.||+++..|+||++|+.|... .++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----CceE
Confidence 36678999999999999999999999999999863 46788899999999999999999999988543 7899
Q ss_pred EEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 95 VVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
||||||+ |++.++++. +.+|+++++..+++..|+||+|||...-+|||||..|||+|.+|..||+|||.|......-.
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999998 799999975 46899999999999999999999999999999999999999999999999999965322111
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
.....+||+.|+|||++.. -.|+..+||||||+...||..|+|||.+-.....+.+| --.|++.
T Consensus 185 ---KRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPT-------- 248 (502)
T KOG0574|consen 185 ---KRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPT-------- 248 (502)
T ss_pred ---hhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCC--------
Confidence 1245679999999999987 68999999999999999999999999765543322222 1112111
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
| ..-...+.++-|||++||...|++|-||.+ +++|||.++.
T Consensus 249 ----------------F-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~------------------L~~H~FiknA 289 (502)
T KOG0574|consen 249 ----------------F-KKPEEWSSEFNDFIRSCLIKKPEERKTALR------------------LCEHTFIKNA 289 (502)
T ss_pred ----------------C-CChHhhhhHHHHHHHHHhcCCHHHHHHHHH------------------HhhhhhhcCC
Confidence 1 111236788999999999999999999999 8999999874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.82 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=196.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCC-----cEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTG-----EKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~-----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|++++.||+|+||.||+|++..+| ..||||+++... .......+.+|+.+++.+ +||||+++++.+..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 457999999999999999999865443 579999996432 233456688999999999 79999999998843
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhC------------------------------------------------------
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAN------------------------------------------------------ 111 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~------------------------------------------------------ 111 (506)
.+.+|+||||+. |+|.+++...
T Consensus 114 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 114 ---GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ---CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 368999999997 5999888542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcc
Q 044076 112 ----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175 (506)
Q Consensus 112 ----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 175 (506)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-V 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-e
Confidence 14788899999999999999999999999999999999999999999999999754322111 1
Q ss_pred cccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 176 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 176 ~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||++......+..+....
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~---------------- 331 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG---------------- 331 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc----------------
Confidence 1122335567999999977 689999999999999999997 999998755433222221100
Q ss_pred HHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.... .-...++++.+||.+||+.||.+|||+.+|
T Consensus 332 ----------~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~l 365 (374)
T cd05106 332 ----------YQMS---RPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365 (374)
T ss_pred ----------cCcc---CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0000 012357899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=317.28 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=196.9
Q ss_pred EEeecCceEEEEEEE--CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEe
Q 044076 21 IIGIGSYGVVASAID--THTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFE 98 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d--~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E 98 (506)
.||+|+||.||+|.+ ..++..||+|+++....+......+.+|+.+++.+.||||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 589999999999964 467789999998754444455677889999999999999999998862 246799999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccc
Q 044076 99 LME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177 (506)
Q Consensus 99 ~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 177 (506)
|++ ++|.+++.....+++..+..++.||+.||+|||++||+||||||.||+++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 998 5899999887889999999999999999999999999999999999999999999999999997643322111111
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+....
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~------------------ 215 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE------------------ 215 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC------------------
Confidence 22334578999999876 678899999999999999998 999998776555444442110
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ...+.+++++.+||.+||+.||.+|||+++|
T Consensus 216 ---------~~---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i 248 (257)
T cd05116 216 ---------RM---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248 (257)
T ss_pred ---------CC---CCCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence 00 1113578999999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.31 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=215.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
+..+-|+|+..||.|+||.||+|.++.++-..|.|+|.. ........++-||.||..+.||+||+|++.|+..
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e----- 101 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE----- 101 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----
Confidence 344568899999999999999999999998899998843 4556677888999999999999999999988654
Q ss_pred CcEEEEEecCCCCH-HHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELMESDL-DQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~~L-~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
+.++|+.|||+|.. ..++.. ...|++..++.+++|++.||.|||+++|||||||..|||+.-+|.++|+|||.+....
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK 181 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch
Confidence 78999999999744 444433 4579999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
.. ......++||++|||||+.... ..+|++++||||||++|.||..+.||-..-+....+-+|.+- .|
T Consensus 182 ~t---~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--eP---- 252 (1187)
T KOG0579|consen 182 ST---RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EP---- 252 (1187)
T ss_pred hH---HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CC----
Confidence 21 1123567899999999996431 267999999999999999999999999887776666555321 01
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
+.- -.-...+..+.|||.+||..||..||++.+ +|+||||
T Consensus 253 --------------------PTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaq------------------ll~Hpfv 292 (1187)
T KOG0579|consen 253 --------------------PTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQ------------------LLKHPFV 292 (1187)
T ss_pred --------------------Ccc--cCcchhhhHHHHHHHHHHhcCCccCCCHHH------------------HhhCccc
Confidence 100 011346788999999999999999999999 8999999
Q ss_pred CCCC
Q 044076 326 HGLA 329 (506)
Q Consensus 326 ~~~~ 329 (506)
++..
T Consensus 293 ~~~~ 296 (1187)
T KOG0579|consen 293 QNAP 296 (1187)
T ss_pred ccCC
Confidence 8743
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.97 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=196.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEE-----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d-----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|++.+.||+|+||.||+|.+ ..++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC-cCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 35899999999999999999974 356778999998643 2234456788999999999 79999999998843
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC-----------------------------------------------------
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND----------------------------------------------------- 112 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~----------------------------------------------------- 112 (506)
.+..|+||||++ |+|.+++....
T Consensus 111 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 111 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred ---CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 367899999998 59998886421
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 113 ----------------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 113 ----------------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 4678889999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+..
T Consensus 268 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~------------- 331 (375)
T cd05104 268 SNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK------------- 331 (375)
T ss_pred ccc-cccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH-------------
Confidence 211 11122335667999999987 689999999999999999998 8999976554322221111
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..... ......+.++.+||.+||+.||++|||+.||
T Consensus 332 -------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 367 (375)
T cd05104 332 -------------EGYRM---LSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367 (375)
T ss_pred -------------hCccC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 00000 0112357889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=357.71 Aligned_cols=148 Identities=24% Similarity=0.427 Sum_probs=133.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||.||+|.+..+++.||||+++.. .........+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 47899999999999999999999999999999999642 223344567889999999999999999998873 347
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.+||||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 8999999996 5999999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=321.53 Aligned_cols=248 Identities=22% Similarity=0.341 Sum_probs=196.7
Q ss_pred CCCEEEeEEE--eecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEII--GIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~L--G~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~ 89 (506)
.+.|++.+.+ |.|+||.||++.+..++..+|+|.+...... . .|+.....+ .||||+++++.+..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~-----~e~~~~~~~~~h~~iv~~~~~~~~----- 80 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--A-----IEPMVHQLMKDNPNFIKLYYSVTT----- 80 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--h-----hhHHHHHHhhcCCCEEEEEEEEec-----
Confidence 3566776666 9999999999999999999999998642111 1 122223323 69999999999854
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-CEEEeecCCcccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-KLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-~lKL~DFGla~~~ 167 (506)
.+.+|+||||++ ++|.+++..+..+++..++.++.||++||.|||+.|++||||||+||+++.++ .++|+|||+++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 368999999997 59999998888999999999999999999999999999999999999999998 9999999998753
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhh-HHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQ-LDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~-l~~I~~~~g~p~~e~~ 246 (506)
... ....++..|+|||++.+ ..++.++|+||+||++|+|++|+.||.+...... ...+
T Consensus 161 ~~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~------------ 219 (267)
T PHA03390 161 GTP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL------------ 219 (267)
T ss_pred CCC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH------------
Confidence 221 23458889999999977 6789999999999999999999999975443210 0111
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-AEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-a~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.... .......+..++.+.+||.+||+.||.+||+ ++| +|+||||
T Consensus 220 -----------~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~------------------~l~h~~~ 265 (267)
T PHA03390 220 -----------LKRQ-----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNE------------------IIKHPFL 265 (267)
T ss_pred -----------HHhh-----cccCCcccccCHHHHHHHHHHhccChhhCCchHHH------------------HhcCCcc
Confidence 0000 0001222468999999999999999999996 599 8999999
Q ss_pred CC
Q 044076 326 HG 327 (506)
Q Consensus 326 ~~ 327 (506)
.+
T Consensus 266 ~~ 267 (267)
T PHA03390 266 KI 267 (267)
T ss_pred cC
Confidence 63
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=318.60 Aligned_cols=253 Identities=21% Similarity=0.346 Sum_probs=199.9
Q ss_pred EEEeEEEeecCceEEEEEEECCC---CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-CCCC
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHT---GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-REFK 91 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t---~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~~~~ 91 (506)
|++++.||+|+||.||.|.+..+ +..||||+++...........+.+|+.+++.+.||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999987653 4789999987543444556678899999999999999999998765422 2334
Q ss_pred cEEEEEecCC-CCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 92 DIYVVFELME-SDLDQVIKAN------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
..++|+||+. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 5899999998 5998888542 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~------ 231 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG------ 231 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------
Confidence 7643322110 0111234567999999876 678999999999999999999 99999876654433333110
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ......+++.+.++|.+||+.||.+|||+.||
T Consensus 232 ---------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~ 265 (273)
T cd05035 232 ---------------------NR---LKQPEDCLDELYDLMYSCWRADPKDRPTFTKL 265 (273)
T ss_pred ---------------------CC---CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00 01123578899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=320.17 Aligned_cols=257 Identities=29% Similarity=0.468 Sum_probs=207.7
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC---CCCcceeceeecCCCcCCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK---HPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~---HpnIv~l~~v~~~~~~~~~~ 91 (506)
.|++++.||.|+||.||+|.+..+++.||||.++... .......+.+|+.+++.+. ||||+++++++.. ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CC
Confidence 5888999999999999999999999999999986422 2234556889999999996 9999999998743 36
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
..|+||||+.+ +|.+++.. +.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 89999999975 89988865 47999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. ......++..|+|||.+.+. ..++.++|+||+||++|+|++|.+||.+.........+..
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------------- 216 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-------------- 216 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc--------------
Confidence 21 12345688999999988652 5678899999999999999999999976543322211100
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.....+ .....+.++.++|.+||+.||.+|||+.+ ++.||||+...
T Consensus 217 -------------~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~------------------il~~~~~~~~~ 262 (277)
T cd06917 217 -------------SKPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEE------------------LLKSKWIKAHS 262 (277)
T ss_pred -------------CCCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHH------------------HhhChHhhccc
Confidence 000000 00126788999999999999999999999 89999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=318.10 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=199.6
Q ss_pred EEEeEEEeecCceEEEEEEECCCCc--EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-CCCCc
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGE--KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-REFKD 92 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~--~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~~~~~ 92 (506)
|.+.+.||+|+||.||+|.+..++. .||+|.++...........+.+|+.+++.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999877775 69999987544455667788899999999999999999997654321 22346
Q ss_pred EEEEEecCC-CCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 93 IYVVFELME-SDLDQVIKA------NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~------~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.++||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 899999998 599888742 1348899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |++||++....+....+..
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------- 229 (272)
T cd05075 161 KIYNGDYY-RQGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-------- 229 (272)
T ss_pred ccCcccce-ecCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 64332211 01122235678999999987 678999999999999999999 8999987655433332211
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.... ...+.++..+.++|.+||+.||.+|||+++|
T Consensus 230 -------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 264 (272)
T cd05075 230 -------------------GNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264 (272)
T ss_pred -------------------CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 0000 1123577889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=317.57 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=198.9
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++.+.||+|+||.||+|.+..+ ..||+|+++... .....+.+|+.+++.++||||+++++.+. .
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~ 72 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------E 72 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC------C
Confidence 3457899999999999999999988655 459999986422 22356789999999999999999998762 1
Q ss_pred CcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 91 KDIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
...|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||.++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence 45799999998 4999999763 35889999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
....... .....++..|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+....+.+..+.....
T Consensus 153 ~~~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------- 221 (262)
T cd05071 153 EDNEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------- 221 (262)
T ss_pred ccccccc--ccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-------
Confidence 3222111 123346678999999876 678999999999999999999 8999987765544444321110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+ ..+.++..+.+||.+||+.||.+|||+.++
T Consensus 222 --------------------~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~ 253 (262)
T cd05071 222 --------------------MP---CPPECPESLHDLMCQCWRKEPEERPTFEYL 253 (262)
T ss_pred --------------------CC---CccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 00 113477889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=353.55 Aligned_cols=254 Identities=24% Similarity=0.424 Sum_probs=203.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceece-eecCCCcCC-
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKH-IMLPPCRRE- 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~-v~~~~~~~~- 89 (506)
..+++|.++|.+|||+.||.|.+...|..||+|++-. .+......+.+||.+|+.|+ |+|||.+++ .......+.
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~--~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV--NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec--CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3578999999999999999999998889999999853 36667778999999999998 999999999 333332232
Q ss_pred CCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 90 FKDIYVVFELME-SDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
.-.++|.||||. |.|.+++.. ...|++.++..|++|+++|+++||... |||||||-+|||++.+|..||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 356899999999 699999974 346999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCcc---cc---cccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhh
Q 044076 165 RVSFTDTPSAI---FW---TDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDL 237 (506)
Q Consensus 165 ~~~~~~~~~~~---~~---~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~ 237 (506)
.-......... .. -....|+.|||||.+.- .+...++++|||+|||+||-|+....||.+......+
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl------ 267 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL------ 267 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE------
Confidence 54222111100 00 12347899999998721 1267899999999999999999999999765432211
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..++..| .+|+++..+.+||+.||+.||.+||++-||
T Consensus 268 ------------------------ng~Y~~P---~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv 304 (738)
T KOG1989|consen 268 ------------------------NGNYSFP---PFPNYSDRLKDLIRTMLQPNPDERPNIYQV 304 (738)
T ss_pred ------------------------eccccCC---CCccHHHHHHHHHHHHhccCcccCCCHHHH
Confidence 1111111 236789999999999999999999999995
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=310.78 Aligned_cols=259 Identities=28% Similarity=0.431 Sum_probs=212.0
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+|.+.+.||.|++|.||+|.+..+++.|++|++............+.+|+.+++.++||||+++++.+.... ...+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 588999999999999999999999999999999654333456778899999999999999999999885421 26789
Q ss_pred EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 95 VVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
+|+||++ ++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999995 699999988879999999999999999999999999999999999999999999999999999765443221
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhH
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~ 253 (506)
.......++..|+|||.+.+ ..++.++|||||||++++|++|..||...+. ....+.....
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~-------------- 218 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGS-------------- 218 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccc--------------
Confidence 01133568889999999877 5689999999999999999999999977652 1111111100
Q ss_pred HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...........+..+.+||.+||+.||.+|||+.+ ++.||||
T Consensus 219 ------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~------------------ll~~~~~ 260 (260)
T cd06606 219 ------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE------------------LLQHPFL 260 (260)
T ss_pred ------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHH------------------HhhCCCC
Confidence 00011122345889999999999999999999999 8999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.41 Aligned_cols=276 Identities=24% Similarity=0.282 Sum_probs=201.4
Q ss_pred CceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecCC-CCH
Q 044076 26 SYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDL 104 (506)
Q Consensus 26 ~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-~~L 104 (506)
++|.||.+++..+++.||||+++...........+.+|+.+++.++||||+++++++.. .+..|++|||++ ++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEeccCCCCH
Confidence 45666667767899999999997543345567789999999999999999999999854 367899999998 589
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC----ccccc
Q 044076 105 DQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS----AIFWT 178 (506)
Q Consensus 105 ~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~----~~~~~ 178 (506)
.+++... ..+++..+..+++||+.||+|||++||+||||||+||+++.++.+||+|||.+......... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 9988753 46899999999999999999999999999999999999999999999999998653322111 11123
Q ss_pred ccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHH
Q 044076 179 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYL 258 (506)
Q Consensus 179 ~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~ 258 (506)
...++..|+|||++.+....|+.++||||+||++++|++|+.||...+....+. ....|...... .... .....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~-~~~~---~~~~~ 240 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCLL-DKST---YPLYE 240 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCcccc-ccCc---hhhhc
Confidence 345778899999986633468899999999999999999999998765433221 12222211100 0000 00000
Q ss_pred hhhhc--------cCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 259 SSLRR--------KWAVPF-SHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 259 ~~~~~--------~~~~~~-~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
..+.. ...... ......+++++.+||.+||++||.+|||+++ +|+||||+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~------------------ll~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ------------------LLNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH------------------HhcCchHhhhc
Confidence 00000 000000 0111235678999999999999999999999 89999999876
Q ss_pred C
Q 044076 330 N 330 (506)
Q Consensus 330 ~ 330 (506)
.
T Consensus 303 ~ 303 (314)
T cd08216 303 R 303 (314)
T ss_pred c
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=320.29 Aligned_cols=263 Identities=23% Similarity=0.382 Sum_probs=208.5
Q ss_pred CEEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccc--cChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVF--EHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~ 88 (506)
.|++.+.||.|+||.||.|.+. .+|+.||+|.++... ........+.+|+.+++.+. |+||+.+++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 4899999999999999999875 478999999986421 12234566788999999995 9999999988743
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
...+|+||||+++ +|.+.+.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||+++..
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 4678999999984 99999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
...... ......++..|+|||.+.+....++.++|||||||++|+|++|..||...+.......+....
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--------- 224 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--------- 224 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh---------
Confidence 322111 123456889999999987533457889999999999999999999996543322222221100
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
+....+ .-+.+++.+.+|+.+||+.||.+|| ++++ ++.|
T Consensus 225 -------------~~~~~~-----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~------------------l~~~ 268 (290)
T cd05613 225 -------------LKSEPP-----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADE------------------IKKH 268 (290)
T ss_pred -------------hccCCC-----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH------------------HHcC
Confidence 000000 1134788999999999999999997 7888 8999
Q ss_pred cccCCCC
Q 044076 323 PYFHGLA 329 (506)
Q Consensus 323 P~f~~~~ 329 (506)
|||....
T Consensus 269 ~~~~~~~ 275 (290)
T cd05613 269 PFFQKIN 275 (290)
T ss_pred cccccCC
Confidence 9998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=324.61 Aligned_cols=257 Identities=27% Similarity=0.390 Sum_probs=210.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..+.|...+.||.|+||.||+|.+..+++.|+||++..... .......+.+|+.+++.++|||++++++++.. .
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 93 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----E 93 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----C
Confidence 34457888999999999999999999999999999864322 33344678899999999999999999999843 3
Q ss_pred CcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
...|+||||+.++|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 94 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 77999999999999888865 45689999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.....++..|+|||++... ...++.++||||+||++|+|++|.+||.+.+....+..+.... .|
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~------- 238 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SP------- 238 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CC-------
Confidence 1345688899999997421 2468889999999999999999999997766544443332100 00
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
....+.++..+.+||.+||+.||.+|||+.+ ++.||||+.
T Consensus 239 ---------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~------------------~l~~~~~~~ 278 (313)
T cd06633 239 ---------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAE------------------LLRHDFVRR 278 (313)
T ss_pred ---------------------CCCccccCHHHHHHHHHHccCChhhCcCHHH------------------HhcCcccCC
Confidence 0112346778999999999999999999999 899999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=316.09 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=200.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++.+.||.|+||.||+|++..+++.||||+++... ........+.+|+.+++.++||||+++++++.. .+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 68999999999999999999999999999999885422 233445668899999999999999999998853 368
Q ss_pred EEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 93 IYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.|+|+||+++ +|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 8999999985 88888753 345899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc--hhhHHHHHhhcCCCChHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV--AHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~--~~~l~~I~~~~g~p~~e~ 245 (506)
..... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||..... ......+ ...+.|+
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--- 227 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPP--- 227 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCC---
Confidence 32211 1233468889999999877 6788999999999999999999999865432 1111111 1111110
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
......+..+.+||.+||..||.+|||+.+|
T Consensus 228 -------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~v 258 (267)
T cd08228 228 -------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258 (267)
T ss_pred -------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHH
Confidence 0012367789999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=326.36 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=198.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcE----EEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEK----VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~----vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
..+|++.+.||+|+||.||+|.+..+++. ||||+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---- 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT---- 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC----
Confidence 56799999999999999999998766654 899998642 233455678899999999999999999998743
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
...++|+||+. |+|.+++.... .++...+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 81 --STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred --CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 34689999987 69999998754 688999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
........ ......++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.+....+....+..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (316)
T cd05108 159 LGADEKEY-HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------- 226 (316)
T ss_pred ccCCCcce-eccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC---------
Confidence 43322111 1122234667999999977 688999999999999999997 9999977654332221110
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+ ..+..+.++.+++.+||..||.+|||+.+|
T Consensus 227 ------------------~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l 261 (316)
T cd05108 227 ------------------GERLP---QPPICTIDVYMIMVKCWMIDADSRPKFREL 261 (316)
T ss_pred ------------------CCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00001 113467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=313.66 Aligned_cols=243 Identities=24% Similarity=0.388 Sum_probs=192.6
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEec
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFEL 99 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~ 99 (506)
+.||+|+||.||+|++..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.. ...+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEee
Confidence 46899999999999999999999999886432 23345678899999999999999999999843 3679999999
Q ss_pred CC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccc
Q 044076 100 ME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177 (506)
Q Consensus 100 ~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 177 (506)
+. ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 97 49999987644 68999999999999999999999999999999999999999999999999997533211110 00
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
.....+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+...
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~------------------- 212 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG------------------- 212 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-------------------
Confidence 11123456999999877 678999999999999999997 89999665443322222110
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+ .....+..+.+|+.+||+.||.+|||+.+|
T Consensus 213 --------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 246 (252)
T cd05084 213 --------VRLP---CPELCPDAVYRLMERCWEYDPGQRPSFSTV 246 (252)
T ss_pred --------CCCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0001 112467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=315.12 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=200.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+.+++.++|+||+++++.+.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 74 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EE 74 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CC
Confidence 4578999999999999999999864 5677999987632 2345678899999999999999999988743 36
Q ss_pred cEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..|+||||+. ++|.++++.. ..++...+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++...
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecC
Confidence 7899999997 5999998753 468899999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||++....+....+....
T Consensus 155 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--------- 221 (261)
T cd05072 155 DNEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY--------- 221 (261)
T ss_pred CCcee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---------
Confidence 22111 1123345678999999876 678999999999999999998 999998766554444332111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. .....++.++.+|+.+||..||++|||+++|
T Consensus 222 ------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 254 (261)
T cd05072 222 ------------------RM---PRMENCPDELYDIMKTCWKEKAEERPTFDYL 254 (261)
T ss_pred ------------------CC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 00 1123478899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=316.17 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=199.3
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||.||+|.+. .+..||+|++.... .....+.+|+.+++.++|+||+++++++. .
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~ 72 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGT---MSPESFLEEAQIMKKLRHDKLVQLYAVVS------E 72 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCC---CCHHHHHHHHHHHHhcCCCceEEEEeEEC------C
Confidence 34568999999999999999999865 56679999986422 22345889999999999999999998762 1
Q ss_pred CcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 91 KDIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
...|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 45799999997 5999998764 35899999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------- 221 (260)
T cd05070 153 EDNEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR------- 221 (260)
T ss_pred cCcccc--cccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 322111 1122345678999999876 678999999999999999999 9999988766555544422110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ......+..+.+|+.+||..||.+|||+.+|
T Consensus 222 --------------------~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 253 (260)
T cd05070 222 --------------------M---PCPQDCPISLHELMLQCWKKDPEERPTFEYL 253 (260)
T ss_pred --------------------C---CCCCcCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 0 1113467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.81 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=197.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECC-----CCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTH-----TGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~-----t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|++.+.||.|+||.||+|.+.. +++.||+|+++... .......+.+|+.+++++ .|+||+++++.+...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 3689999999999999999997543 45789999986432 233456678999999999 799999999987432
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhC------------------------------------------------------
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKAN------------------------------------------------------ 111 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~------------------------------------------------------ 111 (506)
...+|+||||+.+ +|.+++...
T Consensus 84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 3578999999985 898888642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCC
Q 044076 112 -------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184 (506)
Q Consensus 112 -------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~ 184 (506)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCc
Confidence 25788999999999999999999999999999999999999999999999999764322211 1112345667
Q ss_pred cccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhc
Q 044076 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRR 263 (506)
Q Consensus 185 ~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~ 263 (506)
.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+..... .
T Consensus 240 ~y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~--------------------------~ 291 (337)
T cd05054 240 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK--------------------------E 291 (337)
T ss_pred cccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh--------------------------c
Confidence 8999999987 789999999999999999998 9999987543322211110 0
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 264 KWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 264 ~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.... ..-...++++.+++.+||+.+|.+|||+.||
T Consensus 292 ~~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~el 326 (337)
T cd05054 292 GTRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326 (337)
T ss_pred cCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000 0012467899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=314.05 Aligned_cols=246 Identities=23% Similarity=0.366 Sum_probs=198.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++.+.||+|+||.||+|... .+..+|+|.+... ......+.+|+.+|+.++||||+++++++. +...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 73 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKP 73 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCC
Confidence 467999999999999999999864 4567999987532 223456789999999999999999999884 3467
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||.++.....
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 999999997 5999988753 46899999999999999999999999999999999999999999999999999753222
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... ......++..|+|||++.+ ..++.++|+||+||++|+|++ |++||.+.+..+.+..+......
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--------- 220 (256)
T cd05114 154 EYT--SSSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL--------- 220 (256)
T ss_pred cee--ccCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC---------
Confidence 111 1122335567999999876 678999999999999999999 99999887766555555321100
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ....+..+.+|+.+||+.||.+|||+++|
T Consensus 221 ------------------~~---~~~~~~~~~~li~~c~~~~p~~Rps~~~l 251 (256)
T cd05114 221 ------------------YR---PKLASMTVYEVMYSCWHEKPEGRPTFAEL 251 (256)
T ss_pred ------------------CC---CCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 00 01256789999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=320.25 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=201.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEE-----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d-----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
....|.+.+.||.|+||.||++.+ ..++..||+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 78 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE-- 78 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 346799999999999999999985 335567999988642 33445678899999999999999999999843
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND-------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA 152 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~-------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~ 152 (506)
...+|+||||++ ++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||++++
T Consensus 79 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~ 155 (288)
T cd05093 79 ---GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155 (288)
T ss_pred ---CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 377999999997 59999997543 4899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhH
Q 044076 153 DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQL 231 (506)
Q Consensus 153 ~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l 231 (506)
++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~ 232 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232 (288)
T ss_pred CCcEEeccCCccccccCCcee-ecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999754322111 11123345778999999877 678999999999999999998 99999877655544
Q ss_pred HHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 232 ~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+... . .. ......++++.+|+.+||+.||.+|||+.+|
T Consensus 233 ~~i~~~--~-------------------------~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v 272 (288)
T cd05093 233 ECITQG--R-------------------------VL---QRPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272 (288)
T ss_pred HHHHcC--C-------------------------cC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 444221 0 00 0112467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.94 Aligned_cols=251 Identities=31% Similarity=0.525 Sum_probs=207.7
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
.|++.+.||.|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 48899999999999999999999999999999964322 3566788999999999999999999988443 7799
Q ss_pred EEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 95 VVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
+|+||++ ++|.+++... ..+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 5999998776 5799999999999999999999999999999999999999999999999999976433221
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
.....++..|+|||.+.+ ..++.++|+|||||++++|++|+.||...+....+..+.. ...+
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~----------- 215 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPP----------- 215 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCC-----------
Confidence 134568889999999877 5688999999999999999999999977654433332211 0000
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
.. ..-..++..+.++|.+||+.||.+|||+.| +|+|||
T Consensus 216 -------------~~---~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~------------------~l~~~~ 253 (253)
T cd05122 216 -------------GL---RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ------------------LLKHPF 253 (253)
T ss_pred -------------Cc---CcccccCHHHHHHHHHHccCChhhCCCHHH------------------HhcCCC
Confidence 00 000124788999999999999999999999 899998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=321.46 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=197.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCc--EEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGE--KVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~--~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~ 90 (506)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ........+.+|+.++.++ .||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----R 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----C
Confidence 579999999999999999999887765 4788887632 2334456788999999999 69999999998743 3
Q ss_pred CcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC
Q 044076 91 KDIYVVFELME-SDLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD 153 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~ 153 (506)
+.+|+|+||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 67999999997 59999997542 48889999999999999999999999999999999999999
Q ss_pred CCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHH
Q 044076 154 CKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLD 232 (506)
Q Consensus 154 ~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~ 232 (506)
+.+||+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864221111 011123456999999876 678999999999999999997 999998776554443
Q ss_pred HHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 233 LVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 233 ~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+.... .. .....+++++.+||.+||+.||.+|||+++|
T Consensus 230 ~~~~~~---------------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 230 KLPQGY---------------------------RM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred HHhcCC---------------------------CC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 331110 00 1113478899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=317.33 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=208.1
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
-|++++.||.|+||.||+|.+..+++.||||.+... ........+.+|+.+++.++||||+++++.+.. ....|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc-cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEE
Confidence 477889999999999999999999999999987532 223345678899999999999999999998843 37899
Q ss_pred EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 95 VVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 95 lV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999985 88888764 4689999999999999999999999999999999999999999999999999865432211
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhH
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~ 253 (506)
......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+.. +
T Consensus 157 --~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~-------------- 216 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK--N-------------- 216 (277)
T ss_pred --hhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc--C--------------
Confidence 1233468889999999876 6788899999999999999999999976554333322210 0
Q ss_pred HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
. .......++.++.++|.+||+.||.+||++.+ +++||||...
T Consensus 217 -----------~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~------------------~l~~~~~~~~ 259 (277)
T cd06641 217 -----------N---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKE------------------LLKHKFIVRF 259 (277)
T ss_pred -----------C---CCCCCcccCHHHHHHHHHHccCChhhCcCHHH------------------HHhCHHHhhh
Confidence 0 00111346889999999999999999999999 8999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=322.82 Aligned_cols=256 Identities=27% Similarity=0.376 Sum_probs=207.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
..|++.+.||.|+||.||+|.+..++..||+|.+... ........+.+|+.+++.++||||+++++.+.. ....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccc-cchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCce
Confidence 4577888999999999999999999999999998632 223345678899999999999999999998843 3679
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999985 88888764 5789999999999999999999999999999999999999999999999999975432211
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
......++..|+|||.+.+ ..++.++|+|||||++++|++|++||...........+.
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----------------- 214 (277)
T ss_pred ---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-----------------
Confidence 1123457889999999987 678999999999999999999999996554332222110
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.... .......+..+.+||.+||+.||.+|||+.+ ++.||||....
T Consensus 215 ----------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------il~~~~~~~~~ 260 (277)
T cd06642 215 ----------KNSP---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKE------------------LLKHKFITRYT 260 (277)
T ss_pred ----------cCCC---CCCCcccCHHHHHHHHHHccCCcccCcCHHH------------------HHHhHHHHHHh
Confidence 0000 0111246788999999999999999999999 78999987543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=318.10 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=198.8
Q ss_pred CCCEEEeEEEeecCceEEEEEEECC-----CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTH-----TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~-----t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---
Confidence 4679999999999999999999887 7789999988632 223334568899999999999999999998743
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC---CE
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAND-------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC---KL 156 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~-------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~---~l 156 (506)
....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+
T Consensus 81 --~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 --RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred --CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 366799999996 59999997653 489999999999999999999999999999999999998765 59
Q ss_pred EEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 044076 157 KICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVT 235 (506)
Q Consensus 157 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~ 235 (506)
||+|||+++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 159 KIADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred EeccCccccccCCccce-ecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999764221110 00112233567999999976 679999999999999999997 999998876554433331
Q ss_pred hhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 236 ~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... .. ...+.++..+.+++.+||+.||++|||+.+|
T Consensus 236 ~~~---------------------------~~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~v 271 (277)
T cd05036 236 GGG---------------------------RL---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271 (277)
T ss_pred cCC---------------------------cC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 110 00 1113467899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=311.86 Aligned_cols=243 Identities=27% Similarity=0.446 Sum_probs=200.8
Q ss_pred EEEeecCceEEEEEEECCC---CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHT---GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t---~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
+.||+|+||.||+|.+... +..||+|.+....... ....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence 4699999999999999866 8999999997543332 46778899999999999999999998854 4789999
Q ss_pred EecCC-CCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 97 FELME-SDLDQVIKAN---------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 97 ~E~~~-~~L~~~i~~~---------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
|||++ ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.++.
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99995 6999999875 6799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
...... ........++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+.. +
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~------ 223 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--G------ 223 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--C------
Confidence 443221 111234557888999999877 578999999999999999999 6999988765544444322 0
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... ...+.+++++.+++.+||..||.+|||+.||
T Consensus 224 -------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 257 (262)
T cd00192 224 -------------------YRL---PKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257 (262)
T ss_pred -------------------CCC---CCCccCChHHHHHHHHHccCCcccCcCHHHH
Confidence 000 1123468899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.22 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=209.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...+|...+.||.|+||.||+|++..+++.||||.+... .........+.+|+.+++.++|+|++++++++.. .
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----E 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----C
Confidence 456788899999999999999999999999999998632 1233345668899999999999999999998854 3
Q ss_pred CcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
...|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 67899999999999888764 44689999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
. ....++..|+|||.+.+. ...++.++|||||||++|+|++|..||...+..+.+..+....
T Consensus 168 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---------- 230 (308)
T cd06634 168 A-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---------- 230 (308)
T ss_pred c-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC----------
Confidence 1 334688899999997531 1457889999999999999999999987654433332221100
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
. + .......+..+.+||++||+.+|.+|||+++ ++.|||+...
T Consensus 231 -----------------~-~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~------------------ll~~~~~~~~ 273 (308)
T cd06634 231 -----------------S-P-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV------------------LLKHRFVLRE 273 (308)
T ss_pred -----------------C-C-CcCcccccHHHHHHHHHHhhCCcccCCCHHH------------------HhhCcccccc
Confidence 0 0 0011246788999999999999999999999 8999999874
Q ss_pred C
Q 044076 329 A 329 (506)
Q Consensus 329 ~ 329 (506)
.
T Consensus 274 ~ 274 (308)
T cd06634 274 R 274 (308)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.29 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=209.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
...|...+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++|||++++++++.. ..
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 98 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EH 98 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CC
Confidence 345889999999999999999999999999999986432 233445678899999999999999999998844 36
Q ss_pred cEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
..|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 99 ~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 99 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 7899999999998888764 456999999999999999999999999999999999999999999999999998653221
Q ss_pred CCCcccccccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
....++..|+|||.+.. ....++.++||||+||++|+|++|++||.+.+....+..+......+
T Consensus 179 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 243 (317)
T cd06635 179 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-------- 243 (317)
T ss_pred -------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--------
Confidence 23458889999999742 12468889999999999999999999997765444443332211100
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
......++.+.+||.+||+.||.+|||+.+ ++.|||+..
T Consensus 244 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~------------------il~~~~~~~ 282 (317)
T cd06635 244 ---------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEE------------------LLKHMFVLR 282 (317)
T ss_pred ---------------------CCCccccHHHHHHHHHHccCCcccCcCHHH------------------HHhChhhhc
Confidence 011246788999999999999999999999 899999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=319.36 Aligned_cols=260 Identities=33% Similarity=0.537 Sum_probs=214.5
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
+..+.|++.+.||.|++|.||+|.+..++..|++|++..... ....+.+|+.+++.++|+||+++++.+...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 87 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG----- 87 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----
Confidence 556789999999999999999999998999999999864222 456688999999999999999999988543
Q ss_pred CcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...|+|+||++ ++|.+++.... .++...+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 78999999999 69999998876 89999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+... +.+
T Consensus 168 ~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~------- 234 (286)
T cd06614 168 KEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIP------- 234 (286)
T ss_pred cchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCC-------
Confidence 2211 1123357888999999877 67899999999999999999999999766554333332110 000
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+ ....+.++..+.+||.+||+.||.+|||+.+ +|.||||...
T Consensus 235 -------------------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~------------------il~~~~~~~~ 276 (286)
T cd06614 235 -------------------P-LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEE------------------LLQHPFLKKA 276 (286)
T ss_pred -------------------C-CcchhhCCHHHHHHHHHHhccChhhCcCHHH------------------HhhChHhhcc
Confidence 0 0111236788999999999999999999999 8999999974
Q ss_pred C
Q 044076 329 A 329 (506)
Q Consensus 329 ~ 329 (506)
.
T Consensus 277 ~ 277 (286)
T cd06614 277 C 277 (286)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.81 Aligned_cols=246 Identities=27% Similarity=0.432 Sum_probs=199.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++.+.||+|++|.||+|.+. +++.||||.++.. ......+.+|+.+++.++||||+++++++.. .+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPG---TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCC---cccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCC
Confidence 467999999999999999999875 4568999998642 2234568899999999999999999998743 367
Q ss_pred EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.|+||||+. ++|.+++.... .++...+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 899999995 69999997654 689999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
..... ......+..|+|||.+.+ ..++.++|+|||||++++|++ |+.||.+.+....+..+....
T Consensus 156 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05068 156 DIYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY---------- 221 (261)
T ss_pred Ccccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------
Confidence 21111 111223457999999877 678999999999999999999 999998776554444332111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+ ..+..+..+.+|+.+||+.||.+|||+.+|
T Consensus 222 -----------------~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l 254 (261)
T cd05068 222 -----------------RMP---CPPGCPKELYDIMLDCWKEDPDDRPTFETL 254 (261)
T ss_pred -----------------CCC---CCCcCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 001 113467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=318.09 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=199.1
Q ss_pred CCEEEeEEEeecCceEEEEEEEC----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDT----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
..|++.+.||+|+||+||+|.+. .++..||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ----- 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----
Confidence 57899999999999999999853 45678999999743 223344678899999999999999999998743
Q ss_pred CCcEEEEEecCC-CCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC
Q 044076 90 FKDIYVVFELME-SDLDQVIKAN-----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~-----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~ 151 (506)
....|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 367899999998 5999988532 2478889999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhh
Q 044076 152 ADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQ 230 (506)
Q Consensus 152 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~ 230 (506)
.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCcce-ecccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999764322211 11123345677999999876 678999999999999999998 9999987665444
Q ss_pred HHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 231 l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+... ... .....+++.+.+|+.+||+.||.+||++.+|
T Consensus 236 ~~~~~~~---------------------------~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 276 (283)
T cd05090 236 IEMVRKR---------------------------QLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276 (283)
T ss_pred HHHHHcC---------------------------CcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 4333210 000 1113478899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=313.69 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=201.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCc---EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.++|+..+.||+|+||.||+|.+..++. .||+|+++.. ........+.+|+.+++.++||||+++.+++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----K 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----c
Confidence 5689999999999999999999876665 7999998642 22334567889999999999999999999984 3
Q ss_pred CCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.+..|+||||+++ +|.+++... +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 4678999999985 899988764 57899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...............+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....|......|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~---- 231 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA---- 231 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC----
Confidence 332221111111223456999999876 678999999999999999997 9999987666555554432111111
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+.++.+|+.+||+.||.+||++.+|
T Consensus 232 --------------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 232 --------------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred --------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 12367889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=331.59 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=214.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecc-cccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKE-VFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~-~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.+.|+.-++||+|+||.||-++.+.||+.+|.|++.+ ...........++|-.||.+++.+.||.+--.| +..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence 5678888999999999999999999999999999943 222333445678999999999999999998777 4458
Q ss_pred cEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+|+|+..|. |||.-.|.+.+ .+++..+++++.+|+.||.+||..+||.|||||+|||+|+.|+++|+|+|||.-..
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999998 49998888765 79999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.+.+ .+..+||..|||||++.+ ..|+...|.|||||++|||+.|+.||........-+.+
T Consensus 339 ~g~~----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv-------------- 398 (591)
T KOG0986|consen 339 EGKP----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV-------------- 398 (591)
T ss_pred CCCc----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH--------------
Confidence 4443 255699999999999988 66999999999999999999999999665432221111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
.+.+...+. +.-...|+++++|++.+|+.||.+|.. +++ +.+||
T Consensus 399 ------drr~~~~~~-------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~e------------------vk~Hp 447 (591)
T KOG0986|consen 399 ------DRRTLEDPE-------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQE------------------VKEHP 447 (591)
T ss_pred ------HHHHhcchh-------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcch------------------hhhCc
Confidence 111111111 111358999999999999999999986 456 78999
Q ss_pred ccCCCCC
Q 044076 324 YFHGLAN 330 (506)
Q Consensus 324 ~f~~~~~ 330 (506)
||+.+.-
T Consensus 448 fFk~lnw 454 (591)
T KOG0986|consen 448 FFKDLNW 454 (591)
T ss_pred ccccCCH
Confidence 9987653
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=321.84 Aligned_cols=258 Identities=28% Similarity=0.495 Sum_probs=209.8
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
..|.....||+|+||.||++.+..+++.||||++.. ........+.+|+.+++.++|+||+++++.+.. .+..
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 92 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDEL 92 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecc--cchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEE
Confidence 344555789999999999999999999999999853 223345668899999999999999999998844 3789
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||+++ +|.+++. ...+++..+..++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 93 WVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 999999985 7888765 45689999999999999999999999999999999999999999999999999865432221
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
. .....++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+....+..+....
T Consensus 172 ~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------------- 232 (292)
T cd06657 172 R---RKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 232 (292)
T ss_pred c---ccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--------------
Confidence 1 133568899999999876 678899999999999999999999998766554433332110
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
+..+ .....+++.+.++|.+||+.||.+|||+.+ +|.||||.....
T Consensus 233 -------------~~~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~------------------ll~~~~~~~~~~ 278 (292)
T cd06657 233 -------------PPKL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAE------------------LLKHPFLAKAGP 278 (292)
T ss_pred -------------Cccc-CCcccCCHHHHHHHHHHHhCCcccCcCHHH------------------HhcChHHhccCC
Confidence 0000 112457889999999999999999999999 899999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.70 Aligned_cols=252 Identities=27% Similarity=0.366 Sum_probs=199.7
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||.||+|++..+|+.||||++..... ......++.+|+.+++.++||||+++++++.. .+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence 689999999999999999999999999999999964322 33445678999999999999999999998843 478
Q ss_pred EEEEEecCCC-CHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEee
Q 044076 93 IYVVFELMES-DLDQVIKAN-----------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICD 160 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~-----------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~D 160 (506)
.|+||||++| +|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 9999999985 999988642 2355667888999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCCC---------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Q 044076 161 FGLARVSFTDTPS---------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR 225 (506)
Q Consensus 161 FGla~~~~~~~~~---------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~ 225 (506)
||+++........ .......+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999764111100 001123579999999999987 68899999999999999999999999775
Q ss_pred CchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 226 NVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 226 ~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
........ .....|. .. ..+.++++.+.+++.+||+.||++|++..+
T Consensus 235 ~~~ki~~~--~~i~~P~-------------------------~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e 281 (932)
T PRK13184 235 KGRKISYR--DVILSPI-------------------------EV-APYREIPPFLSQIAMKALAVDPAERYSSVQ 281 (932)
T ss_pred chhhhhhh--hhccChh-------------------------hc-cccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 43222111 0000000 00 112357889999999999999999987666
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=322.86 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=196.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcE--EEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEK--VAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~--vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~ 88 (506)
..++|++.+.||+|+||+||+|.+..++.. +|+|.++.. ........+.+|+.++.++ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~---- 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH---- 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC----
Confidence 356899999999999999999998877764 577776532 2233456788999999999 79999999999843
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC
Q 044076 89 EFKDIYVVFELME-SDLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~ 151 (506)
.+.+|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 80 -RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred -CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 467999999997 59999987542 478999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhh
Q 044076 152 ADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQ 230 (506)
Q Consensus 152 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~ 230 (506)
.++.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 232 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232 (303)
T ss_pred CCCcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHH
Confidence 999999999999864211111 011224567999999876 678999999999999999998 9999977665443
Q ss_pred HHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 231 l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+.. .... ......++++.+||.+||+.||.+|||++++
T Consensus 233 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 273 (303)
T cd05088 233 YEKLPQ---------------------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 273 (303)
T ss_pred HHHHhc---------------------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 332210 0000 0112367889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.94 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=200.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCC---CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHT---GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t---~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.++|++.+.||+|+||+||+|.+..+ ...||||+++... .......+.+|+.+++.++||||+++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----- 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----
Confidence 56899999999999999999988654 4589999986432 23345568899999999999999999998743
Q ss_pred CCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.+..|+||||+.+ +|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 3678999999975 999998764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+......
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------ 227 (266)
T cd05033 157 EDSEAT-YTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL------ 227 (266)
T ss_pred cccccc-eeccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 321111 11112335678999999876 678999999999999999998 99999766554443333221110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+ .....++.+.+|+.+||+.||++|||+.||
T Consensus 228 ---------------------~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei 258 (266)
T cd05033 228 ---------------------P---PPMDCPSALYQLMLDCWQKDRNERPTFSQI 258 (266)
T ss_pred ---------------------C---CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 1 012467889999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=319.16 Aligned_cols=250 Identities=21% Similarity=0.314 Sum_probs=199.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCC-----CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHT-----GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t-----~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..+|++.+.||+|+||.||+|.+..+ +..||||+++... .......+.+|+.++..++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-- 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-- 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--
Confidence 34688999999999999999987543 5789999987432 223345688999999999999999999998443
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA 150 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv 150 (506)
...++++||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 81 ---~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 81 ---QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred ---CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 67899999997 5898888532 247888999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchh
Q 044076 151 NADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAH 229 (506)
Q Consensus 151 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~ 229 (506)
+.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred cCCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999998754322111 11123346778999999876 678999999999999999998 899998876655
Q ss_pred hHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 230 QLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 230 ~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+..+...... ..-.+++..+.+|+.+||+.||.+|||+++|
T Consensus 235 ~~~~i~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i 276 (283)
T cd05091 235 VIEMIRNRQVL------------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276 (283)
T ss_pred HHHHHHcCCcC------------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 55544321111 1113578889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=311.59 Aligned_cols=243 Identities=22% Similarity=0.318 Sum_probs=194.4
Q ss_pred EEEeecCceEEEEEEECCCC---cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTG---EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+.+++.+.||||+++++++. ....++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEE
Confidence 47999999999999876655 78999998643222 45567889999999999999999999863 2467999
Q ss_pred EecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcc
Q 044076 97 FELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175 (506)
Q Consensus 97 ~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 175 (506)
|||+. ++|.+++.....+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99997 59999999888899999999999999999999999999999999999999999999999999976433221111
Q ss_pred cccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHH
Q 044076 176 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 176 ~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~ 254 (506)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~----------------- 214 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG----------------- 214 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----------------
Confidence 1111223457999999876 678999999999999999998 99999766554333333110
Q ss_pred HHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... .....+++.+.+||.+||..||.+|||+.+|
T Consensus 215 ----------~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 215 ----------ERL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred ----------CcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 000 1123477899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=312.14 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=197.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||.|.+.. +..||||.+... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG---SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCC---cccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCC
Confidence 4679999999999999999997643 456999988642 1223568899999999999999999998843 356
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.+||+|||.++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 899999997 5899998764 36899999999999999999999999999999999999999999999999999754332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 154 ~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 220 (256)
T cd05113 154 EYTS--SVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--------- 220 (256)
T ss_pred ceee--cCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC---------
Confidence 2111 112335677999999976 678999999999999999998 99999776654444433221110
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. .....++.+.+++.+||+.||.+|||+.+|
T Consensus 221 ------------------~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 251 (256)
T cd05113 221 ------------------Y---RPHLASEKVYAIMYSCWHEKAEERPTFQQL 251 (256)
T ss_pred ------------------C---CCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 0 012357889999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=313.31 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=197.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
..+|++.+.||+|+||.||+|.+. ++..+|+|++.... .....+.+|+.+++.++||||+++++++.. .+.
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-----QRP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----CCc
Confidence 456899999999999999999875 56789999986321 223457789999999999999999998743 367
Q ss_pred EEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.|+||||++ ++|.+++..+ ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 899999997 4899998764 46899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |++||.+.+..+....+.....
T Consensus 154 ~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 219 (256)
T cd05059 154 QYTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---------- 219 (256)
T ss_pred cccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc----------
Confidence 1111 112224457999999887 678999999999999999998 8999977665444333321100
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ...+..++.+.+|+.+||..+|.+|||+.||
T Consensus 220 -----------------~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~ 251 (256)
T cd05059 220 -----------------L---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251 (256)
T ss_pred -----------------C---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 0 1113478899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=313.33 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=201.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCc---EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
..+|++.+.||+|+||.||+|.+..++. .||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----- 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 5689999999999999999999865543 79999986432 23345678899999999999999999998843
Q ss_pred CCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.+..|+||||++ ++|.+++... +.++...+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 367899999997 5899998765 46899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
..............++..|+|||.+.+ ..++.++|+||+||++|++++ |..||.+.+..+....+.+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------ 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL------ 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC------
Confidence 332221111122233567999999976 678999999999999999886 99999776655444444221110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+ .....++.+.+|+.+||+.+|.+|||+.+|
T Consensus 229 ---------------------~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (267)
T cd05066 229 ---------------------P---APMDCPAALHQLMLDCWQKDRNERPKFEQI 259 (267)
T ss_pred ---------------------C---CCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence 1 113467899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.00 Aligned_cols=257 Identities=22% Similarity=0.314 Sum_probs=201.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCC----------------cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTG----------------EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~----------------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv 76 (506)
.++|++++.||+|+||.||+|.+..++ ..||+|.+... ........+.+|+.+++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 468999999999999999999876544 56899998642 2234566788999999999999999
Q ss_pred eeceeecCCCcCCCCcEEEEEecCC-CCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 044076 77 EIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKAND-----------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLK 144 (506)
Q Consensus 77 ~l~~v~~~~~~~~~~~~ylV~E~~~-~~L~~~i~~~~-----------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLK 144 (506)
++++++.. .+..++|||++. ++|.+++.... .+++..+..++.||+.||+|||++||+|||||
T Consensus 83 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 99998843 378999999997 59999997765 68999999999999999999999999999999
Q ss_pred CCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh--CCCCC
Q 044076 145 PKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GRPLF 222 (506)
Q Consensus 145 p~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~--G~~pF 222 (506)
|+||+++.++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999999999999999999753322111 11123446778999999876 678999999999999999998 67888
Q ss_pred CCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 223 PGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 223 ~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+..+.+..+....... .........+..+.++.+||.+||+.||.+|||+.||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 235 EHLTDQQVIENAGHFFRDD-----------------------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred CCcChHHHHHHHHhccccc-----------------------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 6665544443332211100 0000011123567899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.11 Aligned_cols=244 Identities=31% Similarity=0.481 Sum_probs=202.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~ 90 (506)
....|++...+|.|+||+|-.+.+..+++..++|++.+. .....+|+.++... .||||+++++++ .+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~ 388 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDG 388 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeeccee-----cCC
Confidence 356788989999999999999999999999999999653 22244677666555 599999999999 445
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE-CCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA-NADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv-~~~~~lKL~DFGla~~~~ 168 (506)
.++|+|||++.| .|.+-+.....+. .++..|+.||+.|+.|||++|||||||||+|||+ +..++++|||||.++...
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 899999999986 5666666555555 7888899999999999999999999999999999 699999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. +...+-|..|.|||++.. ..|++++|+||||++||+||+|+.||...... ..|...++.|...
T Consensus 468 ~~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s---- 532 (612)
T KOG0603|consen 468 RS------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS---- 532 (612)
T ss_pred hh------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----
Confidence 33 233457889999999986 89999999999999999999999999876654 2232333333221
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..+|..|+|||++||++||.+|+++.+ ++.||||
T Consensus 533 -------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~------------------i~~h~w~ 566 (612)
T KOG0603|consen 533 -------------------------ECVSDEAKDLLQQLLQVDPALRLGADE------------------IGAHPWF 566 (612)
T ss_pred -------------------------cccCHHHHHHHHHhccCChhhCcChhh------------------hccCcch
Confidence 348999999999999999999999999 8999999
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.50 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=199.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCC-----cEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTG-----EKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~-----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 468999999999999999999876443 68999998643 2234456688999999999 79999999998843
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEE
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNIL 149 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NIL 149 (506)
.+.+|+||||+. ++|..++... ..+++..+..++.||+.||+|||++||+||||||+||+
T Consensus 88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 367999999997 5999998642 35889999999999999999999999999999999999
Q ss_pred ECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCch
Q 044076 150 ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVA 228 (506)
Q Consensus 150 v~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~ 228 (506)
++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYY-RKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCccccccccccccce-eccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999999999999999764332111 01122234567999999876 678999999999999999997 99999877654
Q ss_pred hhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 229 HQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 229 ~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+....+... ... ......+..+.+|+.+||..||.+|||+.||
T Consensus 242 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ei 284 (293)
T cd05053 242 ELFKLLKEG---------------------------YRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284 (293)
T ss_pred HHHHHHHcC---------------------------CcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 443333110 000 1113467899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=309.19 Aligned_cols=249 Identities=28% Similarity=0.444 Sum_probs=200.6
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++.+.||.|+||.||+|.+..+|+.||+|.++.. .........+.+|+.+++.++|+||+++++.+.. .+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 6899999999999999999999999999999988632 2233446678899999999999999999999854 367
Q ss_pred EEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 93 IYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.++||||+++ +|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||+++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 8999999984 99998864 245899999999999999999999999999999999999999999999999998753
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch--hhHHHHHhhcCCCChHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA--HQLDLVTDLLGTPSAES 245 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~--~~l~~I~~~~g~p~~e~ 245 (506)
...... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.... +....+..
T Consensus 157 ~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 222 (267)
T cd08224 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--------- 222 (267)
T ss_pred cCCCcc---cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc---------
Confidence 322111 133468889999999876 67899999999999999999999999654311 11111100
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+ ...+..+..+.++|.+||..||.+|||+.+|
T Consensus 223 ------------------~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~i 258 (267)
T cd08224 223 ------------------CDYPP--LPADHYSEELRDLVSRCINPDPEKRPDISYV 258 (267)
T ss_pred ------------------CCCCC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 00000 0012467789999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.60 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=200.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCC-----CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHT-----GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t-----~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
..++|++.+.||+|+||.||+|.+... +..||||.+... ........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-- 80 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-- 80 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--
Confidence 357899999999999999999988654 478999998532 233445568899999999999999999999843
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND----------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK 155 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~----------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~ 155 (506)
....|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.
T Consensus 81 ---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 81 ---GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred ---CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC
Confidence 377999999997 69999986532 3678889999999999999999999999999999999999999
Q ss_pred EEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHH
Q 044076 156 LKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLV 234 (506)
Q Consensus 156 lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I 234 (506)
+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+
T Consensus 158 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 158 VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred EEECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 999999999754322111 11123346778999999876 678999999999999999998 99999876655443333
Q ss_pred HhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 235 TDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 235 ~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. + ... ......+..+.+||.+||+.||.+|||+.+|
T Consensus 235 ~~--~-------------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 271 (277)
T cd05032 235 ID--G-------------------------GHL---DLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271 (277)
T ss_pred hc--C-------------------------CCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 20 0 000 1112357889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=314.07 Aligned_cols=246 Identities=25% Similarity=0.411 Sum_probs=202.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
..+|++++.||.|+||.||+|.+.. +..||+|++... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-----GEP 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEec-----CCC
Confidence 3579999999999999999999877 889999998642 23345668899999999999999999998743 367
Q ss_pred EEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.|+||||+++ +|.+++... ..++...+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||.+.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 8999999985 999999763 4689999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......
T Consensus 157 ~~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 223 (261)
T cd05148 157 DVYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-------- 223 (261)
T ss_pred cccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC--------
Confidence 2111 123345677999999876 678999999999999999998 89999887755555444221110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+ ..+..++.+.++|.+||+.||.+|||+.+|
T Consensus 224 -------------------~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (261)
T cd05148 224 -------------------P---CPAKCPQEIYKIMLECWAAEPEDRPSFKAL 254 (261)
T ss_pred -------------------C---CCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 0 113578899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=307.75 Aligned_cols=245 Identities=30% Similarity=0.486 Sum_probs=203.4
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecC
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELM 100 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~ 100 (506)
||.|+||.||++.+..+++.||+|.+... .........+.+|+.+++.++||||+++++.+. ....+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence 68999999999999989999999998643 222335567889999999999999999998873 447899999999
Q ss_pred -CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccc
Q 044076 101 -ESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD 179 (506)
Q Consensus 101 -~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 179 (506)
+++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 569999999888899999999999999999999999999999999999999999999999999976433211 1234
Q ss_pred cccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHh
Q 044076 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLS 259 (506)
Q Consensus 180 ~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~ 259 (506)
..++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.. +
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~-------------------- 208 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D-------------------- 208 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C--------------------
Confidence 567889999999877 5688899999999999999999999977654333333211 0
Q ss_pred hhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH---hhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 260 SLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA---EEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 260 ~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa---~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..+ .-...+..+.++|.+||..||.+|||+ ++ ++.||||
T Consensus 209 ------~~~---~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~------------------l~~~~~f 250 (250)
T cd05123 209 ------PLR---FPEFLSPEARDLISGLLQKDPTKRLGSGGAEE------------------IKAHPFF 250 (250)
T ss_pred ------CCC---CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHH------------------HHhCCCC
Confidence 000 112347889999999999999999999 88 8999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=310.09 Aligned_cols=247 Identities=27% Similarity=0.424 Sum_probs=201.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||.|+||.||+|.+. .+..||||.+... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 74 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPG---TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EE 74 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCC---ccCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CC
Confidence 3578999999999999999999975 4577999998632 2334568899999999999999999998733 36
Q ss_pred cEEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..|+||||+++ +|.+++.... .++...+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++...
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 78999999974 9999997653 68999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
...... ......+..|+|||.+.+ ..++.++||||+||++++|++ |+.||.+.+....+..+......+
T Consensus 155 ~~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 224 (261)
T cd05034 155 DDEYTA--REGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------ 224 (261)
T ss_pred chhhhh--hhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 221110 112234567999999987 678999999999999999998 999998877665555543211111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+.++.+++.+||+.||.+|||+++|
T Consensus 225 ------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 254 (261)
T cd05034 225 ------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYL 254 (261)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 112357889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=318.11 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=206.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~ 90 (506)
..+.|++.+.||.|+||.||+|.+..+++.||||.++... .......+.+|+.++.... ||||+++++++.. .
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~ 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----D 86 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC-ChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----C
Confidence 4578999999999999999999999999999999996432 2233455677887776665 9999999999844 3
Q ss_pred CcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...|+||||++++|..++.. ...+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 68999999999988888766 4578999999999999999999997 599999999999999999999999999987532
Q ss_pred CCCCCcccccccccCCcccCcccccccC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCc-hhhHHHHHhhcCCCChHH
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGRPLFPGRNV-AHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~--~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~-~~~l~~I~~~~g~p~~e~ 245 (506)
.... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||..... .+.+..+....
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------- 235 (296)
T cd06618 167 DSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE------- 235 (296)
T ss_pred CCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-------
Confidence 2211 12335778899999986521 3478899999999999999999999965322 12222211100
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
....+ ....++.++.+||.+||..||.+|||+++ ++.||||
T Consensus 236 ------------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~------------------il~~~~~ 276 (296)
T cd06618 236 ------------------PPSLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRE------------------LLQHPFI 276 (296)
T ss_pred ------------------CCCCC---CCCCCCHHHHHHHHHHccCChhhCCCHHH------------------HhcChhh
Confidence 00000 01146788999999999999999999999 8999999
Q ss_pred CCCCC
Q 044076 326 HGLAN 330 (506)
Q Consensus 326 ~~~~~ 330 (506)
.....
T Consensus 277 ~~~~~ 281 (296)
T cd06618 277 RRYET 281 (296)
T ss_pred hccch
Confidence 86543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=313.15 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=199.7
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCc----EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGE----KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
-..++|+++++||.|+||+||+|.+..++. .||+|+++.. ........+.+|+.+++.+.||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--
Confidence 346789999999999999999999877776 4899988642 233445678899999999999999999998743
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
...++++||++ |+|.+++..+ +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ----~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 81 ----STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred ----CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCce
Confidence 35789999997 6999999764 46999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
+........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.........+.. .
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~----- 227 (279)
T cd05109 157 RLLDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-G----- 227 (279)
T ss_pred eecccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-C-----
Confidence 764322111 11122335677999999877 678999999999999999998 9999976554332222211 0
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... ...+..++++.++|.+||..||.+|||+.+|
T Consensus 228 ---------------------~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l 261 (279)
T cd05109 228 ---------------------ERL---PQPPICTIDVYMIMVKCWMIDSECRPRFREL 261 (279)
T ss_pred ---------------------CcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 000 1123578899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=316.19 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=199.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..+|.+.+.||+|+||.||+|.+. .++..|++|.+.. ........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD--- 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc---
Confidence 457999999999999999999754 3456799998864 233344668899999999999999999999843
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA 150 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv 150 (506)
....++||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||++
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 79 --GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 367899999997 59999997542 37899999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchh
Q 044076 151 NADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAH 229 (506)
Q Consensus 151 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~ 229 (506)
+.++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |++||...+..+
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred ccCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999975332211 111233456788999999887 678999999999999999998 999997766544
Q ss_pred hHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 230 QLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 230 ~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.++.+.. +. . .......+..+.+|+.+||+.||.+|||+.+|
T Consensus 234 ~~~~~~~--~~-------------------------~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v 275 (291)
T cd05094 234 VIECITQ--GR-------------------------V---LERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275 (291)
T ss_pred HHHHHhC--CC-------------------------C---CCCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 4333211 00 0 01112367889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.24 Aligned_cols=262 Identities=28% Similarity=0.447 Sum_probs=216.6
Q ss_pred cccCCCCCEEE-eEEEeecCceEEEEEEECCCCcEEEEEEe--cccccChhHHHHHHHHHHHHHhCCCCCcceeceeecC
Q 044076 8 TEYGEASQYEI-QEIIGIGSYGVVASAIDTHTGEKVAIKKM--KEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLP 84 (506)
Q Consensus 8 ~~~~~~~rY~i-~~~LG~G~~g~V~~a~d~~t~~~vAIK~i--~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~ 84 (506)
.+-...+||-. ..+||+|+|-+||+|.|..+|..||.--+ .+..+......++..|+.+|+.|+||||+++++.+.+
T Consensus 33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 34445667755 57999999999999999999999997655 3455677778999999999999999999999999876
Q ss_pred CCcCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECCC-CCEEEee
Q 044076 85 PCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANAD-CKLKICD 160 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~~-~~lKL~D 160 (506)
.. ...+-+|+|+|. |+|..++++.+.++...++.|++|||+||.|||++. |+|||||.+||+||.+ |.+||+|
T Consensus 113 ~~---n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 113 TD---NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred CC---CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence 52 266889999997 799999999999999999999999999999999997 9999999999999975 8999999
Q ss_pred cCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhh-HHHHHhhcC
Q 044076 161 FGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQ-LDLVTDLLG 239 (506)
Q Consensus 161 FGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~-l~~I~~~~g 239 (506)
+|||....... ....+||+.|||||++.. .|+..+||||||+++.||.|+..||..=.+..| ..++.. |
T Consensus 190 LGLAtl~r~s~-----aksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--G 259 (632)
T KOG0584|consen 190 LGLATLLRKSH-----AKSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--G 259 (632)
T ss_pred hhHHHHhhccc-----cceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--C
Confidence 99998743322 245789999999999874 899999999999999999999999965443333 333311 2
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLA 319 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~a 319 (506)
.. +..|... -+|++++||.+||.. ..+|+|+.| +
T Consensus 260 iK------------------------P~sl~kV---~dPevr~fIekCl~~-~~~R~sa~e------------------L 293 (632)
T KOG0584|consen 260 IK------------------------PAALSKV---KDPEVREFIEKCLAT-KSERLSAKE------------------L 293 (632)
T ss_pred CC------------------------HHHhhcc---CCHHHHHHHHHHhcC-chhccCHHH------------------H
Confidence 11 1111111 378999999999999 999999999 7
Q ss_pred ccCcccCCC
Q 044076 320 LADPYFHGL 328 (506)
Q Consensus 320 L~HP~f~~~ 328 (506)
|.||||..-
T Consensus 294 L~d~Ff~~d 302 (632)
T KOG0584|consen 294 LKDPFFDED 302 (632)
T ss_pred hhChhhccc
Confidence 999999863
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=310.27 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=199.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|+++++||.|+||.||+|.+. +++.||+|.+... ......+.+|+.+++.++||||+++++++. .+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 73 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQG---SMSPEAFLAEANLMKQLQHPRLVRLYAVVT------QE 73 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCC---CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cC
Confidence 4578999999999999999999864 5778999998642 223456889999999999999999998862 24
Q ss_pred cEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..|+||||+. ++|.+++... ..++...+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 6899999997 5999988753 368999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 154 ~~~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------- 222 (260)
T cd05067 154 DNEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM------- 222 (260)
T ss_pred CCCcc--cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-------
Confidence 22111 1122345678999999876 678899999999999999998 99999887755544443221111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
......+.++.+||.+||..||++|||+++|
T Consensus 223 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 253 (260)
T cd05067 223 -----------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYL 253 (260)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 1113467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=330.70 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=197.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCC-----CcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHT-----GEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPP 85 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t-----~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~ 85 (506)
..++|++++.||+|+||.||+|.+... +..||||+++.. ........+.+|+.+|+++. ||||+++++++..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~- 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK- 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence 357899999999999999999987433 357999999643 23344567889999999996 9999999999843
Q ss_pred CcCCCCcEEEEEecCC-CCHHHHHHhC-----------------------------------------------------
Q 044076 86 CRREFKDIYVVFELME-SDLDQVIKAN----------------------------------------------------- 111 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~-~~L~~~i~~~----------------------------------------------------- 111 (506)
...+|+|||||+ |+|.+++..+
T Consensus 113 ----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 113 ----SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred ----CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 377999999997 5998887542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcE
Q 044076 112 -------------------------------------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNI 148 (506)
Q Consensus 112 -------------------------------------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NI 148 (506)
..+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2377888899999999999999999999999999999
Q ss_pred EECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCc
Q 044076 149 LANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNV 227 (506)
Q Consensus 149 Lv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~ 227 (506)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||++...
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999999999764322211 11123346778999999977 678999999999999999997 9999976543
Q ss_pred hhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 228 AHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 228 ~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+.+..... .....+ .-..+++++.+||.+||+.||++|||+.+|
T Consensus 346 ~~~~~~~~~--------------------------~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 390 (400)
T cd05105 346 DSTFYNKIK--------------------------SGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390 (400)
T ss_pred hHHHHHHHh--------------------------cCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence 222211110 000000 113578899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=312.37 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=200.6
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++.+.||.|+||.||+|.+..+++.||||++.... ........+.+|+.+++.+.||||+++++.+.. .+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 57899999999999999999999999999999885422 233445678899999999999999999998853 378
Q ss_pred EEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 93 IYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.|+||||+++ +|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999985 89988864 346899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch--hhHHHHHhhcCCCChHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA--HQLDLVTDLLGTPSAES 245 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~--~~l~~I~~~~g~p~~e~ 245 (506)
...... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.... .....+..
T Consensus 157 ~~~~~~---~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 222 (267)
T cd08229 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--------- 222 (267)
T ss_pred ccCCcc---cccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc---------
Confidence 332211 234568899999999977 67889999999999999999999999654321 11111100
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+ ......++.+.+||.+||..||.+|||+.+|
T Consensus 223 ------------------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 258 (267)
T cd08229 223 ------------------CDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDITYV 258 (267)
T ss_pred ------------------CCCCC--CCcccccHHHHHHHHHhcCCCcccCCCHHHH
Confidence 00000 0112467899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=309.90 Aligned_cols=252 Identities=30% Similarity=0.475 Sum_probs=202.0
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc---ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE---HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
||.+.+.||+|+||.||++.+..++..+++|+++.... .......+.+|+.+++.++||||+++++.+.. ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence 69999999999999999999988888787777754221 22344557789999999999999999998743 36
Q ss_pred cEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 92 DIYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..++|+||+.+ +|..++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 78999999985 88887753 457999999999999999999999999999999999999975 6799999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
....... .....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+.......+.. +.+
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~----- 222 (260)
T cd08222 155 LMGSCDL---ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPT----- 222 (260)
T ss_pred cCCCccc---ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCC-----
Confidence 4332211 123457889999999866 6788899999999999999999999976654333322211 100
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
......++.++.+||.+||..||.+||++.| +++||||
T Consensus 223 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~------------------il~~~~~ 260 (260)
T cd08222 223 -----------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAE------------------ILRNPFI 260 (260)
T ss_pred -----------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHH------------------HhhCCCC
Confidence 0111346789999999999999999999999 8999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=312.69 Aligned_cols=268 Identities=25% Similarity=0.412 Sum_probs=199.1
Q ss_pred CCCEEEeEEEeecCceEEEEEE----ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAI----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~----d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
..+|++++.||+|+||.||+|. +..++..||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 77 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--- 77 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---
Confidence 4589999999999999999997 4567889999998642 334456788999999999999999999987543
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
+...+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 2356899999997 5999998764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...............++..|+|||.+.+ ..++.++|||||||+++||++|..++..... .... .++......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~----~~~~~~~~~- 229 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMR----MMGNDKQGQ- 229 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhh----hcccccccc-
Confidence 4332211111112224456999999876 6789999999999999999998876643321 1111 111110000
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.........+......+ ..+.++.++.+||.+||..||.+|||+.||
T Consensus 230 -----~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 276 (284)
T cd05081 230 -----MIVYHLIELLKNNGRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSEL 276 (284)
T ss_pred -----cchHHHHHHHhcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 00001111111111111 124578899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=314.05 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=199.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..+|++.++||+|+||.||+|... .++..+|+|.+... .......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE--- 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec---
Confidence 468899999999999999999743 35678999988642 33445678899999999999999999998744
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAND---------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~---------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~ 151 (506)
.+..|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 79 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred --CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 367899999997 59999987643 488999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhh
Q 044076 152 ADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQ 230 (506)
Q Consensus 152 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~ 230 (506)
+++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999999754322111 11122345678999999877 678999999999999999998 9999977665444
Q ss_pred HHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 231 l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+..+.... .. .....+++.+.+||.+||+.||.+|||++||
T Consensus 234 ~~~~~~~~---------------------------~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 234 IECITQGR---------------------------EL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred HHHHHcCc---------------------------cC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 33331110 00 1113478899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=315.39 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=198.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCC--------------cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCccee
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTG--------------EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEI 78 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~--------------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l 78 (506)
.++|++.+.||+|+||.||+|++..++ ..||+|+++... .......+.+|+++++.++||||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 468999999999999999999875432 359999986432 23344568899999999999999999
Q ss_pred ceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCC
Q 044076 79 KHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKP 145 (506)
Q Consensus 79 ~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp 145 (506)
++++.. ....|+||||+.+ +|.+++.... .+++..+..++.||+.||+|||+.|++||||||
T Consensus 83 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 83 LGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred EEEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 999843 3678999999984 9999886532 368889999999999999999999999999999
Q ss_pred CcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh--CCCCCC
Q 044076 146 KNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GRPLFP 223 (506)
Q Consensus 146 ~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~--G~~pF~ 223 (506)
+||+++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|+|||||++++|++ |..||.
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999999754322111 11122345678999999877 678999999999999999988 677887
Q ss_pred CCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 224 GRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 224 ~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+..+.+..+.... .... ........+..++.+.+|+.+||+.||.+|||+++|
T Consensus 235 ~~~~~~~~~~~~~~~--------------------~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i 289 (295)
T cd05097 235 LLSDEQVIENTGEFF--------------------RNQG---RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289 (295)
T ss_pred ccChHHHHHHHHHhh--------------------hhcc---ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 766544443332111 0000 000011223467899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=309.40 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=200.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCc---EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.+.|++.+.||+|+||.||+|.+..+++ .||||.++.. ........+.+|+.+++.+.||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----- 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----- 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----
Confidence 4679999999999999999999887665 6999998643 234456678899999999999999999998843
Q ss_pred CCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
....++||||+++ +|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 3678999999985 899988764 46899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccc--cccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 168 FTDTPSAIFWTD--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 168 ~~~~~~~~~~~~--~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
............ ...+..|+|||.+.+ ..++.++||||+||++|||++ |..||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~----- 229 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR----- 229 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-----
Confidence 332211111111 112457999999876 688999999999999999886 9999977665544444321111
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+ ..+.++..+.+++.+||..||.+|||+++|
T Consensus 230 ----------------------~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 261 (269)
T cd05065 230 ----------------------LP---PPMDCPTALHQLMLDCWQKDRNARPKFGQI 261 (269)
T ss_pred ----------------------CC---CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 11 113467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=307.45 Aligned_cols=247 Identities=28% Similarity=0.372 Sum_probs=197.7
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++.+.||+|++|.||+|.+..+ ..||+|++... ......+.+|+.+++.+.||||+++++++. .
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~ 72 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPG---TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS------E 72 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccC---CccHHHHHHHHHHHHhCCCCCeeeEEEEEc------C
Confidence 3457899999999999999999987655 46999987532 123456789999999999999999998862 1
Q ss_pred CcEEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 91 KDIYVVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
...|+||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||++++++.+||+|||+++..
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 457999999985 9999997643 4889999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+....+....+....
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------- 220 (260)
T cd05069 153 EDNEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-------- 220 (260)
T ss_pred cCCccc--ccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 322111 1122345677999999876 678999999999999999999 999998766554444332210
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ....+.+..+.+|+++||..||.+|||+++|
T Consensus 221 -------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 253 (260)
T cd05069 221 -------------------RM---PCPQGCPESLHELMKLCWKKDPDERPTFEYI 253 (260)
T ss_pred -------------------CC---CCCcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 00 1113467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=306.13 Aligned_cols=242 Identities=25% Similarity=0.458 Sum_probs=198.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||.|+||.||+|.+ .|+.||||+++... ...+++.+|+.+++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~ 73 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GN 73 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CC
Confidence 356899999999999999999976 48899999996432 246678899999999999999999999853 37
Q ss_pred cEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..|+||||++ ++|.++++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++...
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence 7999999998 59999998765 69999999999999999999999999999999999999999999999999997642
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... .....+..|+|||.+.+ ..++.++|||||||++++|++ |..||...+..+....+..
T Consensus 154 ~~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----------- 214 (256)
T cd05039 154 QGQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK----------- 214 (256)
T ss_pred ccc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-----------
Confidence 211 12234567999999876 678899999999999999997 9999976654433222211
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.... ......++.+.+||.+||..||.+|||+.+|
T Consensus 215 ----------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 249 (256)
T cd05039 215 ----------------GYRM---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQL 249 (256)
T ss_pred ----------------CCCC---CCccCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 0000 1113468899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=307.61 Aligned_cols=241 Identities=24% Similarity=0.432 Sum_probs=196.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
..+|++.+.||+|+||.||++.. .|..||+|.++.. ...+.+.+|+.+++.++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 74 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGG 74 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCc
Confidence 46899999999999999999965 4788999998532 234568899999999999999999987643 2356
Q ss_pred EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+|+|+||++ ++|.++++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 899999998 59999997654 488999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 155 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05082 155 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 214 (256)
T ss_pred cC------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 21 12234567999999876 678999999999999999997 9999976654433333211
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... ....+.+++.+.+||.+||+.||.+|||+.+|
T Consensus 215 ---------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 249 (256)
T cd05082 215 ---------------GYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQL 249 (256)
T ss_pred ---------------CCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 000 01124578899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=317.16 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=198.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECC-------CCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeec
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTH-------TGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIML 83 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~-------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~ 83 (506)
..++|.+++.||+|+||.||+|.+.. +...||+|.++.. ........+.+|+.+++.+ +||||+++++++.
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34789999999999999999998643 2357999998642 2334456788999999999 6999999999884
Q ss_pred CCCcCCCCcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 044076 84 PPCRREFKDIYVVFELME-SDLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPK 146 (506)
Q Consensus 84 ~~~~~~~~~~ylV~E~~~-~~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~ 146 (506)
. .+.+|+||||+. ++|.+++.... .++...+..++.||+.||+|||+.|++||||||+
T Consensus 95 ~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 95 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred c-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 3 367999999997 59999997642 4788999999999999999999999999999999
Q ss_pred cEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCC
Q 044076 147 NILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGR 225 (506)
Q Consensus 147 NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~ 225 (506)
||+++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999999754221110 01112234567999999877 678999999999999999998 89999776
Q ss_pred CchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 226 NVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 226 ~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+..+....+.. .... ......+.++.+||.+||..+|.+|||+.+|
T Consensus 247 ~~~~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 247 PVEELFKLLKE---------------------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred CHHHHHHHHHc---------------------------CCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 54433332211 0000 1123578899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=307.26 Aligned_cols=242 Identities=22% Similarity=0.340 Sum_probs=191.2
Q ss_pred EEeecCceEEEEEEEC--CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEe
Q 044076 21 IIGIGSYGVVASAIDT--HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFE 98 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d~--~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E 98 (506)
.||+|+||.||+|.+. .++..||+|++... ........+.+|+.+++.++||||+++++++. ....|+|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEE
Confidence 3899999999999765 44567999998643 22334566889999999999999999999862 246899999
Q ss_pred cCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 99 LME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 99 ~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
|++ ++|.+++.. ...+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++...........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 997 599998875 457999999999999999999999999999999999999999999999999999754332211111
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~ 255 (506)
.+...++..|+|||.+.. ..++.++|||||||++|+|++ |.+||.+....+....+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------------ 214 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG------------------ 214 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC------------------
Confidence 122233567999999876 678999999999999999996 99999876654433333110
Q ss_pred HHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 256 RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... ...+..++++.+||.+||..||++||++.+|
T Consensus 215 ---------~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i 248 (257)
T cd05115 215 ---------KRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248 (257)
T ss_pred ---------CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 000 1113568999999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=311.97 Aligned_cols=267 Identities=23% Similarity=0.359 Sum_probs=206.5
Q ss_pred CEEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccc--cChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVF--EHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~ 88 (506)
+|++.+.||.|+||.||+|.+. .+++.||||.++... ........+.+|+.++..+. ||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 4899999999999999999864 467899999986421 12334566789999999995 9999999988743
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
...+|+||||+.+ +|.+.+..+..+++..++.++.|+++||.|||+.|++||||||.||+++.++.++|+|||+++..
T Consensus 77 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 77 -DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred -CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 3678999999974 99999987778999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
...... ......++..|+|||.+.+.....+.++|+||+||++++|++|..||...........+..
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------- 222 (288)
T cd05583 156 LAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------- 222 (288)
T ss_pred cccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-----------
Confidence 332211 1123458889999999876323478899999999999999999999965432211111100
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.... ... ...+.+++.+.+||.+||+.||.+|||+.++. .+|.||||+.
T Consensus 223 --------~~~~---~~~-----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~---------------~~l~~~~~~~ 271 (288)
T cd05583 223 --------RILK---SKP-----PFPKTMSAEARDFIQKLLEKDPKKRLGANGAD---------------EIKNHPFFQG 271 (288)
T ss_pred --------HHHc---cCC-----CCCcccCHHHHHHHHHHhcCCHhhccCcchHH---------------HHhcCccccc
Confidence 0000 000 11134678899999999999999999965421 1799999988
Q ss_pred CCC
Q 044076 328 LAN 330 (506)
Q Consensus 328 ~~~ 330 (506)
+..
T Consensus 272 ~~~ 274 (288)
T cd05583 272 IDW 274 (288)
T ss_pred CCH
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=311.45 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=194.1
Q ss_pred EEeEEEeecCceEEEEEEEC----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 17 EIQEIIGIGSYGVVASAIDT----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 17 ~i~~~LG~G~~g~V~~a~d~----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.+.+.||.|+||.||+|... ..+..|+||.++. .........+.+|+++++.++||||+++++++... +.
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-----cc
Confidence 57899999999999999887 4567899999964 23444578899999999999999999999999632 56
Q ss_pred EEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.++|+||+. |+|.+++... ..+++..+..++.||+.||.|||+++|+|+||+++||+++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999998 6999999987 6899999999999999999999999999999999999999999999999999976422
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ...........|+|||.+.. ..++.++||||||+++|||++ |+.||.+.+..+....+.+..
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~---------- 222 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ---------- 222 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE----------
T ss_pred cccc-cccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 2111 11123446678999999977 568999999999999999999 789998776555444442110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. .....++..+.+||.+||..||.+|||+.+|
T Consensus 223 -----------------~~---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i 255 (259)
T PF07714_consen 223 -----------------RL---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEI 255 (259)
T ss_dssp -----------------ET---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred -----------------cc---eeccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00 1113478899999999999999999999994
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=311.14 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=196.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCc----EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGE----KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.++|++++.||.|+||+||+|.+..++. .|++|++... ........+..|+.++..+.||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~----- 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP----- 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----
Confidence 4689999999999999999999887776 4777776432 12233456778999999999999999999863
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
....++|+||+. ++|.+++... +.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 145789999997 6999999764 5789999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
....... ...+...++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.......+.+.. |
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~------ 227 (279)
T cd05111 159 LYPDDKK-YFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK--G------ 227 (279)
T ss_pred ccCCCcc-cccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--C------
Confidence 4332211 11233456778999999976 679999999999999999998 9999987654333222211 0
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+. ....+.++.+++.+||..||.+|||+.||
T Consensus 228 -------------------~~~~~---~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 228 -------------------ERLAQ---PQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred -------------------CcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 00000 11256788999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=311.70 Aligned_cols=265 Identities=24% Similarity=0.331 Sum_probs=196.2
Q ss_pred CCE-EEeEEEeecCceEEEEEE----ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 14 SQY-EIQEIIGIGSYGVVASAI----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 14 ~rY-~i~~~LG~G~~g~V~~a~----d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
+|| ++++.||+|+||+||++. ...++..||+|.++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc-cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 456 999999999999998764 3457889999998643 1223455678999999999999999999987432
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
....+|+||||+.+ +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 23568999999984 899888764 5999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHH-hhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVT-DLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~-~~~g~p~~e~~ 246 (506)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ...+. ...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~-- 231 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVV-- 231 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchh--
Confidence 332211111122345667999999876 67899999999999999999999998543321 11110 000000000
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..... .......+ .....+..+.+|+.+||+.||.+|||+++|
T Consensus 232 ------~~~~~---~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i 274 (283)
T cd05080 232 ------RLIEL---LERGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSL 274 (283)
T ss_pred ------hhhhh---hhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 00000 01111111 123578899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.62 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=198.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEE-----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d-----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++.. ........+.+|+.+++++ +||||+++++.+..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc-CChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 45899999999999999999975 334568999998643 2234456788999999999 79999999998843
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCC
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
.+.+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+
T Consensus 111 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 ---GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ---CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 367999999997 69999997643 389999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
++........ .......++..|+|||.+.+ ..++.++||||+||++|+|++ |.+||.+....+.+..+..
T Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~------ 258 (302)
T cd05055 188 ARDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------ 258 (302)
T ss_pred cccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH------
Confidence 9754322111 11122346778999999877 678999999999999999998 9999977654332222111
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..... ...+..++.+.+|+.+||..||.+|||+.||
T Consensus 259 --------------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~el 294 (302)
T cd05055 259 --------------------EGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294 (302)
T ss_pred --------------------cCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 00000 0112467899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=312.13 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=195.3
Q ss_pred CEEEeEEEeecCceEEEEEEECC-----CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTH-----TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~-----t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
+|++.+.||+|+||.||+|.+.. ....||+|.+... ........+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----- 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----
Confidence 58899999999999999998754 2357888888642 223445678899999999999999999998743
Q ss_pred CCcEEEEEecCC-CCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 044076 90 FKDIYVVFELME-SDLDQVIKAN------------------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLK 144 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~------------------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLK 144 (506)
.+..|+|+||+. ++|.+++... ..+++..+..++.||+.||+|||++||+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 367899999998 5899888642 247888999999999999999999999999999
Q ss_pred CCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCC
Q 044076 145 PKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFP 223 (506)
Q Consensus 145 p~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~ 223 (506)
|+|||+++++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++++|++ |..||+
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchh-cccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999997543222110 1122235678999999876 678999999999999999998 999998
Q ss_pred CCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 224 GRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 224 ~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+.......+.+.... .. ......+.++.+|+.+||+.||.+|||+.||
T Consensus 232 ~~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 232 GIAPERLFNLLKTGY---------------------------RM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred CCCHHHHHHHHhCCC---------------------------CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 765443333221100 00 0113467899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.31 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=198.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECC-------CCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTH-------TGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLP 84 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~-------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~ 84 (506)
.++|.+.+.||+|+||.||+|.+.. ....||+|.++... .......+.+|+.+++.+ .||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4689999999999999999997632 34579999986432 234456688999999999 59999999998843
Q ss_pred CCcCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 044076 85 PCRREFKDIYVVFELME-SDLDQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKN 147 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~-~~L~~~i~~~----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~N 147 (506)
.+.+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 90 -----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 90 -----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 367999999997 5999999753 248889999999999999999999999999999999
Q ss_pred EEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCC
Q 044076 148 ILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN 226 (506)
Q Consensus 148 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~ 226 (506)
||++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999997543211110 0111224467999999877 678999999999999999999 899998776
Q ss_pred chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 227 VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 227 ~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+....+... ... .....++.++.+||.+||..||.+|||+.+|
T Consensus 242 ~~~~~~~~~~~---------------------------~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l 286 (314)
T cd05099 242 VEELFKLLREG---------------------------HRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286 (314)
T ss_pred HHHHHHHHHcC---------------------------CCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 55444433210 000 1123567889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.08 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=199.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEEC-------CCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeec
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDT-------HTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIML 83 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~-------~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~ 83 (506)
...+|.+.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3578999999999999999999753 234579999986432 234456788999999999 7999999999884
Q ss_pred CCCcCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 044076 84 PPCRREFKDIYVVFELME-SDLDQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPK 146 (506)
Q Consensus 84 ~~~~~~~~~~ylV~E~~~-~~L~~~i~~~----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~ 146 (506)
. ...+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+
T Consensus 92 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 92 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred c-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 3 367899999997 5999999764 24778889999999999999999999999999999
Q ss_pred cEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCC
Q 044076 147 NILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGR 225 (506)
Q Consensus 147 NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~ 225 (506)
||+++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999754322111 11122345678999999877 678999999999999999998 88999877
Q ss_pred CchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 226 NVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 226 ~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+..+....+... ... .....++..+.+||.+||..+|.+|||+.||
T Consensus 244 ~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 244 PVEELFKLLKEG---------------------------HRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred CHHHHHHHHHcC---------------------------CcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 655444433110 000 1113578899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=332.78 Aligned_cols=257 Identities=23% Similarity=0.292 Sum_probs=207.6
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
+....+...+++.||+|.||+||+|.+-. .||||+++.........+.+.+|+..+++-+|.||+=+.+++..+
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p--- 460 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP--- 460 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---
Confidence 33456778889999999999999997643 499999987666777888999999999999999999999998543
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+.||+-+|+| +|+.+|.-. ..|.....+.|+.||++|+.|||.++|||||||..||++.++++|||+|||++.+
T Consensus 461 ---~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 461 ---PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred ---ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 34999999998 899988653 3688889999999999999999999999999999999999999999999999965
Q ss_pred ccCCCCCcccccccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
..-- ..........|...|+|||++.. ....|++.+||||+||++|||++|..||...+....+.++-...+.|.
T Consensus 538 k~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd--- 613 (678)
T KOG0193|consen 538 KTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD--- 613 (678)
T ss_pred eeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc---
Confidence 2211 11222344557888999999843 236799999999999999999999999985554444444422222221
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
......+.+.++++|+..||.+++++||++.+|
T Consensus 614 -----------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~i 646 (678)
T KOG0193|consen 614 -----------------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQL 646 (678)
T ss_pred -----------------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence 123334577799999999999999999999996
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=351.43 Aligned_cols=256 Identities=32% Similarity=0.472 Sum_probs=193.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC--------
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP-------- 85 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~-------- 85 (506)
++|+.++.||+||||.||+++++-+|..||||+|.-.. ......++.||+++|.+|+|||||+++..+...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45778899999999999999999999999999997554 566778899999999999999999986332100
Q ss_pred ----------------------------------------------C-------c-------------------------
Q 044076 86 ----------------------------------------------C-------R------------------------- 87 (506)
Q Consensus 86 ----------------------------------------------~-------~------------------------- 87 (506)
+ .
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 0
Q ss_pred ------------------C---C-------CCcEEEEEecCCCCHH-HHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 044076 88 ------------------R---E-------FKDIYVVFELMESDLD-QVIKANDDL-TPEHHQFFLYQLLRALKYIHSAN 137 (506)
Q Consensus 88 ------------------~---~-------~~~~ylV~E~~~~~L~-~~i~~~~~l-s~~~~~~i~~QIl~gL~yLH~~g 137 (506)
+ + ...+||-||||+.++. +++..+... ....++++++||++||+|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 0 0347999999997554 445544333 47789999999999999999999
Q ss_pred eeecCCCCCcEEECCCCCEEEeecCCccccc----C-----------CCCCcccccccccCCcccCcccccccC-CCCCc
Q 044076 138 VFHRDLKPKNILANADCKLKICDFGLARVSF----T-----------DTPSAIFWTDYVATRWYRAPELCGSFF-SKYTP 201 (506)
Q Consensus 138 IvHrDLKp~NILv~~~~~lKL~DFGla~~~~----~-----------~~~~~~~~~~~vgt~~Y~APE~l~~~~-~~~s~ 201 (506)
||||||||.||++++++.|||+|||+|.... . ........|..+||-.|+|||++.+.. ..|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997611 0 011112357789999999999998742 26999
Q ss_pred hhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCC-CCCCCCCHHH
Q 044076 202 AIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFS-HKFPGADPLA 280 (506)
Q Consensus 202 ~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~ 280 (506)
++||||||+||+||+. ||...- +.. ..+.+++ +...|+. ..+-+--+..
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsM--ERa------------------------~iL~~LR-~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSM--ERA------------------------SILTNLR-KGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchH--HHH------------------------HHHHhcc-cCCCCCCcccccccchHH
Confidence 9999999999999986 364322 111 1122233 2222222 2233445667
Q ss_pred HHHHHHhhhcCCCCCCCHhh
Q 044076 281 LRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 281 ~dLI~~mL~~DP~~RpTa~e 300 (506)
..+|+.||+.||.+||||.|
T Consensus 848 ~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHH
Confidence 89999999999999999999
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=321.29 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=194.8
Q ss_pred CCCEEEeEEEeecCceEEEEEEE-----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d-----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|++++.||+|+||+||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 46899999999999999999984 3567899999996422 223455688999999999 589999999887432
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC-----------------------------------------------------
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND----------------------------------------------------- 112 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~----------------------------------------------------- 112 (506)
...+|+||||++ ++|.+++....
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 84 ---GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ---CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 356899999998 59999886531
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccccc
Q 044076 113 --------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT 178 (506)
Q Consensus 113 --------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~ 178 (506)
.++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 3677788899999999999999999999999999999999999999999999764222111 1112
Q ss_pred ccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHH
Q 044076 179 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257 (506)
Q Consensus 179 ~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~ 257 (506)
...++..|+|||++.+ ..++.++|||||||++|+|++ |..||++......+.....
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------------------- 296 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--------------------- 296 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh---------------------
Confidence 2335677999999877 688999999999999999997 9999976543222211110
Q ss_pred HhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 258 LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...... .....++++.+++.+||+.||.+|||+.||
T Consensus 297 -----~~~~~~---~~~~~~~~~~~~~~~cl~~~p~~Rps~~ei 332 (343)
T cd05103 297 -----EGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSEL 332 (343)
T ss_pred -----ccCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 000000 011357889999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.25 Aligned_cols=252 Identities=21% Similarity=0.347 Sum_probs=200.8
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECC----CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTH----TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~----t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..++|++.+.||+|+||.||+|.+.. ++..|++|++... ........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 35789999999999999999999876 3578999988632 3445567788999999999999999999986432
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEE
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN--------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKI 158 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~--------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL 158 (506)
....+++++|+. ++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||
T Consensus 81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 356899999997 6999998653 45899999999999999999999999999999999999999999999
Q ss_pred eecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhh
Q 044076 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDL 237 (506)
Q Consensus 159 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~ 237 (506)
+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|++++ |++||.+.+..+....+...
T Consensus 159 ~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 159 TDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred CCCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 9999997543322110 1122345677999999877 678999999999999999998 99999776543322222110
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+ ....+++++.+++.+||..||++|||+.+|
T Consensus 236 ---------------------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 269 (280)
T cd05043 236 ---------------------------YRLA---QPINCPDELFAVMACCWALDPEERPSFSQL 269 (280)
T ss_pred ---------------------------CCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0000 112467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=303.30 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=197.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+.+|++.+.||.|+||.||+|.+. .+..+|+|++.... .....+.+|+.+++.+.||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCc
Confidence 568999999999999999999875 46789999986422 223457889999999999999999998743 367
Q ss_pred EEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.|+||||+.+ +|.+++... +.++++.+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 8999999984 899888764 46899999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.... .....++..|+|||.+.+ ..++.++||||+||++|+|++ |++||........+..+...
T Consensus 154 ~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05112 154 QYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG------------ 217 (256)
T ss_pred cccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC------------
Confidence 1110 112235678999999876 678999999999999999998 99999776655444433110
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..... ....+..+.+|+.+||+.||.+|||+.++
T Consensus 218 ---------------~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~ 251 (256)
T cd05112 218 ---------------FRLYK---PRLASQSVYELMQHCWKERPEDRPSFSLL 251 (256)
T ss_pred ---------------CCCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 00000 01257889999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.90 Aligned_cols=246 Identities=29% Similarity=0.469 Sum_probs=200.1
Q ss_pred EEEeEEEeecCceEEEEEEECCCC----cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTG----EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
+++++.||.|+||.||+|.+...+ ..||+|+++.. ........+.+|+.+++.++|+||+++++++... +
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----E 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----C
Confidence 357889999999999999998766 89999999643 2222567788999999999999999999998543 6
Q ss_pred cEEEEEecCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELME-SDLDQVIKANDD--LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~--ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..|+||||+. ++|.+++..... +++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||+++...
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 8999999997 499999976554 9999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
...... .....++..|+|||.+.+ ..++.++||||+||++++|++ |.+||.+.+..+....+....
T Consensus 155 ~~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------- 221 (258)
T smart00219 155 DDDYYK--KKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY--------- 221 (258)
T ss_pred cccccc--cccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------
Confidence 331111 012236788999999865 678999999999999999998 899998766554444432110
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ......+.++.+++.+||..||.+|||+.||
T Consensus 222 ------------------~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (258)
T smart00219 222 ------------------RL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSEL 254 (258)
T ss_pred ------------------CC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence 00 1112378899999999999999999999994
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=361.31 Aligned_cols=266 Identities=26% Similarity=0.375 Sum_probs=219.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.-|++....||.|.||.||.|.+..+|+..|+|-++-.-........+.+|+++|..|+|||+|+.++|-++. +.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ek 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EK 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HH
Confidence 4477788899999999999999999999999999864323334456688999999999999999999986543 67
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+||.||||+ |+|.+++...+...+...+.+..|++.|++|||++|||||||||+||+++.+|-+|++|||.|.......
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 899999998 5999999988888899999999999999999999999999999999999999999999999997754432
Q ss_pred -CCcccccccccCCcccCcccccccC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 172 -PSAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 172 -~~~~~~~~~vgt~~Y~APE~l~~~~-~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
........++||+.|||||++.+.. ..-.-|.|||||||++.||.||+.||...++.-++.--+..
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------------ 1456 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------------ 1456 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc------------
Confidence 1223346789999999999997642 34567999999999999999999999776665444322222
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
..+++.| ..++++..|||++||..||+.|.++.| +|+|-|-+.-.
T Consensus 1457 ------------gh~Pq~P-----~~ls~~g~dFle~Cl~~dP~~Rw~~~q------------------lle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1457 ------------GHKPQIP-----ERLSSEGRDFLEHCLEQDPKMRWTASQ------------------LLEHAFGKSCT 1501 (1509)
T ss_pred ------------cCCCCCc-----hhhhHhHHHHHHHHHhcCchhhhHHHH------------------HHHhhcccccc
Confidence 2222222 238999999999999999999999999 78998876543
Q ss_pred C
Q 044076 330 N 330 (506)
Q Consensus 330 ~ 330 (506)
+
T Consensus 1502 d 1502 (1509)
T KOG4645|consen 1502 D 1502 (1509)
T ss_pred c
Confidence 3
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=304.06 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=195.8
Q ss_pred EEEeecCceEEEEEEECC-CCc--EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEE
Q 044076 20 EIIGIGSYGVVASAIDTH-TGE--KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~-t~~--~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
+.||+|++|+||+|.+.. .++ .||||.+...... ...+.+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999999865 333 6999999653322 556778899999999999999999998742 678999
Q ss_pred EecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 97 FELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 97 ~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
+||++ ++|.+.+.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 59999998764 6899999999999999999999999999999999999999999999999999765332211
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+....
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------- 217 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-------------- 217 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--------------
Confidence 111123456778999999877 678999999999999999998 999997766555444442100
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+ .....+..+.+|+.+||+.+|.+|||+.+|
T Consensus 218 ------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 218 ------------ERLE---RPEACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred ------------CcCC---CCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 0000 012367889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.78 Aligned_cols=267 Identities=25% Similarity=0.373 Sum_probs=200.2
Q ss_pred CCEEEeEEEeecCceEEEEEEE----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAID----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.-|++++.||+|+||.||.|.. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 4578999999999999999974 4678899999986432 234456788999999999999999999987442 2
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
....|+||||++ ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 356899999997 59999987653 5899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
..............++..|+|||++.+ ..++.++|||||||++|+|+++..++.... .......|....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~-----~~~~~~~~~~~~~~~- 231 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPM-----TLFLKMIGPTHGQMT- 231 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCcccc-----chhhhhccccccccc-
Confidence 332221111233456778999999877 678999999999999999999876543221 111122222211110
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.......+...... .....+++.+.+||.+||+.||.+|||+.+|
T Consensus 232 ------~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 276 (284)
T cd05079 232 ------VTRLVRVLEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276 (284)
T ss_pred ------HHHHHHHHHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 00111111111111 1234678999999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=305.64 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=199.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCC---CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHT---GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t---~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.++|.+.+.||.|+||.||+|.+... ...||||..... ......+.+.+|+.+++.+.||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence 45799999999999999999987644 457999988642 223455678899999999999999999998742
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 45789999997 59999998744 5899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
..... ...+...++..|+|||.+.. ..++.++|||||||++++|++ |..||.+.+..+.+..+....
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------- 225 (270)
T cd05056 158 EDESY--YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------- 225 (270)
T ss_pred ccccc--eecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 33211 11122234567999999876 678999999999999999996 999998877655444432110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ...+.+++.+.+||.+||..+|.+|||+.++
T Consensus 226 -------------------~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 258 (270)
T cd05056 226 -------------------RL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258 (270)
T ss_pred -------------------cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00 1124578899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.06 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=197.6
Q ss_pred CCEEEeEEEeecCceEEEEEEECCC-------CcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHT-------GEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPP 85 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t-------~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~ 85 (506)
.+|++++.||+|+||.||+|.+... +..||+|.++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 4799999999999999999986432 236999988642 2334456788999999999 79999999999843
Q ss_pred CcCCCCcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcE
Q 044076 86 CRREFKDIYVVFELME-SDLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNI 148 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~-~~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NI 148 (506)
.+.+|+|+||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 367999999997 59999987532 377788899999999999999999999999999999
Q ss_pred EECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCc
Q 044076 149 LANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNV 227 (506)
Q Consensus 149 Lv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~ 227 (506)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999754322111 11122334567999999977 688999999999999999998 8999988765
Q ss_pred hhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 228 AHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 228 ~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+....+.... .. ......+..+.+||.+||+.+|.+|||+.||
T Consensus 243 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~el 286 (334)
T cd05100 243 EELFKLLKEGH---------------------------RM---DKPANCTHELYMIMRECWHAVPSQRPTFKQL 286 (334)
T ss_pred HHHHHHHHcCC---------------------------CC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 55444332100 00 1123467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=302.38 Aligned_cols=242 Identities=26% Similarity=0.420 Sum_probs=192.6
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEec
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFEL 99 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~ 99 (506)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+.+++.+.||||+++++++.. ....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEc
Confidence 468999999999999877 999999998653222 345678899999999999999999998843 3678999999
Q ss_pred CC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccc
Q 044076 100 ME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177 (506)
Q Consensus 100 ~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 177 (506)
+. ++|.+++... ..++...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 97 5899998653 468999999999999999999999999999999999999999999999999997533211110 00
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
.....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+....+
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~----------------- 213 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR----------------- 213 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-----------------
Confidence 11223566999999876 678999999999999999998 8999977664433333211100
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+ .....+..+.+|+.+||+.+|.+|||+.||
T Consensus 214 ----------~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~el 245 (251)
T cd05041 214 ----------MP---APQLCPEEIYRLMLQCWAYDPENRPSFSEI 245 (251)
T ss_pred ----------CC---CCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 00 112467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=309.47 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=198.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++|++++.||.|+||.||+|.+. .++..||||.+... ........+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAV--- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC---
Confidence 468999999999999999999874 36789999998642 223344668899999999999999999998843
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAND----------------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLK 144 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~----------------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLK 144 (506)
....|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++|++|||||
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 80 --GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred --CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 367899999998 59999987432 37788899999999999999999999999999
Q ss_pred CCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCC
Q 044076 145 PKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFP 223 (506)
Q Consensus 145 p~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~ 223 (506)
|+||+++.++.+||+|||+++......... .......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987532221110 0122335667999999876 679999999999999999997 888887
Q ss_pred CCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 224 GRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 224 ~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+.+..+.+..+.. .... ...+..+.++.+||.+||+.||.+|||+.||
T Consensus 235 ~~~~~~~~~~~~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 235 GMAHEEVIYYVRD---------------------------GNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred CCCHHHHHHHHhc---------------------------CCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 7655443333211 0000 1113467899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=302.87 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=198.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||+|+||.||+|.+. .+..||+|.+.. .......+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKP---GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCC---ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------C
Confidence 4679999999999999999999854 556799998863 22334568899999999999999999988732 5
Q ss_pred cEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..|+||||++ ++|.+++... ..++...+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 6899999997 5999999763 357888999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
..... ......++..|+|||++.. ..++.++|+|||||++|+|++ |+.||.+.+..+....+.....
T Consensus 154 ~~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------- 221 (260)
T cd05073 154 DNEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-------- 221 (260)
T ss_pred CCCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC--------
Confidence 22111 1122345677999999876 678999999999999999998 9999988765544443321100
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ...+..+.++.+++.+||+.||.+|||+.+|
T Consensus 222 -------------------~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 253 (260)
T cd05073 222 -------------------M---PRPENCPEELYNIMMRCWKNRPEERPTFEYI 253 (260)
T ss_pred -------------------C---CCcccCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 0 1123577899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=307.95 Aligned_cols=264 Identities=15% Similarity=0.188 Sum_probs=193.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCC---CcEEEEEEecccccChhHH---------HHHHHHHHHHHhCCCCCcceec
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHT---GEKVAIKKMKEVFEHVSDA---------TRILREIKLLRMLKHPDIVEIK 79 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t---~~~vAIK~i~~~~~~~~~~---------~~~~rEi~iL~~l~HpnIv~l~ 79 (506)
..++|++.+.||+|+||+||+|.+..+ +..+|+|+........... .....++..+..+.|+||+.++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 457999999999999999999998877 6677777643211111000 1122344455667899999999
Q ss_pred eeecCCCcCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEe
Q 044076 80 HIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKIC 159 (506)
Q Consensus 80 ~v~~~~~~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~ 159 (506)
+...... ......|++++++..++.+.+......++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 8653321 111245788998888888888766667899999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCCCc----ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHH
Q 044076 160 DFGLARVSFTDTPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVT 235 (506)
Q Consensus 160 DFGla~~~~~~~~~~----~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~ 235 (506)
|||+|+......... .......||+.|+|||++.+ ..++.++||||+||++++|++|++||.+.+....+....
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999997643221110 11123469999999999887 789999999999999999999999998764332221111
Q ss_pred hhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 236 ~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ..++..+.... ...++.++.+.++++.|+..+|.+||++++|
T Consensus 247 ~------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l 289 (294)
T PHA02882 247 K------------------CDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDAL 289 (294)
T ss_pred H------------------HHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHH
Confidence 0 11111111111 1234578899999999999999999999994
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.67 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=198.3
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCc----EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGE----KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
-..++|++.+.||+|+||.||+|.+..++. .||+|.+... ........+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-- 80 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-- 80 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--
Confidence 346789999999999999999999887776 4788887542 222334467899999999999999999998743
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
...++|+||+. |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ----~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 81 ----PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred ----CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccc
Confidence 34679999998 68999987654 6899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
+........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~------- 226 (303)
T cd05110 157 RLLEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK------- 226 (303)
T ss_pred ccccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-------
Confidence 764322211 11223446778999999876 678999999999999999997 8999977553332222210
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+ ..+..+..+.+++.+||..||++|||+.+|
T Consensus 227 --------------------~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l 261 (303)
T cd05110 227 --------------------GERLP---QPPICTIDVYMVMVKCWMIDADSRPKFKEL 261 (303)
T ss_pred --------------------CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00001 113467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=308.72 Aligned_cols=257 Identities=24% Similarity=0.370 Sum_probs=195.8
Q ss_pred CCCEEEeEEEeecCceEEEEEEECC----------------CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTH----------------TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~----------------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv 76 (506)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3579999999999999999986432 3457999998642 2333456788999999999999999
Q ss_pred eeceeecCCCcCCCCcEEEEEecCC-CCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 044076 77 EIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKAND-----------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLK 144 (506)
Q Consensus 77 ~l~~v~~~~~~~~~~~~ylV~E~~~-~~L~~~i~~~~-----------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLK 144 (506)
++++++... +..|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+|||||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 83 RLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred eEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 999988443 67899999997 59999987642 36677899999999999999999999999999
Q ss_pred CCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh--CCCCC
Q 044076 145 PKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GRPLF 222 (506)
Q Consensus 145 p~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~--G~~pF 222 (506)
|+|||++.++.++|+|||+++........ .......++..|+|||...+ ..++.++|+|||||++|||++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999754322111 11122344678999998776 678999999999999999998 77888
Q ss_pred CCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 223 PGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 223 ~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+..+.+.... .+...... .......+.+++.+.+|+.+||+.||.+|||+.+|
T Consensus 235 ~~~~~~~~~~~~~--------------------~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 290 (296)
T cd05095 235 SQLSDEQVIENTG--------------------EFFRDQGR---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290 (296)
T ss_pred cccChHHHHHHHH--------------------HHHhhccc---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 7655443322110 01000000 00001123467899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=303.94 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=187.4
Q ss_pred EEEeecCceEEEEEEEC--CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDT--HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~--~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||.||+|... .....+|+|.+... ........+.+|+.+++.++||||+++++.+.. ....|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEE
Confidence 35899999999999643 24457888877532 233345567899999999999999999998843 36799999
Q ss_pred ecCC-CCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 98 ELME-SDLDQVIKAND-----DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~-----~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
||++ ++|.+++.... ..++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 59999987643 24677889999999999999999999999999999999999999999999986532221
Q ss_pred CCcccccccccCCcccCccccccc-----CCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
... ......++..|+|||++... ...++.++|||||||++|+|++ |.+||......+.+..+......+
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---- 229 (269)
T cd05042 155 YYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK---- 229 (269)
T ss_pred hee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc----
Confidence 110 01223456779999987431 1457889999999999999999 888998766555444432211110
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+........++...+++..|+ .||.+|||+++|
T Consensus 230 ---------------------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v 263 (269)
T cd05042 230 ---------------------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263 (269)
T ss_pred ---------------------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHH
Confidence 0111122357788899999998 599999999995
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.25 Aligned_cols=279 Identities=21% Similarity=0.258 Sum_probs=189.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCC----CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC-
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHT----GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC- 86 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t----~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~- 86 (506)
..++|++.+.||+|+||.||+|++..+ +..||||++.... ......+| .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 457999999999999999999999988 9999999986421 11111111 122223334444333332221
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCC
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKANDD--------------------LTPEHHQFFLYQLLRALKYIHSANVFHRDLKP 145 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~~~--------------------ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp 145 (506)
......+++|+||+++ +|.+++..... .....++.++.||+.||.|||+.||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 1345779999999984 89988875421 12345678999999999999999999999999
Q ss_pred CcEEECC-CCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccC--------------------CCCCchhh
Q 044076 146 KNILANA-DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 204 (506)
Q Consensus 146 ~NILv~~-~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~--------------------~~~s~~~D 204 (506)
+|||++. ++.+||+|||+|+....... .....+++|+.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 58999999999975322211 1124567899999999763311 12445679
Q ss_pred hhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCC---CCCCCCCHHHH
Q 044076 205 IWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFS---HKFPGADPLAL 281 (506)
Q Consensus 205 IWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~ 281 (506)
|||+|||||||+++. |+..+...++..+....+.... .|.... .......+. ..+...+..+.
T Consensus 362 VwSlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~~-~~~~~~-----------~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDLV-AWRKLV-----------EPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcHH-HHHHhh-----------ccccchhhhhhhhhccccchHHH
Confidence 999999999999854 4555555555555544443322 111110 000000111 11222355678
Q ss_pred HHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 282 RLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 282 dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
|||.+||++||.+|||+.| +|+||||++...
T Consensus 428 dLi~~mL~~dP~kR~ta~e------------------~L~Hpff~~~~~ 458 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKA------------------ALAHPYFDREGL 458 (566)
T ss_pred HHHHHHccCCcccCCCHHH------------------HhCCcCcCCCCc
Confidence 9999999999999999999 999999987543
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=306.11 Aligned_cols=240 Identities=26% Similarity=0.393 Sum_probs=189.6
Q ss_pred EEEeecCceEEEEEEECCCCc--EEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCcEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGE--KVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~--~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
+.||+|+||.||+|.+..++. .+|+|.++.. ........+.+|+.++.++ .||||+++++++.. .+.+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEE
Confidence 368999999999999988776 4688887632 2234456788999999999 69999999999843 3678999
Q ss_pred EecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEe
Q 044076 97 FELME-SDLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKIC 159 (506)
Q Consensus 97 ~E~~~-~~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~ 159 (506)
|||+. ++|.+++..+. .+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99997 59999997543 47899999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhc
Q 044076 160 DFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 160 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~ 238 (506)
|||+++....... ......+..|+|||++.. ..++.++|||||||++++|++ |..||.+.+..+....+..
T Consensus 155 dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-- 226 (270)
T cd05047 155 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 226 (270)
T ss_pred CCCCccccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC--
Confidence 9999863221111 011223567999999876 678999999999999999997 9999977654433332211
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.... ......+.++.+|+.+||..||.+|||+.+|
T Consensus 227 -------------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 227 -------------------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred -------------------------CCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 0000 1112467889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=305.31 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=200.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCc----EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGE----KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
...+|++++.||+|+||+||+|.+..+|. .||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-TSPKANKEILDEAYVMASVDHPHVVRLLGICLS--- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 35789999999999999999999877665 5899987643 223455678899999999999999999998743
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
...++||||+. ++|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus 81 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 81 ---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 57899999997 5999998764 469999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
......... ......++..|+|||.+.. ..++.++|+||+||++++|++ |+.||.+....+....+...
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------- 227 (279)
T cd05057 158 LLDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG------- 227 (279)
T ss_pred cccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-------
Confidence 643222111 1111223567999999876 678999999999999999998 99999876654433333211
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+ ..+..+..+.+++.+||..||.+|||+.+|
T Consensus 228 --------------------~~~~---~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l 261 (279)
T cd05057 228 --------------------ERLP---QPPICTIDVYMVLVKCWMIDAESRPTFKEL 261 (279)
T ss_pred --------------------CCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0000 112367889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=305.03 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=197.5
Q ss_pred EEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC-CC
Q 044076 16 YEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE-FK 91 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~-~~ 91 (506)
|++.+.||+|+||.||+|.+. .++..||||.+..........+.+.+|+++++.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 35789999999755445556677889999999999999999999886542211 12
Q ss_pred cEEEEEecCC-CCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 92 DIYVVFELME-SDLDQVIKAN------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
..++++||+. ++|..++... ..++...+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999997 5888876432 14789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
+......... ......++..|++||.+.+ ..++.++|||||||++|+|++ |++||.+.+..+....+...
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------ 231 (273)
T cd05074 161 KKIYSGDYYR-QGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG------ 231 (273)
T ss_pred ccccCCccee-cCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC------
Confidence 7543221110 1122345567999999877 678899999999999999999 89999776544333222110
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... ..-+..++.+.+|+.+||+.+|.+|||+.+|
T Consensus 232 ---------------------~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~ 265 (273)
T cd05074 232 ---------------------NRL---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265 (273)
T ss_pred ---------------------CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 000 0113567899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=339.28 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=212.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..+-+..+.||+|+||+||+|.-. .....||||.++.. .+......+.||+.+|..|+|||||+|++++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--- 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCRE--- 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc---
Confidence 456778899999999999999743 34467999999853 233356779999999999999999999999944
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAND----------D----LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA 152 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~----------~----ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~ 152 (506)
.+-+|+|||||. |||+++++.+. + |+..+...|+.||+.|+.||-++.+|||||-.+|+||++
T Consensus 561 --~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 561 --GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred --CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 478999999998 79999997642 3 889999999999999999999999999999999999999
Q ss_pred CCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhH
Q 044076 153 DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQL 231 (506)
Q Consensus 153 ~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l 231 (506)
+-.|||+|||++|.....+... ....-.-...|||||.+.- .+|+.++||||+||+|||+++ |+.|+.|.++.+.+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk-~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYK-VRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred ceEEEecccccchhhhhhhhhc-ccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 9999999999998644332211 1112234567999999987 899999999999999999999 99999999999998
Q ss_pred HHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhH
Q 044076 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNW 310 (506)
Q Consensus 232 ~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~ 310 (506)
+.|.+.--- ..-.+++.++.+|+..||+.+|.+|||+.|| +..++.|
T Consensus 716 e~i~~g~lL------------------------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI--~~~L~~~ 762 (774)
T KOG1026|consen 716 ECIRAGQLL------------------------------SCPENCPTEVYSLMLECWNENPKRRPSFKEI--HSRLQAW 762 (774)
T ss_pred HHHHcCCcc------------------------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHH--HHHHHHH
Confidence 888431110 1113688999999999999999999999996 4555555
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=297.84 Aligned_cols=241 Identities=26% Similarity=0.422 Sum_probs=191.4
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEec
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFEL 99 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~ 99 (506)
++||.|+||.||+|.. .++..||+|+++.... ......+.+|+.+++.+.||||+++++++.. .+..++||||
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEEC
Confidence 4689999999999985 4688999999865332 2334468899999999999999999998843 3678999999
Q ss_pred CC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccc
Q 044076 100 ME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177 (506)
Q Consensus 100 ~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 177 (506)
++ ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 97 5999988754 468999999999999999999999999999999999999999999999999997532221110 0
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~------------------- 210 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG------------------- 210 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 11234567999999876 678999999999999999998 99999876544333222110
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... .....++..+.+|+.+||+.||.+|||+.||
T Consensus 211 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 244 (250)
T cd05085 211 --------YRM---SCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244 (250)
T ss_pred --------CCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 000 1123578899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=298.63 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=212.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+..+++.-||.|+-|+||+++.+.+|...|||.+.+. .+..+.+++++.+.++.... .|.||+.+++|... .+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~d 165 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TD 165 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----ch
Confidence 4456678899999999999999999999999999753 45567888999999887665 89999999999764 78
Q ss_pred EEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+++.||.|..-+..+++. .++++|..+-.+...++.||.||-+ +||+|||+||+|||+++.|++||||||.+......
T Consensus 166 V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 166 VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 899999999766666654 4579999999999999999999985 58999999999999999999999999999654332
Q ss_pred CCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-chhhHHHHHhhcCCCChHHHhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRN-VAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~-~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. .+.-.|.+.|||||-+.-. ...|+-.+||||||+.++||.||+.||++-+ +.+.+.+|.+- .|+
T Consensus 246 kA----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP------ 313 (391)
T KOG0983|consen 246 KA----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPP------ 313 (391)
T ss_pred cc----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCC------
Confidence 22 2445688999999998542 3679999999999999999999999999854 45666666441 110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
..+ .-.+.|+++.+|+..||+.|+.+||...+ +|+|||+...
T Consensus 314 -----------------~L~---~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~------------------Ll~h~Fi~~y 355 (391)
T KOG0983|consen 314 -----------------LLP---GHMGFSPDFQSFVKDCLTKDHRKRPKYNK------------------LLEHPFIKRY 355 (391)
T ss_pred -----------------CCC---cccCcCHHHHHHHHHHhhcCcccCcchHH------------------HhcCcceeec
Confidence 111 11247999999999999999999999999 8999999864
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=300.70 Aligned_cols=245 Identities=23% Similarity=0.370 Sum_probs=188.3
Q ss_pred EEEeecCceEEEEEEECC---CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEE
Q 044076 20 EIIGIGSYGVVASAIDTH---TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~---t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++... .+..|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEE
Confidence 468999999999998653 3457999988532 2334566788999999999999999999976432 2457899
Q ss_pred EecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC-
Q 044076 97 FELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS- 173 (506)
Q Consensus 97 ~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~- 173 (506)
|||+. ++|.+++... ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99997 5999998764 35678888999999999999999999999999999999999999999999999753221110
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
........++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+.. +.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~--~~------------ 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GR------------ 219 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--CC------------
Confidence 001123345678999999876 678999999999999999999 5778876554332222211 00
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+. -...++.+.+|+.+||..||.+|||+.+|
T Consensus 220 -------------~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 252 (262)
T cd05058 220 -------------RLLQ---PEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252 (262)
T ss_pred -------------CCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0000 01357789999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=303.18 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=198.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECC-----CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTH-----TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~-----t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++|++++.||.|+||.||+|+... +.+.|++|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 79 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--- 79 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC---
Confidence 3689999999999999999999654 3467999987532 222245678899999999999999999998733
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEE
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAND---------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLK 157 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~---------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lK 157 (506)
....|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++
T Consensus 80 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 80 --AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred --CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEE
Confidence 367899999998 59999998765 689999999999999999999999999999999999999999999
Q ss_pred EeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHh
Q 044076 158 ICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236 (506)
Q Consensus 158 L~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~ 236 (506)
|+|||+++....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 158 l~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~ 233 (275)
T cd05046 158 VSLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA 233 (275)
T ss_pred EcccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence 999999865322211 11233456777999999876 568899999999999999998 8889976554333332211
Q ss_pred hcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 237 LLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 237 ~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+ ...+ ......+..+.++|.+||+.||.+|||+.||
T Consensus 234 --~--------------------------~~~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~ 269 (275)
T cd05046 234 --G--------------------------KLEL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269 (275)
T ss_pred --C--------------------------CcCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 0 0000 0113477899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=323.97 Aligned_cols=282 Identities=22% Similarity=0.361 Sum_probs=234.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..+.+++..||-|+||.|=++........+|+|++++. .-+....+.+..|-.||...+.|.||+||..| .+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 45778889999999999999976666556899999642 22445567789999999999999999999998 4458
Q ss_pred cEEEEEecC-CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELM-ESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~-~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
++|++||-| +|.|+.+++.++.+.+...++++.-+++|+.|||++|||.|||||+|++++.+|-+||.|||+|+....+
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999987 5799999999999999999999999999999999999999999999999999999999999999876555
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
... .+++||+.|.|||++++ ...+.++|.||||+++||||+|.|||.+.+.....+.|.+.+-.
T Consensus 574 ~KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~---------- 637 (732)
T KOG0614|consen 574 RKT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK---------- 637 (732)
T ss_pred Cce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------
Confidence 443 45789999999999998 78889999999999999999999999999998888888542211
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
. +.-..++..+.+||+++...+|.+|.. +.+|..|.|+..+-+.+.-...|..|+.
T Consensus 638 ----------------i---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~ 698 (732)
T KOG0614|consen 638 ----------------I---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPII 698 (732)
T ss_pred ----------------h---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCcc
Confidence 0 111247788999999999999999987 7787767776666666665556666666
Q ss_pred CCCCCCCCC
Q 044076 326 HGLANLEEE 334 (506)
Q Consensus 326 ~~~~~~~~~ 334 (506)
..+.++.+.
T Consensus 699 ~~va~ptD~ 707 (732)
T KOG0614|consen 699 PSVANPTDV 707 (732)
T ss_pred ccCCCcccc
Confidence 666554443
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=300.46 Aligned_cols=239 Identities=28% Similarity=0.470 Sum_probs=195.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++.+.||.|+||.||.+. .+++.||+|+++.. .....+.+|+.+++.++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~ 72 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NG 72 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CC
Confidence 4679999999999999999985 57889999998642 234568899999999999999999998743 34
Q ss_pred EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 799999998 59999997654 588999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||.+.+..+....+...
T Consensus 153 ~~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------- 213 (254)
T cd05083 153 GV------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG----------- 213 (254)
T ss_pred cC------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-----------
Confidence 11 12234567999999876 678999999999999999997 99999876654433332110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... .....+++.+.+|+.+||+.+|.+|||+++|
T Consensus 214 ----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 247 (254)
T cd05083 214 ----------------YRM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKL 247 (254)
T ss_pred ----------------CCC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 000 1113578899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=312.61 Aligned_cols=264 Identities=23% Similarity=0.379 Sum_probs=219.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~ 89 (506)
.+.+|..+.+||+|+||.|.+|..+.+.+.+|||++++.. -...+.+-.+.|-++|.... -|.+++++..| ..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QT 421 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QT 421 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hh
Confidence 3567889999999999999999999999999999996532 22234444567888887775 78899988877 44
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+.+|+||||+. |+|.-.|+.-+.+.+.++.+++..|+-||-+||+.||+.||||.+|||++.+|++||+|||+++-..
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 589999999998 5999999999999999999999999999999999999999999999999999999999999997533
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.+... ...++||+.|+|||++.- .+|+.++|.||+|++|||||.|++||.|.+..+..+.|++.--.
T Consensus 502 ~~~~T---TkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-------- 568 (683)
T KOG0696|consen 502 FDGVT---TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-------- 568 (683)
T ss_pred cCCcc---eeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--------
Confidence 32222 256899999999999976 89999999999999999999999999999999888888542211
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+-..+|.+|.++++.+|...|.+|..+.-- -...+-.||||+.+
T Consensus 569 -----------------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~-------------ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 569 -----------------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPE-------------GERDIREHPFFRRI 612 (683)
T ss_pred -----------------------CcccccHHHHHHHHHHhhcCCccccCCCCc-------------cccchhhCcchhhc
Confidence 113589999999999999999999864210 00117899999976
Q ss_pred C
Q 044076 329 A 329 (506)
Q Consensus 329 ~ 329 (506)
.
T Consensus 613 D 613 (683)
T KOG0696|consen 613 D 613 (683)
T ss_pred c
Confidence 4
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.78 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=186.7
Q ss_pred EEEeecCceEEEEEEEC--CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDT--HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~--~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.||+|+||.||+|.+. .++..+|+|+++.... ......+.+|+.+++.++||||+++++.+.. ...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEE
Confidence 36899999999999754 4567899999864322 2334568899999999999999999998743 36789999
Q ss_pred ecCC-CCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 98 ELME-SDLDQVIKAND-----DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~-----~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
||++ ++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9998 59999987532 35677888999999999999999999999999999999999999999999996532221
Q ss_pred CCcccccccccCCcccCcccccccC-----CCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~-----~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
. ........++..|+|||++.+.. ..++.++||||+||++|+|++ |++||+.....+.+......
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------- 225 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-------- 225 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc--------
Confidence 1 11112345678899999985421 246789999999999999996 99999765544332221110
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+-.......++.+.+++++|+ .||.+|||++||
T Consensus 226 -----------------~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l 263 (269)
T cd05087 226 -----------------QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEV 263 (269)
T ss_pred -----------------ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHH
Confidence 00000001111246778999999998 689999999995
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=302.42 Aligned_cols=235 Identities=22% Similarity=0.292 Sum_probs=181.9
Q ss_pred EEEeecCceEEEEEEECC------------CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 20 EIIGIGSYGVVASAIDTH------------TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~------------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
+.||+|+||.||+|.... ....|++|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 468999999999997432 2336889987542 233445678899999999999999999998543
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC-------EEE
Q 044076 88 REFKDIYVVFELMES-DLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK-------LKI 158 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~-------lKL 158 (506)
...++||||+++ +|..++.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.++. +|+
T Consensus 77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 567999999985 77777765 356999999999999999999999999999999999999987664 899
Q ss_pred eecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHH-hCCCCCCCCCchhhHHHHHhh
Q 044076 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL-TGRPLFPGRNVAHQLDLVTDL 237 (506)
Q Consensus 159 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl-~G~~pF~~~~~~~~l~~I~~~ 237 (506)
+|||++...... ....++..|+|||++... ..++.++|||||||++|+|+ .|..||.+....+.....
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--- 222 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY--- 222 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---
Confidence 999998653221 234578889999988642 67899999999999999998 588888665432211100
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. . .......++++.+||.+||+.||.+|||+.+|
T Consensus 223 ---------------------~~---~-----~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~i 257 (262)
T cd05077 223 ---------------------EG---Q-----CMLVTPSCKELADLMTHCMNYDPNQRPFFRAI 257 (262)
T ss_pred ---------------------hc---C-----ccCCCCChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00 0 00112345789999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=298.69 Aligned_cols=228 Identities=25% Similarity=0.355 Sum_probs=184.5
Q ss_pred cCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecCC-CC
Q 044076 25 GSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SD 103 (506)
Q Consensus 25 G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-~~ 103 (506)
|.+|.||+|++..+++.||+|++.... ...+|...+....||||+++++++.. ....|+||||++ ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCC
Confidence 899999999999999999999996421 12345555555679999999998843 378999999998 49
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccC
Q 044076 104 LDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT 183 (506)
Q Consensus 104 L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt 183 (506)
|.+.+.....+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||.+...... .....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcC
Confidence 9999988778999999999999999999999999999999999999999999999999988653221 1233467
Q ss_pred CcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhc
Q 044076 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRR 263 (506)
Q Consensus 184 ~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~ 263 (506)
..|+|||.+.+ ..++.++|+||+||++|+|++|+.+|...... + . .
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~---------------~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------N---------------T 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------c---------------c
Confidence 78999999876 67889999999999999999999887432110 0 0 0
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----hhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 264 KWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA-----EEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 264 ~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa-----~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.... ..-+.+++.+.+||.+||+.||.+|||+ ++ ++.||||
T Consensus 192 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~------------------~~~h~~~ 237 (237)
T cd05576 192 HTTL---NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVED------------------IKSHPFF 237 (237)
T ss_pred cccc---CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHH------------------HHcCCCC
Confidence 0000 0113478899999999999999999997 66 8999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=303.50 Aligned_cols=235 Identities=19% Similarity=0.289 Sum_probs=184.0
Q ss_pred EEEeecCceEEEEEEECCCCc-------EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 20 EIIGIGSYGVVASAIDTHTGE-------KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~-------~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+.||.|+||.||+|.+..++. .||+|.+... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 468999999999998866544 4888887532 233455678899999999999999999998543 67
Q ss_pred EEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC--------EEEeecC
Q 044076 93 IYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK--------LKICDFG 162 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~--------lKL~DFG 162 (506)
.++||||++ ++|.+++..++ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 899999997 48999997654 5899999999999999999999999999999999999987765 6999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhC-CCCCCCCCchhhHHHHHhhcCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G-~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
++...... ....++..|+|||++.+. ..++.++||||+||++|+|++| .+||...+........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------- 218 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------- 218 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------
Confidence 98643211 234578889999998752 4578899999999999999998 4666544432221111
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.... ...+..+.++.+||.+||+.||.+|||+++|
T Consensus 219 --------------------~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 253 (258)
T cd05078 219 --------------------EDRH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAI 253 (258)
T ss_pred --------------------Hccc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHH
Confidence 0000 0112356789999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.76 Aligned_cols=232 Identities=28% Similarity=0.427 Sum_probs=192.0
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEe
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFE 98 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E 98 (506)
++.||+|+.|.||+|+ -.++.||||+++.. + ..+|+-||+|+||||+.+.+|+... ..+|||||
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~el-------k--ETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVREL-------K--ETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhh-------h--hhhHHHHHhccCcceeeEeeeecCC-----ceeEEeee
Confidence 5789999999999995 56789999998631 1 2478889999999999999999554 67899999
Q ss_pred cCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccc
Q 044076 99 LME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177 (506)
Q Consensus 99 ~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 177 (506)
||. |-|..+++....++......+..+|+.|++|||.+.|||||||.-||||..+..+||+|||-++-..... . .
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---T-k 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---T-K 268 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh---h-h
Confidence 997 7999999999999999999999999999999999999999999999999999999999999997543221 1 1
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~ 257 (506)
-.+.||..|||||++.+ ...+.++||||+||+|||||||..||.+-+.. ..|. ..|+-
T Consensus 269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIw-GVGsN---------------- 326 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIW-GVGSN---------------- 326 (904)
T ss_pred hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccchh---eeEE-eccCC----------------
Confidence 35789999999999998 79999999999999999999999999654322 1111 01110
Q ss_pred HhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHhhhh
Q 044076 258 LSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSAEEIR 302 (506)
Q Consensus 258 ~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~RpTa~eL~ 302 (506)
.+.-.. ..+++-++=||+.||+-.|..||++.+|+
T Consensus 327 ----------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil 362 (904)
T KOG4721|consen 327 ----------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQIL 362 (904)
T ss_pred ----------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHH
Confidence 011111 24667789999999999999999999953
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.51 Aligned_cols=251 Identities=26% Similarity=0.373 Sum_probs=197.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~ 86 (506)
.++|.+++.||+|+||.||+|++. .+++.||||+++... .......+.+|+.+|..+. ||||+++++.+..
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 367899999999999999999853 455789999997532 2233456889999999997 9999999998844
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC-----------------------------------------------------
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND----------------------------------------------------- 112 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~----------------------------------------------------- 112 (506)
.+.+|+||||+. |+|.+++..+.
T Consensus 113 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 113 ---GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ---CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 367999999998 59999886432
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 044076 113 ---------------------------------------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKN 147 (506)
Q Consensus 113 ---------------------------------------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~N 147 (506)
.++...+..++.||+.||.|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 35667788999999999999999999999999999
Q ss_pred EEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCC
Q 044076 148 ILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN 226 (506)
Q Consensus 148 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~ 226 (506)
||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++||||+||++|||++ |..||....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999754222111 11123356788999999977 678999999999999999998 899997655
Q ss_pred chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 227 VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 227 ~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+.+...... .... ...+.++.++.+||.+||..||.+|||+.||
T Consensus 347 ~~~~~~~~~~~--------------------------~~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 347 MNEQFYNAIKR--------------------------GYRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred chHHHHHHHHc--------------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 44332222110 0000 1123478899999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.56 Aligned_cols=268 Identities=26% Similarity=0.404 Sum_probs=200.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
...|++.+.||+|+||.||+|... .+++.||||+++..... .....+.+|+.+++.+.||||+++++++...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~--- 78 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKP--- 78 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecC---
Confidence 467889999999999999999854 34789999999753222 3466788999999999999999999987442
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
+....|+||||++ ++|.+++.... .++...+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 2367899999997 59999997654 699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...............++..|+|||.+.+ ..++.++|||||||++++|++|..||....... ....|......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~- 230 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQM- 230 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccccc-
Confidence 4322111111122345667999999877 678899999999999999999998885533211 11111110000
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
........+......+. ....+.++.+|+.+||+.||.+|||+.||
T Consensus 231 ------~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 276 (284)
T cd05038 231 ------IVTRLLELLKEGERLPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADL 276 (284)
T ss_pred ------cHHHHHHHHHcCCcCCC---CccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 00111111111111111 12456889999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=300.73 Aligned_cols=243 Identities=28% Similarity=0.410 Sum_probs=191.5
Q ss_pred EEEeecCceEEEEEEECCCC------cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 20 EIIGIGSYGVVASAIDTHTG------EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
+.||+|+||.||+|.+.... ..||||.+.... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCe
Confidence 36899999999999876543 689999885421 12345668899999999999999999998844 3678
Q ss_pred EEEEecCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-----CEEEee
Q 044076 94 YVVFELME-SDLDQVIKAN-------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-----KLKICD 160 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~~-------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-----~lKL~D 160 (506)
|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++ .+||+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999997 5999998642 2478899999999999999999999999999999999999887 899999
Q ss_pred cCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcC
Q 044076 161 FGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 161 FGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g 239 (506)
||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||+..+..+....+... +
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~ 230 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G 230 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C
Confidence 99997532221111 1122345678999999977 678999999999999999998 99999877655444333110 0
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ......+++.+.+||.+||..+|.+|||+++|
T Consensus 231 --------------------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 263 (269)
T cd05044 231 --------------------------R---LQKPENCPDKIYQLMTNCWAQDPSERPTFDRI 263 (269)
T ss_pred --------------------------c---cCCcccchHHHHHHHHHHcCCCcccCCCHHHH
Confidence 0 01123467889999999999999999999994
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=298.69 Aligned_cols=247 Identities=26% Similarity=0.463 Sum_probs=198.1
Q ss_pred CEEEeEEEeecCceEEEEEEECC-CCcEEEEEEecccc--------cChhHHHHHHHHHHHHHh-CCCCCcceeceeecC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTH-TGEKVAIKKMKEVF--------EHVSDATRILREIKLLRM-LKHPDIVEIKHIMLP 84 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~-t~~~vAIK~i~~~~--------~~~~~~~~~~rEi~iL~~-l~HpnIv~l~~v~~~ 84 (506)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 68899999885321 122344567789998875 789999999998843
Q ss_pred CCcCCCCcEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEE
Q 044076 85 PCRREFKDIYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKI 158 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL 158 (506)
.+..|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+ .||+|+||+|+||+++.++.+||
T Consensus 81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 -----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred -----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 4789999999985 88877743 3469999999999999999999996 78999999999999999999999
Q ss_pred eecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhc
Q 044076 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 159 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~ 238 (506)
+|||.+....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|++||...+.......+....
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 9999997643322 2245668899999999977 678999999999999999999999997665444333332211
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..|. .....++.+.+||.+||+.||.+|||+.||
T Consensus 230 ~~~~-----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~ 263 (269)
T cd08528 230 YEPL-----------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQV 263 (269)
T ss_pred CCcC-----------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence 1110 011367889999999999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.29 Aligned_cols=234 Identities=21% Similarity=0.280 Sum_probs=181.4
Q ss_pred EEeecCceEEEEEEECC------------------------CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcc
Q 044076 21 IIGIGSYGVVASAIDTH------------------------TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d~~------------------------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv 76 (506)
.||+|+||.||+|.... ....||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999997432 1246889988532 223345678899999999999999
Q ss_pred eeceeecCCCcCCCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC
Q 044076 77 EIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC 154 (506)
Q Consensus 77 ~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~ 154 (506)
++++++.. ....|+||||+++ +|..++.. .+.+++..+..++.||++||+|||+.||+||||||+|||++.++
T Consensus 80 ~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVR-----GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEe-----CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 99999854 3678999999985 78888865 45789999999999999999999999999999999999997643
Q ss_pred -------CEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHH-hCCCCCCCCC
Q 044076 155 -------KLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL-TGRPLFPGRN 226 (506)
Q Consensus 155 -------~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl-~G~~pF~~~~ 226 (506)
.+|++|||++...... ....++..|+|||.+.+. ..++.++|||||||++|||+ +|+.||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999998643221 223477889999988652 56899999999999999985 6999997654
Q ss_pred chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 227 VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 227 ~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+....+ . .....+ ...++.+.+||.+||+.||.+|||+.+|
T Consensus 227 ~~~~~~~~------------------------~---~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~i 269 (274)
T cd05076 227 PSEKERFY------------------------E---KKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTI 269 (274)
T ss_pred hHHHHHHH------------------------H---hccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHH
Confidence 33221111 0 000001 1245789999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.98 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=212.0
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.-|..++.||-|+||.|++++...|...||+|.+.+. .........+..|-.||..-..+-||+|+-.| .+.+.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence 4577899999999999999999999999999998542 12234455677899999999999999999888 45589
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC-
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD- 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~- 170 (506)
+|+||+|+. ||+..+|-+.+-+.|+.+++++..|.+|+.+.|..|+|||||||+||||+.+|++||+|||||......
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998 599999999999999999999999999999999999999999999999999999999999999542111
Q ss_pred --------CCC-c-----------------------------ccccccccCCcccCcccccccCCCCCchhhhhhhhHHH
Q 044076 171 --------TPS-A-----------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 212 (506)
Q Consensus 171 --------~~~-~-----------------------------~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il 212 (506)
... . ......|||..|+|||++.. ..|+..+|.||+||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHH
Confidence 000 0 00123589999999999988 7999999999999999
Q ss_pred HHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 044076 213 AELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDP 292 (506)
Q Consensus 213 ~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP 292 (506)
|||+.|++||.+....+...+|.+. +.++.. ..-.++++++.+||.+|. .++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw-----------------~~~l~~----------~~~~~ls~e~~~li~kLc-~sa 913 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINW-----------------RNFLHI----------PYQGNLSKEALDLIQKLC-CSA 913 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeeh-----------------hhcccc----------ccccccCHHHHHHHHHHh-cCh
Confidence 9999999999877655444333211 111100 111368999999999876 578
Q ss_pred CCCCC---HhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 293 KDRPS---AEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 293 ~~RpT---a~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
++|.. ++| +..||||+++.
T Consensus 914 d~RLGkng~d~------------------vKaHpfFkgID 935 (1034)
T KOG0608|consen 914 DSRLGKNGADQ------------------VKAHPFFKGID 935 (1034)
T ss_pred hhhhcccchhh------------------hhcCccccccc
Confidence 88874 667 78999998864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=320.62 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=204.0
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCc---E-EEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGE---K-VAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~---~-vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
++-.+.++||+|+||.||+|.-+..+. . ||||..+.. .........+++|.++|+.++|||||+++++....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--- 233 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--- 233 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC---
Confidence 445566999999999999998765422 3 899998742 24556678899999999999999999999998654
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..+|||||+|.| +|.++++..+ .++..+...++++.++||+|||+++++||||-.+|+|++.++.+||+|||+++.
T Consensus 234 --~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 234 --EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred --CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 779999999985 9999999887 499999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
....... .........|+|||.+.. ..|++++||||+||++||+++ |..||+|....+....|.....
T Consensus 312 ~~~~~~~---~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~------ 380 (474)
T KOG0194|consen 312 GSQYVMK---KFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY------ 380 (474)
T ss_pred Ccceeec---cccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc------
Confidence 4211100 012235678999999988 699999999999999999999 8899999988776666622111
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+.+.. +..+.++..++.+|+..||++|||+.++
T Consensus 381 --------------------r~~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i 413 (474)
T KOG0194|consen 381 --------------------RMPIP---SKTPKELAKVMKQCWKKDPEDRPTMSTI 413 (474)
T ss_pred --------------------cCCCC---CCCHHHHHHHHHHhccCChhhccCHHHH
Confidence 11111 2356778899999999999999999995
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=295.30 Aligned_cols=234 Identities=20% Similarity=0.287 Sum_probs=184.3
Q ss_pred EEEeecCceEEEEEEECCCC----------cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 20 EIIGIGSYGVVASAIDTHTG----------EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~----------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
+.||+|+||.||+|.+..++ ..|++|.+... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD---HRDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc---hhhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46899999999999998777 35788876532 1225678899999999999999999998743
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-------CEEEee
Q 044076 90 FKDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-------KLKICD 160 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-------~lKL~D 160 (506)
...|+||||++ ++|.+++.... .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 45699999998 58999998766 799999999999999999999999999999999999999887 799999
Q ss_pred cCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcC
Q 044076 161 FGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 161 FGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g 239 (506)
||++...... ....++..|+|||++.+....++.++||||+||++++|++ |..||...+.........
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 9999753321 2334667899999987622378999999999999999999 577776544221111110
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+ ......+.+||.+||..||.+|||+.+|
T Consensus 221 -----------------------~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~i 254 (259)
T cd05037 221 -----------------------DQHRLP-----MPDCAELANLINQCWTYDPTKRPSFRAI 254 (259)
T ss_pred -----------------------cCCCCC-----CCCchHHHHHHHHHhccChhhCCCHHHH
Confidence 000000 1123789999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=312.89 Aligned_cols=274 Identities=27% Similarity=0.397 Sum_probs=214.0
Q ss_pred cccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-----ChhHHHHHHHHHHHHHhCCCCCcceece
Q 044076 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-----HVSDATRILREIKLLRMLKHPDIVEIKH 80 (506)
Q Consensus 6 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-----~~~~~~~~~rEi~iL~~l~HpnIv~l~~ 80 (506)
|-+.-...+||-++..||+|||+.||+|.|...++.||+|+-..... .....+...||.+|.+.|.||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 33444567899999999999999999999999999999998632111 1223456789999999999999999999
Q ss_pred eecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECC---CC
Q 044076 81 IMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANA---DC 154 (506)
Q Consensus 81 v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~---~~ 154 (506)
+|... .+.+|-|+|||+| ||.-+++.+..+++.+++.|+.||+.||.||.+.. |||-||||.|||+-. -|
T Consensus 535 yfslD----tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 535 YFSLD----TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeec----cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence 98532 3678999999997 89999999999999999999999999999999765 999999999999743 47
Q ss_pred CEEEeecCCcccccCCCCCc----ccccccccCCcccCcccccc--cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch
Q 044076 155 KLKICDFGLARVSFTDTPSA----IFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA 228 (506)
Q Consensus 155 ~lKL~DFGla~~~~~~~~~~----~~~~~~vgt~~Y~APE~l~~--~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~ 228 (506)
.+||+|||++++...+.... .......||.||.+||.+.- .....+.++||||+|||||.++.|+.||......
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 89999999999865543331 22245679999999998743 1356788999999999999999999999543221
Q ss_pred -hhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhh
Q 044076 229 -HQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIV 307 (506)
Q Consensus 229 -~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~ 307 (506)
+.|+.- ..+.. ....| ..-|-+++++.+||++||++--++|..+.+
T Consensus 691 QdILqeN------------------------TIlkA-tEVqF-P~KPvVsseAkaFIRRCLaYRKeDR~DV~q------- 737 (775)
T KOG1151|consen 691 QDILQEN------------------------TILKA-TEVQF-PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQ------- 737 (775)
T ss_pred HHHHhhh------------------------chhcc-eeccC-CCCCccCHHHHHHHHHHHHhhhhhhhhHHH-------
Confidence 111100 00000 00000 112568999999999999999999999999
Q ss_pred hhHHHHHhhhhhccCcccCC
Q 044076 308 FNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 308 ~~~~~~~~~~~aL~HP~f~~ 327 (506)
+-.||||.-
T Consensus 738 -----------LA~dpyllP 746 (775)
T KOG1151|consen 738 -----------LACDPYLLP 746 (775)
T ss_pred -----------HccCccccc
Confidence 789999964
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=293.11 Aligned_cols=248 Identities=21% Similarity=0.284 Sum_probs=185.4
Q ss_pred EEeecCceEEEEEEECCC--CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEe
Q 044076 21 IIGIGSYGVVASAIDTHT--GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFE 98 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d~~t--~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E 98 (506)
.||+|+||.||+|..... ...+++|.+... ........+.+|+.+++.++||||+++++.+.. ....|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEe
Confidence 589999999999975433 345667766532 223445678999999999999999999998854 367899999
Q ss_pred cCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 99 LME-SDLDQVIKAN----DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 99 ~~~-~~L~~~i~~~----~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
|++ ++|.+++... ..++...++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-
Confidence 998 5999998754 2466778889999999999999999999999999999999999999999999864221111
Q ss_pred cccccccccCCcccCccccccc-----CCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 174 AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
........++..|+|||++... ...++.++|||||||++|||++ |.+||...+..+.+..+....+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------- 227 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV------- 227 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc-------
Confidence 0111345678899999997531 1346789999999999999997 67888766655444433211000
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...-.......++.+.+++..|| .||++|||+++|
T Consensus 228 ------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i 262 (268)
T cd05086 228 ------------------KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262 (268)
T ss_pred ------------------ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHH
Confidence 00001112347788999999999 689999999995
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=335.29 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=206.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCC-----cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTG-----EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~-----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
...-+..+.||+|+||.||.|.-.... ..||||.+++. .+..+...+++|..+|..++|||||+++++.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-- 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-- 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--
Confidence 356678899999999999999865433 35999999753 4556778899999999999999999999999764
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEe
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN-------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKIC 159 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~-------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~ 159 (506)
...+|++|||+ |||..+|+.. ..++......|+.||++|++||+++++|||||-.+|+|++....+||+
T Consensus 768 ---~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 ---GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred ---CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 67899999998 5999999875 259999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhc
Q 044076 160 DFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 160 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~ 238 (506)
|||+|+........... ....-...|||||.+.. ..++.++|||||||++||+++ |..||++.++.+.+.......
T Consensus 845 DFGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred ccchhHhhhhchheecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 99999943332221110 11123457999999987 789999999999999999999 999999999887776543321
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ..-+.++..+.+|+..||+.+|++||++..|
T Consensus 922 -RL-----------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i 954 (1025)
T KOG1095|consen 922 -RL-----------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTI 954 (1025)
T ss_pred -cc-----------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHH
Confidence 10 1113578889999999999999999999994
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.06 Aligned_cols=261 Identities=27% Similarity=0.452 Sum_probs=193.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC-
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK- 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~- 91 (506)
.+.|.-...||+|+||.||+|.- .+|..||||++....... ...+.+|+.+|.+++|||+|+|++++... +
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~-----~~ 145 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEG-----GE 145 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecC-----Cc
Confidence 35677778999999999999985 445899999886432221 44599999999999999999999998543 4
Q ss_pred cEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 92 DIYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSAN---VFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~g---IvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
+.+||+|||. |+|.+.+.... .++|.....|+.++++||+|||... |+|||||+.|||+|++...||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 5999999998 79999997755 8999999999999999999999864 9999999999999999999999999997
Q ss_pred cccC-CCCCccccccc-ccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 166 VSFT-DTPSAIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 166 ~~~~-~~~~~~~~~~~-vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
.... .... ... .||..|+|||.+.. ...+.++||||+|+++.||++|+.+............+ ..
T Consensus 226 ~~~~~~~~~----~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~-~w------ 292 (361)
T KOG1187|consen 226 LGPEGDTSV----STTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV-EW------ 292 (361)
T ss_pred cCCccccce----eeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH-HH------
Confidence 6433 2111 112 79999999999976 68999999999999999999999887644311111110 00
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP--GADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+..+......+.+.. . ..- ..++ ..-..+..+..+|++.+|.+||++.||
T Consensus 293 -~~~~~~~~~~~eiiD~---~--l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~V 345 (361)
T KOG1187|consen 293 -AKPLLEEGKLREIVDP---R--LKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQV 345 (361)
T ss_pred -HHHHHHCcchhheeCC---C--ccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHH
Confidence 0111111111111110 0 000 0111 011236778899999999999999994
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.33 Aligned_cols=268 Identities=28% Similarity=0.421 Sum_probs=201.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC-cCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC-RRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~-~~~ 89 (506)
+...-+..-+.||+|+||.||+++++.+|+.||||.++... .....++..+|+.+|++|+|||||++.++-.+.. .-.
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 55567778899999999999999999999999999997543 4566777889999999999999999998843221 001
Q ss_pred CCcEEEEEecCC-CCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC--CCCC--EEEeec
Q 044076 90 FKDIYVVFELME-SDLDQVIKA---NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN--ADCK--LKICDF 161 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~---~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~--~~~~--lKL~DF 161 (506)
...-.+|||||. |||..++.+ ...|++.++..++..+..||.|||++||+||||||.||++- .+|+ -|||||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 245689999997 599999975 33699999999999999999999999999999999999864 4454 699999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch----hhHHHHHhh
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA----HQLDLVTDL 237 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~----~~l~~I~~~ 237 (506)
|.|+-...+. .++..+||+.|.+||++.. ...|+..+|.||+||++|++.||..||...... +....+ .
T Consensus 169 G~Arel~d~s----~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~--~ 241 (732)
T KOG4250|consen 169 GAARELDDNS----LFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI--I 241 (732)
T ss_pred cccccCCCCC----eeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh--h
Confidence 9998754443 3578899999999999974 278999999999999999999999999543222 222222 1
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCC---CCCH----HHHHHHHHhhhcCCCCCCC
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP---GADP----LALRLLQRLLAFDPKDRPS 297 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~----~~~dLI~~mL~~DP~~RpT 297 (506)
.+.|..-.+... ...+.+..++..+| ..++ .+-.+|..||.+||++|..
T Consensus 242 tkkp~~v~i~~~-----------~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 242 TKKPSGVAIGAQ-----------EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred ccCCCceeEeee-----------cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 222222111100 01112333333343 2232 3456888999999999993
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=312.98 Aligned_cols=265 Identities=25% Similarity=0.405 Sum_probs=216.5
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~ 89 (506)
...+.++|.++||.|.+|.||++.++.+++.+|+|+..... .....+.-|..+|+... |||++.++++|.......
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 45678999999999999999999999999999999986432 22334667889999887 999999999987655566
Q ss_pred CCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+.+|||||||+ |+.-++++. ...+.|..+.+|++.+++||.+||.+.++|||||-.|||++.++.|||+|||.+..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 789999999998 588888875 45799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
....- ......+||+.|||||++... ...|+..+|+||||++..||--|.||+-+....-.|.+| .-.|++
T Consensus 173 ldsT~---grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPP 246 (953)
T KOG0587|consen 173 LDSTV---GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPP 246 (953)
T ss_pred eeccc---ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCc
Confidence 43221 122457899999999998542 245788999999999999999999999765544333333 111211
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
. .......+.++.|+|..||..|-.+||+..+ +|.||
T Consensus 247 k-------------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~------------------ll~hp 283 (953)
T KOG0587|consen 247 K-------------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEE------------------LLKHP 283 (953)
T ss_pred c-------------------------ccchhhHHHHHHHHHHHHHhhccccCcchhh------------------hccCC
Confidence 1 1223457889999999999999999999999 79999
Q ss_pred ccCC
Q 044076 324 YFHG 327 (506)
Q Consensus 324 ~f~~ 327 (506)
|+..
T Consensus 284 Fi~e 287 (953)
T KOG0587|consen 284 FITE 287 (953)
T ss_pred cccc
Confidence 9984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=276.71 Aligned_cols=242 Identities=40% Similarity=0.654 Sum_probs=197.0
Q ss_pred CceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecCCC-CH
Q 044076 26 SYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DL 104 (506)
Q Consensus 26 ~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L 104 (506)
+||.||+|.+..+|+.||+|++........ ...+.+|++.++.++|+||+++++.+.. ....++|+|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCH
Confidence 589999999998999999999864322211 5778899999999999999999998744 3789999999997 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCC
Q 044076 105 DQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184 (506)
Q Consensus 105 ~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~ 184 (506)
.+++.....++...+..++.+++.+|.+||+.||+|+||+|.||+++.++.++|+|||.+....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877669999999999999999999999999999999999999999999999999997643322 123456888
Q ss_pred cccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch-hhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhc
Q 044076 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA-HQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRR 263 (506)
Q Consensus 185 ~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~-~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~ 263 (506)
.|++||.+.+ ..++.++|+||+|+++++|++|..||...... ..+..+.. .
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~----~---------------------- 202 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK----P---------------------- 202 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc----c----------------------
Confidence 9999999876 67888999999999999999999999763322 22221110 0
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 264 KWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 264 ~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..........++.++.+++.+||..||.+|||+.+ +++||||
T Consensus 203 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~------------------~~~~~~~ 244 (244)
T smart00220 203 --KPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE------------------ALQHPFF 244 (244)
T ss_pred --CCCCccccccCCHHHHHHHHHHccCCchhccCHHH------------------HhhCCCC
Confidence 00011111126788999999999999999999999 8999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.04 Aligned_cols=250 Identities=26% Similarity=0.467 Sum_probs=204.2
Q ss_pred EeEEEeecCceEEEEEEECCC--C--cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 18 IQEIIGIGSYGVVASAIDTHT--G--EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~t--~--~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
..+.||.|-||.||+|....- | -.||||..+.... ..+.+.++.|..+|+.+.||||++|++++.. ..+
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P~ 465 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QPM 465 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeec------cce
Confidence 356899999999999985432 3 3599998875433 3457789999999999999999999999843 578
Q ss_pred EEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 94 YVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
|||||++. |.|..+++.+. .|+......+++||+.||+|||+.+.|||||-..||||.+...+||+|||++|....+.
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999998 89999998765 68999999999999999999999999999999999999999999999999999864443
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
... .+...-..-|||||-+.- ..++.++|||.|||++||+++ |..||.|-.+.+.+-.|.+.-..|
T Consensus 546 yYk--aS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP--------- 612 (974)
T KOG4257|consen 546 YYK--ASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP--------- 612 (974)
T ss_pred hhh--ccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC---------
Confidence 211 111223456999999875 789999999999999999998 999999877766655553321111
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh--hhhhhhh
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI--RFTEIVF 308 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL--~~~~~~~ 308 (506)
.-|+++|.+..|+.+||.+||.+||++.|| ..+++++
T Consensus 613 ---------------------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 613 ---------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 126799999999999999999999999997 4555554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=297.77 Aligned_cols=287 Identities=28% Similarity=0.422 Sum_probs=217.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECC---CCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTH---TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~---t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~ 86 (506)
...+.|.++++||.|.|++||+|.+.. .++.||+|.+... +...++.+|+.+|..+. +.||+++.+.+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~---- 104 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF---- 104 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh----
Confidence 345679999999999999999999887 7889999999642 45667999999999997 99999999887
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-CCCEEEeecCCc
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLA 164 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-~~~lKL~DFGla 164 (506)
...+.+.+|+||++. +..++.. .++...++.+++.++.||+++|.+|||||||||.|+|.+. .++-.|+|||+|
T Consensus 105 -rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 105 -RNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred -ccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 445889999999996 6666665 3779999999999999999999999999999999999985 577899999999
Q ss_pred ccccCC--------------CC-----------------Cc----------ccccccccCCcccCcccccccCCCCCchh
Q 044076 165 RVSFTD--------------TP-----------------SA----------IFWTDYVATRWYRAPELCGSFFSKYTPAI 203 (506)
Q Consensus 165 ~~~~~~--------------~~-----------------~~----------~~~~~~vgt~~Y~APE~l~~~~~~~s~~~ 203 (506)
...... .+ .. .......||+.|+|||++... ..-++++
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~Qttai 259 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAI 259 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCcc
Confidence 621000 00 00 001134799999999999873 6788999
Q ss_pred hhhhhhHHHHHHHhCCCC-CCCCCchhhHHHHHhhcCCCChHHHhhhhhh----------HHHHHHh--------hhhcc
Q 044076 204 DIWSIGCIFAELLTGRPL-FPGRNVAHQLDLVTDLLGTPSAESIAGIRNE----------KAKRYLS--------SLRRK 264 (506)
Q Consensus 204 DIWSlG~il~eLl~G~~p-F~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~----------~~~~~~~--------~~~~~ 264 (506)
||||.|+|+..+++++.| |...++.+.+..|+.++|.-...-....... .+.+... .+.+.
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999998765 5788888888888888885433222211110 0111111 11110
Q ss_pred CC-CCCCCCCC-CCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 265 WA-VPFSHKFP-GADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 265 ~~-~~~~~~~~-~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.. ......+. -.+..+.||+.+||..||.+|+||++ ||.||||...
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEe------------------ALkHpFF~~~ 387 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAED------------------ALKHPFFDEA 387 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHH------------------HhcCcCCcch
Confidence 00 01111222 23558999999999999999999999 9999999953
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=286.43 Aligned_cols=264 Identities=25% Similarity=0.390 Sum_probs=212.6
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
...+-++.||.|+||+|++-.++.+|+..|||.|+.. ....+.++++.|.....+- +.||||++++..... ++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~-n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----Gd 137 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSN-NIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GD 137 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeec-cchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----Cc
Confidence 3445567899999999999999999999999999643 2346778899999876555 599999999987543 88
Q ss_pred EEEEEecCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 93 IYVVFELMESDLDQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~-----~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.||.||+|+.+|..+.+. ...+++.-+-.|.--.+.||.||-+ .+|||||+||+|||++..|.+||||||.+..
T Consensus 138 cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 138 CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 999999999877665542 3469999999999999999999985 5899999999999999999999999999965
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc-hhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV-AHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~-~~~l~~I~~~~g~p~~e~ 245 (506)
....- .-+.-.|.+.|+|||-+......|+-.+|+||||++|||+.+|..|+.+.+. .+|+.++ ..|.|+.-
T Consensus 218 Lv~Si----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V--v~gdpp~l- 290 (361)
T KOG1006|consen 218 LVDSI----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV--VIGDPPIL- 290 (361)
T ss_pred HHHHH----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH--HcCCCCee-
Confidence 32221 1245579999999999976556799999999999999999999999987654 4555555 33444321
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
.+...--+.+..+..+|.-||..|-.+||...+ ++.+||+
T Consensus 291 ----------------------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~------------------Lk~~~fy 330 (361)
T KOG1006|consen 291 ----------------------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDD------------------LKKFPFY 330 (361)
T ss_pred ----------------------cCcccccccCHHHHHHHHHHhhcccccCcchhh------------------hhcCchh
Confidence 111222347889999999999999999999999 7999999
Q ss_pred CCCCC
Q 044076 326 HGLAN 330 (506)
Q Consensus 326 ~~~~~ 330 (506)
+....
T Consensus 331 r~y~~ 335 (361)
T KOG1006|consen 331 RMYAV 335 (361)
T ss_pred hhhhh
Confidence 87543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.10 Aligned_cols=278 Identities=18% Similarity=0.238 Sum_probs=187.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEEC----------------CCCcEEEEEEecccccCh------------hHHHHHHHH
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDT----------------HTGEKVAIKKMKEVFEHV------------SDATRILRE 63 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~----------------~t~~~vAIK~i~~~~~~~------------~~~~~~~rE 63 (506)
..++|++.++||+|+||+||+|.+. ..++.||||+++...... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3679999999999999999999753 345679999986421110 011123347
Q ss_pred HHHHHhCCCCCc-----ceeceeecCCCc---CCCCcEEEEEecCC-CCHHHHHHhC-----------------------
Q 044076 64 IKLLRMLKHPDI-----VEIKHIMLPPCR---REFKDIYVVFELME-SDLDQVIKAN----------------------- 111 (506)
Q Consensus 64 i~iL~~l~HpnI-----v~l~~v~~~~~~---~~~~~~ylV~E~~~-~~L~~~i~~~----------------------- 111 (506)
+.++.+++|.++ +++++++..... ...+..|+|+||++ ++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 556666543211 12356899999998 4888887632
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcc
Q 044076 112 -DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190 (506)
Q Consensus 112 -~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE 190 (506)
..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 123567788999999999999999999999999999999999999999999996533221111 11223478999999
Q ss_pred cccccCC------------------CCC--chhhhhhhhHHHHHHHhCCC-CCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 191 LCGSFFS------------------KYT--PAIDIWSIGCIFAELLTGRP-LFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 191 ~l~~~~~------------------~~s--~~~DIWSlG~il~eLl~G~~-pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
++..... .|+ ...||||+|||+++|++|.. +|.+......... ..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~--------------~~ 446 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELR--------------QY 446 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHh--------------hc
Confidence 9754110 122 24799999999999999874 6644321111000 00
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCC---CCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDP---KDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP---~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.+ .... ++.. ......+. .+...++.++|||.+||..+| .+|+|++| ||+||||.
T Consensus 447 ~~-~~~~-~r~~-~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e------------------aL~Hp~f~ 504 (507)
T PLN03224 447 DN-DLNR-WRMY-KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQ------------------ALSHRFFL 504 (507)
T ss_pred cc-hHHH-HHhh-cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHH------------------HhCCCCcC
Confidence 00 0000 0000 11112222 456789999999999999876 78999999 99999996
Q ss_pred C
Q 044076 327 G 327 (506)
Q Consensus 327 ~ 327 (506)
.
T Consensus 505 ~ 505 (507)
T PLN03224 505 P 505 (507)
T ss_pred C
Confidence 4
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=283.94 Aligned_cols=271 Identities=22% Similarity=0.387 Sum_probs=211.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~ 90 (506)
.++|.++.+||+|+|+.|..++.+.|.+.+|+|++++. +.+..+..-+..|-.+..... ||.+|.|+..|. ..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq-----te 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ-----TE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc-----cc
Confidence 46899999999999999999999999999999999754 345556666777888887764 999999998874 44
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+++|.||.+| +|.-.++++..|++++++++...|+.||.|||+.||+.||||.+|+|++..|.+||+|+|+++-...
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 889999999984 9988888888999999999999999999999999999999999999999999999999999975332
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... ....++||+.|.|||++.+ ..|+..+|.|+||++++||+.|+.||.- .|...++.
T Consensus 404 ~gd---~tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdi-------------vgm~n~d~---- 461 (593)
T KOG0695|consen 404 PGD---TTSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDI-------------VGMDNPDM---- 461 (593)
T ss_pred CCc---ccccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcce-------------ecCCCccc----
Confidence 222 2367899999999999998 8999999999999999999999999931 11111100
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh-hhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE-IRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e-L~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
..+.|+-...-...+. +-..+|-.+..+++..|..||++|....- +. +..+-.||||+.+
T Consensus 462 ---ntedylfqvilekqir---iprslsvkas~vlkgflnkdp~erlgc~~~~g-------------~~dik~h~ffr~i 522 (593)
T KOG0695|consen 462 ---NTEDYLFQVILEKQIR---IPRSLSVKASHVLKGFLNKDPKERLGCRPQTG-------------FSDIKSHAFFRSI 522 (593)
T ss_pred ---chhHHHHHHHhhhccc---ccceeehhhHHHHHHhhcCCcHHhcCCCcccc-------------hhhhhcchhhhhC
Confidence 0112221111111110 11236677889999999999999976421 00 0116789999865
Q ss_pred C
Q 044076 329 A 329 (506)
Q Consensus 329 ~ 329 (506)
.
T Consensus 523 d 523 (593)
T KOG0695|consen 523 D 523 (593)
T ss_pred C
Confidence 4
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.86 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=218.0
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCc---EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..++...|.++||.|.||.||+|+-+..|+ .||||.++. ...+.....++.|..||-++.||||++|.++....
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-- 702 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-- 702 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC--
Confidence 446778899999999999999999876664 699999974 33455667799999999999999999999998543
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.-+.||+|||+ |+|..+++.+ +.++..++.-+++-|+.|++||-+.|.|||||-..|||||.+-..|++|||++|
T Consensus 703 ---~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 703 ---KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred ---ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence 77999999998 7999999876 469999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
+..++.+.......---...|.|||.+.- .+++.++||||+|++|||.++ |..||=..++.+.+..|.+-..-|++
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP- 856 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP- 856 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-
Confidence 87666533222122223467999999976 799999999999999999887 99999999999999999776666654
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+++..+..|+..||+.|-..||++.||
T Consensus 857 -----------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qi 884 (996)
T KOG0196|consen 857 -----------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQI 884 (996)
T ss_pred -----------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHH
Confidence 3588899999999999999999999996
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.83 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=204.5
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++..++++||+|-||.|.+|.- ..+..||+|+++.. ........+.+||++|.+|+||||+.|++++... +.+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----Cch
Confidence 5677899999999999999974 34689999999753 2333457799999999999999999999998653 779
Q ss_pred EEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 94 YVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
++|+|||+ |+|.+++..+. .+.......|+.||+.|++||.+.++|||||.+.|||++.++++||+|||++|-...+
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999998 79999998873 3345566779999999999999999999999999999999999999999999865444
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh--CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~--G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
+.... -...+-...|+|+|.++. .+++.++|+|++|+++||+++ ...||....+.+..+....++..+.....
T Consensus 691 ~yy~v-qgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~-- 765 (807)
T KOG1094|consen 691 DYYRV-QGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV-- 765 (807)
T ss_pred Cceee-ecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee--
Confidence 32211 123456788999999876 799999999999999999875 78899777766665555444443332211
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
-..-+-++..+.+||.+||..|-.+|||+++|
T Consensus 766 ---------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 766 ---------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred ---------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 01113367789999999999999999999995
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.03 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=207.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCC---cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTG---EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.++..+.+.||+|+||+|++|.++..+ ..||||+++...... ....+++|+.+|.+|+|||+++||++.++
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~----- 182 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD----- 182 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-----
Confidence 345667789999999999999876533 369999997543332 56779999999999999999999999864
Q ss_pred CCcEEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..+.+|||++. |+|++-++. ...|....+..|+.||+.|+.||.++++|||||-..|+|+-..-.+|||||||.|.
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 45789999998 699999876 34688889999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
.........+....-....|.|||.|.. ..++.++|+|++||++|||++ |+.||.|.+..+.|++|-+.---
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL----- 334 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL----- 334 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC-----
Confidence 6554433333233345567999999987 799999999999999999999 89999999988888877321000
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~ 302 (506)
..-+.++.++.+++..||..+|.+|||+..|.
T Consensus 335 -------------------------pRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 335 -------------------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred -------------------------CCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 11134788999999999999999999999964
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=311.18 Aligned_cols=247 Identities=33% Similarity=0.470 Sum_probs=191.3
Q ss_pred eEEEeecCce-EEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCcEEEE
Q 044076 19 QEIIGIGSYG-VVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 19 ~~~LG~G~~g-~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
.+++|.|+.| +||+|. ..|+.||||.+-. .....+.|||..|+.-. |||||+.+..- .+.+.+||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 3678899887 679995 5788999998853 34556789999999986 99999998764 445789999
Q ss_pred EecCCCCHHHHHHhC-CC---CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC---C--CCEEEeecCCcccc
Q 044076 97 FELMESDLDQVIKAN-DD---LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA---D--CKLKICDFGLARVS 167 (506)
Q Consensus 97 ~E~~~~~L~~~i~~~-~~---ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~---~--~~lKL~DFGla~~~ 167 (506)
.|+|..+|.+++... .. ........++.|++.||++||+.+||||||||.||||.. + .+++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999999999874 11 122456789999999999999999999999999999976 3 46899999999876
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhC-CCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G-~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
..+...-....+..||-.|+|||++.. ..-+.++||+|+||++|..++| ..||...-. .+ ..|. .|..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-R~-~NIl--~~~~----- 730 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-RQ-ANIL--TGNY----- 730 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchHH-hh-hhhh--cCcc-----
Confidence 555444333566779999999999987 5556799999999999999995 899954321 11 1121 0111
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.+.+.-+....+|.|||.+||.+||..||||.+ +|.||+|-
T Consensus 731 ---------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~------------------VL~HPlFW 771 (903)
T KOG1027|consen 731 ---------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATD------------------VLNHPLFW 771 (903)
T ss_pred ---------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHH------------------HhCCCccC
Confidence 111111222338999999999999999999999 89999996
Q ss_pred C
Q 044076 327 G 327 (506)
Q Consensus 327 ~ 327 (506)
.
T Consensus 772 ~ 772 (903)
T KOG1027|consen 772 D 772 (903)
T ss_pred C
Confidence 5
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.68 Aligned_cols=245 Identities=25% Similarity=0.454 Sum_probs=206.3
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+.....+||.|-||.||.|.++.-.-.||||.++ ++.-....++.|..+|+.+.|||+|+|++++... ..+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPFY 339 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPFY 339 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCeE
Confidence 4556789999999999999999888899999987 3556778899999999999999999999998543 6689
Q ss_pred EEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 95 VVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
||+|||. |+|.++++... .++.-.+.+++.||..|+.||..+++|||||-..|+||.++..+||+||||+|....+.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999997 89999998754 57888889999999999999999999999999999999999999999999999876654
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.... ...--..-|.|||-|.- ..++.++|||+|||+|||+.+ |-.||+|-+.-+...++.+-.
T Consensus 420 YTAH--AGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy------------ 483 (1157)
T KOG4278|consen 420 YTAH--AGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY------------ 483 (1157)
T ss_pred eecc--cCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc------------
Confidence 4321 12224566999998865 678999999999999999998 999999988665555543211
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+. ..-.++++.+.+|++.||+|+|.+||++.||
T Consensus 484 -----------RM-------~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 484 -----------RM-------DGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred -----------cc-------cCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 11 1113689999999999999999999999995
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=276.91 Aligned_cols=268 Identities=22% Similarity=0.294 Sum_probs=200.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHh--CCCCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM--LKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~--l~HpnIv~l~~v~~~~~~~~ 89 (506)
.....++++.||+|.||.||+|. -+++.||||++.. .+...+.+|-.|... ++|+||++++..-..... .
T Consensus 208 ~l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-D 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-c
Confidence 34567788999999999999995 5679999999863 455556667666655 469999999877543322 2
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeecCCCCCcEEECCCCCEEEe
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA---------NVFHRDLKPKNILANADCKLKIC 159 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~---------gIvHrDLKp~NILv~~~~~lKL~ 159 (506)
...++||++|.+ |+|.++++.+ .+++....+++..|++||+|||+- .|+|||||..||||.+|++..|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 467999999997 8999999875 699999999999999999999963 59999999999999999999999
Q ss_pred ecCCcccccCCCCCcccccccccCCcccCcccccccCCCCC-----chhhhhhhhHHHHHHHhCCCCCC-CCCchhhHHH
Q 044076 160 DFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAELLTGRPLFP-GRNVAHQLDL 233 (506)
Q Consensus 160 DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s-----~~~DIWSlG~il~eLl~G~~pF~-~~~~~~~l~~ 233 (506)
|||+|.....+.+.. .....|||+.|||||+|.+- ..+. ..+||||+|.++|||+++...+. +....-|+--
T Consensus 359 DFGLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred ccceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 999998765444332 23458999999999999762 3333 47999999999999999876553 4444444444
Q ss_pred HHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP--GADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 234 I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
-..+..+|+.+.+.... -..+..+.. ...|. ..-..+.+.++.||..||+-|+||.=
T Consensus 437 e~evG~hPt~e~mq~~V--------V~kK~RP~~--p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELV--------VRKKQRPKI--PDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred hHHhcCCCCHHHHHHHH--------HhhccCCCC--hhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 44455577777664421 111111111 11121 12345789999999999999999976
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=315.20 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=182.3
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
.|...++||+|+||.||+|.+..++..||||++..... ...+|+.++++++||||+++++++... ...|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~ 759 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAY 759 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCE
Confidence 45667899999999999999999999999999864211 112568899999999999999998543 6789
Q ss_pred EEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 95 VVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH---SANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH---~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|||||+ ++|.++++ .+++.....++.||++||+||| +.+|+||||||+||+++.++..+++ ||.+......
T Consensus 760 lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred EEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999998 59999986 3889999999999999999999 6799999999999999999888876 6665432111
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch-hhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA-HQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~-~~l~~I~~~~g~p~~e~~~~~ 249 (506)
....+|..|+|||++.+ ..|+.++||||+||++|||++|+.||...... ..+.......-
T Consensus 836 -------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~---------- 896 (968)
T PLN00113 836 -------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY---------- 896 (968)
T ss_pred -------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc----------
Confidence 23368899999999887 78999999999999999999999999432211 11111100000
Q ss_pred hhhHHHHHHhhhhccCCCCCC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFS-HKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.......++. +..... ...+....++.+++.+||+.||.+|||+.||
T Consensus 897 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev 944 (968)
T PLN00113 897 SDCHLDMWID-----PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944 (968)
T ss_pred CccchhheeC-----ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHH
Confidence 0000000000 000000 0001122357889999999999999999994
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=252.26 Aligned_cols=213 Identities=27% Similarity=0.448 Sum_probs=175.7
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+...-+..||+|+||+|-+.++..+|...|+|.+..... ....+++++|+.+..+. ..|.+|.+++.+.. ..+
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-----egd 119 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-----EGD 119 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----ccc
Confidence 445557889999999999999999999999999975444 45567788999987655 59999999997743 388
Q ss_pred EEEEEecCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 93 IYVVFELMESDLDQV----IKANDDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~----i~~~~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
+++.||.|+.+|..+ ++.++.+++..+-.|+..++.||.|||++ .|+|||+||+|||+|.+|++|+||||.+...
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999999988654 45677899999999999999999999975 8999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCccccccc--CCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCchhhHHHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGRPLFPG-RNVAHQLDLVTD 236 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~--~~~~s~~~DIWSlG~il~eLl~G~~pF~~-~~~~~~l~~I~~ 236 (506)
.+.-. -+-..|...|+|||.+... ...|+-++||||||+.+.||.+++.||+. .+..+||..+++
T Consensus 200 ~dSiA----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 200 VDSIA----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhhH----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 33322 1334578889999998432 24799999999999999999999999974 445666666643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=284.94 Aligned_cols=203 Identities=24% Similarity=0.394 Sum_probs=175.7
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc--c--C--hhHHHHHHHHHHHHHhCC---CCCcceece
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF--E--H--VSDATRILREIKLLRMLK---HPDIVEIKH 80 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~--~--~--~~~~~~~~rEi~iL~~l~---HpnIv~l~~ 80 (506)
+.....|..++.+|.|+||.|+.|+++.+...|+||.|.+.. . . ....-.+--||+||..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 344567999999999999999999999999999999996421 0 1 111223567999999997 999999999
Q ss_pred eecCCCcCCCCcEEEEEecCC-C-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEE
Q 044076 81 IMLPPCRREFKDIYVVFELME-S-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKI 158 (506)
Q Consensus 81 v~~~~~~~~~~~~ylV~E~~~-~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL 158 (506)
+| ++.+++||+||.-+ | ||.++|...+.+++.+++.|++||..|+++||+.||||||||-+|+.++.+|-+||
T Consensus 637 fF-----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 637 FF-----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ee-----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEE
Confidence 99 66799999999876 4 99999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCC
Q 044076 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFP 223 (506)
Q Consensus 159 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~ 223 (506)
+|||.|.....++ +..++||..|.|||++.+. ...+..-|||+||++||.++...-||.
T Consensus 712 idfgsaa~~ksgp-----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP-----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCCC-----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999997644432 3567899999999999983 444788999999999999999888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-33 Score=289.27 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=208.0
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
+..++|+.+.++|+|+||.||+|+|+.+++..|+|+++- +-..+..-+..||-+++..+||||+.+++-|...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL--ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~----- 84 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL--EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR----- 84 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeec--cCCccccccccceeeeecCCCcChHHHHhhhhhh-----
Confidence 667899999999999999999999999999999999974 3344566688999999999999999999988543
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+.++++||||+| +|.++-.-.+++++.++.++++..++||+|||+.|=+|||||-.|||+++.|.+|+.|||.+.....
T Consensus 85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 789999999985 8888877788999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCcccccccccCCcccCcccc-cccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l-~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.- .....+.||++|||||+. .+....|+..+|||++|+...|+---++|.-.......+.++.+-.-.|+.-
T Consensus 165 ti---~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l---- 237 (829)
T KOG0576|consen 165 TI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL---- 237 (829)
T ss_pred hh---hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc----
Confidence 21 123567899999999985 2223679999999999999999988777764444444444433222211110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+--...++.+-+|++.+|..+|++|||++-+
T Consensus 238 ----------------------kDk~kws~~fh~fvK~altknpKkRptaekl 268 (829)
T KOG0576|consen 238 ----------------------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKL 268 (829)
T ss_pred ----------------------cCCccchHHHHHHHHHHhcCCCccCCChhhh
Confidence 0012367889999999999999999999993
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=284.37 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=200.3
Q ss_pred EEEeEEEeecCceEEEEEEECCCCc----EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGE----KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.+..++||+|+||+||+|.+.-.|+ +||||++.. +...+....++.|+-+|..+.|||+++|+++...+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------ 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------ 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------
Confidence 3446899999999999998876655 688988753 34555567799999999999999999999998653
Q ss_pred cEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+-||++||+ |.|.++++.+ +.+-.+....|.+||++||+|||.++++||||-.+|+||.+-..+||.|||+|+....
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 3789999998 6999999865 4799999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
+.... .....-..+-|+|-|.+.. ..|+.++||||+||.+|||+| |..|+.+....+.-+.+...
T Consensus 851 d~~ey-~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g----------- 916 (1177)
T KOG1025|consen 851 DEKEY-SAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG----------- 916 (1177)
T ss_pred ccccc-cccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-----------
Confidence 43221 1122234556888888876 799999999999999999999 99999888766544443211
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+-. .-|..+-++.-++.+||..|+..||+++++
T Consensus 917 --------------eRLs-----qPpiCtiDVy~~mvkCwmid~~~rp~fkel 950 (1177)
T KOG1025|consen 917 --------------ERLS-----QPPICTIDVYMVMVKCWMIDADSRPTFKEL 950 (1177)
T ss_pred --------------ccCC-----CCCCccHHHHHHHHHHhccCcccCccHHHH
Confidence 0011 125578899999999999999999999994
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=285.69 Aligned_cols=245 Identities=27% Similarity=0.436 Sum_probs=196.0
Q ss_pred EEeEEEeecCceEEEEEEEC----C---CCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcC
Q 044076 17 EIQEIIGIGSYGVVASAIDT----H---TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 17 ~i~~~LG~G~~g~V~~a~d~----~---t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~ 88 (506)
.+.+.||+|+||.|++|.-. . ....||||.++..... .+.+.+..|+.+|+.+. ||||+.+++.+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 56779999999999999632 1 1457999999765444 67788999999999996 9999999998854
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC
Q 044076 89 EFKDIYVVFELME-SDLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~ 151 (506)
.+.+++|+||+. |+|..+++.+. .++......+.+||+.|+.||++.+++||||-.+|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 478999999998 79999998765 389999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCcccccCCCCCcccccccc--cCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCC-c
Q 044076 152 ADCKLKICDFGLARVSFTDTPSAIFWTDYV--ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN-V 227 (506)
Q Consensus 152 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~v--gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~-~ 227 (506)
.+..+||+|||+|+.......... ..-. -...|||||.+.. ..|+.++||||+|++||||++ |..||++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999986433322111 1111 2344999999987 799999999999999999999 899998743 2
Q ss_pred hhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 228 AHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 228 ~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+.++.+ +...+.. .-..+++++.++++.||+.+|++||++.++
T Consensus 529 ~~l~~~l---------------------------~~G~r~~---~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~ 572 (609)
T KOG0200|consen 529 EELLEFL---------------------------KEGNRME---QPEHCSDEIYDLMKSCWNADPEDRPTFSEC 572 (609)
T ss_pred HHHHHHH---------------------------hcCCCCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 2222211 1111111 112478999999999999999999999995
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=261.26 Aligned_cols=263 Identities=25% Similarity=0.343 Sum_probs=189.3
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHH--HhCCCCCcceeceeecCCC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL--RMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL--~~l~HpnIv~l~~v~~~~~ 86 (506)
.-.++.+..+++.||+|.||.||+|. ..|+.||||++.. .+.....||..|. ..|+|+||+.++..-...
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~- 277 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKD- 277 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecc--ccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccC-
Confidence 34567889999999999999999995 5799999999863 2333345555555 556999999998764332
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCCCCcEEECCCCCEE
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA--------NVFHRDLKPKNILANADCKLK 157 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~--------gIvHrDLKp~NILv~~~~~lK 157 (506)
...-..+|||++|.+ |+|++++.. ..++.+....+++.++.||++||.. .|.|||||..||||.++|...
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 123367999999998 799999987 5799999999999999999999953 499999999999999999999
Q ss_pred EeecCCcccccCCC-CCcccccccccCCcccCcccccccC--CCC--CchhhhhhhhHHHHHHHhC----------CCCC
Q 044076 158 ICDFGLARVSFTDT-PSAIFWTDYVATRWYRAPELCGSFF--SKY--TPAIDIWSIGCIFAELLTG----------RPLF 222 (506)
Q Consensus 158 L~DFGla~~~~~~~-~~~~~~~~~vgt~~Y~APE~l~~~~--~~~--s~~~DIWSlG~il~eLl~G----------~~pF 222 (506)
|+|+|||.....+. .........|||..|||||+|...- ..+ -..+||||||.++||+..+ ++||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999996644432 2223345679999999999985420 111 1358999999999999863 4666
Q ss_pred CCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCC--HHHHHHHHHhhhcCCCCCCCHhh
Q 044076 223 PGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGAD--PLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 223 ~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
.+-.. ..|+.+++.++.- ++.++.. ....|...+ ..+..|++.||..||.-|.||--
T Consensus 437 yd~Vp-----------~DPs~eeMrkVVC------v~~~RP~----ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALr 495 (513)
T KOG2052|consen 437 YDVVP-----------SDPSFEEMRKVVC------VQKLRPN----IPNRWKSDPALRVMAKLMKECWYANPAARLTALR 495 (513)
T ss_pred ccCCC-----------CCCCHHHHhccee------ecccCCC----CCcccccCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence 54322 2244444333211 0111111 111121111 23567899999999999999876
Q ss_pred h
Q 044076 301 I 301 (506)
Q Consensus 301 L 301 (506)
|
T Consensus 496 i 496 (513)
T KOG2052|consen 496 I 496 (513)
T ss_pred H
Confidence 4
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=235.17 Aligned_cols=207 Identities=39% Similarity=0.643 Sum_probs=177.3
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecCC
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME 101 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~ 101 (506)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.++|++|+++++++... ...++|+|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999986432211 356788999999999999999999998543 78999999999
Q ss_pred -CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-CCCEEEeecCCcccccCCCCCccccc
Q 044076 102 -SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLARVSFTDTPSAIFWT 178 (506)
Q Consensus 102 -~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-~~~lKL~DFGla~~~~~~~~~~~~~~ 178 (506)
++|.+++... ..++...+..++.+++++|++||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6999999876 47999999999999999999999999999999999999999 89999999999976433221 123
Q ss_pred ccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHH
Q 044076 179 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYL 258 (506)
Q Consensus 179 ~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~ 258 (506)
...+...|.+||.+... ..++.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 35578889999998762 3788899999999999998
Q ss_pred hhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 259 SSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
..+.+++.+||+.||.+|||+.+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHH
Confidence 23688999999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-29 Score=238.21 Aligned_cols=210 Identities=39% Similarity=0.616 Sum_probs=176.8
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
|.+.+.||.|++|.||+|.+..+++.+|||.+...... .....+.+|+..++.++|+|++++++.+.. ....++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEE
Confidence 67889999999999999999988999999999643222 256778899999999999999999998743 367999
Q ss_pred EEecCCC-CHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 96 VFELMES-DLDQVIKANDD-LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 96 V~E~~~~-~L~~~i~~~~~-ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
|+|++++ +|.+++..... +++..+..++.|++.+|.+||++|++|+||+|.||+++.++.++|+|||.+.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999987 99999988766 899999999999999999999999999999999999999999999999999775433211
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCc-hhhHHHH
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG-RNV-AHQLDLV 234 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~-~~~-~~~l~~I 234 (506)
......++..|++||.+.+ ...++.++|+|++||++++|++|+.||.+ .+. ....+.|
T Consensus 155 --~~~~~~~~~~~~~pe~~~~-~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLG-GKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred --cccceeccCCcCCHhHhcC-CCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 1234567888999999842 26788899999999999999999999977 333 3555555
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=294.89 Aligned_cols=209 Identities=16% Similarity=0.175 Sum_probs=150.1
Q ss_pred hCCC-CCcceeceeecCCCc--CCCCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 044076 69 MLKH-PDIVEIKHIMLPPCR--REFKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLK 144 (506)
Q Consensus 69 ~l~H-pnIv~l~~v~~~~~~--~~~~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLK 144 (506)
.++| +||+.+++.|..... .....+++++|+++++|.+++... ..+++.+++.+++||++||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 4455 588888887633221 222467889999999999999753 469999999999999999999999999999999
Q ss_pred CCcEEECCC-------------------CCEEEeecCCcccccCCC-------------CCcccccccccCCcccCcccc
Q 044076 145 PKNILANAD-------------------CKLKICDFGLARVSFTDT-------------PSAIFWTDYVATRWYRAPELC 192 (506)
Q Consensus 145 p~NILv~~~-------------------~~lKL~DFGla~~~~~~~-------------~~~~~~~~~vgt~~Y~APE~l 192 (506)
|+|||++.. +.+||+|||+++...... +........++|++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 445566666664311000 000011235689999999999
Q ss_pred cccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCC
Q 044076 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHK 272 (506)
Q Consensus 193 ~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (506)
.+ ..|+.++|||||||+||||++|.++|..... .+..+.... ++ ..
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~----------------------~~--------~~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV----------------------LP--------PQ 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh----------------------cC--------hh
Confidence 87 6899999999999999999999888743211 111110000 00 00
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 273 FPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 273 ~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.....+.+.+++.+||+.||.+|||+.| +|+||||....
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~e------------------il~h~~~~~~~ 272 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSE------------------LLQSEFINEPR 272 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHH------------------Hhhchhhhhhh
Confidence 0112456789999999999999999999 89999998754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=240.47 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=193.7
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~ 89 (506)
...+.|.|.+.||+|.||.+.+|.++.+++.+++|.+.+. ......+.||...--.|. |.||+.-+++....
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt---- 93 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT---- 93 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhc----
Confidence 4467899999999999999999999999999999998753 345666889988877776 99999999886543
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC--CCCEEEeecCCccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA--DCKLKICDFGLARV 166 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~--~~~lKL~DFGla~~ 166 (506)
.+.+++++||++ |||..-+..+ .+-+...+.++.|++.||.|||+.++||||||.+||||-. .-++||||||+++.
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred CceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 367889999998 7998887664 5889999999999999999999999999999999999842 35799999999975
Q ss_pred ccCCCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
....- ...--+..|.+||++... .....+..|+|.||+|+|.+|+|.+||......+ +
T Consensus 173 ~g~tV------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-----------~-- 233 (378)
T KOG1345|consen 173 VGTTV------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-----------K-- 233 (378)
T ss_pred cCcee------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-----------c--
Confidence 32211 111234569999987431 1345788999999999999999999996332211 1
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC---CCHhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR---PSAEE 300 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R---pTa~e 300 (506)
.+.+|++=... ........|...++.+..+.++-|..+|++| .++..
T Consensus 234 ---------~Y~~~~~w~~r-k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 234 ---------PYWEWEQWLKR-KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ---------hHHHHHHHhcc-cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 11122111111 1123345677799999999999999999999 55555
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=268.31 Aligned_cols=269 Identities=27% Similarity=0.355 Sum_probs=203.5
Q ss_pred CCE-EEeEEEeecCceEEEEEEECCCCcEEEEEEecc---cccChhH-HHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 14 SQY-EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKE---VFEHVSD-ATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 14 ~rY-~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~---~~~~~~~-~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
..| .-..++|.|++|.|+.+......+.++.|.... ....... ...+..|..+-..+.|||++....++...
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--- 393 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--- 393 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc---
Confidence 445 346789999999998888877777777776541 1122222 22377788888999999998887776443
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...+-+||||++||..++.+.+.++..++..++.||+.||+|||+.||.||||||+|+++..+|.+||||||.+.+..
T Consensus 394 --~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 394 --DGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred --ccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 333444999999999999998889999999999999999999999999999999999999999999999999997743
Q ss_pred CCCCC-cccccccccCCcccCcccccccCCCCCc-hhhhhhhhHHHHHHHhCCCCCCCCCchhhHH-HHHhhcCCCChHH
Q 044076 169 TDTPS-AIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGRPLFPGRNVAHQLD-LVTDLLGTPSAES 245 (506)
Q Consensus 169 ~~~~~-~~~~~~~vgt~~Y~APE~l~~~~~~~s~-~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~-~I~~~~g~p~~e~ 245 (506)
..... .....+.+|+-.|+|||++.+ ..|.+ .+||||.|+++..|++|+.||.-....++.. .+....
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~------- 542 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD------- 542 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc-------
Confidence 33222 234467889999999999987 67764 7999999999999999999996443322211 000000
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...........+..++...+.+|.+||++||.+|.|+++ +++.+||
T Consensus 543 ----------------~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~------------------i~~d~W~ 588 (601)
T KOG0590|consen 543 ----------------QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQ------------------ILNDEWI 588 (601)
T ss_pred ----------------ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHH------------------HhhChHh
Confidence 000011111222346677899999999999999999999 8999999
Q ss_pred CCCCC
Q 044076 326 HGLAN 330 (506)
Q Consensus 326 ~~~~~ 330 (506)
+.+..
T Consensus 589 ~~i~~ 593 (601)
T KOG0590|consen 589 RSIEC 593 (601)
T ss_pred hhcce
Confidence 98654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=217.22 Aligned_cols=165 Identities=21% Similarity=0.231 Sum_probs=126.2
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccccccc
Q 044076 102 SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180 (506)
Q Consensus 102 ~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~ 180 (506)
|+|.+++... ..+++..++.+++||+.||+|||+.| ||+|||++.++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6899999874 46999999999999999999999998 999999999999999 9999764321 12
Q ss_pred ccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch-hhHHHHHhhcCCCChHHHhhhhhhHHHHHHh
Q 044076 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA-HQLDLVTDLLGTPSAESIAGIRNEKAKRYLS 259 (506)
Q Consensus 181 vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~-~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~ 259 (506)
.||+.|+|||++.+ ..|+.++||||+||++|||++|++||...... ..+..+.........
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------- 126 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---------------- 126 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc----------------
Confidence 58899999999987 78999999999999999999999999665432 222222111100000
Q ss_pred hhhccCCCCCCCCCCCCCH--HHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 260 SLRRKWAVPFSHKFPGADP--LALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 260 ~~~~~~~~~~~~~~~~~s~--~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.. ......++. .+.+||.+||..||.+|||+.| ++.|+|+.
T Consensus 127 -------~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~------------------ll~~~~~~ 169 (176)
T smart00750 127 -------RD-RSNLESVSAARSFADFMRVCASRLPQRREAANH------------------YLAHCRAL 169 (176)
T ss_pred -------cc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHH------------------HHHHHHHH
Confidence 00 000011222 6899999999999999999999 78888765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-25 Score=219.06 Aligned_cols=254 Identities=36% Similarity=0.536 Sum_probs=198.5
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChh-HHHHHHHHHHHHHhCCCC-CcceeceeecCCCcCCCCcE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVS-DATRILREIKLLRMLKHP-DIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~-~~~~~~rEi~iL~~l~Hp-nIv~l~~v~~~~~~~~~~~~ 93 (506)
|.+.+.||.|+||.||.+.+. ..+++|.+........ ....+.+|+.+++.+.|+ +|+++.+++... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence 889999999999999999887 7899999976544433 567789999999999988 799999998332 448
Q ss_pred EEEEecCCC-CHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-CEEEeecCCccccc
Q 044076 94 YVVFELMES-DLDQVIKAND---DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-KLKICDFGLARVSF 168 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~---~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-~lKL~DFGla~~~~ 168 (506)
++|++++.+ ++.+++.... .++......++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999985 7887777664 799999999999999999999999999999999999999998 79999999997533
Q ss_pred CCCCCc---ccccccccCCcccCcccccccC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCc---hhhHHHHHhhcCCC
Q 044076 169 TDTPSA---IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGRPLFPGRNV---AHQLDLVTDLLGTP 241 (506)
Q Consensus 169 ~~~~~~---~~~~~~vgt~~Y~APE~l~~~~-~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~---~~~l~~I~~~~g~p 241 (506)
...... ......++|.+|+|||.+.+.. ..++...|+||+|+++++++.|..||..... ...........+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 322211 1246778999999999987621 4688899999999999999999999877664 22332222222222
Q ss_pred -ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 242 -SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 242 -~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
... ...... ......+.+++.+++..+|..|.+..+
T Consensus 234 ~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ 271 (384)
T COG0515 234 SLAS-----------------------PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271 (384)
T ss_pred cccc-----------------------ccCccccchhhHHHHHHHHHHHhcCchhcCCHHH
Confidence 000 000000 122357899999999999999999998
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=230.07 Aligned_cols=251 Identities=20% Similarity=0.330 Sum_probs=200.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCC-----CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHT-----GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t-----~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..|++....+-+|.||.||.|+.+.. .+.|-+|.++.. ..+-....++.|-.++..+.|||+..+.++..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~i---- 357 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI---- 357 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe----
Confidence 35677788899999999999976543 345777877632 34455677889999999999999999999864
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEE
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN--------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKI 158 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~--------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL 158 (506)
++....++++++++ |+|..++... +.++..+...++.||+.|+.|||+.||||.||-..|+++++.-++||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 34566789999998 7999998721 25777788889999999999999999999999999999999999999
Q ss_pred eecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhh
Q 044076 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDL 237 (506)
Q Consensus 159 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~ 237 (506)
+|=.++|..+..+..... ..--....||+||.+.. ..|+.++|+||||++||||++ |+.|+..-+..++...+.+.
T Consensus 438 tDsaLSRDLFP~DYhcLG-DnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLG-DNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred ccchhccccCcccccccC-CCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 999999987665443221 12234567999999988 799999999999999999998 99999777766554444221
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+ -..| -++++++..++..||..+|++||+.+||
T Consensus 515 -----------------------yR--laQP-----~NCPDeLf~vMacCWallpeeRPsf~Ql 548 (563)
T KOG1024|consen 515 -----------------------YR--LAQP-----FNCPDELFTVMACCWALLPEERPSFSQL 548 (563)
T ss_pred -----------------------ce--ecCC-----CCCcHHHHHHHHHHHhcCcccCCCHHHH
Confidence 00 0111 2589999999999999999999999995
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=231.71 Aligned_cols=181 Identities=18% Similarity=0.197 Sum_probs=135.3
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECC-CCcEEEEEEeccccc---ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTH-TGEKVAIKKMKEVFE---HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~-t~~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
...++|.+.+.||+|+||+||+|++.. +++.||||++..... .......+.+|+.+|+.++|+||+..+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 346789999999999999999999876 678889998753211 223456688999999999999998533221
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC-CCCcEEECCCCCEEEeecCCc
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDL-KPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDL-Kp~NILv~~~~~lKL~DFGla 164 (506)
+..|+||||++| +|. .+.. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 ----~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999986 675 2221 11 2568899999999999999999999 999999999999999999999
Q ss_pred ccccCCCCCcc-----cccccccCCcccCcccccccC----CCCCchhhhh
Q 044076 165 RVSFTDTPSAI-----FWTDYVATRWYRAPELCGSFF----SKYTPAIDIW 206 (506)
Q Consensus 165 ~~~~~~~~~~~-----~~~~~vgt~~Y~APE~l~~~~----~~~s~~~DIW 206 (506)
+.......... ..+...+++.|.|||.+.... ...+...|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 86543321111 124567888899999985421 2234456766
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-22 Score=207.57 Aligned_cols=253 Identities=21% Similarity=0.225 Sum_probs=188.2
Q ss_pred CEEEeEEEeecCceEEEEEEECCCC-cEEEEEEecccccChhHHHHHHHHHHHHHhCCC----CCcceeceeecCCCcCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTG-EKVAIKKMKEVFEHVSDATRILREIKLLRMLKH----PDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~-~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~H----pnIv~l~~v~~~~~~~~ 89 (506)
+|++.+.||+|+||.||.|.+..++ ..+|+|.......... ..+..|+.++..+.. .++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999988775 6788888754222111 156788999988873 57888877763 12
Q ss_pred CCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-----CCEEEeecC
Q 044076 90 FKDIYVVFELMESDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-----CKLKICDFG 162 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~-----~~lKL~DFG 162 (506)
...-|+||++++.+|.++.+.. +.++...+..++.|++.+|.+||+.|++||||||.|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 3678999999999999988654 479999999999999999999999999999999999999865 459999999
Q ss_pred Ccc--cccCCCC----Cc-ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHH
Q 044076 163 LAR--VSFTDTP----SA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVT 235 (506)
Q Consensus 163 la~--~~~~~~~----~~-~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~ 235 (506)
+|+ ....... .. .......||..|.++.+..+ ...+...|+||++-++.+|+.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 3222111 01 11134569999999999888 788999999999999999999999996655332222221
Q ss_pred hhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 236 ~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.... ...... .....+..+.++...+-..+...+|....+
T Consensus 251 ~~~~-----------------------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~ 290 (322)
T KOG1164|consen 251 KDPR-----------------------KLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKL 290 (322)
T ss_pred HHhh-----------------------hhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHH
Confidence 1000 000000 112244567777777777899999998874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=235.92 Aligned_cols=248 Identities=29% Similarity=0.404 Sum_probs=182.6
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc--cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF--EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.|...+.||++.|=.|++|.+. .| .|+||++-+.. -......+.++|++ ...++|||++.+.-+.. ....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~-----t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV-----TDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH-----hhHH
Confidence 7888999999999999999753 34 49999984432 23445556667777 77778999999876642 2366
Q ss_pred EEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc--cCC
Q 044076 93 IYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS--FTD 170 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~--~~~ 170 (506)
.|||-+|...+|++-+..++-+..-+.+-|+.||+.||+-+|..||+|||||.+||||++=+=+.|+||..-+.. ..+
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 899999999999999998888999999999999999999999999999999999999998888999999876542 222
Q ss_pred CCCc--ccccccccCCcccCccccccc---------CCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhc
Q 044076 171 TPSA--IFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 171 ~~~~--~~~~~~vgt~~Y~APE~l~~~---------~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~ 238 (506)
.+.. .++.+-..-..|.|||-+... ....+++.||||+||+++||++ |+|||.- .||-.. .-
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aY--r~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAY--RS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhH--hc
Confidence 2221 111111222459999987431 1126789999999999999998 8999931 121111 11
Q ss_pred C-CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 239 G-TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 239 g-~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
| ...+ ...++.+ -+...+.||..|++.||.+|.+|++.
T Consensus 250 ~~~~~~-----------e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedy 288 (1431)
T KOG1240|consen 250 GNADDP-----------EQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDY 288 (1431)
T ss_pred cCccCH-----------HHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHH
Confidence 1 1111 1111111 23458999999999999999999995
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=203.79 Aligned_cols=240 Identities=22% Similarity=0.272 Sum_probs=153.7
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCC----------CCcceeceeec
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKH----------PDIVEIKHIML 83 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~H----------pnIv~l~~v~~ 83 (506)
.+...+.||.|+++.||.++|..||+.+|+|++.... ......+.+.+|.-....+.+ -.++-.+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5667899999999999999999999999999984322 223345666666655555433 12222223322
Q ss_pred CCC---------cCCCC---cEEEEEecCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Q 044076 84 PPC---------RREFK---DIYVVFELMESDLDQVIKA---NDD----LTPEHHQFFLYQLLRALKYIHSANVFHRDLK 144 (506)
Q Consensus 84 ~~~---------~~~~~---~~ylV~E~~~~~L~~~i~~---~~~----ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLK 144 (506)
... ..... ..+++|+-+.+||.+++.. ... +.......+..|+++.+++||+.||+|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 110 00111 3478999999998888652 222 2222334566999999999999999999999
Q ss_pred CCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCccccccc------CCCCCchhhhhhhhHHHHHHHhC
Q 044076 145 PKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTG 218 (506)
Q Consensus 145 p~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~------~~~~s~~~DIWSlG~il~eLl~G 218 (506)
|+|++++.+|.++|+||+......... .....+..|.+||+.... ...++.+.|.|+||+++|.|+||
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999998876432211 113455779999986431 23588999999999999999999
Q ss_pred CCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 044076 219 RPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR 295 (506)
Q Consensus 219 ~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R 295 (506)
..||........ ...+|..+. +++...++||.+||+.||.+|
T Consensus 247 ~lPf~~~~~~~~----------------------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEAD----------------------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGST----------------------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccc----------------------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999965432100 000333444 688999999999999999988
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-22 Score=187.31 Aligned_cols=215 Identities=25% Similarity=0.324 Sum_probs=171.1
Q ss_pred cccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCC-CCcceeceeecC
Q 044076 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH-PDIVEIKHIMLP 84 (506)
Q Consensus 6 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~H-pnIv~l~~v~~~ 84 (506)
-..++...++|+++++||+|+||.+|.|....+|+.||||.-+.... -..+..|.++.+.|++ ..|..+.++.
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~-- 80 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYG-- 80 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhc--
Confidence 44567788999999999999999999999999999999998653222 2346789999999984 5566666655
Q ss_pred CCcCCCCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC---CCEEEee
Q 044076 85 PCRREFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD---CKLKICD 160 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~---~~lKL~D 160 (506)
.+..+-.+||++++.+|.++..- ...++...+.-++-|++.-+.|+|..+++||||||+|+|..-+ .++.|+|
T Consensus 81 ---~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 81 ---TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred ---cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEe
Confidence 33467789999999988888763 3469999999999999999999999999999999999997533 4699999
Q ss_pred cCCcccccCCCCC----cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhH
Q 044076 161 FGLARVSFTDTPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL 231 (506)
Q Consensus 161 FGla~~~~~~~~~----~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l 231 (506)
||+|+.+.+-... ........||..|.+--...+ ..-+..-|+=|+|-+|..+..|..||.|-......
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 9999764332211 112345679999998877766 56677899999999999999999999886654433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=194.86 Aligned_cols=176 Identities=11% Similarity=0.098 Sum_probs=133.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh-hHHHH------HHHHHHHHHhCCCCCcceeceeecCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV-SDATR------ILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~-~~~~~------~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
.++|+++++||.|+||.||++.+ ++..+|||.+....... ....+ +.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 68999999999999999999754 57789999996543322 22222 57899999999999999999886543
Q ss_pred CcC---CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeec
Q 044076 86 CRR---EFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 86 ~~~---~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DF 161 (506)
... .....++||||++| +|.++.. +++ ..+.+|+.+|..||+.|++|||+||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 111 12468999999997 7877632 333 2466999999999999999999999999999998 999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHH
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 216 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl 216 (506)
|..+........ ..+.+. ..|+.++|+||||+.+..+.
T Consensus 179 g~~~~~~e~~a~---------------d~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK---------------DRIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH---------------HHHHHH--hHhcccccccceeEeehHHH
Confidence 988653221110 002333 45777999999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-23 Score=225.34 Aligned_cols=231 Identities=26% Similarity=0.386 Sum_probs=173.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
....|..++.|..|+||.||.++|+.+.+++|+ ++++. ..++|- |..+- +
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq-------~lilRn-----------ilt~a-----------~ 130 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ-------NLILRN-----------ILTFA-----------G 130 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-ccccc-------chhhhc-----------ccccc-----------C
Confidence 356889999999999999999999999999999 45421 112221 22211 2
Q ss_pred cEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 92 DIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
..++| ||-...++.-+.++.+. +.+++|||+-||+|||+||+|++|..-|++|++|||+++......
T Consensus 131 npfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 131 NPFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred Cccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 22333 66666667666666643 789999999999999999999999999999999999997633221
Q ss_pred CC------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcC
Q 044076 172 PS------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 172 ~~------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g 239 (506)
.. .......+||+.|+|||++.. ..|++.+|.|++|+|+||.+-|..||-|+...+.+..++.-.+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 11 011123589999999999987 7899999999999999999999999999888777766644333
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HhhhhhhhhhhhHHHHHhhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-AEEIRFTEIVFNWLFLYFYVL 318 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-a~eL~~~~~~~~~~~~~~~~~ 318 (506)
..+++ -....+++.+||.+||+.+|..|.- ..++.
T Consensus 276 ~wpE~----------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e---------------- 311 (1205)
T KOG0606|consen 276 EWPEE----------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALE---------------- 311 (1205)
T ss_pred ccccc----------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhh----------------
Confidence 22221 1347899999999999999999973 22211
Q ss_pred hccCcccCCCCCC
Q 044076 319 ALADPYFHGLANL 331 (506)
Q Consensus 319 aL~HP~f~~~~~~ 331 (506)
+.+|+||+.+-..
T Consensus 312 vk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 312 VKQHGFFQLLDWK 324 (1205)
T ss_pred hhhccceeecccc
Confidence 7899999987553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=191.75 Aligned_cols=139 Identities=24% Similarity=0.276 Sum_probs=108.7
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhH------------------------HHHHHHHHHHHHhCCCCC
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSD------------------------ATRILREIKLLRMLKHPD 74 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~------------------------~~~~~rEi~iL~~l~Hpn 74 (506)
.+.||+|++|.||+|.+. +|+.||||+++........ .....+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999643211111 122345999999998887
Q ss_pred cceeceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCeeecCCCCCcEEECC
Q 044076 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYI-HSANVFHRDLKPKNILANA 152 (506)
Q Consensus 75 Iv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yL-H~~gIvHrDLKp~NILv~~ 152 (506)
+.....+.. ...+|||||++| ++...+.....++...+..++.||+.+|.+| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 744332221 223899999997 4544444456799999999999999999999 799999999999999998
Q ss_pred CCCEEEeecCCccc
Q 044076 153 DCKLKICDFGLARV 166 (506)
Q Consensus 153 ~~~lKL~DFGla~~ 166 (506)
++.++|+|||+|..
T Consensus 153 ~~~v~LiDFG~a~~ 166 (190)
T cd05147 153 DGKLYIIDVSQSVE 166 (190)
T ss_pred CCcEEEEEcccccc
Confidence 58899999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-24 Score=222.12 Aligned_cols=241 Identities=27% Similarity=0.406 Sum_probs=196.1
Q ss_pred EEeecCceEEEEEE---ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCcEEEE
Q 044076 21 IIGIGSYGVVASAI---DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 21 ~LG~G~~g~V~~a~---d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
++|.|+||.|++++ ....|..+|+|+.++.............|-.++...+ ||.+++++..+.. ...+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence 47899999998764 2356778999998765444333335556888888887 9999999988744 4889999
Q ss_pred EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcc
Q 044076 97 FELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175 (506)
Q Consensus 97 ~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 175 (506)
+++..| +|...+.....+++...+.+...++-++.++|+.||+|||+|++||+++.+|.+|+.|||+++......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999975 898888888889999999999999999999999999999999999999999999999999998643322
Q ss_pred cccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHh-hcCCCChHHHhhhhhhHH
Q 044076 176 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD-LLGTPSAESIAGIRNEKA 254 (506)
Q Consensus 176 ~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~-~~g~p~~e~~~~~~~~~~ 254 (506)
..+||..|||||++.+ ...++|.||+|+++++|++|..||.+ +....|.. .++.|
T Consensus 152 ---~~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p------------- 207 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP------------- 207 (612)
T ss_pred ---hcccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-------------
Confidence 1279999999999863 57799999999999999999999977 44444432 11111
Q ss_pred HHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----hhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA-----EEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa-----~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
...+..+.+++..|+..+|..|.-+ .| +++|++|+.+.
T Consensus 208 -------------------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~e------------------ik~h~f~~~i~ 250 (612)
T KOG0603|consen 208 -------------------RELSAEARSLFRQLFKRNPENRLGAGPDGVDE------------------IKQHEFFQSID 250 (612)
T ss_pred -------------------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHH------------------Hhccchheeee
Confidence 2367889999999999999999876 45 78999999865
Q ss_pred CC
Q 044076 330 NL 331 (506)
Q Consensus 330 ~~ 331 (506)
..
T Consensus 251 ~~ 252 (612)
T KOG0603|consen 251 WN 252 (612)
T ss_pred Hh
Confidence 43
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.6e-21 Score=185.82 Aligned_cols=238 Identities=20% Similarity=0.284 Sum_probs=182.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~ 90 (506)
+.-.|+++++||+|+||+.+.|.+.-+++.||||.-.. .+++-.+.-|.+..+.|. .+.|..++-+- .+.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG 96 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEG 96 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeec-----ccc
Confidence 34579999999999999999999999999999997643 345666777888888886 67777765432 333
Q ss_pred CcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-----CCEEEeecCCc
Q 044076 91 KDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-----CKLKICDFGLA 164 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~-----~~lKL~DFGla 164 (506)
.+-.||+|+++.+|.++..-. ..++...+.-++.|++.-+.|+|++++|.|||||+|+||... ..+-|+|||+|
T Consensus 97 ~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 97 KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 667899999999888888654 469999999999999999999999999999999999999754 34899999999
Q ss_pred ccccCCCCCc----ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---CchhhHHHHHhh
Q 044076 165 RVSFTDTPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR---NVAHQLDLVTDL 237 (506)
Q Consensus 165 ~~~~~~~~~~----~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~---~~~~~l~~I~~~ 237 (506)
+.+.+..... .......||..||+=-..++ ..-+..-|+=|||-+|...|-|..||.|. +..+..++|-+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 8754322111 11234579999999888877 67888999999999999999999999875 455666666554
Q ss_pred cCCCChHHHhhhhhhHHHHHHhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSS 260 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~ 260 (506)
--..+.+.+..--......|+.-
T Consensus 255 Kr~T~i~~Lc~g~P~efa~Yl~y 277 (449)
T KOG1165|consen 255 KRSTPIEVLCEGFPEEFATYLRY 277 (449)
T ss_pred cccCCHHHHHhcCHHHHHHHHHH
Confidence 44444444433233333444443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=184.10 Aligned_cols=141 Identities=24% Similarity=0.219 Sum_probs=111.0
Q ss_pred EeEEEeecCceEEEEEEECCCCcEEEEEEecccccChh------------------------HHHHHHHHHHHHHhCCCC
Q 044076 18 IQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVS------------------------DATRILREIKLLRMLKHP 73 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~------------------------~~~~~~rEi~iL~~l~Hp 73 (506)
+.+.||+|++|.||+|.+. +|+.||||+++....... ......+|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999864321100 012245799999999999
Q ss_pred CcceeceeecCCCcCCCCcEEEEEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEEC
Q 044076 74 DIVEIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILAN 151 (506)
Q Consensus 74 nIv~l~~v~~~~~~~~~~~~ylV~E~~~~~-L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~ 151 (506)
+|.....+.. ...|+||||++|. +.........++...+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEe-------cCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 8755444431 1248999999873 43332334568889999999999999999999 9999999999999999
Q ss_pred CCCCEEEeecCCcccc
Q 044076 152 ADCKLKICDFGLARVS 167 (506)
Q Consensus 152 ~~~~lKL~DFGla~~~ 167 (506)
++.++|+|||+|+..
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 899999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.2e-21 Score=190.12 Aligned_cols=256 Identities=30% Similarity=0.380 Sum_probs=172.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCC-----------------------------------cEEEEEEecccccChhHH
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTG-----------------------------------EKVAIKKMKEVFEHVSDA 57 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~-----------------------------------~~vAIK~i~~~~~~~~~~ 57 (506)
.++|+|++.||+|+...||.|.-...| -+.|||.+.+. +..+..
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~-~~~s~~ 234 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNF-EHDSGD 234 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccc-ccCCch
Confidence 467999999999999999998643211 13566666432 222222
Q ss_pred HHHH----HHHH------H--------HHh--------CCCCCcceeceeecCCC----------------------cCC
Q 044076 58 TRIL----REIK------L--------LRM--------LKHPDIVEIKHIMLPPC----------------------RRE 89 (506)
Q Consensus 58 ~~~~----rEi~------i--------L~~--------l~HpnIv~l~~v~~~~~----------------------~~~ 89 (506)
..++ +|+- . .+. -+|||||++...|.+.- ...
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 2222 2221 1 111 25999999987764321 123
Q ss_pred CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC--CCC--CEEEeecCCcc
Q 044076 90 FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN--ADC--KLKICDFGLAR 165 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~--~~~--~lKL~DFGla~ 165 (506)
...+|+||..+..+|++++-.+ ..+....+-++.|+++|+.|||++||.|||+|.+|||+. +|+ .+.|+|||.+-
T Consensus 315 ~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred CceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 4669999999999999999764 577788888999999999999999999999999999974 443 48999999985
Q ss_pred cccCCCCCcccc---cccccCCcccCcccccccCCC---C-CchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhc
Q 044076 166 VSFTDTPSAIFW---TDYVATRWYRAPELCGSFFSK---Y-TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 166 ~~~~~~~~~~~~---~~~vgt~~Y~APE~l~~~~~~---~-s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~ 238 (506)
......-.-.+. -+.-|.-..+|||+....-.+ . -.++|.|+.|.+.||++...-||.+..... +.
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~------ 466 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LD------ 466 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ec------
Confidence 422211111111 223466778999997542111 1 237999999999999999999997743210 00
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~ 299 (506)
.+.|-+. .+...-..+++.+.+|+..+|+.||.+|+++.
T Consensus 467 ---------------~r~Yqe~-------qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 467 ---------------TRTYQES-------QLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ---------------hhhhhhh-------hCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 0111111 01112235889999999999999999999975
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=174.91 Aligned_cols=190 Identities=17% Similarity=0.084 Sum_probs=137.1
Q ss_pred EeEEEeecCceEEEEEEECCCCcEEEEEEeccccc--ChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCcEE
Q 044076 18 IQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE--HVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~--~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
+...|++|+||+|+.+.. .+.+++.+.+..... .......+.+|+++|++|. |++|.+++++ ...|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~~ 74 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGRH 74 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCEE
Confidence 568899999999998753 778888887764322 1122335789999999996 5889988875 3469
Q ss_pred EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC-CCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 95 VVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDL-KPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 95 lV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDL-Kp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
+||||+.| +|.+.+.. . ...++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||+|........
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999987 66544321 1 2357889999999999999999999 79999999999999999999975332211
Q ss_pred Ccc--ccc--------ccccCCcccCcccccccCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCC
Q 044076 173 SAI--FWT--------DYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGRPLFPGRN 226 (506)
Q Consensus 173 ~~~--~~~--------~~vgt~~Y~APE~l~~~~~~~s-~~~DIWSlG~il~eLl~G~~pF~~~~ 226 (506)
... ... -...++.|++|+...-. ...+ ...+.++.|+.+|.++||..++-+.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 000 000 01246677888754221 1233 56788899999999999988775443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=176.04 Aligned_cols=136 Identities=21% Similarity=0.269 Sum_probs=107.3
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-----CCCCcceeceeecCCCcCCCCcE
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-----KHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-----~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
.+.||+|+||.||. +..++.. +||++... .......+.+|+.+++.+ .||||+++++++.... +.+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 57899999999995 6777776 69988542 223456689999999999 5799999999996642 22444
Q ss_pred E-EEEecCC---CCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCeeecCCCCCcEEECCC----CCEEEeecCCc
Q 044076 94 Y-VVFELME---SDLDQVIKANDDLTPEHHQFFLYQLLRAL-KYIHSANVFHRDLKPKNILANAD----CKLKICDFGLA 164 (506)
Q Consensus 94 y-lV~E~~~---~~L~~~i~~~~~ls~~~~~~i~~QIl~gL-~yLH~~gIvHrDLKp~NILv~~~----~~lKL~DFGla 164 (506)
+ +|+||++ ++|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 5999999764 46665 46688999888 99999999999999999999743 47999995544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=176.21 Aligned_cols=147 Identities=18% Similarity=0.150 Sum_probs=113.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEE-ECCCCcEEEEEEecccccCh--------------------h--HHHHHHHHHHHHH
Q 044076 12 EASQYEIQEIIGIGSYGVVASAI-DTHTGEKVAIKKMKEVFEHV--------------------S--DATRILREIKLLR 68 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~-d~~t~~~vAIK~i~~~~~~~--------------------~--~~~~~~rEi~iL~ 68 (506)
...-|.+.+.||+|++|.||+|. +..+|+.||||+++...... . ....+.+|+.++.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34468899999999999999999 77899999999986421100 0 1123568999999
Q ss_pred hCCCCCcceeceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCCC
Q 044076 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN-VFHRDLKPK 146 (506)
Q Consensus 69 ~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~g-IvHrDLKp~ 146 (506)
.+.+. .+.+..++.. ...|+||||++| +|.........+....+..++.||+.+|++||+.| |+||||||+
T Consensus 106 ~L~~~-~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 106 RLYEA-GVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HHHhc-CCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 99753 3333333311 235899999998 55554434456677778899999999999999999 999999999
Q ss_pred cEEECCCCCEEEeecCCccc
Q 044076 147 NILANADCKLKICDFGLARV 166 (506)
Q Consensus 147 NILv~~~~~lKL~DFGla~~ 166 (506)
||+++ ++.++|+|||.|..
T Consensus 179 NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hEEEE-CCCEEEEEChhhhc
Confidence 99999 88999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=199.82 Aligned_cols=193 Identities=24% Similarity=0.321 Sum_probs=151.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC---CCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK---HPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~---HpnIv~l~~v~~~~~~~~ 89 (506)
...|.|.+.||.|+||.||.|.+.. |+.||+|+-+..... .+.-=.+++.+|+ -+-|+.+...++-.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~---- 766 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-----EFYICLQVMERLKPQMLPSIMHISSAHVFQ---- 766 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-----eeeehHHHHHhhchhhhcchHHHHHHHccC----
Confidence 4589999999999999999999876 999999987543222 1222233344444 23455554443322
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-------CCCEEEeec
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-------DCKLKICDF 161 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-------~~~lKL~DF 161 (506)
+.-++|+||.+ |+|.+++..++.+++..+.+|.+|||+.+..||.+|||||||||+|+|+.. +--++|+||
T Consensus 767 -~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 767 -NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred -CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 45689999998 899999998889999999999999999999999999999999999999753 234999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR 219 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~ 219 (506)
|.+-...--... ..+....+|-.+-.+|...| ..|++.+|.|.|+-+++-||.|+
T Consensus 846 G~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCC-cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 999543222222 23456678888999999988 89999999999999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=166.84 Aligned_cols=135 Identities=21% Similarity=0.257 Sum_probs=110.1
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccccC------hhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH------VSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~------~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
+.||+|++|.||+|.+ .|..|++|+....... .....++.+|+.++..+.|++|.....++.. ....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCC
Confidence 6799999999999976 7788999986532111 1123467789999999999988776655532 2567
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
++||||++| +|.+++..... ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||.++.
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 899999986 89988865432 7888999999999999999999999999999999 88999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-20 Score=190.19 Aligned_cols=249 Identities=27% Similarity=0.357 Sum_probs=166.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCC---CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceece-------e
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHT---GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKH-------I 81 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t---~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~-------v 81 (506)
....+.+.+..+.++++.+....-... .+.++-+... ..+........+++-.+....|.+..-+.+ .
T Consensus 242 ~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~--~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 242 ESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD--VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES 319 (516)
T ss_pred ccccccccccccccccCCchhhhhcccchhhhhccchhhh--ccchhhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence 344555666666666666655543222 2333333221 122234455667777777776555444433 1
Q ss_pred ecCCCcCCCCcEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEE
Q 044076 82 MLPPCRREFKDIYVVFELME-SDLDQVIKAND---DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLK 157 (506)
Q Consensus 82 ~~~~~~~~~~~~ylV~E~~~-~~L~~~i~~~~---~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lK 157 (506)
+.........++||.|++|. .+|.++|.... ..+....+.++.|+..|+.| +|.+|||+||.||++..++.+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 11111112246899999998 59999997543 47778899999999999999 9999999999999999999999
Q ss_pred EeecCCcccccCCC---CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhC-CCCCCCCCchhhHHH
Q 044076 158 ICDFGLARVSFTDT---PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQLDL 233 (506)
Q Consensus 158 L~DFGla~~~~~~~---~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G-~~pF~~~~~~~~l~~ 233 (506)
|.|||+........ +.....+..+||.||++||.+.+ ..|+.++||||||+||+||+.- ...|.. ...+..
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d 471 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQFSTQFER---IATLTD 471 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhh
Confidence 99999986543332 12234577899999999999998 7999999999999999999971 111100 000001
Q ss_pred HHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 234 I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
| +. ..+...+..-.|...+|+.+||...|.+||++.+
T Consensus 472 ~---------------------------r~---g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 472 I---------------------------RD---GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred h---------------------------hc---CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 1 10 0011111123456789999999999999998877
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.4e-20 Score=199.46 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=199.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECC-CCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTH-TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~-t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~ 90 (506)
...|.+.+.||+|+|+.|-.+.... +...+|.|.+............+..|..+-+.+. |.|++.+++.... .
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-----~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-----P 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-----C
Confidence 5679999999999999999887644 3456788877655444556667778999999998 9999999988743 4
Q ss_pred CcEEEEEecCCC-CHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCCCcEEECCCC-CEEEeecCCcc
Q 044076 91 KDIYVVFELMES-DLDQVI-KAND-DLTPEHHQFFLYQLLRALKYIH-SANVFHRDLKPKNILANADC-KLKICDFGLAR 165 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i-~~~~-~ls~~~~~~i~~QIl~gL~yLH-~~gIvHrDLKp~NILv~~~~-~lKL~DFGla~ 165 (506)
+..+++++|..| ++...+ .... ..+.....+++.|+..++.|+| ..++.|+||||+|.+++.++ .+|+.|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 778999999875 888877 5444 6888899999999999999999 99999999999999999999 99999999997
Q ss_pred cccCCCCCccccccccc-CCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDTPSAIFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vg-t~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
...............+| ++.|.|||...+. ....+..|+||.|+++.-+++|..|+......+.
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------------- 238 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------------- 238 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc--------------
Confidence 75441222223355678 9999999998772 4557899999999999999999988854432220
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.|.. +.......-...|..++..+.+++.++|..+|..|.+.+++
T Consensus 239 -----------~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 239 -----------RYSS-WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred -----------ccee-ecccccccccCccccCChhhhhcccccccCCchhccccccc
Confidence 0000 00011111124456789999999999999999999999993
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=166.50 Aligned_cols=243 Identities=18% Similarity=0.249 Sum_probs=179.5
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
...++-+|.....|..|+|+ ..|..++.|+++...-.......+..|.-.|+-+.||||+.+++.+-. ..++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGR--WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLV 263 (448)
T ss_pred hhhhhhhhccCCCccccccc--ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCce
Confidence 33455678888999999995 567778888875322222233457778889999999999999998743 37889
Q ss_pred EEEecCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 95 VVFELME-SDLDQVIKANDD--LTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 95 lV~E~~~-~~L~~~i~~~~~--ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
++..||+ |+|+.++..... .+..++..|+..|++|++|||+.. |.---|....++++++.+.+|. .+-++..+.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfq 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeee
Confidence 9999998 799999987553 667788899999999999999875 4444578889999998776663 111221111
Q ss_pred CCCCcccccccccCCcccCcccccccC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~-~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
. .+..-.+.|++||.+.... ...-.++|||||++++|||-++..||...+..+.-.+|.
T Consensus 343 e-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------- 402 (448)
T KOG0195|consen 343 E-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------- 402 (448)
T ss_pred c-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------------
Confidence 1 2233567899999986521 122358999999999999999999998877665444331
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
++.++ .++-|++++....|+.-|+..||.+||.++.|
T Consensus 403 ---------leglr-------v~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 403 ---------LEGLR-------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred ---------hcccc-------ccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 11111 13447899999999999999999999999884
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.3e-18 Score=159.54 Aligned_cols=136 Identities=23% Similarity=0.236 Sum_probs=105.3
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh--------------------hHHHHHHHHHHHHHhCCCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV--------------------SDATRILREIKLLRMLKHPD 74 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~--------------------~~~~~~~rEi~iL~~l~Hpn 74 (506)
.|.+.+.||.|+||.||+|.+. +|+.||||++....... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999864 89999999875321000 01123568999999998775
Q ss_pred c--ceeceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC
Q 044076 75 I--VEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151 (506)
Q Consensus 75 I--v~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~ 151 (506)
+ ...++ ....++||||++| +|..+.. ......++.+|+.++.++|+.||+||||||+||+++
T Consensus 95 i~v~~~~~---------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPID---------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceee---------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3 32222 1345899999987 6655432 134677899999999999999999999999999999
Q ss_pred CCCCEEEeecCCccc
Q 044076 152 ADCKLKICDFGLARV 166 (506)
Q Consensus 152 ~~~~lKL~DFGla~~ 166 (506)
.++.++|+|||.+..
T Consensus 160 ~~~~~~liDfg~~~~ 174 (198)
T cd05144 160 DDEKIYIIDWPQMVS 174 (198)
T ss_pred CCCcEEEEECCcccc
Confidence 999999999999954
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=157.56 Aligned_cols=131 Identities=26% Similarity=0.362 Sum_probs=102.8
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEeccc-ccC-----hhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 21 IIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEH-----VSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~-----~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
.||+|++|.||+|. .++..|++|+.... ... .....++.+|+.+++.+.|+++....-+... ....+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCE
Confidence 37999999999997 56788999986421 111 1124667899999999998775444333322 24568
Q ss_pred EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 95 VVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 95 lV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
+||||++| +|.+++..... .++.||+.+|.+||+.|++|||++|.||+++ ++.++++|||+++.
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999986 88887754321 7899999999999999999999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.4e-17 Score=172.18 Aligned_cols=208 Identities=24% Similarity=0.308 Sum_probs=151.3
Q ss_pred HHhCCCCCcceeceeecCCCcCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCe-eecCC
Q 044076 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANV-FHRDL 143 (506)
Q Consensus 67 L~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gI-vHrDL 143 (506)
|+.+.|.|+.++++..... ...++|.+||. |+|.+++.. ...++.-..-.+++.|+.||.|||..-| .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678899999999998764 78899999998 799999987 3468888889999999999999998766 99999
Q ss_pred CCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCccccccc--CC---CCCchhhhhhhhHHHHHHHhC
Q 044076 144 KPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF--FS---KYTPAIDIWSIGCIFAELLTG 218 (506)
Q Consensus 144 Kp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~--~~---~~s~~~DIWSlG~il~eLl~G 218 (506)
+..|++++....+||.|||+.......... .......-...|.|||++.+. .. ..+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999999765321000 001111233458999998652 11 146789999999999999999
Q ss_pred CCCCCCCCchhh-HHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 044076 219 RPLFPGRNVAHQ-LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS 297 (506)
Q Consensus 219 ~~pF~~~~~~~~-l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT 297 (506)
..||+....... .+.|..+ +........|.-.......+++..++..||..+|..||+
T Consensus 155 ~~~~~~~~~~~~~~eii~~~---------------------~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs 213 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRV---------------------KKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPS 213 (484)
T ss_pred cCccccccccCChHHHHHHH---------------------HhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCcc
Confidence 999976432211 1111111 000011111111111135568999999999999999999
Q ss_pred Hhhh
Q 044076 298 AEEI 301 (506)
Q Consensus 298 a~eL 301 (506)
+++|
T Consensus 214 ~~~i 217 (484)
T KOG1023|consen 214 IEQI 217 (484)
T ss_pred HHHH
Confidence 9996
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.4e-17 Score=175.35 Aligned_cols=137 Identities=20% Similarity=0.315 Sum_probs=107.2
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEe-ccccc-----ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFE-----HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i-~~~~~-----~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..|...+.||+|+||+||+|... +..+++|+. .+... ......++.+|+.+++.++|++|+....+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 34566889999999999999754 334455543 22111 112345688999999999999988766554332
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 REFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
...++||||+++ +|.+++. ....++.||+++|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 409 ---~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 ---EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 456899999986 8988875 356789999999999999999999999999999 688999999999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.7e-17 Score=151.28 Aligned_cols=135 Identities=25% Similarity=0.285 Sum_probs=95.4
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHH----------------------HHHHHHHHHhCCCCC--
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR----------------------ILREIKLLRMLKHPD-- 74 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~----------------------~~rEi~iL~~l~Hpn-- 74 (506)
.+.||+|+||.||+|.+. +++.||||+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999976 8999999998642211111111 124555555554332
Q ss_pred cceeceeecCCCcCCCCcEEEEEecCCC-CHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEEC
Q 044076 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLD-QVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILAN 151 (506)
Q Consensus 75 Iv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~-~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~ 151 (506)
+.+.+.. ...++||||+++ .+. ..+.... . ...++.++.+++.++.++|. .||+||||||+||+++
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 2222221 345899999987 211 1121111 1 16788999999999999999 9999999999999999
Q ss_pred CCCCEEEeecCCccc
Q 044076 152 ADCKLKICDFGLARV 166 (506)
Q Consensus 152 ~~~~lKL~DFGla~~ 166 (506)
++.++|+|||.++.
T Consensus 150 -~~~~~liDfg~a~~ 163 (187)
T cd05119 150 -DGKVYIIDVPQAVE 163 (187)
T ss_pred -CCcEEEEECccccc
Confidence 99999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-15 Score=148.11 Aligned_cols=139 Identities=21% Similarity=0.293 Sum_probs=104.0
Q ss_pred EEEe-ecCceEEEEEEECCCCcEEEEEEeccc------cc-----ChhHHHHHHHHHHHHHhCCCCCc--ceeceeecCC
Q 044076 20 EIIG-IGSYGVVASAIDTHTGEKVAIKKMKEV------FE-----HVSDATRILREIKLLRMLKHPDI--VEIKHIMLPP 85 (506)
Q Consensus 20 ~~LG-~G~~g~V~~a~d~~t~~~vAIK~i~~~------~~-----~~~~~~~~~rEi~iL~~l~HpnI--v~l~~v~~~~ 85 (506)
..|| .|+.|+||.+.. .+..++||.+... .. ......++.+|+.++..|.|++| ...+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 788888988865 4788999987431 11 11234568899999999998775 5555543221
Q ss_pred CcCCCCcEEEEEecCCC--CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCC
Q 044076 86 CRREFKDIYVVFELMES--DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~--~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
. ......++|||+++| +|.+++.. ..+++.. +.||+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111234699999985 88888765 3566543 67899999999999999999999999999999999999999
Q ss_pred ccc
Q 044076 164 ARV 166 (506)
Q Consensus 164 a~~ 166 (506)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.8e-15 Score=130.78 Aligned_cols=131 Identities=23% Similarity=0.219 Sum_probs=106.3
Q ss_pred EeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCC--CCcceeceeecCCCcCCCCcEEE
Q 044076 18 IQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH--PDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~H--pnIv~l~~v~~~~~~~~~~~~yl 95 (506)
+++.||.|.++.||++.+. +..++||.+..... ...+.+|+.+++.+.| .++.+++..... .+..|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES-----DGWSYL 70 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEE
Confidence 4678999999999999864 37899998864322 4567899999999986 588888776532 267899
Q ss_pred EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 96 VFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA---NVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 96 V~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~---gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
+|||+++ .+..+ +......++.+++++|++||.. +++|+|++|+||+++.++.++++|||.++.
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999986 34332 4566677899999999999985 699999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-15 Score=159.48 Aligned_cols=257 Identities=27% Similarity=0.283 Sum_probs=198.1
Q ss_pred CCCEEEeEEEee--cCceEEEEEEE--CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGI--GSYGVVASAID--THTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~--G~~g~V~~a~d--~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~ 87 (506)
...+.+.+.+|. |.+|.||.+.. ..++..+|+|+=+..+.......+=++|+...+.++ |+|.++.+..+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~----- 187 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW----- 187 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----
Confidence 346677899999 99999999998 889999999986555554455555668888888887 99999977666
Q ss_pred CCCCcEEEEEecCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCeeecCCCCCcEEECCC-CCEEEeec
Q 044076 88 REFKDIYVVFELMESDLDQVIKANDD-LTPEHHQFFLYQLLR----ALKYIHSANVFHRDLKPKNILANAD-CKLKICDF 161 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~~L~~~i~~~~~-ls~~~~~~i~~QIl~----gL~yLH~~gIvHrDLKp~NILv~~~-~~lKL~DF 161 (506)
++.+..|+-+|+++.+|..+...... +++..++..+.+... ||..+|+.+|+|-|+||.||+...+ ...+++||
T Consensus 188 e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 188 EGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred ccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 55588999999999999888876544 889999999999999 9999999999999999999999999 88999999
Q ss_pred CCcccccCCCCCcccc--cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC--CchhhHHHHHhh
Q 044076 162 GLARVSFTDTPSAIFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR--NVAHQLDLVTDL 237 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~--~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~--~~~~~l~~I~~~ 237 (506)
|+........-...+. ....+...|++||++.+ .++.+.|++++|.++.+-.+|..++... +.-.++..+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~--- 341 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG--- 341 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---
Confidence 9987654433221111 12246677999999876 6889999999999999999887666433 111111111
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~ 317 (506)
. ++ .+...+.+.++...+..|+..||..|++++.
T Consensus 342 ---------------------------~-ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~----------------- 375 (524)
T KOG0601|consen 342 ---------------------------Y-IP-LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQI----------------- 375 (524)
T ss_pred ---------------------------c-Cc-hhhhcCcchhhhhHHHHhcCcchhhhhHHHH-----------------
Confidence 0 00 1222345566666999999999999999999
Q ss_pred hhccCcccCC
Q 044076 318 LALADPYFHG 327 (506)
Q Consensus 318 ~aL~HP~f~~ 327 (506)
++.|++...
T Consensus 376 -~~~l~~i~s 384 (524)
T KOG0601|consen 376 -LTALNVIHS 384 (524)
T ss_pred -Hhccccccc
Confidence 778888764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.1e-14 Score=149.29 Aligned_cols=185 Identities=23% Similarity=0.374 Sum_probs=139.4
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
-|.+ +..+-++.+..-.|..+.++.+|.|.+.+.... .....+.+-++-|+.++||||+++++.+ +..+.+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~y 85 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLY 85 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceE
Confidence 4555 555555555444567788999999999875322 4455677889999999999999999987 4457899
Q ss_pred EEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 95 VVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH-SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 95 lV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH-~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
||+|-+.. |..+++. ++...+...++||+.||.||| +++++|++|.-..|+|+..|..||++|.++.........
T Consensus 86 lvTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 86 LVTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP 161 (690)
T ss_pred EEeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc
Confidence 99998763 4445554 347888999999999999997 789999999999999999999999999998653222211
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhC
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 218 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G 218 (506)
...+.--..|..|+.+.. .. -..|.|.|||++++++.|
T Consensus 162 ---~~~~~~~~s~~~P~~~~~--s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 ---AKSLYLIESFDDPEEIDP--SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---cccchhhhcccChhhcCc--cc--cchhhhhHHHHHHHHhCc
Confidence 111222233777877654 22 468999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.4e-15 Score=146.43 Aligned_cols=250 Identities=20% Similarity=0.211 Sum_probs=161.0
Q ss_pred EEEEEEECCCCcEEEEEEeccc-ccChhH-HHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecCC-CCHH
Q 044076 29 VVASAIDTHTGEKVAIKKMKEV-FEHVSD-ATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLD 105 (506)
Q Consensus 29 ~V~~a~d~~t~~~vAIK~i~~~-~~~~~~-~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-~~L~ 105 (506)
.||.+.|+..|..|+.-.+.-. ..+... ......-..-|-.+-|.||++++.++.+...++...+.++.|||. |+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 4566666666666655444210 011111 111111122344456999999999987776667788999999998 6898
Q ss_pred HHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECCCCCEEEeecCCccc--ccCCCCCcccc
Q 044076 106 QVIKA----NDDLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANADCKLKICDFGLARV--SFTDTPSAIFW 177 (506)
Q Consensus 106 ~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~~~~lKL~DFGla~~--~~~~~~~~~~~ 177 (506)
+++++ +..+.....++|+.||+.||.|||+.. |+|+++..+.|++..+|-+||.--.-... ....... ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~-~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE-AEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH-hhh
Confidence 88875 346899999999999999999999986 99999999999999999888842111110 0000000 000
Q ss_pred cccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCC-CCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHH
Q 044076 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPL-FPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKR 256 (506)
Q Consensus 178 ~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~p-F~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~ 256 (506)
....+-+.|.|||.-.. ...+.++|||++|+...+|..|..- -.+.+....-..|.+
T Consensus 240 ~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~-------------------- 297 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN-------------------- 297 (458)
T ss_pred hccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh--------------------
Confidence 12235677899987544 5667799999999999999887632 222222111111100
Q ss_pred HHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHh
Q 044076 257 YLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYF 315 (506)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~ 315 (506)
.++.--++.-.+++.+||+-.|..||++.++++|+.+++.+.+..
T Consensus 298 --------------~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkl 342 (458)
T KOG1266|consen 298 --------------VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKL 342 (458)
T ss_pred --------------heeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecchHHH
Confidence 011112233467999999999999999999766666666655543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-14 Score=160.83 Aligned_cols=265 Identities=24% Similarity=0.289 Sum_probs=194.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC-hhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH-VSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~-~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.+.+.+.+-+-+|++|.++.+.-..+|...++|.....-.- ..+.+.+.++-.++-...+|.++...--+ .-..
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence 45677788889999999999987778877777765432111 11233333444444434456665443322 1236
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc-cccC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR-VSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~-~~~~ 169 (506)
..+||++|+. ++|...+...+..+.+..+.++..+..++.|||...+.|+|++|.|++...++..++.|||... +...
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 7899999997 4899988888889999999999999999999999999999999999999999999999998432 2110
Q ss_pred ----CC---CC--------------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCC
Q 044076 170 ----DT---PS--------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222 (506)
Q Consensus 170 ----~~---~~--------------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF 222 (506)
+. .. ...-...++|+.|.+||.+.+ ..-..++|.|++|++++|.++|.+||
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 00 000123578999999999988 67788999999999999999999999
Q ss_pred CCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh---
Q 044076 223 PGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE--- 299 (506)
Q Consensus 223 ~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~--- 299 (506)
.........+.|... ..++...--..++++.+++.++|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~----------------------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNR----------------------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred CCcchhhhhhccccC----------------------------CCCCCCCccccChhhhhhhhhhhccCchhccCccccc
Confidence 887765544443211 1122222234688999999999999999999988
Q ss_pred hhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 300 EIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 300 eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
+ .-.||+|+....
T Consensus 1088 e------------------~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1088 E------------------VKGHPFFQDVDW 1100 (1205)
T ss_pred c------------------cccCCccCCCCc
Confidence 6 689999997654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.1e-13 Score=125.08 Aligned_cols=138 Identities=22% Similarity=0.270 Sum_probs=100.4
Q ss_pred eEEEeecCceEEEEEEECC------CCcEEEEEEecccc---cC-----------------hhHHHHHH----HHHHHHH
Q 044076 19 QEIIGIGSYGVVASAIDTH------TGEKVAIKKMKEVF---EH-----------------VSDATRIL----REIKLLR 68 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~------t~~~vAIK~i~~~~---~~-----------------~~~~~~~~----rEi~iL~ 68 (506)
...||.|--+.||.|.... .+..+|||+.+... .+ ......+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998653 35799999885211 11 01122223 7999999
Q ss_pred hCC--CCCcceeceeecCCCcCCCCcEEEEEecCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCeeecCCC
Q 044076 69 MLK--HPDIVEIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKANDDLTPEHHQFFLYQLLRALKYI-HSANVFHRDLK 144 (506)
Q Consensus 69 ~l~--HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~~-L~~~i~~~~~ls~~~~~~i~~QIl~gL~yL-H~~gIvHrDLK 144 (506)
++. .-++..++++ ..-+|||||++++ +..-......+++.....++.|++.+|..| |.+||+||||+
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 886 3455555554 3458999999863 321111223466677788899999999998 89999999999
Q ss_pred CCcEEECCCCCEEEeecCCccc
Q 044076 145 PKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 145 p~NILv~~~~~lKL~DFGla~~ 166 (506)
+.|||+. ++.+.|+|||.|..
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HHHEEEE-CCcEEEEECCCcee
Confidence 9999996 57899999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.4e-13 Score=146.34 Aligned_cols=141 Identities=21% Similarity=0.319 Sum_probs=96.2
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC---------------------------h-----hHHHHHHH
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH---------------------------V-----SDATRILR 62 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~---------------------------~-----~~~~~~~r 62 (506)
.|.. +.||+|++|+|++|+.+.+|+.||||+++..... . ...+.+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3554 7899999999999999888999999999632100 0 11222334
Q ss_pred HHHHHHhC----------CCCCcceeceeecCCCcCCCCcEEEEEecCCC-CHHHH--HHhCC----CCCHHHHHHHHHH
Q 044076 63 EIKLLRML----------KHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQV--IKAND----DLTPEHHQFFLYQ 125 (506)
Q Consensus 63 Ei~iL~~l----------~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~--i~~~~----~ls~~~~~~i~~Q 125 (506)
|+..++.. .+.+.+.+-.++.+- ....+|||||++| .+.++ +...+ .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 44443333 233334444444222 2456899999997 67654 33333 3566667777777
Q ss_pred HHHHHHHHHhCCeeecCCCCCcEEECCCC----CEEEeecCCcccc
Q 044076 126 LLRALKYIHSANVFHRDLKPKNILANADC----KLKICDFGLARVS 167 (506)
Q Consensus 126 Il~gL~yLH~~gIvHrDLKp~NILv~~~~----~lKL~DFGla~~~ 167 (506)
|+ ..|++|+|+||.||+++.+| +++++|||++...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 76 48999999999999999988 9999999998653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.3e-12 Score=136.78 Aligned_cols=139 Identities=23% Similarity=0.289 Sum_probs=93.7
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccccChh--H------------------------------H------HHHH
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVS--D------------------------------A------TRIL 61 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~--~------------------------------~------~~~~ 61 (506)
+.||+|++|+||+|+. .+|+.||||+.+......- + . -.+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999985 5899999999853210000 0 0 0133
Q ss_pred HHHHHHHhC----CCCCcceeceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHH
Q 044076 62 REIKLLRML----KHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLR-ALKYIH 134 (506)
Q Consensus 62 rEi~iL~~l----~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~-gL~yLH 134 (506)
+|...+.++ +|.+-+.+-.++... .+..+|||||++| +|.++.... .... ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 445444444 233334444444322 2446999999986 676665421 1222 2345556665 467899
Q ss_pred hCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 135 SANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 135 ~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..|++|+|+||.||+++.+++++|+|||++..
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 99999999999999999999999999999865
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.3e-12 Score=117.22 Aligned_cols=127 Identities=18% Similarity=0.131 Sum_probs=92.9
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcc-eeceeecCCCcCCCCcEEEEE
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV-EIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv-~l~~v~~~~~~~~~~~~ylV~ 97 (506)
++.|+.|.++.||++.. .+..|++|....... ......+|+.+++.+.+.+++ +++... . ...++||
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEE
Confidence 57789999999999975 478899998753211 122356899999988755544 333332 1 2347999
Q ss_pred ecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCe-----eecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 98 ELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANV-----FHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 98 E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gI-----vHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
|+++| ++... ......++.+++++|+.||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99997 44322 11123457899999999999985 9999999999999 67899999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.8e-12 Score=133.08 Aligned_cols=244 Identities=24% Similarity=0.234 Sum_probs=174.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~ 90 (506)
..++..+..||.|.|+.|+.+.-. .++..|++|.+.+......+...-+.|+.+...+. |.+++.....+. ..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-----~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-----QL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----cc
Confidence 346778899999999999987654 67789999988765554444455667888887776 999998877763 34
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-CCEEEeecCCccccc
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~-~~lKL~DFGla~~~~ 168 (506)
...|+-.||+++ ++.-.+.....+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+....
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 677899999975 333333333458888999999999999999999999999999999999886 778999999885311
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... .....+++.|-..|++... ..+..+.|++|||.-+.+.++|.++-...+.. ..|
T Consensus 419 ~~~-----~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i-------------- 475 (524)
T KOG0601|consen 419 FSS-----GVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI-------------- 475 (524)
T ss_pred eec-----ccccccccccccchhhccc-cccccccccccccccccccccCcccCcccccc---eee--------------
Confidence 100 0112234444235555442 77888999999999999999988664332211 000
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. .. .....++....+..+.+.|+..|+..|+.+.++
T Consensus 476 -~-----------~~-----~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l 511 (524)
T KOG0601|consen 476 -R-----------SG-----DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVEL 511 (524)
T ss_pred -e-----------cc-----cccCCCchHHhhhhhhhhhcCCccccchhhhhh
Confidence 0 00 001123444678899999999999999999993
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.3e-10 Score=104.99 Aligned_cols=143 Identities=22% Similarity=0.304 Sum_probs=105.2
Q ss_pred EeEEEeecCceEEEEEEECCCCcEEEEEEec-ccccC-----hhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 18 IQEIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEH-----VSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~-~~~~~-----~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.+..|-+|+-+.|+++ ...|+..+||.-. +...+ .-...+..+|+++|.++.--.|.-..-++.+. .
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----Y 83 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----C
Confidence 5788889999999999 4688998898752 11122 22356778899999888533332222233222 3
Q ss_pred cEEEEEecCCC--CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC---EEEeecCCc
Q 044076 92 DIYVVFELMES--DLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK---LKICDFGLA 164 (506)
Q Consensus 92 ~~ylV~E~~~~--~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~---lKL~DFGla 164 (506)
.-.|+|||.+| ++.+++.... ...+.....++.+|-+.+.-||.++|+|+||..+||++..++. +.++|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 34799999998 8888887642 3444445789999999999999999999999999999987653 589999999
Q ss_pred ccc
Q 044076 165 RVS 167 (506)
Q Consensus 165 ~~~ 167 (506)
.+.
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 763
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-10 Score=105.94 Aligned_cols=130 Identities=20% Similarity=0.306 Sum_probs=94.2
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEe-cccccChh-----HHHHHHHHHHHHHhCCC--CCcceeceeecCCCcCCCC
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVS-----DATRILREIKLLRMLKH--PDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i-~~~~~~~~-----~~~~~~rEi~iL~~l~H--pnIv~l~~v~~~~~~~~~~ 91 (506)
..+++|+-+.++.+.. -|..+++|.- ++...+.. ...+..+|.+++..+.- -++..++++. .+
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-------~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-------PD 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-------CC
Confidence 3578899999999843 4556777754 22222222 24567789999988863 3444445543 24
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
...|||||.+| .|.+++... .-.++..|-.-+.-||.+||+|+||.++||++..++ +.++||||+..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 56799999998 556577654 145677788888899999999999999999998665 99999999975
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.5e-11 Score=130.02 Aligned_cols=153 Identities=22% Similarity=0.329 Sum_probs=113.6
Q ss_pred HHHHHHHHH-hCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccccc--------ccccCCcccCcccccccC
Q 044076 126 LLRALKYIH-SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT--------DYVATRWYRAPELCGSFF 196 (506)
Q Consensus 126 Il~gL~yLH-~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~--------~~vgt~~Y~APE~l~~~~ 196 (506)
+..||.|+| ++++||++|.|++|.++.++.+||+.|+.+........ ..+. -......|.|||++.+
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~~~yd~~lp~~~~~~~~f~apE~~~~-- 183 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPFSEYDPPLPLLLQPHLNFLAPEYLLG-- 183 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--cccccCCCCCChhhccCcccccchhhcc--
Confidence 338999999 56999999999999999999999999999865332111 1111 1234567999999988
Q ss_pred CCCCchhhhhhhhHHHHHHH-hCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCC
Q 044076 197 SKYTPAIDIWSIGCIFAELL-TGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPG 275 (506)
Q Consensus 197 ~~~s~~~DIWSlG~il~eLl-~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (506)
...+.++|++|+||++|.+. .|+++|.+.+.......-....+.. ....-.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~---------------------------~~~~s~~ 236 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG---------------------------AFGYSNN 236 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc---------------------------ccccccc
Confidence 78899999999999999999 6888887765432222111111110 0111146
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 276 ADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 276 ~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
+++++++=|.++|..|+..||++.+ .+..|||.+
T Consensus 237 ~p~el~~~l~k~l~~~~~~rp~~~~------------------l~~~~ff~D 270 (700)
T KOG2137|consen 237 LPSELRESLKKLLNGDSAVRPTLDL------------------LLSIPFFSD 270 (700)
T ss_pred CcHHHHHHHHHHhcCCcccCcchhh------------------hhcccccCC
Confidence 8899999999999999999999988 678888876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.2e-10 Score=105.85 Aligned_cols=143 Identities=18% Similarity=0.265 Sum_probs=100.9
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCC--CCcceeceeecCCCcCCCCcEEEE
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH--PDIVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~H--pnIv~l~~v~~~~~~~~~~~~ylV 96 (506)
.+.||.|.++.||++... +|+.+++|+....... .....+.+|..+++.+.+ .++.+++.+.... ...+..|+|
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v 78 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYV 78 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEE
Confidence 367899999999999763 3678999987532111 134467899999999975 3455565554221 112356899
Q ss_pred EecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 044076 97 FELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS---------------------------------------- 135 (506)
Q Consensus 97 ~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~---------------------------------------- 135 (506)
|||++| ++...+.. ..+++.....++.+++++|..||+
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999987 44443321 346666777777777777777773
Q ss_pred ----------------CCeeecCCCCCcEEECC--CCCEEEeecCCccc
Q 044076 136 ----------------ANVFHRDLKPKNILANA--DCKLKICDFGLARV 166 (506)
Q Consensus 136 ----------------~gIvHrDLKp~NILv~~--~~~lKL~DFGla~~ 166 (506)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56789999999864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.7e-09 Score=110.13 Aligned_cols=210 Identities=18% Similarity=0.190 Sum_probs=151.1
Q ss_pred ceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecCCC--CH
Q 044076 27 YGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES--DL 104 (506)
Q Consensus 27 ~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~--~L 104 (506)
-.+.|+|....+|..|++|.+.. ... ........-+.+++++.|+|||++.++|..... ++..+++|++|.++ +|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg-~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHG-DRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeecc-ccc-cCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchH
Confidence 45789999999999999999932 111 111123355778999999999999999974322 33568999999984 78
Q ss_pred HHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 105 DQVIKA---------------NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 105 ~~~i~~---------------~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.++.-. +...++..++.++.||..||.++|+.|+.-+-|.|.+|++..+.+++|..-|...+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 877622 22478899999999999999999999999999999999999998899887776655433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCC-CCCCchhh-HHHHHhhcCCCChHHHh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF-PGRNVAHQ-LDLVTDLLGTPSAESIA 247 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF-~~~~~~~~-l~~I~~~~g~p~~e~~~ 247 (506)
+.. |.+. --..-|.=.||.+++.|.+|..-= ........ +..
T Consensus 446 d~~-----------------~~le-----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------------- 489 (655)
T KOG3741|consen 446 DPT-----------------EPLE-----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------------- 489 (655)
T ss_pred CCC-----------------cchh-----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------------
Confidence 320 1111 123678889999999999985321 11111100 111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
+.+..+.++.++|.-+...++++ -++++
T Consensus 490 ------------------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ 517 (655)
T KOG3741|consen 490 ------------------------ITTTYSTDLRNVVEYLESLNFRE-KSIQD 517 (655)
T ss_pred ------------------------hhhhhhHHHHHHHHHHHhcCccc-ccHHH
Confidence 12347788889999999988886 57777
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.3e-09 Score=106.47 Aligned_cols=144 Identities=13% Similarity=0.111 Sum_probs=96.9
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEecccccCh---------hHHHHHHHHHHHHHhCCCCCc--ceeceeecCCCcCC
Q 044076 21 IIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV---------SDATRILREIKLLRMLKHPDI--VEIKHIMLPPCRRE 89 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~---------~~~~~~~rEi~iL~~l~HpnI--v~l~~v~~~~~~~~ 89 (506)
.+-......|.++. ..|+.|.||......... .-...+.+|...+..|..-+| ..++.+........
T Consensus 29 ~v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33333333455553 467789999764211000 001136788888888753332 23333332211111
Q ss_pred CCcEEEEEecCCC--CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-------CCCEEE
Q 044076 90 FKDIYVVFELMES--DLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-------DCKLKI 158 (506)
Q Consensus 90 ~~~~ylV~E~~~~--~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-------~~~lKL 158 (506)
....++|||++++ +|.+++.. ....+......++.+|+..+.-||.+||+|+|+++.|||++. +..+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 3567899999997 79888864 345667788899999999999999999999999999999975 467999
Q ss_pred eecCCccc
Q 044076 159 CDFGLARV 166 (506)
Q Consensus 159 ~DFGla~~ 166 (506)
+||+.++.
T Consensus 187 IDl~r~~~ 194 (268)
T PRK15123 187 IDLHRAQI 194 (268)
T ss_pred EECCcccc
Confidence 99998853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=3e-09 Score=101.70 Aligned_cols=138 Identities=21% Similarity=0.271 Sum_probs=97.1
Q ss_pred eEEEEEEEC---CCCcEEEEEEecccc-----cChhHHHHHHHHHHHHHhCCCC--CcceeceeecCCCcCCCCcEEEEE
Q 044076 28 GVVASAIDT---HTGEKVAIKKMKEVF-----EHVSDATRILREIKLLRMLKHP--DIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 28 g~V~~a~d~---~t~~~vAIK~i~~~~-----~~~~~~~~~~rEi~iL~~l~Hp--nIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
+.+|.+... ..++.+-+|...... .......+..+|...+..|..- .+.+.+.+....... ....|+|+
T Consensus 18 ~~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lit 96 (206)
T PF06293_consen 18 RGGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLIT 96 (206)
T ss_pred ceEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEE
Confidence 344444433 345566666542211 1112345677888888777532 233333433322111 24578999
Q ss_pred ecCCC--CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC---CEEEeecCCccc
Q 044076 98 ELMES--DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC---KLKICDFGLARV 166 (506)
Q Consensus 98 E~~~~--~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~---~lKL~DFGla~~ 166 (506)
|++++ +|.+++.....++......++.+++..++-||.+||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 97 e~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 97 EALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99986 7999998755578888899999999999999999999999999999999887 899999998865
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.4e-09 Score=100.62 Aligned_cols=125 Identities=30% Similarity=0.381 Sum_probs=82.3
Q ss_pred EEEEEEECCCCcEEEEEEeccc---c-------------c-------C-hhHHHHHHHHHHHHHhCCCC--Ccceeceee
Q 044076 29 VVASAIDTHTGEKVAIKKMKEV---F-------------E-------H-VSDATRILREIKLLRMLKHP--DIVEIKHIM 82 (506)
Q Consensus 29 ~V~~a~d~~t~~~vAIK~i~~~---~-------------~-------~-~~~~~~~~rEi~iL~~l~Hp--nIv~l~~v~ 82 (506)
.||.|.. ..|..+|+|+.+.. | . . ........+|.+.|..+..- ++.+++++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 3888876 57789999988521 1 0 0 11124467899999999754 56666654
Q ss_pred cCCCcCCCCcEEEEEecCC--C-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCeeecCCCCCcEEECCCCCEEE
Q 044076 83 LPPCRREFKDIYVVFELME--S-DLDQVIKANDDLTPEHHQFFLYQLLRALKY-IHSANVFHRDLKPKNILANADCKLKI 158 (506)
Q Consensus 83 ~~~~~~~~~~~ylV~E~~~--~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~y-LH~~gIvHrDLKp~NILv~~~~~lKL 158 (506)
..-+|||||++ | .+.. +... .++.+....++.+++..+.. +|.+||+|+||.+.||+++.+ .+.|
T Consensus 79 --------~~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --------NRNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --------ETTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE
T ss_pred --------eCCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEE
Confidence 23479999999 6 3333 2221 12255677788899996555 689999999999999999987 9999
Q ss_pred eecCCccc
Q 044076 159 CDFGLARV 166 (506)
Q Consensus 159 ~DFGla~~ 166 (506)
+|||.+..
T Consensus 148 IDf~qav~ 155 (188)
T PF01163_consen 148 IDFGQAVD 155 (188)
T ss_dssp --GTTEEE
T ss_pred EecCccee
Confidence 99999864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.2e-08 Score=94.01 Aligned_cols=142 Identities=18% Similarity=0.158 Sum_probs=103.9
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccc----ccChhHHHHHHHHHHHHHhCCCCC--cceeceeecCCCcCCCCcEEE
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEV----FEHVSDATRILREIKLLRMLKHPD--IVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~----~~~~~~~~~~~rEi~iL~~l~Hpn--Iv~l~~v~~~~~~~~~~~~yl 95 (506)
-|+||.|.|+... ..|..+-+|.-.+. .....-...+.+|+..|..|..-+ +.++. ++........-..+|
T Consensus 26 ~~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 3678999998874 34557888876421 111334556889999999986333 44333 221111122355789
Q ss_pred EEecCCC--CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC--EEEeecCCccc
Q 044076 96 VFELMES--DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK--LKICDFGLARV 166 (506)
Q Consensus 96 V~E~~~~--~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~--lKL~DFGla~~ 166 (506)
|+|-+++ +|.+++... .+.+......++.+|+..+.-||++|+.|+|+-+.||+++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998884 999988653 35678888999999999999999999999999999999987777 99999988864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.3e-08 Score=97.35 Aligned_cols=135 Identities=28% Similarity=0.319 Sum_probs=101.4
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc---c-------------cC----hhHHHHHHHHHHHHHhCCCC--
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV---F-------------EH----VSDATRILREIKLLRMLKHP-- 73 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~---~-------------~~----~~~~~~~~rEi~iL~~l~Hp-- 73 (506)
+.++..||-|--|.||.|.+. .|.++|||.=+.- | .+ ........+|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999874 7899999964310 0 00 11223466899999988643
Q ss_pred CcceeceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC
Q 044076 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA 152 (506)
Q Consensus 74 nIv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~ 152 (506)
.|.+.++. +...+|||+.+| .|..+ +++.+....++..|++-+.-+-..||||+|+.+-||++++
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 55554443 667899999998 33332 2345666777888888888878999999999999999999
Q ss_pred CCCEEEeecCCcc
Q 044076 153 DCKLKICDFGLAR 165 (506)
Q Consensus 153 ~~~lKL~DFGla~ 165 (506)
||.+.++||-.+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.3e-07 Score=87.51 Aligned_cols=143 Identities=17% Similarity=0.227 Sum_probs=89.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhH-H------HHHHHHHHHHHhCCCCC---cceeceee
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSD-A------TRILREIKLLRMLKHPD---IVEIKHIM 82 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~-~------~~~~rEi~iL~~l~Hpn---Iv~l~~v~ 82 (506)
.++|.+++++-.....-|.+. .-+|+.+++|..+........ . ....+++..+..+.... ...++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 678999999998887777776 457789999987542211110 0 11223444344443222 22222121
Q ss_pred cCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeec
Q 044076 83 LPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 83 ~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DF 161 (506)
.-...+--...++||||++| .|.++.. +++ .+.-.|.+++.-||+.|++|+|..|.|+++..+ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 11111112445689999998 5544322 333 234567788999999999999999999999854 5999999
Q ss_pred CCccc
Q 044076 162 GLARV 166 (506)
Q Consensus 162 Gla~~ 166 (506)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.8e-07 Score=91.96 Aligned_cols=259 Identities=15% Similarity=0.143 Sum_probs=158.3
Q ss_pred EeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCC----CcCCCCc
Q 044076 18 IQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPP----CRREFKD 92 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~----~~~~~~~ 92 (506)
....||+|+-+.+|-.- .-+. .+.|+....- .....+ -+..|... .||-+-. .+..+. ..+....
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d-~VAKIYh~Pp--pa~~aq---k~a~la~~p~~p~~~~--rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRD-QVAKIYHAPP--PAAQAQ---KVAELAATPDAPLLNY--RVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCccccCCccceeeecc--hhhc-hhheeecCCC--chHHHH---HHHHhccCCCCcchhh--hhcccHHHhhCCCccce
Confidence 46789999999998763 2222 3446664321 111111 12223333 3664432 111111 1122334
Q ss_pred EEEEEecCCC--CHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 93 IYVVFELMES--DLDQVIKA------NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 93 ~ylV~E~~~~--~L~~~i~~------~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
+-+.|+.+.| .++.+... .....+....++.+.|+.+.+.||.+|-+-+|+.++|+||.+++.+.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 7889998875 45554421 235778889999999999999999999999999999999999999999985443
Q ss_pred ccccCCCCCcccccccccCCcccCccccc-ccC--CCCCchhhhhhhhHHHHHHHhC-CCCCCCCCchhhHHHHHhhcCC
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQLDLVTDLLGT 240 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~-~~~--~~~s~~~DIWSlG~il~eLl~G-~~pF~~~~~~~~l~~I~~~~g~ 240 (506)
.+.. ........+|...|.+||.-. +.. ..-+...|.|.||+++++||.| +.||.|-.. ....
T Consensus 165 qi~~----ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~a 231 (637)
T COG4248 165 QINA----NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISDA 231 (637)
T ss_pred eecc----CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cCCC
Confidence 3321 222345678999999999853 211 2346689999999999999996 999987431 1111
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcC--CCCCCCHhh
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFD--PKDRPSAEE 300 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~D--P~~RpTa~e 300 (506)
|++-+. .|....+..--+.-+...+.|-+--|.-+++++.-|..+|+..- +.-|||++-
T Consensus 232 p~p~E~-~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 232 PNPLET-DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CCcchh-hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 211110 11111000000111122223333344457889999999998753 568999987
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.2e-07 Score=96.47 Aligned_cols=134 Identities=23% Similarity=0.306 Sum_probs=85.9
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccccC--------------------------------hhHHH------HHH
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH--------------------------------VSDAT------RIL 61 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~--------------------------------~~~~~------~~~ 61 (506)
+.|+.++-|+|++|+- .+|+.||||+.+.-... ....+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 7899999999999986 45999999988531100 00011 133
Q ss_pred HHHHHHHhCC----CCCcceeceeecCCCcCCCCcEEEEEecCCC-CHHHH--HHhCCCCC-----HHHHHHHHHHHHHH
Q 044076 62 REIKLLRMLK----HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQV--IKANDDLT-----PEHHQFFLYQLLRA 129 (506)
Q Consensus 62 rEi~iL~~l~----HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~--i~~~~~ls-----~~~~~~i~~QIl~g 129 (506)
+|..-+.+++ ...-+.+=.+|.+- -+.-.|+|||++| .+.++ ++. ..++ ..-++.++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~----t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~-- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY----TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL-- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc----cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH--
Confidence 4444444442 22222333444322 2456899999998 45444 344 2344 333344444444
Q ss_pred HHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 130 L~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..|++|.|..|.||+++.+|++.+.|||....
T Consensus 283 -----~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 283 -----RDGFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred -----hcCccccCCCccceEEecCCcEEEEcCcceec
Confidence 37999999999999999999999999999854
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.3e-06 Score=81.72 Aligned_cols=135 Identities=21% Similarity=0.204 Sum_probs=90.6
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccccChh-----------------HHHH-----HHHHHHHHHhCC--CCCc
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVS-----------------DATR-----ILREIKLLRMLK--HPDI 75 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~-----------------~~~~-----~~rEi~iL~~l~--HpnI 75 (506)
..|+.|--+.||.|.. .++..||+|+++.....-. ...+ ..+|..-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3555666778999864 5788999999864211100 0111 235666666664 3333
Q ss_pred ceeceeecCCCcCCCCcEEEEEecCCCCH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECC
Q 044076 76 VEIKHIMLPPCRREFKDIYVVFELMESDL--DQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANA 152 (506)
Q Consensus 76 v~l~~v~~~~~~~~~~~~ylV~E~~~~~L--~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~ 152 (506)
.+-+.+ .+-.|||||++... .-.++. -.+..++...+..++++.+.-|-. +|+||+||..=|||+.
T Consensus 133 P~Pi~~---------~~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 133 PEPIAF---------RNNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH- 201 (268)
T ss_pred CCceee---------cCCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence 333333 44589999998531 111111 134444788889999999999887 9999999999999999
Q ss_pred CCCEEEeecCCccc
Q 044076 153 DCKLKICDFGLARV 166 (506)
Q Consensus 153 ~~~lKL~DFGla~~ 166 (506)
++.+.|+|||.|..
T Consensus 202 ~~~p~iID~~QaV~ 215 (268)
T COG1718 202 DGEPYIIDVSQAVT 215 (268)
T ss_pred CCeEEEEECccccc
Confidence 88999999999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.2e-05 Score=78.11 Aligned_cols=133 Identities=16% Similarity=0.165 Sum_probs=78.2
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC--cceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD--IVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn--Iv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
..||.|..+.||+. .+..+++|..... .....+.+|.++++.+..-. +.+.+++. +..+..++||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeee
Confidence 57899999999984 2556778876531 23345789999998886332 34444444 2224568899
Q ss_pred ecCCCC--HHHHHH---------------------hC--CCCCHHH-HHHHHHH----------HHHH-HHHHH----hC
Q 044076 98 ELMESD--LDQVIK---------------------AN--DDLTPEH-HQFFLYQ----------LLRA-LKYIH----SA 136 (506)
Q Consensus 98 E~~~~~--L~~~i~---------------------~~--~~ls~~~-~~~i~~Q----------Il~g-L~yLH----~~ 136 (506)
|+++|. +...+. .- ....... ...+-.+ +... ..+|. ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999873 211110 00 0011000 0111001 1111 11222 12
Q ss_pred CeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 137 NVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 137 gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 478999999999999888 99999998854
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=2e-05 Score=75.30 Aligned_cols=140 Identities=21% Similarity=0.228 Sum_probs=80.1
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC--cceeceeecCCCcCCCCcEEEE
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD--IVEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn--Iv~l~~v~~~~~~~~~~~~ylV 96 (506)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.+.... +..++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5789999999999997644 58999987531 45667889999998886332 34444432111 222447999
Q ss_pred EecCCC-CHHH----------------HHH---hC--C--CCCHHH------HHHH---------------HHHHHH-HH
Q 044076 97 FELMES-DLDQ----------------VIK---AN--D--DLTPEH------HQFF---------------LYQLLR-AL 130 (506)
Q Consensus 97 ~E~~~~-~L~~----------------~i~---~~--~--~ls~~~------~~~i---------------~~QIl~-gL 130 (506)
|++++| .+.. .+. .. . .+.... ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999987 4444 111 11 0 011000 0000 111222 23
Q ss_pred HHHH-------hCCeeecCCCCCcEEEC-CCCCEEEeecCCccc
Q 044076 131 KYIH-------SANVFHRDLKPKNILAN-ADCKLKICDFGLARV 166 (506)
Q Consensus 131 ~yLH-------~~gIvHrDLKp~NILv~-~~~~lKL~DFGla~~ 166 (506)
..++ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3333 24599999999999999 667778999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.15 E-value=6.6e-06 Score=93.49 Aligned_cols=203 Identities=19% Similarity=0.205 Sum_probs=137.0
Q ss_pred HHHHHHHHHhCCCCCcceeceeecCCCcCCCC-cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 044076 60 ILREIKLLRMLKHPDIVEIKHIMLPPCRREFK-DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN 137 (506)
Q Consensus 60 ~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~-~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~g 137 (506)
..-|+..+..+.|+|++.++.+-+..-. .+ .+.+..+++.. ++...+..-+.++...++.+..++++||.|+|++.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~--~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLF--RGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhc--chHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3456777888899999999887654311 12 23344566765 88888888889999999999999999999999996
Q ss_pred eeecCCCCC---cEEECCCCCEEEe--ecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHH
Q 044076 138 VFHRDLKPK---NILANADCKLKIC--DFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 212 (506)
Q Consensus 138 IvHrDLKp~---NILv~~~~~lKL~--DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il 212 (506)
..|.-|... +--++..+...+. ||+..+........ .....+.-+.++|.............|+|.+|..+
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 665555444 3334455666666 88877653222211 22334556778888765222333347999999999
Q ss_pred HHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCH-HHHHHHHHhhhcC
Q 044076 213 AELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADP-LALRLLQRLLAFD 291 (506)
Q Consensus 213 ~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~dLI~~mL~~D 291 (506)
..+..|..+-.-. ..+. ...+..+. ...+++.+|+.-|
T Consensus 383 ~~~~~~~~i~~~~------~~~~-----------------------------------~~l~~~~~~~~~d~~~~~~~~~ 421 (1351)
T KOG1035|consen 383 LQLSQGEDISEKS------AVPV-----------------------------------SLLDVLSTSELLDALPKCLDED 421 (1351)
T ss_pred hhhhhcCcccccc------cchh-----------------------------------hhhccccchhhhhhhhhhcchh
Confidence 9998876432100 0000 00111221 6788999999999
Q ss_pred CCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 292 PKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 292 P~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
+++|+++.+ ++.|||.+.
T Consensus 422 ~~~Rl~~~~------------------ll~~~f~~~ 439 (1351)
T KOG1035|consen 422 SEERLSALE------------------LLTHPFLRF 439 (1351)
T ss_pred hhhccchhh------------------hhhchhccc
Confidence 999999999 788888764
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.1e-05 Score=74.24 Aligned_cols=130 Identities=19% Similarity=0.271 Sum_probs=91.8
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
-++.+.||+|.+|+||++. ..|..+|+|+-+. ++....+..|.++|..+.-.++.+=+-.+ +..++
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDFI 89 (201)
T ss_pred hhhhhhhhcccccEEEEee--ccCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhhh
Confidence 3456789999999999995 5677999998753 34455688999999999877666533333 44456
Q ss_pred EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC-CCcEEECCCCCEEEeecCCccc
Q 044076 96 VFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLK-PKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 96 V~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLK-p~NILv~~~~~lKL~DFGla~~ 166 (506)
+|||..| .|..+-... +..+ +..+++.---|-..||-|+.|. |..+++-.++.+-|+||..|+.
T Consensus 90 ~me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7999998 776654321 2333 3355566555778899999997 4444444455999999999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.1e-05 Score=74.12 Aligned_cols=135 Identities=15% Similarity=0.062 Sum_probs=77.3
Q ss_pred EEEeecCc-eEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSY-GVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~-g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
..|..|.+ +.||++.. .+..+.+|...... ...+.+|+.+++.+. +--+.++++.... .+..++||
T Consensus 4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~ 71 (244)
T cd05150 4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLT 71 (244)
T ss_pred eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEE
Confidence 34555655 78999954 34678888765321 335678999998885 3234444554421 24578999
Q ss_pred ecCCC-CHHHHH----------------HhCC-------CCCHH------HHHHH-------------------HHHHHH
Q 044076 98 ELMES-DLDQVI----------------KAND-------DLTPE------HHQFF-------------------LYQLLR 128 (506)
Q Consensus 98 E~~~~-~L~~~i----------------~~~~-------~ls~~------~~~~i-------------------~~QIl~ 128 (506)
|+++| +|.... ..-. .+... ..... ..++..
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 99987 333221 1000 11100 00000 111111
Q ss_pred HHHHH----HhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 129 ALKYI----HSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 129 gL~yL----H~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.|... ....++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 11111 123489999999999999987788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=4e-05 Score=82.53 Aligned_cols=138 Identities=27% Similarity=0.322 Sum_probs=83.8
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccccC-----------------------------hhHHHHHH------HHH
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH-----------------------------VSDATRIL------REI 64 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~-----------------------------~~~~~~~~------rEi 64 (506)
+.||.-+.|+|++|+-+ +|+.||||+-+..... .+-.+.+. +|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 68999999999999865 5999999987532211 01112222 233
Q ss_pred HHH----HhCCCCCc---ceeceeecCCCcCCCCcEEEEEecCCC----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-
Q 044076 65 KLL----RMLKHPDI---VEIKHIMLPPCRREFKDIYVVFELMES----DLDQVIKANDDLTPEHHQFFLYQLLRALKY- 132 (506)
Q Consensus 65 ~iL----~~l~HpnI---v~l~~v~~~~~~~~~~~~ylV~E~~~~----~L~~~i~~~~~ls~~~~~~i~~QIl~gL~y- 132 (506)
+-. +.+.|-+. |.+=.+|..- -..-.|+||||+| || +.|++.+ ++...+ +.-+.++...
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i---~~~l~~~~~~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDI---LNKLVEAYLEQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCH-HHHHHcC-CCHHHH---HHHHHHHHHHH
Confidence 222 22234441 1222333221 1456899999997 66 4445443 444433 2233333221
Q ss_pred HHhCCeeecCCCCCcEEECC----CCCEEEeecCCcccc
Q 044076 133 IHSANVFHRDLKPKNILANA----DCKLKICDFGLARVS 167 (506)
Q Consensus 133 LH~~gIvHrDLKp~NILv~~----~~~lKL~DFGla~~~ 167 (506)
|=..|++|.|-.|.||++.. ++.+.+-|||+....
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 23468999999999999984 678999999998653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.1e-07 Score=95.98 Aligned_cols=188 Identities=16% Similarity=0.110 Sum_probs=132.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC-cceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD-IVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn-Iv~l~~v~~~~~~~~~~ 91 (506)
...|...+-+++|+++.+++.+...+...+ .+.+... ....-++.+|.+++||| .+..++ +.+.+.
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~ 307 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGED 307 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCccc
Confidence 445667778899999999999887776665 7766421 23445888999999999 332222 225557
Q ss_pred cEEEEEecCCCC--HHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELMESD--LDQVI-KANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~~~--L~~~i-~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..+++++++.+. ..... .+.-.+.+-....+.+.-+++|++||+.-=+|+| ||+..+ +..|..||+......
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC
Confidence 889999999753 11111 1111244445566777778899999998778998 766654 788999999886543
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG 224 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~ 224 (506)
... ......+|+.++|||+... ..+....|.|++|.-..+|--|-+|-..
T Consensus 383 ~~~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 383 RTM----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccc----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCC
Confidence 221 1245679999999999877 7888899999999877777777776533
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.97 E-value=4.1e-05 Score=72.46 Aligned_cols=132 Identities=27% Similarity=0.338 Sum_probs=92.3
Q ss_pred CCEEEeEEEeecCc-eEEEEEEECCCCcEEEEEEeccc-----------cc-Ch-------hHHHHHHHHHHHHHhCC--
Q 044076 14 SQYEIQEIIGIGSY-GVVASAIDTHTGEKVAIKKMKEV-----------FE-HV-------SDATRILREIKLLRMLK-- 71 (506)
Q Consensus 14 ~rY~i~~~LG~G~~-g~V~~a~d~~t~~~vAIK~i~~~-----------~~-~~-------~~~~~~~rEi~iL~~l~-- 71 (506)
..++.++.||.|.- |.||++. -.|+.||+|.++.- +. .. ....-+..|.+..-+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 9999995 57889999994210 00 00 12234667777766664
Q ss_pred -CCCc--ceeceeecCCCc-------------CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 044076 72 -HPDI--VEIKHIMLPPCR-------------REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135 (506)
Q Consensus 72 -HpnI--v~l~~v~~~~~~-------------~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~ 135 (506)
+.++ +++++++.-... .......||.||....- .++... +.+|++-|..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHHH
Confidence 4566 888887743310 11123468889887532 222222 4588888999999
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
.||+-+|+++.|.. + =||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---C--CEEEecccC
Confidence 99999999999986 2 389999975
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00013 Score=83.94 Aligned_cols=83 Identities=17% Similarity=0.235 Sum_probs=54.8
Q ss_pred EeEEEeecCceEEEEEEECCCC--cEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCc--ceeceeecCCCcCCCCc
Q 044076 18 IQEIIGIGSYGVVASAIDTHTG--EKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDI--VEIKHIMLPPCRREFKD 92 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~t~--~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnI--v~l~~v~~~~~~~~~~~ 92 (506)
-++.++.|.++.+|+......+ ..+++|+.... ........+.+|.++|+.+. |.+| .+++.++.+. ...+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~-~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPG-KLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCC-ccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3678899999999998754332 46778875321 11123456789999999996 6664 5555554332 22356
Q ss_pred EEEEEecCCCC
Q 044076 93 IYVVFELMESD 103 (506)
Q Consensus 93 ~ylV~E~~~~~ 103 (506)
.|+||||++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 78999999873
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00021 Score=69.53 Aligned_cols=31 Identities=35% Similarity=0.503 Sum_probs=26.0
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+++|+|+.+.||+++.++..-|+||+.|..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4589999999999998665567999998854
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00077 Score=65.24 Aligned_cols=72 Identities=10% Similarity=0.162 Sum_probs=44.5
Q ss_pred eEEEeecCceEEEEEEECC-CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCc-ceeceeecCCCcCCCCcEEEE
Q 044076 19 QEIIGIGSYGVVASAIDTH-TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI-VEIKHIMLPPCRREFKDIYVV 96 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~-t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnI-v~l~~v~~~~~~~~~~~~ylV 96 (506)
++.|..|-...||++.... .++.|++|+....... .....+|+.+++.+....+ .+++... + -.+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~----~~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATF-----Q----NGLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEe-----C----CcEE
Confidence 4678888889999996432 3578889976432111 1123478989988863333 3333322 1 1379
Q ss_pred EecCCC
Q 044076 97 FELMES 102 (506)
Q Consensus 97 ~E~~~~ 102 (506)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00023 Score=75.14 Aligned_cols=167 Identities=26% Similarity=0.395 Sum_probs=111.2
Q ss_pred HHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 044076 56 DATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135 (506)
Q Consensus 56 ~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~ 135 (506)
....++-...+++.+.|+|....+++-... .....+|+|+++.+|.++++.+. +-.. +++ .
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~----~~r~IVV~e~~~~Sled~~~~~~-l~~~-------s~~-------~ 85 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGK----HERVIVVMEHYTMSLEDILKTGN-LKDE-------SLL-------A 85 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCc----cceEEEEehhhccchHHHHHhcc-cchh-------hhc-------c
Confidence 345577788899999999999988886443 24489999999999999988654 2111 111 2
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHH
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 215 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eL 215 (506)
+|+.|- | .++++| -++ +. | | ....+++||||+|.|+.++
T Consensus 86 ~~~~~~-----~-------~~~~td-~~~-------------t~------~--~-------~~~~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 86 HGVLHL-----N-------IIYITD-HFL-------------TK------Y--P-------SPIGPKSDVWSLGFIILEL 124 (725)
T ss_pred ccccee-----h-------hhhccc-ccc-------------cc------C--C-------CCCCcchhhhhHHHHHHHH
Confidence 222222 1 223333 000 00 0 1 1222599999999999999
Q ss_pred HhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 044076 216 LTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR 295 (506)
Q Consensus 216 l~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R 295 (506)
..|..+++.....+++..|.+..-.+.....-.... ..+ -.++....+++.+|+...|..|
T Consensus 125 ~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~---~~~----------------~~~d~~~~~~~~~c~~~~~~ir 185 (725)
T KOG1093|consen 125 YLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH---LIQ----------------LLADKKRLPLLKKCLWLEPIIR 185 (725)
T ss_pred HHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH---HHH----------------HhhhHhHHHHhccCCccccccc
Confidence 999999988888888888876655543332211111 000 1256678999999999999999
Q ss_pred CCHhhh
Q 044076 296 PSAEEI 301 (506)
Q Consensus 296 pTa~eL 301 (506)
|...++
T Consensus 186 ~l~~~~ 191 (725)
T KOG1093|consen 186 PLPMEL 191 (725)
T ss_pred cchhHH
Confidence 999993
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0011 Score=63.02 Aligned_cols=128 Identities=21% Similarity=0.281 Sum_probs=88.9
Q ss_pred EEEeecCceEEEEEEECCCCcEEEEEEecccc--------------cChhHHHHHHHHHHHHHhCC------CCCcceec
Q 044076 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF--------------EHVSDATRILREIKLLRMLK------HPDIVEIK 79 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~--------------~~~~~~~~~~rEi~iL~~l~------HpnIv~l~ 79 (506)
..||+|+.=.||.- . ......||++.... ..........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57899999998876 3 33446789886432 11123456677887776665 77888999
Q ss_pred eeecCCCcCCCCcEEEEEecCC---C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC
Q 044076 80 HIMLPPCRREFKDIYVVFELME---S----DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA 152 (506)
Q Consensus 80 ~v~~~~~~~~~~~~ylV~E~~~---~----~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~ 152 (506)
++.... ....+|+|.+. | +|.++++.. .+++ .+. ..+-+-.+||-+++|+.+||+|.||++..
T Consensus 84 G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETN-----LGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecC-----CceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 988543 55678888762 2 789988654 4666 333 33444457889999999999999999864
Q ss_pred C--C--CEEEee
Q 044076 153 D--C--KLKICD 160 (506)
Q Consensus 153 ~--~--~lKL~D 160 (506)
+ + .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 3 2 578887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0031 Score=66.27 Aligned_cols=77 Identities=21% Similarity=0.176 Sum_probs=53.2
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccc----c-ChhHHHHHHHHHHHHHhCC---CCCcceeceeecCCCcCCC
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF----E-HVSDATRILREIKLLRMLK---HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~----~-~~~~~~~~~rEi~iL~~l~---HpnIv~l~~v~~~~~~~~~ 90 (506)
.+.||.|.+..||++.+...++.|+||.-.... . ......+...|...|+.+. ..++.+++++- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-------~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-------E 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-------C
Confidence 467999999999999986444689999753111 1 1234567778888888874 24566666652 2
Q ss_pred CcEEEEEecCCC
Q 044076 91 KDIYVVFELMES 102 (506)
Q Consensus 91 ~~~ylV~E~~~~ 102 (506)
...++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 457899999874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0032 Score=63.69 Aligned_cols=79 Identities=14% Similarity=0.074 Sum_probs=52.2
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCC---CCcceeceeecCCCcCCCCc
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH---PDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~H---pnIv~l~~v~~~~~~~~~~~ 92 (506)
-.-.+.||.|..+.||...+ .+..+.+|..+. ......+.+|...|+.|.- -.|.++++++... ...+.
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~ 87 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD--SQGNPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGP 87 (297)
T ss_pred hheeeecCCccceeEEEEEc--CCCCEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCC
Confidence 34467899999999999853 223566776432 1123467889999988853 2456666554322 22356
Q ss_pred EEEEEecCCC
Q 044076 93 IYVVFELMES 102 (506)
Q Consensus 93 ~ylV~E~~~~ 102 (506)
.|+|||+++|
T Consensus 88 ~~LVmE~i~G 97 (297)
T PRK10593 88 DVLLLERLRG 97 (297)
T ss_pred eEEEEeccCC
Confidence 8999999885
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0012 Score=66.81 Aligned_cols=152 Identities=16% Similarity=0.126 Sum_probs=84.5
Q ss_pred ccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC--cceeceeecC
Q 044076 7 FTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD--IVEIKHIMLP 84 (506)
Q Consensus 7 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn--Iv~l~~v~~~ 84 (506)
+..|+. +....++.++.|....+|++.. .+ ..+++|+.... .....+..|+.+++.|.... +.+++.....
T Consensus 16 l~~y~~-~~~~~i~~~~~G~~n~~y~v~t-~~-~~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g 88 (307)
T TIGR00938 16 LDGYDL-GELLSLKGIAEGVENSNYLLTT-DV-GRYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVKSRDG 88 (307)
T ss_pred HHhcCC-CCceeccccCCccccceEEEEe-CC-CcEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCC
Confidence 334443 3455577788888889998853 33 46778876431 12334567888888875322 3333221100
Q ss_pred C-CcCCCCcEEEEEecCCC-C-----HH------HHH----HhCCCC--------CHHH-----HH----------HHHH
Q 044076 85 P-CRREFKDIYVVFELMES-D-----LD------QVI----KANDDL--------TPEH-----HQ----------FFLY 124 (506)
Q Consensus 85 ~-~~~~~~~~ylV~E~~~~-~-----L~------~~i----~~~~~l--------s~~~-----~~----------~i~~ 124 (506)
. .....+..++|++|++| . .. ..+ .....+ .... .. ....
T Consensus 89 ~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~ 168 (307)
T TIGR00938 89 RQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGA 168 (307)
T ss_pred CeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHH
Confidence 0 00123567899999876 1 11 111 000111 0010 00 0011
Q ss_pred HHHHHHHHHH-------hCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 125 QLLRALKYIH-------SANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 125 QIl~gL~yLH-------~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.+...++++. ..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 169 ~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 169 ELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2233455553 2589999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00015 Score=72.71 Aligned_cols=135 Identities=20% Similarity=0.282 Sum_probs=94.3
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecc---cccChh-----------------HHHHHHHHHHHHHhCC-CC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKE---VFEHVS-----------------DATRILREIKLLRMLK-HP 73 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~---~~~~~~-----------------~~~~~~rEi~iL~~l~-Hp 73 (506)
-|.++.+||-|--+.||.+-+ ..|++.++|.-+- .|.+.. ..-...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 467889999999999999976 5688888885321 010000 1122457888888775 32
Q ss_pred C-cceeceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC
Q 044076 74 D-IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151 (506)
Q Consensus 74 n-Iv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~ 151 (506)
. |.+.+ +....++|||++.| .|.++..- .....+...+..-+.-|-.+|+||+|..-=||++.
T Consensus 172 fpVPkpi---------D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPI---------DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCcc---------cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 2 22222 23678999999987 56554321 12334555666667789999999999999999999
Q ss_pred CCCCEEEeecCCcc
Q 044076 152 ADCKLKICDFGLAR 165 (506)
Q Consensus 152 ~~~~lKL~DFGla~ 165 (506)
+++.++++||-...
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997664
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0027 Score=64.59 Aligned_cols=30 Identities=33% Similarity=0.352 Sum_probs=26.0
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.|+||+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999866556899999884
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0011 Score=65.23 Aligned_cols=132 Identities=17% Similarity=0.237 Sum_probs=73.8
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcc-eeceeecCCCcCCCCcEEEEEec
Q 044076 21 IIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV-EIKHIMLPPCRREFKDIYVVFEL 99 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv-~l~~v~~~~~~~~~~~~ylV~E~ 99 (506)
.+..|-.+.+|+.. .++..+++|......... .....+|..+++.+..-.+. +++... .-++|+||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~---------~~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN---------EHWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe---------CCEEEEEe
Confidence 34568888999885 456788888754311111 01245788899888643332 222221 12689999
Q ss_pred CCC-CH--------------HHHHHh---C----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCee
Q 044076 100 MES-DL--------------DQVIKA---N----DDLTP-EHHQFFLYQL---------LRALKYIHS--------ANVF 139 (506)
Q Consensus 100 ~~~-~L--------------~~~i~~---~----~~ls~-~~~~~i~~QI---------l~gL~yLH~--------~gIv 139 (506)
++| .+ .+.+.+ . .+++. ..+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 886 21 111111 0 01121 1222222222 111222211 2589
Q ss_pred ecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 140 HRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 140 HrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
|+|+.|.||+++.++ +.|+||+.|..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999877 78999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0018 Score=65.24 Aligned_cols=29 Identities=38% Similarity=0.416 Sum_probs=26.4
Q ss_pred CeeecCCCCCcEEECCC----CCEEEeecCCcc
Q 044076 137 NVFHRDLKPKNILANAD----CKLKICDFGLAR 165 (506)
Q Consensus 137 gIvHrDLKp~NILv~~~----~~lKL~DFGla~ 165 (506)
.++|+|+.+.||+++.+ +.+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999985 889999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0017 Score=65.25 Aligned_cols=149 Identities=16% Similarity=0.088 Sum_probs=84.2
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC--cceeceeecCC
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD--IVEIKHIMLPP 85 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn--Iv~l~~v~~~~ 85 (506)
..|+. ....-++.|..|....+|+... .+..+++|+... .....+..|+.+++.+.+-. +.+++... ..
T Consensus 9 ~~y~~-~~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~g 79 (296)
T cd05153 9 ADYDL-GELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADR-DG 79 (296)
T ss_pred HHcCC-CchhheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCC-CC
Confidence 34443 2333366787888889999853 345788898753 23345778888888885332 33332210 00
Q ss_pred C--cCCCCcEEEEEecCCC-CH--------HHH---HH----hCCCCC--------HHHH----H--------HHHHHHH
Q 044076 86 C--RREFKDIYVVFELMES-DL--------DQV---IK----ANDDLT--------PEHH----Q--------FFLYQLL 127 (506)
Q Consensus 86 ~--~~~~~~~ylV~E~~~~-~L--------~~~---i~----~~~~ls--------~~~~----~--------~i~~QIl 127 (506)
. ....+..++|+++++| .+ .++ +. ....+. .... . .....+.
T Consensus 80 ~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 159 (296)
T cd05153 80 EYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLA 159 (296)
T ss_pred cEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHH
Confidence 0 0122457899999976 21 111 10 000000 0000 0 0111223
Q ss_pred HHHHHHHh-------CCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 128 RALKYIHS-------ANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 128 ~gL~yLH~-------~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.++.++.. .+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 160 DELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 33444443 479999999999999998778999999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0017 Score=61.24 Aligned_cols=97 Identities=22% Similarity=0.223 Sum_probs=76.7
Q ss_pred HHHHHHHHhCCC-CCcceeceeecCCCcCCCCcEEEEEecCC-CCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 044076 61 LREIKLLRMLKH-PDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQV---IKANDDLTPEHHQFFLYQLLRALKYIHS 135 (506)
Q Consensus 61 ~rEi~iL~~l~H-pnIv~l~~v~~~~~~~~~~~~ylV~E~~~-~~L~~~---i~~~~~ls~~~~~~i~~QIl~gL~yLH~ 135 (506)
..|.-+|+.+++ +++.++++.+ ++ ++|.||.+ ++++.. +..--.-++.....++.++++.+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--------G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--------GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--------CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358889999985 6899999987 44 45778887 344321 1111236788999999999999999997
Q ss_pred ---CCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 136 ---ANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 136 ---~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..+.-.|++|+|+-+++++++|++|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 4588899999999999999999999988754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00011 Score=85.61 Aligned_cols=155 Identities=19% Similarity=0.141 Sum_probs=114.7
Q ss_pred HHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH
Q 044076 60 ILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKAN----DDLTPEHHQFFLYQLLRALKYIH 134 (506)
Q Consensus 60 ~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~-~~L~~~i~~~----~~ls~~~~~~i~~QIl~gL~yLH 134 (506)
.+.|...++...|+++.....-..+. +....|.+++|+. |++..+|.++ +++...-+-....+.+.+..-+|
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 33454555667899987765544332 3356789999987 6899888654 24555555555555577777777
Q ss_pred hCC-----eeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhh
Q 044076 135 SAN-----VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 209 (506)
Q Consensus 135 ~~g-----IvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG 209 (506)
+.. .+|++||+-|.++..+-.+|++++|+.++. .+...+....++++.|++|++... -.++.++|+|..|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk---np~~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK---NPVLSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRS 1427 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCccccccccccccc---CchHhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHH
Confidence 542 699999999999999999999999999842 222223345678889999999877 6788889999999
Q ss_pred HHHHHHHhCCCCC
Q 044076 210 CIFAELLTGRPLF 222 (506)
Q Consensus 210 ~il~eLl~G~~pF 222 (506)
|-+|++--|.++|
T Consensus 1428 ~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHhcccHHH
Confidence 9999998888777
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0041 Score=63.65 Aligned_cols=140 Identities=25% Similarity=0.302 Sum_probs=94.3
Q ss_pred EEeEEEeecCceEEEEEEECCCCcEEEEEEeccc---ccC-------------------hhHHHH--HHHHHHHHHhCCC
Q 044076 17 EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV---FEH-------------------VSDATR--ILREIKLLRMLKH 72 (506)
Q Consensus 17 ~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~---~~~-------------------~~~~~~--~~rEi~iL~~l~H 72 (506)
.|-..|..|--+-||.|. ..+|..+|||+++.. |.+ ....-+ ...|++-|.+|..
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 345677788889999997 467888999998632 111 111111 2257777777755
Q ss_pred CCcceeceeecCCCcCCCCcEEEEEecCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCCCcEEE
Q 044076 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQV-IKANDDLTPEHHQFFLYQLLRALKYIH-SANVFHRDLKPKNILA 150 (506)
Q Consensus 73 pnIv~l~~v~~~~~~~~~~~~ylV~E~~~~~L~~~-i~~~~~ls~~~~~~i~~QIl~gL~yLH-~~gIvHrDLKp~NILv 150 (506)
-.|....-+.+ ....|||++++.+=+.. ....-.++...+..+-.|++.-+.-|. .+++||.||.--|+|+
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY 298 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence 44433222222 34579999998532111 112335788888888888888887765 6899999999999998
Q ss_pred CCCCCEEEeecCCcc
Q 044076 151 NADCKLKICDFGLAR 165 (506)
Q Consensus 151 ~~~~~lKL~DFGla~ 165 (506)
. +|.+.|+|-+.+.
T Consensus 299 h-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 299 H-DGKLYIIDVSQSV 312 (520)
T ss_pred E-CCEEEEEEccccc
Confidence 5 6789999998874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.022 Score=57.51 Aligned_cols=29 Identities=24% Similarity=0.377 Sum_probs=25.8
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 678999998774
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.02 Score=57.27 Aligned_cols=30 Identities=33% Similarity=0.570 Sum_probs=25.7
Q ss_pred CeeecCCCCCcEEECCCCC-EEEeecCCccc
Q 044076 137 NVFHRDLKPKNILANADCK-LKICDFGLARV 166 (506)
Q Consensus 137 gIvHrDLKp~NILv~~~~~-lKL~DFGla~~ 166 (506)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997566 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.025 Score=58.49 Aligned_cols=81 Identities=17% Similarity=0.068 Sum_probs=52.9
Q ss_pred EEeecCceEEEEEEECCCCcEEEEEEecc----cc-cChhHHHHHHHHHHHHHhCC--CC-CcceeceeecCCCcCCCCc
Q 044076 21 IIGIGSYGVVASAIDTHTGEKVAIKKMKE----VF-EHVSDATRILREIKLLRMLK--HP-DIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 21 ~LG~G~~g~V~~a~d~~t~~~vAIK~i~~----~~-~~~~~~~~~~rEi~iL~~l~--Hp-nIv~l~~v~~~~~~~~~~~ 92 (506)
.||.|....||++.+...++.|+||--.. .. .......+...|...|+... -| .+.+++++- ...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------ccc
Confidence 47999999999999754446899996521 11 22445667778888888774 34 455555542 245
Q ss_pred EEEEEecCCC--CHHHHH
Q 044076 93 IYVVFELMES--DLDQVI 108 (506)
Q Consensus 93 ~ylV~E~~~~--~L~~~i 108 (506)
..+|||+++. .|.+.+
T Consensus 75 ~~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGL 92 (370)
T ss_pred ceehHhhCccchHHHHHH
Confidence 5799999863 444444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.038 Score=57.07 Aligned_cols=138 Identities=16% Similarity=0.094 Sum_probs=75.8
Q ss_pred EEEeEEEeecCceEEEEEEECC----CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcc-eeceeecCCCcCCC
Q 044076 16 YEIQEIIGIGSYGVVASAIDTH----TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV-EIKHIMLPPCRREF 90 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~----t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv-~l~~v~~~~~~~~~ 90 (506)
..-+..|-.|-...+|++.... .++.|++|+...... .... -.+|..+++.+..-++. ++++.+. +
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~id-R~~E~~~~~~l~~~gl~P~~~~~~~-----~- 108 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFD-RDDEIRTFECMSRHGQGPRLLGRFP-----N- 108 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeec-hHHHHHHHHHHHHcCCCCceEEEEC-----C-
Confidence 3344566568888999986322 346899998754221 1122 24788888888633332 3344431 1
Q ss_pred CcEEEEEecCCC-CHH-----------HH---HHh---CC------CCCHHHHHHHHHHHH-----------------HH
Q 044076 91 KDIYVVFELMES-DLD-----------QV---IKA---ND------DLTPEHHQFFLYQLL-----------------RA 129 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~-----------~~---i~~---~~------~ls~~~~~~i~~QIl-----------------~g 129 (506)
..|.+|+++ +|. .+ +++ .. ......+..++.++. ..
T Consensus 109 ---g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~ 185 (344)
T PLN02236 109 ---GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE 185 (344)
T ss_pred ---ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence 157787764 221 11 110 00 011223333332221 11
Q ss_pred HHH----HH----hCCeeecCCCCCcEEECC-CCCEEEeecCCcc
Q 044076 130 LKY----IH----SANVFHRDLKPKNILANA-DCKLKICDFGLAR 165 (506)
Q Consensus 130 L~y----LH----~~gIvHrDLKp~NILv~~-~~~lKL~DFGla~ 165 (506)
+.. +. ...++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111 11 235899999999999986 5789999998874
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.024 Score=59.36 Aligned_cols=83 Identities=19% Similarity=0.174 Sum_probs=55.7
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecc---cc-cChhHHHHHHHHHHHHHhCC--CC-CcceeceeecCCCcCCCC
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKE---VF-EHVSDATRILREIKLLRMLK--HP-DIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~---~~-~~~~~~~~~~rEi~iL~~l~--Hp-nIv~l~~v~~~~~~~~~~ 91 (506)
.+.||.|.-.-||++.+...++.|+||--.. .. ...-...+...|..+|+... -| .+.+++++- ..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence 6788999999999998744456799986421 11 23456778888999998874 34 455555542 24
Q ss_pred cEEEEEecCCC--CHHHHH
Q 044076 92 DIYVVFELMES--DLDQVI 108 (506)
Q Consensus 92 ~~ylV~E~~~~--~L~~~i 108 (506)
...+|||+++. .|.+.+
T Consensus 107 ~~~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 107 MNCCVMEDLSDHTILRTAL 125 (409)
T ss_pred HhhHHHHhCcccHHHHHHH
Confidence 56789998863 344444
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.047 Score=55.40 Aligned_cols=30 Identities=17% Similarity=0.135 Sum_probs=27.9
Q ss_pred CeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 137 NVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 137 gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
++||+|+.+.|+|++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998854
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.078 Score=54.00 Aligned_cols=146 Identities=20% Similarity=0.252 Sum_probs=82.2
Q ss_pred EEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC-CcEEE
Q 044076 17 EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF-KDIYV 95 (506)
Q Consensus 17 ~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~-~~~yl 95 (506)
.+++.+..|....+|...+. ++.+++. ..........+....+|..+|+.+.---|-.-..+.. |.++. +..|.
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~--~~~~~~g~pf~ 102 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGL--CGEGYLGTPFY 102 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccc--cccCCCCCceE
Confidence 34555544545566666543 7788888 3322233455666778888888774322221112211 11222 56799
Q ss_pred EEecCCC-------------------CHHHHHHhC--------------CCCCHHHHHHHHHHH--------------HH
Q 044076 96 VFELMES-------------------DLDQVIKAN--------------DDLTPEHHQFFLYQL--------------LR 128 (506)
Q Consensus 96 V~E~~~~-------------------~L~~~i~~~--------------~~ls~~~~~~i~~QI--------------l~ 128 (506)
||++++| +|.+++..- +.....++..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 9999876 111122110 001122222222222 22
Q ss_pred HHHHHHhC--------CeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 129 ALKYIHSA--------NVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 129 gL~yLH~~--------gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
-..+|+.+ .++|+|+.+.||+++.++.+-|.||+++.+.
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 23444433 4899999999999999988999999999763
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.044 Score=56.27 Aligned_cols=28 Identities=32% Similarity=0.464 Sum_probs=25.0
Q ss_pred eeecCCCCCcEEECC-CCCEEEeecCCcc
Q 044076 138 VFHRDLKPKNILANA-DCKLKICDFGLAR 165 (506)
Q Consensus 138 IvHrDLKp~NILv~~-~~~lKL~DFGla~ 165 (506)
++|.|+.+.|||+++ ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999999884
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.15 Score=53.73 Aligned_cols=76 Identities=16% Similarity=0.140 Sum_probs=50.2
Q ss_pred EeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-----ChhHHHHHHHHHHHHHhCC---CCCcceeceeecCCCcCC
Q 044076 18 IQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-----HVSDATRILREIKLLRMLK---HPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-----~~~~~~~~~rEi~iL~~l~---HpnIv~l~~v~~~~~~~~ 89 (506)
..+.||.|....||+..+ .+..|+||.-..... ......+...|...|+.+. ..++.+++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------ 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------ 107 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence 467889999999999976 345688987531111 1124555667777777664 246666776641
Q ss_pred CCcEEEEEecCCC
Q 044076 90 FKDIYVVFELMES 102 (506)
Q Consensus 90 ~~~~ylV~E~~~~ 102 (506)
+..++|||++++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 446788999965
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.35 Score=50.72 Aligned_cols=29 Identities=31% Similarity=0.287 Sum_probs=24.2
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
...+|.|+-+.||+.+. +.+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 45799999999999754 569999998774
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.3 Score=49.14 Aligned_cols=75 Identities=16% Similarity=0.099 Sum_probs=43.5
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC--C-CCcceeceeecCCCcCCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK--H-PDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~--H-pnIv~l~~v~~~~~~~~~~ 91 (506)
.-+-.+.++.|....+|+.. .+++.+.+|+-.. .....+..|..-|+.|. . -.+.+++.+... .+
T Consensus 18 ~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-----~~ 85 (288)
T PF03881_consen 18 KITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-----DD 85 (288)
T ss_dssp ---EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE------SS
T ss_pred ceeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-----cC
Confidence 34557789999999999986 6788899998652 23344667888887774 2 234455555422 23
Q ss_pred cEEEEEecCC
Q 044076 92 DIYVVFELME 101 (506)
Q Consensus 92 ~~ylV~E~~~ 101 (506)
.-|||+||++
T Consensus 86 ~~fLlle~l~ 95 (288)
T PF03881_consen 86 DAFLLLEFLE 95 (288)
T ss_dssp CCEEEEE---
T ss_pred CceEEEEeec
Confidence 4599999986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.39 Score=56.80 Aligned_cols=31 Identities=42% Similarity=0.574 Sum_probs=26.7
Q ss_pred CCeeecCCCCCcEEECCCC--CEE-EeecCCccc
Q 044076 136 ANVFHRDLKPKNILANADC--KLK-ICDFGLARV 166 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~--~lK-L~DFGla~~ 166 (506)
.++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999875 565 999999854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.21 Score=48.09 Aligned_cols=99 Identities=18% Similarity=0.264 Sum_probs=63.9
Q ss_pred EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEEecCCC---CHHHHHHhCCCCCHH
Q 044076 41 KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES---DLDQVIKANDDLTPE 117 (506)
Q Consensus 41 ~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~---~L~~~i~~~~~ls~~ 117 (506)
...+||+...--.. ...-+.++.+++.++. .|++|.. ++...+-++.|.|-. ....++
T Consensus 87 ~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~~~N~i--------- 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKINFSNFI--------- 147 (308)
T ss_pred hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccchhHHH---------
Confidence 45667775321111 2233467788887763 3666652 234567799998863 111111
Q ss_pred HHHHHHHHHHHHHHHHHh--CCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 118 HHQFFLYQLLRALKYIHS--ANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 118 ~~~~i~~QIl~gL~yLH~--~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
..=+.+|.-.|+ .+.+|||..|+||+-++.|-+||.|-+.-
T Consensus 148 ------~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 148 ------TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ------HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 122456777884 46999999999999999999999997643
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.00 E-value=0.54 Score=48.13 Aligned_cols=28 Identities=36% Similarity=0.387 Sum_probs=24.1
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4789999999999995 4 57899999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.12 Score=53.28 Aligned_cols=73 Identities=23% Similarity=0.388 Sum_probs=58.0
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
+..+.|++|++-++.|.-. + ....+++..|+.+.+..++-+... ..-|||+...|||++ +|++-|+||-++|.
T Consensus 297 e~~y~yl~~kdhgt~is~i-k---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII-K---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecCCceeeee-e---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3466889999888765422 2 234677888888888887777754 589999999999999 99999999999985
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.10 E-value=0.41 Score=50.09 Aligned_cols=62 Identities=19% Similarity=0.177 Sum_probs=43.9
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCCCcEEECCC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH-SANVFHRDLKPKNILANAD 153 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH-~~gIvHrDLKp~NILv~~~ 153 (506)
.+..+|-+|+.| ++..+++.. ..++..++.+..-...||--|- --|.+|.|+.|.||++..+
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ccceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 344566678887 777777643 4556667777777777765544 5689999999999998543
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.82 E-value=1 Score=48.19 Aligned_cols=28 Identities=32% Similarity=0.665 Sum_probs=23.7
Q ss_pred CeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 137 NVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 137 gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.++|.|+-+.|||...++ ++|+||..|.
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeecccc
Confidence 479999999999886544 9999998774
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.44 E-value=0.22 Score=49.60 Aligned_cols=48 Identities=29% Similarity=0.331 Sum_probs=37.4
Q ss_pred HHHHHHHHHHHHHHHHhC--CeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 119 HQFFLYQLLRALKYIHSA--NVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 119 ~~~i~~QIl~gL~yLH~~--gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
++..+..+-.++.-.+.. -++|+|+.|+|++.++.+.++|+||..|..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344555555555555544 589999999999999999999999998854
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.37 E-value=0.58 Score=47.70 Aligned_cols=61 Identities=25% Similarity=0.283 Sum_probs=39.7
Q ss_pred EEEEEecCCCC-----HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCCCcEEECCC
Q 044076 93 IYVVFELMESD-----LDQVIKANDDLTPEHHQFFLYQLLRALKYIH----SANVFHRDLKPKNILANAD 153 (506)
Q Consensus 93 ~ylV~E~~~~~-----L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH----~~gIvHrDLKp~NILv~~~ 153 (506)
-.+|++++-++ +.....-+-.--.+-++.++.||+.-.-.+. -.+.+|-||||+|||+-+.
T Consensus 250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 46888887642 3333222212234567889999987664443 3479999999999997543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 506 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-79 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-79 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-73 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-73 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-73 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-73 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-73 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-73 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-73 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-73 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-73 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-73 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-73 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-73 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-72 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-72 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-71 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-71 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-71 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-71 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-71 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-71 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-71 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-70 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-70 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-69 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-69 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-69 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-69 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-69 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-69 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-69 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-69 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-69 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-69 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-69 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-69 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-69 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-69 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-69 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-69 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-69 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-69 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-69 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-69 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-69 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-69 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-68 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-68 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-68 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-68 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-68 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-68 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-68 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-68 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-68 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-68 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-68 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-68 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-68 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-68 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-68 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-68 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-68 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-68 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-68 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-68 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-68 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-68 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-68 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-68 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-68 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-68 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-68 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-68 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-68 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-68 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-68 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-68 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-67 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-67 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-67 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-67 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-67 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-67 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-67 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-66 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-65 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-64 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-62 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-62 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-59 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-59 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-58 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-57 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-55 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-49 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-48 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-48 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-48 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-47 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-47 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-47 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-47 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-47 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-47 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-47 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-47 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-47 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-47 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-46 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-46 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-46 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-46 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-46 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-46 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-46 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-46 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-46 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-46 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-46 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-46 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-46 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-46 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-46 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-46 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-46 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-45 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-45 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-45 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-45 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-44 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-44 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-43 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-43 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-41 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-40 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-39 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-39 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-39 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-39 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-39 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-39 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-39 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-39 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-39 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-39 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-39 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-39 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-39 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-39 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-39 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-39 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-39 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-39 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-39 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-39 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-39 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-39 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-39 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-39 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-38 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-38 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-38 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-38 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-38 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-38 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-38 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-38 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-38 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-38 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-38 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-38 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-38 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-38 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-38 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-38 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-38 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-37 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-36 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-35 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-35 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-35 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-35 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-35 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-35 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-34 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-34 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-34 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-34 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-34 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-34 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-34 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-34 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-34 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-34 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-33 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-33 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-33 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-33 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-33 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-33 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-33 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-33 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-33 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-33 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-33 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-33 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-33 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-33 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-33 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-32 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-32 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-32 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-32 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-32 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-27 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-26 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-26 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-25 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-24 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-24 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-24 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-23 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-23 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-23 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-23 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-22 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-21 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-21 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-20 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-19 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-19 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-19 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-19 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-18 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-18 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-18 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-18 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-18 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-18 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-18 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-18 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-18 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-18 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-18 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-18 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-18 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-18 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-18 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-18 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-18 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-18 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-18 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-18 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-18 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-17 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-17 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-17 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-17 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-17 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-17 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-17 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-17 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-17 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-16 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-16 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-15 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-15 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-08 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 531 bits (1370), Expect = 0.0
Identities = 148/369 (40%), Positives = 217/369 (58%), Gaps = 31/369 (8%)
Query: 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL 67
Y +S ++++ ++G G+YGVV SA TGE VAIKK++ F+ A R LREIK+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKIL 63
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLL 127
+ KH +I+ I +I P F ++Y++ ELM++DL +VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD-------TPSAIFWTDY 180
RA+K +H +NV HRDLKP N+L N++C LK+CDFGLAR+ T ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
VATRWYRAPE+ + +KY+ A+D+WS GCI AEL RP+FPGR+ HQL L+ ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 241 PSAES-IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299
P +++ + I + +A+ Y+ SL A P FP +P + LLQR+L FDP R +A+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 300 EIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEF--ERRKLIKDDV 357
E AL PY + +EP +PI FEF + L D+
Sbjct: 302 E------------------ALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDL 343
Query: 358 RELIYREIL 366
++LI+ EI
Sbjct: 344 KKLIWNEIF 352
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 530 bits (1368), Expect = 0.0
Identities = 157/365 (43%), Positives = 214/365 (58%), Gaps = 23/365 (6%)
Query: 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIK 65
+ +Y IG G+YG+V SA D +VAIKK+ FEH + R LREIK
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIK 77
Query: 66 LLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQ 125
+L +H +I+ I I+ P + KD+Y+V +LME+DL +++K L+ +H +FLYQ
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQ 136
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW 185
+LR LKYIHSANV HRDLKP N+L N C LKICDFGLARV+ D F T+YVATRW
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
YRAPE+ + YT +IDIWS+GCI AE+L+ RP+FPG++ QL+ + +LG+PS E
Sbjct: 197 YRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305
+ I N KA+ YL SL K VP++ FP AD AL LL ++L F+P R E+
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ----- 310
Query: 306 IVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREI 365
ALA PY + +EP + F+ E L K+ ++ELI+ E
Sbjct: 311 -------------ALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEET 355
Query: 366 LEYHP 370
+ P
Sbjct: 356 ARFQP 360
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 524 bits (1352), Expect = 0.0
Identities = 128/419 (30%), Positives = 198/419 (47%), Gaps = 67/419 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Y I+ +IG GSYG V A D +T + VAIKK+ +FE + D RILREI +L LK
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
I+ + +++P +F ++Y+V E+ +SDL ++ K LT EH + LY LL +I
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI------------------ 175
H + + HRDLKP N L N DC +K+CDFGLAR ++ + I
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205
Query: 176 -FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-----------RPLFP 223
T +V TRWYRAPEL YT +IDIWS GCIFAELL PLFP
Sbjct: 206 KQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 224 G-----------------RNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWA 266
G ++ QL+++ +++GTP+ + + I + +Y+ +
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 267 VPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326
+ K+P + LL+ +L F+P R + ++ AL PY
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQ------------------ALDHPYLK 366
Query: 327 GLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHPHMLEEYLQGTDHTHF 385
+ + E L F+ + L + +R + +E+ +HP ++ + +F
Sbjct: 367 DVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIHENNF 424
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 508 bits (1311), Expect = e-180
Identities = 120/375 (32%), Positives = 181/375 (48%), Gaps = 38/375 (10%)
Query: 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM---------KEVFEHVSD 56
+ S Y +Q I GSYG V + +D+ G VAIK++ +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 57 ATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDD-LT 115
R+LREI+LL HP+I+ ++ I + +Y+V ELM +DL QVI ++
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVIS 132
Query: 116 PEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175
P+H Q+F+Y +L L +H A V HRDL P NIL + + ICDF LAR D
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---- 188
Query: 176 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVT 235
T YV RWYRAPEL F +T +D+WS GC+ AE+ + LF G +QL+ +
Sbjct: 189 NKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 236 DLLGTPSAESIAGIRNEKAKRYL-SSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD 294
+++GTP E + + A+ YL +SL A ++ P ADP+AL L+ ++L F+P+
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
Query: 295 RPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIK 354
R S E+ AL PYF L + + F F+
Sbjct: 308 RISTEQ------------------ALRHPYFESLFDPLDLTEGLSER---FHFDESVTDV 346
Query: 355 DDVRELIYREILEYH 369
D+ ++ E+ ++
Sbjct: 347 YDMHKIFTAEVERFN 361
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 508 bits (1310), Expect = e-180
Identities = 133/358 (37%), Positives = 193/358 (53%), Gaps = 30/358 (8%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Y +G G+YG V SAID +GEKVAIKK+ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 74 DIVEIKHIMLPPCR-REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+++ + + P R F D Y+V M++DL +++ + E Q+ +YQ+L+ LKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
IHSA V HRDLKP N+ N DC+LKI DFGLAR + + T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
S+ Y +DIWS+GCI AE+LTG+ LF G++ QL + + G P E + + ++
Sbjct: 196 LSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLF 312
AK Y+ SL + F+ FP A P A LL+++L D R +A +
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ------------ 302
Query: 313 LYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370
AL P+F + EEE + E KL D+ ++ IY+EI+ + P
Sbjct: 303 ------ALTHPFFEPFRDPEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 507 bits (1308), Expect = e-179
Identities = 130/358 (36%), Positives = 201/358 (56%), Gaps = 30/358 (8%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ Y + +G G+YG V SA+D TG KVAIKK+ F+ A R RE++LL+ ++H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 74 DIVEIKHIMLP-PCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+++ + + P +F D Y+V M +DL +++K L + QF +YQ+L+ L+Y
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
IH+A + HRDLKP N+ N DC+LKI DFGLAR + ++ T YV TRWYRAPE+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVI 197
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
++ +YT +DIWS+GCI AE++TG+ LF G + QL + + GTP AE + ++++
Sbjct: 198 LNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLF 312
+AK Y+ L F+ A PLA+ LL+++L D + R +A E
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE------------ 304
Query: 313 LYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370
ALA PYF L + E+EP + F+ D+ + + Y+E+L + P
Sbjct: 305 ------ALAHPYFESLHDTEDEPQVQKYD---DSFDDVDRTLDEWKRVTYKEVLSFKP 353
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 506 bits (1306), Expect = e-179
Identities = 142/405 (35%), Positives = 211/405 (52%), Gaps = 61/405 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-H 72
+YE+ + +G G+YG+V +ID TGE VA+KK+ + F++ +DA R REI +L L H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+IV + +++ +D+Y+VF+ ME+DL VI+AN L P H Q+ +YQL++ +KY
Sbjct: 69 ENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKY 124
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARV------------------SFTDTPSA 174
+HS + HRD+KP NIL NA+C +K+ DFGL+R +
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 175 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L G+P+FPG + +QL+
Sbjct: 185 PILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKF----------------PGAD 277
+ ++ PS E + I++ AK + SL+ K + S+K +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 278 PLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSR 337
AL LL +LL F+P R SA + AL P+ N EEP+
Sbjct: 303 EEALDLLDKLLQFNPNKRISAND------------------ALKHPFVSIFHNPNEEPNC 344
Query: 338 KPISKLVFEFERRKLIKDDVRELIYREILEYHPHMLEEYLQGTDH 382
I + + K DD R L+Y EI ++ Q +
Sbjct: 345 DHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISNKHQNVQN 388
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 504 bits (1300), Expect = e-178
Identities = 148/373 (39%), Positives = 217/373 (58%), Gaps = 31/373 (8%)
Query: 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL 67
T + +Y+ +G G+YG V +A DT TG +VA+KK+ F+ + A R RE++LL
Sbjct: 23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 68 RMLKHPDIVEIKHIMLPPCRRE-FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQL 126
+ +KH +++ + + P E F D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQI 141
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
LR LKYIHSA++ HRDLKP N+ N DC+LKI DFGLAR + T YVATRWY
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD------EMTGYVATRWY 195
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
RAPE+ ++ Y +DIWS+GCI AELLTGR LFPG + QL L+ L+GTP AE +
Sbjct: 196 RAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEI 306
I +E A+ Y+ SL + + F++ F GA+PLA+ LL+++L D R +A +
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ------ 308
Query: 307 VFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREIL 366
ALA YF + ++EP P E R L+ D+ + L Y E++
Sbjct: 309 ------------ALAHAYFAQYHDPDDEPVADPYD---QSLESRDLLIDEWKSLTYDEVI 353
Query: 367 EYHPHML-EEYLQ 378
+ P L +E ++
Sbjct: 354 SFVPPPLDQEEME 366
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 501 bits (1292), Expect = e-176
Identities = 142/424 (33%), Positives = 200/424 (47%), Gaps = 75/424 (17%)
Query: 4 KEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILRE 63
+++ +YEI+ +IG GSYG V A D VAIKK+ VFE + D RILRE
Sbjct: 43 PRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE 102
Query: 64 IKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFL 123
I +L L H +V++ I++P +F ++YVV E+ +SD ++ + LT H + L
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL 162
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV----------------- 166
Y LL +KY+HSA + HRDLKP N L N DC +K+CDFGLAR
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 167 -------SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-- 217
T +V TRWYRAPEL YT AID+WSIGCIFAELL
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSIGCIFAELLNMI 281
Query: 218 ---------GRPLFPGRNVA--------------------HQLDLVTDLLGTPSAESIAG 248
PLFPG + QL+++ ++LGTPS E I
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVF 308
+ E AKRY+ ++ + +FP + A+ LL+R+L F+P R + E
Sbjct: 342 LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINE-------- 393
Query: 309 NWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEY 368
LA P+F + E E + +L F + + + +R +EI Y
Sbjct: 394 ----------CLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRY 442
Query: 369 HPHM 372
HP +
Sbjct: 443 HPEI 446
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-171
Identities = 119/371 (32%), Positives = 187/371 (50%), Gaps = 41/371 (11%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+Y+ + IG G+ G+V +A D VAIKK+ F++ + A R RE+ L++ + H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 74 DIVEIKHIMLPPCRRE-FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+I+ + ++ P E F+D+Y+V ELM+++L QVI+ +L E + LYQ+L +K+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKH 142
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+HSA + HRDLKP NI+ +DC LKI DFGLAR ++ T YV TR+YRAPE+
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVI 198
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
Y +DIWS+GCI E++ G LFPG + Q + V + LGTP E + +
Sbjct: 199 LGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QP 255
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGA------------DPLALRLLQRLLAFDPKDRPSAEE 300
+ Y+ + + F FP A LL ++L D R S +E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315
Query: 301 IRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVREL 360
AL PY + + E + P + + R+ ++ +EL
Sbjct: 316 ------------------ALQHPYINVWYDPSEAEAP-PPKIPDKQLDEREHTIEEWKEL 356
Query: 361 IYREILEYHPH 371
IY+E+++ H
Sbjct: 357 IYKEVMDLEHH 367
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 490 bits (1262), Expect = e-171
Identities = 119/397 (29%), Positives = 194/397 (48%), Gaps = 41/397 (10%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+Y+ + IG G+ G+V +A D VAIKK+ F++ + A R RE+ L++ + H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 74 DIVEIKHIMLPPCRRE-FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+I+ + ++ P E F+D+Y+V ELM+++L QVI+ +L E + LYQ+L +K+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKH 179
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+HSA + HRDLKP NI+ +DC LKI DFGLAR ++ T YV TR+YRAPE+
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRYYRAPEVI 235
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
Y +DIWS+GCI E++ + LFPGR+ Q + V + LGTP E + +
Sbjct: 236 LGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QP 292
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGA------------DPLALRLLQRLLAFDPKDRPSAEE 300
+ Y+ + + + F FP + A LL ++L DP R S ++
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 301 IRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVREL 360
AL PY + + E + P + + R+ ++ +EL
Sbjct: 353 ------------------ALQHPYINVWYDPAEVEAP-PPQIYDKQLDEREHTIEEWKEL 393
Query: 361 IYREILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQ 397
IY+E++ ++G + +
Sbjct: 394 IYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPS 430
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 481 bits (1239), Expect = e-170
Identities = 120/333 (36%), Positives = 173/333 (51%), Gaps = 33/333 (9%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
S+Y + +G G G+V SA+D ++VAIKK+ V LREIK++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 73 PDIVEIKHIMLPPCRR---------EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFL 123
+IV++ I+ P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
YQLLR LKYIHSANV HRDLKP N+ N D LKI DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
T+WYR+P L S + YT AID+W+ GCIFAE+LTG+ LF G + Q+ L+ + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
E + + Y+ + + P + PG A+ L+++L F P DR +AEE
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE-- 302
Query: 303 FTEIVFNWLFLYFYVLALADPYFHGLANLEEEP 335
AL+ PY + +EP
Sbjct: 303 ----------------ALSHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 449 bits (1156), Expect = e-156
Identities = 114/366 (31%), Positives = 179/366 (48%), Gaps = 39/366 (10%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
E +++++ + G G++G V + TG VAIKK V + R L+ ++ L +L
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPRFRNRELQIMQDLAVLH 77
Query: 72 HPDIVEIKHIMLPPCRREFKDIY--VVFELMESDLDQVIK----ANDDLTPEHHQFFLYQ 125
HP+IV+++ R+ +DIY VV E + L + + P + FL+Q
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 126 LLRALKYIH--SANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
L+R++ +H S NV HRD+KP N+L N AD LK+CDFG A+ P+ Y+
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN----VAYIC 193
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
+R+YRAPEL YT A+DIWS+GCIFAE++ G P+F G N A QL + +LG PS
Sbjct: 194 SRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 243 AESIAGIRNEKAKRYLSSLRR-KWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
E + + L + + W+ FS A LL LL + P++R E
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE- 311
Query: 302 RFTEIVFNWLFLYFYVLALADPYFHGLANLEEE-PSRKPISKLVFEFERRKL--IKDDVR 358
AL PYF L + + P+ K + + +F F ++ + + +
Sbjct: 312 -----------------ALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQK 354
Query: 359 ELIYRE 364
+ R+
Sbjct: 355 AKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 415 bits (1069), Expect = e-143
Identities = 122/394 (30%), Positives = 192/394 (48%), Gaps = 49/394 (12%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Y ++IG GS+GVV A + E VAIKK+ + D RE++++R++KHP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ------DKRFKNRELQIMRIVKHP 92
Query: 74 DIVEIKHIMLPPC-RREFKDIYVVFELMESDLDQVI----KANDDLTPEHHQFFLYQLLR 128
++V++K +++ + +V E + + + K + + ++YQLLR
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 129 ALKYIHSANVFHRDLKPKNILANADC-KLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
+L YIHS + HRD+KP+N+L + LK+ DFG A++ P+ Y+ +R+YR
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN----VSYICSRYYR 208
Query: 188 APELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APEL G+ + YT IDIWS GC+ AEL+ G+PLFPG + QL + +LGTPS E I
Sbjct: 209 APELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305
+ + +R PFS F P P A+ L+ RLL + P R +A E
Sbjct: 267 KTMNPNYMEHKFPQIRPH---PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE----- 318
Query: 306 IVFNWLFLYFYVLALADPYFHGLANLE-EEPSRKPISKLVFEFERRKLIKDDVRELIYRE 364
AL P+F L E P+ + + L F + + +L VR +
Sbjct: 319 -------------ALCHPFFDELRTGEARMPNGRELPPL-FNWTKEEL---SVRPDLISR 361
Query: 365 ILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQF 398
++ H E +G D +F P ++ K
Sbjct: 362 LVPQHAEA-ELLSRGIDVHNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 402 bits (1035), Expect = e-138
Identities = 106/412 (25%), Positives = 188/412 (45%), Gaps = 87/412 (21%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
+ +Y + + +G GS+G+V D +G++ A+KK+ + D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 73 PDIVEIKHIM---------------------------------LPPCRREFKDIYVVFEL 99
+I+++ + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 100 MESDLDQVI----KANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DC 154
+ L +V+ ++ + ++YQL RA+ +IHS + HRD+KP+N+L N+ D
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 155 KLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 213
LK+CDFG A+ PS Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 214 ELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKF 273
EL+ G+PLF G QL + ++GTP+ E + + + +L+ K +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK---DWRKIL 290
Query: 274 PGADP-LALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLE 332
P P LA+ LL+++L ++P R + E A+A P+F L N
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYE------------------AMAHPFFDHLRNSY 332
Query: 333 EEP----------SRKPISKLVFEFERRKL---IKDDVRELIYREILEYHPH 371
E + I +L F F +L + + ++ + + H
Sbjct: 333 ESEVKNNSNFPHGVNQNIPQL-FNFSPYELSIIPGNVLNRILPKNFSPNYKH 383
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 399 bits (1026), Expect = e-136
Identities = 106/372 (28%), Positives = 178/372 (47%), Gaps = 42/372 (11%)
Query: 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL 67
+ + Y ++IG GS+GVV A +GE VAIKK+ + D RE++++
Sbjct: 48 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIM 101
Query: 68 RMLKHPDIVEIKHIMLPPC-RREFKDIYVVFELMESDLDQVIK----ANDDLTPEHHQFF 122
R L H +IV +++ +++ + +V + + + +V + A L + + +
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADC-KLKICDFGLARVSFTDTPSAIFWTDYV 181
+YQL R+L YIHS + HRD+KP+N+L + D LK+CDFG A+ P+ Y+
Sbjct: 162 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYI 217
Query: 182 ATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
+R+YRAPEL G+ + YT +ID+WS GC+ AELL G+P+FPG + QL + +LGT
Sbjct: 218 CSRYYRAPELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSAE 299
P+ E I + + ++ P++ F P P A+ L RLL + P R +
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAH---PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 300 EIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKL-IKDDVR 358
E A A +F L + + + +F F ++L +
Sbjct: 333 E------------------ACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLA 374
Query: 359 ELIYREILEYHP 370
++
Sbjct: 375 TILIPPHARIQA 386
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 362 bits (932), Expect = e-123
Identities = 90/336 (26%), Positives = 148/336 (44%), Gaps = 42/336 (12%)
Query: 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIK 65
E+G Y++ +G G Y V AI+ EKV +K +K V +I REIK
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 66 LLRMLK-HPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLY 124
+L L+ P+I+ + I+ P V + +D Q+ LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMY 137
Query: 125 QLLRALKYIHSANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFTDTPSAIFWTDYVAT 183
++L+AL Y HS + HRD+KP N++ + KL++ D+GLA + VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVAS 193
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR-PLFPGRNVAHQLDLVTDLLGTPS 242
R+++ PEL + Y ++D+WS+GC+ A ++ + P F G + QL + +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 243 AESIAG-IRNEKAKRYLSSLRRKWAVPFSHKFPG-----ADPLALRLLQRLLAFDPKDRP 296
E R+ L R + P AL L +LL +D + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 297 SAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLE 332
+A E A+ PYF+ + +
Sbjct: 313 TARE------------------AMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 347 bits (892), Expect = e-117
Identities = 107/327 (32%), Positives = 158/327 (48%), Gaps = 30/327 (9%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+YE IG GSYGVV + TG+ VAIKK E + LREI++L+ LKHP+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYI 133
+V + + R + +++VFE + + + + + +Q L+A+ +
Sbjct: 64 LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-LC 192
H N HRD+KP+NIL +K+CDFG AR T PS + D VATRWYR+PE L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLV 175
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
G ++Y P +D+W+IGC+FAELL+G PL+PG++ QL L+ LG
Sbjct: 176 GD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLF 312
+ + + P KFP AL LL+ L DP +R + E+
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ------------ 281
Query: 313 LYFYVLALADPYFHGLANLEEEPSRKP 339
L PYF + +E+
Sbjct: 282 ------LLHHPYFENIREIEDLAKEHD 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-108
Identities = 99/329 (30%), Positives = 153/329 (46%), Gaps = 33/329 (10%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+YE ++G GSYG+V + TG VAIKK E + +REIKLL+ L+H +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYI 133
+V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ + +
Sbjct: 86 LVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC- 192
HS N+ HRD+KP+NIL + +K+CDFG AR + P ++ D VATRWYRAPEL
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELLV 197
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
G KY A+D+W+IGC+ E+ G PLFPG + QL + LG
Sbjct: 198 GD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLF 312
+ K P ++P + + L ++ L DP RP E
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE------------ 303
Query: 313 LYFYVLALADPYFHGL---ANLEEEPSRK 338
L +F +E K
Sbjct: 304 ------LLHHDFFQMDGFAERFSQELQLK 326
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 1e-98
Identities = 116/342 (33%), Positives = 165/342 (48%), Gaps = 54/342 (15%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRI--LREIKLLRM 69
A +YE + +G G + V A D +T + VAIKK+K D LREIKLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDD-LTPEHHQFFLYQLLR 128
L HP+I+ + +I +VF+ ME+DL+ +IK N LTP H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFG-----HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
L+Y+H + HRDLKP N+L + + LK+ DFGLA+ SF P+ + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
PE L G+ Y +D+W++GCI AELL P PG + QL + + LGTP+ E
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 248 GIRNEKAKRYLSSLR-----RKW-AVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ SL + + +P H F A L L+Q L F+P R +A +
Sbjct: 239 DM---------CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ- 288
Query: 302 RFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKL 343
AL YF P P +L
Sbjct: 289 -----------------ALKMKYFS------NRPGPTPGCQL 307
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = 1e-97
Identities = 101/328 (30%), Positives = 148/328 (45%), Gaps = 50/328 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI-----LREIKLLR 68
S+YE IG+G+YG V A D H+G VA+K ++ + +RE+ LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLR 66
Query: 69 MLK---HPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKA--NDDLTPEHHQFFL 123
L+ HP++V + + + +VFE ++ DL + L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT 183
Q LR L ++H+ + HRDLKP+NIL + +K+ DFGLAR ++ + T V T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA---LTPVVVT 182
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
WYRAPE+ S Y +D+WS+GCIFAE+ +PLF G + A QL + DL+G P
Sbjct: 183 LWYRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240
Query: 244 ESIAGIRNEKAKRYLSSLRR----KW-AVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
+ SL R P P + +LL +L F+P R SA
Sbjct: 241 DDWPRD---------VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291
Query: 299 EEIRFTEIVFNWLFLYFYVLALADPYFH 326
AL Y H
Sbjct: 292 FR------------------ALQHSYLH 301
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 6e-97
Identities = 118/360 (32%), Positives = 179/360 (49%), Gaps = 41/360 (11%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
Y + +G G+Y V T VA+K+++ E + T I RE+ LL+ LKH +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHAN 61
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYI 133
IV + I+ K + +VFE ++ DL Q + + + + + FL+QLLR L Y
Sbjct: 62 IVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE-LC 192
H V HRDLKP+N+L N +LK+ DFGLAR + + P+ + + V T WYR P+ L
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDILL 173
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
GS + Y+ ID+W +GCIF E+ TGRPLFPG V QL + +LGTP+ E+ GI
Sbjct: 174 GS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI--L 229
Query: 253 KAKRYLSSLRRKW-AVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWL 311
+ + + K+ A P D LL +LL F+ ++R SAE+
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED----------- 278
Query: 312 FLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHPH 371
A+ P+F +L E + P + +F + +L K+ R +H H
Sbjct: 279 -------AMKHPFFL---SLGERIHKLPDTTSIFALKEIQLQKEASL----RSAHHHHHH 324
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 2e-96
Identities = 117/330 (35%), Positives = 172/330 (52%), Gaps = 38/330 (11%)
Query: 4 KEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI--L 61
+E G +Y+ E +G G+YGVV A D+ G VA+K+++ + + +
Sbjct: 11 RENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDAEDEGIPSTAI 67
Query: 62 REIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQ 120
REI LL+ L HP+IV + ++ + + +VFE ME DL +V+ L +
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQDSQIK 122
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
+LYQLLR + + H + HRDLKP+N+L N+D LK+ DFGLAR +F P + T
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI-PVRSY-THE 179
Query: 181 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239
V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TG+PLFPG QL + +LG
Sbjct: 180 VVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237
Query: 240 TPSAESIAGIRNEKAKRYLSSLRRKW-AVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
TP+ + ++ + + + P+S PG + LL +L FDP R SA
Sbjct: 238 TPNPREWPQV--QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295
Query: 299 EEIRFTEIVFNWLFLYFYVLALADPYFHGL 328
+ A+ PYF L
Sbjct: 296 RD------------------AMNHPYFKDL 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 3e-96
Identities = 111/315 (35%), Positives = 166/315 (52%), Gaps = 37/315 (11%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRMLKH 72
+Y E IG G+YGVV A + GE A+KK++ E + +REI +L+ LKH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALK 131
+IV++ ++ K + +VFE ++ DL +++ L + FL QLL +
Sbjct: 60 SNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE- 190
Y H V HRDLKP+N+L N + +LKI DFGLAR +F P + T + T WYRAP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDV 171
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
L GS KY+ IDIWS+GCIFAE++ G PLFPG + A QL + +LGTP++++ +
Sbjct: 172 LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNW 310
+ +Y + +P+ G D + LL ++L DP R +A++
Sbjct: 230 --ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ---------- 277
Query: 311 LFLYFYVLALADPYF 325
AL YF
Sbjct: 278 --------ALEHAYF 284
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 7e-96
Identities = 120/319 (37%), Positives = 164/319 (51%), Gaps = 37/319 (11%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRMLKH 72
+YE E IG G+YG V A + T E VA+K+++ + + LREI LL+ LKH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 60
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALK 131
+IV + ++ K + +VFE + DL + + N DL PE + FL+QLL+ L
Sbjct: 61 KNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE- 190
+ HS NV HRDLKP+N+L N + +LK+ +FGLAR +F P + + V T WYR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDV 172
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
L G+ Y+ +ID+WS GCIFAEL GRPLFPG +V QL + LLGTP+ E +
Sbjct: 173 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFN 309
K Y + P + LLQ LL +P R SAEE
Sbjct: 231 T--KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE--------- 279
Query: 310 WLFLYFYVLALADPYFHGL 328
AL PYF
Sbjct: 280 ---------ALQHPYFSDF 289
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 1e-94
Identities = 108/348 (31%), Positives = 159/348 (45%), Gaps = 49/348 (14%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDT-HTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRML 70
QYE IG G+YG V A D + G VA+K+++ + + + +RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 71 K---HPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKA--NDDLTPEHHQFFLYQ 125
+ HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW 185
LLR L ++HS V HRDLKP+NIL + ++K+ DFGLAR ++ + T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA---LTSVVVTLW 184
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
YRAPE+ S Y +D+WS+GCIFAE+ +PLF G + QL + D++G P E
Sbjct: 185 YRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242
Query: 246 IAGIRNEKAKRYLSSLRR----KW-AVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+L R A P D L LL + L F+P R SA
Sbjct: 243 WPRD---------VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 301 IRFTEIVFNWLFLYFYVLALADPYFHGL-ANLEEEPSRKPISKLVFEF 347
AL+ PYF L E S P S+ E
Sbjct: 294 ------------------ALSHPYFQDLERCKENLDSHLPPSQNTSEL 323
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 1e-94
Identities = 110/360 (30%), Positives = 157/360 (43%), Gaps = 52/360 (14%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRM 69
E S+YE IG G++G V A TG+KVA+KK+ E+ + I LREIK+L++
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 70 LKHPDIVEIKHIM---LPPCRREFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQ 125
LKH ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY---VA 182
LL L YIH + HRD+K N+L D LK+ DFGLAR Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR--AFSLAKNSQPNRYTNRVV 190
Query: 183 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL L++ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 242 SAESIAGIRN-EKAKRYLSSLRRKWAVPFSHKFP--GADPLALRLLQRLLAFDPKDRPSA 298
+ E + N E ++ L + + DP AL L+ +LL DP R +
Sbjct: 249 TPEVWPNVDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 299 EEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKL-------VFEFERRK 351
++ AL +F +P + + +FE+
Sbjct: 307 DD------------------ALNHDFFW------SDPMPSDLKGMLSTHLTSMFEYLAPP 342
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 2e-94
Identities = 109/324 (33%), Positives = 158/324 (48%), Gaps = 41/324 (12%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRMLK 71
+Y +G G+YG V AIDT T E VAIK+++ EH + +RE+ LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
H +I+E+K ++ ++++FE E+DL + + N D++ + FLYQL+ +
Sbjct: 92 HRNIIELKSVIHHN-----HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 132 YIHSANVFHRDLKPKNILANADCK-----LKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
+ HS HRDLKP+N+L + LKI DFGLAR +F P F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 187 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG + QL + ++LG P +
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGA-DPLALRLLQRLLAFDPKDRPSAEEIRFT 304
G+ + S + D L LL +L DP R SA+
Sbjct: 262 WPGV--TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN---- 315
Query: 305 EIVFNWLFLYFYVLALADPYFHGL 328
AL PYF
Sbjct: 316 --------------ALEHPYFSHN 325
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 1e-93
Identities = 110/330 (33%), Positives = 165/330 (50%), Gaps = 45/330 (13%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
+SQ++ E +G G+Y V ++ TG VA+K++K E + +T I REI L++ LK
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKELK 61
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKAN------DDLTPEHHQFFLYQ 125
H +IV + ++ + +VFE M++DL + + + L ++F +Q
Sbjct: 62 HENIVRLYDVIHTE-----NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW 185
LL+ L + H + HRDLKP+N+L N +LK+ DFGLAR +F P F + V T W
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLW 173
Query: 186 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
YRAP+ L GS Y+ +IDIWS GCI AE++TG+PLFPG N QL L+ D++GTP+
Sbjct: 174 YRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 245 SIAGI------RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
+ +R LR+ H D + L LL +P R SA
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQ---PHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 299 EEIRFTEIVFNWLFLYFYVLALADPYFHGL 328
++ AL P+F
Sbjct: 289 KQ------------------ALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 1e-82
Identities = 108/386 (27%), Positives = 167/386 (43%), Gaps = 76/386 (19%)
Query: 13 ASQYEIQEI-IGIGSYGVV--ASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM 69
+E + +G G+YG V A D + A+K+++ +S + REI LLR
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSA--CREIALLRE 74
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDD---------LTPEHHQ 120
LKHP+++ ++ + L + ++++F+ E DL +IK + L +
Sbjct: 75 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCK----LKICDFGLARV------SFTD 170
LYQ+L + Y+H+ V HRDLKP NIL + +KI D G AR+ D
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 171 TPSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN--- 226
V T WYRAPE L G+ YT AIDIW+IGCIFAELLT P+F R
Sbjct: 192 ------LDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 227 ------VAHQLDLVTDLLGTPSAESIAGIRN-------EKAKRYLSSLRRKWAVPFSHKF 273
QLD + +++G P+ + I+ K R +
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 274 PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEE 333
D A LLQ+LL DP R ++E+ A+ DPYF +
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQ------------------AMQDPYFLE----DP 341
Query: 334 EPSRKPISKLVFEFERRKLIKDDVRE 359
P+ + + +R+ + ++ +
Sbjct: 342 LPTSDVFAGCQIPYPKREFLTEEEPD 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-65
Identities = 89/418 (21%), Positives = 154/418 (36%), Gaps = 85/418 (20%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHP 73
+ ++++G G+ G + VA+K++ +D RE++LLR +HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLRALKY 132
+++ ++ + Y+ EL + L + ++ D L Q L +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 133 IHSANVFHRDLKPKNIL-----ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
+HS N+ HRDLKP NIL A+ K I DFGL + S + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 188 APE-LCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245
APE L T +DI+S GC+F +++ G F
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------------------- 234
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305
+R + L ++ H D +A L+++++A DP+ RPSA+
Sbjct: 235 ---------QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKH----- 280
Query: 306 IVFNWLFLYFYVLALADPYFHGLAN-----------LEEEPSRKPISKLVFEFERRKLIK 354
L P+F L +E+E PI K E R ++K
Sbjct: 281 -------------VLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQ-LERGGRAVVK 326
Query: 355 DDVRELIYREILE-------YHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARLEEQY 405
D RE I + Y + + L+ + Y + ++ L + +
Sbjct: 327 MDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDF 384
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-58
Identities = 47/320 (14%), Positives = 81/320 (25%), Gaps = 57/320 (17%)
Query: 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRM 69
+ ++ E + +G VV D E A+K S+ R+
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 70 LKHPDIVEIK---HIMLPPC------------------RREFKDIYVVFELMESDLDQVI 108
L E + ++LP + ++ DL+ +
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 109 KANDDLTPEHH-------QFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDF 161
D + QL+R + S + H P N+ D +L + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPL 221
T P+ Y E + + +T A++ W +G +
Sbjct: 239 SALWKVGTRGPA------SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
Query: 222 FPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLAL 281
F + L P A P
Sbjct: 293 FGLVTPGIKGSWKRPSLRVPG-------------------TDSLAFGSCTPLP---DFVK 330
Query: 282 RLLQRLLAFDPKDRPSAEEI 301
L+ R L FD + R E
Sbjct: 331 TLIGRFLNFDRRRRLLPLEA 350
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-58
Identities = 74/300 (24%), Positives = 108/300 (36%), Gaps = 49/300 (16%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP- 73
Y I + IG G V ++ + AIK + EI L L+
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 74 -DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
I+ + + + IY+V E DL+ +K + P + + +L A+
Sbjct: 88 DKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL- 191
IH + H DLKP N L D LK+ DFG+A DT S + V T Y PE
Sbjct: 143 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQVGTVNYMPPEAI 200
Query: 192 --------CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
G SK +P D+WS+GCI + G+ F
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------------------- 239
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP-GADPLALRLLQRLLAFDPKDRPSAEEIR 302
I N+ +K L +FP + +L+ L DPK R S E+
Sbjct: 240 ---QQIINQISK-----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-56
Identities = 89/324 (27%), Positives = 145/324 (44%), Gaps = 50/324 (15%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK--KMKEVFEHVSDATRILREIKLLRML 70
A +YE+ ++IG GS+G V A D + VA+K + ++ F + EI++L L
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-----AEEIRILEHL 150
Query: 71 KHPDIVEIKHIMLPPCRREFKD-IYVVFELMESDLDQVIKANDD--LTPEHHQFFLYQLL 127
+ D +++ F++ I + FEL+ +L ++IK N + + F + +L
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 128 RALKYIHSANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW 185
+ L +H + H DLKP+NIL +K+ DFG + + Y+ +R+
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRV----YTYIQSRF 264
Query: 186 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
YRAPE + G+ +Y ID+WS+GCI AELLTG PL PG + QL + +LLG PS +
Sbjct: 265 YRAPEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321
Query: 245 SIAGIRN----------------------EKAKRYLSSLRRKWAVPFSHK-----FPGAD 277
+ + S R K P + G D
Sbjct: 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCD 381
Query: 278 PLALR-LLQRLLAFDPKDRPSAEE 300
L++ L +DP R + +
Sbjct: 382 DPLFLDFLKQCLEWDPAVRMTPGQ 405
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-55
Identities = 74/299 (24%), Positives = 107/299 (35%), Gaps = 49/299 (16%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP- 73
Y I + IG G V ++ + AIK + EI L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 74 -DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
I+ + + IY+V E DL+ +K + P + + +L A+
Sbjct: 69 DKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL- 191
IH + H DLKP N L D LK+ DFG+A DT S + V T Y PE
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQVGTVNYMPPEAI 181
Query: 192 --------CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
G SK +P D+WS+GCI + G+ F
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------------------- 220
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP-GADPLALRLLQRLLAFDPKDRPSAEEI 301
I N+ +K L +FP + +L+ L DPK R S E+
Sbjct: 221 ---QQIINQISK-----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-54
Identities = 73/311 (23%), Positives = 116/311 (37%), Gaps = 56/311 (18%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
AS +E ++G G++G V A + AIKK++ E + IL E+ LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE---KLSTILSEVMLLASLNH 61
Query: 73 PDIVEIKH--------IMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHH-QFF 122
+V + ++ +++ E E L +I + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW----- 177
Q+L AL YIHS + HRDLKP NI + +KI DFGLA+
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 178 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL 231
T + T Y A E+ Y ID++S+G IF E++ P G + L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238
Query: 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGAD-PLALRLLQRLLAF 290
+ R ++ F F + ++++ L+
Sbjct: 239 KKL----------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDH 270
Query: 291 DPKDRPSAEEI 301
DP RP A +
Sbjct: 271 DPNKRPGARTL 281
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-54
Identities = 60/303 (19%), Positives = 104/303 (34%), Gaps = 28/303 (9%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+ + +I+G G+ V TG+ AIK + + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAN---DDLTPEHHQFFLYQLLRAL 130
IV++ I + ++ E L V++ L L ++ +
Sbjct: 69 IVKLFAIEEET---TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 131 KYIHSANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
++ + HR++KP NI+ + K+ DFG AR D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 187 RAPEL------CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD--LL 238
P++ KY +D+WSIG F TG F + V +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
G PS + E S G L +L +L D +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVS----CSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 299 EEI 301
++
Sbjct: 298 DQF 300
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-54
Identities = 74/300 (24%), Positives = 110/300 (36%), Gaps = 51/300 (17%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
Y I + IG G V ++ + AIK + E ++ EI L L+
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 114
Query: 74 --DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
I+ + + + IY+V E DL+ +K + P + + +L A+
Sbjct: 115 SDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
IH + H DLKP N L D LK+ DFG+A DT S + V Y PE
Sbjct: 170 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQVGAVNYMPPEA 227
Query: 192 ---------CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
G SK +P D+WS+GCI + G+ F
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-------------------- 267
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP-GADPLALRLLQRLLAFDPKDRPSAEEI 301
I N+ +K L +FP + +L+ L DPK R S E+
Sbjct: 268 ----QQIINQISK-----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-54
Identities = 88/334 (26%), Positives = 144/334 (43%), Gaps = 63/334 (18%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK--KMKEVFEHVSDATRILREIKLLRML 70
+YEI +IG GS+G V A D E VAIK K K+ F + + E++LL ++
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLLELM 107
Query: 71 KHPDIVEIKHIMLPPCRREFKD-IYVVFELMESDLDQVIKANDD--LTPEHHQFFLYQLL 127
D +I+ F++ + +VFE++ +L +++ + ++ + F Q+
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 128 RALKYIHS--ANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFTDTPSAIFWTD---- 179
AL ++ + ++ H DLKP+NIL +KI DFG S+
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----------SSCQLGQRIYQ 217
Query: 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239
Y+ +R+YR+PE+ Y AID+WS+GCI E+ TG PLF G N Q++ + ++LG
Sbjct: 218 YIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 240 TPSA--------------------------ESIAGIRNEKAKRYLSSLRRKWAVPFSHKF 273
P A + R L ++ +
Sbjct: 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR 335
Query: 274 PG------ADPLALR-LLQRLLAFDPKDRPSAEE 300
G AD L + L+ R+L +DPK R
Sbjct: 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-53
Identities = 72/308 (23%), Positives = 116/308 (37%), Gaps = 55/308 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ +E + +G G +GVV A + AIK+++ + +++RE+K L L+HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALAKLEHP 63
Query: 74 DIVEIKH-------IMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQF---F 122
IV + +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV---------SFTDTPS 173
Q+ A++++HS + HRDLKP NI D +K+ DFGL T P+
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233
T V T+ Y +PE + Y+ +DI+S+G I ELL P L
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239
Query: 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPK 293
+RN K F F P ++Q +L+ P
Sbjct: 240 ---------------VRNLK---------------FPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 294 DRPSAEEI 301
+RP A I
Sbjct: 270 ERPEAINI 277
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 9e-53
Identities = 86/299 (28%), Positives = 131/299 (43%), Gaps = 47/299 (15%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIK---KMK---EVFEHVSDATRILREIKLLR 68
+Y + + +G G+ G V A + T +KVAI+ K K A + EI++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLL 127
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 128 RALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
A++Y+H + HRDLKP+N+L DC +KI DFG +++ +T T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETS---LMRTLCGTP 305
Query: 185 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ I K+ + AL L+++LL DPK R + EE
Sbjct: 355 DQI--------------TSGKYNFI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 9e-53
Identities = 78/358 (21%), Positives = 134/358 (37%), Gaps = 67/358 (18%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
++Y + +G G + V A D VA+K ++ + ++A EIKLL+ +
Sbjct: 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVND 74
Query: 73 PDIVEIKHIMLPPCRR-----EFKDIYV-----VFELMESDLDQVIKANDD--LTPEHHQ 120
D + + + K VFE++ +L +IK + + + +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 121 FFLYQLLRALKYIHS-ANVFHRDLKPKNILAN------ADCKLKICDFGLARVSFTDTPS 173
QLL L Y+H + H D+KP+N+L ++KI D G A + D
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHY 192
Query: 174 AIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA---- 228
T+ + TR YR+PE L G+ + DIWS C+ EL+TG LF
Sbjct: 193 ----TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 229 --HQLDLVTDLLGTPSAESIAGIRN-------EKAKRYLSSLRRKW---AVPFSHKFPGA 276
+ + +LLG + + + R +S L+ + +KF
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 277 DPLALR-LLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEE 333
+ + L +L DP+ R A + P+ +EE
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGG------------------LVNHPWLKDTLGMEE 345
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-52
Identities = 60/303 (19%), Positives = 104/303 (34%), Gaps = 28/303 (9%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+ + +I+G G+ V TG+ AIK + + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAN---DDLTPEHHQFFLYQLLRAL 130
IV++ I + ++ E L V++ L L ++ +
Sbjct: 69 IVKLFAIEEET---TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 131 KYIHSANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
++ + HR++KP NI+ + K+ DFG AR D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 187 RAPEL------CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD--LL 238
P++ KY +D+WSIG F TG F + V +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
G PS + E S G L +L +L D +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVS----CSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 299 EEI 301
++
Sbjct: 298 DQF 300
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-52
Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 55/296 (18%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLKH 72
+Y + IG GS+G T G + IK++ +S R RE+ +L +KH
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN--ISRMSSKEREESRREVAVLANMKH 82
Query: 73 PDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIK-ANDDLTPEHH-QFFLYQL 126
P+IV+ R F++ +Y+V + E DL + I L E + Q+
Sbjct: 83 PNIVQ--------YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
ALK++H + HRD+K +NI D +++ DFG+ARV + A + T +Y
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA---RACIGTPYY 191
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
+PE+C + Y DIW++GC+ EL T + F + +LV
Sbjct: 192 LSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLVLK---------- 236
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALR-LLQRLLAFDPKDRPSAEEI 301
I + LR L+ +L +P+DRPS I
Sbjct: 237 --IISGSFPP----------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-52
Identities = 86/332 (25%), Positives = 136/332 (40%), Gaps = 63/332 (18%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTG-EKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
+++YEI + +G G++G V ID G VA+K +K V + +A R EI++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 72 HPDIVEIKHIMLPPCRREFKD-IYVVFELMESDLDQVIKANDD--LTPEHHQFFLYQLLR 128
D + E I +VFEL+ IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 129 ALKYIHSANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVSFT 169
++ ++HS + H DLKP+NIL + +K+ DFG
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG------- 182
Query: 170 DTPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG 224
SA + + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 183 ---SATYDDEHHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 225 RNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHK---FPGADPLA- 280
+ L ++ +LG I+ + ++Y R W S PL
Sbjct: 237 HDSKEHLAMMERILGPLPKHM---IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293
Query: 281 ------------LRLLQRLLAFDPKDRPSAEE 300
L+Q++L +DP R + E
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-51
Identities = 73/347 (21%), Positives = 129/347 (37%), Gaps = 87/347 (25%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
+ + + +G G++G V + A+K ++ + + + + +I E +L+ +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI--EADILKKIQN 90
Query: 73 PD-----IVEIK-------HIMLPPCRREFKDIYVVFELMESDLDQVIKANDD--LTPEH 118
D IV+ H+ C ++FE + L ++I N+ E
Sbjct: 91 DDINNNNIVKYHGKFMYYDHM----C--------LIFEPLGPSLYEIITRNNYNGFHIED 138
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNIL-------------------------ANAD 153
+ + ++L+AL Y+ ++ H DLKP+NIL
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 154 CKLKICDFGLARVSFTDTPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSI 208
+K+ DFG A F +D + TR YRAPE + + + D+WS
Sbjct: 199 TGIKLIDFG----------CATFKSDYHGSIINTRQYRAPEVILNL---GWDVSSDMWSF 245
Query: 209 GCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVP 268
GC+ AEL TG LF L ++ ++ + +Y++ K A P
Sbjct: 246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWP 305
Query: 269 FSHKF-----------PGA----DPLALRLLQRLLAFDPKDRPSAEE 300
+ P L L +L DP RPS E
Sbjct: 306 ENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-51
Identities = 84/302 (27%), Positives = 119/302 (39%), Gaps = 52/302 (17%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRM 69
A YE+ IG GSYG G+ + K++ + +++A + ++ E+ LLR
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRE 61
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKA---NDDLTPEHH-QFFLY 124
LKHP+IV ++ R +Y+V E E DL VI E +
Sbjct: 62 LKHPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 125 QLLRALKYIHSAN-----VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD 179
QL ALK H + V HRDLKP N+ + +K+ DFGLAR+ DT A
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KT 175
Query: 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239
+V T +Y +PE Y DIWS+GC+ EL P F + +
Sbjct: 176 FVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----- 228
Query: 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299
G RY L ++ R+L RPS E
Sbjct: 229 ------REGKFRRIPYRYSDELN-------------------EIITRMLNLKDYHRPSVE 263
Query: 300 EI 301
EI
Sbjct: 264 EI 265
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-51
Identities = 87/299 (29%), Positives = 131/299 (43%), Gaps = 47/299 (15%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIK---KMK---EVFEHVSDATRILREIKLLR 68
+Y + + +G G+ G V A + T +KVAIK K K A + EI++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLL 127
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 128 RALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
A++Y+H + HRDLKP+N+L DC +KI DFG +++ +T T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETS---LMRTLCGTP 180
Query: 185 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 229
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ I K+ + AL L+++LL DPK R + EE
Sbjct: 230 DQI--------------TSGKYNFI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-51
Identities = 70/305 (22%), Positives = 113/305 (37%), Gaps = 65/305 (21%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
++ E+IG G +G V A G+ IK++K + + RE+K L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 73 PDIVEIKH-----------IMLPPCRREFKDIYVVFELMES-DLDQVIK-ANDDLTPEHH 119
+IV R + K +++ E + L+Q I+ + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 120 -QFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT 178
Q+ + + YIHS + +RDLKP NI ++KI DFGL + T
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKNDGKR---T 179
Query: 179 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDL 237
T Y +PE S Y +D++++G I AELL F
Sbjct: 180 RSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKF---------- 227
Query: 238 LGTPSAESIAGIRNEK-AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP 296
+R+ + + + LLQ+LL+ P+DRP
Sbjct: 228 --------FTDLRDGIISDIFDKKEK-------------------TLLQKLLSKKPEDRP 260
Query: 297 SAEEI 301
+ EI
Sbjct: 261 NTSEI 265
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-51
Identities = 70/291 (24%), Positives = 102/291 (35%), Gaps = 48/291 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIK-LLRMLKH 72
++ +G GSYG V G A+K+ F D R L E+ ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLRALK 131
P V ++ E +Y+ EL L Q +A PE +L L AL
Sbjct: 117 PCCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
++HS + H D+KP NI + K+ DFGL T + Y APEL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPEL 227
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
Y A D++S+G E+ L G E +R
Sbjct: 228 LQ---GSYGTAADVFSLGLTILEVACNMELPHG------------------GEGWQQLRQ 266
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALR-LLQRLLAFDPKDRPSAEEI 301
+F LR +L +L DPK R +AE +
Sbjct: 267 GY---------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 85/329 (25%), Positives = 131/329 (39%), Gaps = 57/329 (17%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTG-EKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
+YEI +G G++G V +D G +VA+K ++ V +A R+ EI +L+ +K
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL--EINVLKKIK 74
Query: 72 HPDIVEIKHIMLPPCRREFKD-IYVVFELMESDLDQVIKANDD--LTPEHHQFFLYQLLR 128
D +L F + + FEL+ + + +K N+ H + YQL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 129 ALKYIHSANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVSFT 169
AL+++H + H DLKP+NIL + + +++ DFG
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG------- 187
Query: 170 DTPSAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG 224
SA F + VATR YR PE + + D+WSIGCI E G LF
Sbjct: 188 ---SATFDHEHHTTIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 225 RNVAHQLDLVTDLLGTPSAESIAGIRNEK-------AKRYLSSLRRKWAV---PFSHKFP 274
L ++ +LG + I R +K SS R P
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 275 GA---DPLALRLLQRLLAFDPKDRPSAEE 300
L++R+L FDP R + E
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-50
Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 51/298 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLK 71
+ + I++ IG G + V A G VA+KK++ +F+ + R ++EI LL+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 90
Query: 72 HPDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKA---NDDLTPEHH-QFFL 123
HP++++ F + + +V EL ++ DL ++IK L PE +
Sbjct: 91 HPNVIK--------YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT 183
QL AL+++HS V HRD+KP N+ A +K+ D GL R + T +A V T
Sbjct: 143 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGT 199
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
+Y +PE + Y DIWS+GC+ E+ + F G + + L
Sbjct: 200 PYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKK------- 249
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
I S +S + +L+ + DP+ RP +
Sbjct: 250 -----IEQCDYPPLPSD-------HYSEELR-------QLVNMCINPDPEKRPDVTYV 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-49
Identities = 58/300 (19%), Positives = 102/300 (34%), Gaps = 45/300 (15%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
Y + +G G + V H G A+K++ D RE + R+ HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPN 87
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKA---NDDLTPEHH--QFFLYQLLR 128
I+ + L R + +++ + L I+ + E + R
Sbjct: 88 ILRLVAYCLRE-RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL-LGICR 145
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA------IFWTDYVA 182
L+ IH+ HRDLKP NIL + + + D G + + W
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 183 TRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
T YRAPEL D+WS+GC+ ++ G +
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM----------------- 248
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+K +++ + ++P S + +LL ++ DP RP +
Sbjct: 249 --------VFQKGDSVALAVQNQLSIPQSPRHS---SALWQLLNSMMTVDPHQRPHIPLL 297
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-49
Identities = 83/347 (23%), Positives = 131/347 (37%), Gaps = 73/347 (21%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
+Y +G G + D T E A K + K + ++ EI + R L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+V ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 102 HVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD---------TPSAIFWTDYVAT 183
+H V HRDLK N+ N D ++KI DFGLA D TP +Y+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 208
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
APE+ ++ +D+WSIGCI LL G+P F
Sbjct: 209 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----------------- 245
Query: 244 ESIAGIRNEKAKRYLSSLRRK-WAVPFSHKFPG-ADPLALRLLQRLLAFDPKDRPSAEEI 301
L + + P +P+A L+Q++L DP RP+ E+
Sbjct: 246 --------------LKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINEL 289
Query: 302 R----FTEIVFNWLFLYFYVLALAD-PYFHGLANLEEEPSRKPISKL 343
FT ++ + L P F + + +RKP++ L
Sbjct: 290 LNDEFFTS---GYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 333
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 9e-49
Identities = 74/301 (24%), Positives = 114/301 (37%), Gaps = 65/301 (21%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
+Y +G G + D T E A K + K + ++ EI + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+V ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 76 HVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD---------TPSAIFWTDYVAT 183
+H V HRDLK N+ N D ++KI DFGLA D TP +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 182
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
APE+ ++ +D+WSIGCI LL G+P F
Sbjct: 183 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----------------- 219
Query: 244 ESIAGIRNEKAKRYLSSLRRK-WAVPFSHKFPG-ADPLALRLLQRLLAFDPKDRPSAEEI 301
L + + P +P+A L+Q++L DP RP+ E+
Sbjct: 220 --------------LKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINEL 263
Query: 302 R 302
Sbjct: 264 L 264
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-47
Identities = 80/336 (23%), Positives = 127/336 (37%), Gaps = 34/336 (10%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+E++E +G G +G V I TGE+VAIK+ ++ + R EI++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 75 IVEIKHIMLPPCRREFKD-IYVVFELMES-DLDQVIKANDD---LTPEHHQFFLYQLLRA 129
+V + + + D + E E DL + + ++ L + L + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 130 LKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARV----SFTDTPSAIFWTDYVA 182
L+Y+H + HRDLKP+NI+ KI D G A+ +V
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--------FVG 185
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
T Y APEL KYT +D WS G + E +TG F Q S
Sbjct: 186 TLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKS 240
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
E I + SS+ +H R LQ +L + + R + +
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTP----NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296
Query: 303 ----FTEIVFNWLFLYFYVLALADPYFHGLANLEEE 334
F + V+ + H E E
Sbjct: 297 NVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENE 332
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 86/340 (25%), Positives = 139/340 (40%), Gaps = 67/340 (19%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Y+ + +G G+YG V D T + AIK +++ S +++L E+ +L++L HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 74 DIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRA 129
+I+++ F+D Y+V E + +L I + Q+L
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 130 LKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
+ Y+H N+ HRDLKP+N+L D +KI DFGL+ V F + + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-FENQK---KMKERLGTAYY 204
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APE+ KY D+WSIG I LL G P F G+ L V G + +S
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYTFDS- 258
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEI 306
+W A L++++L FD + R SA++
Sbjct: 259 ----------------PEW--------KNVSEGAKDLIKQMLQFDSQRRISAQQ------ 288
Query: 307 VFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFE 346
AL P+ + + +E P E
Sbjct: 289 ------------ALEHPWIKEMCSKKESGIELPSLANAIE 316
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-47
Identities = 88/341 (25%), Positives = 135/341 (39%), Gaps = 69/341 (20%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+Y I ++G GS+G V D T ++ A+K + + D + ILRE++LL+ L HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 74 DIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRA 129
+I+++ I +D Y+V EL +L I + + Q+
Sbjct: 82 NIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 130 LKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ F D + T +Y
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTK---MKDRIGTAYY 189
Query: 187 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
APE L G Y D+WS G I LL+G P F G+N L V G + +
Sbjct: 190 IAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDL 243
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305
+W A L++++L F P R +A +
Sbjct: 244 -----------------PQW--------RTISDDAKDLIRKMLTFHPSLRITATQ----- 273
Query: 306 IVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFE 346
L P+ ++ S P +
Sbjct: 274 -------------CLEHPWIQKYSSETPTISDLPSLESAMT 301
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 9e-47
Identities = 82/339 (24%), Positives = 136/339 (40%), Gaps = 68/339 (20%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
+Y+ Q ++G GS+G V D TG++ A+K + K + +D +LRE++LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 73 PDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLR 128
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 129 ALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW 185
+ Y+H + HRDLKP+N+L + D ++I DFGL+ F + D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEASK---KMKDKIGTAY 193
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
Y APE+ Y D+WS G I LL+G P F G N L V G + E
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFEL 248
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305
+W A L++++L + P R SA +
Sbjct: 249 -----------------PQW--------KKVSESAKDLIRKMLTYVPSMRISARD----- 278
Query: 306 IVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLV 344
AL + + + +
Sbjct: 279 -------------ALDHEWIQTYTKEQISVDVPSLDNAI 304
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-46
Identities = 81/335 (24%), Positives = 123/335 (36%), Gaps = 79/335 (23%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK---KMKEVFEHVSDATRILREIKLLRML 70
+Y ++ IG GSYGVV AI+ T AIK K K + D RI E++L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQF-------- 121
HP+I + + + + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 122 --------------------------------FLYQLLRALKYIHSANVFHRDLKPKNIL 149
+ Q+ AL Y+H+ + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 150 --ANADCKLKICDFGLARVSFTDTPSAIF-WTDYVATRWYRAPELCGSFFSKYTPAIDIW 206
N ++K+ DFGL++ + + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 207 SIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWA 266
S G + LL G FPG N A + V L +K
Sbjct: 261 SAGVLLHLLLMGAVPFPGVNDADTISQV--------------------------LNKKLC 294
Query: 267 VPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ + PLA LL LL + +R A
Sbjct: 295 FE-NPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 78/398 (19%), Positives = 138/398 (34%), Gaps = 102/398 (25%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-H 72
+ ++I+G GS G V + G VA+K+M F L EIKLL H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDH 68
Query: 73 PDIVEIKHIMLPPCRREFKD---IYVVFELMESDLDQVIKANDDLTPEHHQF-------F 122
P+++ +Y+ EL +L ++++ +
Sbjct: 69 PNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNIL-------------ANADCKLKICDFGLAR-VSF 168
L Q+ + ++HS + HRDLKP+NIL + ++ I DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 169 TDTPSAIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAELLT-GRPLF 222
+ + T +RAPEL + T +IDI+S+GC+F +L+ G+ F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 223 PGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALR 282
+ + I L ++ A
Sbjct: 241 GDKY-----------------SRESNIIRGIFS--LDEMKCLHDRSLI-------AEATD 274
Query: 283 LLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA----------NLE 332
L+ +++ DP RP+A + L P F + +
Sbjct: 275 LISQMIDHDPLKRPTAMK------------------VLRHPLFWPKSKKLEFLLKVSDRL 316
Query: 333 EEPSRKPISKLVFEFERRK---LIKDDVRELIYREILE 367
E +R P S L+ +F+ + D + ++
Sbjct: 317 EIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMD 354
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 72/301 (23%), Positives = 120/301 (39%), Gaps = 64/301 (21%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
+++ ++G GS+ V A HTG +VAIK + K+ R+ E+K+ LKHP
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
I+E+ + +Y+V E+ + + + F++Q++ +
Sbjct: 72 SILELYNYFEDS-----NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD---------TPSAIFWTDYVA 182
Y+HS + HRDL N+L + +KI DFGLA TP +Y+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP------NYI- 179
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
+PE+ S + D+WS+GC+F LL GRP F V
Sbjct: 180 -----SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-------------- 218
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPG-ADPLALRLLQRLLAFDPKDRPSAEEI 301
++L + + + P A L+ +LL +P DR S +
Sbjct: 219 ----------------NTLNKVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260
Query: 302 R 302
Sbjct: 261 L 261
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 68/297 (22%), Positives = 117/297 (39%), Gaps = 57/297 (19%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
+EI +G G +G V A + + +A+K + K E ++ RE+++ L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALK 131
P+I+ + + +Y++ E + + ++ + ++ +L AL
Sbjct: 69 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT-----DYVATRWY 186
Y HS V HRD+KP+N+L + +LKI DFG + PS+ DY+
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYL----- 174
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
PE+ + +D+WS+G + E L G+P F
Sbjct: 175 -PPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------------------ 213
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPG-ADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ +R V F FP A L+ RLL +P RP E+
Sbjct: 214 ------------ETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 83/352 (23%), Positives = 124/352 (35%), Gaps = 81/352 (23%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK-----------KMKEVFEHVSDATRILR 62
Y +G G+YG V + + + AIK + I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEH 118
EI LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAI 175
+ Q+L + Y+H N+ HRD+KP+NIL N+ +KI DFGL+ F+
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-FSKDY--- 203
Query: 176 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLV 234
D + T +Y APE L KY D+WS G I LL G P F G+N + V
Sbjct: 204 KLRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 235 TDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD 294
G + W A L++ +L +D
Sbjct: 260 --EKGKYYFDF-----------------NDW--------KNISDEAKELIKLMLTYDYNK 292
Query: 295 RPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFE 346
R +AEE AL + AN + +
Sbjct: 293 RCTAEE------------------ALNSRWIKKYANNINKSD-QKTLCGALS 325
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 80/293 (27%), Positives = 120/293 (40%), Gaps = 47/293 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Y ++ IG GS+G V A+ T + A KK+ + V D R +EI++++ L HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+I+ + + DIY+V EL +L + + + +L A+ Y
Sbjct: 67 NIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 133 IHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
H NV HRDLKP+N L + D LK+ DFGLA F V T +Y +P
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGK---MMRTKVGTPYYVSP 177
Query: 190 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
+ L G Y P D WS G + LL G P F + + + GT +
Sbjct: 178 QVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPE--- 228
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ W P A L++RLL PK R ++ +
Sbjct: 229 --------------KDW--------LNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 3e-44
Identities = 71/353 (20%), Positives = 116/353 (32%), Gaps = 100/353 (28%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ +E + +G G +GVV A + AIK+++ + +++RE+K L L+HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALAKLEHP 64
Query: 74 DIV-------------------------------------------------EIKHIMLP 84
IV
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 85 PCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQ---FFLYQLLRALKYIHSAN 137
+ ++ M+ +L + L H Q+ A++++HS
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 138 VFHRDLKPKNILANADCKLKICDFGLARV---------SFTDTPSAIFWTDYVATRWYRA 188
+ HRDLKP NI D +K+ DFGL T P+ T V T+ Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
PE + Y+ +DI+S+G I ELL +
Sbjct: 245 PEQIHG--NNYSHKVDIFSLGLILFELLY--SFSTQMERVRIIT---------------D 285
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+RN K F F P ++Q +L+ P +RP A +I
Sbjct: 286 VRNLK---------------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-44
Identities = 75/301 (24%), Positives = 117/301 (38%), Gaps = 49/301 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK-------KMKEVFEHVSDATRILREIKL 66
YE +EI+G G VV I T ++ A+K E L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 67 LRMLK-HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLY 124
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGE---KLREVCGTP 187
Query: 185 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
Y APE + S Y +D+WS G I LL G P F R L ++ + G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGN 245
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
S +W L+ R L P+ R +AEE
Sbjct: 246 YQFGS-----------------PEW--------DDYSDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 301 I 301
Sbjct: 281 A 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-44
Identities = 83/293 (28%), Positives = 128/293 (43%), Gaps = 45/293 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+Y I ++G GS+G V D T ++ A+K + + D + ILRE++LL+ L HP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+I+++ I+ + Y+V EL +L I + + Q+ + Y
Sbjct: 82 NIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 133 IHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
+H N+ HRDLKP+NIL DC +KI DFGL+ +T D + T +Y AP
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAP 192
Query: 190 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
E L G Y D+WS G I LL+G P F G+N L V G + +
Sbjct: 193 EVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDL--- 243
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+W A L++++L F P R +A +
Sbjct: 244 --------------PQW--------RTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-44
Identities = 59/307 (19%), Positives = 112/307 (36%), Gaps = 56/307 (18%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HP 73
+ ++ ++ G + V A D +G + A+K++ + I++E+ ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIK--ANDDLTPEHHQFFLYQLL 127
+IV+ L E ++ + K + L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 128 RALKYIHSAN--VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA--- 182
RA++++H + HRDLK +N+L + +K+CDFG A +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 183 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLV 234
T YR PE+ +S DIW++GCI L + F
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK------- 258
Query: 235 TDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD 294
L + K+++P + L++ +L +P++
Sbjct: 259 -----------------------LRIVNGKYSIPPHDTQY---TVFHSLIRAMLQVNPEE 292
Query: 295 RPSAEEI 301
R S E+
Sbjct: 293 RLSIAEV 299
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 68/291 (23%), Positives = 119/291 (40%), Gaps = 41/291 (14%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
+++ + +G G+YG V A++ T E VA+K + + V I +EI + +ML H
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHE 65
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
++V+ Y+ E +L I+ + + Q F +QL+ + Y
Sbjct: 66 NVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELL 179
Query: 193 GSFFSKYT-PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
++ +D+WS G + +L G + +
Sbjct: 180 KR--REFHAEPVDVWSCGIVLTAMLAGELPWDQ-------------------------PS 212
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ + Y +K + K D L LL ++L +P R + +I+
Sbjct: 213 DSCQEYSDWKEKKTYLNPWKKI---DSAPLALLHKILVENPSARITIPDIK 260
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 67/298 (22%), Positives = 114/298 (38%), Gaps = 59/298 (19%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
++I +G G +G V A + +A+K + K E ++ REI++ L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALK 131
P+I+ + + K IY++ E +L + ++ + + F+ +L AL
Sbjct: 74 PNILRMYNYFHDR-----KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT-----DYVATRWY 186
Y H V HRD+KP+N+L +LKI DFG + PS T DY+
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRTMCGTLDYL----- 179
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
PE+ + +D+W G + E L G P F +
Sbjct: 180 -PPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-------------------- 216
Query: 247 AGIRNEKAKRYLSSLRRK-WAVPFSHKFPG-ADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ R+ V KFP + L+ +LL + P R + +
Sbjct: 217 -----------HTETHRRIVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVM 261
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 44/293 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Y+++E +G G++ VV + TG + A K + D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+IV + + +E Y+VF+L+ +L + I A + + + Q+L ++ Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 133 IHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
HS + HR+LKP+N+L +K+ DFGLA D+ W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGYLSP 176
Query: 190 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
E L Y+ +DIW+ G I LL G P F + + G S
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPS--- 228
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+W P A L+ +L +PK R +A++
Sbjct: 229 --------------PEW--------DTVTPEAKSLIDSMLTVNPKKRITADQA 259
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-43
Identities = 66/300 (22%), Positives = 122/300 (40%), Gaps = 55/300 (18%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM--KEVFEHVSDATRILREIKLLRMLKH 72
+Y + +++G GSYG V +D+ T + A+K + K++ + + +EI+LLR L+H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESD----LDQVIKANDDLTPEHHQFFLYQLLR 128
+++++ ++ + + +Y+V E LD V + + QL+
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLID 120
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT-----DYVAT 183
L+Y+HS + H+D+KP N+L LKI G+A T +
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ-- 178
Query: 184 RWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
PE+ + ++ +DIWS G + TG F G N+ + +
Sbjct: 179 ----PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI-------- 225
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ +A+P P LL+ +L ++P R S +IR
Sbjct: 226 ------------------GKGSYAIPGD-----CGPPLSDLLKGMLEYEPAKRFSIRQIR 262
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-43
Identities = 68/315 (21%), Positives = 125/315 (39%), Gaps = 64/315 (20%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIK------------------------KMKEV 50
QY +++ IG GSYGVV A + + A+K
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 51 FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESD--LDQVI 108
+ ++ +EI +L+ L HP++V++ ++ P +Y+VFEL+ ++ +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVME--V 128
Query: 109 KANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168
L+ + +F+ L++ ++Y+H + HRD+KP N+L D +KI DFG++
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF- 187
Query: 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGRPLFPGRNV 227
S ++ V T + APE ++ A+D+W++G + G+ F
Sbjct: 188 --KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER- 244
Query: 228 AHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRL 287
+ L K K + P P L+ R+
Sbjct: 245 ------IMCLH-------------SKIK------SQALEFP---DQPDIAEDLKDLITRM 276
Query: 288 LAFDPKDRPSAEEIR 302
L +P+ R EI+
Sbjct: 277 LDKNPESRIVVPEIK 291
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-43
Identities = 74/303 (24%), Positives = 121/303 (39%), Gaps = 69/303 (22%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
Y + + +G+G++G V TG KVA+K + ++ + +I REI+ L++ +HP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
I+++ ++ P D ++V E + +L I + + + Q+L A+ Y
Sbjct: 72 HIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW-----YR 187
H V HRDLKP+N+L +A KI DFGL S + Y
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL---------SNMMSDGEFLRTSCGSPNYA 177
Query: 188 APELCGSFFSKYT-PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APE+ Y P +DIWS G I LL G F +
Sbjct: 178 APEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEH-------------------- 215
Query: 247 AGIRNEKAKRYLSSLRRK-----WAVP--FSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299
+ +L +K + +P + LL +L DP R + +
Sbjct: 216 -----------VPTLFKKIRGGVFYIPEYLN-------RSVATLLMHMLQVDPLKRATIK 257
Query: 300 EIR 302
+IR
Sbjct: 258 DIR 260
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 78/295 (26%), Positives = 127/295 (43%), Gaps = 54/295 (18%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
Y I+E +G GS+G V A T +KVA+K + +++ + R+ REI L++L+HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
I+++ ++ P DI +V E +L I +T + + F Q++ A++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW-----YRA 188
H + HRDLKP+N+L + + +KI DFGL S I Y A
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGL---------SNIMTDGNFLKTSCGSPNYAA 175
Query: 189 PELCGSFFSKYT-PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
PE+ Y P +D+WS G + +L GR F + + V
Sbjct: 176 PEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV------------- 220
Query: 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ +P P A L++R++ DP R + +EIR
Sbjct: 221 -------------NSCVYVMPDF-----LSPGAQSLIRRMIVADPMQRITIQEIR 257
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 74/298 (24%), Positives = 129/298 (43%), Gaps = 60/298 (20%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
Y + + IG G++ V A TG +VAIK + + + + ++ RE++++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
IV++ ++ K +Y++ E ++ + A+ + + + Q++ A++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW-----YRA 188
H + HRDLK +N+L +AD +KI DFG S F + Y A
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGF---------SNEFTVGGKLDAFCGAPPYAA 181
Query: 189 PELCGSFFS--KYT-PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD-LLGTPSAE 244
PEL F KY P +D+WS+G I L++G F G+N+ + V P
Sbjct: 182 PEL----FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF-- 235
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
Y+S LL+R L +P R + E+I
Sbjct: 236 ------------YMS------------------TDCENLLKRFLVLNPIKRGTLEQIM 263
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 83/353 (23%), Positives = 130/353 (36%), Gaps = 72/353 (20%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK---KMKEVFEHVSDATRILREIKLLRML 70
YE+ E+IG G + VV I+ TG++ A+K K + RE + ML
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDL-DQVIK---ANDDLTPEHHQFFLYQ 125
KHP IVE+ +Y+VFE M+ +DL +++K A + ++ Q
Sbjct: 84 KHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 126 LLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
+L AL+Y H N+ HRD+KP +L +K+ FG+A V
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGGRVG 195
Query: 183 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
T + APE + Y +D+W G I LL+G F G
Sbjct: 196 TPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK--------------- 237
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPF-SHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
E + +Y ++ A L++R+L DP +R + E
Sbjct: 238 --ERLF--EGIIKGKY----------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYE 283
Query: 301 IRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFE-RRKL 352
AL P+ + + + +F RRKL
Sbjct: 284 ------------------ALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKL 318
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 48/300 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK-----KMKEVFEHVSDAT-RILREIKLL 67
+Y+ +++IG G VV + TG + A+K + E + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 68 RMLK-HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQ 125
R + HP I+ + +++VF+LM +L + L+ + + +
Sbjct: 154 RQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW 185
LL A+ ++H+ N+ HRDLKP+NIL + + ++++ DFG + + T
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGE---KLRELCGTPG 264
Query: 186 YRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
Y APE L S Y +D+W+ G I LL G P F R L ++ + G
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEGQY 322
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
S +W L+ RLL DP+ R +AE+
Sbjct: 323 QFSS-----------------PEW--------DDRSSTVKDLISRLLQVDPEARLTAEQA 357
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 62/289 (21%), Positives = 115/289 (39%), Gaps = 41/289 (14%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+ IG GS+ V +DT T +VA ++++ S+ R E ++L+ L+HP+I
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V + + K I +V ELM S L +K + + + + Q+L+ L+++H
Sbjct: 88 VRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 135 SAN--VFHRDLKPKNILANA-DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
+ + HRDLK NI +KI D GLA + A+ T + APE+
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FM-APEM 201
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
KY ++D+++ G E+ T + A Q+ + +
Sbjct: 202 YE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--------------VTS 244
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ A P +++ + + +R S ++
Sbjct: 245 GVKPASFDKV--------------AIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 68/293 (23%), Positives = 119/293 (40%), Gaps = 45/293 (15%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
+++ + +G G+YG V A++ T E VA+K + + V I +EI + +ML H
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHE 65
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
++V+ Y+ E +L I+ + + Q F +QL+ + Y
Sbjct: 66 NVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL- 178
Query: 193 GSFFS--KYT-PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
++ +D+WS G + +L G +
Sbjct: 179 ---LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ------------------------- 210
Query: 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
++ + Y +K + K D L LL ++L +P R + +I+
Sbjct: 211 PSDSCQEYSDWKEKKTYLNPWKKI---DSAPLALLHKILVENPSARITIPDIK 260
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 83/345 (24%), Positives = 138/345 (40%), Gaps = 63/345 (18%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Y+++E +G G++ VV + TG + A K + D ++ RE ++ R L+HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+IV + + +E Y+VF+L+ +L + I A + + + Q+L ++ Y
Sbjct: 89 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 133 IHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
HS + HR+LKP+N+L +K+ DFGLA D+ W + T Y +P
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGYLSP 199
Query: 190 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
E L Y+ +DIW+ G I LL G P F + + G S
Sbjct: 200 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPS--- 251
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVF 308
+W P A L+ +L +PK R +A++
Sbjct: 252 --------------PEW--------DTVTPEAKSLIDSMLTVNPKKRITADQ-------- 281
Query: 309 NWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFE-RRKL 352
AL P+ + R+ + +F RRKL
Sbjct: 282 ----------ALKVPWICNRERVASAIHRQDTVDCLKKFNARRKL 316
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-42
Identities = 77/300 (25%), Positives = 129/300 (43%), Gaps = 61/300 (20%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIK-----KMKEVFEHVSDATRILREIKLLRML 70
+ + +G G++G V + +G + IK + + +I EI++L+ L
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV------PMEQIEAEIEVLKSL 77
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELMESD--LDQVIKANDD---LTPEHHQFFLYQ 125
HP+I++I + ++ ++Y+V E E L++++ A L+ + + Q
Sbjct: 78 DHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 126 LLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
++ AL Y HS +V H+DLKP+NIL + +KI DFGLA + F T+
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDE---HSTNAAG 188
Query: 183 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
T Y APE T DIWS G + LLTG F G ++
Sbjct: 189 TALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------- 237
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
K + + P + P A+ LL+++L DP+ RPSA ++
Sbjct: 238 -----------TYKEP--NYAVECR-PLT-------PQAVDLLKQMLTKDPERRPSAAQV 276
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-42
Identities = 50/325 (15%), Positives = 111/325 (34%), Gaps = 72/325 (22%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK---------------EVFEHVSDATR 59
Y I + G + + + A+KK + + S
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 60 ILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEH 118
E++++ +K+ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 119 HQ--------FFLYQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVSFT 169
+ +L + YIH+ N+ HRD+KP NIL + + ++K+ DFG +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY--- 201
Query: 170 DTPSAIFWT-----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG 224
+++ PE + S +DIWS+G + F
Sbjct: 202 -MVDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 225 RNVAHQL-------DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGAD 277
+ +L ++ L + ++ + +LS
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS------------------ 296
Query: 278 PLALRLLQRLLAFDPKDRPSAEEIR 302
+ L+ L +P +R ++E+
Sbjct: 297 NEDIDFLKLFLRKNPAERITSEDAL 321
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-42
Identities = 79/345 (22%), Positives = 134/345 (38%), Gaps = 62/345 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+Y++ E +G G++ VV + G++ A + D ++ RE ++ R+LKHP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+IV + + E Y++F+L+ +L + I A + + + Q+L A+ +
Sbjct: 71 NIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 133 IHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
H V HR+LKP+N+L +K+ DFGLA + W + T Y +P
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQA-WFGFAGTPGYLSP 182
Query: 190 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
E L Y +D+W+ G I LL G P F + + G S
Sbjct: 183 EVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPS--- 234
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVF 308
+W P A L+ ++L +P R +A E
Sbjct: 235 --------------PEW--------DTVTPEAKDLINKMLTINPSKRITAAE-------- 264
Query: 309 NWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFE-RRKL 352
AL P+ + + R+ + +F RRKL
Sbjct: 265 ----------ALKHPWISHRSTVASCMHRQETVDCLKKFNARRKL 299
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 79/297 (26%), Positives = 119/297 (40%), Gaps = 53/297 (17%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIK---KMKEVFEHVSDATRILREIKLLRMLK 71
+Y+ + IG G++GV D T E VA+K + + E+V REI R L+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ------REIINHRSLR 74
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRAL 130
HP+IV K ++L P + ++ E +L + I + + +FF QLL +
Sbjct: 75 HPNIVRFKEVILTP-----THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV 129
Query: 131 KYIHSANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
Y HS + HRDLK +N L + +LKICDFG ++ S + V T Y A
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIA 185
Query: 189 PELCGSFFS--KYT-PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
PE+ +Y D+WS G +L G F
Sbjct: 186 PEV----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-------------- 227
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
K L K+++P + P L+ R+ DP R S EI+
Sbjct: 228 --------RKTIQRILSVKYSIPDDIRIS---PECCHLISRIFVADPATRISIPEIK 273
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-41
Identities = 42/330 (12%), Positives = 86/330 (26%), Gaps = 81/330 (24%)
Query: 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK-----------------------KM 47
++G A D TGE + ++
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 48 KEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQV 107
++ A LR I ++K P ++ + L + ++ M+S+L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 108 IKANDDLTPEHHQF-------FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICD 160
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 161 FGLARVSFTDTPSAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCI 211
F S +R + PEL + T + D W++G +
Sbjct: 250 FEHLVRDGARVVS-------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 212 FAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSH 271
+ + + R +P
Sbjct: 303 IYWIWCADLPITKDAALGGSEWI--------------------------FRSCKNIP--- 333
Query: 272 KFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
LL+ L + +DR +
Sbjct: 334 ------QPVRALLEGFLRYPKEDRLLPLQA 357
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 71/296 (23%), Positives = 117/296 (39%), Gaps = 47/296 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK----EVFEHVSDATRILREIKLLRM 69
YE+ E +G G + +V TG++ A K +K I RE+ +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLR 128
++HP+I+ + I D+ ++ EL+ +L + + LT + FL Q+L
Sbjct: 65 IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 129 ALKYIHSANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
+ Y+HS + H DLKP+NI+ + ++K+ DFG+A + + T
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFGTP 175
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
+ APE+ + D+WSIG I LL+G F G L +
Sbjct: 176 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI---------- 223
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ F LA ++RLL DPK R + +
Sbjct: 224 ----------------SAVNYDFD-EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ 262
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 63/317 (19%), Positives = 102/317 (32%), Gaps = 77/317 (24%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-K 71
+++ E IG G +G V + G AIK+ K+ D LRE+ +L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 72 HPDIVEIKHIMLPPCRREFKD--IYVVFELME-SDLDQVIKANDDLT---PEHH-QFFLY 124
H +V +D + + E L I N + E + L
Sbjct: 70 HSHVVRYF-------SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 125 QLLRALKYIHSANVFHRDLKPKNIL-------------------ANADCKLKICDFGLAR 165
Q+ R L+YIHS ++ H D+KP NI A+ KI D G
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR 225
+ + A E+ ++ + P DI+++ PL
Sbjct: 183 -RISSPQV------EEGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNG 234
Query: 226 NVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALR-LL 284
+ H+ IR + R P LL
Sbjct: 235 DQWHE------------------IRQGRLPR----------------IPQVLSQEFTELL 260
Query: 285 QRLLAFDPKDRPSAEEI 301
+ ++ DP+ RPSA +
Sbjct: 261 KVMIHPDPERRPSAMAL 277
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 67/304 (22%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK-----KMKEVFEHVSDATRILREIKLLR 68
++Y + ++G G +G V + +VAIK ++ +SD+ E+ LL
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW-SPLSDSVTCPLEVALLW 89
Query: 69 ML----KHPDIVEIKHIMLPPCRREFKDIYVVFELMES--DLDQVIKANDDLTPEHHQFF 122
+ HP ++ + + +V E DL I L + F
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF 144
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLARVSFTDTPSAIFWTDYV 181
Q++ A+++ HS V HRD+K +NIL + K+ DFG + D P +TD+
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEP----YTDFD 199
Query: 182 ATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGRPLFPGRN--VAHQLDLVTDLL 238
TR Y PE +Y +WS+G + +++ G F + +L
Sbjct: 200 GTRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF----- 252
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
++S P L++R LA P RPS
Sbjct: 253 ----------------PAHVS------------------PDCCALIRRCLAPKPSSRPSL 278
Query: 299 EEIR 302
EEI
Sbjct: 279 EEIL 282
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 77/316 (24%), Positives = 130/316 (41%), Gaps = 66/316 (20%)
Query: 16 YEIQ-EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HP 73
Y++Q +++G G++ V + I+ T ++ A+K +++ + +R+ RE+++L + H
Sbjct: 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHR 71
Query: 74 DIVEIKHIMLPPCRREFKD---IYVVFELME--SDLDQVIKANDDLTPEHHQFF------ 122
+++E+ F++ Y+VFE M S L + K + F
Sbjct: 72 NVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHK---------RRHFNELEAS 114
Query: 123 --LYQLLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARV----SFTDTPS 173
+ + AL ++H+ + HRDLKP+NIL N +KICDF L S
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 174 AIFWTDYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQ 230
+ Y APE+ S Y D+WS+G I LL+G P F GR +
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234
Query: 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGAD-----PLALRLLQ 285
+ I+ K ++FP D A L+
Sbjct: 235 GWDRGEACPACQNMLFESIQEGK-----------------YEFPDKDWAHISCAAKDLIS 277
Query: 286 RLLAFDPKDRPSAEEI 301
+LL D K R SA ++
Sbjct: 278 KLLVRDAKQRLSAAQV 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 41/324 (12%), Positives = 82/324 (25%), Gaps = 70/324 (21%)
Query: 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK----------KMKEVFEHVSDATRI 60
++G A D TGE + + + R+
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 61 LREIK-------------LLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQV 107
LR IK ++K P ++ + L + ++ M+S+L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 108 IKANDDLTPEHHQ-------FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICD 160
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 161 FGLARVSFTDTPSAIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAELLT 217
F + A A + + T A D W++G +
Sbjct: 255 FEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 218 GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGAD 277
+ + R +P
Sbjct: 313 ADLPNTDDAALGGSEWI--------------------------FRSCKNIP--------- 337
Query: 278 PLALRLLQRLLAFDPKDRPSAEEI 301
LL+ L + +DR +
Sbjct: 338 QPVRALLEGFLRYPKEDRLLPLQA 361
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 71/348 (20%), Positives = 124/348 (35%), Gaps = 68/348 (19%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Y+I E +G G++GVV ++ TG K + + D + EI ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 74 DIVEIKHIMLPPCRREFKD---IYVVFELME-SDL-DQVIKANDDLTPEHHQFFLYQLLR 128
++ + F+D + ++ E + +L D++ + ++ ++ Q
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 129 ALKYIHSANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
LK++H ++ H D+KP+NI+ +KI DFGLA P I AT +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVT-TATAEF 216
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APE+ D+W+IG + LL+G F G + L V
Sbjct: 217 AAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------------ 262
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEI 306
R W F P A ++ LL +P+ R + +
Sbjct: 263 --------------KRCDWEFD-EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD------ 301
Query: 307 VFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIK 354
AL P+ G + + + + K
Sbjct: 302 ------------ALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-40
Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 65/301 (21%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIK-----KMKEVFEHVSDATRILREIKLLRM 69
QY++ ++G G +G V S I VAIK ++ + + + TR+ E+ LL+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-GELPNGTRVPMEVVLLKK 102
Query: 70 LKH--PDIVEIKHIMLPPCRREFKDIYVVFELMES--DLDQVIKANDDLTPEHHQFFLYQ 125
+ ++ + P ++ E E DL I L E + F +Q
Sbjct: 103 VSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 126 LLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
+L A+++ H+ V HRD+K +NIL + + +LK+ DFG + DT +TD+ TR
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTV----YTDFDGTR 212
Query: 185 WYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGRPLFPGRN--VAHQLDLVTDLLGTP 241
Y PE + +Y + +WS+G + +++ G F + Q+
Sbjct: 213 VYSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF-------- 262
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
++ +S L++ LA P DRP+ EEI
Sbjct: 263 -------------RQRVS------------------SECQHLIRWCLALRPSDRPTFEEI 291
Query: 302 R 302
+
Sbjct: 292 Q 292
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-40
Identities = 71/299 (23%), Positives = 119/299 (39%), Gaps = 53/299 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK----EVFEHVSDATRILREIKLLRM 69
Y+ E +G G + VV + TG + A K +K + I RE+ +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 70 LKHPDIVEIKHIMLPPCRREFKD---IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQ 125
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 126 LLRALKYIHSANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFTDTPSAIFWTDYV 181
+L + Y+HS + H DLKP+NI+ ++KI DFGLA + +
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIF 178
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
T + APE+ + D+WSIG I LL+G F G L V
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ F LA ++RLL DPK R + ++
Sbjct: 230 -------------------SAVNYEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 93/458 (20%), Positives = 162/458 (35%), Gaps = 80/458 (17%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
Y + + +G+G++G V TG KVA+K + ++ + +I REI+ L++ +HP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
I+++ ++ P DI++V E + +L I N L + + Q+L + Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW-----YR 187
H V HRDLKP+N+L +A KI DFGL S + Y
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGL---------SNMMSDGEFLRTSCGSPNYA 182
Query: 188 APELCGSFFSKYT-PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APE+ Y P +DIWS G I LL G F +
Sbjct: 183 APEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------------------- 220
Query: 247 AGIRNEKAKRYLSSLRRK-----WAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ +L +K + P +P + LL+ +L DP R + ++I
Sbjct: 221 -----------VPTLFKKICDGIFYTPQY-----LNPSVISLLKHMLQVDPMKRATIKDI 264
Query: 302 RFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELI 361
R E W + + +++E ++ K FE +++
Sbjct: 265 REHE----WFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEK--FECSEEEVLSCLYNR-- 316
Query: 362 YREILEYHPHMLEEY--LQGTDHTHFMYPSGVDQFKQQFARLEEQYGKRERHIPLRRKYT 419
+ + Y + + L++ + R +
Sbjct: 317 -----NHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVA 371
Query: 420 SLPRERISTSEDEATDQTDSLKKRTASVTRATLQSPPS 457
PR R + E ++ QS P+
Sbjct: 372 ETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPN 409
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-39
Identities = 69/294 (23%), Positives = 118/294 (40%), Gaps = 50/294 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Y+I E +G G++GVV + TG A K + H SD + +EI+ + +L+HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 74 DIVEIKHIMLPPCRREFKD---IYVVFELME-SDL-DQVIKANDDLTPEHHQFFLYQLLR 128
+V + F+D + +++E M +L ++V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 129 ALKYIHSANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
L ++H N H DLKP+NI+ +LK+ DFGL P T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSV-KVTTGTAEF 322
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APE+ D+WS+G + LL+G F G N L V
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------------ 368
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
W + F G +++LL DP R + +
Sbjct: 369 --------------KSCDWNMD-DSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 407
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 47/296 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK----EVFEHVSDATRILREIKLLRM 69
Y+I E +G G + +V + TG + A K +K I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLR 128
+ H +++ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 129 ALKYIHSANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
+ Y+H+ + H DLKP+NI+ +K+ DFGLA + + T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTP 182
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
+ APE+ + D+WSIG I LL+G F G L +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---------- 230
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ F LA +++LL + + R + +E
Sbjct: 231 ----------------TSVSYDFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 62/295 (21%), Positives = 120/295 (40%), Gaps = 53/295 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+Y I E +G G +G+V ++T + + K +K +D + +EI +L + +H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHR 61
Query: 74 DIVEIKHIMLPPCRREFKD---IYVVFELME-SDL-DQVIKANDDLTPEHHQFFLYQLLR 128
+I+ + F+ + ++FE + D+ +++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 129 ALKYIHSANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
AL+++HS N+ H D++P+NI+ +KI +FG AR P F Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNF-RLLFTAPEY 169
Query: 187 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
APE + A D+WS+G + LL+G F ++ +
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI----------- 215
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ ++ F A+ + RLL + K R +A E
Sbjct: 216 ---------------MNAEYTFD-EEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 72/353 (20%), Positives = 128/353 (36%), Gaps = 68/353 (19%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK----EVFEHVSDATRILREIKLLRM 69
Y+I E +G G + +V + TG + A K +K I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLR 128
+ HP+I+ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 129 ALKYIHSANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
+ Y+H+ + H DLKP+NI+ +K+ DFGLA + + T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTP 182
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
+ APE+ + D+WSIG I LL+G F G L +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---------- 230
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFT 304
+ F LA +++LL + + R + +E
Sbjct: 231 ----------------TAVSYDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQE---- 269
Query: 305 EIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPIS---KLVFEFERRKLIK 354
AL P+ + + R+ + ++ RR+
Sbjct: 270 --------------ALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKL 308
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 71/313 (22%), Positives = 125/313 (39%), Gaps = 61/313 (19%)
Query: 3 DKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR 62
D F+ Y + +G GS+ + + + + A+K + + +
Sbjct: 3 DSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQK 54
Query: 63 EIKLLRMLK-HPDIVEIKHIMLPPCRREFKD---IYVVFELME-SDLDQVIKANDDLTPE 117
EI L++ + HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 55 EITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSET 106
Query: 118 HHQFFLYQLLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSA 174
+ + +L+ A+ ++H V HRDLKP+N+L N + ++KI DFG AR+ D
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165
Query: 175 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233
T Y APE L + Y + D+WS+G I +L+G+ F + +
Sbjct: 166 --LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGAD-----PLALRLLQRLL 288
+++ + I K + F G A L+Q LL
Sbjct: 221 AVEIM-----KKI------KKGDF--------------SFEGEAWKNVSQEAKDLIQGLL 255
Query: 289 AFDPKDRPSAEEI 301
DP R +
Sbjct: 256 TVDPNKRLKMSGL 268
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 56/300 (18%)
Query: 15 QYEI-QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KH 72
Y++ ++++G+G G V TG+K A+K + D+ + +E+
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL-------LYDSPKARQEVDHHWQASGG 81
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHH-QFFLYQLLRA 129
P IV I + + + + ++ E ME ++ + D E + + A
Sbjct: 82 PHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 130 LKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
++++HS N+ HRD+KP+N+L D LK+ DFG A+ T + T +Y
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNA---LQTPCYTPYY 195
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APE+ G KY + D+WS+G I LL G P F T A S
Sbjct: 196 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSN--------------TGQAISP 239
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGAD-----PLALRLLQRLLAFDPKDRPSAEEI 301
R + +Y FP + A +L++ LL DP +R + +
Sbjct: 240 GMKRRIRLGQY--------------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 74/294 (25%), Positives = 115/294 (39%), Gaps = 49/294 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+E++ +G G+ +V T + A+K +K+ D + EI +L L HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHP 108
Query: 74 DIVEIKHIMLPPCRREFKD-IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALK 131
+I+++K I E I +V EL+ +L I + + Q+L A+
Sbjct: 109 NIIKLKEIF------ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 132 YIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
Y+H + HRDLKP+N+L D LKI DFGL+++ T Y A
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQV---LMKTVCGTPGYCA 218
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
PE L G Y P +D+WS+G I LL G F + I
Sbjct: 219 PEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-----------FRRI- 263
Query: 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
Y W + A L+++L+ DPK R + +
Sbjct: 264 -----LNCEY--YFISPW-------WDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 77/305 (25%), Positives = 119/305 (39%), Gaps = 70/305 (22%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIK---KMKEVFEHVSDATRILREIK-LLRML 70
YE++E IG+GSY V I T + A+K K K EI+ LLR
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYG 73
Query: 71 KHPDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQL 126
+HP+I+ +K + + D +YVV ELM+ +L I + L+ +
Sbjct: 74 QHPNIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125
Query: 127 LRALKYIHSANVFHRDLKPKNIL----ANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
+ ++Y+H+ V HRDLKP NIL + ++ICDFG A+ +
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCY 182
Query: 183 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
T + APE L Y A DIWS+G + +LTG F ++
Sbjct: 183 TANFVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI-------- 231
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGAD-----PLALRLLQRLLAFDPKDRP 296
I + ++ G A L+ ++L DP R
Sbjct: 232 -LARI------GSGKF--------------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRL 270
Query: 297 SAEEI 301
+A +
Sbjct: 271 TAALV 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 70/304 (23%), Positives = 110/304 (36%), Gaps = 58/304 (19%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRIL-----REIKLLR 68
++ E ++ IG G +G+V VAIK + RE+ ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 69 MLKHPDIVEIKHIML-PPCRREFKDIYVVFELMES-DLDQVI-KANDDLTPEHHQFFLYQ 125
L HP+IV++ +M PP +V E + DL + + +
Sbjct: 79 NLNHPNIVKLYGLMHNPPR--------MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 126 LLRALKYIHSAN--VFHRDLKPKNIL-----ANADCKLKICDFGLARVSFTDTPSAIFWT 178
+ ++Y+ + N + HRDL+ NI NA K+ DFGL++ S +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV------S 184
Query: 179 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238
+ + APE G+ YT D +S I +LTG F
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-------------Y 231
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALR-LLQRLLAFDPKDRPS 297
+ I IR E LR P P P LR +++ + DPK RP
Sbjct: 232 SYGKIKFINMIREEG-------LR-----P---TIPEDCPPRLRNVIELCWSGDPKKRPH 276
Query: 298 AEEI 301
I
Sbjct: 277 FSYI 280
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 59/299 (19%), Positives = 112/299 (37%), Gaps = 61/299 (20%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM------KEVFEHVSDATRILREIKLLR 68
+Y +G G++G V +A+D ++V +K + ++ + ++ EI +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES--DLDQVIKANDDLTPEHHQFFLYQL 126
++H +I+++ I +V E S DL I + L + QL
Sbjct: 85 RVEHANIIKVLDIFENQ-----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
+ A+ Y+ ++ HRD+K +NI+ D +K+ DFG A +F+T + T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYT-FCGTIEY 195
Query: 187 RAPELCGSFFS--KYT-PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
APE+ Y P +++WS+G L+ F
Sbjct: 196 CAPEV----LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE----------------- 234
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ + P+ + L+ LL P+ R + E++
Sbjct: 235 -----------ET----VEAAIHPPYL-----VSKELMSLVSGLLQPVPERRTTLEKLV 273
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 66/325 (20%), Positives = 107/325 (32%), Gaps = 53/325 (16%)
Query: 12 EASQYEIQEIIGIG--SYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM 69
E YE+ +IG G V A TGE V ++++ T + E+ + ++
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHH-QFFLYQL 126
HP+IV + + +++VV M S D + D E + L +
Sbjct: 83 FNHPNIVPYRATFI-----ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS-----AIFWTDYV 181
L+AL YIH HR +K +IL + D K+ + S F V
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL-SMISHGQRQRVVHDFPKYSV 196
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRP----------LF--------- 222
+ +PE+ Y DI+S+G EL G L
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256
Query: 223 -------PGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPG 275
P + G + + + R R ++ F H F
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF-HHF-- 313
Query: 276 ADPLALRLLQRLLAFDPKDRPSAEE 300
+++ L +P RPSA
Sbjct: 314 --------VEQCLQRNPDARPSAST 330
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 73/299 (24%), Positives = 111/299 (37%), Gaps = 69/299 (23%)
Query: 20 EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
++G G+YG+V + D ++AIK++ E S + EI L + LKH +IV+
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP--LHEEIALHKHLKHKNIVQYL 85
Query: 80 HIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
E I + E + S L + + F+ Q+L LKY+H
Sbjct: 86 G-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 136 ANVFHRDLKPKNILANA-DCKLKICDFGLARV---------SFTDTPSAIFWTDYVATRW 185
+ HRD+K N+L N LKI DFG ++ +FT T +
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL---QYM------- 190
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
APE+ Y A DIWS+GC E+ TG+P F ++L E
Sbjct: 191 --APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF------YELG-----------EP 231
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFP----GADPLALRLLQRLLAFDPKDRPSAEE 300
A + + V P A + + DP R A +
Sbjct: 232 QAAM---------------FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACAND 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
Q +G GS+G V D TG + A+KK++ E E+ L P I
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVACAGLSSPRI 112
Query: 76 VEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
V + RE + + EL+E S L Q+IK L + ++L Q L L+Y+
Sbjct: 113 VPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 134 HSANVFHRDLKPKNILANAD-CKLKICDFGLARVSFTDTPSAIFWTDY--VATRWYRAPE 190
H+ + H D+K N+L ++D + +CDFG A D T T + APE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRP 220
+ +DIWS C+ +L G
Sbjct: 227 VVMG--KPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 54/297 (18%)
Query: 14 SQYEI--QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
S Y + EI+G G +G V +T TG K+A K +K + D + EI ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 72 HPDIVEIKHIMLPPCRREF---KDIYVVFELME-SDL-DQVIKANDDLTPEHHQFFLYQL 126
H +++++ F DI +V E ++ +L D++I + +LT F+ Q+
Sbjct: 145 HANLIQLYDA--------FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 127 LRALKYIHSANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
++++H + H DLKP+NIL ++KI DFGLAR P T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKL-KVNFGTP 252
Query: 185 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
+ APE + F + D+WS+G I LL+G F G N A L+ +
Sbjct: 253 EFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI--------- 300
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
L +W + +F A + +LL + R SA E
Sbjct: 301 -----------------LACRWDLE-DEEFQDISEEAKEFISKLLIKEKSWRISASE 339
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 68/298 (22%), Positives = 116/298 (38%), Gaps = 52/298 (17%)
Query: 14 SQYEIQ-EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
+ Y + + +G G + VV I TG++ A K +K+ IL EI +L + K
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 73 -PDIVEIKHIMLPPCRREFKD---IYVVFELME-SDL-DQVIKANDDLTPEHH-QFFLYQ 125
P ++ + + +++ I ++ E ++ + ++ E+ + Q
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 126 LLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
+L + Y+H N+ H DLKP+NIL +KI DFG++R + +
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LREIMG 195
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
T Y APE+ + T A D+W+IG I LLT F G + +
Sbjct: 196 TPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI-------- 245
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ F LA +Q LL +P+ RP+AE
Sbjct: 246 ------------------SQVNVDYS-EETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-37
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 49/300 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRML 70
Q + + IG GS+G V + G+ VA+K + E+ +LR
Sbjct: 24 GQITVGQRIGSGSFGTV------YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD-LTPEHHQFFLYQLLR 128
+H +I+ P + +V + E S L + A++ + Q R
Sbjct: 78 RHVNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
+ Y+H+ ++ HRDLK NI + D +KI DFGLA + + + + + A
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK-SRWSGSHQFEQLSGSILWMA 190
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
PE + + Y+ D+++ G + EL+TG+ + N + I
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--------------NRDQIIE 236
Query: 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIV 307
+ LS +R RL+ L +RPS F I+
Sbjct: 237 MVGRGSLSPDLSKVR-----------SNCPKRMKRLMAECLKKKRDERPS-----FPRIL 280
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 71/316 (22%), Positives = 120/316 (37%), Gaps = 73/316 (23%)
Query: 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREI 64
+Y +++G+G G V + T EK A+K + D + RE+
Sbjct: 58 AIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKM-------LQDCPKARREV 105
Query: 65 KLL-RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQF 121
+L R + P IV I + K + +V E ++ ++ Q
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD-------RGDQA 157
Query: 122 F--------LYQLLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTD 170
F + + A++Y+HS N+ HRD+KP+N+L + LK+ DFG A+ + +
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQ 230
T T +Y APE+ G KY + D+WS+G I LL G P F +
Sbjct: 218 NS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH---- 267
Query: 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGAD-----PLALRLLQ 285
G + + + +Y +FP + L++
Sbjct: 268 --------GLAISPGMK--TRIRMGQY--------------EFPNPEWSEVSEEVKMLIR 303
Query: 286 RLLAFDPKDRPSAEEI 301
LL +P R + E
Sbjct: 304 NLLKTEPTQRMTITEF 319
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-36
Identities = 71/305 (23%), Positives = 119/305 (39%), Gaps = 30/305 (9%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
+ +E +G G+ GVV +G +A K + + + +I+RE+++L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECN 89
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKANDDLTPEHHQFFLYQLLRAL 130
P IV +I + E M+ LDQV+K + + +++ L
Sbjct: 90 SPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 131 KYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
Y+ + HRD+KP NIL N+ ++K+CDFG++ D+ + F V TR Y +P
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSF----VGTRSYMSP 199
Query: 190 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGR-PLFPGRNVAHQLDLVTDLLGTPSAESIA 247
E L G + Y+ DIWS+G E+ GR P+ P +L + G +
Sbjct: 200 ERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 248 GIRNEKAKRYLSSLRRKWAVPFS--HKFPGADPLALRLLQRLLAF----------DPKDR 295
+ R F P L L F +P +R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316
Query: 296 PSAEE 300
++
Sbjct: 317 ADLKQ 321
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 56/306 (18%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Q EI E+IG G +G V GE VAI+ + ++ RE+ R +H
Sbjct: 33 EQLEIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 74 DIVE-IKHIMLPPCRREFKDIYVVFELME-SDLDQVI-KANDDLTPEHHQFFLYQLLRAL 130
++V + M PP + ++ L + L V+ A L + ++++ +
Sbjct: 90 NVVLFMGACMSPPH------LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGM 143
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR--A 188
Y+H+ + H+DLK KN+ + + K+ I DFGL +S + W A
Sbjct: 144 GYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 189 PEL-------CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
PE+ ++ D++++G I+ EL F +
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP--------------- 247
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
AE+I K LS + G +L AF+ ++RP+
Sbjct: 248 -AEAIIWQMGTGMKPNLSQI-------------GMGKEISDILLFCWAFEQEERPT---- 289
Query: 302 RFTEIV 307
FT+++
Sbjct: 290 -FTKLM 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-36
Identities = 80/303 (26%), Positives = 124/303 (40%), Gaps = 64/303 (21%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ E++E++G G++GVV A + VAIK+++ S+ + E++ L + HP
Sbjct: 8 KEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIE----SESERKAFIVELRQLSRVNHP 61
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVI---KANDDLTPEHHQFFLYQLLRA 129
+IV++ L P +V E E L V+ + T H + Q +
Sbjct: 62 NIVKLYGACLNPV-------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 130 LKYIHSAN---VFHRDLKPKNILANADCK-LKICDFGLARVSFTDTPSAIFWTDYVATRW 185
+ Y+HS + HRDLKP N+L A LKICDFG A T T+ +
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGSAA 168
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
+ APE+ S Y+ D++S G I E++T R F +G P+
Sbjct: 169 WMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDE-------------IGGPAFRI 213
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALR-LLQRLLAFDPKDRPSAEEIRFT 304
+ + N R P P + L+ R + DP RPS
Sbjct: 214 MWAVHN--------GTR-----P---PLIKNLPKPIESLMTRCWSKDPSQRPS-----ME 252
Query: 305 EIV 307
EIV
Sbjct: 253 EIV 255
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 83/305 (27%), Positives = 124/305 (40%), Gaps = 76/305 (24%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+Y E IG G+ G V +A+D TG++VAI++M + I+ EI ++R K+P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 74 DIVEIKHIMLPPCRREFKDIY-------VVFELME--SDLDQVIKANDDLTPEHHQFFLY 124
+IV + D Y VV E + S D V+ +
Sbjct: 78 NIVN------------YLDSYLVGDELWVVMEYLAGGSLTD-VVTETC-MDEGQIAAVCR 123
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFTDTPSAI 175
+ L+AL+++HS V HRD+K NIL D +K+ DFG R + TP
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP--- 180
Query: 176 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVT 235
+W APE+ Y P +DIWS+G + E++ G P + N L L+
Sbjct: 181 YWM---------APEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR 295
GTP ++ K + F F L R L D + R
Sbjct: 230 T-NGTPELQN----------------PEKLSAIF-RDF----------LNRCLEMDVEKR 261
Query: 296 PSAEE 300
SA+E
Sbjct: 262 GSAKE 266
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 70/302 (23%), Positives = 117/302 (38%), Gaps = 62/302 (20%)
Query: 17 EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
I+E IG GS+G V A G VA+K + E H LRE+ +++ L+HP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 77 EIKHIML-PPCRREFKDIYVVFELME-SDLDQVIKANDD---LTPEHHQFFLYQLLRALK 131
+ PP + +V E + L +++ + L Y + + +
Sbjct: 98 LFMGAVTQPPN------LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 132 YIHSAN--VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
Y+H+ N + HR+LK N+L + +K+CDFGL+R+ + S+ T + AP
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAP 208
Query: 190 ELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
E+ D++S G I EL T + +
Sbjct: 209 EVLRD--EPSNEKSDVYSFGVILWELATLQQPWGN------------------------- 241
Query: 250 RNEKAKRYLSSLRRKWAVPFSHKFP----GADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305
L+ + AV F K +P +++ +P RPS F
Sbjct: 242 --------LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPS-----FAT 288
Query: 306 IV 307
I+
Sbjct: 289 IM 290
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIKLLRMLK 71
+ IG GS+G V A D E VAIKKM + I++E++ L+ L+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRAL 130
HP+ ++ + L ++V E S D + L + L+ L
Sbjct: 113 HPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLA-----RVSFTDTPSAIFWTDYVATRW 185
Y+HS N+ HRD+K NIL + +K+ DFG A SF TP +W
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP---YWM------- 217
Query: 186 YRAPEL-CGSFFSKYTPAIDIWSIGCIFA-ELLTGRP 220
APE+ +Y +D+WS+G I EL +P
Sbjct: 218 --APEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP 251
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 71/296 (23%), Positives = 123/296 (41%), Gaps = 62/296 (20%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+ IG GS G+V A + H+G +VA+K M + E+ ++R +H ++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNV 104
Query: 76 VEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
VE M ++++V+ E ++ + D ++ L E +L+AL Y+
Sbjct: 105 VE----MYKSYLVG-EELWVLMEFLQGGALTD-IVSQVR-LNEEQIATVCEAVLQALAYL 157
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFTDTPSAIFWTDYVATR 184
H+ V HRD+K +IL D ++K+ DFG R S TP +W
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP---YWM------ 208
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
APE+ S Y +DIWS+G + E++ G P + + + + D P +
Sbjct: 209 ---APEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKLK 262
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300
+ K + F L+R+L DP++R +A+E
Sbjct: 263 N----------------SHKVSPVL-RDF----------LERMLVRDPQERATAQE 291
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-35
Identities = 68/293 (23%), Positives = 109/293 (37%), Gaps = 54/293 (18%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTH-TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
A QYE++ I G G + A+D + G V +K + + + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRAL 130
HP IV+I + + R Y+V E + L + L +L ++L AL
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
Y+HS + + DLKP+NI+ + +LK+ D G T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY------GTPGFQAPE 247
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
+ + T A DI+++G A L P GR V
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------- 283
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-SAEEIR 302
+P RLL+R + DP+ R +AEE+
Sbjct: 284 ----------------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 35/227 (15%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDAT---RILREIKLLRMLKH 72
Y ++ ++G G G V A DT VA+K M E SD R+ RE + L+
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQE 93
Query: 73 PDIV------EIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQ 125
P +V EI + YV L+ DL +++ L P + Q
Sbjct: 94 PHVVPIHDFGEIDGQL-----------YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQ 142
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR----VSFTDTPSAIFWTDYV 181
+ AL H+A HRD+KP+NIL +AD + DFG+A T + V
Sbjct: 143 IGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT------V 196
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA 228
T +Y APE S T DI+++ C+ E LTG P + G ++
Sbjct: 197 GTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLS 241
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-K 71
A +E+ E++G G+YG V TG+ AIK M + + I +EI +L+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---IKQEINMLKKYSH 79
Query: 72 HPDIVEIKHIMLPPCRREFKD-IYVVFELME----SDLDQVIKANDDLTPEHHQFFLYQL 126
H +I + D +++V E +DL + K N L E + ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREI 138
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFTDTPSAIFW 177
LR L ++H V HRD+K +N+L + ++K+ DFG++ R +F TP +W
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP---YW 195
Query: 178 TDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCIFA-ELLTGRP 220
APE C + Y D+WS+G I A E+ G P
Sbjct: 196 M---------APEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAP 232
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 62/306 (20%), Positives = 112/306 (36%), Gaps = 56/306 (18%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
S E++G G +G TGE + +K++ E L+E+K++R L+
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLE 65
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLLRA 129
HP++++ + ++ K + + E ++ L +IK+ D F +
Sbjct: 66 HPNVLK----FIGVLYKD-KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV-----------SFTDTPSAIFWT 178
+ Y+HS N+ HRDL N L + + + DFGLAR+ P
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 179 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG---RNVAHQLDLVT 235
V ++ APE+ Y +D++S G + E++ P R + L++
Sbjct: 181 TVVGNPYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR- 237
Query: 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR 295
+ P P P + R DP+ R
Sbjct: 238 -----------GFLDRY--------------CP-----PNCPPSFFPITVRCCDLDPEKR 267
Query: 296 PSAEEI 301
PS ++
Sbjct: 268 PSFVKL 273
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 49/230 (21%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
+EI +G G++G V A + TG A K ++ + + + EI++L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDH 75
Query: 73 PDIVEIKHIMLPPCRREFKDIY-------VVFELME--SDLDQVIKANDDLTPEHHQFFL 123
P IV+ Y ++ E + +++ + LT Q
Sbjct: 76 PYIVK------------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVC 123
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFTDTPSA 174
Q+L AL ++HS + HRDLK N+L + +++ DFG++ R SF TP
Sbjct: 124 RQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP-- 181
Query: 175 IFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-ELLTGRP 220
+W APE+ K Y DIWS+G I E+ P
Sbjct: 182 -YWM---------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 22/222 (9%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK-EVFEHVSDATRILREIK-LLRM 69
E + E +G G+ G V TG +A+K+M+ + + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKS 80
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPE-HHQFFLYQLLR 128
P IV+ + D+++ ELM + +++ K PE +++
Sbjct: 81 HDCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 129 ALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVS--FTDTPSAIFWTDYVATRW 185
AL Y+ V HRD+KP NIL + ++K+CDFG +S D +
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAK---DRSAGCAA 189
Query: 186 YRAPE---LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG 224
Y APE Y D+WS+G EL TG+ +
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 74/303 (24%), Positives = 118/303 (38%), Gaps = 64/303 (21%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDAT---RILREIKLLRMLKH 72
Y+I + +G G V A DT KVAIK + R RE+ L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQLSH 70
Query: 73 PDIVEIKHIMLPPCRREFKDI-------YVVFELME-SDLDQVIKANDDLTPEHHQFFLY 124
+IV + D+ Y+V E +E L + I+++ L+ + F
Sbjct: 71 QNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTN 118
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR----VSFTDTPSAIFWTDY 180
Q+L +K+ H + HRD+KP+NIL +++ LKI DFG+A+ S T T +
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL----- 173
Query: 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
T Y +PE DI+SIG + E+L G P F G
Sbjct: 174 -GTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNG---------------- 214
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-SAE 299
+A SIA + ++ + ++ R D +R + +
Sbjct: 215 ETAVSIA----------IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQ 264
Query: 300 EIR 302
E++
Sbjct: 265 EMK 267
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 70/301 (23%), Positives = 117/301 (38%), Gaps = 50/301 (16%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIK-LLRML 70
A + IG G+YG V + +G+ +A+K+++ + ++L ++ ++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSS 78
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELM----ESDLDQVIKANDDLTPEHH-QFFLYQ 125
P IV+ + D ++ ELM + V DD+ PE
Sbjct: 79 DCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 126 LLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVS--FTDTPSAIFWTDYVA 182
++AL ++ + HRD+KP NIL + +K+CDFG +S D+ + T
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAK---TRDAG 187
Query: 183 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLTGR-PLFPGRNVAHQLDLVTDLLG 239
R Y APE + Y D+WS+G EL TGR P +V QL
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ------ 241
Query: 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299
+ + +S R+++ F F + L D RP +
Sbjct: 242 ---------VVKGDPPQLSNSEEREFSPSF-INF----------VNLCLTKDESKRPKYK 281
Query: 300 E 300
E
Sbjct: 282 E 282
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 64/313 (20%), Positives = 105/313 (33%), Gaps = 84/313 (26%)
Query: 3 DKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR 62
+Y +++G+G G V + T EK A+K + D + R
Sbjct: 12 KNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKM-------LQDCPKARR 59
Query: 63 EIKLL-RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESD--LDQVIKANDDLTPEHH 119
E++L R + P IV I + K + +V E ++ ++
Sbjct: 60 EVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD-------RGD 111
Query: 120 QFF--------LYQLLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSF 168
Q F + + A++Y+HS N+ HRD+KP+N+L + LK+ DFG
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----- 166
Query: 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA 228
A E G KY + D+WS+G I LL G P F +
Sbjct: 167 -------------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSNH-- 202
Query: 229 HQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLL 288
G++ +W L++ LL
Sbjct: 203 -------------GLAISPGMKTRIRMGQYEFPNPEW--------SEVSEEVKMLIRNLL 241
Query: 289 AFDPKDRPSAEEI 301
+P R + E
Sbjct: 242 KTEPTQRMTITEF 254
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 79/302 (26%), Positives = 124/302 (41%), Gaps = 69/302 (22%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM--KEVFEHVSDATRILREIKLLRML 70
+ E IG GS+G V ID T + VAIK + +E + + D I +EI +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED---IQQEITVLSQC 77
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLR 128
P + + L + ++++ E + S LD +++ L L ++L+
Sbjct: 78 DSPYVTKYYGSYL-----KDTKLWIIMEYLGGGSALD-LLEPGP-LDETQIATILREILK 130
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFTDTPSAIFWTD 179
L Y+HS HRD+K N+L + ++K+ DFG+A R +F TP FW
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP---FWM- 186
Query: 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLTGRPLFPGRNVAHQLDLVTDLL 238
APE+ S Y DIWS+G I A EL G P +L + L
Sbjct: 187 --------APEVIKQ--SAYDSKADIWSLG-ITAIELARGEPPH------SELHPMKVLF 229
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
P +N L ++ P +F ++ L +P RP+A
Sbjct: 230 LIP--------KNNPPT-----LEGNYSKPL-KEF----------VEACLNKEPSFRPTA 265
Query: 299 EE 300
+E
Sbjct: 266 KE 267
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 35/232 (15%), Positives = 72/232 (31%), Gaps = 36/232 (15%)
Query: 15 QYEIQEIIGIGSYGVVASAI-----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM 69
+ ++G G++ V A D +K +K K + + + ++ L+
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKP 123
Query: 70 LKHPDIVEIKHIMLPPCRREFKD-IYVVFELME-SDLDQVIK-----ANDDLTPEHHQFF 122
++ F++ +V EL L I + F
Sbjct: 124 SMQHMFMKFYSAH------LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNIL-----------ANADCKLKICDFGLARVSFTDT 171
++L ++ +H + H D+KP N + + L + D G +
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 172 PSAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222
IF T ++ E L + ID + + +L G +
Sbjct: 238 KGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMK 285
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 24/241 (9%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIK-LLRML 70
+A E +G G+YGVV +G+ +A+K+++ + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTV 63
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLT---PEHH-QFFLYQL 126
P V + D+++ ELM++ LD+ K D PE +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 127 LRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVS--FTDTPSAIFWTDYVAT 183
++AL+++HS +V HRD+KP N+L NA ++K+CDFG +S D +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDD---VAKDIDAGC 172
Query: 184 RWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
+ Y APE Y+ DIWS+G EL R FP + + ++ P
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEP 230
Query: 242 S 242
S
Sbjct: 231 S 231
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-33
Identities = 76/367 (20%), Positives = 135/367 (36%), Gaps = 91/367 (24%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
+Y + +G G + V + D + VA+K +K + A L EI+LL+ +++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA---LDEIRLLKSVRN 92
Query: 73 PDIVEIKHIMLPPCRREFKD-------IYVVFELMESDLDQVIKANDD--LTPEHHQFFL 123
D + M+ +FK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 124 YQLLRALKYIHS-ANVFHRDLKPKNILANAD----------------------------- 153
Q+L+ L Y+H+ + H D+KP+NIL + +
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 154 --------------------CKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
K+KI D G A + T+ + TR YR+ E+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHF----TEDIQTRQYRSLEVL- 265
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN------VAHQLDLVTDLLGTPSAESIA 247
S Y DIWS C+ EL TG LF + + L+ +LLG + I
Sbjct: 266 -IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 248 GIRNEKAKRYLSS---LRRKWAVPFS---------HKFPGAD-PLALRLLQRLLAFDPKD 294
+ +K + + L+ + +++ + L +L P+
Sbjct: 325 --AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 295 RPSAEEI 301
R +A E
Sbjct: 383 RATAAEC 389
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 78/313 (24%), Positives = 124/313 (39%), Gaps = 73/313 (23%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLK 71
++ ++EIIGIG +G V A G++VA+K + + T + +E KL MLK
Sbjct: 7 AELTLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 72 HPDIVEIKHI-MLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRA 129
HP+I+ ++ + + P + +V E L++V+ + P+ + Q+ R
Sbjct: 65 HPNIIALRGVCLKEPN------LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARG 117
Query: 130 LKYIHSAN---VFHRDLKPKNIL--------ANADCKLKICDFGLARVSFTDTPSAIFWT 178
+ Y+H + HRDLK NIL ++ LKI DFGLAR T +
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA 177
Query: 179 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238
W APE+ + S ++ D+WS G + ELLTG F G
Sbjct: 178 ----YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRG-------------- 216
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP----GADPLALRLLQRLLAFDPKD 294
+ L + V + +L++ DP
Sbjct: 217 -------------------IDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHS 257
Query: 295 RPSAEEIRFTEIV 307
RPS FT I+
Sbjct: 258 RPS-----FTNIL 265
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 50/224 (22%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+++ E +G GSYG V AI TG+ VAIK++ V + + I++EI +++ P +
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQE---IIKEISIMQQCDSPHV 86
Query: 76 VEIKHIMLPPCRREFKDIY-------VVFELME--SDLDQVIKANDDLTPEHHQFFLYQL 126
V+ + Y +V E S D + N LT + L
Sbjct: 87 VK------------YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQST 134
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA---------RVSFTDTPSAIFW 177
L+ L+Y+H HRD+K NIL N + K+ DFG+A R + TP FW
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP---FW 191
Query: 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLTGRP 220
APE+ Y DIWS+G I A E+ G+P
Sbjct: 192 M---------APEVIQE--IGYNCVADIWSLG-ITAIEMAEGKP 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 74/321 (23%), Positives = 129/321 (40%), Gaps = 73/321 (22%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIK--------KMKEVFEHVSDATRILREIKLL 67
++ +I+G GS+ V A + T + AIK K +V +V RE ++
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV-PYV------TRERDVM 84
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFL 123
L HP V++ F+D +Y ++ +L + I+ +F+
Sbjct: 85 SRLDHPFFVKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT 183
+++ AL+Y+H + HRDLKP+NIL N D ++I DFG A+V ++ A + +V T
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGT 195
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
Y +PEL + D+W++GCI +L+ G P F N
Sbjct: 196 AQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------------- 237
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP------S 297
+ ++ ++ P P A L+++LL D R
Sbjct: 238 ----------YLIFQKIIKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEG 282
Query: 298 AEEIR----FTEIVFNWLFLY 314
++ F + W L+
Sbjct: 283 YGPLKAHPFFESV--TWENLH 301
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 51/301 (16%), Positives = 92/301 (30%), Gaps = 55/301 (18%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Q + G + G + +K +K + E LR+ HP
Sbjct: 10 KQLNFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 74 DIVEIKHIML-PPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQF--FLYQLLRA 129
+++ + PP ++ M L V+ + + Q F + R
Sbjct: 68 NVLPVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARG 123
Query: 130 LKYIHSAN--VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
+ ++H+ + L ++++ + D +I + SF + W
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-SFQSP--GRMYA----PAWV- 175
Query: 188 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APE L + D+WS + EL+T F + + E
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIG 220
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEI 306
+ E LR PG P +L++ + DP RP F I
Sbjct: 221 MKVALEG-------LR----PTIP---PGISPHVSKLMKICMNEDPAKRPK-----FDMI 261
Query: 307 V 307
V
Sbjct: 262 V 262
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 78/315 (24%), Positives = 126/315 (40%), Gaps = 71/315 (22%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
YE+QE+IG G+ VV +A EKVAIK++ + + + +L+EI+ + H
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME----SDLDQVIKANDDLTP----EHH-QFFL 123
P+IV + ++++V +L+ D+ + I A + E L
Sbjct: 73 PNIVSYYTSFV-----VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA--------------RVSFT 169
++L L+Y+H HRD+K NIL D ++I DFG++ R +F
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAH 229
TP W APE+ Y DIWS G EL TG + H
Sbjct: 188 GTP---CWM---------APEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY------H 228
Query: 230 QLDLVTDLLGTPSAESIAGIRNE----KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQ 285
+ + L+ T +N+ + + +K+ F K +
Sbjct: 229 KYPPMKVLMLTL--------QNDPPSLETGVQDKEMLKKYGKSF-RKM----------IS 269
Query: 286 RLLAFDPKDRPSAEE 300
L DP+ RP+A E
Sbjct: 270 LCLQKDPEKRPTAAE 284
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 55/301 (18%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDAT---RILREIKLLRMLKH 72
YE+ EI+G G V A D VA+K ++ + D + R RE + L H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNH 71
Query: 73 PDIVEI--------KHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFL 123
P IV + LP Y+V E ++ L ++ +TP+ +
Sbjct: 72 PAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYV-A 182
+AL + H + HRD+KP NI+ +A +K+ DFG+AR + D+ +++ T V
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVIG 181
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
T Y +PE D++S+GC+ E+LTG P F G S
Sbjct: 182 TAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTG----------------DS 223
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-SAEEI 301
S+A +R +P S + G ++ + LA +P++R +A E+
Sbjct: 224 PVSVA----------YQHVRED-PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272
Query: 302 R 302
R
Sbjct: 273 R 273
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 74/306 (24%), Positives = 115/306 (37%), Gaps = 32/306 (10%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
A Q ++ + IG G YG V GEKVA+K E S EI +++
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT-EEASWFRE--TEIYQTVLMR 89
Query: 72 HPDIVE-IKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRA 129
H +I+ I + +Y++ + E+ L +K+ L + Y +
Sbjct: 90 HENILGFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSG 146
Query: 130 LKYIHSANVF--------HRDLKPKNILANADCKLKICDFGLARVSFTDTPSA-IFWTDY 180
L ++H+ HRDLK KNIL + I D GLA +DT I
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 181 VATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD 236
V T+ Y PE L S + + D++S G I E+ R + G +QL
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDL 265
Query: 237 LLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP 296
+ PS E + I K R + P +L+ A +P R
Sbjct: 266 VPSDPSYEDMREIVCIKKLRP--------SFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
Query: 297 SAEEIR 302
+A ++
Sbjct: 318 TALRVK 323
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 72/309 (23%), Positives = 114/309 (36%), Gaps = 40/309 (12%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
A +QE IG G +G V GE+VA+K R EI ML+H
Sbjct: 41 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRH 95
Query: 73 PDIV-----EIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQL 126
+I+ + K +++V + E L + +T E
Sbjct: 96 ENILGFIAADNKDNGTWTQ------LWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALST 148
Query: 127 LRALKYIHSANVF--------HRDLKPKNILANADCKLKICDFGLARV-SFTDTPSAIFW 177
L ++H V HRDLK KNIL + I D GLA I
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 178 TDYVATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233
V T+ Y APE L S K+ + DI+++G +F E+ R G + +QL
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPY 267
Query: 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPK 293
+ PS E + + E+ R ++ +W +A ++++ +
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLR--PNIPNRW-----QSCEALRVMA-KIMRECWYANGA 319
Query: 294 DRPSAEEIR 302
R +A I+
Sbjct: 320 ARLTALRIK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 67/311 (21%), Positives = 115/311 (36%), Gaps = 46/311 (14%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
A + E +G G YG V + GE VA+K R E+ ML+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRH 61
Query: 73 PDIV-----EIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQL 126
+I+ ++ ++++ E L ++ L + +
Sbjct: 62 ENILGFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSI 114
Query: 127 LRALKYIHSA--------NVFHRDLKPKNILANADCKLKICDFGLARV-SFTDTPSAIFW 177
L ++H + HRDLK KNIL + + I D GLA + S + +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 178 TDYVATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL-- 231
V T+ Y APE L + +DIW+ G + E+ R + G ++
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPF 233
Query: 232 -DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAF 290
D+V + PS E + + +R ++ +W P LA +L++
Sbjct: 234 YDVVPN---DPSFEDMRKVVCVDQQR--PNIPNRW-----FSDPTLTSLA-KLMKECWYQ 282
Query: 291 DPKDRPSAEEI 301
+P R +A I
Sbjct: 283 NPSARLTALRI 293
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 72/303 (23%), Positives = 113/303 (37%), Gaps = 32/303 (10%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
++ E+ G +G V A E VA+K + E+ L +KH
Sbjct: 24 MPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPI--QDKQSWQNE-YEVYSLPGMKHE 78
Query: 74 DIVE-IKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
+I++ I D++++ E L +KAN ++ + R L
Sbjct: 79 NILQFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLA 135
Query: 132 YIHSA----------NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYV 181
Y+H + HRD+K KN+L + I DFGLA F SA V
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHGQV 194
Query: 182 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238
TR Y APE+ +F ID++++G + EL + G + L ++
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
PS E + + K KR LR W K G L ++ D + R SA
Sbjct: 255 QHPSLEDMQEVVVHKKKR--PVLRDYW-----QKHAGMAMLC-ETIEECWDHDAEARLSA 306
Query: 299 EEI 301
+
Sbjct: 307 GCV 309
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-30
Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 12 EASQYEIQEIIGIGSYGVV----ASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL 67
E + + +G G++G V + +TGE VA+KK++ REI++L
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEIL 65
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQ 125
+ L+H +IV+ K + RR ++ ++ E + L ++ + + + + Q
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-- 183
+ + ++Y+ + HRDL +NIL + ++KI DFGL +V D +
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKEP 176
Query: 184 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
WY APE SK++ A D+WS G + EL T
Sbjct: 177 GESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 12 EASQYEIQEIIGIGSYGVV----ASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL 67
E + + +G G++G V + +TGE VA+KK++ REI++L
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEIL 96
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQ 125
+ L+H +IV+ K + RR ++ ++ E + L ++ + + + + Q
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-- 183
+ + ++Y+ + HRDL +NIL + ++KI DFGL +V D Y
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK------EYYKVKEP 207
Query: 184 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
WY APE SK++ A D+WS G + EL T
Sbjct: 208 GESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 243
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLK 71
+ ++ + IG G +G V + G KVA+K +K DAT L E ++ L+
Sbjct: 21 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 72
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQF--FLYQLLR 128
H ++V++ + E +Y+V E M L +++ F +
Sbjct: 73 HSNLVQLLGV----IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF---WTDYVATRW 185
A++Y+ N HRDL +N+L + D K+ DFGL + + + + WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
APE K++ D+WS G + E+ + GR +P + + V
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 17 EIQEIIGIGSYGVV----ASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRML 70
+ +G G +G V +TGE+VA+K +K + +EI++LR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP---ESGGNHIADLKKEIEILRNL 80
Query: 71 KHPDIVEIKHIMLPPCRREFKD-IYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLL 127
H +IV+ K I C + + I ++ E + S L + + N + + + + Q+
Sbjct: 81 YHENIVKYKGI----CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT---- 183
+ + Y+ S HRDL +N+L ++ ++KI DFGL + TD Y
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVKDDRD 190
Query: 184 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
WY APE SK+ A D+WS G ELLT
Sbjct: 191 SPVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 59/234 (25%), Positives = 107/234 (45%), Gaps = 30/234 (12%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ ++ +G G YG V + VA+K +KE + L+E +++ +KHP
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHP 69
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQF--FLYQLLRAL 130
++V+ +L C RE Y++ E M +L ++ + Q+ A+
Sbjct: 70 NLVQ----LLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA-------IFWTDYVAT 183
+Y+ N HRDL +N L + +K+ DFGL+R+ DT +A I WT
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----- 179
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
APE ++K++ D+W+ G + E+ T G +PG +++ +L+
Sbjct: 180 ----APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 74/312 (23%), Positives = 132/312 (42%), Gaps = 53/312 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
+EI IG GS+G V T + A+K M K+ ++ + +E+++++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 73 PDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLR 128
P +V + + F+D +++V +L+ DL ++ N E + F+ +L+
Sbjct: 75 PFLVNLWY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
AL Y+ + + HRD+KP NIL + + I DF +A + +T T+ Y A
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMA 182
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
PE + Y+ A+D WS+G ELL GR + R+ T S E +
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS------------STSSKEIVH 230
Query: 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-PSAEEIR---- 302
V + + LL++LL +P R +++
Sbjct: 231 TFETTV-------------VTYP---SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274
Query: 303 FTEIVFNWLFLY 314
+I NW ++
Sbjct: 275 MNDI--NWDAVF 284
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 26/227 (11%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATR--ILREIKLLRMLK 71
+ ++ + IG G +G V + G KVA+K +K DAT L E ++ L+
Sbjct: 193 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 244
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLR 128
H ++V++ + E +Y+V E M L +++ L + F +
Sbjct: 245 HSNLVQLLGV----IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
A++Y+ N HRDL +N+L + D K+ DFGL + + + + +W A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT-A 354
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLV 234
PE K++ D+WS G + E+ + GR +P + + V
Sbjct: 355 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 68/313 (21%), Positives = 122/313 (38%), Gaps = 55/313 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
+EI ++IG G++G VA + + A+K + K ++ E +L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 73 PDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHH-QFFLYQLL 127
I + + F+D +Y+V + DL ++ +D PE +F+L +++
Sbjct: 134 KWITTLHY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV 185
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
A+ +H + HRD+KP NIL + + +++ DFG D + V T Y
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSV-AVGTPDYI 243
Query: 188 APEL---CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
+PE+ +Y P D WS+G E+L G F ++ E
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---------------VE 288
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR---PSAEEI 301
+ I N K + F + A L++RL+ + R E+
Sbjct: 289 TYGKIMNHKER-----------FQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDF 336
Query: 302 R----FTEIVFNW 310
+ F+ I +W
Sbjct: 337 KKHPFFSGI--DW 347
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 12 EASQYEIQEIIGIGSYGVV----ASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL 67
E + +G G++G V + +TG VA+K+++ REI++L
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQIL 78
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQ 125
+ L IV+ + + P R + + +V E + S L ++ + L + Q
Sbjct: 79 KALHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-- 183
+ + ++Y+ S HRDL +NIL ++ +KI DFGLA++ D YV
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK------DYYVVREP 189
Query: 184 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
WY APE + ++ D+WS G + EL T
Sbjct: 190 GQSPIFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 63/314 (20%), Positives = 116/314 (36%), Gaps = 43/314 (13%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
++ E+IG G YG V + VA+K + + + I + +++H
Sbjct: 13 DNLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSF--ANRQNFIN-EKNIYRVPLMEHD 67
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+I + +V E + L + + + + + R L Y
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAY 126
Query: 133 IHSANVF---------HRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY--- 180
+H+ HRDL +N+L D I DFGL+ + D
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 181 --VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNV-AHQL 231
V T Y APE L G+ +D++++G I+ E+ LFPG +V +Q+
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLL--- 288
T++ P+ E + + + + +R W + LA+R L+ +
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQR--PKFPEAWK---------ENSLAVRSLKETIEDC 295
Query: 289 -AFDPKDRPSAEEI 301
D + R +A+
Sbjct: 296 WDQDAEARLTAQXA 309
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 73/315 (23%), Positives = 119/315 (37%), Gaps = 55/315 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
YE+ ++IG G++G V T + A+K + K SD+ E ++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 73 PDIVEIKHIMLPPCRREFKD---IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLR 128
P +V++ + F+D +Y+V E M DL ++ N D+ + +F+ +++
Sbjct: 129 PWVVQLFY--------AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVL 179
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA-RVSFTDTPSAIFWTDYVATRWYR 187
AL IHS HRD+KP N+L + LK+ DFG +++ T V T Y
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC--DT-AVGTPDYI 236
Query: 188 APE--LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
+PE Y D WS+G E+L G F ++
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------------ 278
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR---PSAEEIR 302
Y + K ++ F A L+ L D + R EEI+
Sbjct: 279 --------VGTYSKIMNHKNSLTF-PDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIK 328
Query: 303 ----FTEIVFNWLFL 313
F + W L
Sbjct: 329 RHLFFKNDQWAWETL 343
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 41/292 (14%), Positives = 68/292 (23%), Gaps = 71/292 (24%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDAT---RILREIKLLRMLKH 72
Y + G A+DT +VA+ + + V L L +
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVD--PQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
P + + ++ VV E + L +V + +P + L A
Sbjct: 91 PGVARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAAD 143
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
H A V P + + D + +
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------------------TMPDA- 179
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL-DLVTDLLGTPSAESIAGIR 250
P DI IG LL R P V L D G P
Sbjct: 180 --------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP--------- 222
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ + + R + D R ++ +
Sbjct: 223 ----------------IEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLN 258
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 56/234 (23%), Positives = 110/234 (47%), Gaps = 30/234 (12%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ ++ +G G YG V + VA+K +KE + L+E +++ +KHP
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHP 276
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLRAL 130
++V++ + C RE Y++ E M +L ++ + +++ + Q+ A+
Sbjct: 277 NLVQLLGV----CTRE-PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT------- 183
+Y+ N HR+L +N L + +K+ DFGL+R+ DT Y A
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKFPI 383
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
+W APE ++K++ D+W+ G + E+ T G +PG +++ +L+
Sbjct: 384 KWT-APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 52/233 (22%), Positives = 98/233 (42%), Gaps = 30/233 (12%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ + + +G G +GVV VA+K +KE +E + + L HP
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKE---GSMSEDEFFQEAQTMMKLSHP 63
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRALK 131
+V+ + C +E IY+V E + + L ++++ L P Y + +
Sbjct: 64 KLVKFYGV----CSKE-YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-------R 184
++ S HRDL +N L + D +K+ DFG+ R + YV++ +
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--------VLDDQYVSSVGTKFPVK 170
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
W APE + KY+ D+W+ G + E+ + G+ + + + V+
Sbjct: 171 WS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 54/233 (23%), Positives = 99/233 (42%), Gaps = 30/233 (12%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
S+ + IG G +G+V + KVAIK ++E + E +++ L HP
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIRE---GAMSEEDFIEEAEVMMKLSHP 63
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLLRALK 131
+V++ + C + I +V E ME L ++ E + +
Sbjct: 64 KLVQLYGV----CLEQ-APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-------R 184
Y+ A V HRDL +N L + +K+ DFG+ R D Y ++ +
Sbjct: 119 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFPVK 170
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
W +PE FS+Y+ D+WS G + E+ + G+ + R+ + ++ ++
Sbjct: 171 WA-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 67/311 (21%), Positives = 120/311 (38%), Gaps = 58/311 (18%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
++G G +G V + TG+ A KK+ K+ + + E K+L + IV +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 80 HIMLPPCRREFKDIYVVFELMES-DL----DQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
+ D+ +V +M D+ V + N F+ Q++ L+++H
Sbjct: 252 Y-----AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLAR--VSFTDTPSAIFWTDYVATRWYRAPELC 192
N+ +RDLKP+N+L + D ++I D GLA + Y T + APEL
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-----YAGTPGFMAPELL 361
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
+Y ++D +++G E++ R F R + + + +
Sbjct: 362 LG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR-----------VLEQ 408
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAEEIR----F 303
V + KF P + + LL DP+ R S + +R F
Sbjct: 409 A-------------VTYPDKFS---PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
Query: 304 TEIVFNWLFLY 314
+I +W L
Sbjct: 453 RDI--SWRQLE 461
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 18/229 (7%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRMLK 71
+ E IG G++G V S VA+K +E + + L+E ++L+
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE---TLPPDLKAKFLQEARILKQYS 170
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRA 129
HP+IV + + C ++ + IY+V EL++ D ++ L + +
Sbjct: 171 HPNIVRLIGV----CTQK-QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
++Y+ S HRDL +N L LKI DFG++R +A V +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-AP 284
Query: 190 ELCGSF-FSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
E + + +Y+ D+WS G + E + G +P + + V
Sbjct: 285 E---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 70/317 (22%), Positives = 117/317 (36%), Gaps = 61/317 (19%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
+EI ++IG G++ VA TG+ A+K M K + + E +L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 73 PDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHH-QFFLYQLL 127
I ++ F+D +Y+V E DL ++ + P +F+L +++
Sbjct: 121 RWITQLHF--------AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIV 172
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR--VSFTDTPSAIFWTDYVATRW 185
A+ +H HRD+KP NIL + +++ DFG + S + V T
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA----VGTPD 228
Query: 186 YRAPEL-----CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
Y +PE+ G Y P D W++G E+ G+ F +
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------------- 275
Query: 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR---PS 297
AE+ I + K + G A +QRLL P+ R
Sbjct: 276 --AETYGKIVHYKEH-----------LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGG 321
Query: 298 AEEIR----FTEIVFNW 310
A + R F + +W
Sbjct: 322 AGDFRTHPFFFGL--DW 336
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 52/236 (22%), Positives = 100/236 (42%), Gaps = 34/236 (14%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEK----VAIKKMKEVFEHVSDATRILREIKLLRM 69
++++ +++G G++G V + GEK VAIK+++E IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMAS 73
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLL 127
+ +P + + I C + ++ +LM L ++ + D + ++ + Q+
Sbjct: 74 VDNPHVCRLLGI----CLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT---- 183
+ + Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGK 180
Query: 184 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQLD 232
+W A E YT D+WS G EL+T G + G ++ L+
Sbjct: 181 VPIKWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 29/228 (12%)
Query: 19 QEIIGIGSYGVVASAIDTHTGE--KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
+ +G G++G V VA+K +K + +L E +++ L +P IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 77 EIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS 135
+ I C E +V E+ E L++ ++ N + ++ ++Q+ +KY+
Sbjct: 82 RMIGI----CEAE--SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 136 ANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-------RWYRA 188
+N HRDL +N+L KI DFGL++ D Y A +WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE------NYYKAQTHGKWPVKWY-A 188
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQLD 232
PE + K++ D+WS G + E + G+ + G V L+
Sbjct: 189 PE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKLLR 68
+ E+ IG G +G V I VAIK K SD+ R L+E +R
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTMR 71
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQL 126
HP IV++ + ++++ EL +L ++ L + YQL
Sbjct: 72 QFDHPHIVKLIGV----ITEN--PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT--- 183
AL Y+ S HRD+ +N+L +++ +K+ DFGL+R + + Y
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------MEDSTYYKASKG 177
Query: 184 ----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQLD 232
+W APE F ++T A D+W G E+L G F G +V +++
Sbjct: 178 KLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 48/236 (20%), Positives = 93/236 (39%), Gaps = 34/236 (14%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGE----KVAIKKMKEVFEHVSDATRILREIKLLRM 69
++ +++G G +G V + GE V IK +++ + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGS 71
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLL 127
L H IV + + C + +V + + L ++ + L P+ + Q+
Sbjct: 72 LDHAHIVRLLGL----CPGS--SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT---- 183
+ + Y+ + HR+L +N+L + ++++ DFG+A + D +
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSEAK 178
Query: 184 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQLD 232
+W A E F KYT D+WS G EL+T G + G V L+
Sbjct: 179 TPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 30/225 (13%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKLLR 68
S+ I++IIG G G V G+ VAIK +K ++ R L E ++
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA---GYTERQRRDFLSEASIMG 105
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQL 126
HP+I+ ++ + R + +V E ME+ LD ++ +D T L +
Sbjct: 106 QFDHPNIIRLEGV----VTRG-RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT--- 183
++Y+ HRDL +N+L +++ K+ DFGL+RV D +A Y T
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTGGK 215
Query: 184 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG 224
RW APE F ++ A D+WS G + E+L G +
Sbjct: 216 IPIRWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 50/233 (21%), Positives = 95/233 (40%), Gaps = 30/233 (12%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ +G G +GVV VAIK +KE + E K++ L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHE 79
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLLRALK 131
+V++ + C ++ + I+++ E M + L ++ + + A++
Sbjct: 80 KLVQLYGV----CTKQ-RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-------R 184
Y+ S HRDL +N L N +K+ DFGL+R + +Y ++ R
Sbjct: 135 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--------VLDDEYTSSVGSKFPVR 186
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
W PE +SK++ DIW+ G + E+ + G+ + + + +
Sbjct: 187 WS-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 57/215 (26%), Positives = 86/215 (40%), Gaps = 30/215 (13%)
Query: 17 EIQEIIGIGSYGVVASAI----DTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRML 70
+ +G G +G V+ + TGE VA+K +K R +EI +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA---DAGPQHRSGWKQEIDILRTL 90
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRA 129
H I++ K + +V E + L + + + F Q+
Sbjct: 91 YHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT------ 183
+ Y+H+ + HRDL +N+L + D +KI DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH------EYYRVREDGDSP 200
Query: 184 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217
WY APE K+ A D+WS G ELLT
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 61/244 (25%), Positives = 102/244 (41%), Gaps = 47/244 (19%)
Query: 15 QYEI-------QEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LR 62
QY I I+G G +G V + T+ VA+K K+ + + +
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKK---DCTLDNKEKFMS 62
Query: 63 EIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQ 120
E +++ L HP IV++ I E +++ EL +L ++ N + L
Sbjct: 63 EAVIMKNLDHPHIVKLIGI----IEEE--PTWIIMELYPYGELGHYLERNKNSLKVLTLV 116
Query: 121 FFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180
+ Q+ +A+ Y+ S N HRD+ +NIL + +K+ DFGL+R I DY
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY--------IEDEDY 168
Query: 181 VAT-------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN---VA 228
+W +PE S F ++T A D+W E+L+ G+ F V
Sbjct: 169 YKASVTRLPIKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224
Query: 229 HQLD 232
L+
Sbjct: 225 GVLE 228
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 32/234 (13%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
++ E +G G +G V KVA+K +K+ L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQ 68
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQF--FLYQLLRAL 130
+V + + +E IY++ E ME+ L +K + ++ Q+ +
Sbjct: 69 RLVRLYAV----VTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT------- 183
+I N HRDL+ NIL + KI DFGLAR+ I +Y A
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--------IEDNEYTAREGAKFPI 174
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
+W APE + +T D+WS G + E++T GR +PG + +
Sbjct: 175 KWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 32/241 (13%)
Query: 12 EASQYEIQEIIGIGSYGVV--ASAIDTHTGE-KVAIKKMKEVFEHVSDATRILREIKLLR 68
+ E+IG G +G V + +D + A+K + + + + ++ L E +++
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMK 81
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQL 126
HP+++ + I C R VV M+ DL I+ + T + F Q+
Sbjct: 82 DFSHPNVLSLLGI----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT--- 183
+ +KY+ S HRDL +N + + +K+ DFGLAR ++ +Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNK 189
Query: 184 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVT 235
+W A E K+T D+WS G + EL+T G P +P N +
Sbjct: 190 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
Query: 236 D 236
Sbjct: 247 Q 247
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 72/308 (23%), Positives = 123/308 (39%), Gaps = 55/308 (17%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
++G G +G V + TG+ A KK+ K+ + L E ++L + +V +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 80 HIMLPPCRREFKDIYVVFELMES-DLD-QVIKANDDLTPEHH-QFFLYQLLRALKYIHSA 136
+ + +V LM DL + PE F+ ++ L+ +H
Sbjct: 251 Y-----AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 137 NVFHRDLKPKNILANADCKLKICDFGLAR-VSFTDTPSAIFWTDYVATRWYRAPELCGSF 195
+ +RDLKP+NIL + ++I D GLA V T V T Y APE+ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-----RVGTVGYMAPEVVKN- 359
Query: 196 FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255
+YT + D W++GC+ E++ G+ F R + + V ++
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-----------LVKEVP-- 405
Query: 256 RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAEEIR----FTEI 306
+S +F P A L +LL DP +R SA E++ F ++
Sbjct: 406 -----------EEYSERFS---PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
Query: 307 VFNWLFLY 314
N+ L
Sbjct: 452 --NFKRLG 457
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 35/225 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK--------KMKEVFEHVSDATRILREIK 65
Q++ + +G GS+G V +G A+K K+K++ EH + RIL+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-EHTLNEKRILQAVN 99
Query: 66 LLRMLKHPDIVEIKHIMLPPCRREFKD---IYVVFELME-SDLDQVIKANDDLTPEHHQF 121
P +V+++ FKD +Y+V E + ++ ++ + H +F
Sbjct: 100 ------FPFLVKLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYV 181
+ Q++ +Y+HS ++ +RDLKP+N+L + +++ DFG A+ T WT
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WT-LC 199
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN 226
T APE+ S Y A+D W++G + E+ G P F
Sbjct: 200 GTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
++ +G G +G V T +VAIK +K L+E ++++ L+H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA---FLQEAQVMKKLRHE 322
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQF--FLYQLLRAL 130
+V++ + E IY+V E M L +K Q Q+ +
Sbjct: 323 KLVQLYAV----VSEE--PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT------- 183
Y+ N HRDL+ NIL + K+ DFGLAR+ + +Y A
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKFPI 428
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG 224
+W APE + + ++T D+WS G + EL T GR +PG
Sbjct: 429 KWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
++ +G G +G V T +VAIK +K L+E ++++ L+H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA---FLQEAQVMKKLRHE 239
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQF--FLYQLLRAL 130
+V++ + E IY+V E M L +K Q Q+ +
Sbjct: 240 KLVQLYAV----VSEE--PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT------- 183
Y+ N HRDL+ NIL + K+ DFGLAR+ + +Y A
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKFPI 345
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG 224
+W APE + + ++T D+WS G + EL T GR +PG
Sbjct: 346 KWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEK---VAIKKMKEVFEHVSDATRI--LREIKL 66
+A+ I +++G G +G V S +K VAIK +K ++ R L E +
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV---GYTEKQRRDFLGEASI 99
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLY 124
+ HP+I+ ++ + + K + +V E ME+ LD ++ +D T L
Sbjct: 100 MGQFDHPNIIRLEGV----VTKS-KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT- 183
+ +KY+ HRDL +NIL N++ K+ DFGL RV D Y
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRG 209
Query: 184 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG 224
RW +PE + K+T A D+WS G + E+++ G +
Sbjct: 210 GKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 32/236 (13%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE-KVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
E+IG G +G V + +D + A+K + + + + ++ L E +++ HP
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHP 150
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRALK 131
+++ + I C R VV M+ DL I+ + T + F Q+ + +K
Sbjct: 151 NVLSLLGI----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-------- 183
++ S HRDL +N + + +K+ DFGLAR ++ ++ +
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNKTGAKL 258
Query: 184 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
+W A E K+T D+WS G + EL+T G P +P N +
Sbjct: 259 PVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 53/237 (22%), Positives = 88/237 (37%), Gaps = 34/237 (14%)
Query: 14 SQYEIQEIIGIGSYGVVASAI---DTHTGEKVAIKKMKE-VFEHVSDATRILREIKLLRM 69
+ E +G GS+GVV + VA+K +K V +RE+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLL 127
L H +++ + + + +V EL L ++ + + Q+
Sbjct: 78 LDHRNLIRLYGV----VLTP--PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT---- 183
+ Y+ S HRDL +N+L +KI DFGL R + YV
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRK 185
Query: 184 ---RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQLD 232
W APE S ++ A D W G E+ T G+ + G + H++D
Sbjct: 186 VPFAWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 69/319 (21%), Positives = 115/319 (36%), Gaps = 63/319 (19%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGE--------KVAIKKMKEVFEHVSDATRILREIK 65
+ + + IIG G +G V TG+ K IK + + +L +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLALNERIMLSLVS 247
Query: 66 LLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLY 124
P IV + + + + +LM DL + + + +F+
Sbjct: 248 ---TGDCPFIVCMSY-----AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 299
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
+++ L+++H+ V +RDLKP NIL + ++I D GLA P A V T
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTH 354
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244
Y APE+ Y + D +S+GC+ +LL G F
Sbjct: 355 GYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHK------------------ 395
Query: 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAE 299
K K + + AV F P LL+ LL D R A+
Sbjct: 396 -------TKDKHEIDRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQ 445
Query: 300 EIR----FTEIVFNWLFLY 314
E++ F + +W ++
Sbjct: 446 EVKESPFFRSL--DWQMVF 462
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 34/237 (14%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEK----VAIKKMKEVFEHVSDATRI--LREIKLL 67
S Q++IG G +G V + + K VAIK +K ++ R+ L E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA---GYTEKQRVDFLGEAGIM 100
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQ 125
H +I+ ++ + + K + ++ E ME+ LD+ ++ D + L
Sbjct: 101 GQFSHHNIIRLEGV----ISKY-KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-- 183
+ +KY+ + N HRDL +NIL N++ K+ DFGL+RV D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 184 ----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQLD 232
RW APE + K+T A D+WS G + E++T G + V ++
Sbjct: 211 KIPIRWT-APE--AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 49/239 (20%), Positives = 89/239 (37%), Gaps = 30/239 (12%)
Query: 17 EIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ +I+G G +G V KVA+K MK + L E ++ HP
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAN------DDLTPEHHQFFLYQL 126
+++ + + + + V+ M+ DL + + + + F+ +
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTD-YVAT-- 183
++Y+ + N HRDL +N + D + + DFGL++ I+ D Y
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYYRQGRI 208
Query: 184 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
+W A E YT D+W+ G E+ T G +PG D +
Sbjct: 209 AKMPVKWI-AIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 32/236 (13%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE-KVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+IG G +GVV ID + AIK + + E LRE L+R L HP
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMRGLNHP 82
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRALK 131
+++ + + +V+ M DL Q I++ + T + F Q+ R ++
Sbjct: 83 NVLAL----IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-------- 183
Y+ HRDL +N + + +K+ DFGLAR I +Y +
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--------ILDREYYSVQQHRHARL 190
Query: 184 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
+W A E ++T D+WS G + ELLT G P + + +
Sbjct: 191 PVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 52/236 (22%), Positives = 100/236 (42%), Gaps = 34/236 (14%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEK----VAIKKMKEVFEHVSDATRILREIKLLRM 69
++++ +++G G++G V + GEK VAIK+++E IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMAS 73
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLL 127
+ +P + + I C + ++ +LM L ++ + D + ++ + Q+
Sbjct: 74 VDNPHVCRLLGI----CLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT---- 183
+ + Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGK 180
Query: 184 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQLD 232
+W A E YT D+WS G EL+T G + G ++ L+
Sbjct: 181 VPIKWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 57/242 (23%), Positives = 102/242 (42%), Gaps = 41/242 (16%)
Query: 15 QYEIQEI--------IGIGSYGVVASAIDTHTGE--KVAIKKMKEVFEHVSDATRILREI 64
+ ++ +G G++G V + + VAIK +K+ E +D ++RE
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREA 61
Query: 65 KLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFF 122
+++ L +P IV + + C+ E + +V E+ L + + + + +
Sbjct: 62 QIMHQLDNPYIVRLIGV----CQAE--ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
L+Q+ +KY+ N HRDL +N+L KI DFGL++ D Y A
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTA 169
Query: 183 T-------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQ 230
+WY APE F K++ D+WS G E L+ G+ + V
Sbjct: 170 RSAGKWPLKWY-APE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225
Query: 231 LD 232
++
Sbjct: 226 IE 227
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 32/219 (14%)
Query: 17 EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIV 76
++++ +G G +G V A KVA+K MK V L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLV 246
Query: 77 EIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQF--FLYQLLRALKYI 133
++ + +E IY++ E M L +K+++ + F Q+ + +I
Sbjct: 247 KLHAV----VTKE--PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-------RWY 186
N HRDL+ NIL +A KI DFGLARV + +Y A +W
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--------EYTAREGAKFPIKWT 352
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG 224
APE F +T D+WS G + E++T GR +PG
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 31/240 (12%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE-KVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ ++G G +G V A KVA+K +K SD LRE ++ HP
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 74 DIVEIKHIMLPP-CRREFKDIYVVFELMES-DLDQVIKAN------DDLTPEHHQFFLYQ 125
+ ++ + L + V+ M+ DL + A+ +L + F+
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY----- 180
+ ++Y+ S N HRDL +N + D + + DFGL+R I+ DY
Sbjct: 146 IACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDYYRQGC 197
Query: 181 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
+ +W A E + YT D+W+ G E++T G+ + G A + +
Sbjct: 198 ASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 77/327 (23%), Positives = 131/327 (40%), Gaps = 87/327 (26%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIK--------KMKEVFEHVSDATRILREIK 65
++I +G GS+G V H G A+K ++K+V EH +D +L +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV-EHTNDERLMLSIVT 64
Query: 66 LLRMLKHPDIVEIKHIMLPPCRREFKD---IYVVFELME-SDLDQVIKANDDLTPEHHQF 121
HP I+ + F+D I+++ + +E +L +++ + +F
Sbjct: 65 ------HPFIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF 110
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT--- 178
+ ++ AL+Y+HS ++ +RDLKP+NIL + + +KI DFG A+ T +T
Sbjct: 111 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCG 165
Query: 179 --DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD 236
DY+ APE+ + Y +ID WS G + E+L G F N +
Sbjct: 166 TPDYI------APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK--- 214
Query: 237 LLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR- 295
I N + + F F + LL RL+ D R
Sbjct: 215 ------------ILNAE-------------LRFPPFF---NEDVKDLLSRLITRDLSQRL 246
Query: 296 ----PSAEEIR----FTEIVFNWLFLY 314
E+++ F E+ W L
Sbjct: 247 GNLQNGTEDVKNHPWFKEV--VWEKLL 271
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 35/235 (14%)
Query: 17 EIQEIIGIGSYGVVASAIDTHTGEK---VAIKKMKEVFEHVSDATRI--LREIKLLRMLK 71
E+ IG G +G V I VAIK K SD+ R L+E +R
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMRQFD 449
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLLRA 129
HP IV+ ++ ++++ EL +L ++ L + YQL A
Sbjct: 450 HPHIVK----LIGVITEN--PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT------ 183
L Y+ S HRD+ +N+L +++ +K+ DFGL+R + + Y
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------MEDSTYYKASKGKLP 555
Query: 184 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTD 236
+W APE F ++T A D+W G E+L G F G + + +
Sbjct: 556 IKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 9e-23
Identities = 42/243 (17%), Positives = 81/243 (33%), Gaps = 37/243 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGE-------KVAIKKMKEVFEHVSDATRILREIKL 66
E +G G++ + + G+ +V +K + + + S++ +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASM 65
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLY 124
+ L H +V + C + +V E ++ LD +K N + +
Sbjct: 66 MSKLSHKHLVLNYGV----CVCG-DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANADCKL--------KICDFGLARVSFTDTPSAIF 176
QL A+ ++ + H ++ KNIL + K+ D G++ +
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--------VL 172
Query: 177 WTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDL 233
D W PE C A D WS G E+ + G + +L
Sbjct: 173 PKDILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230
Query: 234 VTD 236
D
Sbjct: 231 YED 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 31/230 (13%)
Query: 18 IQEIIGIGSYGVVASAIDTHTGE--KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+G G++G V + + VAIK +K+ E +D ++RE +++ L +P I
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 398
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD-LTPEHHQFFLYQLLRALKYI 133
V + + C+ E + +V E+ L + + + + + L+Q+ +KY+
Sbjct: 399 VRLIGV----CQAE--ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT-------RWY 186
N HR+L +N+L KI DFGL++ D Y A +WY
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 506
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPG---RNVAHQLD 232
APE F K++ D+WS G E L+ G+ + V ++
Sbjct: 507 -APE--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 78/315 (24%), Positives = 129/315 (40%), Gaps = 64/315 (20%)
Query: 14 SQYEIQEIIGIGSYG---VVASAIDTHTGEKVAIKKMK--EVFEHVSDATRILREIKLLR 68
+E+ ++G G YG V +TG+ A+K +K + + D E +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLL 127
+KHP IV++ + + +Y++ E + +L ++ + F+L ++
Sbjct: 77 EVKHPFIVDLIY-----AFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS 131
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYR 187
AL ++H + +RDLKP+NI+ N +K+ DFGL + S D + T Y
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYM 188
Query: 188 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APE L S + A+D WS+G + ++LTG P F G N ++I
Sbjct: 189 APEILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENR---------------KKTI 230
Query: 247 AGIRNEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAE 299
I K YL+ A LL++LL + R A
Sbjct: 231 DKILKCKLNLPPYLT------------------QEARDLLKKLLKRNAASRLGAGPGDAG 272
Query: 300 EIR----FTEIVFNW 310
E++ F I NW
Sbjct: 273 EVQAHPFFRHI--NW 285
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 77/324 (23%), Positives = 131/324 (40%), Gaps = 78/324 (24%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
+ ++ +++G G++G V + TG A+K + KEV + + E ++L+ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
P + +K+ + + V E +L + T E +F+ +++ AL+
Sbjct: 65 PFLTALKY-----AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD---------TPSAIFWTDYVA 182
Y+HS +V +RD+K +N++ + D +KI DFGL + +D TP
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE--------- 170
Query: 183 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
Y APE L + Y A+D W +G + E++ GR F ++
Sbjct: 171 ---YLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------------- 210
Query: 242 SAESIAGIRNEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR---- 295
I E+ + R LS P A LL LL DPK R
Sbjct: 211 -ERLFELILMEEIRFPRTLS------------------PEAKSLLAGLLKKDPKQRLGGG 251
Query: 296 -PSAEEIR----FTEIVFNWLFLY 314
A+E+ F I NW +
Sbjct: 252 PSDAKEVMEHRFFLSI--NWQDVV 273
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 63/256 (24%), Positives = 107/256 (41%), Gaps = 53/256 (20%)
Query: 14 SQYEIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKL 66
++ +G G++G V A + + VA+K +K+ + A R RE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAEL 70
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAN---------DDLTP 116
L L+H IV+ C + +VFE M+ DL++ ++A+
Sbjct: 71 LTNLQHEHIVKF----YGVCGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 117 EHHQFFLYQLL-------RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169
+ L Q+L + Y+ S + HRDL +N L A+ +KI DFG++R
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--- 182
Query: 170 DTPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRP 220
++ TDY RW PE + K+T D+WS G I E+ T G+
Sbjct: 183 -----VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 221 LFPGRNVAHQLDLVTD 236
+ + ++ +T
Sbjct: 235 PWFQLSNTEVIECITQ 250
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 77/315 (24%), Positives = 131/315 (41%), Gaps = 59/315 (18%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
+++E +++G G++G V + TG A+K + KEV + L E ++L+ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
P + +K+ + + V E +L + + + +F+ +++ AL
Sbjct: 208 PFLTALKY-----SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 132 YIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
Y+HS NV +RDLK +N++ + D +KI DFGL + D + + T Y APE
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPE 319
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
+ + Y A+D W +G + E++ GR F ++ + I
Sbjct: 320 VLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------------EKLFELIL 362
Query: 251 NEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR----PS-AEEIR- 302
E+ + R L P A LL LL DPK R A+EI
Sbjct: 363 MEEIRFPRTLG------------------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404
Query: 303 ---FTEIVFNWLFLY 314
F I W +Y
Sbjct: 405 HRFFAGI--VWQHVY 417
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 56/251 (22%), Positives = 93/251 (37%), Gaps = 54/251 (21%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKLLRM 69
+ +G GS+G+V A E +VAIK + E S RI L E +++
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE---AASMRERIEFLNEASVMKE 84
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAN----------DDLTPEH 118
+V +L + + V+ ELM DL +++ +
Sbjct: 85 FNCHHVVR----LLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT 178
++ + Y+++ HRDL +N + D +KI DFG+ R I+ T
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--------IYET 191
Query: 179 DYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGR 225
DY YR +PE +T D+WS G + E+ T + G
Sbjct: 192 DY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 226 NVAHQLDLVTD 236
+ L V +
Sbjct: 245 SNEQVLRFVME 255
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 62/256 (24%), Positives = 103/256 (40%), Gaps = 54/256 (21%)
Query: 14 SQYEIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKL 66
++ +G G++G V A + + VA+K +KE S++ R RE +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAEL 96
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD------------ 113
L ML+H IV C + + +VFE M DL++ ++++
Sbjct: 97 LTMLQHQHIVRF----FGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 114 ---LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170
L Q+ + Y+ + HRDL +N L +KI DFG++R
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD---- 207
Query: 171 TPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GRP 220
I+ TDY RW PE + K+T D+WS G + E+ T +P
Sbjct: 208 ----IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 221 LFPGRNVAHQLDLVTD 236
+ + +D +T
Sbjct: 261 -WYQLSNTEAIDCITQ 275
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 75/308 (24%), Positives = 121/308 (39%), Gaps = 73/308 (23%)
Query: 22 IGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIK-LLRMLKHPDIVEIK 79
+G GS+G V A T + AIK + K+V D + E + L +HP + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 80 HIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANV 138
+ ++++ V E + DL I++ F+ +++ L+++HS +
Sbjct: 85 C-----TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 139 FHRDLKPKNILANADCKLKICDFGLAR---------VSFTDTPSAIFWTDYVATRWYRAP 189
+RDLK NIL + D +KI DFG+ + +F TP Y AP
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD------------YIAP 187
Query: 190 ELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
E+ KY ++D WS G + E+L G+ F G++ E I
Sbjct: 188 EILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---------------EELFHSI 230
Query: 250 RNEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-PSAEEIR---- 302
R + R+L A LL +L +P+ R +IR
Sbjct: 231 RMDNPFYPRWLE------------------KEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272
Query: 303 FTEIVFNW 310
F EI NW
Sbjct: 273 FREI--NW 278
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 55/257 (21%), Positives = 96/257 (37%), Gaps = 54/257 (21%)
Query: 14 SQYEIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKL 66
S E +G +G V GE VAIK +K+ R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD---KAEGPLREEFRHEAML 65
Query: 67 LRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAN---------DDLTP 116
L+HP++V + L ++ + + ++F DL + + DD
Sbjct: 66 RARLQHPNVVCL----LGVVTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 117 EHHQFFLYQLL-------RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169
+ ++Y+ S +V H+DL +N+L +KI D GL R
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--- 177
Query: 170 DTPSAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GR 219
++ DY RW APE + K++ DIWS G + E+ + +
Sbjct: 178 -----VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
Query: 220 PLFPGRNVAHQLDLVTD 236
P + G + ++++ +
Sbjct: 230 P-YCGYSNQDVVEMIRN 245
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 6e-21
Identities = 84/319 (26%), Positives = 139/319 (43%), Gaps = 66/319 (20%)
Query: 14 SQYEIQEIIGIGSYG---VVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML 70
SQ+E+ +++G GS+G +V + + A+K +K+ V D R E +L +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 71 KHPDIVEIKHIMLPPCRREF---KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQL 126
HP IV++ + F +Y++ + + DL + T E +F+L +L
Sbjct: 84 NHPFIVKLHY--------AFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
AL ++HS + +RDLKP+NIL + + +K+ DFGL++ S A + T Y
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEY 192
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APE+ +T + D WS G + E+LTG F G++ E++
Sbjct: 193 MAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---------------KETM 235
Query: 247 AGIRNEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAE 299
I K ++LS P A LL+ L +P +R E
Sbjct: 236 TMILKAKLGMPQFLS------------------PEAQSLLRMLFKRNPANRLGAGPDGVE 277
Query: 300 EIR----FTEIVFNWLFLY 314
EI+ F+ I +W LY
Sbjct: 278 EIKRHSFFSTI--DWNKLY 294
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 7e-21
Identities = 64/321 (19%), Positives = 115/321 (35%), Gaps = 79/321 (24%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIK-LLRMLK 71
+ + ++G GS+G V + T E A+K + K+V D + E + L K
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRAL 130
P + ++ C + +Y V E + DL I+ H F+ ++ L
Sbjct: 401 PPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 455
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD---------TPSAIFWTDYV 181
++ S + +RDLK N++ +++ +KI DFG+ + + D TP
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD-------- 507
Query: 182 ATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
Y APE + Y ++D W+ G + E+L G+ F G +
Sbjct: 508 ----YIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------------- 547
Query: 241 PSAESIAGIRNEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR--- 295
E I + +S A+ + + L+ P R
Sbjct: 548 --DELFQSIMEHNVAYPKSMS------------------KEAVAICKGLMTKHPGKRLGC 587
Query: 296 --PSAEEIR----FTEIVFNW 310
+I+ F I +W
Sbjct: 588 GPEGERDIKEHAFFRYI--DW 606
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-21
Identities = 50/248 (20%), Positives = 87/248 (35%), Gaps = 48/248 (19%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKLLRM 69
+ +G G++G V +VA+K + E S+ + L E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALIISK 89
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLL- 127
H +IV + + +++ ELM DL ++ + + LL
Sbjct: 90 FNHQNIVRC----IGVSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 128 ------RALKYIHSANVFHRDLKPKNILANA---DCKLKICDFGLARVSFTDTPSAIFWT 178
+Y+ + HRD+ +N L KI DFG+AR I+
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------IYRA 196
Query: 179 DYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GRPLFPGRNVA 228
Y +W PE +T D WS G + E+ + P +P ++
Sbjct: 197 SYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQ 252
Query: 229 HQLDLVTD 236
L+ VT
Sbjct: 253 EVLEFVTS 260
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 61/249 (24%), Positives = 103/249 (41%), Gaps = 52/249 (20%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKLLRM 69
++ + +G G++G V A A VA+K +KE + + + E+K+L
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIH 86
Query: 70 L-KHPDIVEIKHIMLPPCRREFKDIYVVFELME-----------------SDLDQVIKAN 111
+ H ++V +L C + + V+ E + +
Sbjct: 87 IGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 112 DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171
D LT EH + +Q+ + ++++ S HRDL +NIL + +KICDFGLAR
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD----- 197
Query: 172 PSAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLF 222
I+ YV +W APE F YT D+WS G + E+ + G +
Sbjct: 198 ---IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 223 PGRNVAHQL 231
PG + +
Sbjct: 252 PGVKIDEEF 260
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 76/323 (23%), Positives = 122/323 (37%), Gaps = 76/323 (23%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIK-LLRMLK 71
S + ++IG GS+G V A A+K + K+ + I+ E LL+ +K
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRAL 130
HP +V + + +Y V + + +L ++ +F+ ++ AL
Sbjct: 98 HPFLVGLHF-----SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 152
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD---------TPSAIFWTDYV 181
Y+HS N+ +RDLKP+NIL ++ + + DFGL + + TP
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE-------- 204
Query: 182 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
Y APE+ Y +D W +G + E+L G P F RN
Sbjct: 205 ----YLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------------- 244
Query: 242 SAESIAGIRNEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR---- 295
AE I N+ + ++ A LL+ LL D R
Sbjct: 245 -AEMYDNILNKPLQLKPNIT------------------NSARHLLEGLLQKDRTKRLGAK 285
Query: 296 PSAEEIR----FTEIVFNWLFLY 314
EI+ F+ I NW L
Sbjct: 286 DDFMEIKSHVFFSLI--NWDDLI 306
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 63/311 (20%), Positives = 116/311 (37%), Gaps = 59/311 (18%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIK-LLRMLK 71
+ + ++G GS+G V + T E A+K + K+V D + E + L K
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRAL 130
P + ++ C + +Y V E + DL I+ H F+ ++ L
Sbjct: 80 PPFLTQLHS-----CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
++ S + +RDLK N++ +++ +KI DFG+ + + D + + T Y APE
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYIAPE 191
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
+ Y ++D W+ G + E+L G+ F G + E I
Sbjct: 192 IIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------------DELFQSIM 234
Query: 251 NEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAEEIR- 302
+ +S A+ + + L+ P R +I+
Sbjct: 235 EHNVAYPKSMS------------------KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276
Query: 303 ---FTEIVFNW 310
F I +W
Sbjct: 277 HAFFRYI--DW 285
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 50/248 (20%), Positives = 87/248 (35%), Gaps = 48/248 (19%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKLLRM 69
+ +G G++G V +VA+K + E S+ + L E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALIISK 130
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLL- 127
H +IV + + +++ ELM DL ++ + + LL
Sbjct: 131 FNHQNIVRC----IGVSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 128 ------RALKYIHSANVFHRDLKPKNILANA---DCKLKICDFGLARVSFTDTPSAIFWT 178
+Y+ + HRD+ +N L KI DFG+AR I+
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------IYRA 237
Query: 179 DYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GRPLFPGRNVA 228
Y +W PE +T D WS G + E+ + P +P ++
Sbjct: 238 GYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQ 293
Query: 229 HQLDLVTD 236
L+ VT
Sbjct: 294 EVLEFVTS 301
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 70/322 (21%), Positives = 120/322 (37%), Gaps = 80/322 (24%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIK-LLRMLK 71
+E ++G GS+G V A TG+ A+K + K+V D + E + L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRAL 130
HP + ++ C + ++ V E + DL I+ + +F+ +++ AL
Sbjct: 83 HPFLTQLFC-----CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISAL 137
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARV---------SFTDTPSAIFWTDYV 181
++H + +RDLK N+L + + K+ DFG+ + +F TP DY+
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTP------DYI 191
Query: 182 ATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
APE L Y PA+D W++G + E+L G F N
Sbjct: 192 ------APEILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------------- 229
Query: 241 PSAESIAGIRNEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR--- 295
+ I N++ +L A +L+ + +P R
Sbjct: 230 --DDLFEAILNDEVVYPTWLH------------------EDATGILKSFMTKNPTMRLGS 269
Query: 296 ---PSAEEIR----FTEIVFNW 310
I F EI +W
Sbjct: 270 LTQGGEHAILRHPFFKEI--DW 289
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 70/315 (22%), Positives = 120/315 (38%), Gaps = 71/315 (22%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIK-LLRMLKHPDIVEI 78
+IG GSY V T A+K + KE+ D + E + HP +V +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 79 KHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN 137
C + ++ V E + DL ++ L EH +F+ ++ AL Y+H
Sbjct: 76 HS-----CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 138 VFHRDLKPKNILANADCKLKICDFGLAR---------VSFTDTPSAIFWTDYVATRWYRA 188
+ +RDLK N+L +++ +K+ D+G+ + +F TP+ Y A
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN------------YIA 178
Query: 189 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
PE L G Y ++D W++G + E++ GR F + D
Sbjct: 179 PEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQ 229
Query: 248 GIRNEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR------PSAE 299
I ++ + R LS A +L+ L DPK+R
Sbjct: 230 VILEKQIRIPRSLS------------------VKAASVLKSFLNKDPKERLGCHPQTGFA 271
Query: 300 EIR----FTEIVFNW 310
+I+ F + +W
Sbjct: 272 DIQGHPFFRNV--DW 284
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 70/322 (21%), Positives = 136/322 (42%), Gaps = 62/322 (19%)
Query: 14 SQYEIQEIIGIGSYG---VVASAIDTHTGEKVAIKKMK--EVFEHVSDATRILREIK-LL 67
+E+ +++G G+YG +V TG+ A+K +K + + E + L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKD---IYVVFELMES-DLDQVIKANDDLTPEHHQFFL 123
+ + P +V + + F+ ++++ + + +L + + T Q ++
Sbjct: 114 HIRQSPFLVTLHY--------AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 165
Query: 124 YQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVAT 183
+++ AL+++H + +RD+K +NIL +++ + + DFGL++ D + + + T
Sbjct: 166 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYD-FCGT 223
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
Y AP++ S + A+D WS+G + ELLTG F + ++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR------ 277
Query: 244 ESIAGIRNEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----P 296
I + + +S LA L+QRLL DPK R
Sbjct: 278 -----ILKSEPPYPQEMS------------------ALAKDLIQRLLMKDPKKRLGCGPR 314
Query: 297 SAEEIR----FTEIVFNWLFLY 314
A+EI+ F +I NW L
Sbjct: 315 DADEIKEHLFFQKI--NWDDLA 334
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 65/257 (25%), Positives = 108/257 (42%), Gaps = 57/257 (22%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE-----KVAIKKMKEVFEHVSDATRI--LREIKLL 67
+ + +G G +G V A A+ + VA+K +K+ ++ + E++++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMM 140
Query: 68 RML-KHPDIVEIKHIMLPPCRREFKDIYVVFELM-----------------ESDLDQVIK 109
+M+ KH +I+ +L C ++ +YV+ E E D
Sbjct: 141 KMIGKHKNIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 110 ANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169
+ +T + YQL R ++Y+ S HRDL +N+L + +KI DFGLAR
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--- 252
Query: 170 DTPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLT-GR 219
I D Y T +W APE + F YT D+WS G + E+ T G
Sbjct: 253 -----INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 220 PLFPGRNVAHQLDLVTD 236
+PG V L+ +
Sbjct: 304 SPYPGIPVEELFKLLKE 320
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 69/322 (21%), Positives = 123/322 (38%), Gaps = 71/322 (22%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIK-LLRMLK 71
+++ +IG GSY V T A++ + KE+ D + E +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRAL 130
HP +V + C + ++ V E + DL ++ L EH +F+ ++ AL
Sbjct: 112 HPFLVGLHS-----CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 166
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLAR---------VSFTDTPSAIFWTDYV 181
Y+H + +RDLK N+L +++ +K+ D+G+ + +F TP+
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN-------- 218
Query: 182 ATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240
Y APE L G Y ++D W++G + E++ GR F + D
Sbjct: 219 ----YIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QN 265
Query: 241 PSAESIAGIRNEKAK--RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR--- 295
I ++ + R LS A +L+ L DPK+R
Sbjct: 266 TEDYLFQVILEKQIRIPRSLS------------------VKAASVLKSFLNKDPKERLGC 307
Query: 296 ---PSAEEIR----FTEIVFNW 310
+I+ F + +W
Sbjct: 308 HPQTGFADIQGHPFFRNV--DW 327
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 59/262 (22%), Positives = 102/262 (38%), Gaps = 62/262 (23%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKLLRM 69
+ + +G G +G V A+A VA+K +KE + S + L E +L+
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE---NASPSELRDLLSEFNVLKQ 82
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELME-------------------------SDL 104
+ HP +++ + C ++ + ++ E + +
Sbjct: 83 VNHPHVIK----LYGACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 105 DQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164
LT F +Q+ + ++Y+ + HRDL +NIL K+KI DFGL+
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 165 RVSFTDTPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEL 215
R ++ D YV +W A E S F YT D+WS G + E+
Sbjct: 198 RD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEI 245
Query: 216 LT-GRPLFPGRNVAHQLDLVTD 236
+T G +PG +L+
Sbjct: 246 VTLGGNPYPGIPPERLFNLLKT 267
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 64/256 (25%), Positives = 107/256 (41%), Gaps = 55/256 (21%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE-----KVAIKKMKEVFEHVSDATRI--LREIKLL 67
+ + +G G++G V A A+ + VA+K +K+ ++ + E++++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMM 94
Query: 68 RML-KHPDIVEIKHIMLPPCRREFKDIYVVFELME-----------------SDLDQVIK 109
+M+ KH +I+ +L C ++ +YV+ E D
Sbjct: 95 KMIGKHKNIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 110 ANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169
+ +T + YQL R ++Y+ S HRDL +N+L + +KI DFGLAR
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--- 206
Query: 170 DTPSAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRP 220
I D Y T +W APE F YT D+WS G + E+ T G
Sbjct: 207 -----INNIDYYKKTTNGRLPVKWM-APE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 221 LFPGRNVAHQLDLVTD 236
+PG V L+ +
Sbjct: 259 PYPGIPVEELFKLLKE 274
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 66/257 (25%), Positives = 109/257 (42%), Gaps = 57/257 (22%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE-----KVAIKKMKEVFEHVSDATRI--LREIKLL 67
+ + +G G++G V A AI + KVA+K +K ++ + E++++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMM 128
Query: 68 RML-KHPDIVEIKHIMLPPCRREFKDIYVVFELM-----------------ESDLDQVIK 109
+M+ KH +I+ +L C ++ +YV+ E E +
Sbjct: 129 KMIGKHKNIIN----LLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 110 ANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169
+ L+ + YQ+ R ++Y+ S HRDL +N+L D +KI DFGLAR
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD--- 240
Query: 170 DTPSAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLT-GR 219
I D Y T +W APE + F YT D+WS G + E+ T G
Sbjct: 241 -----IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 220 PLFPGRNVAHQLDLVTD 236
+PG V L+ +
Sbjct: 292 SPYPGVPVEELFKLLKE 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 59/245 (24%), Positives = 96/245 (39%), Gaps = 47/245 (19%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRML- 70
+ + +G G++G V A+A + KVA+K +K H + ++ E+K++ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLG 107
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELME---------------SDLDQVIKANDDLT 115
+H +IV +L C + V+ E AN +
Sbjct: 108 QHENIVN----LLGACTHG-GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 116 PEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175
F Q+ + + ++ S N HRD+ +N+L KI DFGLAR I
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD--------I 214
Query: 176 FWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN 226
Y+ +W APE F YT D+WS G + E+ + G +PG
Sbjct: 215 MNDSNYIVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271
Query: 227 VAHQL 231
V +
Sbjct: 272 VNSKF 276
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 67/251 (26%), Positives = 95/251 (37%), Gaps = 55/251 (21%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKLLRM 69
+ +G G++G V A+A + VA+K +K R + E+K+L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP---SAHLTEREALMSELKVLSY 82
Query: 70 L-KHPDIVEIKHIMLPPCRREFKDIYVVFELME-----------------SDLDQVIKAN 111
L H +IV +L C V+ E S I +
Sbjct: 83 LGNHMNIVN----LLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 112 DDLTPEHHQF--FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169
D+L + F YQ+ + + ++ S N HRDL +NIL KICDFGLAR
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--- 194
Query: 170 DTPSAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRP 220
I YV +W APE F YT D+WS G EL + G
Sbjct: 195 -----IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 221 LFPGRNVAHQL 231
+PG V +
Sbjct: 247 PYPGMPVDSKF 257
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 61/267 (22%), Positives = 96/267 (35%), Gaps = 72/267 (26%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKLLRM 69
E IG G++G V A A E VA+K +KE S + RE L+
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASADMQADFQREAALMAE 106
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELME-------------------------SDL 104
+P+IV+ +L C K + ++FE M +
Sbjct: 107 FDNPNIVK----LLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 105 DQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164
L+ Q+ + Y+ HRDL +N L + +KI DFGL+
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 165 RVSFTDTPSAIFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIWSIGCI 211
R I+ DY Y+ PE S F+++YT D+W+ G +
Sbjct: 222 RN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVWAYGVV 265
Query: 212 FAELLT--GRPLFPGRNVAHQLDLVTD 236
E+ + +P + G + V D
Sbjct: 266 LWEIFSYGLQP-YYGMAHEEVIYYVRD 291
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 63/250 (25%), Positives = 95/250 (38%), Gaps = 53/250 (21%)
Query: 18 IQEIIGIGSYGVV--ASAIDTHTGEKVAIKKMKEVFEHVSDATRI--LREIKLLRML-KH 72
Q++IG G++G V A AIK+MKE + S E+++L L H
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHH 85
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME---------------SDLDQVIKANDDLTPE 117
P+I+ +L C +Y+ E +D I + T
Sbjct: 86 PNIIN----LLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 118 HHQF--FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175
Q F + R + Y+ HRDL +NIL + KI DFGL+R +
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEV---- 194
Query: 176 FWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GRPLFPGRN 226
YV RW A E +S YT D+WS G + E+++ G P + G
Sbjct: 195 ----YVKKTMGRLPVRWM-AIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-YCGMT 246
Query: 227 VAHQLDLVTD 236
A + +
Sbjct: 247 CAELYEKLPQ 256
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 40/167 (23%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRIL-REIKLLRMLK 71
+ + + IG G++G + + +T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 72 H-PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFL------- 123
I ++ + K +V EL+ L+ + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 124 YQLLRALKYIHSANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 165
QL+ ++Y+HS N+ +RD+KP+N L + I DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
++Y + IG GS+G + D GE+VAIK +H + E K+ +M++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 63
Query: 73 -PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFL-------Y 124
I I+ C E +V EL+ L+ + +F L
Sbjct: 64 GVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLAD 112
Query: 125 QLLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLAR 165
Q++ ++YIHS N HRD+KP N L + I DFGLA+
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 66/257 (25%), Positives = 103/257 (40%), Gaps = 62/257 (24%)
Query: 17 EIQEIIGIGSYGVV--ASAIDTHTGE---KVAIKKMKEVFEHVSDATRI--LREIKLLRM 69
E +++G G++G V A+A +VA+K +KE + R + E+K++
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE---KADSSEREALMSELKMMTQ 104
Query: 70 L-KHPDIVEIKHIMLPPCRREFKDIYVVFELME------------------------SDL 104
L H +IV +L C IY++FE
Sbjct: 105 LGSHENIVN----LLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 105 DQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164
+ + + LT E F YQ+ + ++++ + HRDL +N+L +KICDFGLA
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 165 RVSFTDTPSAIFWTD-YVAT-------RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEL 215
R I YV +W APE S F YT D+WS G + E+
Sbjct: 220 RD--------IMSDSNYVVRGNARLPVKWM-APE---SLFEGIYTIKSDVWSYGILLWEI 267
Query: 216 LT-GRPLFPGRNVAHQL 231
+ G +PG V
Sbjct: 268 FSLGVNPYPGIPVDANF 284
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 81.9 bits (201), Expect = 3e-17
Identities = 52/325 (16%), Positives = 93/325 (28%), Gaps = 63/325 (19%)
Query: 7 FTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM------KEVFEHVSDATRI 60
F+ + + E IG G +G V I HT VAIK + H I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 61 LREIKLLRML---------KHPDIVEIKHIML-------------------------PPC 86
L EI + + L + + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 87 RREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVF-HRDLKP 145
+ +++V E +D + + L+QL +L ++ F HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 146 KNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 205
N+L K+ + S + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV------------------SIIDYTLSRLE 232
Query: 206 WSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKW 265
+F ++ LF G +Q D + L+ + +L L K
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFD-IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 266 AVPFSHKFPGADPLALRLLQRLLAF 290
+ K P ++ +++ F
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEF 315
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 37/175 (21%), Positives = 73/175 (41%), Gaps = 35/175 (20%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
Q+ + + IG G +G++ A T+ EK A +K E+ + + E+K + + D
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAKKD 94
Query: 75 IVE-------IKHIMLPPCR-------REFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
++ + ++ +P + ++V E + DL ++ N
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN-------GT 147
Query: 121 FFL-------YQLLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLAR 165
F ++L L+YIH H D+K N+L N D ++ + D+GL+
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 39/164 (23%), Positives = 72/164 (43%), Gaps = 26/164 (15%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK- 71
+++ + IG GS+G + + T E+VAIK +H ++L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQG 61
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFL-------Y 124
I ++ E +V +L+ L+ + + L
Sbjct: 62 GTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCS------RKLSLKTVLMLAD 110
Query: 125 QLLRALKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLAR 165
Q++ ++++HS + HRD+KP N L ++ I DFGLA+
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 32/166 (19%), Positives = 67/166 (40%), Gaps = 28/166 (16%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
Y++ IG GS+GV+ + ++VAIK + + E + ++L
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 64
Query: 73 -PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFL-------Y 124
I + + +E +V +L+ L+ ++ +F +
Sbjct: 65 CTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAAK 113
Query: 125 QLLRALKYIHSANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 165
Q+L ++ IH ++ +RD+KP N L + + + DFG+ +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 36/174 (20%), Positives = 70/174 (40%), Gaps = 30/174 (17%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+++ IG G +G + A D ++ E V V SD + E+K + P+
Sbjct: 36 AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 75 IVE-------IKHIMLPPCR-------REFKDIYVVFELMESDLDQVIKANDDLTPEHHQ 120
++ +K++ +P +++ + SDL ++ +AN +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------KR 148
Query: 121 FFL-------YQLLRALKYIHSANVFHRDLKPKNIL--ANADCKLKICDFGLAR 165
F ++L L+YIH H D+K N+L ++ + D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 27/185 (14%), Positives = 64/185 (34%), Gaps = 41/185 (22%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTG--------EKVAIKKMKEVFEHVSDATRILREIKL 66
Q++++ + G++ A T T +K ++K + R+ E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKD--GRLFNEQNF 95
Query: 67 L-RMLKHPDIVE------IKHIMLPPCR----REFKDIYVVFELMESDLDQVIKANDDLT 115
R K + + + +P C + K ++V + L + +
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP--- 152
Query: 116 PEHHQFFL-------YQLLRALKYIHSANVFHRDLKPKNILANADCKLKI--CDFGLARV 166
H +LL AL+++H H ++ +NI + + + ++ +G A
Sbjct: 153 --KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF- 209
Query: 167 SFTDT 171
+ +
Sbjct: 210 RYCPS 214
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 55/227 (24%), Positives = 89/227 (39%), Gaps = 59/227 (25%)
Query: 21 IIGIGSYGVVAS-AIDTHTGEKVAIKKMKEVFEHVSD--ATRILREIKLLRMLKHPDIV- 76
+G G +GVV ++ VA+KK+ + + ++ + +EIK++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 77 ------EIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLL--- 127
+ + L V+ M N L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL--LDRLSCLDGTPPLS 131
Query: 128 ------------RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAI 175
+ ++H + HRD+K NIL + KI DFGLAR S + +
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 176 FWTDYVA-TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRP 220
T + T Y APE L G + TP DI+S G + E++TG P
Sbjct: 192 --TSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 42/129 (32%), Positives = 62/129 (48%), Gaps = 18/129 (13%)
Query: 111 NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170
D LT EH + +Q+ + ++++ S HRDL +NIL + +KICDFGLAR + D
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 171 TPSAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLF 222
DYV +W APE F YT D+WS G + E+ + G +
Sbjct: 247 -------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
Query: 223 PGRNVAHQL 231
PG + +
Sbjct: 297 PGVKIDEEF 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 55/241 (22%), Positives = 90/241 (37%), Gaps = 88/241 (36%)
Query: 21 IIGIGSYGVVASAIDTHTGEKVAIKKM--------KEVFEHVSDATRILREIKLLRMLKH 72
+IG G +G V + G KVA+K+ +E F EI+ L +H
Sbjct: 46 LIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEE-F---------ETEIETLSFCRH 94
Query: 73 PDIV-------EIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQ 125
P +V E ++L +++ ME N +L + H LY
Sbjct: 95 PHLVSLIGFCDERNEMIL------------IYKYME---------NGNL--KRH---LYG 128
Query: 126 LL-------------------RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166
R L Y+H+ + HRD+K NIL + + KI DFG+++
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 167 SFTDTPSAIFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAELLTGR 219
+ +++T Y PE +F + T D++S G + E+L R
Sbjct: 189 GTELDQT------HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 220 P 220
Sbjct: 239 S 239
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 128 RALKYIH---SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATR 184
R L Y+H + HRD+K NIL + + + + DFGLA++ + + T T
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-TAVRGTI 199
Query: 185 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLTGR 219
+ APE G K + D++ G + EL+TG+
Sbjct: 200 GHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 6e-07
Identities = 52/401 (12%), Positives = 110/401 (27%), Gaps = 139/401 (34%)
Query: 30 VASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI------ML 83
V + T +++ + +L + R P E+ ++
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTP-DEVKSLLLKYLDCRPQDLP--REVLTTNPRRLSII 333
Query: 84 PPCRREFKDIYVVFELMESD-LDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHR 141
R+ + ++ + D L +I+++ + L P ++ ++ L +VF
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK-MFDRL---------SVFPP 383
Query: 142 DLK-PKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYT 200
P +L+ + W D + + + KY+
Sbjct: 384 SAHIPTILLS------------------------LIWFDVI----KSDVMVVVNKLHKYS 415
Query: 201 PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSS 260
L+ +P + L +L + NE A
Sbjct: 416 --------------LVEKQP-KESTISIPSIYL--ELKVK--------LENEYAL----- 445
Query: 261 LRRKWAVPFSHKFPGADPLALRLLQR---LLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317
H+ ++ FD D +L YFY
Sbjct: 446 ----------HR---------SIVDHYNIPKTFDSDDLIP-----------PYLDQYFYS 475
Query: 318 -LALADPYFHGLANLE--EEPSRKPISKLVFEFERRKLIK------------DDVREL-I 361
+ H L N+E E + + L F F +K+ + +++L
Sbjct: 476 HIG-----HH-LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF 529
Query: 362 YRE-ILEYHPHMLEEYLQGTDHTHFMYPSGVDQFKQQFARL 401
Y+ I + P E + F+ + ++ L
Sbjct: 530 YKPYICDNDPK-YERLVN--AILDFLPKIEENLICSKYTDL 567
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 506 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.75 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.52 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.85 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.47 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.25 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.19 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.17 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.05 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.97 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.95 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.94 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.62 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.43 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.38 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.58 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.36 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-70 Score=573.34 Aligned_cols=343 Identities=49% Similarity=0.843 Sum_probs=303.5
Q ss_pred ccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC-
Q 044076 7 FTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP- 85 (506)
Q Consensus 7 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~- 85 (506)
...|...++|++++.||+|+||+||+|+++.+|+.||||+++.........+++.+|+.+|+.++|||||++++++...
T Consensus 47 ~~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 47 DVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp -CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred CCCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 3446677899999999999999999999999999999999987666667788899999999999999999999998654
Q ss_pred CcCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 86 CRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
...+.+.+|||||||+|+|.+++..++.+++.+++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 127 ~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 127 PYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred ccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 23455789999999999999999998999999999999999999999999999999999999999999999999999998
Q ss_pred cccCCC-CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDT-PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~-~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
...... ......+.++||++|+|||++.+. ..|+.++||||+|||+|||++|++||++.+..+++..|....|.|+..
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 643321 122234678999999999998772 567999999999999999999999999999999999999999999999
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
.+..+.......++..++...+.++...+++++++++|||.+||++||.+||||+| ||+|||
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e------------------~L~Hp~ 347 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA------------------ALRHPF 347 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH------------------HTTSGG
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH------------------HhcCHh
Confidence 99888888888888888888888888899999999999999999999999999999 999999
Q ss_pred cCCCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 325 FHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
|+..+++.++|.+.+ .+++.|+...++.+++|++|++||.+||.
T Consensus 348 f~~~~~p~~~p~~~~--~~~~~~~~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 348 LAKYHDPDDEPDCAP--PFDFAFDREALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp GTTTCCGGGSCCCSS--CCCCHHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred hCcCCCCccccCCCC--CCCCccchhhcCHHHHHHHHHHHHHHHHH
Confidence 999999888887654 46778889999999999999999999886
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=511.77 Aligned_cols=347 Identities=36% Similarity=0.664 Sum_probs=301.2
Q ss_pred cccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 6 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
.+..+...++|++++.||+|+||+||+|++..+++.||||+++..+......+++.+|+.+|+.++||||+++++++...
T Consensus 18 ~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 18 GIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp CGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 45678889999999999999999999999999999999999987777777888999999999999999999999999776
Q ss_pred CcCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 86 CRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.......+|+||||++++|.++++....+++.+++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 98 DLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp CTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 55555789999999999999999988889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC-------------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh---------
Q 044076 166 VSFTDTPS-------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--------- 217 (506)
Q Consensus 166 ~~~~~~~~-------------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~--------- 217 (506)
........ ....+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccccccc
Confidence 64332211 0234678999999999987542 679999999999999999997
Q ss_pred --CCCCCCCCC-----------------chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCH
Q 044076 218 --GRPLFPGRN-----------------VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADP 278 (506)
Q Consensus 218 --G~~pF~~~~-----------------~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 278 (506)
|.++|+|.+ ..+++..|.+.+|+|+.+.+..+.......++..++.....++...++++++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 788888876 4789999999999999999999999999999999888888888888899999
Q ss_pred HHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCCCCCCCCCCCccchhhHHh-hcCCHHHH
Q 044076 279 LALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFER-RKLIKDDV 357 (506)
Q Consensus 279 ~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 357 (506)
++++||++||++||.+|||++| +|+||||++++....++.+... +.+.|+. ..++.+++
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e------------------~L~Hp~f~~~~~~~~e~~~~~~--~~~~~~~~~~~~~~~~ 396 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQ------------------ALDHPYLKDVRKKKLENFSTKK--IILPFDDWMVLSETQL 396 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHH------------------HHTCGGGTTTCCTTTC---CCC--CCCSSCTTCCCCHHHH
T ss_pred HHHHHHHHHhcCCcccCCCHHH------------------HhcChhhhhccCcccCcCCCCC--CCCChhhcccCCHHHH
Confidence 9999999999999999999999 9999999999988777655321 2223333 57899999
Q ss_pred HHHHHHHHHhhCchhH
Q 044076 358 RELIYREILEYHPHML 373 (506)
Q Consensus 358 r~~~~~ei~~~~~~~~ 373 (506)
|+++++||..|||+..
T Consensus 397 ~~~~~~e~~~~~~~~~ 412 (432)
T 3n9x_A 397 RYIFLKEVQSFHPELV 412 (432)
T ss_dssp HHHHHHHHHHHCTTCC
T ss_pred HHHHHHHHHHhCcccc
Confidence 9999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-62 Score=516.12 Aligned_cols=345 Identities=41% Similarity=0.723 Sum_probs=289.3
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..|...++|++++.||+|+||+||+|++..+++.||||++..........+++.+|+.+|+.++||||+++++++.....
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 45677899999999999999999999999999999999998777777788899999999999999999999999977655
Q ss_pred CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 88 REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
+....+|+||||++++|.++++....+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 127 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 127 EKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp TTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred ccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 66688999999999999999998889999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCC------------------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh------
Q 044076 168 FTDTPS------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT------ 217 (506)
Q Consensus 168 ~~~~~~------------------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~------ 217 (506)
...... ....+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 322111 0134677899999999987542 679999999999999999998
Q ss_pred -----CCCCCCCCC--------------------chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCC
Q 044076 218 -----GRPLFPGRN--------------------VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHK 272 (506)
Q Consensus 218 -----G~~pF~~~~--------------------~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (506)
|+++|+|.+ ..+++..|.+.+|+|+.+.+..+....+..++..++.....++...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 889998876 3689999999999999999999999999999999999888899999
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCCCCCCCCCCCccchhhHHhhcC
Q 044076 273 FPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKL 352 (506)
Q Consensus 273 ~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (506)
++.+++++++||.+||++||.+|||++| +|+||||+++.....++.+.....+.+. +...+
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e------------------~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~ 426 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINE------------------CLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNM 426 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHH------------------HHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCC
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHH------------------HhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccC
Confidence 9999999999999999999999999999 8999999999887777655322222221 23578
Q ss_pred CHHHHHHHHHHHHHhhCchh
Q 044076 353 IKDDVRELIYREILEYHPHM 372 (506)
Q Consensus 353 ~~~~~r~~~~~ei~~~~~~~ 372 (506)
+.+++|+.+++||..|||++
T Consensus 427 ~~~~~~~~~~~e~~~~~~~~ 446 (458)
T 3rp9_A 427 DEPQLRYAFVKEIQRYHPEI 446 (458)
T ss_dssp CHHHHHHHHHHHHTTTCTTC
T ss_pred CHHHHHHHHHHHHHHhCccc
Confidence 89999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=491.45 Aligned_cols=335 Identities=39% Similarity=0.725 Sum_probs=288.8
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC-
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC- 86 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~- 86 (506)
+.|...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 4567789999999999999999999999999999999999766666677788999999999999999999999997652
Q ss_pred cCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 87 RREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..+...+|+||||++++|.++++. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 99 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 234567899999998899999987 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... .+.+++|++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+..|+|+.+.+
T Consensus 178 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 4321 3567899999999998762 57999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
..+.+...+.++..++.....++...++++++++.+||.+||++||.+|||++| +|+||||+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e------------------~l~hp~f~ 312 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE------------------ALAHPYFE 312 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH------------------HHHSGGGT
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHH------------------HhcChHHH
Confidence 999999999999999988888888999999999999999999999999999999 99999999
Q ss_pred CCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCch
Q 044076 327 GLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHPH 371 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~~ 371 (506)
.+.+..+++...+ +++.|+....+.++|++++|+|++.|+|.
T Consensus 313 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (367)
T 1cm8_A 313 SLHDTEDEPQVQK---YDDSFDDVDRTLDEWKRVTYKEVLSFKPP 354 (367)
T ss_dssp TTC------CCCC---CCCC-----CCHHHHHHHHHHHHHTCCC-
T ss_pred hhcCCccCCCCCC---CCCChhhhcCCHHHHHHHHHHHHHHhccc
Confidence 9998888777653 56778888899999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-61 Score=486.27 Aligned_cols=266 Identities=26% Similarity=0.436 Sum_probs=228.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .........+.+|+.+|+.++|||||+++++|.. .+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 45799999999999999999999999999999999642 1223446678999999999999999999999943 47
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|||||||+| +|.++++..+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 89999999985 99999999889999999999999999999999999999999999999999999999999999875332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+.- +
T Consensus 186 ~~~-~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~--------- 251 (311)
T 4aw0_A 186 SKQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--Y--------- 251 (311)
T ss_dssp TTC-CCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C---------
T ss_pred CCc-ccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C---------
Confidence 221 22356789999999999987 789999999999999999999999999988877777764311 0
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.....++++++|||.+||+.||.+|||++|+..++ ++++||||+++.
T Consensus 252 --------------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~------------~i~~Hp~F~~id 298 (311)
T 4aw0_A 252 --------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG------------PLKAHPFFESVT 298 (311)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHH------------HHHTSGGGTTCC
T ss_pred --------------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCH------------HHHCCCCcCCCC
Confidence 01135899999999999999999999999953222 268999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-61 Score=476.40 Aligned_cols=255 Identities=30% Similarity=0.515 Sum_probs=207.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||+||+|++..+|+.||||++++.. .......++.+|+.+|+.++|||||++++++.. .+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CC
Confidence 368999999999999999999999999999999996432 233345678999999999999999999999944 47
Q ss_pred cEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 92 DIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.+|+||||++|+|.+.+..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999997643322
Q ss_pred CCcccccccccCCcccCcccccccCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.....+||+.|+|||++.+ ..| +.++|||||||++|+|++|++||.+.+....+..|.+.. +
T Consensus 167 ----~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~--------- 229 (275)
T 3hyh_A 167 ----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--Y--------- 229 (275)
T ss_dssp ------------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C---------
T ss_pred ----ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--C---------
Confidence 2356789999999999987 454 689999999999999999999999887766665553211 0
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.....+++++.+||.+||+.||.+|||++| +|+||||+.
T Consensus 230 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~e------------------il~hpw~k~ 268 (275)
T 3hyh_A 230 --------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHE------------------IMQDDWFKV 268 (275)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHH------------------HHHCHHHHT
T ss_pred --------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHH------------------HHcCccccc
Confidence 011358999999999999999999999999 899999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-61 Score=488.97 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=223.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
..+|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.. .+.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 357999999999999999999999999999999996432 2234557899999999999999999999954 478
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|||||||+| +|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999985 99998876 569999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ..+..+||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|......
T Consensus 225 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------- 288 (346)
T 4fih_A 225 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP----------- 288 (346)
T ss_dssp C---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-----------
T ss_pred C---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-----------
Confidence 2 2356789999999999987 78999999999999999999999999998888777776442110
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
....++.+++++++||.+||+.||.+|||++| +|+||||+...
T Consensus 289 -----------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e------------------~l~Hp~~~~~~ 331 (346)
T 4fih_A 289 -----------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE------------------LLKHPFLAKAG 331 (346)
T ss_dssp -----------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHH------------------HTTCGGGGGCC
T ss_pred -----------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHH------------------HhcCHhhcCCC
Confidence 01223458999999999999999999999999 89999998643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-61 Score=489.64 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=220.9
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
|...++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.|+|||||++++++..
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~----- 94 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE----- 94 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----
Confidence 345679999999999999999999999999999999997655556667889999999999999999999999943
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+.+|||||||+ |+|.++|...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEccccccee
Confidence 478999999998 59999997643 579999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... ....+..+||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|...--
T Consensus 175 ~~~~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~------- 242 (350)
T 4b9d_A 175 LNST---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF------- 242 (350)
T ss_dssp CCHH---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-------
T ss_pred ecCC---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-------
Confidence 4221 112345789999999999988 7899999999999999999999999999988877777643211
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
......+++++.+||.+||+.||.+|||++| +|+||||+
T Consensus 243 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e------------------~l~hp~~~ 281 (350)
T 4b9d_A 243 -----------------------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNS------------------ILEKGFIA 281 (350)
T ss_dssp -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH------------------HHTSHHHH
T ss_pred -----------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCHHhh
Confidence 0122468999999999999999999999999 89999997
Q ss_pred C
Q 044076 327 G 327 (506)
Q Consensus 327 ~ 327 (506)
.
T Consensus 282 ~ 282 (350)
T 4b9d_A 282 K 282 (350)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-60 Score=490.32 Aligned_cols=341 Identities=40% Similarity=0.715 Sum_probs=277.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||+||+|.+..+|+.||||++...+.......++.+|+.+|+.+. ||||+++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 47899999999999999999999999999999999877777788888999999999998 99999999998643 336
Q ss_pred cEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 92 DIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.+|+|||||+++|.++++. +.+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 7999999999999999987 479999999999999999999999999999999999999999999999999997643211
Q ss_pred ------------------CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHH
Q 044076 172 ------------------PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233 (506)
Q Consensus 172 ------------------~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~ 233 (506)
......+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||++.+..+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234567899999999998762 6799999999999999999999999999999999999
Q ss_pred HHhhcCCCChHHHhhhhhhHHHHHHhhhhccC---CCCCCCCCC-------------CCCHHHHHHHHHhhhcCCCCCCC
Q 044076 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKW---AVPFSHKFP-------------GADPLALRLLQRLLAFDPKDRPS 297 (506)
Q Consensus 234 I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-------------~~s~~~~dLI~~mL~~DP~~RpT 297 (506)
|...+|.|..+.+..+.......++..++... ...+...++ ++++++.+||.+||++||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 99999999999998887777777777665543 333333333 78999999999999999999999
Q ss_pred HhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCCCCCCCCCCCccchhhHH-hhcCCHHHHHHHHHHHHHhhCchhHHHh
Q 044076 298 AEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFE-RRKLIKDDVRELIYREILEYHPHMLEEY 376 (506)
Q Consensus 298 a~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~r~~~~~ei~~~~~~~~~~~ 376 (506)
++| +|+||||+.++++.++|.+... +.+.|+ ....+.+++|+++|.||.++++++..+.
T Consensus 323 ~~e------------------~l~Hp~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 382 (388)
T 3oz6_A 323 AND------------------ALKHPFVSIFHNPNEEPNCDHI--ITIPINDNVKHSIDDYRNLVYSEISRRKRELISNK 382 (388)
T ss_dssp HHH------------------HTTSTTTTTTCCGGGCCCCSSC--CCCC------CCHHHHHHHHHHHHHHHHHHHTCC-
T ss_pred HHH------------------HhCCHHHHHhcCCccCCCCCCC--CCCCccccccCCHHHHHHHHHHHHHHhhhhhhhhc
Confidence 999 9999999999998888877543 333444 4577899999999999999998876654
Q ss_pred hh
Q 044076 377 LQ 378 (506)
Q Consensus 377 ~~ 378 (506)
.+
T Consensus 383 ~~ 384 (388)
T 3oz6_A 383 HQ 384 (388)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=490.77 Aligned_cols=336 Identities=43% Similarity=0.795 Sum_probs=286.5
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC-C
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP-C 86 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~-~ 86 (506)
+.|...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++... .
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 346677999999999999999999999999999999999977666667788899999999999999999999998764 2
Q ss_pred cCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 87 RREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.++...+|+|+|+++++|.++++. +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 103 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp GGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred cccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 234577899999999999998876 5799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... .+.+++|++|+|||++.+. ..|+.++|||||||++|+|++|++||++.+..+++..|.+.+|.|..+.+
T Consensus 182 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 182 TADE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 3221 3567899999999998762 57899999999999999999999999999999999999999999999999
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
..+.+...+.++..++.....++...+++.++++.+||.+||++||.+|||+.| +|+||||+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e------------------~L~hp~~~ 316 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ------------------ALAHAYFA 316 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHH------------------HHTSGGGT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHH------------------HhcChhhh
Confidence 999999999999998888888888888999999999999999999999999999 99999999
Q ss_pred CCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCchh
Q 044076 327 GLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHPHM 372 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~~~ 372 (506)
.+.++.++|.+.| +++.++...+..++|++++|+|+.+|+|..
T Consensus 317 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 359 (367)
T 2fst_X 317 QYHDPDDEPVADP---YDQSLESRDLLIDEWKSLTYDEVISFVPPP 359 (367)
T ss_dssp TTCCGGGCCCCCC---CCGGGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred hccCCCCCCCCCC---CCcchhhccCCHHHHHHHHHHHHHHhccCc
Confidence 9999888877764 556777888999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=490.45 Aligned_cols=258 Identities=29% Similarity=0.486 Sum_probs=223.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|+.++|||||+++++|.. .+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST--TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCE
Confidence 35799999999999999999999999999999999643 22334568899999999999999999999954 478
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|||||||+| +|.++++. +.+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999985 99999876 469999999999999999999999999999999999999999999999999998643332
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ..+..+||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|.....
T Consensus 302 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------ 364 (423)
T 4fie_A 302 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------ 364 (423)
T ss_dssp C---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------------
T ss_pred c---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC------------
Confidence 2 2356789999999999987 7899999999999999999999999999888877777643211
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
+....+..+++++++||.+||+.||.+|||++| +|+||||+...
T Consensus 365 ----------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e------------------ll~Hp~~~~~~ 408 (423)
T 4fie_A 365 ----------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE------------------LLKHPFLAKAG 408 (423)
T ss_dssp ----------------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHH------------------HTTCGGGGGCC
T ss_pred ----------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHH------------------HhcCHHhcCCC
Confidence 111233568999999999999999999999999 89999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-59 Score=467.11 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=218.2
Q ss_pred CCCCE-EEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQY-EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY-~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..+|| ++.+.||+|+||+||+|++..++..||||++...........++.+|+.+|+.++|||||++++++.... ...
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCC
Confidence 34566 7788999999999999999999999999999765555666778999999999999999999999985421 223
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECC-CCCEEEeecCCccc
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANA-DCKLKICDFGLARV 166 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~-~~~lKL~DFGla~~ 166 (506)
..+|||||||+ |+|.++++..+.+++..++.++.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+.
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 56899999998 599999999889999999999999999999999999 999999999999984 89999999999975
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... .....+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+.+...++...... +.++.
T Consensus 182 ~~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~--- 249 (290)
T 3fpq_A 182 KRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA--- 249 (290)
T ss_dssp CCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG---
T ss_pred CCCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCC---
Confidence 3221 2356789999999999864 6999999999999999999999999876655444333211 11111
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
...+..++++.+||.+||+.||.+|||++| +|+||||+
T Consensus 250 ------------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e------------------~l~Hp~~~ 287 (290)
T 3fpq_A 250 ------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKD------------------LLNHAFFQ 287 (290)
T ss_dssp ------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHH------------------HHTSGGGC
T ss_pred ------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCcccc
Confidence 011347889999999999999999999999 89999997
Q ss_pred C
Q 044076 327 G 327 (506)
Q Consensus 327 ~ 327 (506)
+
T Consensus 288 ~ 288 (290)
T 3fpq_A 288 E 288 (290)
T ss_dssp -
T ss_pred C
Confidence 5
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-59 Score=473.76 Aligned_cols=271 Identities=25% Similarity=0.311 Sum_probs=224.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.++|||||++++++.. .+.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~-----~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVRE-----GPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEE-----TTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 4679999999999999999999999999999999964211 2479999999999999999999843 478
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-CEEEeecCCcccccCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-KLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-~lKL~DFGla~~~~~~ 170 (506)
+|||||||+ |+|.++++..+.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+....+
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999998 59999999988999999999999999999999999999999999999999987 6999999999875433
Q ss_pred CCCcc--cccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 171 TPSAI--FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 171 ~~~~~--~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|... .
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~-------- 272 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--P-------- 272 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--C--------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--C--------
Confidence 22111 1234579999999999988 78999999999999999999999999988877766666431 1
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.++....+++++++.+||.+||+.||.+|||+.||+ ++.....-...+|+|||+...
T Consensus 273 ------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~-----~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 273 ------------------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELR-----RKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp ------------------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH-----HHHHHHHHHTTSSCSCSSSSC
T ss_pred ------------------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHH-----HHHHHHHhhhhhccCCCcCCC
Confidence 112234467999999999999999999999999953 333333334457999999886
Q ss_pred CC
Q 044076 329 AN 330 (506)
Q Consensus 329 ~~ 330 (506)
+.
T Consensus 330 ~~ 331 (336)
T 4g3f_A 330 KE 331 (336)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-59 Score=494.78 Aligned_cols=334 Identities=35% Similarity=0.637 Sum_probs=271.0
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-C
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-R 88 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~ 88 (506)
|...++|++++.||+|+||+||+|++..+|+.||||++...........++.+|+.+|+.++||||+++++++..... +
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 58 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 344689999999999999999999999999999999998766677778889999999999999999999999976532 4
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
+..++|+|||||+++|.+.+.. .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 138 ~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 138 EFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp TCCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred cCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 5578999999999999988864 59999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... ..+.++||++|+|||++.+ ..|+.++||||||||+|+|++|++||++.+..+++..|.+.+|.|.++.+..
T Consensus 216 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 216 TSF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -CC----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred CCc----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 321 2366789999999999988 6899999999999999999999999999999999999999999999998887
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCC------------CHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGA------------DPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFY 316 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~ 316 (506)
+. ...+.++...+......+...++.. ++++++||.+||++||.+|||++|
T Consensus 290 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e---------------- 352 (464)
T 3ttj_A 290 LQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD---------------- 352 (464)
T ss_dssp SC-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH----------------
T ss_pred cc-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHH----------------
Confidence 64 4556666665554444444444432 678999999999999999999999
Q ss_pred hhhccCcccCCCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCch
Q 044076 317 VLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHPH 371 (506)
Q Consensus 317 ~~aL~HP~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~~ 371 (506)
+|+||||+.+.++.+.+... ...++..++....+.++|++++++|++.++..
T Consensus 353 --~L~Hp~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 404 (464)
T 3ttj_A 353 --ALQHPYINVWYDPAEVEAPP-PQIYDKQLDEREHTIEEWKELIYKEVMNSEEK 404 (464)
T ss_dssp --HHTSTTTGGGCCHHHHSCCC------------CCCHHHHHHHHHHHHHC----
T ss_pred --HhcChhhhhccCcccccCCC-CccCCcchhhccCCHHHHHHHHHHHHHHhhhc
Confidence 89999999887655433222 23355667788889999999999999876543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-60 Score=476.58 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=215.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
+++|++++.||+|+||+||+|++. .+++.||||++++.........++.+|+.+|+.++|||||++++++..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----- 97 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT----- 97 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----
Confidence 478999999999999999999874 468899999996543333344467899999999999999999999944
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+.+|||||||+ |+|.++++..+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 478999999998 5999999998899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|.+.. +
T Consensus 178 ~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~------- 243 (304)
T 3ubd_A 178 DHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--L------- 243 (304)
T ss_dssp ---C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C-------
T ss_pred CCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--C-------
Confidence 2221 2356789999999999987 789999999999999999999999999998887777764311 1
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----hhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA-----EEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa-----~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
...+.+|+++.+||.+||+.||.+|||+ +| +|+||
T Consensus 244 ----------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~e------------------il~Hp 283 (304)
T 3ubd_A 244 ----------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE------------------IKRHS 283 (304)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHH------------------HHTSG
T ss_pred ----------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHH------------------HHcCc
Confidence 1113589999999999999999999995 67 89999
Q ss_pred ccCCCC
Q 044076 324 YFHGLA 329 (506)
Q Consensus 324 ~f~~~~ 329 (506)
||+++.
T Consensus 284 ~f~~id 289 (304)
T 3ubd_A 284 FFSTID 289 (304)
T ss_dssp GGTTCC
T ss_pred cccCCC
Confidence 998753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=475.68 Aligned_cols=287 Identities=26% Similarity=0.408 Sum_probs=225.6
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
...++|++++.||+|+||+||+|+++ .+++.||||++... ....++.+|+.+|+.+ .||||++++++|..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-- 91 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK-- 91 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--
Confidence 34678999999999999999999875 46789999998642 3345688999999998 59999999999843
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-CCEEEeecCCc
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLA 164 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~-~~lKL~DFGla 164 (506)
.+++|+|||||+ ++|.++++ .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus 92 ---~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 92 ---NDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp ---TTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ---CCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 478999999998 59999884 59999999999999999999999999999999999999877 79999999999
Q ss_pred ccccCCCCC-------------------------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCC
Q 044076 165 RVSFTDTPS-------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR 219 (506)
Q Consensus 165 ~~~~~~~~~-------------------------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~ 219 (506)
+........ ....+..+||++|+|||++.+. ..|+.++||||+|||+|||++|+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTC
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCC
Confidence 754322110 1123456899999999999762 56999999999999999999999
Q ss_pred CCC-CCCCchhhHHHHHhhcCCCChHHHhhhhh-----------hHHHHHHhhhhcc------------CCCCCCCCCCC
Q 044076 220 PLF-PGRNVAHQLDLVTDLLGTPSAESIAGIRN-----------EKAKRYLSSLRRK------------WAVPFSHKFPG 275 (506)
Q Consensus 220 ~pF-~~~~~~~~l~~I~~~~g~p~~e~~~~~~~-----------~~~~~~~~~~~~~------------~~~~~~~~~~~ 275 (506)
+|| .+.+..+++..|...+|++....+..... ...+.....+... ........++.
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 877 67788999999999999765544332110 0111111111100 00111234678
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 276 ADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 276 ~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
++++++|||++||++||.+||||+| ||+||||+++
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~e------------------aL~Hp~f~~i 359 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEE------------------ALLHPFFKDM 359 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHH------------------HHTSGGGTTC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHH------------------HhcCcccCCC
Confidence 9999999999999999999999999 9999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=461.96 Aligned_cols=341 Identities=46% Similarity=0.806 Sum_probs=294.7
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.+...++|++++.||+|+||.||+|.+..+++.||||++.. .........+.+|+.+|+.++||||+++++++.....+
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc-ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 45677899999999999999999999999999999999964 23445567789999999999999999999999766545
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
....+|+||||++++|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 55789999999999999999764 69999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
............+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|...+|.|+.+.+..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 333322234567899999999987652 5689999999999999999999999999999999999999999999999998
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+.+.....+....+.....++...++++++++.+||.+||++||.+|||+.| +|+||||++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------------------~l~hp~~~~~ 320 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ------------------ALAHPYLEQY 320 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHH------------------HHTSGGGTTT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHH------------------HhcCcchhhc
Confidence 8888888888888877777788888999999999999999999999999999 8999999998
Q ss_pred CCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCchh
Q 044076 329 ANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHPHM 372 (506)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~~~ 372 (506)
..+..++.... .+.+.++...+..+++++++++|+..|+|..
T Consensus 321 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 362 (364)
T 3qyz_A 321 YDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGY 362 (364)
T ss_dssp CCGGGSCCCSS--CCCCC-----CCHHHHHHHHHHHTGGGCC--
T ss_pred cCcccccCCCC--cCCcccccccCCHHHHHHHHHHHHHHhhhhc
Confidence 77666655443 3455667778899999999999999998863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=453.15 Aligned_cols=333 Identities=40% Similarity=0.727 Sum_probs=287.0
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR- 87 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~- 87 (506)
.|...++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 37 ~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 37 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred eecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 3566789999999999999999999999999999999997665566667889999999999999999999999965422
Q ss_pred CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 88 REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.....+|+||||++++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 117 ~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 117 RNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp TTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred ccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 2233469999999999988874 45999999999999999999999999999999999999999999999999999753
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ....++|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....|.|..+.+.
T Consensus 195 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 195 DAE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccC------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 222 2456789999999998762 578999999999999999999999999999999999999999999999998
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.+.......+...++......+...++.+++++.+||.+||+.||.+|||+.| +|+||||+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------ll~hp~f~~ 329 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ------------------ALTHPFFEP 329 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHH------------------HHTSGGGTT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHH------------------HhcCccccc
Confidence 88877788888887777777777778899999999999999999999999999 899999999
Q ss_pred CCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 328 LANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
+..+..+.... ..+....+..+++.++|++.|++|+++|+|
T Consensus 330 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 330 FRDPEEETEAQ--QPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp TCCGGGCCCCS--SCCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred CCCcccccccc--cCcCcchhhcccchHHHHHHHHHHHHhccc
Confidence 88766554432 223334456788899999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=442.35 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=200.5
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc------
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR------ 87 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~------ 87 (506)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ......+++.+|+.+|+.++|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 3599999999999999999999999999999999642 234456778999999999999999999999865321
Q ss_pred -CCCCcEEEEEecCC-CCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecC
Q 044076 88 -REFKDIYVVFELME-SDLDQVIKANDD---LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG 162 (506)
Q Consensus 88 -~~~~~~ylV~E~~~-~~L~~~i~~~~~---ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFG 162 (506)
.....+|+|||||+ |+|.+++..... ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 12345899999997 599999987654 4556789999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCC---------cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHH
Q 044076 163 LARVSFTDTPS---------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233 (506)
Q Consensus 163 la~~~~~~~~~---------~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~ 233 (506)
+|+........ ....+..+||+.|+|||++.+ ..|+.++||||||||+|||++ ||.+. .+....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 99864332211 112345689999999999987 789999999999999999996 66432 222322
Q ss_pred HHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHH
Q 044076 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFL 313 (506)
Q Consensus 234 I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~ 313 (506)
+........+ ..++..++.+.+||.+||+.||.+|||+.|
T Consensus 237 ~~~~~~~~~p---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e------------- 276 (299)
T 4g31_A 237 LTDVRNLKFP---------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAIN------------- 276 (299)
T ss_dssp HHHHHTTCCC---------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHH-------------
T ss_pred HHHHhcCCCC---------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHH-------------
Confidence 2222111111 111235677899999999999999999999
Q ss_pred HhhhhhccCcccCCCC
Q 044076 314 YFYVLALADPYFHGLA 329 (506)
Q Consensus 314 ~~~~~aL~HP~f~~~~ 329 (506)
+|+||||+++.
T Consensus 277 -----il~h~~~~~~~ 287 (299)
T 4g31_A 277 -----IIENAVFEDLD 287 (299)
T ss_dssp -----HHTSGGGCCC-
T ss_pred -----HhcCHhhCCCC
Confidence 89999998764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=444.26 Aligned_cols=332 Identities=40% Similarity=0.726 Sum_probs=286.6
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-C
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-R 88 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~ 88 (506)
+...++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 445689999999999999999999999999999999997655566667788999999999999999999999865421 2
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
....+|+||||++++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 234579999999999888774 359999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. ....++|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|....|.|..+.+..
T Consensus 178 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp ------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CC------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 21 2456789999999998762 5789999999999999999999999999999999999999999999999888
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+.......++..++......+...++.+++++.+||.+||+.||.+|||+.| +|+||||+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e------------------~l~hp~f~~~ 312 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ------------------ALTHPFFEPF 312 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHH------------------HHTSGGGTTT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHH------------------HhcCcchhhc
Confidence 8887788888888877777788888899999999999999999999999999 8999999998
Q ss_pred CCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 329 ANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
..+..++... ..+....+...++.++|++.|++|+++++|
T Consensus 313 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 313 RDPEEETEAQ--QPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp CCGGGCCCCS--SCCCCTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred cCccccccCC--CCCccchhhccCCHHHHHHHHHHHHHhhcc
Confidence 8766554433 234455567788999999999999999876
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=438.61 Aligned_cols=337 Identities=44% Similarity=0.797 Sum_probs=281.4
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.+...++|++.+.||+|+||.||+|.+..+|+.||||++.. .........+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc-cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 45678999999999999999999999999999999999963 23445566788999999999999999999998765545
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.....|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 5678999999999999999886 479999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCc-------ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 169 TDTPSA-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 169 ~~~~~~-------~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....|.|
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 221110 112346789999999987542 678999999999999999999999999999999999999999988
Q ss_pred ChH-HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 242 SAE-SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 242 ~~e-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
... .+..+.......+...++.....++...++.+++++.+||.+||+.||.+|||+.| +|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------ll 304 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE------------------AL 304 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH------------------HH
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHH------------------Hh
Confidence 643 33444555566666666655555566667889999999999999999999999999 89
Q ss_pred cCcccCCCCCCCCCCCCCCCccchhhH--HhhcCCHHHHHHHHHHHHH
Q 044076 321 ADPYFHGLANLEEEPSRKPISKLVFEF--ERRKLIKDDVRELIYREIL 366 (506)
Q Consensus 321 ~HP~f~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~r~~~~~ei~ 366 (506)
+||||+.......++...+++...+++ ....++.+++++++++||.
T Consensus 305 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 305 EHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp TSGGGTTTCCTTSSCCCCCCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred cCccccccCCcccccccCCCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 999999998877777666665444444 3567889999999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-55 Score=475.15 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=228.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++.. ....+...+.+|+.+|+.++|||||+++++|.. ...
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec--cchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCE
Confidence 3689999999999999999999999999999999964 344556778999999999999999999999944 488
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC--CCEEEeecCCccccc
Q 044076 93 IYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD--CKLKICDFGLARVSF 168 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~--~~lKL~DFGla~~~~ 168 (506)
+|||||||+ |+|.++|.. .+.+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999998 599999864 4579999999999999999999999999999999999999864 899999999998753
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... .....+||++|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+..+++..|......++.
T Consensus 309 ~~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----- 377 (573)
T 3uto_A 309 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----- 377 (573)
T ss_dssp TTS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS-----
T ss_pred CCC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc-----
Confidence 322 2356789999999999988 78999999999999999999999999999988888887654433322
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
..+++++++++|||.+||+.||.+|||++| +|+||||+..
T Consensus 378 ----------------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e------------------~l~Hpw~~~~ 417 (573)
T 3uto_A 378 ----------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQ------------------ALEHPWLTPG 417 (573)
T ss_dssp ----------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHH------------------HHHSTTTSCC
T ss_pred ----------------------ccccCCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCcCcCCC
Confidence 223568999999999999999999999999 8999999976
Q ss_pred CCC
Q 044076 329 ANL 331 (506)
Q Consensus 329 ~~~ 331 (506)
..+
T Consensus 418 ~~~ 420 (573)
T 3uto_A 418 NAP 420 (573)
T ss_dssp CCT
T ss_pred CCC
Confidence 553
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=444.19 Aligned_cols=331 Identities=36% Similarity=0.635 Sum_probs=259.6
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC-cCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC-RRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~-~~~ 89 (506)
...++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... .++
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3468999999999999999999999999999999999765556667778899999999999999999999987642 234
Q ss_pred CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 90 FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
...+|+||||++++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 46899999999999999986 3599999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..|...+|.|.++.+..+
T Consensus 180 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 180 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp --------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cc----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 21 2345679999999999987 68999999999999999999999999999999999999999999999887766
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCC------------CCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPG------------ADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~ 317 (506)
.. ....+....+......+...++. .++++.+||.+||+.||.+|||++|
T Consensus 254 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e----------------- 315 (371)
T 2xrw_A 254 QP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE----------------- 315 (371)
T ss_dssp CH-HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHH-----------------
T ss_pred hh-HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHH-----------------
Confidence 43 23334333332222222222221 1568999999999999999999999
Q ss_pred hhccCcccCCCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhC
Q 044076 318 LALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYH 369 (506)
Q Consensus 318 ~aL~HP~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~ 369 (506)
+|+||||+...++.......| .......+.+..+.++|++++|.++..+.
T Consensus 316 -~l~hp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 316 -ALQHPYINVWYDPSEAEAPPP-KIPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp -HHHSHHHHTTCCHHHHTCCCC-CCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred -HhCCcchhhhcCccccCCCCC-CCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 899999987665432211111 11223345667788999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-54 Score=431.73 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=211.0
Q ss_pred ccccCCCCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceecee
Q 044076 7 FTEYGEASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHI 81 (506)
Q Consensus 7 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v 81 (506)
|......++|.+.+.||+|+||+||+|++. .++..||||+++. ......+.+.+|+.+|++++|||||+++++
T Consensus 6 ~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 83 (299)
T 4asz_A 6 FVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGV 83 (299)
T ss_dssp SCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 344455678999999999999999999864 4688999999975 244556779999999999999999999999
Q ss_pred ecCCCcCCCCcEEEEEecCC-CCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 044076 82 MLPPCRREFKDIYVVFELME-SDLDQVIKAN-------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKN 147 (506)
Q Consensus 82 ~~~~~~~~~~~~ylV~E~~~-~~L~~~i~~~-------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~N 147 (506)
+.. .+.+|||||||+ |+|.++++.. ..+++..+..|+.||+.||+|||++||+||||||+|
T Consensus 84 ~~~-----~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~N 158 (299)
T 4asz_A 84 CVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRN 158 (299)
T ss_dssp ECS-----SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred Eee-----CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhh
Confidence 854 378999999998 6999999764 369999999999999999999999999999999999
Q ss_pred EEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCC
Q 044076 148 ILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN 226 (506)
Q Consensus 148 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~ 226 (506)
||++.++.+||+|||+|+........ .......||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+
T Consensus 159 ILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 159 CLVGENLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred EEECCCCcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999864332211 11233568999999999987 789999999999999999998 999999988
Q ss_pred chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 227 VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 227 ~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+.+..|....- . ...+.+++++.+||.+||+.||++|||++||
T Consensus 236 ~~~~~~~i~~~~~---------------------------~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 236 NNEVIECITQGRV---------------------------L---QRPRTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp HHHHHHHHHHTCC---------------------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHcCCC---------------------------C---CCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 7776666533110 0 1113588999999999999999999999995
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=429.19 Aligned_cols=255 Identities=24% Similarity=0.285 Sum_probs=207.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..+++++.+.||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|+.++|||||++++++.. +
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------C
Confidence 3578999999999999999999753 359999997655566667889999999999999999999998732 4
Q ss_pred cEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++|||||||||+|||+++++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 6899999998 5999999764 5799999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... ....+..+||+.|+|||++.+. ...|+.++|||||||++|||++|++||.+.+...++..+......
T Consensus 185 ~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~-------- 255 (307)
T 3omv_A 185 WSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA-------- 255 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC--------
T ss_pred CCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC--------
Confidence 221 1123556899999999998642 246999999999999999999999999987766555444321111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+....+++++++.+||.+||+.||.+|||+.||
T Consensus 256 -----------------~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 291 (307)
T 3omv_A 256 -----------------SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQI 291 (307)
T ss_dssp -----------------CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHH
T ss_pred -----------------CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 111223446789999999999999999999999995
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-54 Score=468.80 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=213.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc----cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF----EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~----~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.++|+++++||+|+||+||+|+++.+|+.||||++++.. ..........+++.+++.++|||||+++++|..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~---- 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----
Confidence 468999999999999999999999999999999996421 111222223345677778899999999999954
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 89 EFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.+.+|||||||. |+|.++|...+.+++..+++|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 488999999998 599999999899999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ....+||+.|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+....+...+
T Consensus 343 ~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--------- 407 (689)
T 3v5w_A 343 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------- 407 (689)
T ss_dssp SSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---------
T ss_pred CCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---------
Confidence 3322 2456899999999999641 579999999999999999999999998755433322111100
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
.... ...+.+|+++++||.+||+.||.+|++ ++| +++|
T Consensus 408 --------------~~~~-----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~e------------------i~~H 450 (689)
T 3v5w_A 408 --------------TMAV-----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE------------------VKES 450 (689)
T ss_dssp --------------HCCC-----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHH------------------HTTS
T ss_pred --------------CCCC-----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHH------------------HhcC
Confidence 0000 122468999999999999999999998 789 7899
Q ss_pred cccCCCC
Q 044076 323 PYFHGLA 329 (506)
Q Consensus 323 P~f~~~~ 329 (506)
|||+++.
T Consensus 451 pfF~~id 457 (689)
T 3v5w_A 451 PFFRSLD 457 (689)
T ss_dssp GGGTTCC
T ss_pred ccccCCC
Confidence 9998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=422.74 Aligned_cols=291 Identities=39% Similarity=0.664 Sum_probs=240.0
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
+..++|++++.||+|+||+||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++++.. .
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 91 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----E 91 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----S
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----C
Confidence 56789999999999999999999985 58999999997544444456778899999999999999999999843 4
Q ss_pred CcEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 7899999999999999988754 599999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... ..+..++|++|+|||++.+. ..++.++|||||||++|+|++|++||++.+..+++..+...+|.|.+..+...
T Consensus 172 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 172 PVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp CCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred Ccc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 211 12456789999999998762 56899999999999999999999999999999999999999999988877665
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
....... ..........++....+.+++++.+||.+||++||.+|||++| +|+||||+++.
T Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------ll~hp~f~~~~ 308 (311)
T 3niz_A 248 QELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD------------------AMNHPYFKDLD 308 (311)
T ss_dssp TTSHHHH-SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH------------------HHTSGGGTTSC
T ss_pred hccchhh-hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH------------------HhcCcccccCC
Confidence 4321110 0011111222333455678999999999999999999999999 89999999864
Q ss_pred C
Q 044076 330 N 330 (506)
Q Consensus 330 ~ 330 (506)
.
T Consensus 309 ~ 309 (311)
T 3niz_A 309 P 309 (311)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=427.87 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=202.8
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++|.+.+.||+|+||+||+|+.. .+++.||||+++. ......+.+.+|+.+|++++|||||++++++..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--- 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTE--- 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence 467999999999999999999864 4688999999975 344556779999999999999999999999854
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN---------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~---------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~ 151 (506)
.+.+|||||||+ |+|.++++.. +.+++..+..|+.||+.||+|||+.||+||||||+|||++
T Consensus 115 --~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 378999999998 5999999753 3589999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhh
Q 044076 152 ADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQ 230 (506)
Q Consensus 152 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~ 230 (506)
.++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999864332211 12245679999999999987 789999999999999999998 9999999887776
Q ss_pred HHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 231 l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+..|....- . ...+.+++++.+||.+||+.||++|||++||
T Consensus 270 ~~~i~~g~~---------------------------~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 310 (329)
T 4aoj_A 270 IDCITQGRE---------------------------L---ERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310 (329)
T ss_dssp HHHHHHTCC---------------------------C---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred HHHHHcCCC---------------------------C---CCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence 666533110 0 1113588999999999999999999999995
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-53 Score=424.70 Aligned_cols=250 Identities=21% Similarity=0.312 Sum_probs=207.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEE-----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d-----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..++++++.||+|+||+||+|.. ..+++.||||+++... .....+.+.+|+.+|++++|||||++++++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--- 100 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--- 100 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE---
Confidence 46789999999999999999985 3467899999997532 33345678999999999999999999999854
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA 150 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv 150 (506)
.+.+|||||||+ |+|.++|... ..+++..+..|+.||++||+|||+++||||||||+|||+
T Consensus 101 --~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 --DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp --SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 367899999998 5999999653 358999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchh
Q 044076 151 NADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAH 229 (506)
Q Consensus 151 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~ 229 (506)
++++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CCCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999864332211 12345679999999999987 789999999999999999998 899999988777
Q ss_pred hHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 230 QLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 230 ~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+..|...... ...+++++++.+|+.+||+.||.+|||+.||
T Consensus 256 ~~~~i~~~~~~------------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei 297 (308)
T 4gt4_A 256 VVEMIRNRQVL------------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297 (308)
T ss_dssp HHHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHcCCCC------------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 66665331111 1123588999999999999999999999995
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=425.55 Aligned_cols=332 Identities=36% Similarity=0.641 Sum_probs=267.5
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc---------ChhHHHHHHHHHHHHHhCCCCCcceecee
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE---------HVSDATRILREIKLLRMLKHPDIVEIKHI 81 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~---------~~~~~~~~~rEi~iL~~l~HpnIv~l~~v 81 (506)
...++|++++.||+|+||.||+|.+.. |+.||||++..... +......+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 456899999999999999999999854 99999999954222 22334778999999999999999999999
Q ss_pred ecCCCcCCCCcEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEee
Q 044076 82 MLPPCRREFKDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICD 160 (506)
Q Consensus 82 ~~~~~~~~~~~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~D 160 (506)
+..........+|+||||++++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 8665434456799999999999999988654 699999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCC
Q 044076 161 FGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240 (506)
Q Consensus 161 FGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~ 240 (506)
||+++....... .....+|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....|.
T Consensus 178 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCcccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999975332221 2456799999999998762 57899999999999999999999999999999999999999999
Q ss_pred CChHHHhhhhhhHHHHHHhhhhc-cCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhh
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRR-KWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLA 319 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~a 319 (506)
|..+.+..........++..... .....+....+..++.+.+||.+||+.||.+|||+.| +
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------l 314 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ------------------A 314 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH------------------H
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH------------------H
Confidence 99988877766666666543322 2223334455778999999999999999999999999 8
Q ss_pred ccCcccCCCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhC
Q 044076 320 LADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYH 369 (506)
Q Consensus 320 L~HP~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~ 369 (506)
|+||||+++.++.+...... ..+.++.......++++.++.|+.+|+
T Consensus 315 l~hp~f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 315 LRHPYFESLFDPLDLTEGLS---ERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp HTSGGGTTTCCGGGGTTTCC---CCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred HcCchhhhccCccccccccc---cccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 99999999876554433221 223455677788999999999998875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=414.39 Aligned_cols=287 Identities=39% Similarity=0.628 Sum_probs=238.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. .+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence 68999999999999999999999999999999997654555566778899999999999999999999843 4789
Q ss_pred EEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||++++|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988888766 56899999999999999999999999999999999999999999999999999976432211
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCC-CCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR-PLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~-~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
.....++|++|+|||++.+. ..++.++|||||||++|+|++|. |+|.+.+..+++..+...+|.|..+.|..+..
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22456789999999998762 45899999999999999999765 55888899999999999999998887765432
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
... +...........+....+.+++++.+||.+||+.||.+|||++| +|+||||+++.
T Consensus 233 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------------------~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LPD--YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE------------------ALQHPYFSDFC 290 (292)
T ss_dssp STT--CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH------------------HHTSGGGTTC-
T ss_pred ccc--ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHH------------------HhcCcccccCC
Confidence 110 00000001112233455678999999999999999999999999 89999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=419.48 Aligned_cols=260 Identities=27% Similarity=0.483 Sum_probs=226.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+..+|+.||||++.....+.....++.+|+.+|+.++||||+++++++.. .+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 4578999999999999999999999999999999997665566777889999999999999999999999843 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 8999999997 599999988889999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCCcccCcccccccCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
. .....+||++|+|||++.+ ..+ +.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 168 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------- 230 (328)
T 3fe3_A 168 G----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK----------- 230 (328)
T ss_dssp C----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred C----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 2 2356789999999999987 454 589999999999999999999999988766665553211
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
...+ ..+++++.+||.+||+.||.+|||++| +|+||||+...
T Consensus 231 ---------------~~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~e------------------il~h~~~~~~~ 272 (328)
T 3fe3_A 231 ---------------YRIP-----FYMSTDCENLLKRFLVLNPIKRGTLEQ------------------IMKDRWINAGH 272 (328)
T ss_dssp ---------------CCCC-----TTSCHHHHHHHHHHCCSSTTTSCCHHH------------------HTTCTTTTTTC
T ss_pred ---------------CCCC-----CCCCHHHHHHHHHHCCCChhHCcCHHH------------------HhcCHhhcCCC
Confidence 1111 247899999999999999999999999 89999999765
Q ss_pred CC
Q 044076 330 NL 331 (506)
Q Consensus 330 ~~ 331 (506)
..
T Consensus 273 ~~ 274 (328)
T 3fe3_A 273 EE 274 (328)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=413.13 Aligned_cols=284 Identities=37% Similarity=0.644 Sum_probs=235.0
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++++.||+|+||+||+|.+ .+|+.||||++............+.+|+.+++.++||||+++++++.. .+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence 6899999999999999999998 689999999996543333334668899999999999999999999854 3789
Q ss_pred EEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999864 5799999999999999999999999999999999999999999999999999976432211
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.+....|..+...
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12455789999999998752 56899999999999999999999999999999999999999999887766544221
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
..+...+....+.++....+.+++++.+||.+||+.||.+|||++| +|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------~l~hp~f~~ 286 (288)
T 1ob3_A 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ------------------ALEHAYFKE 286 (288)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH------------------HHTSGGGGC
T ss_pred --cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHH------------------HhcCcchhh
Confidence 1111112222333445556789999999999999999999999999 899999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=415.85 Aligned_cols=289 Identities=34% Similarity=0.564 Sum_probs=235.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc---ChhHHHHHHHHHHHHHhCC---CCCcceeceeecCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE---HVSDATRILREIKLLRMLK---HPDIVEIKHIMLPP 85 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~---~~~~~~~~~rEi~iL~~l~---HpnIv~l~~v~~~~ 85 (506)
..++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 36799999999999999999999999999999999963221 1112344667887777765 99999999998655
Q ss_pred CcCCCCcEEEEEecCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCC
Q 044076 86 CRREFKDIYVVFELMESDLDQVIKANDD--LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~~L~~~i~~~~~--ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
.......+|+||||++++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 3333346899999999999999987654 99999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
++....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..|...+|.+..
T Consensus 167 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 167 ARIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp TTTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 976432222 255679999999999987 67999999999999999999999999999999999999999999988
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
..|........ ..++.....++....+.+++++.+||.+||++||.+|||+.| +|+||
T Consensus 241 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------------------~l~h~ 298 (308)
T 3g33_A 241 DDWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR------------------ALQHS 298 (308)
T ss_dssp TTSCSSCSSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHH------------------HHTST
T ss_pred hhccchhhccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHH------------------HhcCc
Confidence 77654322110 111222233334455789999999999999999999999999 89999
Q ss_pred ccCCC
Q 044076 324 YFHGL 328 (506)
Q Consensus 324 ~f~~~ 328 (506)
||+..
T Consensus 299 ~~~~~ 303 (308)
T 3g33_A 299 YLHKD 303 (308)
T ss_dssp TC---
T ss_pred cccCC
Confidence 99864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=410.34 Aligned_cols=292 Identities=36% Similarity=0.629 Sum_probs=232.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.. .+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCe
Confidence 478999999999999999999999999999999997654455556778899999999999999999999843 378
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.|+||||+++ +|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999996 677777777889999999999999999999999999999999999999999999999999997643221
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. ......+|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++...+........
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 12456799999999998652 5789999999999999999999999999999999999999988877655433221
Q ss_pred hHHHHHHhhhhcc---CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 252 EKAKRYLSSLRRK---WAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 252 ~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.. +....... ...++...++++++++.+||.+||+.||.+|||++| +|+||||+++
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------ll~hp~f~~~ 291 (311)
T 4agu_A 233 NQ---YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ------------------LLHHPYFENI 291 (311)
T ss_dssp CG---GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHH------------------HHTSGGGTTC
T ss_pred cc---ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHH------------------HhcChHHHhc
Confidence 11 11110000 111122345689999999999999999999999999 8999999998
Q ss_pred CCCCCC
Q 044076 329 ANLEEE 334 (506)
Q Consensus 329 ~~~~~~ 334 (506)
....+.
T Consensus 292 ~~~~~~ 297 (311)
T 4agu_A 292 REIEDL 297 (311)
T ss_dssp C-----
T ss_pred cCHHHH
Confidence 765443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=432.01 Aligned_cols=289 Identities=35% Similarity=0.617 Sum_probs=234.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-CCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-REFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~~~~~ 92 (506)
.+|++++.||+|+||+||+|.+..+|+.||||++.... ....+|+.+|+.++||||+++++++..... .+...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 47999999999999999999999999999999985421 123479999999999999999998865322 22345
Q ss_pred EEEEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-CCEEEeecCCcccc
Q 044076 93 IYVVFELMESDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLARVS 167 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~-~~lKL~DFGla~~~ 167 (506)
+++||||++++|.+++.. ...+++..++.+++||++||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 789999999988877653 5679999999999999999999999999999999999999965 56899999999864
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
..... ...+++|++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|+|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 33322 2457899999999998762 579999999999999999999999999999999999999999999988775
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.+.... ..+ .++.....++...+ +.+++++++||.+||++||.+|||+.| +|+||||+
T Consensus 283 ~~~~~~-~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e------------------~l~hp~f~ 341 (420)
T 1j1b_A 283 EMNPNY-TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE------------------ACAHSFFD 341 (420)
T ss_dssp HHCSCC-CCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHH------------------HHTSGGGG
T ss_pred hhChhh-hhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHH------------------HhCCHhhc
Confidence 542110 000 01111111222222 467899999999999999999999999 89999999
Q ss_pred CCCCCCCC
Q 044076 327 GLANLEEE 334 (506)
Q Consensus 327 ~~~~~~~~ 334 (506)
++.+....
T Consensus 342 ~~~~~~~~ 349 (420)
T 1j1b_A 342 ELRDPNVK 349 (420)
T ss_dssp GGGCTTCC
T ss_pred cccccccc
Confidence 98775543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=426.96 Aligned_cols=289 Identities=36% Similarity=0.628 Sum_probs=235.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-CCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-REFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~~~~ 91 (506)
..+|++++.||+|+||+||+|.+..+++ ||+|++..... ...+|+.+|+.++||||+++++++..... .+..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4579999999999999999999887766 88988853211 12379999999999999999999865432 3334
Q ss_pred cEEEEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC-CCCCEEEeecCCccc
Q 044076 92 DIYVVFELMESDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN-ADCKLKICDFGLARV 166 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~-~~~~lKL~DFGla~~ 166 (506)
.+|+||||+++++...+.. ...+++..++.+++||++||+|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 5889999999987766643 56899999999999999999999999999999999999999 799999999999986
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...... ...+++|++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|+|+.+.+
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 533322 2456899999999998762 56999999999999999999999999999999999999999999999877
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..+...... ..++.....++...+ +.+++++.+||.+||++||.+|||+.| +|+||||
T Consensus 267 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------------------~l~hp~f 325 (394)
T 4e7w_A 267 KTMNPNYME---HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE------------------ALCHPFF 325 (394)
T ss_dssp HHHCGGGSS---SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH------------------HHTSGGG
T ss_pred HhhChhhhh---hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHH------------------HhcChhh
Confidence 654321100 111222223333333 358999999999999999999999999 8999999
Q ss_pred CCCCCCCCC
Q 044076 326 HGLANLEEE 334 (506)
Q Consensus 326 ~~~~~~~~~ 334 (506)
++++.....
T Consensus 326 ~~~~~~~~~ 334 (394)
T 4e7w_A 326 DELRTGEAR 334 (394)
T ss_dssp STTTSSCCC
T ss_pred hhhcccccc
Confidence 998875543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=416.13 Aligned_cols=291 Identities=34% Similarity=0.599 Sum_probs=223.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+..+|+.||||+++... .......+.+|+.+|+.++||||+++++++.. .+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 76 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHT-----EN 76 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CC
Confidence 3578999999999999999999999999999999996432 22334567899999999999999999999843 47
Q ss_pred cEEEEEecCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 92 DIYVVFELMESDLDQVIKAN------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 89999999999999998753 359999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
....... .....++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|....
T Consensus 157 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 157 AFGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp ETTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred ecCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 6432211 12456789999999998762 4689999999999999999999999999999999999999999998877
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCC-----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPF-----SHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
|..+.... .+...+.......+ ......+++++.+||.+||+.||.+|||++| +|
T Consensus 233 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e------------------~l 292 (317)
T 2pmi_A 233 WPSVTKLP--KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ------------------AL 292 (317)
T ss_dssp CGGGGGCT--TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHH------------------HT
T ss_pred hhhhhhhh--hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHH------------------Hh
Confidence 65543210 00000000001000 0112357899999999999999999999999 89
Q ss_pred cCcccCCCCCCC
Q 044076 321 ADPYFHGLANLE 332 (506)
Q Consensus 321 ~HP~f~~~~~~~ 332 (506)
+||||++.....
T Consensus 293 ~hp~f~~~~~~~ 304 (317)
T 2pmi_A 293 HHPWFAEYYHHA 304 (317)
T ss_dssp TSGGGGGGCC--
T ss_pred CChhhhcccchh
Confidence 999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=416.90 Aligned_cols=290 Identities=36% Similarity=0.621 Sum_probs=234.7
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++.. .+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEE
Confidence 689999999999999999999999999999999964221 1112235589999999999999999999844 4789
Q ss_pred EEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999999999999998754 599999999999999999999999999999999999999999999999999975332211
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
.....++|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.|..+.|......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22456789999999998762 57899999999999999999999999999999999999999999999888765433
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLE 332 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~~ 332 (506)
..... ...+......+....+.+++++.+||.+||++||.+|||++| +|+||||.++....
T Consensus 232 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------------------~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 232 EEFKT-YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED------------------AMKHPFFLSLGERI 292 (324)
T ss_dssp HHHHH-TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHH------------------HTTSGGGGGGCSTT
T ss_pred hhhcc-cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHH------------------HhcChhhhhccccc
Confidence 21111 011111222223345678999999999999999999999999 89999999877543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=421.25 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=207.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCC-----CcEEEEEEecccccChhHHHHHHHHHHHHHhCCC-CCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHT-----GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH-PDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t-----~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~H-pnIv~l~~v~~~~~ 86 (506)
.++|++++.||+|+||+||+|.+..+ ++.||||+++.. ......+.+.+|+.+|.++.| ||||++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 46899999999999999999987654 468999999643 334456778999999999975 8999999998532
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEE
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNIL 149 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NIL 149 (506)
.+.+|||||||+ |+|.++|+.. ..+++.++..|+.||++||+|||+++||||||||+|||
T Consensus 141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 356899999998 5999999763 34899999999999999999999999999999999999
Q ss_pred ECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCch
Q 044076 150 ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVA 228 (506)
Q Consensus 150 v~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~ 228 (506)
+++++.+||+|||+|+....+... ...+..+||+.|+|||++.+ ..|+.++|||||||++|||++ |++||++.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999865433221 22345679999999999987 789999999999999999998 99999987755
Q ss_pred hhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 229 HQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 229 ~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+.+..+...... . ...+.+++++.+||.+||+.||.+|||+.||
T Consensus 295 ~~~~~~i~~g~~--------------------------~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~ei 338 (353)
T 4ase_A 295 EEFCRRLKEGTR--------------------------M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 338 (353)
T ss_dssp HHHHHHHHHTCC--------------------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHcCCC--------------------------C---CCCccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 444333221110 0 1113578999999999999999999999995
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=416.32 Aligned_cols=266 Identities=27% Similarity=0.442 Sum_probs=229.2
Q ss_pred ccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh----hHHHHHHHHHHHHHhCCCCCcceeceee
Q 044076 7 FTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV----SDATRILREIKLLRMLKHPDIVEIKHIM 82 (506)
Q Consensus 7 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~l~HpnIv~l~~v~ 82 (506)
+..-...++|++++.||+|+||+||+|.+..+|+.||||+++...... .....+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 444456789999999999999999999999999999999996532221 2356788999999999999999999998
Q ss_pred cCCCcCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC----CEE
Q 044076 83 LPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC----KLK 157 (506)
Q Consensus 83 ~~~~~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~----~lK 157 (506)
.. ...+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 85 ~~-----~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 85 EN-----RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp EC-----SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred Ee-----CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEE
Confidence 43 478999999996 69999998888999999999999999999999999999999999999998877 799
Q ss_pred EeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhh
Q 044076 158 ICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDL 237 (506)
Q Consensus 158 L~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~ 237 (506)
|+|||+++...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|...
T Consensus 160 l~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 233 (361)
T 2yab_A 160 LIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233 (361)
T ss_dssp ECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred EEecCCceEcCCCC----ccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 99999997643322 1245679999999999987 68999999999999999999999999999888887777654
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~ 317 (506)
...+..+. ++.+++++.+||.+||+.||.+|||++|
T Consensus 234 ~~~~~~~~---------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e----------------- 269 (361)
T 2yab_A 234 SYDFDEEF---------------------------FSQTSELAKDFIRKLLVKETRKRLTIQE----------------- 269 (361)
T ss_dssp CCCCCHHH---------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHH-----------------
T ss_pred CCCCCchh---------------------------ccCCCHHHHHHHHHHCCCChhHCcCHHH-----------------
Confidence 44333322 2458899999999999999999999999
Q ss_pred hhccCcccCCC
Q 044076 318 LALADPYFHGL 328 (506)
Q Consensus 318 ~aL~HP~f~~~ 328 (506)
+|+||||++.
T Consensus 270 -~l~hp~~~~~ 279 (361)
T 2yab_A 270 -ALRHPWITPV 279 (361)
T ss_dssp -HHTSTTTSCS
T ss_pred -HhcCcCcCCC
Confidence 8999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=413.62 Aligned_cols=290 Identities=35% Similarity=0.570 Sum_probs=227.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++||||+++++++.. .
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence 34579999999999999999999999999999999997544444445667899999999999999999999843 4
Q ss_pred CcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC-----CCCCEEEeecCCcc
Q 044076 91 KDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN-----ADCKLKICDFGLAR 165 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~-----~~~~lKL~DFGla~ 165 (506)
..+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 7899999999999999999988999999999999999999999999999999999999994 44569999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
....... .....++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.|....
T Consensus 186 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 186 AFGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 6432211 12456789999999998762 4589999999999999999999999999999999999999999988876
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
+....... .+...++......+...+ ..+++++.+||.+||+.||.+|||++| +|+|||
T Consensus 262 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------------------~l~hp~ 321 (329)
T 3gbz_A 262 WPGVTALP--DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN------------------ALEHPY 321 (329)
T ss_dssp STTGGGST--TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHH------------------HHTSGG
T ss_pred hhhhhhhh--hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHH------------------HhCCcc
Confidence 65432210 000000000000000000 126899999999999999999999999 899999
Q ss_pred cCCCC
Q 044076 325 FHGLA 329 (506)
Q Consensus 325 f~~~~ 329 (506)
|++..
T Consensus 322 f~~~~ 326 (329)
T 3gbz_A 322 FSHND 326 (329)
T ss_dssp GSSSC
T ss_pred cCCCC
Confidence 99753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=420.42 Aligned_cols=287 Identities=33% Similarity=0.657 Sum_probs=232.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc----
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR---- 87 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~---- 87 (506)
..++|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 35799999999999999999999999999999999864211 12379999999999999999999855321
Q ss_pred -----------------------------CCCCcEEEEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH
Q 044076 88 -----------------------------REFKDIYVVFELMESDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIH 134 (506)
Q Consensus 88 -----------------------------~~~~~~ylV~E~~~~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH 134 (506)
.+...+|+||||++++|.+.+.. ...+++..++.+++||++||+|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 23355899999999988777753 568999999999999999999999
Q ss_pred hCCeeecCCCCCcEEEC-CCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHH
Q 044076 135 SANVFHRDLKPKNILAN-ADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 213 (506)
Q Consensus 135 ~~gIvHrDLKp~NILv~-~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~ 213 (506)
++||+||||||+|||++ .++.+||+|||+|+....... ...+.+|+.|+|||++.+. ..|+.++||||+||++|
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHH
Confidence 99999999999999997 689999999999986433322 2456789999999998762 56999999999999999
Q ss_pred HHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCC-CCCCHHHHHHHHHhhhcCC
Q 044076 214 ELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDP 292 (506)
Q Consensus 214 eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLI~~mL~~DP 292 (506)
+|++|++||.+.+..+++..|...+|+|+.+.+..+...... ..++......+...+ +..++++.+||.+||++||
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE---VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc---ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999999999877654321100 001111112222222 3588999999999999999
Q ss_pred CCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 293 KDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 293 ~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
.+|||+.| +|+||||+++.+
T Consensus 311 ~~R~t~~e------------------~l~hp~f~~~~~ 330 (383)
T 3eb0_A 311 DLRINPYE------------------AMAHPFFDHLRN 330 (383)
T ss_dssp GGSCCHHH------------------HHTSGGGHHHHH
T ss_pred hhCCCHHH------------------HhcCHHHHHHHh
Confidence 99999999 899999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=411.25 Aligned_cols=307 Identities=34% Similarity=0.517 Sum_probs=242.8
Q ss_pred cccccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeec
Q 044076 4 KEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIML 83 (506)
Q Consensus 4 ~~~~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~ 83 (506)
...+...+..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 86 (351)
T 3mi9_A 7 SVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (351)
T ss_dssp -CCCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence 34555567789999999999999999999999999999999999654444444556789999999999999999999986
Q ss_pred CCCc---CCCCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEe
Q 044076 84 PPCR---REFKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKIC 159 (506)
Q Consensus 84 ~~~~---~~~~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~ 159 (506)
.... ...+.+|+||||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 87 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp EC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred ccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEc
Confidence 5321 113579999999999999888764 579999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccCCC-CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhc
Q 044076 160 DFGLARVSFTDT-PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 160 DFGla~~~~~~~-~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~ 238 (506)
|||+|+...... .........+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 999997643221 112223556789999999998762 568999999999999999999999999999999999999999
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKF--PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFY 316 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~ 316 (506)
|.++.+.+..+........+...... ...+...+ ...++++.+||.+||+.||.+|||++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e---------------- 308 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD---------------- 308 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSC-CCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH----------------
T ss_pred CCCChhhccccccchhhccccccccc-ccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH----------------
Confidence 99988776655332111000000000 00000000 013788999999999999999999999
Q ss_pred hhhccCcccCCCCC
Q 044076 317 VLALADPYFHGLAN 330 (506)
Q Consensus 317 ~~aL~HP~f~~~~~ 330 (506)
+|+||||.....
T Consensus 309 --~l~hp~f~~~~~ 320 (351)
T 3mi9_A 309 --ALNHDFFWSDPM 320 (351)
T ss_dssp --HHTSGGGGSSSC
T ss_pred --HhCCCCcCCCCC
Confidence 899999987443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=412.35 Aligned_cols=258 Identities=23% Similarity=0.407 Sum_probs=217.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~ 90 (506)
.++|+++++||+|+||.||+|++..+|+.||||++++.. ........+.+|+.+|+.+ +||||+++++++.. .
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-----P 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----C
Confidence 578999999999999999999999999999999996421 1233456688999999988 69999999999854 3
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+.+|+||||+++ +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 789999999985 9999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......
T Consensus 177 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------- 242 (353)
T 3txo_A 177 NGV---TTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--------- 242 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------
T ss_pred CCc---cccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 211 2345689999999999987 67999999999999999999999999998887777766431110
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------hhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA------EEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa------~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
....+++++.+||.+||+.||.+||++ +| +++||
T Consensus 243 ----------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~------------------il~hp 282 (353)
T 3txo_A 243 ----------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHA------------------ILRHP 282 (353)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHH------------------HHTSG
T ss_pred ----------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHH------------------HhhCC
Confidence 112478999999999999999999999 78 89999
Q ss_pred ccCCCC
Q 044076 324 YFHGLA 329 (506)
Q Consensus 324 ~f~~~~ 329 (506)
||+++.
T Consensus 283 ~f~~~~ 288 (353)
T 3txo_A 283 FFKEID 288 (353)
T ss_dssp GGTTCC
T ss_pred cccCCC
Confidence 999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=400.83 Aligned_cols=303 Identities=39% Similarity=0.630 Sum_probs=238.0
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC--
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC-- 86 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~-- 86 (506)
.+...++|++++.||+|+||.||+|.+..+++.||||++.. .+......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 45667899999999999999999999999999999999864 34456677899999999999999999999985432
Q ss_pred -------cCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC-CCCCEEE
Q 044076 87 -------RREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN-ADCKLKI 158 (506)
Q Consensus 87 -------~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~-~~~~lKL 158 (506)
..+...+|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 133477999999999999999864 5799999999999999999999999999999999999997 5679999
Q ss_pred eecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhc
Q 044076 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 159 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~ 238 (506)
+|||+++................+|.+|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998643322222223455689999999988652 578999999999999999999999999999999999998888
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVL 318 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~ 318 (506)
+.+..+....+.... ..++.........++....+.+++++.+||.+||+.||.+|||++|
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------ 302 (320)
T 2i6l_A 242 PVVHEEDRQELLSVI-PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE------------------ 302 (320)
T ss_dssp CCCCHHHHHHHHTTS-CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH------------------
T ss_pred CCCchhhhhhhhhcC-cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH------------------
Confidence 887776655432211 1222222222333344455789999999999999999999999999
Q ss_pred hccCcccCCCCCCCCC
Q 044076 319 ALADPYFHGLANLEEE 334 (506)
Q Consensus 319 aL~HP~f~~~~~~~~~ 334 (506)
+|+||||+....+..+
T Consensus 303 ll~hp~~~~~~~p~~~ 318 (320)
T 2i6l_A 303 ALSHPYMSIYSFPMDE 318 (320)
T ss_dssp HHTSHHHHTTCC----
T ss_pred HhCCcccccccCccCC
Confidence 8999999986654443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=408.75 Aligned_cols=289 Identities=37% Similarity=0.605 Sum_probs=233.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh---hHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV---SDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~---~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
..++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH---- 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee----
Confidence 4679999999999999999999999999999999996422111 112457899999999999999999999843
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.+.+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 84 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 84 -KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp -TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred -CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 47899999999999999987654 6999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
..... ..+..++|++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+++..|....|.|..+.|.
T Consensus 163 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TSCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred cCCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 32221 23456799999999998652 568999999999999999999999999999999999999999999887776
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
...... .+. .+...+..++...++.+++++.+||.+||+.||.+|||++| +|+||||.+
T Consensus 239 ~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------ll~h~~f~~ 297 (346)
T 1ua2_A 239 DMCSLP--DYV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ------------------ALKMKYFSN 297 (346)
T ss_dssp STTSST--TCC-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH------------------HHTSGGGTS
T ss_pred hhccCc--ccc-cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHH------------------HhcChhhhc
Confidence 542210 000 01111222333445678999999999999999999999999 899999987
Q ss_pred CCC
Q 044076 328 LAN 330 (506)
Q Consensus 328 ~~~ 330 (506)
...
T Consensus 298 ~~~ 300 (346)
T 1ua2_A 298 RPG 300 (346)
T ss_dssp SSC
T ss_pred CCC
Confidence 654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=419.73 Aligned_cols=261 Identities=27% Similarity=0.457 Sum_probs=223.8
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++. +.+.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECCE
Confidence 46899999999999999999999999999999999754444456677899999999999999999999984 3478
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC---CCCCEEEeecCCccccc
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN---ADCKLKICDFGLARVSF 168 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~---~~~~lKL~DFGla~~~~ 168 (506)
+|+||||+.+ +|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999975 9999999989999999999999999999999999999999999999998 46889999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ......||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......++
T Consensus 165 ~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 233 (444)
T 3soa_A 165 GEQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP------ 233 (444)
T ss_dssp TTCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC------
T ss_pred CCCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC------
Confidence 3221 2355789999999999987 6899999999999999999999999998887776666643222211
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
...++.+++++.+||.+||+.||.+|||+.| +|+||||+..
T Consensus 234 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e------------------~L~hp~~~~~ 274 (444)
T 3soa_A 234 ---------------------SPEWDTVTPEAKDLINKMLTINPSKRITAAE------------------ALKHPWISHR 274 (444)
T ss_dssp ---------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH------------------HHHSCTTHHH
T ss_pred ---------------------ccccccCCHHHHHHHHHHcCCChhHCCCHHH------------------HhcCccccCC
Confidence 1234578999999999999999999999999 8999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=404.03 Aligned_cols=258 Identities=25% Similarity=0.436 Sum_probs=220.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||.||+|++..+|+.||||++++.. ........+.+|+.+|+.++||||+++++++.. .+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence 468999999999999999999999999999999996421 122345678899999999999999999999854 37
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+||||+++ +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 89999999985 99999998889999999999999999999999999999999999999999999999999999753222
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......|....
T Consensus 159 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------ 221 (337)
T 1o6l_A 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------------ 221 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred CC---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence 21 2345689999999999987 689999999999999999999999998877666555553210
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
. .....+++++.+||.+||+.||.+|| +++| +++||||
T Consensus 222 --------------~-----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~e------------------i~~h~~f 264 (337)
T 1o6l_A 222 --------------I-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE------------------VMEHRFF 264 (337)
T ss_dssp --------------C-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH------------------HHTSGGG
T ss_pred --------------C-----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHH------------------HHcCCCc
Confidence 0 01135789999999999999999999 8999 8999999
Q ss_pred CCCC
Q 044076 326 HGLA 329 (506)
Q Consensus 326 ~~~~ 329 (506)
.++.
T Consensus 265 ~~~~ 268 (337)
T 1o6l_A 265 LSIN 268 (337)
T ss_dssp TTCC
T ss_pred CCCC
Confidence 8753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=408.12 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=222.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++.. .+..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~ 103 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESFH 103 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCEE
Confidence 57999999999999999999999999999999997544455667788999999999999999999999843 4789
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC---CEEEeecCCcccccC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC---KLKICDFGLARVSFT 169 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~---~lKL~DFGla~~~~~ 169 (506)
|+||||+.+ +|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999985 9999998888899999999999999999999999999999999999998654 599999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......|.......+.
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~------ 251 (362)
T 2bdw_A 184 SE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS------ 251 (362)
T ss_dssp CC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------
T ss_pred Cc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc------
Confidence 22 2345679999999999987 68999999999999999999999999988776666665432222111
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
..++.+++++.+||.+||+.||.+|||+.| +|+||||...
T Consensus 252 ---------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------------------~l~hp~~~~~ 291 (362)
T 2bdw_A 252 ---------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQ------------------ALKVPWICNR 291 (362)
T ss_dssp ---------------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHH------------------HTTSHHHHTH
T ss_pred ---------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHH------------------HhcCcccCCC
Confidence 123457899999999999999999999999 8999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=402.60 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=224.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||+||+|.+..+++.||+|++.. .......+.+|+.+|+.++||||+++++++.. .+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 74 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFES-----ME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TT
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CC
Confidence 46899999999999999999999999999999999863 23455668899999999999999999999843 47
Q ss_pred cEEEEEecCCC-CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC--CCCEEEeecCCcccc
Q 044076 92 DIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA--DCKLKICDFGLARVS 167 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~--~~~lKL~DFGla~~~ 167 (506)
.+|+||||+++ +|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 89999999985 9999997654 7999999999999999999999999999999999999987 789999999999864
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+....
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-- 226 (321)
T 1tki_A 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-- 226 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH--
T ss_pred CCCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh--
Confidence 3322 2345679999999999987 6789999999999999999999999999888877777765444433322
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
++.+++++.+||.+||..||.+|||+.| +|+||||++
T Consensus 227 -------------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e------------------~l~hp~~~~ 263 (321)
T 1tki_A 227 -------------------------FKEISIEAMDFVDRLLVKERKSRMTASE------------------ALQHPWLKQ 263 (321)
T ss_dssp -------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHH------------------HHHSHHHHS
T ss_pred -------------------------hccCCHHHHHHHHHHcCCChhHCcCHHH------------------HhcChhhcc
Confidence 2458899999999999999999999999 899999986
Q ss_pred C
Q 044076 328 L 328 (506)
Q Consensus 328 ~ 328 (506)
.
T Consensus 264 ~ 264 (321)
T 1tki_A 264 K 264 (321)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=414.53 Aligned_cols=282 Identities=32% Similarity=0.554 Sum_probs=232.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC------CCCCcceeceeecCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML------KHPDIVEIKHIMLPP 85 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l------~HpnIv~l~~v~~~~ 85 (506)
...+|++++.||+|+||+||+|.+..+++.||||+++. .......+.+|+.+++.+ .|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~- 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF- 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-
Confidence 35689999999999999999999999999999999964 234445677888888777 57799999999844
Q ss_pred CcCCCCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC--EEEeec
Q 044076 86 CRREFKDIYVVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK--LKICDF 161 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~--lKL~DF 161 (506)
...+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 171 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 171 ----RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ----TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred ----CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 37899999999999999998764 4999999999999999999999999999999999999999987 999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
|+|+..... ....++|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..|...+|.|
T Consensus 247 G~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 247 GSSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp TTCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999753221 245679999999999987 689999999999999999999999999999999999999999999
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccC-----------------------------CCCCCCCC-CCCCHHHHHHHHHhhhcC
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKW-----------------------------AVPFSHKF-PGADPLALRLLQRLLAFD 291 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~-~~~s~~~~dLI~~mL~~D 291 (506)
+.+.+..... ...++....... ...+...+ ...++++.+||.+||++|
T Consensus 319 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 319 SQKLLDASKR--AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CHHHHHTBTT--HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CHHHHHhhhh--hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 9987765432 122222110000 00000011 234789999999999999
Q ss_pred CCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 292 PKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 292 P~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
|.+|||++| +|+||||+...
T Consensus 397 P~~Rpta~e------------------~L~Hpw~~~~~ 416 (429)
T 3kvw_A 397 PAVRMTPGQ------------------ALRHPWLRRRL 416 (429)
T ss_dssp TTTSCCHHH------------------HHTSTTTC---
T ss_pred hhhCCCHHH------------------HhCChhhccCC
Confidence 999999999 89999998743
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=395.65 Aligned_cols=260 Identities=29% Similarity=0.450 Sum_probs=219.5
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 89 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV-----G 89 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----C
Confidence 34578999999999999999999999999999999986432 2335568899999999999999999999854 3
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+.+|+||||++ ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 78999999996 5999998765 699999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+..... +.
T Consensus 169 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~------- 235 (297)
T 3fxz_A 169 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE------- 235 (297)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC-------
T ss_pred ccc---ccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC-------
Confidence 222 1245679999999999987 6899999999999999999999999988876665554432111 00
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
....+.+++.+.+||.+||+.||.+|||++| +|+||||+...
T Consensus 236 --------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e------------------ll~h~~~~~~~ 277 (297)
T 3fxz_A 236 --------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE------------------LLQHQFLKIAK 277 (297)
T ss_dssp --------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHH------------------HTTCGGGGGCC
T ss_pred --------------------CCCccccCHHHHHHHHHHccCChhHCcCHHH------------------HhhChhhcccC
Confidence 0111347899999999999999999999999 89999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=409.08 Aligned_cols=299 Identities=22% Similarity=0.284 Sum_probs=222.8
Q ss_pred cCCCCCEEEeEEEeec--CceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 10 YGEASQYEIQEIIGIG--SYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G--~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
....++|++++.||+| +||.||+|++..+|+.||||+++...........+.+|+.+|+.++||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--- 97 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--- 97 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE---
Confidence 4667899999999999 99999999999999999999997655555667788899999999999999999999854
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
.+.+|+|||||+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 98 --DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp --TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred --CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 378999999998 5999999876 67999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCC----CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcC-
Q 044076 165 RVSFTDTP----SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG- 239 (506)
Q Consensus 165 ~~~~~~~~----~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g- 239 (506)
........ ........+||+.|+|||++.+....|+.++|||||||++|+|++|++||.+.+..+.+..+....-
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 65322111 1111233478999999999976335789999999999999999999999998877666554432110
Q ss_pred -------CCChHHHhhhh----hhHHHHHHh---hhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhh
Q 044076 240 -------TPSAESIAGIR----NEKAKRYLS---SLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305 (506)
Q Consensus 240 -------~p~~e~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~ 305 (506)
.+..+...... .......+. ..+.....+.......+++++.+||.+||+.||.+|||++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e----- 330 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST----- 330 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH-----
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH-----
Confidence 00000000000 000000000 00000111112234568999999999999999999999999
Q ss_pred hhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 306 IVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 306 ~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
+|+||||+++...
T Consensus 331 -------------ll~hp~f~~~~~~ 343 (389)
T 3gni_B 331 -------------LLNHSFFKQIKRR 343 (389)
T ss_dssp -------------HTTSGGGGGC---
T ss_pred -------------HhcCHHHHHHhhc
Confidence 8999999987653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=405.01 Aligned_cols=291 Identities=33% Similarity=0.564 Sum_probs=233.1
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
|...++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 95 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK----- 95 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----
Confidence 456789999999999999999999999999999999996554555556678899999999999999999999843
Q ss_pred CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+..|+||||+++ +|..++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 4789999999997 566666666789999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ......+|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....|.+.+.....
T Consensus 176 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 APGE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CCcc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 2211 12456799999999998762 4789999999999999999999999999999999999999999887765433
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
+.......-...-......+....++.+++.+.+||.+||+.||.+|||+.| +|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e------------------ll~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE------------------LLHHDFFQM 312 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG------------------GGGSHHHHG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH------------------HhcCchhcc
Confidence 2111100000000000111222344678999999999999999999999999 899999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=399.72 Aligned_cols=262 Identities=29% Similarity=0.450 Sum_probs=224.2
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC----hhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH----VSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~----~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
...++|++.+.||+|+||.||+|.+..+|+.||||+++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 85 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-- 85 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--
Confidence 3456899999999999999999999999999999999643221 1235678899999999999999999999844
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC----CEEEeec
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC----KLKICDF 161 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~----~lKL~DF 161 (506)
...+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 86 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 86 ---KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp ---SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 478999999997 59999998888899999999999999999999999999999999999999887 8999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
|+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 163 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 163 GLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp TTCEECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred CCCeECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 99976433221 245679999999999977 689999999999999999999999999988777776665433332
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
... .++.+++.+.+||.+||+.||.+|||+.| +|+
T Consensus 237 ~~~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------~l~ 271 (326)
T 2y0a_A 237 EDE---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQD------------------SLQ 271 (326)
T ss_dssp CHH---------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHH------------------HHH
T ss_pred Ccc---------------------------ccccCCHHHHHHHHHHccCChhhCCCHHH------------------Hhc
Confidence 221 12457899999999999999999999999 899
Q ss_pred CcccCCC
Q 044076 322 DPYFHGL 328 (506)
Q Consensus 322 HP~f~~~ 328 (506)
||||+..
T Consensus 272 hp~~~~~ 278 (326)
T 2y0a_A 272 HPWIKPK 278 (326)
T ss_dssp STTTSCC
T ss_pred CCCccCC
Confidence 9999853
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=408.31 Aligned_cols=256 Identities=30% Similarity=0.492 Sum_probs=215.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----PT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 4789999999999999999999999999999999964221 11223568899999999999999999999854 37
Q ss_pred cEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 92 DIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
.+|+||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 89999999999999999888899999999999999999999999999999999999999999999999999997643322
Q ss_pred CCcccccccccCCcccCcccccccCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+....+....+.
T Consensus 163 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--------------- 221 (336)
T 3h4j_B 163 ----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--------------- 221 (336)
T ss_dssp ----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC---------------
T ss_pred ----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH---------------
Confidence 2345679999999999987 454 789999999999999999999997765432221110
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.........+++++.+||.+||+.||.+|||++| +++||||+.-
T Consensus 222 ----------------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~e------------------il~hp~~~~~ 265 (336)
T 3h4j_B 222 ----------------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQE------------------IRRDPWFNVN 265 (336)
T ss_dssp ----------------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHH------------------HTTCHHHHTT
T ss_pred ----------------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHH------------------HHhChhhccC
Confidence 0001112347899999999999999999999999 8999999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=401.75 Aligned_cols=286 Identities=23% Similarity=0.395 Sum_probs=232.5
Q ss_pred ccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-----CCCcceecee
Q 044076 7 FTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-----HPDIVEIKHI 81 (506)
Q Consensus 7 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-----HpnIv~l~~v 81 (506)
-......++|++++.||+|+||+||+|++..+++.||||+++. .........+|+.+++.+. ||||++++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 3344557899999999999999999999999999999999963 2344566778999999996 9999999999
Q ss_pred ecCCCcCCCCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-------
Q 044076 82 MLPPCRREFKDIYVVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA------- 152 (506)
Q Consensus 82 ~~~~~~~~~~~~ylV~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~------- 152 (506)
+.. .+.+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 105 ~~~-----~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 105 FMY-----YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEE-----TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred eeE-----CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 854 37899999999889999998764 5999999999999999999999999999999999999975
Q ss_pred ------------------CCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHH
Q 044076 153 ------------------DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 214 (506)
Q Consensus 153 ------------------~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~e 214 (506)
++.+||+|||+|+..... .....||+.|+|||++.+ ..|+.++|||||||++|+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcC--CCCCCccchHHHHHHHHH
Confidence 789999999999763221 134579999999999987 689999999999999999
Q ss_pred HHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhcc--CCCCC---------CCC----CCCCCHH
Q 044076 215 LLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRK--WAVPF---------SHK----FPGADPL 279 (506)
Q Consensus 215 Ll~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~--~~~~~---------~~~----~~~~s~~ 279 (506)
|++|++||.+.+..+.+..+....+.++...+..........+....... .+... ... ....++.
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999999999999999999999998887765543322111111100000 00000 000 0123578
Q ss_pred HHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 280 ALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 280 ~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
+.+||.+||+.||.+|||+.| +|+||||+
T Consensus 332 l~~li~~~L~~dP~~Rpta~e------------------lL~hp~f~ 360 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAE------------------LLKHKFLE 360 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHH------------------HTTSGGGC
T ss_pred HHHHHHHHhcCChhhCCCHHH------------------HhcCcccC
Confidence 889999999999999999999 89999995
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=397.68 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=220.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence 4689999999999999999999999999999999964211 22345667899999999999999999999844 47
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+||||+++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 89999999985 99999999889999999999999999999999999999999999999999999999999999764321
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|.....
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------- 220 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL----------- 220 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 134579999999999987 6899999999999999999999999998877666665533110
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...+.+++++.+||.+||+.||.+|| +++| +++||||
T Consensus 221 --------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~------------------i~~hp~f 262 (318)
T 1fot_A 221 --------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTED------------------VKNHPWF 262 (318)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHH------------------HHTSGGG
T ss_pred --------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHH------------------HhcCccc
Confidence 01135789999999999999999999 8999 8999999
Q ss_pred CCCC
Q 044076 326 HGLA 329 (506)
Q Consensus 326 ~~~~ 329 (506)
+++.
T Consensus 263 ~~~~ 266 (318)
T 1fot_A 263 KEVV 266 (318)
T ss_dssp SSCC
T ss_pred cCCC
Confidence 8754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=403.92 Aligned_cols=259 Identities=24% Similarity=0.409 Sum_probs=220.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~ 89 (506)
..++|++++.||+|+||.||+|++..+|+.||||+++... ........+.+|..+|..+ +||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----- 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----- 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-----
Confidence 4679999999999999999999999999999999996421 1123455678899999876 89999999999854
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 478999999997 5999999988889999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|... .+
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~------- 235 (345)
T 1xjd_A 170 LGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP------- 235 (345)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred cCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CC-------
Confidence 2211 1355689999999999987 68999999999999999999999999988876666655321 00
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh-hhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE-EIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~-eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
..-..+++++.+||.+||+.||.+|||+. + +++||||++
T Consensus 236 ----------------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~------------------i~~hp~f~~ 275 (345)
T 1xjd_A 236 ----------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGD------------------IRQHPLFRE 275 (345)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSC------------------GGGSGGGTT
T ss_pred ----------------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHH------------------HHcCccccC
Confidence 01134789999999999999999999998 8 899999998
Q ss_pred CC
Q 044076 328 LA 329 (506)
Q Consensus 328 ~~ 329 (506)
+.
T Consensus 276 ~~ 277 (345)
T 1xjd_A 276 IN 277 (345)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=395.36 Aligned_cols=292 Identities=35% Similarity=0.574 Sum_probs=239.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEEC-CCCcEEEEEEecccccChhHHHHHHHHHHHHHhC---CCCCcceeceeecCCCc
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDT-HTGEKVAIKKMKEVFEHVSDATRILREIKLLRML---KHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~-~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l---~HpnIv~l~~v~~~~~~ 87 (506)
..++|++++.||+|+||.||+|.+. .+|+.||||+++...........+.+|+.+++.+ .||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3578999999999999999999995 6789999999964333222233456777777666 89999999999864322
Q ss_pred CCCCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 REFKDIYVVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.....+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 3457799999999999999998754 49999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
...... ......+|..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..|...+|.|..+.
T Consensus 169 ~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGGG----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCCC----CccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 542211 2245678999999999987 6799999999999999999999999999999999999999999988877
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
|........ ..+......++....+.+++.+.+||.+||+.||.+|||+.| +|+||||
T Consensus 243 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------~l~hp~~ 300 (326)
T 1blx_A 243 WPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS------------------ALSHPYF 300 (326)
T ss_dssp SCTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH------------------HHTSGGG
T ss_pred Cccccccch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHH------------------HhcCccc
Confidence 654211100 011122223344556789999999999999999999999999 8999999
Q ss_pred CCCCCC
Q 044076 326 HGLANL 331 (506)
Q Consensus 326 ~~~~~~ 331 (506)
+++...
T Consensus 301 ~~~~~~ 306 (326)
T 1blx_A 301 QDLERC 306 (326)
T ss_dssp TTCCCC
T ss_pred cccchh
Confidence 987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=383.11 Aligned_cols=267 Identities=27% Similarity=0.464 Sum_probs=227.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CC
Confidence 4689999999999999999999999999999999997655555667788999999999999999999999843 47
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC---EEEeecCCcccc
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK---LKICDFGLARVS 167 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~---lKL~DFGla~~~ 167 (506)
..|+||||+++ +|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++...
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 78999999975 99999988888999999999999999999999999999999999999987665 999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.......+
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 227 (284)
T 3kk8_A 159 NDSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP----- 227 (284)
T ss_dssp CSSC----BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----
T ss_pred ccCc----cccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC-----
Confidence 3222 1245679999999999987 6789999999999999999999999988877666555533222111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
...++.+++++.+||.+||+.||.+|||++| +|+||||.+
T Consensus 228 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------------------~l~h~~~~~ 267 (284)
T 3kk8_A 228 ----------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQ------------------ALKVPWICN 267 (284)
T ss_dssp ----------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHH------------------HTTSHHHHS
T ss_pred ----------------------chhhcccCHHHHHHHHHHcccChhhCCCHHH------------------HhcCccccC
Confidence 1223568899999999999999999999999 899999988
Q ss_pred CCCCCCC
Q 044076 328 LANLEEE 334 (506)
Q Consensus 328 ~~~~~~~ 334 (506)
.......
T Consensus 268 ~~~~~~~ 274 (284)
T 3kk8_A 268 RERVASA 274 (284)
T ss_dssp CCCGGGS
T ss_pred ChhHHhH
Confidence 6654433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=398.72 Aligned_cols=267 Identities=22% Similarity=0.395 Sum_probs=215.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~ 90 (506)
.++|++++.||+|+||.||+|++..+++.||||+++... ........+.+|+.+++.+ +||||+++++++.. .
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence 468999999999999999999999999999999996533 3445567788999999988 79999999999844 4
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 78999999997 49999999888899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+....+.... .....
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~~~~---- 226 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDY---- 226 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHH----
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------ccHHH----
Confidence 211 2355689999999999987 6899999999999999999999999965321110000 00000
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------hhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA------EEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa------~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
.... ....... .-+.+++++.+||.+||+.||.+|||+ +| +++||
T Consensus 227 ---~~~~---i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~------------------i~~hp 277 (345)
T 3a8x_A 227 ---LFQV---ILEKQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFAD------------------IQGHP 277 (345)
T ss_dssp ---HHHH---HHHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHH------------------HHTSG
T ss_pred ---HHHH---HHcCCCC-----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHH------------------HhcCC
Confidence 0000 0011111 113589999999999999999999996 67 89999
Q ss_pred ccCCCC
Q 044076 324 YFHGLA 329 (506)
Q Consensus 324 ~f~~~~ 329 (506)
||+++.
T Consensus 278 ~f~~~~ 283 (345)
T 3a8x_A 278 FFRNVD 283 (345)
T ss_dssp GGTTCC
T ss_pred ccCCCC
Confidence 998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=403.60 Aligned_cols=273 Identities=22% Similarity=0.213 Sum_probs=192.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+++|.+.+.||+|+||+||+|++ +|+.||||+++.. ........+|+..+..++|||||++++++.... .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 56899999999999999999976 6899999998642 112222335666677889999999999986431 11246
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCCCCcEEECCCCCEEEeecCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA--------NVFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~--------gIvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
+|||||||+ |+|.++++.. .++++.+..++.|+++||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999998 6999999864 699999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCC-cccccccccCCcccCcccccccC----CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhc
Q 044076 164 ARVSFTDTPS-AIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 164 a~~~~~~~~~-~~~~~~~vgt~~Y~APE~l~~~~----~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~ 238 (506)
|+........ .......+||++|+|||++.+.. ..|+.++|||||||++|||++|.+||......+.... ....
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~-~~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch-hccc
Confidence 9864433221 11223568999999999986521 1467899999999999999999988865432211000 0000
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+.+..+.+. ..+..-...+..+.........+.+.+|+.+||+.||.+|||+.||
T Consensus 234 ~~~~~~~~~--------~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 288 (303)
T 3hmm_A 234 SDPSVEEMR--------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp SSCCHHHHH--------HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred ccchHHHHH--------HHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 111111110 1000000001111000011233568899999999999999999995
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=415.21 Aligned_cols=292 Identities=35% Similarity=0.574 Sum_probs=218.8
Q ss_pred CCCEEE-eEEEeecCceEEEEEEEC--CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEI-QEIIGIGSYGVVASAIDT--HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i-~~~LG~G~~g~V~~a~d~--~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.+.|++ .++||+|+||+||+|++. .+++.||||++... .....+.+|+.+|+.++||||+++++++... .
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~ 91 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSH---A 91 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS----SCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---T
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC----CCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---C
Confidence 456887 458999999999999965 57889999999642 1223577999999999999999999998542 2
Q ss_pred CCcEEEEEecCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE----CCCCCE
Q 044076 90 FKDIYVVFELMESDLDQVIKAN---------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA----NADCKL 156 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~---------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv----~~~~~l 156 (506)
...+|+||||++++|.+++... ..+++..++.+++||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 4689999999999999988632 249999999999999999999999999999999999999 677899
Q ss_pred EEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc---------
Q 044076 157 KICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV--------- 227 (506)
Q Consensus 157 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~--------- 227 (506)
||+|||+|+...............+||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+.
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999998654322222223557899999999998762 4699999999999999999999999987664
Q ss_pred hhhHHHHHhhcCCCChHHHhhhhhhH-HHHHHhhhhccCCCC------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 228 AHQLDLVTDLLGTPSAESIAGIRNEK-AKRYLSSLRRKWAVP------FSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 228 ~~~l~~I~~~~g~p~~e~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
.+++..|...+|.|....|..+.... .......+....... +.......++.+.+||.+||++||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 58999999999999988887653321 122222221111000 01112335788999999999999999999999
Q ss_pred hhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 301 IRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 301 L~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
+|+||||.+...
T Consensus 331 ------------------~L~hp~f~~~~~ 342 (405)
T 3rgf_A 331 ------------------AMQDPYFLEDPL 342 (405)
T ss_dssp ------------------HHTSGGGTSSSC
T ss_pred ------------------HhcChhhccCCC
Confidence 899999987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=419.26 Aligned_cols=259 Identities=30% Similarity=0.488 Sum_probs=217.8
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++++.||+|+||+||+|++..++..||||++............+.+|+.+|+.++||||+++++++.. ...+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCEE
Confidence 47999999999999999999999999999999997544334445678899999999999999999999844 4789
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC---CCEEEeecCCcccccC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD---CKLKICDFGLARVSFT 169 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~---~~lKL~DFGla~~~~~ 169 (506)
|+||||+.+ +|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999975 999999888889999999999999999999999999999999999999764 4599999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. .....+||++|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+......+..
T Consensus 192 ~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 258 (494)
T 3lij_A 192 QK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS------ 258 (494)
T ss_dssp TB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS------
T ss_pred Cc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------
Confidence 22 1345679999999999864 6899999999999999999999999998887777776543332221
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
..++++++.+.+||.+||+.||.+|||+.| +|+||||+...
T Consensus 259 ---------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e------------------~l~hp~~~~~~ 299 (494)
T 3lij_A 259 ---------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQ------------------ALEHPWIKEMC 299 (494)
T ss_dssp ---------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHH------------------HHTCHHHHHHH
T ss_pred ---------------------hhcccCCHHHHHHHHHHCCCChhhCccHHH------------------HhcCcccccCc
Confidence 223568999999999999999999999999 89999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=401.18 Aligned_cols=293 Identities=35% Similarity=0.590 Sum_probs=226.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc--CCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR--REF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~--~~~ 90 (506)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .....+..+|+..++.++||||+++++++..... ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 46899999999999999999999999999999998542 2223345678888899999999999999865322 222
Q ss_pred CcEEEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCCCcEEECC-CCCEEEeecCC
Q 044076 91 KDIYVVFELMESDLDQVIK----ANDDLTPEHHQFFLYQLLRALKYIH--SANVFHRDLKPKNILANA-DCKLKICDFGL 163 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~----~~~~ls~~~~~~i~~QIl~gL~yLH--~~gIvHrDLKp~NILv~~-~~~lKL~DFGl 163 (506)
..+|+||||++++|...+. ....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3488999999998877665 3567999999999999999999999 999999999999999997 89999999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
++....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.|+.
T Consensus 179 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 986433222 2456789999999998662 55899999999999999999999999999999999999999999998
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCC----CCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHK----FPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLA 319 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~a 319 (506)
+.+..+....... ........++... ....++++.+||.+||+.||.+|||+.| +
T Consensus 254 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------~ 312 (360)
T 3e3p_A 254 EVLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE------------------A 312 (360)
T ss_dssp HHHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH------------------H
T ss_pred HHHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH------------------H
Confidence 8776543211100 0011111222222 2346789999999999999999999999 8
Q ss_pred ccCcccCCCCCCCCC
Q 044076 320 LADPYFHGLANLEEE 334 (506)
Q Consensus 320 L~HP~f~~~~~~~~~ 334 (506)
|+||||+++......
T Consensus 313 l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 313 LCHPYFDELHDPATK 327 (360)
T ss_dssp TTSGGGGGGGCTTCC
T ss_pred hcCccccccCCcccc
Confidence 999999998775543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=401.79 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=204.0
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 88 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILT-----P 88 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEee-----C
Confidence 45689999999999999999999999999999999996422 223457799999999999999999999854 3
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC--EEEeecCCcccc
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK--LKICDFGLARVS 167 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~--lKL~DFGla~~~ 167 (506)
..+|+||||++ ++|.+++...+.+++..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+..
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 78999999996 599999988888999999999999999999999999999999999999987765 999999999743
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s-~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
..... ....+||++|+|||++.+ ..++ .++|||||||++|+|++|++||.+.+.......+.....
T Consensus 169 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~------- 235 (361)
T 3uc3_A 169 VLHSQ----PKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL------- 235 (361)
T ss_dssp ----------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH-------
T ss_pred cccCC----CCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh-------
Confidence 22211 244679999999999977 5555 459999999999999999999987655433332211100
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
...... .....+++++.+||.+||+.||.+|||+.| +|+||||.
T Consensus 236 ---------------~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~e------------------ll~hp~f~ 279 (361)
T 3uc3_A 236 ---------------SVKYSI---PDDIRISPECCHLISRIFVADPATRISIPE------------------IKTHSWFL 279 (361)
T ss_dssp ---------------TTCCCC---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHH------------------HHTSHHHH
T ss_pred ---------------cCCCCC---CCcCCCCHHHHHHHHHHccCChhHCcCHHH------------------HHhCcchh
Confidence 000000 011247899999999999999999999999 89999996
Q ss_pred CC
Q 044076 327 GL 328 (506)
Q Consensus 327 ~~ 328 (506)
..
T Consensus 280 ~~ 281 (361)
T 3uc3_A 280 KN 281 (361)
T ss_dssp TT
T ss_pred cC
Confidence 54
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=400.50 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=220.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. .
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----N 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----C
Confidence 4579999999999999999999999999999999996421 122345678899999999999999999999854 4
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 78999999997 59999999888899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
. ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|.... +
T Consensus 194 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~-------- 255 (350)
T 1rdq_E 194 R------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--V-------- 255 (350)
T ss_dssp C------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C--------
T ss_pred C------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--C--------
Confidence 2 134679999999999987 689999999999999999999999999887766666553310 0
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
...+.+++++.+||.+||+.||.+||+ ++| +++|||
T Consensus 256 ---------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~e------------------i~~h~~ 296 (350)
T 1rdq_E 256 ---------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND------------------IKNHKW 296 (350)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHH------------------HHTSGG
T ss_pred ---------------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHH------------------HHhCcC
Confidence 011357899999999999999999998 899 899999
Q ss_pred cCCC
Q 044076 325 FHGL 328 (506)
Q Consensus 325 f~~~ 328 (506)
|.++
T Consensus 297 f~~~ 300 (350)
T 1rdq_E 297 FATT 300 (350)
T ss_dssp GTTC
T ss_pred cCCC
Confidence 9874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=406.16 Aligned_cols=267 Identities=22% Similarity=0.398 Sum_probs=213.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~ 90 (506)
.++|+++++||+|+||.||+|++..+++.||||++++... .......+.+|+.+|+.+ +||||+++++++.. .
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence 4689999999999999999999999999999999965332 233445678999999887 79999999999854 4
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+.+|+||||+++ +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 789999999985 9999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+....+.... ...+.+
T Consensus 206 ~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~~~~--- 270 (396)
T 4dc2_A 206 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 270 (396)
T ss_dssp TTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHH---
T ss_pred CCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhHHHH---
Confidence 221 2356789999999999988 7899999999999999999999999975432111000 000000
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------hhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA------EEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa------~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
.. ....... ...+.+++++.+||++||+.||.+||++ +| +++||
T Consensus 271 -----~~--~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~e------------------i~~Hp 320 (396)
T 4dc2_A 271 -----FQ--VILEKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFAD------------------IQGHP 320 (396)
T ss_dssp -----HH--HHHHCCC-----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHH------------------HHHST
T ss_pred -----HH--HHhcccc-----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHH------------------HhcCc
Confidence 00 0001111 1113589999999999999999999996 67 89999
Q ss_pred ccCCCC
Q 044076 324 YFHGLA 329 (506)
Q Consensus 324 ~f~~~~ 329 (506)
||+++.
T Consensus 321 ff~~i~ 326 (396)
T 4dc2_A 321 FFRNVD 326 (396)
T ss_dssp TTTTCC
T ss_pred cccCCC
Confidence 999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=414.81 Aligned_cols=268 Identities=22% Similarity=0.366 Sum_probs=222.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|+++++||+|+||+||+|++..+++.||||++++.. ........+.+|+.++..++||||+++++++.. .
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-----D 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-----S
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----C
Confidence 3578999999999999999999999999999999996421 111122337789999999999999999999844 4
Q ss_pred CcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
+.+|+|||||. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 78999999996 599999987 5689999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccc---cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~---~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
.... ...+..+||++|+|||++.. ....|+.++|||||||++|||++|++||.+.+..+.+..|....+
T Consensus 227 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------ 298 (437)
T 4aw2_A 227 EDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------ 298 (437)
T ss_dssp TTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------
T ss_pred cCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc------
Confidence 3221 12245689999999999862 125789999999999999999999999999888777777643110
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD--RPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
...+...++.+++++++||++||+.+|++ |++++| +++||
T Consensus 299 --------------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~e------------------il~Hp 340 (437)
T 4aw2_A 299 --------------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIED------------------FKKHP 340 (437)
T ss_dssp --------------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHH------------------HHTSG
T ss_pred --------------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHH------------------HhCCC
Confidence 11222334568999999999999999988 999999 89999
Q ss_pred ccCCCCC
Q 044076 324 YFHGLAN 330 (506)
Q Consensus 324 ~f~~~~~ 330 (506)
||+++..
T Consensus 341 ff~~i~w 347 (437)
T 4aw2_A 341 FFSGIDW 347 (437)
T ss_dssp GGTTCCT
T ss_pred ccCCCCH
Confidence 9998653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=399.49 Aligned_cols=259 Identities=21% Similarity=0.373 Sum_probs=220.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~ 89 (506)
..++|++++.||+|+||.||+|++..+|+.||||+++.... .......+.+|..+|..+ .||||+++++++..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----- 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----- 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----
Confidence 35799999999999999999999999999999999964211 223456678999999988 69999999999844
Q ss_pred CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+.+|+||||++| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 4789999999975 999999988889999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|....-
T Consensus 173 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------- 238 (353)
T 2i0e_A 173 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------- 238 (353)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred cCCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 2221 1345689999999999987 6899999999999999999999999998887766666643110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
...+.+++++.+||.+||+.||.+||+ +++ +++||
T Consensus 239 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~------------------i~~h~ 278 (353)
T 2i0e_A 239 ----------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERD------------------IKEHA 278 (353)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHH------------------HHTSG
T ss_pred ----------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHH------------------HhcCc
Confidence 011358899999999999999999995 588 89999
Q ss_pred ccCCCC
Q 044076 324 YFHGLA 329 (506)
Q Consensus 324 ~f~~~~ 329 (506)
||+++.
T Consensus 279 ~f~~~~ 284 (353)
T 2i0e_A 279 FFRYID 284 (353)
T ss_dssp GGTTCC
T ss_pred cccCCC
Confidence 998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=392.54 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=211.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccc--cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVF--EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
..++|++++.||+|+||.||+|++. .+|+.||||+++... ........+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence 4578999999999999999999985 689999999997532 123345567899999999999999999999844
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.+.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 93 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 ---GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp ---SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 478999999997 5999999988889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|.....
T Consensus 170 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------ 238 (327)
T 3a62_A 170 ESIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------ 238 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------
T ss_pred ccccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------
Confidence 5322211 1245679999999999987 6789999999999999999999999998887666665533110
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL 320 (506)
...+.+++++.+||.+||+.||.+|| |++| +|
T Consensus 239 -------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e------------------~l 275 (327)
T 3a62_A 239 -------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGE------------------VQ 275 (327)
T ss_dssp -------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHH------------------HH
T ss_pred -------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHH------------------HH
Confidence 11135789999999999999999999 7889 89
Q ss_pred cCcccCCCC
Q 044076 321 ADPYFHGLA 329 (506)
Q Consensus 321 ~HP~f~~~~ 329 (506)
+||||+++.
T Consensus 276 ~hp~f~~~~ 284 (327)
T 3a62_A 276 AHPFFRHIN 284 (327)
T ss_dssp HSGGGSSCC
T ss_pred cCCcccCCC
Confidence 999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=416.79 Aligned_cols=261 Identities=31% Similarity=0.519 Sum_probs=222.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.. ...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CCE
Confidence 468999999999999999999999999999999996543333456778999999999999999999999844 478
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC---CCCCEEEeecCCccccc
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN---ADCKLKICDFGLARVSF 168 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~---~~~~lKL~DFGla~~~~ 168 (506)
+|+||||+.+ +|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999974 9999998888999999999999999999999999999999999999995 45679999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+.+..+......+..
T Consensus 176 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 243 (486)
T 3mwu_A 176 QNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL----- 243 (486)
T ss_dssp CC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS-----
T ss_pred CCC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-----
Confidence 322 1345679999999999875 5999999999999999999999999998887777776543222211
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
..++.+++++.+||.+||+.||.+|||+.| +|+||||+..
T Consensus 244 ----------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~------------------~l~hp~~~~~ 283 (486)
T 3mwu_A 244 ----------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQ------------------CLEHPWIQKY 283 (486)
T ss_dssp ----------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHH------------------HHHCHHHHHT
T ss_pred ----------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHH------------------HhcCHhhccC
Confidence 122457899999999999999999999999 8999999876
Q ss_pred CC
Q 044076 329 AN 330 (506)
Q Consensus 329 ~~ 330 (506)
..
T Consensus 284 ~~ 285 (486)
T 3mwu_A 284 SS 285 (486)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=404.46 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=217.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 578999999999999999999999999999999996421 122345678899999999999999999999854 37
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 8999999997 499999998889999999999999999999999999999999999999999999999999999864332
Q ss_pred CCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
. .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|++||.+.+.......+....
T Consensus 169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----------- 233 (384)
T 4fr4_A 169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----------- 233 (384)
T ss_dssp C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-----------
T ss_pred C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-----------
Confidence 2 23567899999999998642 2468999999999999999999999998655432222111100
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-AEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-a~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
... ....+.+++++.+||.+||+.||.+||+ +++ ++.||||.++
T Consensus 234 ------------~~~-----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~------------------l~~hp~f~~~ 278 (384)
T 4fr4_A 234 ------------TTV-----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSD------------------VQNFPYMNDI 278 (384)
T ss_dssp ------------HCC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHH------------------HHTSGGGTTC
T ss_pred ------------hcc-----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHH------------------HHcChhhhcC
Confidence 000 0112357899999999999999999998 788 7899999875
Q ss_pred C
Q 044076 329 A 329 (506)
Q Consensus 329 ~ 329 (506)
.
T Consensus 279 ~ 279 (384)
T 4fr4_A 279 N 279 (384)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=399.30 Aligned_cols=260 Identities=28% Similarity=0.437 Sum_probs=213.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc---cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF---EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~---~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----- 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----- 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 468999999999999999999999999999999985321 111235678899999999999999999999843
Q ss_pred CCcEEEEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC---EEEeec
Q 044076 90 FKDIYVVFELME-SDLDQVIKAN----DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK---LKICDF 161 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~----~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~---lKL~DF 161 (506)
.+.+|+||||++ ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 478999999998 5998877542 35899999999999999999999999999999999999987655 999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
|+++....... .....+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.. ...+..+.......
T Consensus 178 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 178 GVAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp TTCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred cceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 99976433221 2245679999999999987 678999999999999999999999998753 23333332221111
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
... .++.+++++.+||.+||+.||.+|||+.| +|+
T Consensus 252 ~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e------------------~l~ 286 (351)
T 3c0i_A 252 NPR---------------------------QWSHISESAKDLVRRMLMLDPAERITVYE------------------ALN 286 (351)
T ss_dssp CHH---------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHH------------------HHT
T ss_pred Ccc---------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHH------------------Hhc
Confidence 111 12458899999999999999999999999 899
Q ss_pred CcccCCC
Q 044076 322 DPYFHGL 328 (506)
Q Consensus 322 HP~f~~~ 328 (506)
||||++.
T Consensus 287 hp~~~~~ 293 (351)
T 3c0i_A 287 HPWLKER 293 (351)
T ss_dssp SHHHHTH
T ss_pred ChhhcCC
Confidence 9999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=393.70 Aligned_cols=265 Identities=25% Similarity=0.355 Sum_probs=214.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.. .+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CC
Confidence 4679999999999999999999999999999999985321 22234567899999999999999999999843 47
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
..|+||||+++ +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 89999999975 99999988888999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.............
T Consensus 159 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----------- 225 (323)
T 3tki_A 159 NR-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------- 225 (323)
T ss_dssp TE-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC-----------
T ss_pred Cc-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc-----------
Confidence 21 1123456799999999999762 3347899999999999999999999987654332211111000
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
.....+..+++.+.+||.+||+.||.+|||++| +|+||||+....
T Consensus 226 -----------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e------------------il~h~~~~~~~~ 270 (323)
T 3tki_A 226 -----------------TYLNPWKKIDSAPLALLHKILVENPSARITIPD------------------IKKDRWYNKPLK 270 (323)
T ss_dssp -----------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH------------------HTTCTTTTCCCC
T ss_pred -----------------ccCCccccCCHHHHHHHHHHccCChhhCcCHHH------------------HhhChhhccccc
Confidence 001123458899999999999999999999999 899999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=391.72 Aligned_cols=290 Identities=31% Similarity=0.573 Sum_probs=228.5
Q ss_pred ccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCC
Q 044076 7 FTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPP 85 (506)
Q Consensus 7 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~ 85 (506)
...++..++|++++.||+|+||.||+|++..+++.||||+++. .....+.+|+.+|+.++ ||||+++++++..+
T Consensus 29 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 29 VVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp CCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred hhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 3456778899999999999999999999999999999999863 23466889999999998 99999999998643
Q ss_pred CcCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-CEEEeecCC
Q 044076 86 CRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-KLKICDFGL 163 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-~lKL~DFGl 163 (506)
.....++||||++ ++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 104 ---~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 104 ---VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp ---TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ---CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 2367899999998 48888875 489999999999999999999999999999999999999777 899999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCC-CCCCchhhHHHHHhhcCCCC
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF-PGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF-~~~~~~~~l~~I~~~~g~p~ 242 (506)
|+....... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+..+++..+...+|.+.
T Consensus 178 a~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~ 252 (330)
T 3nsz_A 178 AEFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252 (330)
T ss_dssp CEECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred ceEcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCch
Confidence 976433222 2445799999999998762 57899999999999999999999888 56677788888888777543
Q ss_pred hHHHhhh-hhhHHHHHHhhhhccCCCCCCCCC-----CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhh
Q 044076 243 AESIAGI-RNEKAKRYLSSLRRKWAVPFSHKF-----PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFY 316 (506)
Q Consensus 243 ~e~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~ 316 (506)
...+..- .......+...........+...+ ..+++++.+||.+||++||.+|||++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e---------------- 316 (330)
T 3nsz_A 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE---------------- 316 (330)
T ss_dssp HHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHH----------------
T ss_pred hhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHH----------------
Confidence 3222110 000001111111111111221111 237999999999999999999999999
Q ss_pred hhhccCcccCCCCC
Q 044076 317 VLALADPYFHGLAN 330 (506)
Q Consensus 317 ~~aL~HP~f~~~~~ 330 (506)
+|+||||+++..
T Consensus 317 --~l~hp~f~~~~~ 328 (330)
T 3nsz_A 317 --AMEHPYFYTVVK 328 (330)
T ss_dssp --HHTSGGGTTCC-
T ss_pred --HhcCccHhhhcc
Confidence 899999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=392.26 Aligned_cols=258 Identities=24% Similarity=0.451 Sum_probs=194.2
Q ss_pred CCEEEe---EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCC
Q 044076 14 SQYEIQ---EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 14 ~rY~i~---~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~ 89 (506)
++|++. +.||+|+||+||+|.+..+++.||||++.. .....+.+|+.+++.+. ||||+++++++..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~----- 77 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHD----- 77 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----
Confidence 356664 789999999999999999999999999964 23456779999999997 9999999999843
Q ss_pred CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC---CEEEeecCCcc
Q 044076 90 FKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC---KLKICDFGLAR 165 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~---~lKL~DFGla~ 165 (506)
....|+||||+++ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 4789999999975 9999999988999999999999999999999999999999999999998765 79999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch-------hhHHHHHhhc
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA-------HQLDLVTDLL 238 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~-------~~l~~I~~~~ 238 (506)
....... .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.. +.+..|....
T Consensus 158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~ 232 (325)
T 3kn6_A 158 LKPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232 (325)
T ss_dssp ECCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC
T ss_pred ecCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC
Confidence 6433221 2345678999999999987 78999999999999999999999999875432 2222221111
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVL 318 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~ 318 (506)
..+.. ..++++++++.+||.+||+.||.+|||++|
T Consensus 233 ~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e------------------ 267 (325)
T 3kn6_A 233 FSFEG---------------------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSG------------------ 267 (325)
T ss_dssp CCCCS---------------------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTT------------------
T ss_pred CCCCc---------------------------ccccCCCHHHHHHHHHHCCCChhHCCCHHH------------------
Confidence 11111 112358999999999999999999999999
Q ss_pred hccCcccCCCCCC
Q 044076 319 ALADPYFHGLANL 331 (506)
Q Consensus 319 aL~HP~f~~~~~~ 331 (506)
+|+||||++....
T Consensus 268 ll~h~w~~~~~~~ 280 (325)
T 3kn6_A 268 LRYNEWLQDGSQL 280 (325)
T ss_dssp STTCGGGCTTCCC
T ss_pred HhcChhhccCccC
Confidence 8999999975543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=388.24 Aligned_cols=263 Identities=26% Similarity=0.435 Sum_probs=225.2
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh----hHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV----SDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
...++|++++.||+|+||.||+|.+..+|+.||||+++...... .....+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 86 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-- 86 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 34568999999999999999999999999999999996432221 235678899999999999999999999843
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC----CEEEeec
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC----KLKICDF 161 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~----~lKL~DF 161 (506)
...+|+||||++ ++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 87 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 87 ---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp ---SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred ---CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 478999999996 59999999888899999999999999999999999999999999999999888 7999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
|+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 164 g~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 164 GLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237 (321)
T ss_dssp TTCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred ccceecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence 99976433221 245679999999999987 689999999999999999999999999988777777665543333
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
.... ++..++.+.+||.+||+.||.+|||++| +|+
T Consensus 238 ~~~~---------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e------------------~l~ 272 (321)
T 2a2a_A 238 DEEF---------------------------FSHTSELAKDFIRKLLVKETRKRLTIQE------------------ALR 272 (321)
T ss_dssp CHHH---------------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHH------------------HHH
T ss_pred Chhh---------------------------hcccCHHHHHHHHHHcCCChhhCcCHHH------------------Hhc
Confidence 2221 2357899999999999999999999999 899
Q ss_pred CcccCCCC
Q 044076 322 DPYFHGLA 329 (506)
Q Consensus 322 HP~f~~~~ 329 (506)
||||....
T Consensus 273 hp~~~~~~ 280 (321)
T 2a2a_A 273 HPWITPVD 280 (321)
T ss_dssp STTTSCSS
T ss_pred CccccCCC
Confidence 99998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=411.84 Aligned_cols=258 Identities=27% Similarity=0.443 Sum_probs=211.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.+|+.++||||+++++++.. .+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 468999999999999999999999999999999996432 233445667899999999999999999999843 37
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+|+||||+++ +|..++.....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 89999999985 999999888899999999999999999999998 9999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......|.....
T Consensus 302 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------- 366 (446)
T 4ejn_A 302 DGA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------- 366 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred CCc---ccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 221 2355789999999999987 7899999999999999999999999998877666655532110
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
...+.+++++.+||.+||+.||.+|| |++| +|+|||
T Consensus 367 ---------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~e------------------ll~hp~ 407 (446)
T 4ejn_A 367 ---------------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE------------------IMQHRF 407 (446)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH------------------HHTSGG
T ss_pred ---------------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHH------------------HHhCcc
Confidence 01135789999999999999999999 9999 899999
Q ss_pred cCCCC
Q 044076 325 FHGLA 329 (506)
Q Consensus 325 f~~~~ 329 (506)
|+++.
T Consensus 408 f~~~~ 412 (446)
T 4ejn_A 408 FAGIV 412 (446)
T ss_dssp GTTCC
T ss_pred ccCCC
Confidence 99863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=386.65 Aligned_cols=284 Identities=31% Similarity=0.499 Sum_probs=230.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEE-CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCC------CcceeceeecC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAID-THTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP------DIVEIKHIMLP 84 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d-~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hp------nIv~l~~v~~~ 84 (506)
..++|++++.||+|+||.||+|.+ ..+++.||||+++. .......+.+|+.+++.++|+ +|+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 467999999999999999999998 56889999999964 234456788999999988765 48999998843
Q ss_pred CCcCCCCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC----------
Q 044076 85 PCRREFKDIYVVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA---------- 152 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~---------- 152 (506)
.+.+|+||||++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 89 -----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 -----HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp -----TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred -----CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 47899999999999999998765 6899999999999999999999999999999999999987
Q ss_pred ---------CCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCC
Q 044076 153 ---------DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFP 223 (506)
Q Consensus 153 ---------~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~ 223 (506)
++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||+
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 678999999999763322 134579999999999987 689999999999999999999999999
Q ss_pred CCCchhhHHHHHhhcCCCChHHHhhhhhhH--------------HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhh
Q 044076 224 GRNVAHQLDLVTDLLGTPSAESIAGIRNEK--------------AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLA 289 (506)
Q Consensus 224 ~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~ 289 (506)
+.+..+.+..+....+.++...+....... ...+...... ....+.......++++.+||.+||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhC
Confidence 999999999999999988877655432211 1111111100 0001111112346789999999999
Q ss_pred cCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 290 FDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 290 ~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
.||.+|||+.| +|+||||+.++.
T Consensus 315 ~dP~~Rpt~~e------------------ll~hp~f~~~~~ 337 (339)
T 1z57_A 315 YDPAKRITLRE------------------ALKHPFFDLLKK 337 (339)
T ss_dssp SSTTTSCCHHH------------------HTTSGGGGGGGC
T ss_pred cCcccccCHHH------------------HhcCHHHHHHhc
Confidence 99999999999 899999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=400.68 Aligned_cols=259 Identities=26% Similarity=0.409 Sum_probs=220.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCE
Confidence 46899999999999999999999999999999999642 23445678899999999999999999999843 478
Q ss_pred EEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC--CCCEEEeecCCccccc
Q 044076 93 IYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA--DCKLKICDFGLARVSF 168 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~--~~~lKL~DFGla~~~~ 168 (506)
+|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999997 59999987654 7999999999999999999999999999999999999974 5789999999998643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 203 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~------- 269 (387)
T 1kob_A 203 PDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF------- 269 (387)
T ss_dssp TTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred CCcc----eeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 3221 234579999999999987 689999999999999999999999999888776666553321111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
....++.+++++.+||.+||+.||.+|||+.| +|+||||++.
T Consensus 270 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e------------------ll~hp~~~~~ 311 (387)
T 1kob_A 270 --------------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD------------------ALEHPWLKGD 311 (387)
T ss_dssp --------------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHH------------------HHTSTTTSSC
T ss_pred --------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHH------------------HhhCccccCC
Confidence 11334578999999999999999999999999 8999999875
Q ss_pred C
Q 044076 329 A 329 (506)
Q Consensus 329 ~ 329 (506)
.
T Consensus 312 ~ 312 (387)
T 1kob_A 312 H 312 (387)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=411.35 Aligned_cols=262 Identities=28% Similarity=0.463 Sum_probs=221.8
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
..-...++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-- 87 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-- 87 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 33345689999999999999999999999999999999996421 112235678899999999999999999999854
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.+.+|+||||++ ++|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 88 ---~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 88 ---PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164 (476)
T ss_dssp ---SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchh
Confidence 378999999996 5999999888899999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......|......
T Consensus 165 ~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----- 234 (476)
T 2y94_A 165 MMSDGE----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY----- 234 (476)
T ss_dssp ECCTTC----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC-----
T ss_pred hccccc----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC-----
Confidence 643322 23456799999999999872 33478999999999999999999999988776666555331110
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
....+++++.+||.+||+.||.+|||++| +++||||
T Consensus 235 --------------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~e------------------il~hp~~ 270 (476)
T 2y94_A 235 --------------------------TPQYLNPSVISLLKHMLQVDPMKRATIKD------------------IREHEWF 270 (476)
T ss_dssp --------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHH------------------HHTCHHH
T ss_pred --------------------------CCccCCHHHHHHHHHHcCCCchhCcCHHH------------------HHhCHHh
Confidence 11247899999999999999999999999 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
+..
T Consensus 271 ~~~ 273 (476)
T 2y94_A 271 KQD 273 (476)
T ss_dssp HTT
T ss_pred hhc
Confidence 864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=412.60 Aligned_cols=261 Identities=29% Similarity=0.475 Sum_probs=224.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. .+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 468999999999999999999999999999999995432 223456778999999999999999999999844 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE---CCCCCEEEeecCCcccc
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA---NADCKLKICDFGLARVS 167 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv---~~~~~lKL~DFGla~~~ 167 (506)
.+|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+..
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 8999999997 5999999988899999999999999999999999999999999999999 56789999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..|......+..
T Consensus 180 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 248 (484)
T 3nyv_A 180 EASK----KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL---- 248 (484)
T ss_dssp CCCC----SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS----
T ss_pred cccc----ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----
Confidence 3322 1345679999999999865 6899999999999999999999999998887777777543322221
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
..++.+++++.+||.+||+.||.+|||+.| +|+||||+.
T Consensus 249 -----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e------------------~l~h~~~~~ 287 (484)
T 3nyv_A 249 -----------------------PQWKKVSESAKDLIRKMLTYVPSMRISARD------------------ALDHEWIQT 287 (484)
T ss_dssp -----------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHH------------------HHTSHHHHH
T ss_pred -----------------------cccccCCHHHHHHHHHHCCCChhHCcCHHH------------------HhhChhhcc
Confidence 122457899999999999999999999999 899999987
Q ss_pred CCC
Q 044076 328 LAN 330 (506)
Q Consensus 328 ~~~ 330 (506)
...
T Consensus 288 ~~~ 290 (484)
T 3nyv_A 288 YTK 290 (484)
T ss_dssp HTC
T ss_pred ccc
Confidence 654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=377.30 Aligned_cols=258 Identities=30% Similarity=0.466 Sum_probs=222.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 79 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NT 79 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CC
Confidence 35689999999999999999999999999999999965322 345678899999999999999999999843 47
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE---CCCCCEEEeecCCcccc
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA---NADCKLKICDFGLARVS 167 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv---~~~~~lKL~DFGla~~~ 167 (506)
..|+||||+++ +|.+.+.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 89999999975 999999888889999999999999999999999999999999999999 78899999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+......++...
T Consensus 160 ~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (277)
T 3f3z_A 160 KPGK----MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD-- 230 (277)
T ss_dssp CTTS----CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH--
T ss_pred cCcc----chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh--
Confidence 3322 1245679999999999865 489999999999999999999999999887777776655444333322
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
++++++.+.+||.+||+.||.+|||+.| +|+||||++
T Consensus 231 -------------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~------------------~l~h~~~~~ 267 (277)
T 3f3z_A 231 -------------------------WLNVSPQAESLIRRLLTKSPKQRITSLQ------------------ALEHEWFEK 267 (277)
T ss_dssp -------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHH------------------HTTSHHHHH
T ss_pred -------------------------hhcCCHHHHHHHHHHccCChhhCcCHHH------------------HhcCHHHhc
Confidence 1357899999999999999999999999 899999976
Q ss_pred C
Q 044076 328 L 328 (506)
Q Consensus 328 ~ 328 (506)
.
T Consensus 268 ~ 268 (277)
T 3f3z_A 268 Q 268 (277)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=385.30 Aligned_cols=261 Identities=25% Similarity=0.435 Sum_probs=208.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC------------------------hhHHHHHHHHHHHH
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH------------------------VSDATRILREIKLL 67 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~------------------------~~~~~~~~rEi~iL 67 (506)
..++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 357999999999999999999999999999999999642211 11235688999999
Q ss_pred HhCCCCCcceeceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 044076 68 RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPK 146 (506)
Q Consensus 68 ~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~ 146 (506)
+.++||||+++++++... ....+|+||||+++ +|.+++ ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999998643 23679999999984 676654 3457999999999999999999999999999999999
Q ss_pred cEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCC-CCCchhhhhhhhHHHHHHHhCCCCCCCC
Q 044076 147 NILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLTGRPLFPGR 225 (506)
Q Consensus 147 NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~-~~s~~~DIWSlG~il~eLl~G~~pF~~~ 225 (506)
|||++.++.+||+|||+++....... ......||+.|+|||++.+... .++.++|||||||++|+|++|+.||.+.
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HEEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999976433221 2345679999999999876211 1478999999999999999999999876
Q ss_pred CchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhh
Q 044076 226 NVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305 (506)
Q Consensus 226 ~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~ 305 (506)
+.......+..... .. ...+.+++++.+||.+||+.||.+|||+.|
T Consensus 244 ~~~~~~~~~~~~~~--------------------------~~---~~~~~~~~~l~~li~~~l~~dp~~R~s~~e----- 289 (298)
T 2zv2_A 244 RIMCLHSKIKSQAL--------------------------EF---PDQPDIAEDLKDLITRMLDKNPESRIVVPE----- 289 (298)
T ss_dssp SHHHHHHHHHHCCC--------------------------CC---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHH-----
T ss_pred cHHHHHHHHhcccC--------------------------CC---CCccccCHHHHHHHHHHhhcChhhCCCHHH-----
Confidence 65443333321100 00 112468999999999999999999999999
Q ss_pred hhhhHHHHHhhhhhccCcccC
Q 044076 306 IVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 306 ~~~~~~~~~~~~~aL~HP~f~ 326 (506)
+|+||||+
T Consensus 290 -------------~l~hp~~~ 297 (298)
T 2zv2_A 290 -------------IKLHPWVT 297 (298)
T ss_dssp -------------HTTCHHHH
T ss_pred -------------HhcCcccc
Confidence 89999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=394.86 Aligned_cols=281 Identities=31% Similarity=0.509 Sum_probs=228.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCC-----cceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPD-----IVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-Hpn-----Iv~l~~v~~~~~ 86 (506)
.++|++++.||+|+||+||+|.+..+++.||||+++. .......+.+|+.+++.+. |+| |+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 5799999999999999999999999999999999963 2344566778999998886 554 8888888743
Q ss_pred cCCCCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCCCcEEEC--CCCCEEEee
Q 044076 87 RREFKDIYVVFELMESDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIH--SANVFHRDLKPKNILAN--ADCKLKICD 160 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH--~~gIvHrDLKp~NILv~--~~~~lKL~D 160 (506)
.+.+|+||||++++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|
T Consensus 128 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 ---RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ---TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ---CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 3789999999999999999875 36999999999999999999999 57999999999999995 478899999
Q ss_pred cCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCC
Q 044076 161 FGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240 (506)
Q Consensus 161 FGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~ 240 (506)
||+|+..... ....++|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..|...+|.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999764221 245679999999999987 67999999999999999999999999999999999999999999
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCC------CCCCCC----------------------CCC-------CCHHHHHHHH
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWA------VPFSHK----------------------FPG-------ADPLALRLLQ 285 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~------~~~~~~----------------------~~~-------~s~~~~dLI~ 285 (506)
|+...+.... ..+.++..++...- ...... ..+ .++++.+||.
T Consensus 277 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 277 PPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 9887765432 23344433321100 000000 000 1147899999
Q ss_pred HhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 286 RLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 286 ~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
+||++||.+|||++| +|+||||++..
T Consensus 355 ~mL~~dP~~Rpta~e------------------~L~hp~f~~~~ 380 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYY------------------ALQHSFFKKTA 380 (382)
T ss_dssp HHTCSCTTTSCCHHH------------------HTTSGGGCC--
T ss_pred HhcCCChhhCCCHHH------------------HhcCcccccCC
Confidence 999999999999999 89999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=411.33 Aligned_cols=262 Identities=30% Similarity=0.428 Sum_probs=221.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC-----------hhHHHHHHHHHHHHHhCCCCCcceece
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH-----------VSDATRILREIKLLRMLKHPDIVEIKH 80 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~-----------~~~~~~~~rEi~iL~~l~HpnIv~l~~ 80 (506)
..++|++++.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999999999999999999643211 123567889999999999999999999
Q ss_pred eecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC---CE
Q 044076 81 IMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC---KL 156 (506)
Q Consensus 81 v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~---~l 156 (506)
++.. ...+|+||||+++ +|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 114 ~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFED-----KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEC-----SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEc-----CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence 9843 4789999999975 9999998888999999999999999999999999999999999999999876 69
Q ss_pred EEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 044076 157 KICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD 236 (506)
Q Consensus 157 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~ 236 (506)
||+|||+|+...... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..|..
T Consensus 189 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp EECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 999999997643322 1345679999999999864 689999999999999999999999999988888777755
Q ss_pred hcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhh
Q 044076 237 LLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFY 316 (506)
Q Consensus 237 ~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~ 316 (506)
....+.... ++++++++.+||.+||++||.+|||++|
T Consensus 262 ~~~~~~~~~---------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e---------------- 298 (504)
T 3q5i_A 262 GKYYFDFND---------------------------WKNISDEAKELIKLMLTYDYNKRCTAEE---------------- 298 (504)
T ss_dssp CCCCCCHHH---------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHH----------------
T ss_pred CCCCCCccc---------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHH----------------
Confidence 433332222 2458899999999999999999999999
Q ss_pred hhhccCcccCCCCC
Q 044076 317 VLALADPYFHGLAN 330 (506)
Q Consensus 317 ~~aL~HP~f~~~~~ 330 (506)
+|+||||+....
T Consensus 299 --~l~h~~~~~~~~ 310 (504)
T 3q5i_A 299 --ALNSRWIKKYAN 310 (504)
T ss_dssp --HHTSHHHHHTCC
T ss_pred --HhcCHhhhhchh
Confidence 899999987554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=407.48 Aligned_cols=266 Identities=24% Similarity=0.329 Sum_probs=219.8
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
...++|+++++||+|+||.||+|++..+++.||||++++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----- 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD----- 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----
Confidence 34679999999999999999999999999999999996421 111223347799999999999999999999843
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...+|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 478999999996 599999876 469999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~--~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
... .......+||+.|+|||++.+.. ..|+.++|||||||++|||++|++||.+.+..+....|......
T Consensus 220 ~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------ 291 (410)
T 3v8s_A 220 KEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS------ 291 (410)
T ss_dssp TTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH------
T ss_pred cCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc------
Confidence 221 11224568999999999987621 12889999999999999999999999998887777766431100
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKD--RPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~--RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
... ...+.+++++.+||.+||+.+|.+ |++++| +++|||
T Consensus 292 ------------------~~~---p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~e------------------i~~Hp~ 332 (410)
T 3v8s_A 292 ------------------LTF---PDDNDISKEAKNLICAFLTDREVRLGRNGVEE------------------IKRHLF 332 (410)
T ss_dssp ------------------CCC---CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHH------------------HHTSGG
T ss_pred ------------------ccC---CCcccccHHHHHHHHHHccChhhhCCCCCHHH------------------HhcCcc
Confidence 000 112458999999999999999988 999999 899999
Q ss_pred cCCCC
Q 044076 325 FHGLA 329 (506)
Q Consensus 325 f~~~~ 329 (506)
|+++.
T Consensus 333 f~~~~ 337 (410)
T 3v8s_A 333 FKNDQ 337 (410)
T ss_dssp GCCSS
T ss_pred ccCCC
Confidence 99864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=399.30 Aligned_cols=259 Identities=26% Similarity=0.434 Sum_probs=211.8
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHH-HHhCCCCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKL-LRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~i-L~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
..++|++++.||+|+||.||+|++..+++.||||++++.. ........+.+|..+ ++.++||||+++++++..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----- 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----- 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----
Confidence 4578999999999999999999999999999999996432 233345567778877 577899999999999854
Q ss_pred CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+.+|+||||++| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 4789999999985 999999988889999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....|....
T Consensus 191 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------- 255 (373)
T 2r5t_A 191 EHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------- 255 (373)
T ss_dssp CCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC----------
T ss_pred cCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------
Confidence 2221 1245689999999999987 789999999999999999999999999887766666553210
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh----hhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE----EIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~----eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
. ...+.+++++.+||.+||+.||.+||++. + ++.|||
T Consensus 256 ------------------~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~------------------i~~h~~ 296 (373)
T 2r5t_A 256 ------------------L---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME------------------IKSHVF 296 (373)
T ss_dssp ------------------C---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH------------------HHTSGG
T ss_pred ------------------c---CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH------------------HhCCcc
Confidence 0 11246899999999999999999999984 5 899999
Q ss_pred cCCCC
Q 044076 325 FHGLA 329 (506)
Q Consensus 325 f~~~~ 329 (506)
|+++.
T Consensus 297 f~~~~ 301 (373)
T 2r5t_A 297 FSLIN 301 (373)
T ss_dssp GTTCC
T ss_pred ccCCC
Confidence 98754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=405.22 Aligned_cols=268 Identities=24% Similarity=0.353 Sum_probs=219.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|+++++||+|+||.||+|+++.+|+.||||++++.. ........+.+|+.+|..++||||+++++++.. .
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-----E 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-----S
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence 4578999999999999999999999999999999996421 112233447789999999999999999999844 4
Q ss_pred CcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 78999999996 6999999875 479999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCccccccc-----CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
.... ......+||+.|+|||++... ...|+.++|||||||++|||++|++||.+.+..+....|.....
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---- 287 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE---- 287 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----
Confidence 3221 112346899999999998621 14689999999999999999999999999887777766643100
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC---CCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR---PSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R---pTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
...+......+++++.+||++||+ ||.+| ++++| ++
T Consensus 288 ----------------------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~e------------------i~ 326 (412)
T 2vd5_A 288 ----------------------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGD------------------FR 326 (412)
T ss_dssp ----------------------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHH------------------HH
T ss_pred ----------------------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHH------------------Hh
Confidence 001111124689999999999999 99998 59999 89
Q ss_pred cCcccCCCCCC
Q 044076 321 ADPYFHGLANL 331 (506)
Q Consensus 321 ~HP~f~~~~~~ 331 (506)
+||||+++...
T Consensus 327 ~Hpff~~i~w~ 337 (412)
T 2vd5_A 327 THPFFFGLDWD 337 (412)
T ss_dssp TSGGGTTCCST
T ss_pred cCCCcCCCCHH
Confidence 99999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=384.93 Aligned_cols=252 Identities=27% Similarity=0.304 Sum_probs=206.8
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||+||+|.+..+|+.||||++..............+|+..+..+ .||||+++++++. +.+.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 579999999999999999999999999999999876555555556666777766655 7999999999984 3478
Q ss_pred EEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999988764 469999999999999999999999999999999999999999999999999997643322
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|..+|.+.... ..+.. +....
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~--~~~~~-------- 271 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQ--GYLPP-------- 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTT--TCCCH--------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhc--cCCCc--------
Confidence 1 244569999999999875 6899999999999999999998777543221 11111 11111
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
...+.+++++.+||.+||+.||.+|||++| +|+||||++
T Consensus 272 -------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e------------------ll~hp~~~~ 310 (311)
T 3p1a_A 272 -------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEA------------------LLALPVLRQ 310 (311)
T ss_dssp -------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHH------------------HHTSGGGSC
T ss_pred -------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHH------------------HHhCccccC
Confidence 011357899999999999999999999999 899999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=377.53 Aligned_cols=257 Identities=30% Similarity=0.466 Sum_probs=210.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 93 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YH 93 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CC
Confidence 3468999999999999999999999999999999996532 23345678899999999999999999999843 47
Q ss_pred cEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE---CCCCCEEEeecCC
Q 044076 92 DIYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA---NADCKLKICDFGL 163 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv---~~~~~lKL~DFGl 163 (506)
..|+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 89999999985 99888854 3679999999999999999999999999999999999999 4568899999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
++....... .....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 174 a~~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----- 241 (285)
T 3is5_A 174 AELFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE----- 241 (285)
T ss_dssp CCC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----
T ss_pred ceecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC-----
Confidence 976433221 245679999999999854 68999999999999999999999998877554443332111
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
..+......+++++.+||.+||+.||.+|||+.| +|+||
T Consensus 242 -----------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e------------------~l~hp 280 (285)
T 3is5_A 242 -----------------------PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQ------------------VLHHE 280 (285)
T ss_dssp -----------------------CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHH------------------HHTSG
T ss_pred -----------------------cccccccCcCCHHHHHHHHHHccCChhhCcCHHH------------------HhcCH
Confidence 0111122347899999999999999999999999 89999
Q ss_pred ccCC
Q 044076 324 YFHG 327 (506)
Q Consensus 324 ~f~~ 327 (506)
||++
T Consensus 281 ~f~~ 284 (285)
T 3is5_A 281 WFKQ 284 (285)
T ss_dssp GGGC
T ss_pred Hhhc
Confidence 9985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=379.10 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=216.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-----CC
Confidence 478999999999999999999999999999999985421 122234568899999999999999999999843 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
..|+||||++ ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 8999999998 499999988888999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 163 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 225 (279)
T 3fdn_A 163 R-----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---------- 225 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC----------
T ss_pred c-----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC----------
Confidence 1 245679999999999987 68899999999999999999999999887766655555332111
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
....+++.+.+||.+||+.||.+|||+.| +|+||||++...
T Consensus 226 ---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e------------------~l~h~~~~~~~~ 266 (279)
T 3fdn_A 226 ---------------------FPDFVTEGARDLISRLLKHNPSQRPMLRE------------------VLEHPWITANSS 266 (279)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHH------------------HHHCHHHHHHCS
T ss_pred ---------------------CCCcCCHHHHHHHHHHhccChhhCCCHHH------------------HhhCccccCCcc
Confidence 11247889999999999999999999999 899999987554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=391.61 Aligned_cols=257 Identities=29% Similarity=0.442 Sum_probs=202.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~ 122 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTE 122 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCe
Confidence 46799999999999999999999999999999999642 234567799999999999999999999854 378
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC---CCCEEEeecCCccccc
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA---DCKLKICDFGLARVSF 168 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~---~~~lKL~DFGla~~~~ 168 (506)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999997 599999988888999999999999999999999999999999999999975 8899999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchh-hHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAH-QLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~-~l~~I~~~~g~p~~e~~~ 247 (506)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... .+..+....
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~--------- 267 (349)
T 2w4o_A 203 HQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE--------- 267 (349)
T ss_dssp --------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC---------
T ss_pred ccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC---------
Confidence 221 1245679999999999987 689999999999999999999999997765443 222332111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.......++++++++.+||.+||+.||.+|||+.| +|+||||.+
T Consensus 268 ------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------~l~hp~~~~ 311 (349)
T 2w4o_A 268 ------------------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ------------------ALQHPWVTG 311 (349)
T ss_dssp ------------------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHH------------------HHHSTTTTS
T ss_pred ------------------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHH------------------HhcCcccCC
Confidence 11112234578999999999999999999999999 899999987
Q ss_pred CC
Q 044076 328 LA 329 (506)
Q Consensus 328 ~~ 329 (506)
..
T Consensus 312 ~~ 313 (349)
T 2w4o_A 312 KA 313 (349)
T ss_dssp TT
T ss_pred Cc
Confidence 44
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=375.07 Aligned_cols=262 Identities=25% Similarity=0.337 Sum_probs=217.7
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
.....|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... .+.
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence 3456799999999999999999999999999999999765556667788999999999999999999999875432 234
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEEC-CCCCEEEeecCCccc
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILAN-ADCKLKICDFGLARV 166 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~-~~~~lKL~DFGla~~ 166 (506)
..+|+||||+++ +|.+++.....+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 679999999975 99999998888999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+.........+.
T Consensus 182 ~~~~-----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 249 (290)
T 1t4h_A 182 KRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA---- 249 (290)
T ss_dssp CCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----
T ss_pred cccc-----ccccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc----
Confidence 3222 1244579999999998864 589999999999999999999999987655443332211111100
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
......++++.+||.+||+.||.+|||++| +|+||||+
T Consensus 250 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e------------------ll~h~~f~ 287 (290)
T 1t4h_A 250 ------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKD------------------LLNHAFFQ 287 (290)
T ss_dssp ------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHH------------------HHTSGGGC
T ss_pred ------------------------ccCCCCCHHHHHHHHHHccCChhhCCCHHH------------------HhhCcccc
Confidence 111246789999999999999999999999 89999998
Q ss_pred C
Q 044076 327 G 327 (506)
Q Consensus 327 ~ 327 (506)
+
T Consensus 288 ~ 288 (290)
T 1t4h_A 288 E 288 (290)
T ss_dssp -
T ss_pred c
Confidence 5
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=394.72 Aligned_cols=283 Identities=26% Similarity=0.380 Sum_probs=225.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC--------CCCcceeceeecC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK--------HPDIVEIKHIMLP 84 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~--------HpnIv~l~~v~~~ 84 (506)
.++|++++.||+|+||+||+|++..+++.||||+++. .......+.+|+.+|+.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 5799999999999999999999999999999999963 3345667889999999985 7889999998853
Q ss_pred CCcCCCCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEECCCC-------
Q 044076 85 PCRREFKDIYVVFELMESDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANADC------- 154 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~~~~------- 154 (506)
.. .....+|+||||++++|.+.+... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 133679999999999988888765 4699999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------CEEEeecCCcccccCCCCCcccccccccCCcccCcccc
Q 044076 155 ------------------------------------------KLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192 (506)
Q Consensus 155 ------------------------------------------~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l 192 (506)
.+||+|||+|+..... .+..+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999764322 2455799999999999
Q ss_pred cccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC------chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCC
Q 044076 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN------VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWA 266 (506)
Q Consensus 193 ~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~------~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~ 266 (506)
.+ ..|+.++|||||||++|+|++|++||.+.+ ..+++..+...+|.++...+...... ..++........
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCcccccc
Confidence 87 679999999999999999999999998766 56778889999999887665332110 000000000000
Q ss_pred CCC-------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 267 VPF-------------SHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 267 ~~~-------------~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
..- .......++.+.+||.+||+.||.+|||++| +|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE------------------CLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHH------------------HHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHH------------------HhhCccccC
Confidence 000 0001123567899999999999999999999 899999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=390.83 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=210.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+.+|.++ +||||+++++++.. ..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~ 89 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDD-----GK 89 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEEC-----SS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEc-----CC
Confidence 4689999999999999999999999999999999964322 134788888887 69999999999843 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC----CCEEEeecCCccc
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD----CKLKICDFGLARV 166 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~----~~lKL~DFGla~~ 166 (506)
.+|+||||++ ++|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+++.
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 8999999997 5999999988899999999999999999999999999999999999998543 3499999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc---hhhHHHHHhhcCCCCh
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV---AHQLDLVTDLLGTPSA 243 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~---~~~l~~I~~~~g~p~~ 243 (506)
...... .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+... .+.+..|..
T Consensus 170 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~------- 237 (342)
T 2qr7_A 170 LRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS------- 237 (342)
T ss_dssp CBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH-------
T ss_pred CcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc-------
Confidence 433221 1245678999999999977 5789999999999999999999999976432 222222211
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
.........++.+++++.+||.+||+.||.+|||+.| +|+||
T Consensus 238 --------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~------------------il~hp 279 (342)
T 2qr7_A 238 --------------------GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAAL------------------VLRHP 279 (342)
T ss_dssp --------------------CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHH------------------HTTSH
T ss_pred --------------------CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHH------------------HhcCC
Confidence 1111112345678999999999999999999999999 89999
Q ss_pred ccCCCCC
Q 044076 324 YFHGLAN 330 (506)
Q Consensus 324 ~f~~~~~ 330 (506)
||.+...
T Consensus 280 ~~~~~~~ 286 (342)
T 2qr7_A 280 WIVHWDQ 286 (342)
T ss_dssp HHHTGGG
T ss_pred eecCccc
Confidence 9976543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=384.27 Aligned_cols=283 Identities=26% Similarity=0.375 Sum_probs=208.7
Q ss_pred CCCCEEEe-EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQ-EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~-~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~ 89 (506)
..++|++. +.||+|+||.||+|.+..+++.||||++... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----- 82 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE----- 82 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----
Confidence 35789996 7899999999999999999999999999643 223456788999999885 69999999999854
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC---EEEeecCCcc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK---LKICDFGLAR 165 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~---lKL~DFGla~ 165 (506)
.+.+|+||||++ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 378999999997 699999998888999999999999999999999999999999999999998776 9999999997
Q ss_pred cccCCCC----CcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhc
Q 044076 166 VSFTDTP----SAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 166 ~~~~~~~----~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~ 238 (506)
....... ........+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+.+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---- 238 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---- 238 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc----
Confidence 5432111 11112345699999999998641 135788999999999999999999999876543210000
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVL 318 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~ 318 (506)
.+.... ........+...........++.+++++.+||.+||+.||.+|||+.|
T Consensus 239 ----~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e------------------ 292 (316)
T 2ac3_A 239 ----GEACPA----CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ------------------ 292 (316)
T ss_dssp ------CCHH----HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH------------------
T ss_pred ----cccchh----HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHH------------------
Confidence 000000 000011111111100001122458899999999999999999999999
Q ss_pred hccCcccCCCCCC
Q 044076 319 ALADPYFHGLANL 331 (506)
Q Consensus 319 aL~HP~f~~~~~~ 331 (506)
+|+||||++....
T Consensus 293 ~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 293 VLQHPWVQGCAPE 305 (316)
T ss_dssp HHHSTTCC-----
T ss_pred HhcChhhcCCCCc
Confidence 8999999986543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=390.17 Aligned_cols=269 Identities=29% Similarity=0.440 Sum_probs=216.8
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc---cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF---EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~---~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED----- 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-----
Confidence 468999999999999999999999999999999985421 133456778999999999999999999999843
Q ss_pred CCcEEEEEecCC-CCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHH
Q 044076 90 FKDIYVVFELME-SDLDQVIKA----------------------------------------NDDLTPEHHQFFLYQLLR 128 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~----------------------------------------~~~ls~~~~~~i~~QIl~ 128 (506)
.+.+|+||||++ ++|.+++.. ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 478999999997 599998842 112467889999999999
Q ss_pred HHHHHHhCCeeecCCCCCcEEECCCC--CEEEeecCCcccccCCCC-CcccccccccCCcccCcccccccCCCCCchhhh
Q 044076 129 ALKYIHSANVFHRDLKPKNILANADC--KLKICDFGLARVSFTDTP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 205 (506)
Q Consensus 129 gL~yLH~~gIvHrDLKp~NILv~~~~--~lKL~DFGla~~~~~~~~-~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DI 205 (506)
||+|||++||+||||||+|||++.++ .+||+|||+++....... .........||+.|+|||++.+....++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998776 899999999976432211 111234567999999999986544678999999
Q ss_pred hhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHH
Q 044076 206 WSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQ 285 (506)
Q Consensus 206 WSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~ 285 (506)
|||||++|+|++|+.||.+.+..+.+..+......+.. ..++.+++++.+||.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~ 312 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---------------------------PNYNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---------------------------GGGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---------------------------cccccCCHHHHHHHH
Confidence 99999999999999999998877766666442222111 112347899999999
Q ss_pred HhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 286 RLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 286 ~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
+||+.||.+|||+.| +|+||||+++.+.
T Consensus 313 ~~l~~~p~~Rps~~~------------------~l~hp~~~~~~~~ 340 (345)
T 3hko_A 313 NLLNRNVDERFDAMR------------------ALQHPWISQFSDK 340 (345)
T ss_dssp HHSCSCTTTSCCHHH------------------HHHSHHHHTTSSC
T ss_pred HHcCCChhHCCCHHH------------------HhcChhhccChHh
Confidence 999999999999999 8999999987653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=386.69 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=205.7
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc------
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR------ 87 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~------ 87 (506)
++|++++.||+|+||.||+|++..+|+.||||+++.. ........+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECC-STTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecC-CchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5799999999999999999999999999999999643 234456778999999999999999999998754311
Q ss_pred ----------------------------------------------CCCCcEEEEEecCCC-CHHHHHHhCCC---CCHH
Q 044076 88 ----------------------------------------------REFKDIYVVFELMES-DLDQVIKANDD---LTPE 117 (506)
Q Consensus 88 ----------------------------------------------~~~~~~ylV~E~~~~-~L~~~i~~~~~---ls~~ 117 (506)
.....+|+||||+++ +|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 112348999999985 99999987643 5666
Q ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC---------cccccccccCCcccC
Q 044076 118 HHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS---------AIFWTDYVATRWYRA 188 (506)
Q Consensus 118 ~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~---------~~~~~~~vgt~~Y~A 188 (506)
.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ........||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 78999999999999999999999999999999999999999999999865433211 012244679999999
Q ss_pred cccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCC
Q 044076 189 PELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVP 268 (506)
Q Consensus 189 PE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~ 268 (506)
||++.+ ..++.++|||||||++|+|++|..++. +....+........+
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~------------------------- 292 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFP------------------------- 292 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCC-------------------------
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCC-------------------------
Confidence 999987 689999999999999999999876542 111111111111100
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 269 FSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 269 ~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
..++..++++.+||.+||+.||.+|||++| +|+||||+++
T Consensus 293 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------------------~l~~~~f~~~ 332 (332)
T 3qd2_B 293 --LLFTQKYPQEHMMVQDMLSPSPTERPEATD------------------IIENAIFENL 332 (332)
T ss_dssp --HHHHHHCHHHHHHHHHHHCSSGGGSCCHHH------------------HHHSTTCCCC
T ss_pred --cccccCChhHHHHHHHHccCCCCcCCCHHH------------------HhhchhhhcC
Confidence 111235678899999999999999999999 8999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=386.06 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=222.0
Q ss_pred CCCCCEEEe-EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcC
Q 044076 11 GEASQYEIQ-EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 11 ~~~~rY~i~-~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~ 88 (506)
...++|.+. +.||+|+||+||+|.+..+++.||||+++...........+.+|+.+++.+. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~---- 100 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN---- 100 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe----
Confidence 345689998 8999999999999999999999999999765555555677899999999996 7999999999843
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC---CCCEEEeecC
Q 044076 89 EFKDIYVVFELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA---DCKLKICDFG 162 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~---~~~lKL~DFG 162 (506)
...+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 101 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 101 -TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp -SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred -CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 4789999999985 898888543 57999999999999999999999999999999999999998 7899999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+.
T Consensus 180 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 253 (327)
T 3lm5_A 180 MSRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS 253 (327)
T ss_dssp GCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred cccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence 9986433221 244679999999999987 7899999999999999999999999999887776666654433322
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
. ..++.+++.+.+||.+||+.||.+|||++| +|+|
T Consensus 254 ~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~------------------ll~h 288 (327)
T 3lm5_A 254 E---------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEI------------------CLSH 288 (327)
T ss_dssp T---------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHH------------------HTTC
T ss_pred c---------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHH------------------HhCC
Confidence 1 234568999999999999999999999999 8999
Q ss_pred cccCCCCC
Q 044076 323 PYFHGLAN 330 (506)
Q Consensus 323 P~f~~~~~ 330 (506)
|||+++..
T Consensus 289 ~~~~~~~~ 296 (327)
T 3lm5_A 289 SWLQQWDF 296 (327)
T ss_dssp GGGCCCCT
T ss_pred Hhhccccc
Confidence 99998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=395.51 Aligned_cols=257 Identities=29% Similarity=0.416 Sum_probs=213.7
Q ss_pred CCEEE--eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 14 SQYEI--QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 14 ~rY~i--~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
+.|.+ .+.||+|+||.||+|.+..+|+.||||+++. ........+.+|+.+|+.++||||+++++++.. .+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcc--cccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CC
Confidence 34555 6789999999999999999999999999964 233456778999999999999999999999844 37
Q ss_pred cEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE--CCCCCEEEeecCCcccc
Q 044076 92 DIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA--NADCKLKICDFGLARVS 167 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv--~~~~~lKL~DFGla~~~ 167 (506)
.+|+||||+++ +|.+.+... ..+++..+..++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 89999999974 898888654 469999999999999999999999999999999999999 56789999999999864
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|......+..
T Consensus 240 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~---- 309 (373)
T 2x4f_A 240 KPREK----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED---- 309 (373)
T ss_dssp CTTCB----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS----
T ss_pred CCccc----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh----
Confidence 33221 244579999999999977 78999999999999999999999999998888777777543322211
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
..++.+++++.+||.+||+.||.+|||+.| +|+||||++
T Consensus 310 -----------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e------------------~l~hp~~~~ 348 (373)
T 2x4f_A 310 -----------------------EEFQDISEEAKEFISKLLIKEKSWRISASE------------------ALKHPWLSD 348 (373)
T ss_dssp -----------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHH------------------HHHSHHHHC
T ss_pred -----------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHH------------------HhcCcCcCC
Confidence 223568999999999999999999999999 899999986
Q ss_pred C
Q 044076 328 L 328 (506)
Q Consensus 328 ~ 328 (506)
.
T Consensus 349 ~ 349 (373)
T 2x4f_A 349 H 349 (373)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=378.05 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=218.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+..+|+.||||+++.. .......+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 79 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TT 79 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc--cccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CC
Confidence 356899999999999999999999999999999999742 22234568899999999999999999999843 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE---CCCCCEEEeecCCcccc
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA---NADCKLKICDFGLARVS 167 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv---~~~~~lKL~DFGla~~~ 167 (506)
.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 8999999997 5999999888889999999999999999999999999999999999999 77899999999999753
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+......+
T Consensus 160 ~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------ 226 (304)
T 2jam_A 160 QNG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF------ 226 (304)
T ss_dssp CCB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC------
T ss_pred CCC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 221 1234569999999999987 789999999999999999999999998877666555553321111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
....++++++++.+||.+||+.||.+|||++| +|+||||++
T Consensus 227 ---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------------------~l~h~~~~~ 267 (304)
T 2jam_A 227 ---------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEK------------------ALSHPWIDG 267 (304)
T ss_dssp ---------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHH------------------HHTSHHHHS
T ss_pred ---------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHH------------------HhcCccccC
Confidence 01223568999999999999999999999999 899999987
Q ss_pred CC
Q 044076 328 LA 329 (506)
Q Consensus 328 ~~ 329 (506)
..
T Consensus 268 ~~ 269 (304)
T 2jam_A 268 NT 269 (304)
T ss_dssp SC
T ss_pred CC
Confidence 54
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=373.51 Aligned_cols=264 Identities=28% Similarity=0.406 Sum_probs=223.6
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.-...++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 86 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--- 86 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc---
Confidence 3456789999999999999999999999999999999996432 344556778899999999999999999999843
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 REFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+..|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 87 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 87 --NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 478999999998 59999998888899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 165 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------- 230 (294)
T 2rku_A 165 VEYDGE---RKKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------- 230 (294)
T ss_dssp CCSTTC---CBCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT---------
T ss_pred cccCcc---ccccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc---------
Confidence 432222 1244679999999999987 67899999999999999999999999887655444333210
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
.. .....+++.+.+||.+||+.||.+|||++| +|+||||.
T Consensus 231 -----------------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------------------ll~~~~~~ 270 (294)
T 2rku_A 231 -----------------EY-----SIPKHINPVAASLIQKMLQTDPTARPTINE------------------LLNDEFFT 270 (294)
T ss_dssp -----------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGG------------------GGGSHHHH
T ss_pred -----------------cC-----CCccccCHHHHHHHHHHcccChhhCcCHHH------------------HhhChhee
Confidence 00 111357899999999999999999999999 89999998
Q ss_pred CCCCC
Q 044076 327 GLANL 331 (506)
Q Consensus 327 ~~~~~ 331 (506)
+...+
T Consensus 271 ~~~~~ 275 (294)
T 2rku_A 271 SGYIP 275 (294)
T ss_dssp TSCCC
T ss_pred cCCcC
Confidence 75543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=383.52 Aligned_cols=284 Identities=30% Similarity=0.489 Sum_probs=229.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCC-cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC------cceeceeecC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTG-EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD------IVEIKHIMLP 84 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~-~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn------Iv~l~~v~~~ 84 (506)
..++|++++.||+|+||+||+|.+..++ ..||||+++. .......+.+|+.+++.+.|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 3589999999999999999999998877 6899999864 2344566788999999997665 8888887733
Q ss_pred CCcCCCCcEEEEEecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE------------
Q 044076 85 PCRREFKDIYVVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA------------ 150 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv------------ 150 (506)
.+.+|+||||++++|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 94 -----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 -----HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp -----TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred -----CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 47899999999999999887754 69999999999999999999999999999999999999
Q ss_pred -------CCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCC
Q 044076 151 -------NADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFP 223 (506)
Q Consensus 151 -------~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~ 223 (506)
+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 56789999999999763222 134579999999999987 689999999999999999999999999
Q ss_pred CCCchhhHHHHHhhcCCCChHHHhhhhhhH--------------HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhh
Q 044076 224 GRNVAHQLDLVTDLLGTPSAESIAGIRNEK--------------AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLA 289 (506)
Q Consensus 224 ~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~ 289 (506)
+.+..+++..+....|.++...+....... ...+...... ............++++.+||.+||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhc
Confidence 999999999999999988877655432211 0111111000 0000011112235689999999999
Q ss_pred cCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 290 FDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 290 ~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
.||.+|||+.| +|+||||+++..
T Consensus 320 ~dP~~Rpt~~e------------------~l~hp~f~~~~~ 342 (355)
T 2eu9_A 320 FDPAQRITLAE------------------ALLHPFFAGLTP 342 (355)
T ss_dssp SSTTTSCCHHH------------------HTTSGGGGGCCH
T ss_pred CChhhCcCHHH------------------HhcChhhcCCCh
Confidence 99999999999 899999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=386.35 Aligned_cols=272 Identities=24% Similarity=0.350 Sum_probs=217.7
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
-...++|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~- 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP- 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-
Confidence 345789999999999999999999999999999999996533 234456678899999999999999999998854311
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 89 EFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.....|+||||++ ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 1134699999997 599999998889999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+..
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 240 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS---- 240 (311)
T ss_dssp ---------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH----
T ss_pred cccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc----
Confidence 333222222344679999999999987 68999999999999999999999999988776655544332222111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
...+++++++.+||.+||+.||.+||++.+ +|.|+|++.
T Consensus 241 -----------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~------------------~l~~~l~~~ 279 (311)
T 3ork_A 241 -----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAA------------------EMRADLVRV 279 (311)
T ss_dssp -----------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHH------------------HHHHHHHHH
T ss_pred -----------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHH------------------HHHHHHHHH
Confidence 112458999999999999999999999999 899999875
Q ss_pred CC
Q 044076 328 LA 329 (506)
Q Consensus 328 ~~ 329 (506)
..
T Consensus 280 ~~ 281 (311)
T 3ork_A 280 HN 281 (311)
T ss_dssp HT
T ss_pred hc
Confidence 44
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=375.26 Aligned_cols=261 Identities=28% Similarity=0.470 Sum_probs=219.8
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC----hhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH----VSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~----~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
++|++++.||+|+||.||+|.+..+++.||+|+++..... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 5799999999999999999999999999999999643221 1235678899999999999999999999854
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC----CEEEeecCCc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC----KLKICDFGLA 164 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~----~lKL~DFGla 164 (506)
....|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 378999999996 69999998888899999999999999999999999999999999999999877 8999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........+
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T 3bhy_A 160 HKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE 233 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH
T ss_pred eeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch
Confidence 76433221 244569999999999977 689999999999999999999999999888776666664433222221
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcc
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPY 324 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~ 324 (506)
.++..++.+.+||.+||+.||.+|||+.| +|+|||
T Consensus 234 ---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~------------------~l~h~~ 268 (283)
T 3bhy_A 234 ---------------------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQ------------------SLEHSW 268 (283)
T ss_dssp ---------------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHH------------------HHHCHH
T ss_pred ---------------------------hcccCCHHHHHHHHHHccCCHhHCcCHHH------------------HHhCHH
Confidence 12457889999999999999999999999 899999
Q ss_pred cCCCCC
Q 044076 325 FHGLAN 330 (506)
Q Consensus 325 f~~~~~ 330 (506)
|+.+..
T Consensus 269 ~~~~~~ 274 (283)
T 3bhy_A 269 IKAIRR 274 (283)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=380.76 Aligned_cols=262 Identities=28% Similarity=0.413 Sum_probs=222.8
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
....++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 112 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED---- 112 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 345679999999999999999999999999999999996432 344566778899999999999999999999844
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 89 EFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.+.+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 113 -~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 113 -NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 478999999998 599999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
...... .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 192 ~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 256 (335)
T 2owb_A 192 EYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---------- 256 (335)
T ss_dssp CSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------
T ss_pred ccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC----------
Confidence 322221 244679999999999987 67899999999999999999999999887655544433211
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
.. .....+++.+.+||.+||+.||.+|||++| +|+||||..
T Consensus 257 ----------------~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e------------------ll~~~~~~~ 297 (335)
T 2owb_A 257 ----------------EY-----SIPKHINPVAASLIQKMLQTDPTARPTINE------------------LLNDEFFTS 297 (335)
T ss_dssp ----------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGG------------------GGGSHHHHT
T ss_pred ----------------CC-----CCCccCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCccccC
Confidence 00 111357899999999999999999999999 899999987
Q ss_pred CCC
Q 044076 328 LAN 330 (506)
Q Consensus 328 ~~~ 330 (506)
...
T Consensus 298 ~~~ 300 (335)
T 2owb_A 298 GYI 300 (335)
T ss_dssp SCC
T ss_pred CCc
Confidence 544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=375.12 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=199.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+..+|+.||||+++...........+.++...++.++||||+++++++.. .+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cC
Confidence 3578999999999999999999999999999999997543333334444455556888899999999999854 37
Q ss_pred cEEEEEecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 92 DIYVVFELMESDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..|+||||++++|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 8999999999998777754 56899999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccc--cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc-hhhHHHHHhhcCCCCh
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV-AHQLDLVTDLLGTPSA 243 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~--~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~-~~~l~~I~~~~g~p~~ 243 (506)
...... .....+|+.|+|||++.. ....++.++|||||||++|+|++|+.||.+... ...+..+...
T Consensus 160 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------ 229 (290)
T 3fme_A 160 LVDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE------ 229 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS------
T ss_pred cccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc------
Confidence 433221 133469999999999621 126789999999999999999999999976332 2222222110
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
.. .......+++++.+||.+||+.||.+|||+.| +|+||
T Consensus 230 --------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e------------------~l~hp 268 (290)
T 3fme_A 230 --------------------PS---PQLPADKFSAEFVDFTSQCLKKNSKERPTYPE------------------LMQHP 268 (290)
T ss_dssp --------------------CC---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHH------------------HTTSH
T ss_pred --------------------CC---CCcccccCCHHHHHHHHHHhhcChhhCcCHHH------------------HHhCc
Confidence 00 00112357899999999999999999999999 89999
Q ss_pred ccCCC
Q 044076 324 YFHGL 328 (506)
Q Consensus 324 ~f~~~ 328 (506)
||+..
T Consensus 269 ~f~~~ 273 (290)
T 3fme_A 269 FFTLH 273 (290)
T ss_dssp HHHHH
T ss_pred ccccC
Confidence 99863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=379.54 Aligned_cols=255 Identities=27% Similarity=0.483 Sum_probs=214.6
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEE
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIY 94 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~y 94 (506)
.|...+.||+|+||.||+|++..+|+.||||++... .......+.+|+.+++.++||||+++++++.. .+..|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT--TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEE
Confidence 488899999999999999999999999999999642 23345668899999999999999999999854 36799
Q ss_pred EEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCC
Q 044076 95 VVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173 (506)
Q Consensus 95 lV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~ 173 (506)
+||||+++ +|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 99999975 89888764 57999999999999999999999999999999999999999999999999999764332221
Q ss_pred cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhH
Q 044076 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253 (506)
Q Consensus 174 ~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~ 253 (506)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------------- 259 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP------------- 259 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 245679999999999987 68899999999999999999999999887766555444321100
Q ss_pred HHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.......+++.+.+||.+||+.||.+|||+.| +|+||||...
T Consensus 260 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e------------------ll~hp~~~~~ 301 (321)
T 2c30_A 260 ---------------KLKNSHKVSPVLRDFLERMLVRDPQERATAQE------------------LLDHPFLLQT 301 (321)
T ss_dssp ---------------CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH------------------HHTSGGGGGC
T ss_pred ---------------CcCccccCCHHHHHHHHHHccCChhhCcCHHH------------------HhcChhhccC
Confidence 00111347899999999999999999999999 8999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=402.79 Aligned_cols=255 Identities=16% Similarity=0.195 Sum_probs=202.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHH---HHhCCCCCcceec-------ee
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKL---LRMLKHPDIVEIK-------HI 81 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~i---L~~l~HpnIv~l~-------~v 81 (506)
.++|++.+.||+|+||+||+|++..+|+.||||++... .......+.+.+|+.+ |+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999999999999999999643 2344456778899954 5555799999998 44
Q ss_pred ecCCCc-------CCCC-----cEEEEEecCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCeeecC
Q 044076 82 MLPPCR-------REFK-----DIYVVFELMESDLDQVIKANDDLTP-------EHHQFFLYQLLRALKYIHSANVFHRD 142 (506)
Q Consensus 82 ~~~~~~-------~~~~-----~~ylV~E~~~~~L~~~i~~~~~ls~-------~~~~~i~~QIl~gL~yLH~~gIvHrD 142 (506)
+..... .+.+ ..|+||||++|+|.+++...+.+++ ..+..++.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 432210 0111 3889999999999999987655555 78888999999999999999999999
Q ss_pred CCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCC-----------CCCchhhhhhhhHH
Q 044076 143 LKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 211 (506)
Q Consensus 143 LKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~-----------~~s~~~DIWSlG~i 211 (506)
|||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+ . .|+.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999975221 1245567 99999999976 4 79999999999999
Q ss_pred HHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 044076 212 FAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFD 291 (506)
Q Consensus 212 l~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~D 291 (506)
+|+|++|+.||.+.+.......+ ....+.+++++.+||.+||+.|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWI-----------------------------------FRSCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHSSCCC------CCSGGG-----------------------------------GSSCCCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCcccccccchhhh-----------------------------------hhhccCCCHHHHHHHHHHcCCC
Confidence 99999999999775543322111 0122568999999999999999
Q ss_pred CCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 292 PKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 292 P~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
|.+|||+.| +|+||||+++.
T Consensus 348 p~~Rpt~~e------------------~l~hp~f~~~~ 367 (377)
T 3byv_A 348 KEDRLLPLQ------------------AMETPEYEQLR 367 (377)
T ss_dssp GGGCCCHHH------------------HHTSHHHHHHH
T ss_pred chhCCCHHH------------------HhhChHHHHHH
Confidence 999999999 89999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=374.08 Aligned_cols=259 Identities=23% Similarity=0.379 Sum_probs=219.6
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
-..++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD----- 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----
Confidence 34578999999999999999999999999999999985421 112234568899999999999999999999843
Q ss_pred CCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+.+|+||||+++ +|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 3789999999975 999999988889999999999999999999999999999999999999999999999999996533
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 166 ~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 229 (284)
T 2vgo_A 166 SLR-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL--------- 229 (284)
T ss_dssp SSC-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------
T ss_pred ccc-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc---------
Confidence 221 134578999999999987 6789999999999999999999999988776555444422100
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
...+.+++++.+||.+||+.||.+|||++| +|+||||+..
T Consensus 230 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------------------ll~h~~~~~~ 269 (284)
T 2vgo_A 230 ----------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKG------------------VMEHPWVKAN 269 (284)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHH------------------HHTCHHHHHH
T ss_pred ----------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHH------------------HhhCHHHHhh
Confidence 111357899999999999999999999999 8999999875
Q ss_pred CC
Q 044076 329 AN 330 (506)
Q Consensus 329 ~~ 330 (506)
..
T Consensus 270 ~~ 271 (284)
T 2vgo_A 270 SR 271 (284)
T ss_dssp CC
T ss_pred cc
Confidence 44
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=384.46 Aligned_cols=263 Identities=27% Similarity=0.368 Sum_probs=208.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCC--CCcceeceeecCCCcCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH--PDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~H--pnIv~l~~v~~~~~~~~ 89 (506)
..++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.++| |||+++++++..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----- 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----- 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----
Confidence 467899999999999999999987 568999999997554555666788999999999986 999999999854
Q ss_pred CCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 90 FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
...+|+|||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 37899999988889999999999999999999999999999999999999999999999996 67899999999976433
Q ss_pred CCCCcccccccccCCcccCccccccc---------CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch-hhHHHHHhhcC
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA-HQLDLVTDLLG 239 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~---------~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~-~~l~~I~~~~g 239 (506)
... .......+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+.... ..+..+..
T Consensus 160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--- 235 (343)
T 3dbq_A 160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--- 235 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---
T ss_pred ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc---
Confidence 221 1122456799999999998531 156899999999999999999999999764321 11111110
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLA 319 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~a 319 (506)
..... ......++++.+||.+||+.||.+|||+.| +
T Consensus 236 -----------------------~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e------------------~ 271 (343)
T 3dbq_A 236 -----------------------PNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPE------------------L 271 (343)
T ss_dssp -----------------------TTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHH------------------H
T ss_pred -----------------------CCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHH------------------H
Confidence 00000 111235678999999999999999999999 8
Q ss_pred ccCcccCCCC
Q 044076 320 LADPYFHGLA 329 (506)
Q Consensus 320 L~HP~f~~~~ 329 (506)
|+||||+...
T Consensus 272 l~hp~~~~~~ 281 (343)
T 3dbq_A 272 LAHPYVQIQT 281 (343)
T ss_dssp HTSHHHHSCC
T ss_pred HhCccccccC
Confidence 9999998543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=385.74 Aligned_cols=256 Identities=26% Similarity=0.372 Sum_probs=216.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.. .+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 3569999999999999999999999999999999964322 23345678899999999999999999999854 37
Q ss_pred cEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
..|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 128 ~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 128 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred eEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 8999999999999988864 567999999999999999999999999999999999999999999999999999764221
Q ss_pred CCCcccccccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
...+||+.|+|||++.+ ....++.++|||||||++|+|++|++||.+.+....+..+..... |
T Consensus 208 -------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~-------- 271 (348)
T 1u5q_A 208 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P-------- 271 (348)
T ss_dssp -------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C--------
T ss_pred -------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-C--------
Confidence 34579999999999853 125789999999999999999999999988776655544432110 0
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
......+++.+.+||.+||+.||.+|||+++ +|+||||..
T Consensus 272 --------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~------------------ll~h~~~~~ 311 (348)
T 1u5q_A 272 --------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV------------------LLKHRFVLR 311 (348)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH------------------HTTCHHHHS
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHH------------------HhhChhhhc
Confidence 0112357899999999999999999999999 899999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=393.77 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=204.6
Q ss_pred CCCCEEEe-EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHH-HhCCCCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQ-EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL-RMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~-~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL-~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
..++|.+. +.||+|+||+||+|.+..+|+.||||+++. ...+.+|+.++ +..+||||+++++++.... .+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cC
Confidence 45678887 799999999999999999999999999863 13466899887 4557999999999874311 22
Q ss_pred CCcEEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC---CCCEEEeecCC
Q 044076 90 FKDIYVVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA---DCKLKICDFGL 163 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~---~~~lKL~DFGl 163 (506)
...+|+||||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 3679999999975 9999998754 5999999999999999999999999999999999999998 78999999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchh----hHHHHHhhcC
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAH----QLDLVTDLLG 239 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~----~l~~I~~~~g 239 (506)
++...... ..+..+||++|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+... ....|.. |
T Consensus 211 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~--~ 282 (400)
T 1nxk_A 211 AKETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--G 282 (400)
T ss_dssp CEECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--T
T ss_pred ccccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--C
Confidence 98643221 1345679999999999977 789999999999999999999999998765432 1111111 0
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLA 319 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~a 319 (506)
.... ....++.+++++.+||.+||+.||.+|||+.| +
T Consensus 283 ------------------------~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e------------------i 319 (400)
T 1nxk_A 283 ------------------------QYEF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE------------------F 319 (400)
T ss_dssp ------------------------CCCC-CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHH------------------H
T ss_pred ------------------------cccC-CCcccccCCHHHHHHHHHHCCCChhHCcCHHH------------------H
Confidence 0000 11234578999999999999999999999999 8
Q ss_pred ccCcccCCCC
Q 044076 320 LADPYFHGLA 329 (506)
Q Consensus 320 L~HP~f~~~~ 329 (506)
|+||||.+..
T Consensus 320 l~hp~~~~~~ 329 (400)
T 1nxk_A 320 MNHPWIMQST 329 (400)
T ss_dssp HHSHHHHTTT
T ss_pred hcCccccCCC
Confidence 9999998643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=419.24 Aligned_cols=259 Identities=21% Similarity=0.373 Sum_probs=222.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~ 89 (506)
..++|+++++||+|+||.||+|.+..+++.||||++++.. ........+.+|..+|..+ .||||+.+++++. +
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-----~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-----C
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-----e
Confidence 3578999999999999999999999999999999996421 1223455678999999988 5999999999984 3
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+.+||||||++ ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 478999999997 5999999988899999999999999999999999999999999999999999999999999998533
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|.....
T Consensus 494 ~~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------- 559 (674)
T 3pfq_A 494 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------- 559 (674)
T ss_dssp CTTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---------
T ss_pred cCCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 2222 2356789999999999987 7899999999999999999999999999888777777643111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----hhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA-----EEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa-----~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
...+.+++++.+||++||+.||.+||++ +| +++||
T Consensus 560 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~e------------------i~~h~ 599 (674)
T 3pfq_A 560 ----------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERD------------------IKEHA 599 (674)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHH------------------HHSSG
T ss_pred ----------------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHH------------------HhcCc
Confidence 1113589999999999999999999998 88 89999
Q ss_pred ccCCCC
Q 044076 324 YFHGLA 329 (506)
Q Consensus 324 ~f~~~~ 329 (506)
||+++.
T Consensus 600 ff~~i~ 605 (674)
T 3pfq_A 600 FFRYID 605 (674)
T ss_dssp GGSSCC
T ss_pred cccCCC
Confidence 999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=370.85 Aligned_cols=265 Identities=29% Similarity=0.443 Sum_probs=220.8
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-------ChhHHHHHHHHHHHHHhCC-CCCcceeceee
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-------HVSDATRILREIKLLRMLK-HPDIVEIKHIM 82 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-------~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~ 82 (506)
+..++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 456899999999999999999999999999999999964321 1123456789999999996 99999999998
Q ss_pred cCCCcCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeec
Q 044076 83 LPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 83 ~~~~~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DF 161 (506)
.. ....|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 94 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ET-----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp EC-----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cc-----CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 43 478999999998 599999998888999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccc----cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhh
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDL 237 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~----~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~ 237 (506)
|++........ .....+|+.|+|||++.+ ....++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 169 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99976433221 245678999999999852 1256889999999999999999999999887766655555332
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~ 317 (506)
...+. ...++.+++.+.+||.+||+.||.+|||+.|
T Consensus 245 ~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~----------------- 280 (298)
T 1phk_A 245 NYQFG---------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE----------------- 280 (298)
T ss_dssp CCCCC---------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH-----------------
T ss_pred CcccC---------------------------cccccccCHHHHHHHHHHccCCcccCCCHHH-----------------
Confidence 21111 1122457899999999999999999999999
Q ss_pred hhccCcccCCCC
Q 044076 318 LALADPYFHGLA 329 (506)
Q Consensus 318 ~aL~HP~f~~~~ 329 (506)
+|+||||++..
T Consensus 281 -ll~h~~~~~~~ 291 (298)
T 1phk_A 281 -ALAHPFFQQYV 291 (298)
T ss_dssp -HTTSGGGCTTC
T ss_pred -HHhChHhhhcc
Confidence 89999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=384.05 Aligned_cols=259 Identities=28% Similarity=0.481 Sum_probs=218.2
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC------hhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH------VSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~------~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 5799999999999999999999999999999998643211 11245678999999999 79999999999843
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
....|+||||+++ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 172 ---~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 172 ---SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp ---SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ---CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 4789999999985 999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCccccccc----CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~----~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
....... .....||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+.+....+..+......+
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 6433221 2456799999999998531 1358899999999999999999999998887766666664433222
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
.... +++.++.+.+||.+||+.||.+|||+.| +|+
T Consensus 325 ~~~~---------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e------------------ll~ 359 (365)
T 2y7j_A 325 SSPE---------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQ------------------ALQ 359 (365)
T ss_dssp CHHH---------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHH------------------HHH
T ss_pred CCcc---------------------------cccCCHHHHHHHHHHcCCChhHCcCHHH------------------Hhc
Confidence 2211 2357889999999999999999999999 899
Q ss_pred CcccC
Q 044076 322 DPYFH 326 (506)
Q Consensus 322 HP~f~ 326 (506)
||||+
T Consensus 360 hp~f~ 364 (365)
T 2y7j_A 360 HPFFE 364 (365)
T ss_dssp SGGGC
T ss_pred CcccC
Confidence 99997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=374.71 Aligned_cols=270 Identities=23% Similarity=0.409 Sum_probs=219.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc--cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF--EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
.++|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.+++.++||||+++++++... +.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 578999999999999999999999999999999996421 1223456788999999999999999999998542 23
Q ss_pred CcEEEEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELMESDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..+|+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 67999999999888888876 3569999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
..... .......+|..|+|||++.+....++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----------- 228 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----------- 228 (305)
T ss_dssp TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----------
Confidence 22211 122455799999999998763234578999999999999999999999887755544444221
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.. .....+++.+.+||.+||+.||.+|||++| +++||||+..
T Consensus 229 ---------------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~------------------ll~~~~~~~~ 270 (305)
T 2wtk_C 229 ---------------SY-----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQ------------------IRQHSWFRKK 270 (305)
T ss_dssp ---------------CC-----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHH------------------HHHSHHHHSC
T ss_pred ---------------CC-----CCCCccCHHHHHHHHHHccCChhhCCCHHH------------------HhcCcccccC
Confidence 00 112357899999999999999999999999 8999999987
Q ss_pred CCCCCCC
Q 044076 329 ANLEEEP 335 (506)
Q Consensus 329 ~~~~~~~ 335 (506)
......+
T Consensus 271 ~~~~~~~ 277 (305)
T 2wtk_C 271 HPPAEAP 277 (305)
T ss_dssp CCC-CCC
T ss_pred CCCcCCC
Confidence 6554443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=411.40 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=216.8
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
...++|+++++||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----- 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----- 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----
Confidence 34578999999999999999999999999999999995421 122334567899999999999999999999844
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+.+|+||||++ |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 478999999997 59999998754 499999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 336 ~~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~--------- 400 (576)
T 2acx_A 336 VPEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------- 400 (576)
T ss_dssp CCTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH---------
T ss_pred cccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH---------
Confidence 433221 245689999999999987 67999999999999999999999999876532222222110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
+... +. .....+++++.+||.+||+.||.+|| |++| +++
T Consensus 401 -----------i~~~----~~---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~e------------------il~ 444 (576)
T 2acx_A 401 -----------VKEV----PE---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSARE------------------VKE 444 (576)
T ss_dssp -----------HHHC----CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHH------------------HHT
T ss_pred -----------hhcc----cc---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHH------------------HHh
Confidence 0000 00 11245899999999999999999999 7899 899
Q ss_pred CcccCCCC
Q 044076 322 DPYFHGLA 329 (506)
Q Consensus 322 HP~f~~~~ 329 (506)
||||+++.
T Consensus 445 HpfF~~i~ 452 (576)
T 2acx_A 445 HPLFKKLN 452 (576)
T ss_dssp SGGGTTCC
T ss_pred ChhhccCC
Confidence 99999753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=394.47 Aligned_cols=260 Identities=32% Similarity=0.512 Sum_probs=205.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc------ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE------HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~------~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 4789999999999999999999999999999999964221 11222347899999999999999999999732
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC---CEEEeecC
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC---KLKICDFG 162 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~---~lKL~DFG 162 (506)
...|+||||+++ +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 458999999975 9999988888999999999999999999999999999999999999997654 59999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHH-HHHhhcCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLD-LVTDLLGT 240 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~-~I~~~~g~ 240 (506)
+|+...... .....+||+.|+|||++.+ ....|+.++|||||||++|+|++|++||.+......+. .+......
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence 998643221 2245679999999999853 12578899999999999999999999998765443332 22221111
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
+.+ ..++.+++.+.+||.+||+.||.+|||++| +|
T Consensus 364 ~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e------------------~l 398 (419)
T 3i6u_A 364 FIP---------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEE------------------AL 398 (419)
T ss_dssp CCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHH------------------HH
T ss_pred CCc---------------------------hhhcccCHHHHHHHHHHccCChhHCcCHHH------------------Hh
Confidence 111 122458899999999999999999999999 89
Q ss_pred cCcccCC
Q 044076 321 ADPYFHG 327 (506)
Q Consensus 321 ~HP~f~~ 327 (506)
+||||++
T Consensus 399 ~hp~~~~ 405 (419)
T 3i6u_A 399 RHPWLQD 405 (419)
T ss_dssp HSGGGCC
T ss_pred CCcccCC
Confidence 9999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=370.47 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=192.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----S 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----S
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----C
Confidence 3468999999999999999999999999999999995321 112234678899999999999999999999844 3
Q ss_pred CcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
+..|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 789999999974 999999875 579999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 164 ~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 226 (278)
T 3cok_A 164 MPHE---KHYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------ 226 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred CCCC---cceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence 2211 1234568999999999987 6789999999999999999999999987664433322210
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.. ......+++++.+||.+||+.||.+|||+++ +|+||||.+.
T Consensus 227 --------------~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------------------~l~h~~~~~~ 269 (278)
T 3cok_A 227 --------------AD-----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSS------------------VLDHPFMSRN 269 (278)
T ss_dssp --------------SC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHH------------------HTTSTTTC--
T ss_pred --------------cc-----cCCccccCHHHHHHHHHHcccCHhhCCCHHH------------------HhcCccccCC
Confidence 00 0111347899999999999999999999999 8999999864
Q ss_pred C
Q 044076 329 A 329 (506)
Q Consensus 329 ~ 329 (506)
.
T Consensus 270 ~ 270 (278)
T 3cok_A 270 S 270 (278)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=390.55 Aligned_cols=262 Identities=27% Similarity=0.367 Sum_probs=209.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC--CCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK--HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~--HpnIv~l~~v~~~~~~~~~ 90 (506)
..+|++++.||+|+||+||+|.+.. ++.||||++............+.+|+.+|+.+. ||||+++++++...
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~----- 128 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 128 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----
Confidence 3569999999999999999999865 899999999754445566778999999999997 59999999988543
Q ss_pred CcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 91 KDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+.+|+|||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 6799999987889999999988999999999999999999999999999999999999995 689999999999864332
Q ss_pred CCCcccccccccCCcccCccccccc---------CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch-hhHHHHHhhcCC
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA-HQLDLVTDLLGT 240 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~---------~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~-~~l~~I~~~~g~ 240 (506)
.. .......+||+.|+|||++.+. ...|+.++||||||||+|+|++|++||.+.... ..+..+..
T Consensus 208 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~---- 282 (390)
T 2zmd_A 208 TT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---- 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC----
T ss_pred Cc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC----
Confidence 21 1122456799999999998641 136899999999999999999999999765422 22222211
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
...... .....++++.+||.+||+.||.+|||+.| +|
T Consensus 283 ----------------------~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~e------------------ll 319 (390)
T 2zmd_A 283 ----------------------PNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPE------------------LL 319 (390)
T ss_dssp ----------------------TTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHH------------------HH
T ss_pred ----------------------ccccCC---CCccchHHHHHHHHHHcccChhhCCCHHH------------------Hh
Confidence 000111 11234788999999999999999999999 89
Q ss_pred cCcccCCCC
Q 044076 321 ADPYFHGLA 329 (506)
Q Consensus 321 ~HP~f~~~~ 329 (506)
+||||+...
T Consensus 320 ~hp~~~~~~ 328 (390)
T 2zmd_A 320 AHPYVQIQT 328 (390)
T ss_dssp TSHHHHSCC
T ss_pred hCcCccccC
Confidence 999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=368.32 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=208.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||.||+|.+..+++.||||+++...........+.+|+.++..+ +||||+++++++.. .+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CC
Confidence 3689999999999999999999999999999999976555556677889999999999 89999999999844 37
Q ss_pred cEEEEEecCCC-CHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-------------
Q 044076 92 DIYVVFELMES-DLDQVIKAN----DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD------------- 153 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~----~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~------------- 153 (506)
.+|+||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 89999999975 999999764 679999999999999999999999999999999999999844
Q ss_pred ------CCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc
Q 044076 154 ------CKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV 227 (506)
Q Consensus 154 ------~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~ 227 (506)
..+||+|||++...... ....+|+.|+|||++.+. ..++.++|||||||++|+|++|.+++.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred cccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 47999999999764322 223589999999999762 4677899999999999999999988754321
Q ss_pred hhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhh
Q 044076 228 AHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIV 307 (506)
Q Consensus 228 ~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~ 307 (506)
...+.. . ......+.+++++.+||.+||+.||.+|||+.|
T Consensus 237 ---~~~~~~---------------------------~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------- 276 (289)
T 1x8b_A 237 ---WHEIRQ---------------------------G---RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMA------- 276 (289)
T ss_dssp ---HHHHHT---------------------------T---CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH-------
T ss_pred ---HHHHHc---------------------------C---CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHH-------
Confidence 111110 0 011122468899999999999999999999999
Q ss_pred hhHHHHHhhhhhccCcccCCC
Q 044076 308 FNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 308 ~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+|+||||.+.
T Consensus 277 -----------ll~h~~~~~~ 286 (289)
T 1x8b_A 277 -----------LVKHSVLLSA 286 (289)
T ss_dssp -----------HHTCTTC---
T ss_pred -----------HhhChHhhhh
Confidence 8999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=372.28 Aligned_cols=254 Identities=27% Similarity=0.329 Sum_probs=206.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++. +.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----ED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eC
Confidence 4679999999999999999999999999999999985432 34455678899999999999999999999984 34
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+.+|+||||+++ +|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 789999999975 9999999888999999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.... .|..
T Consensus 164 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~------ 232 (294)
T 4eqm_A 164 TSL--TQTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VPNV------ 232 (294)
T ss_dssp -------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CCCH------
T ss_pred ccc--cccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CCCc------
Confidence 211 11234579999999999987 678999999999999999999999998877655433332110 0100
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
.....+++++.+.++|.+||+.||.+||+..+
T Consensus 233 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~ 264 (294)
T 4eqm_A 233 -------------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQ 264 (294)
T ss_dssp -------------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHH
T ss_pred -------------------chhcccCCCHHHHHHHHHHhcCCHhHccccHH
Confidence 01223568899999999999999999995444
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=383.15 Aligned_cols=288 Identities=23% Similarity=0.343 Sum_probs=226.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-----------CCCcceece
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-----------HPDIVEIKH 80 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-----------HpnIv~l~~ 80 (506)
..++|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.+++.+. ||||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35799999999999999999999999999999999863 3344566789999998886 899999999
Q ss_pred eecCCCcCCCCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEEC------
Q 044076 81 IMLPPCRREFKDIYVVFELMESDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILAN------ 151 (506)
Q Consensus 81 v~~~~~~~~~~~~ylV~E~~~~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~------ 151 (506)
++.... .+...+++|||+++++|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+|||++
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 986431 122478999999988999999874 4599999999999999999999998 999999999999994
Q ss_pred CCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-----
Q 044076 152 ADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN----- 226 (506)
Q Consensus 152 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~----- 226 (506)
.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4457999999999764322 234579999999999987 679999999999999999999999998765
Q ss_pred -chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCC-------------CCCCCCCHHHHHHHHHhhhcCC
Q 044076 227 -VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFS-------------HKFPGADPLALRLLQRLLAFDP 292 (506)
Q Consensus 227 -~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~s~~~~dLI~~mL~~DP 292 (506)
..+++..+...+|.++...+...... ..++............ ...+..++++.+||.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchh--hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 56778888899999887765432211 1111110000000000 0112346789999999999999
Q ss_pred CCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 293 KDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 293 ~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
.+|||++| +|+||||++....
T Consensus 323 ~~Rpt~~e------------------ll~hp~f~~~~~~ 343 (373)
T 1q8y_A 323 RKRADAGG------------------LVNHPWLKDTLGM 343 (373)
T ss_dssp TTCBCHHH------------------HHTCGGGTTCTTC
T ss_pred cccCCHHH------------------HhhChhhhcccCc
Confidence 99999999 8999999986543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=367.94 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=214.8
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.. .+..
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence 67999999999999999999999999999999986422 23445678899999999999999999999843 3788
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||+++ +|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999985 9999988777899999999999999999999999999999999999999999999999999976432221
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhH-HHHHhhcCCCChHHHhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL-DLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l-~~I~~~~g~p~~e~~~~~~~ 251 (506)
........+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..... ..+...
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 224 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-------------- 224 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT--------------
T ss_pred -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc--------------
Confidence 1112456789999999999762 33478999999999999999999999876543221 111100
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
......++.+++.+.+||.+||+.||.+|||++| +++||||++..
T Consensus 225 ---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------------------il~~~~~~~~~ 269 (276)
T 2yex_A 225 ---------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPD------------------IKKDRWYNKPL 269 (276)
T ss_dssp ---------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH------------------HTTCTTTTCCC
T ss_pred ---------------ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHH------------------HhcCccccChh
Confidence 0001122457899999999999999999999999 89999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=367.94 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=208.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----P 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence 3579999999999999999999999999999999986421 122335578899999999999999999999844 3
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+..|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 78999999997 59999998888899999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. ......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 164 ~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 228 (276)
T 2h6d_A 164 GE----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF--------- 228 (276)
T ss_dssp -----------------CCTGGGTT--SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred Cc----ceecccCCccccCHHHHcC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---------
Confidence 21 1234568999999999977 444 6899999999999999999999987765544444321100
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.....+++.+.+||.+||+.||.+|||+.| +++||||++.
T Consensus 229 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~------------------~l~h~~~~~~ 268 (276)
T 2h6d_A 229 ----------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKD------------------IREHEWFKQD 268 (276)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH------------------HHHSHHHHTT
T ss_pred ----------------------cCchhcCHHHHHHHHHHccCChhhCCCHHH------------------HHhChhhccC
Confidence 011346889999999999999999999999 8999999763
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=371.40 Aligned_cols=261 Identities=31% Similarity=0.518 Sum_probs=219.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. ...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCe
Confidence 468999999999999999999999999999999997554444566778999999999999999999999844 378
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC---CCEEEeecCCccccc
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD---CKLKICDFGLARVSF 168 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~---~~lKL~DFGla~~~~ 168 (506)
+|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999997 5999999887889999999999999999999999999999999999999764 469999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .....+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......+.
T Consensus 176 ~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 242 (287)
T 2wei_A 176 QNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------ 242 (287)
T ss_dssp CCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred CCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 3221 234568999999999875 489999999999999999999999998876665555533211110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
...++.+++++.+||.+||+.||.+|||+.| +|+||||++.
T Consensus 243 ---------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e------------------ll~hp~~~~~ 283 (287)
T 2wei_A 243 ---------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQ------------------CLEHPWIQKY 283 (287)
T ss_dssp ---------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHH------------------HHHSHHHHHH
T ss_pred ---------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHH------------------HhcCHHHhcc
Confidence 0122457899999999999999999999999 8999999875
Q ss_pred CC
Q 044076 329 AN 330 (506)
Q Consensus 329 ~~ 330 (506)
..
T Consensus 284 ~~ 285 (287)
T 2wei_A 284 SS 285 (287)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=384.27 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=210.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC------hhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH------VSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~------~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
.++|++++.||+|+||.||+|++..+++.||||+++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 46899999999999999999999999999999999653211 1133456789999999999999999999843
Q ss_pred cCCCCcEEEEEecCC-C-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 87 RREFKDIYVVFELME-S-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
.+.+|+||||+. + +|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 478999999985 4 99999998889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
+....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+....
T Consensus 178 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 178 AYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp EECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred eECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 76433222 245679999999999987 444 88999999999999999999999652210
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
..... .....+++++.+||.+||+.||.+|||++| +|+||
T Consensus 237 -----------------~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~e------------------ll~hp 276 (335)
T 3dls_A 237 -----------------VEAAI-----HPPYLVSKELMSLVSGLLQPVPERRTTLEK------------------LVTDP 276 (335)
T ss_dssp -----------------TTTCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHH------------------HHHCT
T ss_pred -----------------Hhhcc-----CCCcccCHHHHHHHHHHccCChhhCcCHHH------------------HhcCc
Confidence 00000 111247899999999999999999999999 89999
Q ss_pred ccCCC
Q 044076 324 YFHGL 328 (506)
Q Consensus 324 ~f~~~ 328 (506)
||++.
T Consensus 277 ~~~~~ 281 (335)
T 3dls_A 277 WVTQP 281 (335)
T ss_dssp TTTCC
T ss_pred cccCC
Confidence 99863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=382.90 Aligned_cols=285 Identities=21% Similarity=0.317 Sum_probs=219.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+..+++.||+|++... ........+.+|+.+|+.++||||+++++++.. .+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 104 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG 104 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TT
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CC
Confidence 457899999999999999999999999999999999643 234556778999999999999999999999854 37
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+|+||||+++ +|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 89999999975 9999999888899999999999999999999996 999999999999999999999999999965322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhc-CCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL-GTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~-g~p~~e~~~~ 248 (506)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... +.+.......
T Consensus 185 ~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 SM-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HC---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cc-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 21 234579999999999987 789999999999999999999999998877655433332111 1111100000
Q ss_pred hh--------------hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHH
Q 044076 249 IR--------------NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLY 314 (506)
Q Consensus 249 ~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~ 314 (506)
.. .......+.......... .....+++++.+||.+||+.||.+|||++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e-------------- 321 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQ-------------- 321 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHH--------------
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHH--------------
Confidence 00 000011111111111111 111347899999999999999999999999
Q ss_pred hhhhhccCcccCCCC
Q 044076 315 FYVLALADPYFHGLA 329 (506)
Q Consensus 315 ~~~~aL~HP~f~~~~ 329 (506)
+|+||||++..
T Consensus 322 ----ll~hp~~~~~~ 332 (360)
T 3eqc_A 322 ----LMVHAFIKRSD 332 (360)
T ss_dssp ----HHTSHHHHHHH
T ss_pred ----HhhChHhhcch
Confidence 89999998744
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=402.26 Aligned_cols=263 Identities=23% Similarity=0.325 Sum_probs=214.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|+++++||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. .
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----K 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----C
Confidence 3578999999999999999999999999999999996422 122334668899999999999999999999844 4
Q ss_pred CcEEEEEecCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 91 KDIYVVFELME-SDLDQVIKAN----DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~----~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
..+|+||||++ ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 78999999998 5999998764 369999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
....... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+..
T Consensus 338 ~~~~~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~--------- 403 (543)
T 3c4z_A 338 ELKAGQT---KTKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--------- 403 (543)
T ss_dssp ECCTTCC---CBCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---------
T ss_pred eccCCCc---ccccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---------
Confidence 6433221 1244689999999999987 7899999999999999999999999987643211111110
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----hhhhhhhhhhhHHHHHhhhhhc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA-----EEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa-----~eL~~~~~~~~~~~~~~~~~aL 320 (506)
.. ..... ...+.+++++.+||.+||+.||.+||++ ++ ++
T Consensus 404 ----------~i---~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~e------------------i~ 447 (543)
T 3c4z_A 404 ----------RV---LEQAV-----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDG------------------LR 447 (543)
T ss_dssp ----------HH---HHCCC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHH------------------HH
T ss_pred ----------HH---hhccc-----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHH------------------HH
Confidence 00 00000 1114689999999999999999999964 67 79
Q ss_pred cCcccCCCC
Q 044076 321 ADPYFHGLA 329 (506)
Q Consensus 321 ~HP~f~~~~ 329 (506)
.||||+++.
T Consensus 448 ~Hpff~~i~ 456 (543)
T 3c4z_A 448 THPLFRDIS 456 (543)
T ss_dssp TSGGGTTCC
T ss_pred cCccccCCC
Confidence 999998753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.32 Aligned_cols=260 Identities=33% Similarity=0.518 Sum_probs=209.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc------ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE------HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~------~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 4689999999999999999999999999999999964211 11223457899999999999999999999843
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC---EEEeecC
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK---LKICDFG 162 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~---lKL~DFG 162 (506)
...|+||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 87 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp ----SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred ----CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 348999999975 99999988889999999999999999999999999999999999999987665 9999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhH-HHHHhhcCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL-DLVTDLLGT 240 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l-~~I~~~~g~ 240 (506)
+++..... .......||+.|+|||++.+ ....++.++|||||||++|+|++|.+||.+......+ ..+......
T Consensus 163 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp TCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred cceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 99764221 11234579999999999742 1257899999999999999999999999876544332 222221111
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
..+ ..++.+++.+.+||.+||+.||.+|||+.| +|
T Consensus 239 ~~~---------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~------------------~l 273 (322)
T 2ycf_A 239 FIP---------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEE------------------AL 273 (322)
T ss_dssp CCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHH------------------HH
T ss_pred cCc---------------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHH------------------Hh
Confidence 111 112457899999999999999999999999 89
Q ss_pred cCcccCC
Q 044076 321 ADPYFHG 327 (506)
Q Consensus 321 ~HP~f~~ 327 (506)
+||||++
T Consensus 274 ~h~~~~~ 280 (322)
T 2ycf_A 274 RHPWLQD 280 (322)
T ss_dssp TSGGGCC
T ss_pred hCcCcCC
Confidence 9999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=370.16 Aligned_cols=266 Identities=23% Similarity=0.360 Sum_probs=213.9
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.....++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 87 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYH---- 87 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee----
Confidence 345678999999999999999999999999999999998642 33445678899999999999999999999854
Q ss_pred CCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+.+|+||||+++ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 88 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 88 -DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp -C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred -CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 3689999999975 89888865 56799999999999999999999999999999999999999999999999999754
Q ss_pred ccCCCCCcccccccccCCcccCcccccc---cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~---~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
...... ......+|..|+|||++.. ....++.++|||||||++|+|++|.+||.+.+....+..+......
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 240 (302)
T 2j7t_A 167 NLKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP--- 240 (302)
T ss_dssp HHHHHH---C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---
T ss_pred cccccc---ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc---
Confidence 211100 1134568999999999831 1267899999999999999999999999887765554444221100
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
.......+++.+.+||.+||+.||.+|||+.| +++||
T Consensus 241 -------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~------------------ll~h~ 277 (302)
T 2j7t_A 241 -------------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ------------------LLEHP 277 (302)
T ss_dssp -------------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHH------------------HTTST
T ss_pred -------------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHH------------------HhcCh
Confidence 00111347889999999999999999999999 89999
Q ss_pred ccCCCCC
Q 044076 324 YFHGLAN 330 (506)
Q Consensus 324 ~f~~~~~ 330 (506)
||+++..
T Consensus 278 ~~~~~~~ 284 (302)
T 2j7t_A 278 FVSSITS 284 (302)
T ss_dssp TTTTCCC
T ss_pred HHhhhcc
Confidence 9997653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=385.70 Aligned_cols=270 Identities=17% Similarity=0.148 Sum_probs=194.8
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhC--CCCCcceec-------eeec
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRML--KHPDIVEIK-------HIML 83 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l--~HpnIv~l~-------~v~~ 83 (506)
..|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999975433 234455677785544444 699988755 3332
Q ss_pred CCCcC------------CCCcEEEEEecCCCCHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHhCCeeecCCC
Q 044076 84 PPCRR------------EFKDIYVVFELMESDLDQVIKAND-DLTPEHH------QFFLYQLLRALKYIHSANVFHRDLK 144 (506)
Q Consensus 84 ~~~~~------------~~~~~ylV~E~~~~~L~~~i~~~~-~ls~~~~------~~i~~QIl~gL~yLH~~gIvHrDLK 144 (506)
..... ....+|+||||++++|.+++...+ .+.+... ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 22110 014589999999999999998643 3444444 5777999999999999999999999
Q ss_pred CCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Q 044076 145 PKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG 224 (506)
Q Consensus 145 p~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~ 224 (506)
|+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+....|+.++|||||||++|+|++|+.||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999864221 124567799999999965335789999999999999999999999987
Q ss_pred CCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhh
Q 044076 225 RNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFT 304 (506)
Q Consensus 225 ~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~ 304 (506)
......- .+.... ..............+++++.+.+||.+||+.||.+|||+.|
T Consensus 296 ~~~~~~~-------------~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e---- 349 (371)
T 3q60_A 296 VTPGIKG-------------SWKRPS---------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE---- 349 (371)
T ss_dssp CCTTCTT-------------CCCBCC---------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHH----
T ss_pred cCccccc-------------chhhhh---------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHH----
Confidence 6432100 000000 00000001111223578999999999999999999999999
Q ss_pred hhhhhHHHHHhhhhhccCcccCCCC
Q 044076 305 EIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 305 ~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
+|+||||+++.
T Consensus 350 --------------~l~hp~f~~~~ 360 (371)
T 3q60_A 350 --------------AMETPEFLQLQ 360 (371)
T ss_dssp --------------HTTSHHHHHHH
T ss_pred --------------HhcCHHHHHHH
Confidence 89999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=372.42 Aligned_cols=274 Identities=27% Similarity=0.404 Sum_probs=195.6
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 85 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK----- 85 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-----
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----
Confidence 45689999999999999999999999999999999986421 223456688999999999999999999998543
Q ss_pred CcEEEEEecCC-CCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeec
Q 044076 91 KDIYVVFELME-SDLDQVIKA--------NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~--------~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DF 161 (506)
+..|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 67999999996 599999874 456999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCC--CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcC
Q 044076 162 GLARVSFTDTP--SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 162 Gla~~~~~~~~--~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g 239 (506)
|++........ .........+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..... +
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~ 242 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--N 242 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--S
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--c
Confidence 99975432211 11112345799999999998652 4689999999999999999999999988776554433321 1
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLA 319 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~a 319 (506)
.+.... .........+.+++++.+||.+||+.||.+|||+.| +
T Consensus 243 ~~~~~~-------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------------------l 285 (303)
T 2vwi_A 243 DPPSLE-------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE------------------L 285 (303)
T ss_dssp SCCCTT-------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHH------------------H
T ss_pred CCCccc-------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHH------------------H
Confidence 110000 000112334568899999999999999999999999 8
Q ss_pred ccCcccCCCCC
Q 044076 320 LADPYFHGLAN 330 (506)
Q Consensus 320 L~HP~f~~~~~ 330 (506)
++||||+....
T Consensus 286 l~h~~~~~~~~ 296 (303)
T 2vwi_A 286 LRHKFFQKAKN 296 (303)
T ss_dssp HTSTTC-----
T ss_pred hhChhhhcCCC
Confidence 99999997654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=384.15 Aligned_cols=265 Identities=24% Similarity=0.376 Sum_probs=212.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccc--cChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVF--EHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|++++.||+|+||.||+|++. .+++.||||+++... ........+.+|+.+|+.+ .||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 369999999999999999999984 589999999996422 1222334567899999999 59999999998843
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
...+|+||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 131 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ---ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp ---TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred ---CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 3789999999985 999999988889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
....... ......+||+.|+|||++.+....++.++|||||||++|+|++|+.||...........+...
T Consensus 208 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-------- 277 (355)
T 1vzo_A 208 EFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-------- 277 (355)
T ss_dssp ECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--------
T ss_pred ecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH--------
Confidence 5432211 122456799999999999753356889999999999999999999999765543322222110
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL 320 (506)
.. .... ...+.+++.+.+||.+||+.||.+|| |++| ++
T Consensus 278 -----------~~---~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~e------------------ll 320 (355)
T 1vzo_A 278 -----------IL---KSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE------------------IK 320 (355)
T ss_dssp -----------HH---HCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHH------------------HH
T ss_pred -----------Hh---ccCC-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHH------------------HH
Confidence 00 0001 12245789999999999999999999 9999 89
Q ss_pred cCcccCCCC
Q 044076 321 ADPYFHGLA 329 (506)
Q Consensus 321 ~HP~f~~~~ 329 (506)
+||||+.+.
T Consensus 321 ~h~~f~~~~ 329 (355)
T 1vzo_A 321 EHLFFQKIN 329 (355)
T ss_dssp TSGGGTTCC
T ss_pred cCcchhcCC
Confidence 999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=369.84 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=201.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||+|+||+||+|.+ +|+.||||++............+.+|+.+|+.++||||+++++++.. ..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 356899999999999999999976 68899999997655555666788999999999999999999999843 36
Q ss_pred cEEEEEecCCC-CHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 92 DIYVVFELMES-DLDQVIKANDD---LTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~---ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.+|+||||+++ +|.+++...+. +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 78999999975 99999987653 999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 188 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----- 257 (309)
T 3p86_A 188 LKASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR----- 257 (309)
T ss_dssp -----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred ccccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----
Confidence 5322211 1245679999999999987 67899999999999999999999999887765544443211111
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+.+++++.+||.+||+.||.+|||+.+|
T Consensus 258 ------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 289 (309)
T 3p86_A 258 ------------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATI 289 (309)
T ss_dssp ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 01224688999999999999999999999995
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=369.97 Aligned_cols=266 Identities=23% Similarity=0.377 Sum_probs=211.5
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCc-
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCR- 87 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~- 87 (506)
-...++|++++.||+|+||.||+|.+..+|+.||||++... ......+.+|+.+++.+ .||||+++++++.....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC---cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 35678999999999999999999999999999999998642 22345678999999999 69999999999865321
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 88 REFKDIYVVFELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
.....+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 124679999999986 999999875 47999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
........ ......+|+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 177 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--- 250 (326)
T 2x7f_A 177 AQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--- 250 (326)
T ss_dssp C----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---
T ss_pred eecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---
Confidence 75432211 12345799999999998621 1568899999999999999999999998776554443332110
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
.. ....+.+++.+.+||.+||..||.+|||+.+ +|+
T Consensus 251 ------------------------~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~------------------ll~ 286 (326)
T 2x7f_A 251 ------------------------AP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQ------------------LMK 286 (326)
T ss_dssp ------------------------CC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHH------------------HHT
T ss_pred ------------------------cc--cCCccccCHHHHHHHHHHhccChhhCCCHHH------------------Hhh
Confidence 00 0112457899999999999999999999999 899
Q ss_pred CcccCCC
Q 044076 322 DPYFHGL 328 (506)
Q Consensus 322 HP~f~~~ 328 (506)
||||++.
T Consensus 287 hp~~~~~ 293 (326)
T 2x7f_A 287 HPFIRDQ 293 (326)
T ss_dssp SHHHHCC
T ss_pred ChHHhhC
Confidence 9999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=364.22 Aligned_cols=261 Identities=31% Similarity=0.444 Sum_probs=216.8
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence 35799999999999999999999999999999999975444556677899999999999999999999987532 236
Q ss_pred cEEEEEecCCC-CHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCCCcEEECCCCCEEEeec
Q 044076 92 DIYVVFELMES-DLDQVIKAN----DDLTPEHHQFFLYQLLRALKYIHSAN-----VFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~----~~ls~~~~~~i~~QIl~gL~yLH~~g-----IvHrDLKp~NILv~~~~~lKL~DF 161 (506)
.+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 79999999985 999998753 34999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
|+++...... .......+|..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 161 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-- 233 (279)
T 2w5a_A 161 GLARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-- 233 (279)
T ss_dssp CHHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--
T ss_pred chheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc--
Confidence 9997643221 11234578999999999987 6899999999999999999999999988765544444422100
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
......+++++.+||.+||+.||.+|||+.| +|+
T Consensus 234 ----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~------------------ll~ 267 (279)
T 2w5a_A 234 ----------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEE------------------ILE 267 (279)
T ss_dssp ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH------------------HHT
T ss_pred ----------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHH------------------HHh
Confidence 0112357899999999999999999999999 899
Q ss_pred CcccCCC
Q 044076 322 DPYFHGL 328 (506)
Q Consensus 322 HP~f~~~ 328 (506)
|+|+.+-
T Consensus 268 ~~~~~~~ 274 (279)
T 2w5a_A 268 NPLILEH 274 (279)
T ss_dssp STTCCGG
T ss_pred Chhhhhh
Confidence 9999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=371.50 Aligned_cols=278 Identities=21% Similarity=0.348 Sum_probs=207.9
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||+||+|.+..+++.||||+++... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 81 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TT 81 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CC
Confidence 45689999999999999999999999999999999996432 123356678999999999999999999998543 23
Q ss_pred CcEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE----CCCCCEEEeecC
Q 044076 91 KDIYVVFELME-SDLDQVIKAND---DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA----NADCKLKICDFG 162 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~---~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv----~~~~~lKL~DFG 162 (506)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 57899999997 59999998644 39999999999999999999999999999999999999 778889999999
Q ss_pred CcccccCCCCCcccccccccCCcccCccccccc------CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch-hhHHHHH
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA-HQLDLVT 235 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~------~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~-~~l~~I~ 235 (506)
+++....... .....||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.... .....+.
T Consensus 162 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 162 AARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 9986433322 2456799999999998520 267899999999999999999999999754432 2222222
Q ss_pred hhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFS-HKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 236 ~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
.+++..+...+..+...... .+.-....+.. .....+++.+.+||.+||+.||.+|||++|
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENG----PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTC----CEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred HHhcCCCcccchhhhcccCC----ccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence 22222222211111100000 00000000100 111234567899999999999999999999
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=367.28 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=210.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CC
Confidence 457899999999999999999999999999999999642 234568899999999999999999999854 37
Q ss_pred cEEEEEecCCC-CHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELMES-DLDQVIK-ANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~-~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+|+||||+++ +|.+++. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 89999999986 9999987 456899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 242 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP---------- 242 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC----------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC----------
Confidence 211 1244578999999999987 6789999999999999999999999987665444333211100
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
+.......+++.+.+||.+||+.||.+|||+.+ +|+||||++..
T Consensus 243 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~------------------ll~~~~~~~~~ 286 (314)
T 3com_A 243 ------------------PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ------------------LLQHPFVRSAK 286 (314)
T ss_dssp ------------------CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHH------------------HTTSHHHHTCC
T ss_pred ------------------cccCCcccCCHHHHHHHHHHccCChhhCcCHHH------------------HHhCHHHhcCC
Confidence 000111246889999999999999999999999 89999998744
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=370.43 Aligned_cols=276 Identities=22% Similarity=0.317 Sum_probs=200.1
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCc---EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
....++|++++.||+|+||.||+|.+..++. .||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3456799999999999999999999887775 8999999765445566778999999999999999999999986542
Q ss_pred c-CCCCcEEEEEecCCC-CHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEE
Q 044076 87 R-REFKDIYVVFELMES-DLDQVIKAND------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKI 158 (506)
Q Consensus 87 ~-~~~~~~ylV~E~~~~-~L~~~i~~~~------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL 158 (506)
. ......|+||||+.+ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence 1 111235999999985 9999986532 5999999999999999999999999999999999999999999999
Q ss_pred eecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhh
Q 044076 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDL 237 (506)
Q Consensus 159 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~ 237 (506)
+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 179 ~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 179 ADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp CCCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred eeccccccccccccc-cccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 999999764332211 11233456788999999987 689999999999999999999 99999988776665554321
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYV 317 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~ 317 (506)
.. ....+.+++++.+||.+||+.||.+|||+.+|+ + ...
T Consensus 256 ~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~-----~------~l~ 294 (323)
T 3qup_A 256 NR------------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR-----M------ELE 294 (323)
T ss_dssp CC------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH-----H------HHH
T ss_pred CC------------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHH-----H------HHH
Confidence 11 012246889999999999999999999988841 1 122
Q ss_pred hhccCcccCCCC
Q 044076 318 LALADPYFHGLA 329 (506)
Q Consensus 318 ~aL~HP~f~~~~ 329 (506)
.++.|||+....
T Consensus 295 ~~l~~~~~~~~~ 306 (323)
T 3qup_A 295 NILGHLSVLSTS 306 (323)
T ss_dssp HHHHC-------
T ss_pred HHHHHhhhcCCC
Confidence 388999998743
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=370.19 Aligned_cols=252 Identities=26% Similarity=0.360 Sum_probs=208.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCc---EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
..++|++.+.||+|+||.||+|.+..+++ .||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR---- 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 46799999999999999999999986655 5999999743 234556778999999999999999999999843
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+..|+||||+++ +|.++++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 122 -GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp -GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred -CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 4678999999975 999999765 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
...............+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---- 274 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---- 274 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC----
T ss_pred cccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC----
Confidence 5443322222334456788999999977 689999999999999999999 999998887766655553321111
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+++.+.+||.+||..||.+|||+.||
T Consensus 275 --------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ei 304 (325)
T 3kul_A 275 --------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQI 304 (325)
T ss_dssp --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHH
Confidence 123578999999999999999999999995
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=363.10 Aligned_cols=258 Identities=25% Similarity=0.354 Sum_probs=216.8
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 92 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----D 92 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----C
Confidence 34568999999999999999999999999999999996432 23446778899999999999999999999854 3
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+||||+++ +|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 689999999985 99998864 5799999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 172 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 234 (303)
T 3a7i_A 172 TQI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN------------ 234 (303)
T ss_dssp TBC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred ccc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC------------
Confidence 221 1245679999999999987 67899999999999999999999999876654443333110
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
.. ......+++.+.+||.+||+.||.+|||+.| +|+||||...
T Consensus 235 ---------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~------------------ll~~~~~~~~ 277 (303)
T 3a7i_A 235 ---------------NP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKE------------------LLKHKFILRN 277 (303)
T ss_dssp ---------------CC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHH------------------HTTCHHHHHH
T ss_pred ---------------CC---CCCccccCHHHHHHHHHHcCCChhhCcCHHH------------------HhhChhhhcC
Confidence 00 1122467899999999999999999999999 8999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=373.20 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=207.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-------CCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-------HTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLP 84 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-------~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~ 84 (506)
.++|++++.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 468999999999999999999875 34568999999653 2344567789999999999 79999999999843
Q ss_pred CCcCCCCcEEEEEecCCC-CHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 044076 85 PCRREFKDIYVVFELMES-DLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKN 147 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~~-~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~N 147 (506)
.+.+|+||||+++ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 4779999999985 9999998753 48999999999999999999999999999999999
Q ss_pred EEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCC
Q 044076 148 ILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN 226 (506)
Q Consensus 148 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~ 226 (506)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999864332211 11234567889999999987 789999999999999999999 999998877
Q ss_pred chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 227 VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 227 ~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+....+..... ......+++++.+||.+||+.||.+|||+.||
T Consensus 311 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 355 (370)
T 2psq_A 311 VEELFKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 355 (370)
T ss_dssp GGGHHHHHHTTCC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHhcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 6655544422110 01123578999999999999999999999995
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=369.29 Aligned_cols=265 Identities=25% Similarity=0.404 Sum_probs=192.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHH-HHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIK-LLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~-iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++++.||+|+||.||+|.+..+|+.||||+++... .......+.+|+. +++.++||||+++++++.. .
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~ 93 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----E 93 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----S
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----C
Confidence 3589999999999999999999999999999999996532 2334455666776 6777899999999999854 3
Q ss_pred CcEEEEEecCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 91 KDIYVVFELMESDLDQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~-----~~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
+..|+||||++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 78999999999999888864 56799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccc--cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~--~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
+....... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.+... ..+....
T Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~---- 243 (327)
T 3aln_A 174 GQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVV---- 243 (327)
T ss_dssp CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCC----
T ss_pred eecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHh----
Confidence 76433221 233469999999999832 11568999999999999999999999997644211 1110000
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
............+.+++.+.+||.+||+.||.+|||+.| +|+|
T Consensus 244 -------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e------------------ll~h 286 (327)
T 3aln_A 244 -------------------KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE------------------LLKH 286 (327)
T ss_dssp -------------------CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHH------------------HTTS
T ss_pred -------------------cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHH------------------HHhC
Confidence 000000011223468999999999999999999999999 8999
Q ss_pred cccCCCC
Q 044076 323 PYFHGLA 329 (506)
Q Consensus 323 P~f~~~~ 329 (506)
|||....
T Consensus 287 p~~~~~~ 293 (327)
T 3aln_A 287 PFILMYE 293 (327)
T ss_dssp HHHHHHH
T ss_pred hHHHHhH
Confidence 9998643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=359.42 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=202.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC------
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC------ 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~------ 86 (506)
.++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4579999999999999999999999999999999853 2345667889999999999999999999875421
Q ss_pred --cCCCCcEEEEEecCCC-CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecC
Q 044076 87 --RREFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG 162 (506)
Q Consensus 87 --~~~~~~~ylV~E~~~~-~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFG 162 (506)
......+|+||||+++ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 1234679999999975 9999998654 68899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCC-----------CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCchhh
Q 044076 163 LARVSFTDTP-----------SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG-RNVAHQ 230 (506)
Q Consensus 163 la~~~~~~~~-----------~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~-~~~~~~ 230 (506)
+++....... .........+|+.|+|||++.+. ..++.++|||||||++|+|++ ||.. .+..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9976432110 01122456799999999998762 478999999999999999998 4432 222222
Q ss_pred HHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhh
Q 044076 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPF-SHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFN 309 (506)
Q Consensus 231 l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~ 309 (506)
+..+... ...+ .......++.+.+||.+||+.||.+|||+.+
T Consensus 238 ~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~--------- 280 (303)
T 1zy4_A 238 LKKLRSV----------------------------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGART--------- 280 (303)
T ss_dssp HHHHHST----------------------------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHH---------
T ss_pred HHhcccc----------------------------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHH---------
Confidence 2222110 0011 1122456788999999999999999999999
Q ss_pred HHHHHhhhhhccCcccCC
Q 044076 310 WLFLYFYVLALADPYFHG 327 (506)
Q Consensus 310 ~~~~~~~~~aL~HP~f~~ 327 (506)
+|+||||..
T Consensus 281 ---------ll~h~~~~~ 289 (303)
T 1zy4_A 281 ---------LLNSGWLPV 289 (303)
T ss_dssp ---------HHHSSCSCC
T ss_pred ---------HhCCCCcCC
Confidence 899999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=373.01 Aligned_cols=273 Identities=18% Similarity=0.293 Sum_probs=214.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChh---------------HHHHHHHHHHHHHhCCCCCcce
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVS---------------DATRILREIKLLRMLKHPDIVE 77 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~---------------~~~~~~rEi~iL~~l~HpnIv~ 77 (506)
.++|++++.||+|+||.||+|.+ +|+.||||++........ ....+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47999999999999999999998 899999999964221111 1167889999999999999999
Q ss_pred eceeecCCCcCCCCcEEEEEecCCC-CHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCc
Q 044076 78 IKHIMLPPCRREFKDIYVVFELMES-DLDQV------IKA--NDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKN 147 (506)
Q Consensus 78 l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~------i~~--~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~N 147 (506)
+++++.. .+.+|+||||+++ +|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999854 3789999999986 99888 655 5679999999999999999999999 999999999999
Q ss_pred EEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCc-hhhhhhhhHHHHHHHhCCCCCCCCC
Q 044076 148 ILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGRPLFPGRN 226 (506)
Q Consensus 148 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~-~~DIWSlG~il~eLl~G~~pF~~~~ 226 (506)
|+++.++.+||+|||++...... ......+|..|+|||++.+. ..++. ++|||||||++|+|++|+.||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999764332 22456799999999999872 25666 9999999999999999999998877
Q ss_pred c-hhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhh
Q 044076 227 V-AHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305 (506)
Q Consensus 227 ~-~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~ 305 (506)
. .+....+.......+... ... . ............+.+++++.+||.+||+.||.+|||+.|
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~-~~~--------~---~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e----- 319 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDR-NHF--------L---YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED----- 319 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSS-SSS--------T---TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHH-----
T ss_pred cHHHHHHHHhccCcCCccch-hhh--------h---ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHH-----
Confidence 6 555554432211111000 000 0 000000011122568999999999999999999999999
Q ss_pred hhhhHHHHHhhhhhccCcccCCC
Q 044076 306 IVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 306 ~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
+|+||||++.
T Consensus 320 -------------~l~hp~f~~~ 329 (348)
T 2pml_X 320 -------------ALKHEWLADT 329 (348)
T ss_dssp -------------HHTSGGGTTC
T ss_pred -------------HhcCccccCC
Confidence 8999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=363.53 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=195.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+..+|+.||||++............+.++..+++.++||||+++++++.. .+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CC
Confidence 4578999999999999999999999999999999996543333333444455567888899999999999854 37
Q ss_pred cEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSA-NVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~-gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+|+||||+++.+..+... ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 8999999997777766654 56799999999999999999999995 999999999999999999999999999975433
Q ss_pred CCCCcccccccccCCcccCcccccc---cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-chhhHHHHHhhcCCCChHH
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN-VAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~---~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~-~~~~l~~I~~~~g~p~~e~ 245 (506)
... .....+|+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.. ..+.+..+...
T Consensus 178 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 245 (318)
T 2dyl_A 178 DKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-------- 245 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS--------
T ss_pred Ccc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc--------
Confidence 221 234569999999999852 12568899999999999999999999997643 22333222110
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
..+......++++++.+||.+||+.||.+|||++| +|+||||
T Consensus 246 --------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~------------------ll~h~~~ 287 (318)
T 2dyl_A 246 --------------------EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK------------------LLEHSFI 287 (318)
T ss_dssp --------------------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHH------------------HTTSHHH
T ss_pred --------------------CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHH------------------HhhCHHH
Confidence 00111112358899999999999999999999999 8999999
Q ss_pred CCCC
Q 044076 326 HGLA 329 (506)
Q Consensus 326 ~~~~ 329 (506)
++..
T Consensus 288 ~~~~ 291 (318)
T 2dyl_A 288 KRYE 291 (318)
T ss_dssp HHHH
T ss_pred Hhcc
Confidence 8654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=376.45 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=204.3
Q ss_pred CCCEEEeEEEeecCceEEEEEE-----ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAI-----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~-----d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++|++++.||+|+||+||+|. +..++..||||+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 4789999999999999999999 5567889999999642 334555678899999999999999999999854
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC---CE
Q 044076 88 REFKDIYVVFELMES-DLDQVIKAND-------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC---KL 156 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~~~-------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~---~l 156 (506)
....|+||||+++ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 --SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred --CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 3678999999974 9999998643 599999999999999999999999999999999999999655 49
Q ss_pred EEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 044076 157 KICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVT 235 (506)
Q Consensus 157 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~ 235 (506)
||+|||+|+........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999753221111 11234568999999999987 689999999999999999998 999999888766665553
Q ss_pred hhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 236 ~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
..... .....+++.+.+||.+||+.||.+|||+.+
T Consensus 301 ~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 335 (367)
T 3l9p_A 301 SGGRM------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 335 (367)
T ss_dssp TTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCC------------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 32111 112357889999999999999999999999
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=368.78 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=207.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEE-----ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAI-----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPP 85 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~-----d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~ 85 (506)
..++|++++.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+|+.+ .||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 35799999999999999999998 5667799999999643 2334556789999999999 699999999998543
Q ss_pred CcCCCCcEEEEEecCCC-CHHHHHHhCCC---------------------------------------------------
Q 044076 86 CRREFKDIYVVFELMES-DLDQVIKANDD--------------------------------------------------- 113 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~-~L~~~i~~~~~--------------------------------------------------- 113 (506)
...+|+||||+++ +|.+++.....
T Consensus 99 ----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 99 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred ----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 3458999999985 99999986543
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccccc
Q 044076 114 ---------------LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT 178 (506)
Q Consensus 114 ---------------ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~ 178 (506)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 253 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 253 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC-
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhcc
Confidence 89999999999999999999999999999999999999999999999999976433222 12234
Q ss_pred ccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHH
Q 044076 179 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257 (506)
Q Consensus 179 ~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~ 257 (506)
...+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+.........+
T Consensus 254 ~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 315 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------- 315 (359)
T ss_dssp -CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------------
T ss_pred ccCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC----------------
Confidence 5678899999999987 789999999999999999998 999998877554433332211100
Q ss_pred HhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 258 LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+++++.+||.+||+.||.+|||+.||
T Consensus 316 -------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 346 (359)
T 3vhe_A 316 -------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 346 (359)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 1113478999999999999999999999994
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=357.78 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=204.0
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEE
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~yl 95 (506)
|.....||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 96 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKI 96 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEE
Confidence 34445999999999999999999999999999643 33445678899999999999999999999843 378999
Q ss_pred EEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-CCCEEEeecCCcccccCC
Q 044076 96 VFELME-SDLDQVIKAND---DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-DCKLKICDFGLARVSFTD 170 (506)
Q Consensus 96 V~E~~~-~~L~~~i~~~~---~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-~~~lKL~DFGla~~~~~~ 170 (506)
||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999997 59999998752 5679999999999999999999999999999999999987 899999999999764322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. ......+|+.|+|||++.+....++.++|||||||++|+|++|+.||.+............
T Consensus 177 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------- 239 (295)
T 2clq_A 177 NP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-------------- 239 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH--------------
T ss_pred CC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc--------------
Confidence 11 1234578999999999865223489999999999999999999999965432221100000
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
..... ......+++++.+||.+||+.||.+|||+.| +|+||||+...
T Consensus 240 ---------~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------------------ll~~~~~~~~~ 286 (295)
T 2clq_A 240 ---------MFKVH-----PEIPESMSAEAKAFILKCFEPDPDKRACAND------------------LLVDEFLKVSS 286 (295)
T ss_dssp ---------HHCCC-----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHH------------------HHTSGGGCC--
T ss_pred ---------ccccc-----ccccccCCHHHHHHHHHHccCChhhCCCHHH------------------HhcChhhhhcc
Confidence 00000 1122468899999999999999999999999 89999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=353.77 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=206.0
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||.||+|.+. +++.||||++.... .....+.+|+.+++.++||||+++++++.. .
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 77 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----Q 77 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 34579999999999999999999986 57789999997432 234568899999999999999999999843 4
Q ss_pred CcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...|+||||+++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence 679999999975 899999764 469999999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ........+|..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 158 ~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~------- 226 (269)
T 4hcu_A 158 DDQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------- 226 (269)
T ss_dssp CHH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------
T ss_pred ccc--cccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC-------
Confidence 221 111234457788999999977 689999999999999999999 99999888776655555322111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
......++.+.+||.+||+.||.+|||+.||
T Consensus 227 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 257 (269)
T 4hcu_A 227 -----------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRL 257 (269)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 0112468899999999999999999999994
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=359.94 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=206.9
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
-..++|++++.||+|+||+||+|.+..+++.||+|++.. ........+.+|+.+|+.++||||+++++++.. .
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 79 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----D 79 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----C
Confidence 346899999999999999999999999999999999854 345567788999999999999999999999854 3
Q ss_pred CcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELMES-DLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
+..|+||||+++ +|.++++. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 789999999975 99999987 5679999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCc-----------ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhh
Q 044076 169 TDTPSA-----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDL 237 (506)
Q Consensus 169 ~~~~~~-----------~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~ 237 (506)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||+..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---- 233 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---- 233 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----
Confidence 322111 01124679999999999987 7899999999999999999999999976432211000
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
......... ...+++++.+.+||.+||+.||.+|||+.+|
T Consensus 234 --------------~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 273 (310)
T 3s95_A 234 --------------LNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273 (310)
T ss_dssp --------------BCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --------------hhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 000011110 1124578889999999999999999999994
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=366.23 Aligned_cols=268 Identities=24% Similarity=0.375 Sum_probs=187.4
Q ss_pred cccCCCCCEEEeE-EEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 8 TEYGEASQYEIQE-IIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 8 ~~~~~~~rY~i~~-~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
..+...++|++++ +||+|+||+||+|.+..+|+.||||++... ... ..+....++.+.||||+++++++....
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 3456678999965 699999999999999999999999998631 111 222333467778999999999985421
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC---CCEEEee
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD---CKLKICD 160 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~---~~lKL~D 160 (506)
.+...+|+||||+++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|
T Consensus 96 -~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 96 -HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp -TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred -CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 123568999999986 9999998764 69999999999999999999999999999999999999864 5599999
Q ss_pred cCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCC
Q 044076 161 FGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240 (506)
Q Consensus 161 FGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~ 240 (506)
||+++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 175 fg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--- 244 (336)
T 3fhr_A 175 FGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR--- 244 (336)
T ss_dssp CTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred cccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh---
Confidence 99997543221 234568999999999976 68899999999999999999999999766543221111000
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
............+..+++++.+||.+||+.||.+|||++| +|
T Consensus 245 --------------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------------ll 286 (336)
T 3fhr_A 245 --------------------IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQ------------------FM 286 (336)
T ss_dssp --------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH------------------HH
T ss_pred --------------------hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHH------------------Hh
Confidence 0000000011233568999999999999999999999999 89
Q ss_pred cCcccCCCCC
Q 044076 321 ADPYFHGLAN 330 (506)
Q Consensus 321 ~HP~f~~~~~ 330 (506)
+||||++...
T Consensus 287 ~hp~~~~~~~ 296 (336)
T 3fhr_A 287 NHPWINQSMV 296 (336)
T ss_dssp HSHHHHTGGG
T ss_pred cCcccccccc
Confidence 9999987543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=359.57 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=208.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
..++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--
Confidence 3579999999999999999999984 45689999999643 344556778999999999999999999999843
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDD------------------------LTPEHHQFFLYQLLRALKYIHSANVFHR 141 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~------------------------ls~~~~~~i~~QIl~gL~yLH~~gIvHr 141 (506)
.+.+|+||||++ ++|.+++..... +++..+..++.||+.||+|||++||+||
T Consensus 98 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 98 ---DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred ---CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 477999999998 699999987543 8999999999999999999999999999
Q ss_pred CCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCC
Q 044076 142 DLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRP 220 (506)
Q Consensus 142 DLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~ 220 (506)
||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchheEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999764332211 11234457888999999987 679999999999999999999 999
Q ss_pred CCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 221 LFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 221 pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
||.+.+.......+..... ....+.+++.+.+||.+||+.||.+|||+.|
T Consensus 252 p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHR------------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHhhcCCc------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9988776555444422110 1122468899999999999999999999999
Q ss_pred h
Q 044076 301 I 301 (506)
Q Consensus 301 L 301 (506)
|
T Consensus 302 l 302 (314)
T 2ivs_A 302 I 302 (314)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.51 Aligned_cols=256 Identities=18% Similarity=0.247 Sum_probs=206.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.+ .|+||+++++++. +.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~ 78 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EG 78 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ET
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC----CccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CC
Confidence 467899999999999999999999999999999998642 2223477899999999 6999999999873 34
Q ss_pred CcEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC-----EEEeecCCc
Q 044076 91 KDIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK-----LKICDFGLA 164 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~-----lKL~DFGla 164 (506)
...|+||||++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 7899999999889999998754 5999999999999999999999999999999999999988776 999999999
Q ss_pred ccccCCCCCc----ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCC
Q 044076 165 RVSFTDTPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240 (506)
Q Consensus 165 ~~~~~~~~~~----~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~ 240 (506)
+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~- 235 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE- 235 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH-
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh-
Confidence 8644332211 11245679999999999987 6799999999999999999999999988653322222211000
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ....+.....+++++++.+||.+||+.||.+|||+++|
T Consensus 236 -------------------~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l 274 (298)
T 1csn_A 236 -------------------K---KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 274 (298)
T ss_dssp -------------------H---HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred -------------------h---ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHH
Confidence 0 00011112234688999999999999999999999995
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=359.58 Aligned_cols=269 Identities=22% Similarity=0.372 Sum_probs=205.0
Q ss_pred CCCCEEEeEEEeecCceEEEEEE----ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 12 EASQYEIQEIIGIGSYGVVASAI----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~----d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..++|++++.||+|+||+||+|+ +..+++.||||++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 83 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-- 83 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH--
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 46899999999999999999998 677899999999964 3445567789999999999999999999998542
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
+...+|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 84 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 84 -GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp -HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred -CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 2256899999996 59999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
................+|..|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-----HHHHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChH-----HHHhhhcCccccc
Confidence 65433222222234557788999999987 6899999999999999999999998854321 1111222221111
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. .......+......+ ....+++++.+||.+||+.||.+|||+.||
T Consensus 236 ~~------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el 282 (295)
T 3ugc_A 236 MI------VFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282 (295)
T ss_dssp HH------HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hh------HHHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 00 011111122211111 224688999999999999999999999995
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=358.99 Aligned_cols=264 Identities=27% Similarity=0.355 Sum_probs=207.5
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC--CCCcceeceeecCCCcC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK--HPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~--HpnIv~l~~v~~~~~~~ 88 (506)
...++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+++.++ ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~---- 99 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT---- 99 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC----
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec----
Confidence 34568999999999999999999985 5889999999654445566778899999999997 5999999999854
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...+|+|||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 100 -~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 100 -DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp -SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred -CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 36799999988889999999988999999999999999999999999999999999999996 5899999999997643
Q ss_pred CCCCCcccccccccCCcccCccccccc---------CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch-hhHHHHHhhc
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA-HQLDLVTDLL 238 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~---------~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~-~~l~~I~~~~ 238 (506)
..... .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ..+..+.
T Consensus 178 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~--- 253 (313)
T 3cek_A 178 PDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 253 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---
T ss_pred Ccccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH---
Confidence 32211 112345789999999998641 136889999999999999999999999764322 1111111
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVL 318 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~ 318 (506)
...... ......++++.+||.+||+.||.+|||+.|
T Consensus 254 -----------------------~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~e------------------ 289 (313)
T 3cek_A 254 -----------------------DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPE------------------ 289 (313)
T ss_dssp -----------------------CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHH------------------
T ss_pred -----------------------hccccc---CCcccchHHHHHHHHHHccCCcccCcCHHH------------------
Confidence 000011 111345788999999999999999999999
Q ss_pred hccCcccCCCC
Q 044076 319 ALADPYFHGLA 329 (506)
Q Consensus 319 aL~HP~f~~~~ 329 (506)
+|+||||+...
T Consensus 290 ll~h~~~~~~~ 300 (313)
T 3cek_A 290 LLAHPYVQIQT 300 (313)
T ss_dssp HHTSHHHHCC-
T ss_pred HhcCccccCCC
Confidence 89999998643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=351.30 Aligned_cols=247 Identities=21% Similarity=0.322 Sum_probs=204.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+. ++..||||+++... .....+.+|+.+++.++||||+++++++. +..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCC
Confidence 4579999999999999999999775 67789999996432 23456889999999999999999999984 347
Q ss_pred cEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..|+||||++ ++|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 7999999997 58999998754 599999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 157 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 224 (268)
T 3sxs_A 157 DQY--VSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-------- 224 (268)
T ss_dssp TCE--EECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred hhh--hcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC--------
Confidence 221 11234456778999999977 678999999999999999998 99999887766555444221110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
......++.+.+||.+||+.||.+|||+.||
T Consensus 225 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 255 (268)
T 3sxs_A 225 ----------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQL 255 (268)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred ----------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0112368899999999999999999999994
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=366.19 Aligned_cols=276 Identities=22% Similarity=0.228 Sum_probs=211.6
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..+-..++|++++.||+|+||+||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 34456789999999999999999999864 799999998632 2334456679999999999999999999865321
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CeeecCCCCCcEEECCCCCE
Q 044076 88 REFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA----------NVFHRDLKPKNILANADCKL 156 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~----------gIvHrDLKp~NILv~~~~~l 156 (506)
....+|+||||+++ +|.++++.. .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+
T Consensus 93 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 93 -VDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp -SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred -CCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 13568999999975 999999874 599999999999999999999999 99999999999999999999
Q ss_pred EEeecCCcccccCCCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHH
Q 044076 157 KICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233 (506)
Q Consensus 157 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~ 233 (506)
||+|||+|+........ .......||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+......+..
T Consensus 171 kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 171 CIADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EECCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999764333221 122446799999999998752 12456789999999999999999999988776555444
Q ss_pred HHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP--GADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 234 I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+.|....+.... . .......+...++ ..++++.+||.+||+.||.+|||+.||
T Consensus 250 ~~~~~~~~~~~~~~~~~--------~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 309 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVV--------V--HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309 (322)
T ss_dssp HHHHCSSCCHHHHHHHH--------T--TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhhhccCCchhhhhhhh--------h--cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHH
Confidence 44445555544432211 0 0111111111111 134569999999999999999999995
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=360.88 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=204.6
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~ 89 (506)
...++|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----- 76 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC----- 76 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEec-----
Confidence 34689999999999999999999999999999999986421 123477999999999 89999999998843
Q ss_pred CCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC-----EEEeecCC
Q 044076 90 FKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK-----LKICDFGL 163 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~-----lKL~DFGl 163 (506)
....|+||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 77 GKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred CCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 378999999998899999987 467999999999999999999999999999999999999999887 99999999
Q ss_pred cccccCCCCCc----ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcC
Q 044076 164 ARVSFTDTPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 164 a~~~~~~~~~~----~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g 239 (506)
++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..+..
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 98643322111 01245679999999999987 7899999999999999999999999988654433322211100
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ...+...... ..+++.+||.+||+.||.+|||+++|
T Consensus 235 ------------~~-----------~~~~~~~~~~-~~p~~~~li~~~l~~~p~~RP~~~~l 272 (330)
T 2izr_A 235 ------------TK-----------RATPIEVLCE-NFPEMATYLRYVRRLDFFEKPDYDYL 272 (330)
T ss_dssp ------------HH-----------HHSCHHHHTT-TCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred ------------hh-----------ccCCHHHHhc-cChHHHHHHHHHHhCCCCCCCCHHHH
Confidence 00 0000000111 23389999999999999999999996
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=354.05 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=203.7
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||+||+|.+. ++..||||+++... .....+.+|+.+++.++||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 91 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----Q 91 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----C
Confidence 45679999999999999999999875 67789999997432 234568899999999999999999999843 4
Q ss_pred CcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..+|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 77999999996 599999986 4579999999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......+
T Consensus 172 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 241 (283)
T 3gen_A 172 DDEY--TSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------ 241 (283)
T ss_dssp CHHH--HSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC------
T ss_pred cccc--ccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC------
Confidence 2211 11233456788999999987 679999999999999999998 999998887766655553321111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....++.+.+||.+||+.||.+|||+.||
T Consensus 242 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 271 (283)
T 3gen_A 242 ------------------------RPHLASEKVYTIMYSCWHEKADERPTFKIL 271 (283)
T ss_dssp ------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred ------------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 112468899999999999999999999994
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=367.32 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=210.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh----hHHHHHHHHHHHHHhCC--CCCcceeceeecC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV----SDATRILREIKLLRMLK--HPDIVEIKHIMLP 84 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~l~--HpnIv~l~~v~~~ 84 (506)
...++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+. ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 35689999999999999999999999999999999996432211 12244668999999996 5999999999854
Q ss_pred CCcCCCCcEEEEEecCC--CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC-CCCCEEEeec
Q 044076 85 PCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN-ADCKLKICDF 161 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~--~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~-~~~~lKL~DF 161 (506)
.+..++|||++. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 120 -----~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 -----PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp -----SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred -----CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 378999999997 69999999888999999999999999999999999999999999999999 7899999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
|+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +..
T Consensus 195 g~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~----- 257 (320)
T 3a99_A 195 GSGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR----- 257 (320)
T ss_dssp TTCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-----
T ss_pred cccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc-----
Confidence 9997643321 2456799999999998762 3347899999999999999999999964311 100
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
.. . ...+.+++++.+||.+||+.||.+|||++| +++
T Consensus 258 ---------------------~~--~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------------------ll~ 293 (320)
T 3a99_A 258 ---------------------GQ--V---FFRQRVSSECQHLIRWCLALRPSDRPTFEE------------------IQN 293 (320)
T ss_dssp ---------------------CC--C---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHH------------------HHT
T ss_pred ---------------------cc--c---cccccCCHHHHHHHHHHccCChhhCcCHHH------------------Hhc
Confidence 00 0 112458899999999999999999999999 899
Q ss_pred CcccCCCC
Q 044076 322 DPYFHGLA 329 (506)
Q Consensus 322 HP~f~~~~ 329 (506)
||||++..
T Consensus 294 hp~~~~~~ 301 (320)
T 3a99_A 294 HPWMQDVL 301 (320)
T ss_dssp SGGGSSCC
T ss_pred CHhhcCcc
Confidence 99998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=353.78 Aligned_cols=254 Identities=24% Similarity=0.423 Sum_probs=213.2
Q ss_pred cccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 6 FFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 6 ~~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
|-..-...++|++.+.||+|+||.||+|.+..++..||||++.. .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 80 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR- 80 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence 33344567899999999999999999999999999999999964 33456778899999999999999999999843
Q ss_pred CcCCCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecC
Q 044076 86 CRREFKDIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG 162 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFG 162 (506)
...+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 81 ----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 81 ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp ----SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred ----CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCc
Confidence 477999999998 5999999874 359999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
++........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+......
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~- 231 (288)
T 3kfa_A 157 LSRLMTGDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM- 231 (288)
T ss_dssp GGGTSCSSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-
T ss_pred cceeccCCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC-
Confidence 9976433221 12234557888999999987 689999999999999999999 99999887766554444221110
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+.+++.+.+||.+||..||.+|||+.||
T Consensus 232 -----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~ 262 (288)
T 3kfa_A 232 -----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262 (288)
T ss_dssp -----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 1124578999999999999999999999995
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=353.45 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=198.5
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCC---CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHT---GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t---~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
...++|++.+.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---
Confidence 3457999999999999999999998754 457999998642 334556778899999999999999999999732
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 REFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
+..|+||||+++ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 88 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 ---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred ---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 568999999985 9999998654 69999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
........ ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~----- 235 (281)
T 1mp8_A 165 YMEDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----- 235 (281)
T ss_dssp ----------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----
T ss_pred ccCccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-----
Confidence 64332211 1133456788999999976 689999999999999999996 9999998877666555532110
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+++++.+.+||.+||+.||.+|||+.||
T Consensus 236 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 267 (281)
T 1mp8_A 236 -------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 267 (281)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 01224688999999999999999999999995
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.30 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=206.5
Q ss_pred CCCCCEEEeE-EEeecCceEEEEEE--ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 11 GEASQYEIQE-IIGIGSYGVVASAI--DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 11 ~~~~rY~i~~-~LG~G~~g~V~~a~--d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
...++|++.+ .||+|+||.||+|. +..+++.||||+++...........+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 88 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---- 88 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC----
Confidence 4467899998 99999999999995 4567889999999765444455678999999999999999999999982
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 REFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+..|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 89 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 89 --AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 256899999998 59999999988899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
...............+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------- 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------- 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------
T ss_pred eccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------
Confidence 4333222111233446788999999977 678999999999999999999 999998877655444432210
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ....+.+++.+.+||.+||+.||.+|||+.+|
T Consensus 238 --------------------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 270 (291)
T 1xbb_A 238 --------------------R---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 270 (291)
T ss_dssp --------------------C---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred --------------------C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 01124588999999999999999999999995
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.68 Aligned_cols=258 Identities=20% Similarity=0.293 Sum_probs=200.9
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECC---CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTH---TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~---t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
...++|++.+.||+|+||.||+|.+.. ++..||||+++...........+.+|+.+++.++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 446799999999999999999998765 56689999997554455667788999999999999999999999876533
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEee
Q 044076 88 REFKDIYVVFELMES-DLDQVIKA------NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICD 160 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~------~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~D 160 (506)
......|+||||+++ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 333467999999985 99999853 34699999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcC
Q 044076 161 FGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 161 FGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g 239 (506)
||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 191 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 191 FGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred cCcceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 9999764332211 11233457889999999987 789999999999999999999 9999988776655544432111
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ...+.+++.+.+||.+||+.||.+|||+.+|
T Consensus 268 ~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (313)
T 3brb_A 268 L------------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299 (313)
T ss_dssp C------------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred C------------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 1124578999999999999999999999995
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=366.37 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=208.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCC-------CcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeec
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHT-------GEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIML 83 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t-------~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~ 83 (506)
..++|++++.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+.+++.+ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 347999999999999999999997543 358999999653 3445567789999999999 8999999999984
Q ss_pred CCCcCCCCcEEEEEecCCC-CHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 044076 84 PPCRREFKDIYVVFELMES-DLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPK 146 (506)
Q Consensus 84 ~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~ 146 (506)
. .+.+|+||||+++ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 146 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 146 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp S-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred c-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 3 4678999999975 9999998754 4999999999999999999999999999999999
Q ss_pred cEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCC
Q 044076 147 NILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGR 225 (506)
Q Consensus 147 NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~ 225 (506)
|||++.++.+||+|||+|+........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999764332211 11234567889999999987 789999999999999999999 99999887
Q ss_pred CchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 226 NVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 226 ~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+..+....+..... ......+++++.+||.+||+.||.+|||+.||
T Consensus 298 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 343 (382)
T 3tt0_A 298 PVEELFKLLKEGHR------------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343 (382)
T ss_dssp CHHHHHHHHHTTCC------------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CHHHHHHHHHcCCC------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 76655444422110 01123578999999999999999999999995
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=362.30 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=207.6
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
...++|++++.||+|+||.||+|.+. .+++.||||+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV- 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-
Confidence 34579999999999999999999987 45689999999743 234456678999999999999999999999843
Q ss_pred CcCCCCcEEEEEecCCC-CHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeee
Q 044076 86 CRREFKDIYVVFELMES-DLDQVIKAN------------------------DDLTPEHHQFFLYQLLRALKYIHSANVFH 140 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~-~L~~~i~~~------------------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvH 140 (506)
.+.+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+|
T Consensus 122 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 122 ----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4779999999985 999999864 56999999999999999999999999999
Q ss_pred cCCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CC
Q 044076 141 RDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GR 219 (506)
Q Consensus 141 rDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~ 219 (506)
|||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCC
Confidence 999999999999999999999999754322111 11234568899999999987 679999999999999999999 99
Q ss_pred CCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh
Q 044076 220 PLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299 (506)
Q Consensus 220 ~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~ 299 (506)
.||.+.+..+....+.... . ....+.+++.+.+||.+||+.||.+|||+.
T Consensus 275 ~p~~~~~~~~~~~~~~~~~---------------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 324 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVRDGN---------------------------I---LACPENCPLELYNLMRLCWSKLPADRPSFC 324 (343)
T ss_dssp CTTTTSCHHHHHHHHHTTC---------------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CcCCCCChHHHHHHHhCCC---------------------------c---CCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 9998877655544442210 0 011235789999999999999999999999
Q ss_pred hh
Q 044076 300 EI 301 (506)
Q Consensus 300 eL 301 (506)
+|
T Consensus 325 ~~ 326 (343)
T 1luf_A 325 SI 326 (343)
T ss_dssp HH
T ss_pred HH
Confidence 95
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=358.26 Aligned_cols=253 Identities=28% Similarity=0.394 Sum_probs=199.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence 45799999999999999999999999999999999965332 33445778899999999999999999999843 3
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+.+|+||||+++ +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 789999999985 9999999888899999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.. .
T Consensus 187 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~----------- 250 (309)
T 2h34_A 187 EKL--TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-A----------- 250 (309)
T ss_dssp ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-C-----------
T ss_pred ccc--ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-C-----------
Confidence 211 11245679999999999987 6889999999999999999999999987654322221111 0
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-CHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-SAEEI 301 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-Ta~eL 301 (506)
........+++++++.+||.+||+.||.+|| |+++|
T Consensus 251 ----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l 287 (309)
T 2h34_A 251 ----------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDL 287 (309)
T ss_dssp ----------------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred ----------------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHH
Confidence 0011123356889999999999999999999 88884
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=370.44 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=205.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||+|+||.||+|.+..+++.||||+++.. ........+.+|+.+|+.++||||+++++++.. .+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 185 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQ 185 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CC
Confidence 357899999999999999999999999999999998743 233445568899999999999999999999843 36
Q ss_pred cEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+|+||||++ ++|.++++..+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 7899999997 69999998654 699999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||++.+..+....+....
T Consensus 266 ~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 332 (377)
T 3cbl_A 266 GVYA-ASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---------- 332 (377)
T ss_dssp SEEE-CCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC----------
T ss_pred Ccee-ecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 1110 00011235678999999976 679999999999999999998 999998877655444332210
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+ ....+++++.+||.+||+.||.+|||+++|
T Consensus 333 -----------------~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 365 (377)
T 3cbl_A 333 -----------------RLP---CPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365 (377)
T ss_dssp -----------------CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------CCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 011 113478899999999999999999999995
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=380.66 Aligned_cols=260 Identities=28% Similarity=0.400 Sum_probs=195.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..+|++.++||+|+||+|+. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++. +..
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~ 91 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEK-----DRQ 91 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETT
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCC
Confidence 35799999999999998763 3457899999999964211 2246899999999 6999999999884 347
Q ss_pred cEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-----CCCEEEeecCCcc
Q 044076 92 DIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-----DCKLKICDFGLAR 165 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-----~~~lKL~DFGla~ 165 (506)
.+|+||||++++|.+++.... .+++..+..+++||+.||+|||++||+||||||+|||++. ...+||+|||+|+
T Consensus 92 ~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 92 FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 799999999999999998754 4666677899999999999999999999999999999953 2358899999998
Q ss_pred cccCCCCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
...............+||++|+|||++.+. ...++.++|||||||++|+|++ |.+||...... +...+ .+....
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~~~---~~~~~~ 247 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANIL---LGACSL 247 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHHHH---TTCCCC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHHHH---hccCCc
Confidence 654332222223557899999999998641 2567889999999999999999 99999554322 22221 111110
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
.........++.+.+||.+||+.||.+|||+.| +|+||
T Consensus 248 ------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e------------------vl~hp 285 (432)
T 3p23_A 248 ------------------------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKH------------------VLKHP 285 (432)
T ss_dssp ------------------------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHH------------------HHTST
T ss_pred ------------------------cccCccccccHHHHHHHHHHHhCCHhhCCCHHH------------------HHhCc
Confidence 000111224566899999999999999999999 89999
Q ss_pred ccCCCC
Q 044076 324 YFHGLA 329 (506)
Q Consensus 324 ~f~~~~ 329 (506)
||.++.
T Consensus 286 ~f~~~~ 291 (432)
T 3p23_A 286 FFWSLE 291 (432)
T ss_dssp TTCCHH
T ss_pred cccChH
Confidence 998643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=347.37 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=202.5
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhH-----HHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSD-----ATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~-----~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
...++|++.+.||+|+||.||+|.+..+++.||||++......... ...+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 3468999999999999999999999999999999998543222111 16788999999999999999999998432
Q ss_pred CcCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECCCCC-----E
Q 044076 86 CRREFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANADCK-----L 156 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~~~~-----l 156 (506)
.++||||++ ++|.+.+... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++. +
T Consensus 96 -------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 -------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 279999998 6998888654 47999999999999999999999999 999999999999988776 9
Q ss_pred EEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhh--HHHH
Q 044076 157 KICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQ--LDLV 234 (506)
Q Consensus 157 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~--l~~I 234 (506)
||+|||+++..... .....+|+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+.... ...+
T Consensus 169 kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999999743221 245679999999999854336789999999999999999999999987654332 1111
Q ss_pred HhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 235 TDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 235 ~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... + .. ....+.+++.+.+||.+||+.||.+|||++||
T Consensus 243 ~~~-~-------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 280 (287)
T 4f0f_A 243 REE-G-------------------------LR---PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI 280 (287)
T ss_dssp HHS-C-------------------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcc-C-------------------------CC---CCCCcccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 100 0 00 11224688999999999999999999999994
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.87 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=207.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEE-----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d-----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 47999999999999999999985 467889999999743 3344567789999999999 89999999999844
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKAND------------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKN 147 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~~------------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~N 147 (506)
.+..|+||||+++ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ---CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 3678999999975 9999998754 48999999999999999999999999999999999
Q ss_pred EEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCC
Q 044076 148 ILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN 226 (506)
Q Consensus 148 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~ 226 (506)
|+++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999764433221 12234557889999999977 689999999999999999998 999998876
Q ss_pred chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 227 VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 227 ~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+..+...... . ...+.+++.+.+||.+||+.||.+|||+.||
T Consensus 253 ~~~~~~~~~~~~~~--------------------------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 298 (313)
T 1t46_A 253 VDSKFYKMIKEGFR--------------------------M---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (313)
T ss_dssp SSHHHHHHHHHTCC--------------------------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred chhHHHHHhccCCC--------------------------C---CCcccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 55443333211100 0 1123578999999999999999999999995
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=360.37 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=199.2
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEE----EEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKV----AIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~v----AIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
....++|++++.||+|+||+||+|++..+++.| |+|.++.. ........+.+|+.+++.++||||+++++++..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 88 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT- 88 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-
Confidence 345689999999999999999999998887754 77776432 223445678899999999999999999999854
Q ss_pred CcCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCC
Q 044076 86 CRREFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
...++|+||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 89 -----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 89 -----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp -----SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred -----CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 34788999987 5999999874 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
|+........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 164 a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-- 238 (327)
T 3poz_A 164 AKLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-- 238 (327)
T ss_dssp HHHHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred eeEccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--
Confidence 9864332221 11234457889999999987 789999999999999999999 99999887765544444221111
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+..++++.+||.+||+.||.+|||+.||
T Consensus 239 ----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 269 (327)
T 3poz_A 239 ----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFREL 269 (327)
T ss_dssp ----------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred ----------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 1124578899999999999999999999995
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=350.75 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=198.6
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++.+.||+|+||.||+|.+. ..||||+++...........+.+|+.+|+.++||||++++++.. .
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------A 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------C
Confidence 34678999999999999999999753 35999999765556667788999999999999999999999652 2
Q ss_pred CcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...++||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 56899999998 5999998643 469999999999999999999999999999999999999999999999999997533
Q ss_pred CCCCCcccccccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ........||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 172 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------- 242 (289)
T 3og7_A 172 RWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-------- 242 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS--------
T ss_pred cccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc--------
Confidence 2111 112345679999999999862 125789999999999999999999999988766554444322111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...++.....++++.+.+||.+||+.||.+|||+.+|
T Consensus 243 -----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 279 (289)
T 3og7_A 243 -----------------LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279 (289)
T ss_dssp -----------------CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 1112233445788999999999999999999999995
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=357.06 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=206.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++|++.+.||+|+||.||+|.+. .+++.||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 99 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 99 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence 468999999999999999999876 46789999999643 334455678899999999999999999999843
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCE
Q 044076 88 REFKDIYVVFELMES-DLDQVIKAN----------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKL 156 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~~----------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~l 156 (506)
.+..|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 3678999999974 999998752 357999999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHH
Q 044076 157 KICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVT 235 (506)
Q Consensus 157 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~ 235 (506)
||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 178 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCcccccccccccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999754322111 11233457889999999987 679999999999999999999 899998877655544442
Q ss_pred hhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 236 ~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... .....+.+++.+.+||.+||+.||.+|||+.||
T Consensus 255 ~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~ 290 (322)
T 1p4o_A 255 EGG------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 290 (322)
T ss_dssp TTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCC------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 210 011224688999999999999999999999995
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=349.71 Aligned_cols=269 Identities=25% Similarity=0.388 Sum_probs=208.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEE----ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 12 EASQYEIQEIIGIGSYGVVASAI----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~----d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED-- 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC--
Confidence 35679999999999999999998 67889999999997432 233456788999999999999999999998643
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 REFKDIYVVFELMES-DLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
+...+|+||||+++ +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 96 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 96 -GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred -CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 23668999999975 99999954 4579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
................+|..|+|||++.+ ..++.++|||||||++|+|++|..|+... ...+....+......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQM 247 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCccccc
Confidence 75443322222345668889999999977 67889999999999999999999886322 222222333222211
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
............... ...+.+++.+.+||.+||+.||.+|||+.||
T Consensus 248 -------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 293 (302)
T 4e5w_A 248 -------TVTRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293 (302)
T ss_dssp -------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred -------CHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 111222222222221 1235689999999999999999999999995
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=355.75 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=201.1
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCC----cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTG----EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
...++|++.+.||+|+||.||+|.+..++ ..||||+++.. ........+.+|+.+++.++||||+++++++.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 116 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--- 116 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe---
Confidence 34789999999999999999999887553 46999999643 23445567889999999999999999999984
Q ss_pred cCCCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 87 RREFKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
..+..|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 117 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 117 --KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp --SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred --cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 34789999999985 999999865 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
+................+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~--- 269 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL--- 269 (333)
T ss_dssp ----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---
T ss_pred hhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---
Confidence 764333222111223456788999999977 689999999999999999998 99999887765555444221110
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+++.+.+||.+||+.||.+|||+.+|
T Consensus 270 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 300 (333)
T 1mqb_A 270 ---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADI 300 (333)
T ss_dssp ---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ---------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1123578899999999999999999999995
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=359.71 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=203.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEE-----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPP 85 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d-----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~ 85 (506)
..++|++++.||+|+||.||+|.+ ..++..||||++.... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence 357999999999999999999997 3466789999997432 233456788999999999 89999999999854
Q ss_pred CcCCCCcEEEEEecCCC-CHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 044076 86 CRREFKDIYVVFELMES-DLDQVIKAND-----------------------DLTPEHHQFFLYQLLRALKYIHSANVFHR 141 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~-~L~~~i~~~~-----------------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHr 141 (506)
.+.+|+||||+++ +|.+++.... .+++..+..++.||+.||.|||++||+||
T Consensus 121 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 121 ----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred ----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 3679999999974 9999998653 27999999999999999999999999999
Q ss_pred CCCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCC
Q 044076 142 DLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRP 220 (506)
Q Consensus 142 DLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~ 220 (506)
||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999764433221 12234567889999999977 689999999999999999998 999
Q ss_pred CCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 221 LFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 221 pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
||.+.+....+..+..... .. .....+++++.+||.+||+.||.+|||+.|
T Consensus 274 p~~~~~~~~~~~~~~~~~~--------------------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGF--------------------------KM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTC--------------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcccCCcHHHHHHHHhcCC--------------------------CC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9988765544333321100 00 112357899999999999999999999999
Q ss_pred h
Q 044076 301 I 301 (506)
Q Consensus 301 L 301 (506)
|
T Consensus 325 l 325 (344)
T 1rjb_A 325 L 325 (344)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=350.63 Aligned_cols=259 Identities=21% Similarity=0.244 Sum_probs=201.1
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
....++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+.. .
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~ 76 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGA----E 76 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE----E
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecC----C
Confidence 356789999999999999999999999999999999875322 22347789999999999888877766532 3
Q ss_pred CCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE---CCCCCEEEeecCCcc
Q 044076 90 FKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA---NADCKLKICDFGLAR 165 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv---~~~~~lKL~DFGla~ 165 (506)
....|+||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 467899999998899999985 4579999999999999999999999999999999999999 788999999999998
Q ss_pred cccCCCCCc----ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 166 VSFTDTPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 166 ~~~~~~~~~----~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--- 231 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS--- 231 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH---
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh---
Confidence 644332211 11235679999999999987 679999999999999999999999998765432222111100
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ....+.....+++++++.+||.+||+.||.+|||+++|
T Consensus 232 ---------~~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 271 (296)
T 4hgt_A 232 ---------EK-----------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 271 (296)
T ss_dssp ---------HH-----------HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred ---------cc-----------cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHH
Confidence 00 00001111224578999999999999999999999995
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.36 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=195.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.++|++.+.||+|+||.||+|++. .++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----- 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----
Confidence 568999999999999999999876 46778999999643 234556778999999999999999999999843
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
...+|+||||++ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 377899999996 59999998754 6999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
..............+|..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+......+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~----- 270 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP----- 270 (373)
T ss_dssp ----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-----
T ss_pred ccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence 433221111122345778999999987 789999999999999999998 999998877655544442211110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+++.+.+||.+||+.||.+|||+.+|
T Consensus 271 -------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i 300 (373)
T 2qol_A 271 -------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300 (373)
T ss_dssp -------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHH
Confidence 113578899999999999999999999995
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=358.71 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=201.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh----hHHHHHHHHHHHHHhC----CCCCcceeceeec
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV----SDATRILREIKLLRML----KHPDIVEIKHIML 83 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~----~~~~~~~rEi~iL~~l----~HpnIv~l~~v~~ 83 (506)
..++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4578999999999999999999999999999999996432111 2233456799999998 8999999999984
Q ss_pred CCCcCCCCcEEEEEec-CC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC-CCCCEEEee
Q 044076 84 PPCRREFKDIYVVFEL-ME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN-ADCKLKICD 160 (506)
Q Consensus 84 ~~~~~~~~~~ylV~E~-~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~-~~~~lKL~D 160 (506)
. .+..|+|+|+ +. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|
T Consensus 109 ~-----~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 109 T-----QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ---------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred c-----CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 3 3678999998 55 69999999888899999999999999999999999999999999999999 889999999
Q ss_pred cCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCC
Q 044076 161 FGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGT 240 (506)
Q Consensus 161 FGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~ 240 (506)
||+++...... .....+|..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.. .+..
T Consensus 184 fg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~---- 247 (312)
T 2iwi_A 184 FGSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE---- 247 (312)
T ss_dssp CSSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH----
T ss_pred cchhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh----
Confidence 99997643322 2456799999999998762 334569999999999999999999996421 1100
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL 320 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL 320 (506)
.. ....+.+++.+.+||.+||+.||.+|||++| +|
T Consensus 248 ----------------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e------------------~l 282 (312)
T 2iwi_A 248 ----------------------AE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEE------------------IL 282 (312)
T ss_dssp ----------------------TC-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHH------------------HH
T ss_pred ----------------------hc-----cCCcccCCHHHHHHHHHHccCChhhCcCHHH------------------Hh
Confidence 00 0112457899999999999999999999999 89
Q ss_pred cCcccCCCCC
Q 044076 321 ADPYFHGLAN 330 (506)
Q Consensus 321 ~HP~f~~~~~ 330 (506)
+||||+....
T Consensus 283 ~~~~~~~~~~ 292 (312)
T 2iwi_A 283 LDPWMQTPAE 292 (312)
T ss_dssp HSTTTCC---
T ss_pred cChhhcCchh
Confidence 9999987543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=346.39 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=205.2
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
....++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.++|++++..+..+.. .
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~ 76 (296)
T 3uzp_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----E 76 (296)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEE----E
T ss_pred ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccC----C
Confidence 3457899999999999999999999999999999999864322 2347899999999999887777665532 3
Q ss_pred CCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC---CCCCEEEeecCCcc
Q 044076 90 FKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN---ADCKLKICDFGLAR 165 (506)
Q Consensus 90 ~~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~---~~~~lKL~DFGla~ 165 (506)
....|+||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 467899999998899999974 45799999999999999999999999999999999999994 78999999999998
Q ss_pred cccCCCCCc----ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch---hhHHHHHhhc
Q 044076 166 VSFTDTPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA---HQLDLVTDLL 238 (506)
Q Consensus 166 ~~~~~~~~~----~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~---~~l~~I~~~~ 238 (506)
......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. +.+..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 644332211 11245679999999999987 67999999999999999999999999875432 2222221110
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+ +.....+.+++++.+||.+||+.||.+|||+++|
T Consensus 235 ~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 271 (296)
T 3uzp_A 235 MST--------------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 271 (296)
T ss_dssp HHS--------------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred cCC--------------------------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHH
Confidence 000 0011124578999999999999999999999995
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=343.85 Aligned_cols=248 Identities=17% Similarity=0.204 Sum_probs=206.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||+|+||.||+|.+. ++.||||+++...........+.+|+.+++.++||||+++++++... ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence 3578999999999999999999874 88999999976545556677899999999999999999999998543 236
Q ss_pred cEEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 92 DIYVVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..|+||||+++ +|.+++.... .+++..+..++.||+.||+|||++| |+||||||+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 78999999984 9999998765 4899999999999999999999999 99999999999999999999999998754
Q ss_pred ccCCCCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
... ....+|+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 163 ~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 230 (271)
T 3kmu_A 163 FQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP---- 230 (271)
T ss_dssp TSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC----
T ss_pred ecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC----
Confidence 211 234689999999998752 1234458999999999999999999998877665544442211111
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+.+++++.+||.+||+.||.+|||++||
T Consensus 231 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (271)
T 3kmu_A 231 -------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMI 261 (271)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1224588999999999999999999999994
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=360.90 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=203.4
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcE----EEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeec
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEK----VAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIML 83 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~----vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~ 83 (506)
...-..++|++++.||+|+||+||+|.+..+++. ||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 3445578999999999999999999999888876 7777764321 1222345678999999999999999999873
Q ss_pred CCCcCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeec
Q 044076 84 PPCRREFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 84 ~~~~~~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DF 161 (506)
....|+||||+. ++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 86 ------GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp ------BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSC
T ss_pred ------CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCC
Confidence 256899999998 5999999864 57999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGT 240 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~ 240 (506)
|+++........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 160 g~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (325)
T 3kex_A 160 GVADLLPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL 236 (325)
T ss_dssp SGGGGSCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC
T ss_pred CcccccCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC
Confidence 999875333221 22345668889999999987 689999999999999999999 99999887765554444221100
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+++++.+||.+||+.||.+|||+.||
T Consensus 237 ------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (325)
T 3kex_A 237 ------------------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267 (325)
T ss_dssp ------------------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHH
T ss_pred ------------------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0112356778999999999999999999995
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=352.22 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=206.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEE-----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPP 85 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d-----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~ 85 (506)
..++|++++.||+|+||.||+|.+ ..+++.||||+++.. ........+.+|+.+++.+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 357999999999999999999985 457789999999643 2334556788999999999 599999999998542
Q ss_pred CcCCCCcEEEEEecCCC-CHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcE
Q 044076 86 CRREFKDIYVVFELMES-DLDQVIKANDD----------------LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNI 148 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~-~L~~~i~~~~~----------------ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NI 148 (506)
...+|+||||+++ +|.+++..... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 104 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 104 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 3568999999985 99999987654 89999999999999999999999999999999999
Q ss_pred EECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCc
Q 044076 149 LANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNV 227 (506)
Q Consensus 149 Lv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~ 227 (506)
+++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999976433222 122244568899999999987 789999999999999999998 9999987664
Q ss_pred hhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 228 AHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 228 ~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+.+........ .. ......++.+.+||.+||+.||.+|||+.||
T Consensus 257 ~~~~~~~~~~~~--------------------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 301 (316)
T 2xir_A 257 DEEFCRRLKEGT--------------------------RM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 301 (316)
T ss_dssp SHHHHHHHHHTC--------------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hHHHHHHhccCc--------------------------cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 433322211100 00 1123478999999999999999999999995
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=357.84 Aligned_cols=271 Identities=23% Similarity=0.356 Sum_probs=211.4
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEE----ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAI----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLP 84 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~----d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~ 84 (506)
.+-..++|++++.||+|+||.||+|. +..+++.||||++.. ........+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc--CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 34557899999999999999999998 577899999999964 344556678999999999999999999998864
Q ss_pred CCcCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecC
Q 044076 85 PCRREFKDIYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG 162 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFG 162 (506)
. +...+|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 96 ~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 96 P---GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp S---SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred C---CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 2 3467999999996 599999976 4569999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
+++................+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~ 245 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-----LRMMGCER 245 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHCC---
T ss_pred cceecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchh-----hhhccccc
Confidence 99865433322222344568889999999977 678999999999999999999999996533211 01111000
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ................. ...+.+++.+.+||.+||+.||.+|||+.||
T Consensus 246 ~-------~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 294 (327)
T 3lxl_A 246 D-------VPALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294 (327)
T ss_dssp --------CCHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred c-------cccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 00001111111111111 1235689999999999999999999999995
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=343.43 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=205.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++.+.||+|+||.||+|.+. +++.||||++.... .....+.+|+.+++.++||||+++++++.. .
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 75 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----Q 75 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----C
Confidence 34679999999999999999999986 67889999997532 233568899999999999999999999844 3
Q ss_pred CcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
+..|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccc
Confidence 67999999997 5999999875 469999999999999999999999999999999999999999999999999997542
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ........+|..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+......
T Consensus 156 ~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~------- 224 (267)
T 3t9t_A 156 DDQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------- 224 (267)
T ss_dssp CHH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------
T ss_pred ccc--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC-------
Confidence 211 111233457788999999987 678999999999999999999 89999887766555444221100
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
......++.+.+||.+||+.||.+|||+.+|
T Consensus 225 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 255 (267)
T 3t9t_A 225 -----------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRL 255 (267)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHH
Confidence 0113468899999999999999999999995
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.93 Aligned_cols=243 Identities=18% Similarity=0.290 Sum_probs=198.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCC-------cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTG-------EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLP 84 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~-------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~ 84 (506)
..++|++.+.||+|+||.||+|.+..++ ..||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3679999999999999999999998877 47999998642 33455678999999999999999999999854
Q ss_pred CCcCCCCcEEEEEecCC-CCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC-------
Q 044076 85 PCRREFKDIYVVFELME-SDLDQVIKANDD-LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK------- 155 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~-~~L~~~i~~~~~-ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~------- 155 (506)
.+..|+||||++ ++|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 84 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 -----GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp -----TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred -----CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 367899999998 599999987654 999999999999999999999999999999999999998887
Q ss_pred -EEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhC-CCCCCCCCchhhHHH
Q 044076 156 -LKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQLDL 233 (506)
Q Consensus 156 -lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G-~~pF~~~~~~~~l~~ 233 (506)
+||+|||++...... ....+|..|+|||++.+. ..++.++|||||||++|+|++| .+||.+.+.......
T Consensus 159 ~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeeeccCcccccccCc-------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 999999999643211 234588899999998752 5689999999999999999995 566655443322222
Q ss_pred HHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 234 I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... .. ...+..++++.+||.+||+.||.+|||+.||
T Consensus 231 ~~~---------------------------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 266 (289)
T 4fvq_A 231 YED---------------------------RH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAI 266 (289)
T ss_dssp HHT---------------------------TC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhc---------------------------cC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 110 00 1113356779999999999999999999994
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=348.01 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=206.7
Q ss_pred CCCCCEEEeE-EEeecCceEEEEEEEC--CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 11 GEASQYEIQE-IIGIGSYGVVASAIDT--HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 11 ~~~~rY~i~~-~LG~G~~g~V~~a~d~--~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
...++|.+.+ .||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 81 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--- 81 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---
Confidence 3457888887 9999999999999864 46788999999753 344567778999999999999999999999822
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 REFKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
+..|+||||+++ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++
T Consensus 82 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 82 ---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp ---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 468999999985 999998654 469999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
................+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~------ 230 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------ 230 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC------
T ss_pred eeccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC------
Confidence 64333221111233456889999999976 678999999999999999998 999998877655444442210
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ....+.+++++.+||.+||+.||.+|||+.+|
T Consensus 231 ---------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 263 (287)
T 1u59_A 231 ---------------------R---MECPPECPPELYALMSDCWIYKWEDRPDFLTV 263 (287)
T ss_dssp ---------------------C---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred ---------------------c---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 01224689999999999999999999999995
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=354.78 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=205.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEEC-------CCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeec
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDT-------HTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIML 83 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~-------~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~ 83 (506)
..++|++++.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+++.+ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3579999999999999999999976 46778999999643 2345567788999999999 7999999999984
Q ss_pred CCCcCCCCcEEEEEecCCC-CHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 044076 84 PPCRREFKDIYVVFELMES-DLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPK 146 (506)
Q Consensus 84 ~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~ 146 (506)
. .+.+|+||||+++ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 112 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 112 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp S-----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred c-----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 3 4679999999975 9999998654 3899999999999999999999999999999999
Q ss_pred cEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCC
Q 044076 147 NILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGR 225 (506)
Q Consensus 147 NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~ 225 (506)
|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999976433221 111234457888999999977 678999999999999999999 99999887
Q ss_pred CchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 226 NVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 226 ~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+..+....+..... ......+++.+.+||.+||+.||.+|||+.||
T Consensus 264 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 309 (334)
T 2pvf_A 264 PVEELFKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309 (334)
T ss_dssp CHHHHHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CHHHHHHHHhcCCC------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 76554444322110 01124578999999999999999999999995
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=357.03 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=200.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEE-----ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAI-----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~-----d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
..++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence 45799999999999999999998 5678889999999642 344556678899999999999999999999854
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC---CC
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND-------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD---CK 155 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~-------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~---~~ 155 (506)
....|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..
T Consensus 105 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 ---SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred ---CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 367899999996 59999998753 48999999999999999999999999999999999999954 46
Q ss_pred EEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHH
Q 044076 156 LKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLV 234 (506)
Q Consensus 156 lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I 234 (506)
+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECcccccccccccccc-ccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 999999999753222211 11234567899999999977 689999999999999999998 99999887766555444
Q ss_pred HhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 235 TDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 235 ~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
..... ....+.+++.+.+||.+||+.||.+|||+.+
T Consensus 259 ~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 294 (327)
T 2yfx_A 259 TSGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 294 (327)
T ss_dssp HTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCCC------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 22110 0112457899999999999999999999999
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=342.99 Aligned_cols=245 Identities=30% Similarity=0.449 Sum_probs=192.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC--hhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH--VSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~--~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
.++|++.+.||+|+||.||+|.+ +++.||||+++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence 57999999999999999999987 4889999998643221 2335678899999999999999999999844 3
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCCCcEEECC--------CCCEEE
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN---VFHRDLKPKNILANA--------DCKLKI 158 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~g---IvHrDLKp~NILv~~--------~~~lKL 158 (506)
+..|+||||++ ++|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 67899999997 58888875 557999999999999999999999999 999999999999986 778999
Q ss_pred eecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhc
Q 044076 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 159 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~ 238 (506)
+|||+++....... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 99999975432221 24568999999999987 689999999999999999999999998876554443332110
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. .. .....+++.+.+||.+||+.||.+|||+.||
T Consensus 231 ~--------------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 264 (271)
T 3dtc_A 231 L--------------------------AL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNI 264 (271)
T ss_dssp C--------------------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred C--------------------------CC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 0 00 1124578999999999999999999999994
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=355.47 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=200.2
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEE----EEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKV----AIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~v----AIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
...++|++++.||+|+||.||+|.+..+++.| |+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--
Confidence 45789999999999999999999998888755 66666432 233456778899999999999999999999854
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
...++|++++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ----~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 ----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ----SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ----CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 34788999887 5999999874 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
+........ .......+|..|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--- 238 (327)
T 3lzb_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--- 238 (327)
T ss_dssp ----------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred eEccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence 764332211 11234457889999999987 789999999999999999999 99999887766555444221111
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+.+++++.+||.+||+.||.+|||+.||
T Consensus 239 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 239 ---------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp ---------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1124578899999999999999999999995
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=354.25 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=186.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCC---cC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPC---RR 88 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~---~~ 88 (506)
..+|++.+.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+++.+. ||||+++++++.... ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 4589999999999999999999999999999999853 34455667889999999996 999999999885321 13
Q ss_pred CCCcEEEEEecCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEECCCCCEEEeecCC
Q 044076 89 EFKDIYVVFELMESDLDQVIKA---NDDLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~---~~~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
....+|+||||++|+|.+++.. .+.+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 3466899999999999998865 457999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---------ccccccccCCcccCcccccc-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHH
Q 044076 164 ARVSFTDTPSA---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDL 233 (506)
Q Consensus 164 a~~~~~~~~~~---------~~~~~~vgt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~ 233 (506)
++......... .......+|+.|+|||++.. ....++.++|||||||++|+|++|+.||.+......+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 97643322110 01124568999999999831 126789999999999999999999999976443221111
Q ss_pred HHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 234 VTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 234 I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ... ......++.+.+||.+||+.||.+|||+.||
T Consensus 265 ~------------------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 299 (337)
T 3ll6_A 265 K------------------------------YSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299 (337)
T ss_dssp -------------------------------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHH
T ss_pred c------------------------------ccC---CcccccchHHHHHHHHHccCChhhCcCHHHH
Confidence 0 000 1113456779999999999999999999994
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.48 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=203.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCC---cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTG---EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
..+|++.+.||+|+||.||+|.+..++ ..||+|++.. .........+.+|+.+++.++||||+++++++.. .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----S 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----S
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----C
Confidence 457999999999999999999975443 4689999874 2344566778999999999999999999998643 2
Q ss_pred CCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.+..|+||||+++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 3678999999986 999999864 46899999999999999999999999999999999999999999999999999754
Q ss_pred cCCCC-CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 168 FTDTP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 168 ~~~~~-~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
..... .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----- 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----- 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-----
T ss_pred cccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-----
Confidence 32211 1112244567889999999977 689999999999999999999 78888877766555444321111
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+++.+.+||.+||+.||.+|||+.||
T Consensus 252 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 282 (298)
T 3f66_A 252 -------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 282 (298)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0113468899999999999999999999995
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=346.03 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=202.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECC---CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTH---TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~---t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
..++|++.+.||+|+||.||+|.+.. ++..||||++... ........+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----
Confidence 35789999999999999999998654 3456999998643 234556778999999999999999999999732
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
+..|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 85 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 --EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred --CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 45699999998 5999999764 4699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
....... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 163 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~----- 233 (281)
T 3cc6_A 163 IEDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL----- 233 (281)
T ss_dssp C-----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-----
T ss_pred ccccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-----
Confidence 4332211 1233457888999999976 689999999999999999998 99999877666555444221111
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+++.+.+||.+||+.||.+|||+.||
T Consensus 234 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 264 (281)
T 3cc6_A 234 -------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL 264 (281)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 1113478999999999999999999999995
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=343.18 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=202.7
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCc---EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
-+|++.+.||+|+||+||+|.+..++. .||+|++.. .........+.+|+.+++.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----E 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----C
Confidence 367788999999999999999765554 799999964 23445567788999999999999999999998543 2
Q ss_pred CcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 34589999996 699999987 4569999999999999999999999999999999999999999999999999997532
Q ss_pred CCCC-CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 169 TDTP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 169 ~~~~-~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... .........+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~----- 248 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP----- 248 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC-----
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC-----
Confidence 2111 1111234567889999999987 789999999999999999999 666676666555444443221111
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+++.+.+||.+||+.||.+|||+.+|
T Consensus 249 -------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 278 (298)
T 3pls_A 249 -------------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVL 278 (298)
T ss_dssp -------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------------------CCccchHHHHHHHHHHccCChhhCcCHHHH
Confidence 113478899999999999999999999995
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=371.27 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=193.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~ 90 (506)
..+.|.+.+.||+|+||+||.+ ...+|+.||||++.. .....+.+|+.+|+.+ +||||+++++++.. .
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~-----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~ 81 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSETT-----D 81 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEG-----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----S
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcH-----HHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----C
Confidence 4567888899999999999875 456899999999864 2344578999999876 79999999998843 4
Q ss_pred CcEEEEEecCCCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC----------
Q 044076 91 KDIYVVFELMESDLDQVIKANDDL-------TPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD---------- 153 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~~~~l-------s~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~---------- 153 (506)
..+|+||||++++|.+++...... ++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 82 RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 789999999999999999875432 233456799999999999999999999999999999754
Q ss_pred ---CCEEEeecCCcccccCCCCC-cccccccccCCcccCccccccc-----CCCCCchhhhhhhhHHHHHHHh-CCCCCC
Q 044076 154 ---CKLKICDFGLARVSFTDTPS-AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GRPLFP 223 (506)
Q Consensus 154 ---~~lKL~DFGla~~~~~~~~~-~~~~~~~vgt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~il~eLl~-G~~pF~ 223 (506)
+.+||+|||+|+........ ........||+.|+|||++.+. ...++.++|||||||++|+|++ |+.||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 48999999999865432211 1112356799999999998641 2568999999999999999999 999997
Q ss_pred CCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhh
Q 044076 224 GRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRF 303 (506)
Q Consensus 224 ~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~ 303 (506)
+..... ..+........ ... ....+.+++++.+||.+||+.||.+|||+.|
T Consensus 242 ~~~~~~--~~i~~~~~~~~-----------------------~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e--- 292 (434)
T 2rio_A 242 DKYSRE--SNIIRGIFSLD-----------------------EMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMK--- 292 (434)
T ss_dssp STTTHH--HHHHHTCCCCC-----------------------CCT-TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH---
T ss_pred CchhhH--HHHhcCCCCcc-----------------------ccc-ccccccchHHHHHHHHHHhhCChhhCCCHHH---
Confidence 654322 11211100000 000 0001124578999999999999999999999
Q ss_pred hhhhhhHHHHHhhhhhccCcccCC
Q 044076 304 TEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 304 ~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
+|+||||..
T Consensus 293 ---------------il~hp~f~~ 301 (434)
T 2rio_A 293 ---------------VLRHPLFWP 301 (434)
T ss_dssp ---------------HHTSGGGSC
T ss_pred ---------------HHhCCccCC
Confidence 899999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.59 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=206.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCc-----EEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGE-----KVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPP 85 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~-----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~ 85 (506)
..++|++.+.||+|+||.||+|.+..+++ .||+|++... ........+.+|+.+|+.+ +||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 35789999999999999999999977664 7999999643 2344567789999999999 79999999999843
Q ss_pred CcCCCCcEEEEEecCCC-CHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE
Q 044076 86 CRREFKDIYVVFELMES-DLDQVIKAN--------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA 150 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~-~L~~~i~~~--------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv 150 (506)
.+.+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 122 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 122 ----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 3679999999975 999998752 358999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchh
Q 044076 151 NADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAH 229 (506)
Q Consensus 151 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~ 229 (506)
+.++.+||+|||+++........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999764333221 12234557889999999987 689999999999999999998 999998876554
Q ss_pred hHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 230 QLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 230 ~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+..+...... . ......++.+.+||.+||+.||.+|||+.||
T Consensus 275 ~~~~~~~~~~~--------------------------~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 317 (333)
T 2i1m_A 275 KFYKLVKDGYQ--------------------------M---AQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317 (333)
T ss_dssp HHHHHHHHTCC--------------------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHhcCCC--------------------------C---CCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 44333221100 0 1113468899999999999999999999995
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=346.89 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=194.6
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
...++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 103 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----- 103 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----
Confidence 4567899999999999999999999999999999999642 2344556778899999999999999999999854
Q ss_pred CCcEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCc
Q 044076 90 FKDIYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLA 164 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla 164 (506)
.+..|+||||+++ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 3789999999986 99998864 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch--hhHHHHHhhcCCCC
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA--HQLDLVTDLLGTPS 242 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~--~~l~~I~~~~g~p~ 242 (506)
+....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+..
T Consensus 184 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------ 252 (310)
T 2wqm_A 184 RFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ------ 252 (310)
T ss_dssp ------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT------
T ss_pred eeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc------
Confidence 76432221 1234578999999999987 68999999999999999999999999765321 11111100
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+ .....+++++.+||.+||..||.+|||+.+|
T Consensus 253 ---------------------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~i 288 (310)
T 2wqm_A 253 ---------------------CDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288 (310)
T ss_dssp ---------------------TCSCC--CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ---------------------ccCCC--CcccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 00000 1124578999999999999999999999995
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=356.64 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=201.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEE--EEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKV--AIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~v--AIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~ 89 (506)
.++|++.+.||+|+||.||+|++..++..+ |||.++.. ........+.+|+.+++.+ +||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----- 97 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----- 97 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----
Confidence 479999999999999999999999898865 99998642 2334456688999999999 89999999999843
Q ss_pred CCcEEEEEecCCC-CHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC
Q 044076 90 FKDIYVVFELMES-DLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA 152 (506)
Q Consensus 90 ~~~~ylV~E~~~~-~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~ 152 (506)
.+.+|+||||+++ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 4789999999974 9999998654 6999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhH
Q 044076 153 DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQL 231 (506)
Q Consensus 153 ~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l 231 (506)
++.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+..
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCcccccccc----ccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 99999999999974222111 133457889999999977 678999999999999999998 99999887755444
Q ss_pred HHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 232 ~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+... ... .....+++.+.+||.+||+.||.+|||++||
T Consensus 252 ~~~~~~---------------------------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 291 (327)
T 1fvr_A 252 EKLPQG---------------------------YRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 291 (327)
T ss_dssp HHGGGT---------------------------CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhhcC---------------------------CCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 333111 000 1123578999999999999999999999995
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=357.84 Aligned_cols=263 Identities=15% Similarity=0.155 Sum_probs=199.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECC---CCcEEEEEEecccccChh---------HHHHHHHHHHHHHhCCCCCcceec
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTH---TGEKVAIKKMKEVFEHVS---------DATRILREIKLLRMLKHPDIVEIK 79 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~---t~~~vAIK~i~~~~~~~~---------~~~~~~rEi~iL~~l~HpnIv~l~ 79 (506)
..++|++++.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45799999999999999999999987 788999999864311100 112356788999999999999999
Q ss_pred eeecCCCcCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC--CEE
Q 044076 80 HIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC--KLK 157 (506)
Q Consensus 80 ~v~~~~~~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~--~lK 157 (506)
+++.... .+...+|+||||++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9986521 2247799999999779999998877899999999999999999999999999999999999998887 999
Q ss_pred EeecCCcccccCCCC----CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc--hhhH
Q 044076 158 ICDFGLARVSFTDTP----SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV--AHQL 231 (506)
Q Consensus 158 L~DFGla~~~~~~~~----~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~--~~~l 231 (506)
|+|||+|+....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999976432211 1111245679999999999987 6899999999999999999999999965322 1111
Q ss_pred HHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKF--PGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 232 ~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..........+... .... ..+++++.+||.+||+.||.+|||+++|
T Consensus 272 ~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 319 (345)
T 2v62_A 272 TAKTNLLDELPQSV------------------------LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQAL 319 (345)
T ss_dssp HHHHHHHHTTTHHH------------------------HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHhhcccccHHH------------------------HhhccccccHHHHHHHHHHHhhcCcccCCCHHHH
Confidence 11111111111100 0011 2588999999999999999999999995
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=361.44 Aligned_cols=267 Identities=16% Similarity=0.149 Sum_probs=200.9
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCC-----CcEEEEEEecccccChhH---------HHHHHHHHHHHHhCCCCCcce
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHT-----GEKVAIKKMKEVFEHVSD---------ATRILREIKLLRMLKHPDIVE 77 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t-----~~~vAIK~i~~~~~~~~~---------~~~~~rEi~iL~~l~HpnIv~ 77 (506)
..++|++++.||+|+||+||+|.+..+ ++.||||++......... .....+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356999999999999999999998765 578999998642111000 112345666777888999999
Q ss_pred eceeecCCCcCCCCcEEEEEecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC--CCC
Q 044076 78 IKHIMLPPCRREFKDIYVVFELMESDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN--ADC 154 (506)
Q Consensus 78 l~~v~~~~~~~~~~~~ylV~E~~~~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~--~~~ 154 (506)
+++++.... .+....|+||||++++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999985431 123568999999988999999876 5799999999999999999999999999999999999999 889
Q ss_pred CEEEeecCCcccccCCCCC----cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhh
Q 044076 155 KLKICDFGLARVSFTDTPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQ 230 (506)
Q Consensus 155 ~lKL~DFGla~~~~~~~~~----~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~ 230 (506)
.+||+|||+|+........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 9999999999764332111 111234569999999999987 6799999999999999999999999986443322
Q ss_pred HHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 231 l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.......... ......+.... ..+++++++.+||..||+.||.+|||+.+|
T Consensus 270 ~~~~~~~~~~-----------~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l 320 (364)
T 3op5_A 270 YVRDSKIRYR-----------ENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENL 320 (364)
T ss_dssp HHHHHHHHHH-----------HCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHHHHHhh-----------hhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHH
Confidence 2221110000 00011111100 014578999999999999999999999996
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=349.46 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=195.6
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHh--CCCCCcceeceeecCCCcC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM--LKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~--l~HpnIv~l~~v~~~~~~~ 88 (506)
...++|++++.||+|+||+||+|.+ +++.||||++.. .......+|..++.. ++||||+++++++.... .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-H 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-T
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-C
Confidence 3567999999999999999999986 789999999863 234556677777776 78999999999865431 2
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeecCCCCCcEEECCCCCEEEe
Q 044076 89 EFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH--------SANVFHRDLKPKNILANADCKLKIC 159 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH--------~~gIvHrDLKp~NILv~~~~~lKL~ 159 (506)
....+|+||||+++ +|.++++. ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 33668999999985 99999954 57999999999999999999999 9999999999999999999999999
Q ss_pred ecCCcccccCCCCCc-ccccccccCCcccCcccccccCC----CCCchhhhhhhhHHHHHHHhC----------CCCCCC
Q 044076 160 DFGLARVSFTDTPSA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTG----------RPLFPG 224 (506)
Q Consensus 160 DFGla~~~~~~~~~~-~~~~~~vgt~~Y~APE~l~~~~~----~~s~~~DIWSlG~il~eLl~G----------~~pF~~ 224 (506)
|||+|+......... .......||+.|+|||++.+... .++.++|||||||++|+|++| .+||.+
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997643322211 11234579999999999876211 455799999999999999999 888855
Q ss_pred CCch----hhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 225 RNVA----HQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 225 ~~~~----~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
.... ..+..+....+. ....+........++++.+||.+||+.||.+|||+.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQ-----------------------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCC-----------------------CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cCCCCcchhhhhHHHhccCC-----------------------CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence 3321 111111110000 0000000001124578999999999999999999999
Q ss_pred h
Q 044076 301 I 301 (506)
Q Consensus 301 L 301 (506)
|
T Consensus 293 i 293 (301)
T 3q4u_A 293 I 293 (301)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=360.68 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=204.1
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++.+.||+|+||.||+|.+ .+++.||||++... .......+.+|+.+++.++||||+++++++. +.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CT
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CC
Confidence 3568999999999999999999996 47899999998643 3345667889999999999999999999984 34
Q ss_pred CcEEEEEecCC-CCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 91 KDIYVVFELME-SDLDQVIKAND----DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~----~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
+..|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 78899999997 59998886543 58999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 188 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------ 258 (321)
T 2qkw_B 188 KGTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE------ 258 (321)
T ss_dssp ECSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH------
T ss_pred cccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh------
Confidence 63322211 11244568999999999977 6899999999999999999999999987654332221110000
Q ss_pred HhhhhhhHHHHHHhhhhccC-CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKW-AVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.... ..+.... +.......+..+..+.+||.+||+.||.+|||+.||
T Consensus 259 --~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 306 (321)
T 2qkw_B 259 --SHNN-------GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306 (321)
T ss_dssp --HHTT-------TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --cccc-------ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHH
Confidence 0000 0000000 000011122345678999999999999999999994
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.56 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=203.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||.||+|.+. ++..||||++... ......+.+|+.+++.++||||+++++++.. +.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCC---cccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CC
Confidence 479999999999999999999975 6678999998642 2235668899999999999999999998732 45
Q ss_pred EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 899999996 59999987543 699999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... .......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+.....
T Consensus 162 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------- 228 (279)
T 1qpc_A 162 NEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------- 228 (279)
T ss_dssp SCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred ccc--ccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---------
Confidence 221 11234457888999999976 678999999999999999999 9999988776655444422110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. .....+++++.+||.+||+.||.+|||+++|
T Consensus 229 ------------------~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 260 (279)
T 1qpc_A 229 ------------------M---VRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260 (279)
T ss_dssp ------------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------C---CCcccccHHHHHHHHHHhccChhhCCCHHHH
Confidence 0 1113578999999999999999999999995
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=374.53 Aligned_cols=248 Identities=24% Similarity=0.441 Sum_probs=208.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
...+|++.+.||+|+||.||+|.+..++..||||+++.. ......+.+|+.+|+.++||||+++++++.. ..
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~ 289 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EP 289 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc---ccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CC
Confidence 346899999999999999999999999999999999642 2345678899999999999999999999843 36
Q ss_pred cEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+|+|||||+ ++|.++++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 7899999998 6999999864 459999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||++.+..+....+.....
T Consensus 370 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------- 437 (495)
T 1opk_A 370 GDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------- 437 (495)
T ss_dssp TCCE--ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------
T ss_pred CCce--eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 3221 11233456788999999977 679999999999999999999 9999998876655544422110
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. .....+++.+.+||.+||+.||.+|||+.+|
T Consensus 438 -------------------~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el 469 (495)
T 1opk_A 438 -------------------M---ERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469 (495)
T ss_dssp -------------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------------C---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 0 1123578999999999999999999999995
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=350.26 Aligned_cols=258 Identities=22% Similarity=0.395 Sum_probs=201.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 45799999999999999999999999999999999854 34456677889999999999999999999985321 1235
Q ss_pred cEEEEEecCCC-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 92 DIYVVFELMES-DLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999986 99999876 46799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCc------ccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCch-hhHHHHHhhc
Q 044076 167 SFTDTPSA------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVA-HQLDLVTDLL 238 (506)
Q Consensus 167 ~~~~~~~~------~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~-~~l~~I~~~~ 238 (506)
........ .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... +.+...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---- 259 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---- 259 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH----
Confidence 32211100 011234579999999998652 123788999999999999999999999431100 000000
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ..... ...+.+++++.+||.+||+.||.+|||+.+|
T Consensus 260 -------------------~~---~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 297 (317)
T 2buj_A 260 -------------------VQ---NQLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297 (317)
T ss_dssp -------------------HH---CC--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------------hh---ccCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 00 00001 1124678999999999999999999999994
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.14 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=204.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||+|+||.||+|.+. ++..||||+++.. ....+.+.+|+.+|+.++||||+++++++. ..
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~ 255 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KE 255 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTT---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCC---CccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CC
Confidence 3468999999999999999999875 5778999999742 234567899999999999999999999973 25
Q ss_pred cEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+|+||||+. ++|.++++.. ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 6899999997 5999999754 368999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... .......+|..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+.+..+......+
T Consensus 336 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------ 405 (454)
T 1qcf_A 336 DNEY--TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------ 405 (454)
T ss_dssp CHHH--HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC------
T ss_pred CCce--eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 2110 11123346788999999976 689999999999999999999 999999887766655553321111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...++++++.+||.+||+.||.+|||+++|
T Consensus 406 ------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i 435 (454)
T 1qcf_A 406 ------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYI 435 (454)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 113578999999999999999999999995
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=364.77 Aligned_cols=243 Identities=23% Similarity=0.407 Sum_probs=202.9
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||.||+|.+. |+.||||+++.. .....+.+|+.+|+.++||||+++++++... .
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~ 259 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----K 259 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECT----T
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcC----C
Confidence 34578999999999999999999864 789999999742 2456688999999999999999999987542 3
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 91 KDIYVVFELME-SDLDQVIKANDD--LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~--ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
..+|+||||++ ++|.++++..+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 47999999997 499999987543 799999999999999999999999999999999999999999999999999753
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||++.+..+....+.....
T Consensus 340 ~~~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------- 404 (450)
T 1k9a_A 340 SSTQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------- 404 (450)
T ss_dssp C------------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-------
T ss_pred cccc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 2211 22357889999999987 789999999999999999998 9999998776665554432110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ...+.+++++.+||.+||+.||.+|||+.+|
T Consensus 405 --------------------~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l 436 (450)
T 1k9a_A 405 --------------------M---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQL 436 (450)
T ss_dssp --------------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred --------------------C---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 0 1124588999999999999999999999995
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=358.67 Aligned_cols=259 Identities=14% Similarity=0.170 Sum_probs=199.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCC--------CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHT--------GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLP 84 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t--------~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~ 84 (506)
.++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+++.++||||+++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57999999999999999999999874 889999998642 357799999999999999984332211
Q ss_pred C-----------CcCCCCcEEEEEecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC
Q 044076 85 P-----------CRREFKDIYVVFELMESDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151 (506)
Q Consensus 85 ~-----------~~~~~~~~ylV~E~~~~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~ 151 (506)
. ...+....|+||||++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 0 01124779999999977999999986 6899999999999999999999999999999999999999
Q ss_pred CCC--CEEEeecCCcccccCCCCC----cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Q 044076 152 ADC--KLKICDFGLARVSFTDTPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR 225 (506)
Q Consensus 152 ~~~--~lKL~DFGla~~~~~~~~~----~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~ 225 (506)
.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 998 8999999999764332111 111234579999999999987 68999999999999999999999999765
Q ss_pred C-chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 226 N-VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 226 ~-~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ....+..... .+..... ........+..+++++.+||.+||+.||.+|||+++|
T Consensus 272 ~~~~~~~~~~~~-------------------~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 327 (352)
T 2jii_A 272 LPNTEDIMKQKQ-------------------KFVDKPG--PFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAML 327 (352)
T ss_dssp TTCHHHHHHHHH-------------------HHHHSCC--CEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred CcCHHHHHHHHH-------------------hccCChh--hhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence 4 2222211110 0000000 0000011123578999999999999999999999995
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=366.64 Aligned_cols=279 Identities=21% Similarity=0.344 Sum_probs=206.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TT 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CC
Confidence 44679999999999999999999999999999999996432 223356678999999999999999999998543 23
Q ss_pred CcEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE----CCCCCEEEeecC
Q 044076 91 KDIYVVFELME-SDLDQVIKAND---DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA----NADCKLKICDFG 162 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~---~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv----~~~~~lKL~DFG 162 (506)
...|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 57899999997 59999997643 39999999999999999999999999999999999999 777889999999
Q ss_pred CcccccCCCCCcccccccccCCcccCccccccc------CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc-hhhHHHHH
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV-AHQLDLVT 235 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~------~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~-~~~l~~I~ 235 (506)
+++...... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+... ......+.
T Consensus 162 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 162 AARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 997643321 12456799999999997531 13578899999999999999999999975432 22222222
Q ss_pred hhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFS-HKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 236 ~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..++..+...+..+...... .+.-....+.. .....+++.+.+||.+||+.||.+|||++|+
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~ 300 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENG----PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTC----CEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred HHhcCCCcccchhheeccCC----CcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHH
Confidence 22222222222111100000 00000000100 1112345678999999999999999999994
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=352.07 Aligned_cols=273 Identities=21% Similarity=0.264 Sum_probs=196.4
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHH--HHhCCCCCcceeceeecCCCcC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKL--LRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~i--L~~l~HpnIv~l~~v~~~~~~~ 88 (506)
...++|++++.||+|+||.||+|.+ +++.||||++... ......+|..+ +..++||||+++++.+......
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 3468999999999999999999975 7899999998632 22333444444 4558899999999765433334
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeecCCCCCcEEECCCCCEEE
Q 044076 89 EFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA---------NVFHRDLKPKNILANADCKLKI 158 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~---------gIvHrDLKp~NILv~~~~~lKL 158 (506)
+...+|+||||++ ++|.+++... ..++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 4567899999996 5999999765 458999999999999999999999 9999999999999999999999
Q ss_pred eecCCcccccCCCC-----CcccccccccCCcccCcccccccC-----CCCCchhhhhhhhHHHHHHHhCC-CCCCCCCc
Q 044076 159 CDFGLARVSFTDTP-----SAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLTGR-PLFPGRNV 227 (506)
Q Consensus 159 ~DFGla~~~~~~~~-----~~~~~~~~vgt~~Y~APE~l~~~~-----~~~s~~~DIWSlG~il~eLl~G~-~pF~~~~~ 227 (506)
+|||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|||++|. ++|++...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999976433211 111223567999999999986510 24567899999999999999995 55555543
Q ss_pred hhhHHHHHh-hcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCC---CCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 228 AHQLDLVTD-LLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFP---GADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 228 ~~~l~~I~~-~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+....+.. ..+.|..+.+... ... ......+...++ .+++++.+||.+||+.||.+|||+.||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVL--------VSR--EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHH--------HTT--SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhh--------hcc--cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 332222222 2223333222111 111 111112222222 245689999999999999999999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=368.38 Aligned_cols=255 Identities=16% Similarity=0.177 Sum_probs=196.6
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCC-CCcceec---------eee
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKH-PDIVEIK---------HIM 82 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~H-pnIv~l~---------~v~ 82 (506)
..|++.+.||+|+||+||+|.+..+|+.||||+++... ......+.+.+|+.+++.+.| +|+..+. ++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34889999999999999999999999999999987322 222335678899999999987 3322111 111
Q ss_pred cC------------CCcCCCCcEEEEEecCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC
Q 044076 83 LP------------PCRREFKDIYVVFELMESDLDQVIKA-------NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDL 143 (506)
Q Consensus 83 ~~------------~~~~~~~~~ylV~E~~~~~L~~~i~~-------~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDL 143 (506)
.. ........++++|+++.++|.++++. ...+++..+..++.||+.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11 00011345789999999999998852 234778889999999999999999999999999
Q ss_pred CCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccc--------cCCCCCchhhhhhhhHHHHHH
Q 044076 144 KPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWSIGCIFAEL 215 (506)
Q Consensus 144 Kp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~--------~~~~~s~~~DIWSlG~il~eL 215 (506)
||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....|+.++|||||||++|+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999999753222 244567 99999999831 115688999999999999999
Q ss_pred HhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 044076 216 LTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR 295 (506)
Q Consensus 216 l~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~R 295 (506)
++|+.||.+.+..+....+ ....+++++++.+||.+||+.||.+|
T Consensus 311 ltg~~Pf~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWI-----------------------------------FRSCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGG-----------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHCCCCCCCcchhhhHHHH-----------------------------------HhhcccCCHHHHHHHHHHccCChhhC
Confidence 9999999776543221111 01224678999999999999999999
Q ss_pred CCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 296 PSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 296 pTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
||+.+ +|+||||+.+
T Consensus 356 pt~~~------------------~l~~~~~~~~ 370 (413)
T 3dzo_A 356 LLPLQ------------------AMETPEYEQL 370 (413)
T ss_dssp CCHHH------------------HTTSHHHHHH
T ss_pred cCHHH------------------HHhCHHHHHH
Confidence 99999 8999999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=341.08 Aligned_cols=242 Identities=24% Similarity=0.409 Sum_probs=196.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+ +|+.||||+++.. ...+.+.+|+.+++.++||||+++++++... .+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~ 88 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KG 88 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CC
Confidence 457999999999999999999976 4889999998642 3456788999999999999999999987432 35
Q ss_pred cEEEEEecCCC-CHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELMES-DLDQVIKANDD--LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~--ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+|+||||+++ +|.+++..... +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 78999999986 99999986543 8999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ....++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+....
T Consensus 169 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--------- 231 (278)
T 1byg_A 169 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------- 231 (278)
T ss_dssp -------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------
T ss_pred ccc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------
Confidence 221 23357889999999977 689999999999999999998 999998876655444432110
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ....+.+++.+.+||.+||+.||.+|||+.||
T Consensus 232 ------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 264 (278)
T 1byg_A 232 ------------------K---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 264 (278)
T ss_dssp ------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------C---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 0 01224578999999999999999999999995
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=379.98 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=202.9
Q ss_pred EEEe-EEEeecCceEEEEEEE--CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 16 YEIQ-EIIGIGSYGVVASAID--THTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 16 Y~i~-~~LG~G~~g~V~~a~d--~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+.+. +.||+|+||.||+|.+ ..+++.||||+++...........+.+|+.+|+.++||||+++++++.. +.
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CC
Confidence 4443 4899999999999954 4567899999998655555667789999999999999999999998832 45
Q ss_pred EEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+|||||+ ++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 899999998 5999999988899999999999999999999999999999999999999999999999999998654332
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
......+...+|..|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+......
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---------- 591 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------- 591 (635)
T ss_dssp -----------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred cccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 22222234457788999999977 789999999999999999998 99999988876665555331111
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....++++++.+||.+||+.||.+|||+++|
T Consensus 592 --------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 622 (635)
T 4fl3_A 592 --------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 622 (635)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred --------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 1123588999999999999999999999995
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=343.03 Aligned_cols=244 Identities=25% Similarity=0.407 Sum_probs=191.5
Q ss_pred CCCCCEEEe-EEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHH-HhCCCCCcceeceeecCCCcC
Q 044076 11 GEASQYEIQ-EIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL-RMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 11 ~~~~rY~i~-~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL-~~l~HpnIv~l~~v~~~~~~~ 88 (506)
...++|.++ +.||+|+||.||+|.+..+++.||||+++. .....+|+.++ +.++||||+++++++.... .
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-A 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-C
Confidence 445788888 789999999999999999999999999863 23466899988 6668999999999885311 2
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC---CCCEEEeecC
Q 044076 89 EFKDIYVVFELMES-DLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA---DCKLKICDFG 162 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~---~~~lKL~DFG 162 (506)
+...+|+||||+++ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 24679999999975 9999998764 6999999999999999999999999999999999999998 7889999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
++.... + ..|+.++|||||||++|+|++|++||.+.+.......+......
T Consensus 166 ~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~-- 216 (299)
T 3m2w_A 166 FAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-- 216 (299)
T ss_dssp TCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCT--
T ss_pred cccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhh--
Confidence 986421 1 35778999999999999999999999776543211110000000
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
.........++.+++++.+||.+||+.||.+|||+.| +|+|
T Consensus 217 ---------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e------------------~l~h 257 (299)
T 3m2w_A 217 ---------------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE------------------FMNH 257 (299)
T ss_dssp ---------------------TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH------------------HHTS
T ss_pred ---------------------ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHH------------------HhcC
Confidence 0000000111458999999999999999999999999 8999
Q ss_pred cccCCCCC
Q 044076 323 PYFHGLAN 330 (506)
Q Consensus 323 P~f~~~~~ 330 (506)
|||.+...
T Consensus 258 p~~~~~~~ 265 (299)
T 3m2w_A 258 PWIMQSTK 265 (299)
T ss_dssp HHHHTGGG
T ss_pred hhhccccc
Confidence 99987654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.08 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=198.9
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECC-CCc--EEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTH-TGE--KVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLP 84 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~-t~~--~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~ 84 (506)
.....++|++++.||+|+||+||+|.+.. +++ .||||+++... ........+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 34556899999999999999999998643 333 69999986432 234456778999999999999999999999853
Q ss_pred CCcCCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecC
Q 044076 85 PCRREFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG 162 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFG 162 (506)
...++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 93 ------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 93 ------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp ------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ------CCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccc
Confidence 34899999998 5999998764 569999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
+++................+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 99765433322222234567888999999977 678999999999999999999 999998887665555442211110
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+++++.+||.+||..||.+|||+.+|
T Consensus 245 -----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 275 (291)
T 1u46_A 245 -----------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275 (291)
T ss_dssp -----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHH
Confidence 1124588999999999999999999999994
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=345.57 Aligned_cols=267 Identities=22% Similarity=0.313 Sum_probs=206.3
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc--cChhHHHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF--EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
..|.....|...+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.+++.++||||+++++++..
T Consensus 25 ~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 101 (307)
T 2nru_A 25 NNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD- 101 (307)
T ss_dssp TTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-
Confidence 4455666677789999999999999975 68899999996432 233456778899999999999999999999844
Q ss_pred CcCCCCcEEEEEecCC-CCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeec
Q 044076 86 CRREFKDIYVVFELME-SDLDQVIKA---NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~-~~L~~~i~~---~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DF 161 (506)
.+..|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 102 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Df 177 (307)
T 2nru_A 102 ----GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDF 177 (307)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred ----CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeec
Confidence 367899999996 599999874 346999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
|+++....... ........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....+..+.......
T Consensus 178 g~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (307)
T 2nru_A 178 GLARASEKFAQ-TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 253 (307)
T ss_dssp TTCEECCSCSS-CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTT
T ss_pred ccccccccccc-cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhh
Confidence 99976433221 112234579999999999865 57899999999999999999999998776554444332211111
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... ...++. ..+....+..++.+.+||.+||+.||.+|||+.+|
T Consensus 254 ~~~---------~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l 297 (307)
T 2nru_A 254 EKT---------IEDYID-------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297 (307)
T ss_dssp SCC---------HHHHSC-------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhh---------hhhhcc-------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHH
Confidence 000 011100 00111112345678999999999999999999994
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=365.30 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=199.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++.+.||+|+||.||+|.+.. +..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 4689999999999999999999864 4679999997432 234568899999999999999999999732 56
Q ss_pred EEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELME-SDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+|+||||++ ++|.++++. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 899999997 599999964 34699999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ......+|..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+......
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------- 400 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 400 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 2111 1123456788999999987 689999999999999999999 99999988776655554321110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+.+++.+.+||.+||+.||.+|||+++|
T Consensus 401 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l 431 (452)
T 1fmk_A 401 ----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYL 431 (452)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 1113578999999999999999999999995
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=342.79 Aligned_cols=241 Identities=30% Similarity=0.436 Sum_probs=192.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||+|+||.||+|.+ .++.||||++.. ......+.+|+.+|+.++||||+++++++. +
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~ 72 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACL-------N 72 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-------T
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------C
Confidence 457899999999999999999986 478999999853 245567889999999999999999999873 3
Q ss_pred cEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCCCcEEECCCCC-EEEeecCC
Q 044076 92 DIYVVFELME-SDLDQVIKAND---DLTPEHHQFFLYQLLRALKYIHS---ANVFHRDLKPKNILANADCK-LKICDFGL 163 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~---~ls~~~~~~i~~QIl~gL~yLH~---~gIvHrDLKp~NILv~~~~~-lKL~DFGl 163 (506)
..|+||||++ ++|.+++.... .++...+..++.||++||+|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 4799999997 49999998765 47899999999999999999999 89999999999999998887 79999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............
T Consensus 153 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------- 216 (307)
T 2eva_A 153 ACDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-------- 216 (307)
T ss_dssp ------------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH--------
T ss_pred ccccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH--------
Confidence 9753221 134469999999999987 689999999999999999999999997543321100000
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..... .....+++++.+.+||.+||+.||.+|||+++|
T Consensus 217 -----------------~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 254 (307)
T 2eva_A 217 -----------------VHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEI 254 (307)
T ss_dssp -----------------HHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------HhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 00000 012234688999999999999999999999995
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=341.54 Aligned_cols=241 Identities=30% Similarity=0.391 Sum_probs=197.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC------
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC------ 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~------ 86 (506)
.++|++++.||+|+||.||+|.+..+++.||||+++... ..+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 357999999999999999999999999999999996421 24668999999999999999999874310
Q ss_pred -----cCCCCcEEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEE
Q 044076 87 -----RREFKDIYVVFELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKI 158 (506)
Q Consensus 87 -----~~~~~~~ylV~E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL 158 (506)
......+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 0123568999999986 999999754 57999999999999999999999999999999999999999999999
Q ss_pred eecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhc
Q 044076 159 CDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238 (506)
Q Consensus 159 ~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~ 238 (506)
+|||++........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..
T Consensus 164 ~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~-------- 227 (284)
T 2a19_B 164 GDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS--KF-------- 227 (284)
T ss_dssp CCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HH--------
T ss_pred Ccchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HH--------
Confidence 99999976433322 244569999999999987 678999999999999999999988773210 00
Q ss_pred CCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 239 g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
...+... ...+.+++.+.+||.+||+.||.+|||+.|
T Consensus 228 -------------------~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 264 (284)
T 2a19_B 228 -------------------FTDLRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSE 264 (284)
T ss_dssp -------------------HHHHHTT------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -------------------HHHhhcc------cccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 0001100 111347889999999999999999999999
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=350.32 Aligned_cols=267 Identities=24% Similarity=0.326 Sum_probs=203.6
Q ss_pred CCCE-EEeEEEeecCceEEEEEE----ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQY-EIQEIIGIGSYGVVASAI----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY-~i~~~LG~G~~g~V~~a~----d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++| ++++.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA-- 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC--
Confidence 3455 999999999999997774 4568899999999753 3345567789999999999999999999998543
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 REFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
+...+|+||||+++ +|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 106 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 106 -GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp -TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred -CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 23678999999975 999998765 599999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...............+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~- 255 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM- 255 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH-
T ss_pred ccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch-
Confidence 5443222222344568889999999987 67899999999999999999999999653211 111111111110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
........+...... .....+++++.+||.+||+.||.+|||+.||
T Consensus 256 ------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 301 (318)
T 3lxp_A 256 ------TVLRLTELLERGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENL 301 (318)
T ss_dssp ------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------hHHHHHHHHhcccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHH
Confidence 001111111111111 1224688999999999999999999999995
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=352.54 Aligned_cols=261 Identities=22% Similarity=0.325 Sum_probs=198.6
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 99 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT-----P 99 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----S
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec-----C
Confidence 4568999999999999999999974 46899999999643211 222357899999999999999999999854 3
Q ss_pred CcEEEEEecCCC-CHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCCCcEEECCCCCEEEeecC
Q 044076 91 KDIYVVFELMES-DLDQVIKAND----DLTPEHHQFFLYQLLRALKYIHSA---NVFHRDLKPKNILANADCKLKICDFG 162 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~----~ls~~~~~~i~~QIl~gL~yLH~~---gIvHrDLKp~NILv~~~~~lKL~DFG 162 (506)
...|+||||+++ +|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 678999999975 9999998643 499999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-----CchhhHHHHHhh
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR-----NVAHQLDLVTDL 237 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~-----~~~~~l~~I~~~ 237 (506)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||... ........+...
T Consensus 180 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 180 LAKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp SCEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9986432222 12345569999999999977 67899999999999999999999999521 111111111111
Q ss_pred cCCCChHHHhhhhhhHHHHHHhhhhccCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPF-SHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 238 ~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
........ ...... ....+..++.+.+||.+||+.||.+|||+.|
T Consensus 256 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 301 (326)
T 3uim_A 256 LKEKKLEA------------------LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301 (326)
T ss_dssp TSSCCSTT------------------SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred hhchhhhh------------------hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHH
Confidence 00000000 000000 0111223467999999999999999999999
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=356.68 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=195.4
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCC---cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTG---EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
.+|++.+.||+|+||.||+|.+..++ ..||||.++.. ........+.+|+.+|+.++||||+++++++... .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence 36889999999999999999875433 46899998643 3445667899999999999999999999987432 3
Q ss_pred CcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
+..|+||||+++ +|.++++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 578999999985 999999865 358999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCC-cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 169 TDTPS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 169 ~~~~~-~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
..... ........+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~------ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------ 315 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC------
Confidence 22211 111234567889999999987 789999999999999999999 78999887765554444221000
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+.+++.+.+||.+||+.||.+|||+.||
T Consensus 316 ------------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 316 ------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0113478899999999999999999999995
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=352.31 Aligned_cols=240 Identities=15% Similarity=0.174 Sum_probs=191.9
Q ss_pred CCCEEEeEEEeecCceEEEEE-----EECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC---CCCcceeceeecC
Q 044076 13 ASQYEIQEIIGIGSYGVVASA-----IDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK---HPDIVEIKHIMLP 84 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a-----~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~---HpnIv~l~~v~~~ 84 (506)
.++|++.+.||+|+||+||+| .+..+++.||||+++. .....+.+|+.+++.+. |+||+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS-----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC-----CChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 578999999999999999999 4678899999999864 23445778888888887 9999999999854
Q ss_pred CCcCCCCcEEEEEecCC-CCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC------
Q 044076 85 PCRREFKDIYVVFELME-SDLDQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA------ 152 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~-~~L~~~i~~-----~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~------ 152 (506)
.+..|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 139 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 -----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp -----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred -----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 377899999997 699999974 457999999999999999999999999999999999999998
Q ss_pred -----CCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCc
Q 044076 153 -----DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV 227 (506)
Q Consensus 153 -----~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~ 227 (506)
++.+||+|||+|+....... ....+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999975432222 223356789999999999987 6799999999999999999999999954321
Q ss_pred hhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhh
Q 044076 228 AHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEE 300 (506)
Q Consensus 228 ~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~e 300 (506)
.... ....+.. ...++...+++.+||+.+|.+|++..+
T Consensus 291 ~~~~---------------------------------~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~ 328 (365)
T 3e7e_A 291 GECK---------------------------------PEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLD 328 (365)
T ss_dssp TEEE---------------------------------ECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHH
T ss_pred Ccee---------------------------------echhccc--cCcHHHHHHHHHHHcCCCCCCcchHHH
Confidence 1000 0000000 124567899999999999999965444
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=342.33 Aligned_cols=268 Identities=22% Similarity=0.369 Sum_probs=206.4
Q ss_pred CCCEEEeEEEeecCceEEEEEE----ECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAI----DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~----d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.++|++++.||+|+||.||+|. +..+++.||||++.. ........+.+|+.+++.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--- 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---
Confidence 4679999999999999999998 567899999999964 3445567789999999999999999999988543
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
+...+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 22478999999975 999999876 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...............++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+.+..+......+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQM 267 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTHH
T ss_pred ccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchhh
Confidence 5433221111233457788999999987 678999999999999999999999885321 112222232221111
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. .......+......+ ..+.+++++.+||.+||+.||.+|||+.||
T Consensus 268 ~------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el 313 (326)
T 2w1i_A 268 I------VFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313 (326)
T ss_dssp H------HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred h------HHHHHHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 011111111111111 224688999999999999999999999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=361.01 Aligned_cols=257 Identities=19% Similarity=0.267 Sum_probs=203.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.|++++..+..+. ....
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~ 76 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG----VEGD 76 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE----EETT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCC
Confidence 468999999999999999999999999999999988643222 23678999999999765555444442 2346
Q ss_pred cEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEE---CCCCCEEEeecCCcccc
Q 044076 92 DIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILA---NADCKLKICDFGLARVS 167 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv---~~~~~lKL~DFGla~~~ 167 (506)
..||||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 7899999998899999985 4579999999999999999999999999999999999999 58899999999999865
Q ss_pred cCCCCCc----ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 168 FTDTPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 168 ~~~~~~~----~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
....... .......||..|+|||++.+ ..++.++||||||||+|+|++|+.||.+.........+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~----- 229 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS----- 229 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH-----
T ss_pred cCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh-----
Confidence 4332211 11235679999999999987 789999999999999999999999998866543333322110
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..... ........++++++.+||.+||+.||.+||++++|
T Consensus 230 -------~~~~~-----------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el 269 (483)
T 3sv0_A 230 -------EKKVA-----------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYL 269 (483)
T ss_dssp -------HHHHH-----------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred -------hcccc-----------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHH
Confidence 00000 00001113578999999999999999999999996
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=384.17 Aligned_cols=285 Identities=27% Similarity=0.358 Sum_probs=211.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC-cCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC-RREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~-~~~~~ 91 (506)
.++|++++.||+|+||.||+|.+..+|+.||||+++.. ........+.+|+.+|+.++||||+++++++.... ....+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47999999999999999999999999999999998643 34455677899999999999999999999875421 12357
Q ss_pred cEEEEEecCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC---EEEeecCCc
Q 044076 92 DIYVVFELME-SDLDQVIKAND---DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK---LKICDFGLA 164 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~---~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~---lKL~DFGla 164 (506)
..|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999996 59999998754 5999999999999999999999999999999999999997765 999999999
Q ss_pred ccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 165 RVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 165 ~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
+....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......... .......
T Consensus 172 ~~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~ 242 (676)
T 3qa8_A 172 KELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNE 242 (676)
T ss_dssp CBTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC-----
T ss_pred cccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccch
Confidence 86433222 245679999999999987 78999999999999999999999999765432211100 0000000
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCC-CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCc
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVP-FSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADP 323 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP 323 (506)
....... ...........+ .....+.+++.+.+||.+||.+||.+|||+.| +|.||
T Consensus 243 ~~~~~~~-----l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e------------------lL~hp 299 (676)
T 3qa8_A 243 HIVVYDD-----LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ------------------NPNVG 299 (676)
T ss_dssp -CCSCCC-----CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT------------------CCCCT
T ss_pred hhhhhhh-----hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH------------------HhcCH
Confidence 0000000 000000000001 11222346789999999999999999999999 89999
Q ss_pred ccCCCCC
Q 044076 324 YFHGLAN 330 (506)
Q Consensus 324 ~f~~~~~ 330 (506)
||+.+.+
T Consensus 300 ~F~~l~~ 306 (676)
T 3qa8_A 300 CFQALDS 306 (676)
T ss_dssp THHHHHH
T ss_pred HHHHHHH
Confidence 9987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=371.25 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=201.3
Q ss_pred CCCCEEEeE-EEeecCceEEEEEEECC--CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 12 EASQYEIQE-IIGIGSYGVVASAIDTH--TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 12 ~~~rY~i~~-~LG~G~~g~V~~a~d~~--t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
..++|.+.+ .||+|+||.||+|.+.. ++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---- 407 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 407 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----
Confidence 345677776 89999999999998753 5667999999753 233456778999999999999999999999842
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
+.+|+||||+++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 408 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp --SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred --CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 458999999985 999998754 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAES 245 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~ 245 (506)
...............+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....|....
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------- 556 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------- 556 (613)
T ss_dssp CC--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-------
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 4332221111122345688999999977 689999999999999999998 999999887766655553211
Q ss_pred HhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ...+++++++.+||.+||+.||.+|||+.+|
T Consensus 557 --------------------~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 589 (613)
T 2ozo_A 557 --------------------RM---ECPPECPPELYALMSDCWIYKWEDRPDFLTV 589 (613)
T ss_dssp --------------------CC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred --------------------CC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 00 1124588999999999999999999999995
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=368.54 Aligned_cols=246 Identities=26% Similarity=0.366 Sum_probs=203.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|+.++||||+++++++.. .
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~ 334 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 334 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------c
Confidence 34689999999999999999999864 4679999997432 234568899999999999999999999732 5
Q ss_pred cEEEEEecCCC-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 92 DIYVVFELMES-DLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
.+|||||||++ +|.++++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 68999999985 999999643 469999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... ........++..|+|||++.. ..++.++|||||||++|||++ |+.||.+....+.+..+.....
T Consensus 415 ~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------- 482 (535)
T 2h8h_A 415 DNE--YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------- 482 (535)
T ss_dssp CHH--HHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC--------
T ss_pred CCc--eecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 211 011123446788999999987 689999999999999999999 9999998877666555532111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ...+.+++.+.+||.+||+.||.+|||+++|
T Consensus 483 -------------------~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 514 (535)
T 2h8h_A 483 -------------------M---PCPPECPESLHDLMCQCWRKEPEERPTFEYL 514 (535)
T ss_dssp -------------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -------------------C---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1 1113578999999999999999999999995
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=341.12 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=188.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC--CCCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRML--KHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l--~HpnIv~l~~v~~~~~~~~~ 90 (506)
.++|++++.||+|+||.||+|.+. ++.||||++.. .......+|..++..+ +||||+++++++.... ...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFT-----TEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEec-----cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCC
Confidence 468999999999999999999874 89999999853 2233445666666555 8999999999886532 122
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCCCCcEEECCCCCEEEeec
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA--------NVFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~--------gIvHrDLKp~NILv~~~~~lKL~DF 161 (506)
..+|+||||+++ +|.++++.. .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 679999999975 999999765 699999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCCCC-cccccccccCCcccCcccccccCCCCCc------hhhhhhhhHHHHHHHhC----------CCCCCC
Q 044076 162 GLARVSFTDTPS-AIFWTDYVATRWYRAPELCGSFFSKYTP------AIDIWSIGCIFAELLTG----------RPLFPG 224 (506)
Q Consensus 162 Gla~~~~~~~~~-~~~~~~~vgt~~Y~APE~l~~~~~~~s~------~~DIWSlG~il~eLl~G----------~~pF~~ 224 (506)
|+++........ ........||+.|+|||++.+ ..++. ++|||||||++|||++| ..||..
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999764332221 111234579999999999876 34443 49999999999999999 555543
Q ss_pred CCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 225 RNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 225 ~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..... +....+ .............+.......+++++.+||.+||+.||.+|||+.||
T Consensus 265 ~~~~~-----------~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 265 LVPSD-----------PSYEDM--------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp TSCSS-----------CCHHHH--------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hcCCC-----------Cchhhh--------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 22111 000000 00000000000000000012356779999999999999999999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=341.93 Aligned_cols=253 Identities=20% Similarity=0.255 Sum_probs=199.2
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++.+.||+|+||.||+|.+.. .||+|+++...........+.+|+.+++.++||||+++++++.. .
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 101 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----P 101 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----S
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence 345899999999999999999998754 49999997543344444557789999999999999999999854 3
Q ss_pred CcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 91 KDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
..+|+||||++ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 67999999997 59999998754 699999999999999999999999999999999999998 7899999999987532
Q ss_pred CCC--CCcccccccccCCcccCccccccc-------CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcC
Q 044076 169 TDT--PSAIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 169 ~~~--~~~~~~~~~vgt~~Y~APE~l~~~-------~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g 239 (506)
... ..........||..|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 211 111122345689999999998641 14589999999999999999999999988776554444322100
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. .....++++++.+||.+||..||.+|||+.+|
T Consensus 261 ---------------------------~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 293 (319)
T 2y4i_B 261 ---------------------------P--NLSQIGMGKEISDILLFCWAFEQEERPTFTKL 293 (319)
T ss_dssp ---------------------------C--CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHH
T ss_pred ---------------------------C--CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 0 01112477889999999999999999999994
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=354.59 Aligned_cols=254 Identities=18% Similarity=0.139 Sum_probs=189.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc------ChhHHHHHHHHHHHHHhCC---------CCCcc
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE------HVSDATRILREIKLLRMLK---------HPDIV 76 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~------~~~~~~~~~rEi~iL~~l~---------HpnIv 76 (506)
..++|++++.||+|+||+||+|++ +|+.||||++..... .......+.+|+.+|+.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 457899999999999999999987 789999999964321 2233467889999998886 66666
Q ss_pred eeceeecCCC-------------------------cCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 044076 77 EIKHIMLPPC-------------------------RREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRAL 130 (506)
Q Consensus 77 ~l~~v~~~~~-------------------------~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL 130 (506)
++.+++.... ..+...+|+||||+++ ++.+.+.. ..+++..++.+++||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 6666542110 0124789999999964 45554433 5789999999999999999
Q ss_pred HHHH-hCCeeecCCCCCcEEECCCC--------------------CEEEeecCCcccccCCCCCcccccccccCCcccCc
Q 044076 131 KYIH-SANVFHRDLKPKNILANADC--------------------KLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189 (506)
Q Consensus 131 ~yLH-~~gIvHrDLKp~NILv~~~~--------------------~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~AP 189 (506)
+||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~aP 246 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTTCS
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecccCh
Confidence 9999 99999999999999999887 899999999986432 234799999999
Q ss_pred ccccccCCCCCchhhhhhhhHH-HHHHHhCCCCCCCCCchh-hHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCC
Q 044076 190 ELCGSFFSKYTPAIDIWSIGCI-FAELLTGRPLFPGRNVAH-QLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAV 267 (506)
Q Consensus 190 E~l~~~~~~~s~~~DIWSlG~i-l~eLl~G~~pF~~~~~~~-~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~ 267 (506)
|++.+ .. +.++||||+|++ .++++.|..||.+..... ....+..... ....
T Consensus 247 E~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------~~~~ 299 (336)
T 2vuw_A 247 DLFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT------------------------FKTK 299 (336)
T ss_dssp GGGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC------------------------CSSC
T ss_pred hhhcC--CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc------------------------cCcc
Confidence 99987 33 889999998777 778888999984321111 1111111000 0001
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhc-cCcccC
Q 044076 268 PFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLAL-ADPYFH 326 (506)
Q Consensus 268 ~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL-~HP~f~ 326 (506)
+....++.+++++.+||++||++| ||+| +| +||||+
T Consensus 300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e------------------~l~~Hp~f~ 336 (336)
T 2vuw_A 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATD------------------LLCQHSLFK 336 (336)
T ss_dssp CCSHHHHHHHHHHHHHHHHGGGSS-----SHHH------------------HHHHCGGGC
T ss_pred cchhhhhhcCHHHHHHHHHHhccC-----CHHH------------------HHhcCCCcC
Confidence 111122346889999999999987 9999 89 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=366.54 Aligned_cols=248 Identities=26% Similarity=0.413 Sum_probs=203.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCC---CcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHT---GEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t---~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~ 89 (506)
.++|++++.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 46899999999999999999998654 457999998642 334455778999999999999999999998732
Q ss_pred CCcEEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 90 FKDIYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
+.+|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 46899999998 59999998654 6999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
..... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 542 ~~~~~--~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------ 611 (656)
T 2j0j_A 542 EDSTY--YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------ 611 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC------
T ss_pred CCCcc--eeccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 33221 11233457789999999977 689999999999999999997 99999988776665555321110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+++++.+.+||.+||..||.+|||+.||
T Consensus 612 ------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el 642 (656)
T 2j0j_A 612 ------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642 (656)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1124688999999999999999999999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=336.39 Aligned_cols=258 Identities=22% Similarity=0.282 Sum_probs=194.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHh--CCCCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM--LKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~--l~HpnIv~l~~v~~~~~~~~~ 90 (506)
.++|++.+.||+|+||.||+|.+ +|+.||||++.. .....+.+|+.+++. ++||||+++++++.... ...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Ccc
Confidence 46899999999999999999987 589999999863 234567789999988 68999999999986542 112
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeecCCCCCcEEECCCCCEEEeec
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH--------SANVFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH--------~~gIvHrDLKp~NILv~~~~~lKL~DF 161 (506)
..+|+||||+++ +|.+++... .+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 479999999985 999999764 6999999999999999999999 899999999999999999999999999
Q ss_pred CCcccccCCCCCc-ccccccccCCcccCcccccccCC----CCCchhhhhhhhHHHHHHHhC----------CCCCCCCC
Q 044076 162 GLARVSFTDTPSA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTG----------RPLFPGRN 226 (506)
Q Consensus 162 Gla~~~~~~~~~~-~~~~~~vgt~~Y~APE~l~~~~~----~~s~~~DIWSlG~il~eLl~G----------~~pF~~~~ 226 (506)
|+++......... .......||+.|+|||++.+... .++.++|||||||++|+|++| ..||.+..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9997643332110 11244579999999999876211 234789999999999999999 66775542
Q ss_pred chh-hHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 227 VAH-QLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKF--PGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 227 ~~~-~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+ ....+... +. .......+...+ ..+++.+.+||.+||+.||.+|||+.||
T Consensus 272 ~~~~~~~~~~~~--------------------~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 272 PSDPSVEEMRKV--------------------VC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp CSSCCHHHHHHH--------------------HT--TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCcccHHHHHHH--------------------HH--HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 211 01111000 00 000000000111 1234678999999999999999999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.06 Aligned_cols=225 Identities=18% Similarity=0.116 Sum_probs=183.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++..++||||+++++++.. .
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 103 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----R 103 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----C
Confidence 45789999999999999999999999999999999975433 34456778999999999999999999999843 3
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+..|+||||++ ++|.++++.+ ....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|.
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~------ 175 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------ 175 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC------
T ss_pred CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc------
Confidence 78999999998 4999998643 46677889999999999999999999999999999999999999985432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHh-hcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD-LLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~-~~g~p~~e~~~~ 248 (506)
++ .++.++|||||||++|+|++|+.||.+.+..+.+..... ..+.+
T Consensus 176 -----------------~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------- 222 (286)
T 3uqc_A 176 -----------------MP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP------- 222 (286)
T ss_dssp -----------------CT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCB-------
T ss_pred -----------------cC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCC-------
Confidence 22 368899999999999999999999988765432210000 01111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.+.....+++++++.+||.+||+.||.+| |+.|+
T Consensus 223 ------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el 256 (286)
T 3uqc_A 223 ------------------IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTL 256 (286)
T ss_dssp ------------------CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHH
T ss_pred ------------------CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHH
Confidence 01112235689999999999999999999 99995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=365.59 Aligned_cols=242 Identities=28% Similarity=0.381 Sum_probs=192.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECC-CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTH-TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~-t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||+||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++......+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4899999999999999999999976 7899999998642 3344556788999999999999999999998654222222
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
..||||||+++ +|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 37999999985 88877654 79999999999999999999999999999999999999875 9999999999764322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.++|.+.... +.+....
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~~----- 289 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDDP----- 289 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTCH-----
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------ccccccc-----
Confidence 34569999999999876 3589999999999999999999998653211 0110000
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhh
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTE 305 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~ 305 (506)
....++.+.+||.+||+.||.+||+..+...++
T Consensus 290 ----------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 322 (681)
T 2pzi_A 290 ----------------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322 (681)
T ss_dssp ----------------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred ----------------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence 001457799999999999999999877743333
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-33 Score=305.58 Aligned_cols=186 Identities=18% Similarity=0.134 Sum_probs=133.4
Q ss_pred EeecCceEEEEEEECCCCcEEEEEEeccccc--------ChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcCCCCc
Q 044076 22 IGIGSYGVVASAIDTHTGEKVAIKKMKEVFE--------HVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 22 LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~--------~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.+.|+.|.+..++...+|+.||+|++..... .....+.+.+|+.+|+++ .|+||+++++++ ++.+.
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECCE
Confidence 4567777777777778899999999964321 123456689999999999 599999999998 55589
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+||||||++| +|.++|+..+.+++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999996 999999998888875 478999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCC
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPL 221 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~p 221 (506)
. ..+..+||+.|+|||++.+ .+..++|+||+|+++++|+++..+
T Consensus 394 ~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred c---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 2 2356789999999999976 467789999999999888766433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=258.71 Aligned_cols=189 Identities=21% Similarity=0.280 Sum_probs=141.1
Q ss_pred EEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-C-----hhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 17 EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-H-----VSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 17 ~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~-----~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...+.||+|+||.||+| ...+..+++|++..... . ....+++.+|+.+|+.++||||+++..+... .
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-----L 411 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----T
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----C
Confidence 44679999999999999 46788999998743211 1 1124568899999999999999944443322 2
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+..|+||||++ ++|.+++.. +..++.||+.||+|||++||+||||||+|||++. .+||+|||+|+....
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 45699999997 699999875 6689999999999999999999999999999998 999999999987432
Q ss_pred CCCCc----ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCC
Q 044076 170 DTPSA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLF 222 (506)
Q Consensus 170 ~~~~~----~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF 222 (506)
..... .......||++|+|||++......|+..+|+|+.++-..+.+.++..|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21110 012356799999999998764456888899999998888887776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9e-25 Score=217.44 Aligned_cols=147 Identities=17% Similarity=0.200 Sum_probs=117.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh----------------hHHHHHHHHHHHHHhCCCCCcc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV----------------SDATRILREIKLLRMLKHPDIV 76 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~----------------~~~~~~~rEi~iL~~l~HpnIv 76 (506)
...|.+++.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 44566779999999999999999 889999999996321110 13456889999999999 5 6
Q ss_pred eeceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCC
Q 044076 77 EIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCK 155 (506)
Q Consensus 77 ~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~ 155 (506)
++.+++. .+..|+||||++| +|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.
T Consensus 165 ~v~~~~~------~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 165 AVPKVYA------WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp SSCCEEE------EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred CcCeEEe------ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence 6666552 1456999999986 8877 32 134567999999999999999999999999999999 999
Q ss_pred EEEeecCCcccccCCCCCcccccccccCCcccCccccc
Q 044076 156 LKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193 (506)
Q Consensus 156 lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~ 193 (506)
+||+|||+|+. +..|.|||++.
T Consensus 231 vkl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred EEEEECCCCeE----------------CCCCCHHHHHH
Confidence 99999999963 33468899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=191.22 Aligned_cols=141 Identities=17% Similarity=0.169 Sum_probs=109.7
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcE--EEEEEecccccCh----------------------hHHHHHHHHHHHHHh
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEK--VAIKKMKEVFEHV----------------------SDATRILREIKLLRM 69 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~--vAIK~i~~~~~~~----------------------~~~~~~~rEi~iL~~ 69 (506)
.-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3588999999999999999998788999 9999875321110 112357899999999
Q ss_pred CCCCCcceeceeecCCCcCCCCcEEEEEecCCC------CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecC
Q 044076 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELMES------DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH-SANVFHRD 142 (506)
Q Consensus 70 l~HpnIv~l~~v~~~~~~~~~~~~ylV~E~~~~------~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH-~~gIvHrD 142 (506)
+.|++|....-+. ....||||||+++ +|.++... .++..+..++.||+.||.||| ++||+|||
T Consensus 127 l~~~~i~~p~~~~-------~~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrD 196 (258)
T 1zth_A 127 AKEAGVSVPQPYT-------YMKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHAD 196 (258)
T ss_dssp HHHTTCCCCCEEE-------EETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred HHhCCCCCCeEEE-------cCCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 9888652221111 1356899999953 67766432 335578899999999999999 99999999
Q ss_pred CCCCcEEECCCCCEEEeecCCccc
Q 044076 143 LKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 143 LKp~NILv~~~~~lKL~DFGla~~ 166 (506)
|||+|||++. .++|+|||+|..
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEE
T ss_pred CCHHHEEEcC--cEEEEECccccc
Confidence 9999999998 999999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.4e-18 Score=176.33 Aligned_cols=137 Identities=15% Similarity=0.195 Sum_probs=96.2
Q ss_pred CEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc---C---------hhHHHH--------HHHHHHHHHhCCCCC
Q 044076 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE---H---------VSDATR--------ILREIKLLRMLKHPD 74 (506)
Q Consensus 15 rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~---~---------~~~~~~--------~~rEi~iL~~l~Hpn 74 (506)
-|++++.||.|++|.||+|.+ .+|+.||||+++.... . ...... ..+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 499999999999999999997 4799999998753110 0 000111 224555565554333
Q ss_pred cceeceeecCCCcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC
Q 044076 75 IVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD 153 (506)
Q Consensus 75 Iv~l~~v~~~~~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~ 153 (506)
+... ..+ .....+|||||++| .|.++. .......++.||+.+|.+||++|||||||||.|||++.+
T Consensus 175 v~vp-~p~------~~~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVP-EPI------AQSRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCC-CEE------EEETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred CCCC-eee------eccCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 2211 111 01234799999987 554432 223456788999999999999999999999999999987
Q ss_pred CC----------EEEeecCCcc
Q 044076 154 CK----------LKICDFGLAR 165 (506)
Q Consensus 154 ~~----------lKL~DFGla~ 165 (506)
+. +.|+||+.+.
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCE
T ss_pred CCcccccccccceEEEEeCCcc
Confidence 73 8999999875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=8.6e-12 Score=121.26 Aligned_cols=139 Identities=13% Similarity=0.107 Sum_probs=106.5
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~ 92 (506)
..|++...++.|+.+.||++.. .+..+++|....... .....+.+|+.+|+.+. +..+.+++++.. +.+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCc
Confidence 4588999999999999999964 468899999864211 12234789999999985 667777887763 2367
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS------------------------------------ 135 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~------------------------------------ 135 (506)
.|+|||+++| +|.+.+. +......++.++.++|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 8999999998 7766521 122345788899999999998
Q ss_pred -----------------------CCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 136 -----------------------ANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 136 -----------------------~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..++|+|++|.||+++.++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765567999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-10 Score=111.88 Aligned_cols=134 Identities=15% Similarity=0.080 Sum_probs=95.2
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC--cceeceeecCCCcCCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD--IVEIKHIMLPPCRREFK 91 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn--Iv~l~~v~~~~~~~~~~ 91 (506)
..|.+....+.|..+.||++. ..+|..+++|..... ....+.+|+.+++.+.+.+ +.+++.+... .+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AG 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SS
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CC
Confidence 456665544566679999995 356778999987542 2234678999999886444 4456666532 25
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN--------------------------------- 137 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~g--------------------------------- 137 (506)
..|+|||+++| +| . . ...+ ...++.++++.|..||+..
T Consensus 89 ~~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 68999999997 55 2 1 1122 2356778888888888754
Q ss_pred -------------------------eeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 138 -------------------------VFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 138 -------------------------IvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
++|+|++|.||+++.++.+.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998853
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1e-10 Score=116.47 Aligned_cols=184 Identities=20% Similarity=0.260 Sum_probs=119.6
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCc--ceeceeecCCCcCCCCcEEE
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDI--VEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnI--v~l~~v~~~~~~~~~~~~yl 95 (506)
++.++.|....||++. ..+++|+... ......+.+|..+|+.+. +..| ..++... .........|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceE
Confidence 4569999999999873 4588998642 234567889999998884 3332 2222221 11122234589
Q ss_pred EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 044076 96 VFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS--------------------------------------- 135 (506)
Q Consensus 96 V~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~--------------------------------------- 135 (506)
||++++| .|..... ..++......++.|++..|+.||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999998 4543322 247788888889999999988886
Q ss_pred -------------------CCeeecCCCCCcEEECC--CCCEEEeecCCcccccCCCCCcccccccccCCcc---cCccc
Q 044076 136 -------------------ANVFHRDLKPKNILANA--DCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY---RAPEL 191 (506)
Q Consensus 136 -------------------~gIvHrDLKp~NILv~~--~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y---~APE~ 191 (506)
..++|+|++|.||+++. ++.+.|+||+.+...... .+......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-------~Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-------NDFISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-------HHHHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-------HHHHHHHhhccccCHHH
Confidence 13799999999999998 456789999998763211 011111111 22322
Q ss_pred ccc---cCCC---------CCchhhhhhhhHHHHHHHhCCCCC
Q 044076 192 CGS---FFSK---------YTPAIDIWSIGCIFAELLTGRPLF 222 (506)
Q Consensus 192 l~~---~~~~---------~s~~~DIWSlG~il~eLl~G~~pF 222 (506)
... .+.. .....+.|++|.+++.+.+|.++|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 110 0001 112368999999999999998766
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=4.2e-10 Score=114.72 Aligned_cols=144 Identities=13% Similarity=0.221 Sum_probs=104.0
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEec--ccccChhHHHHHHHHHHHHHhCC--CCCcceeceeecCCCcCCCC
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK--EVFEHVSDATRILREIKLLRMLK--HPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~--~~~~~~~~~~~~~rEi~iL~~l~--HpnIv~l~~v~~~~~~~~~~ 91 (506)
...++.|+.|.++.||++.. .+..+++|+.. .. ........+.+|+.+|+.+. +..+.+++.+.... ...+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~-~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKS-KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTS
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCC-CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccC
Confidence 34578899999999999964 35678888765 21 11123446789999999997 45577777766432 2225
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS----------------------------------- 135 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~----------------------------------- 135 (506)
..|+|||+++| .+.+. ....++......++.++++.|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 58999999997 44221 12347888889999999999999997
Q ss_pred -----------------------CCeeecCCCCCcEEECCCCC--EEEeecCCccc
Q 044076 136 -----------------------ANVFHRDLKPKNILANADCK--LKICDFGLARV 166 (506)
Q Consensus 136 -----------------------~gIvHrDLKp~NILv~~~~~--lKL~DFGla~~ 166 (506)
.+++|||++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999998764 69999999865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.2e-06 Score=87.27 Aligned_cols=133 Identities=23% Similarity=0.229 Sum_probs=90.9
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC---cceeceeecCCCcCCCCcEEE
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD---IVEIKHIMLPPCRREFKDIYV 95 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn---Iv~l~~v~~~~~~~~~~~~yl 95 (506)
++.++.|....||+. +..+++|+-. .......+.+|..+|+.+.+.. |.+++.+.. ...+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEE
Confidence 566889999999988 5668888753 2234567889999999997531 333333332 12355789
Q ss_pred EEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 044076 96 VFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA-------------------------------------- 136 (506)
Q Consensus 96 V~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~-------------------------------------- 136 (506)
|||+++| .|....- ..++......+..|+.+.|+.||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 4544221 1345555555666666666655542
Q ss_pred ----------------------CeeecCCCCCcEEECC---CCCE-EEeecCCccc
Q 044076 137 ----------------------NVFHRDLKPKNILANA---DCKL-KICDFGLARV 166 (506)
Q Consensus 137 ----------------------gIvHrDLKp~NILv~~---~~~l-KL~DFGla~~ 166 (506)
.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999997 4665 8999999865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=2.9e-06 Score=82.18 Aligned_cols=132 Identities=20% Similarity=0.239 Sum_probs=90.6
Q ss_pred EEeecCce-EEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCcEEEEEe
Q 044076 21 IIGIGSYG-VVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKDIYVVFE 98 (506)
Q Consensus 21 ~LG~G~~g-~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~~ylV~E 98 (506)
.+..|..| .||+......+..+++|+-.. .....+.+|..+|+.+. +--|-+++.+.. +.+..|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEE
Confidence 44455554 699988777778899998642 34566889999999885 322445555542 2367899999
Q ss_pred cCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 044076 99 LMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSA----------------------------------------- 136 (506)
Q Consensus 99 ~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~----------------------------------------- 136 (506)
+++| ++.+..... ......+..++...|.-||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9997 666554321 222334555666666666531
Q ss_pred -----------------CeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 137 -----------------NVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 137 -----------------gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 169999999999999877677999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=5.1e-06 Score=85.48 Aligned_cols=78 Identities=18% Similarity=0.083 Sum_probs=48.7
Q ss_pred EeEEEeecCceEEEEEEECCCCcEEEEEEeccccc--C---hhHHHHHHHHHHHHHhCCC--CCcc-eeceeecCCCcCC
Q 044076 18 IQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE--H---VSDATRILREIKLLRMLKH--PDIV-EIKHIMLPPCRRE 89 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~--~---~~~~~~~~rEi~iL~~l~H--pnIv-~l~~v~~~~~~~~ 89 (506)
..+.||.|..+.||++.+..+++.|+||....... . .....++.+|..+|+.+.. |..+ +++.+.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d------- 106 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD------- 106 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------
Confidence 46789999999999997666678899998643111 0 1123456789999988742 3333 444331
Q ss_pred CCcEEEEEecCCC
Q 044076 90 FKDIYVVFELMES 102 (506)
Q Consensus 90 ~~~~ylV~E~~~~ 102 (506)
....++|||++++
T Consensus 107 ~~~~~lvmE~l~g 119 (397)
T 2olc_A 107 TEMAVTVMEDLSH 119 (397)
T ss_dssp TTTTEEEECCCTT
T ss_pred CCccEEEEEeCCC
Confidence 1345899999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=6.9e-06 Score=81.99 Aligned_cols=30 Identities=20% Similarity=0.324 Sum_probs=27.6
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=1.1e-05 Score=81.53 Aligned_cols=85 Identities=8% Similarity=0.136 Sum_probs=51.6
Q ss_pred EEEeEEE-eecCceEEEEEEECC------CCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCC-C--CCcceeceeecC
Q 044076 16 YEIQEII-GIGSYGVVASAIDTH------TGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLK-H--PDIVEIKHIMLP 84 (506)
Q Consensus 16 Y~i~~~L-G~G~~g~V~~a~d~~------t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~-H--pnIv~l~~v~~~ 84 (506)
....+.| +.|....+|+..... ++..+++|+...... .......+.+|+.+|+.+. + -.+.+++.+...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 888899999886430 256788987643110 0001134678888888875 3 245556655422
Q ss_pred CCcCCCCcEEEEEecCCC
Q 044076 85 PCRREFKDIYVVFELMES 102 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~~ 102 (506)
. ...+..|+|||+++|
T Consensus 102 ~--~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 G--DVLGTPFFLMDYVEG 117 (357)
T ss_dssp S--TTTSSCEEEEECCCC
T ss_pred C--CccCCceEEEEecCC
Confidence 2 112456899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00032 Score=72.67 Aligned_cols=32 Identities=16% Similarity=0.318 Sum_probs=28.4
Q ss_pred HhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 134 HSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 134 H~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999999876 99999999865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00039 Score=68.52 Aligned_cols=68 Identities=13% Similarity=-0.012 Sum_probs=41.4
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCc-ceeceeecCCCcCCCCcEEEEE
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI-VEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnI-v~l~~v~~~~~~~~~~~~ylV~ 97 (506)
++.|+.|....+|++ ..+++|+........ ....+|+.+++.+..-.+ .+++.+. .+.-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEE
Confidence 788999999999999 458888875321111 112468877777752222 2344332 12347899
Q ss_pred ecC-CC
Q 044076 98 ELM-ES 102 (506)
Q Consensus 98 E~~-~~ 102 (506)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0011 Score=66.04 Aligned_cols=75 Identities=15% Similarity=0.092 Sum_probs=53.9
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-C--CCcceeceeecCCCcCCCCc
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-H--PDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-H--pnIv~l~~v~~~~~~~~~~~ 92 (506)
-.-.+.|+.|....+|+... .+..+++|.... .....+.+|...|+.|. + ..+.+++.+.. ..+.
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~ 105 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGH 105 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSE
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCc
Confidence 34467899999999999964 567888998643 23566788999998884 2 34555655542 2367
Q ss_pred EEEEEecCCC
Q 044076 93 IYVVFELMES 102 (506)
Q Consensus 93 ~ylV~E~~~~ 102 (506)
.|+|||+++|
T Consensus 106 ~~lvme~l~G 115 (312)
T 3jr1_A 106 SFLLLEALNK 115 (312)
T ss_dssp EEEEEECCCC
T ss_pred eEEEEEeccC
Confidence 8999999985
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0037 Score=58.74 Aligned_cols=96 Identities=19% Similarity=0.145 Sum_probs=66.1
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH-HhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccccccc
Q 044076 103 DLDQVIKA-NDDLTPEHHQFFLYQLLRALKYI-HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDY 180 (506)
Q Consensus 103 ~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yL-H~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~ 180 (506)
+|.++++. +.++++++++.+++|.+.+|+-+ +.++-..+=+.|..|++..+|.|.+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----~--------- 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----A--------- 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----c---------
Confidence 79999986 56899999999999999998876 222222334457899999999998764 2211 0
Q ss_pred ccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh
Q 044076 181 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 217 (506)
Q Consensus 181 vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~ 217 (506)
....+.|||... ...+.+.=|+|||+++|.-+-
T Consensus 99 -~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 99 -GEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred -cccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence 122356888763 356778899999999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00095 Score=66.04 Aligned_cols=149 Identities=14% Similarity=0.085 Sum_probs=79.2
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC--cceeceeecCCC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD--IVEIKHIMLPPC 86 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn--Iv~l~~v~~~~~ 86 (506)
.|+. +...-++.|+.|....||++... +| .+++|..... .....+..|+.+++.|.... +.+++... ...
T Consensus 18 ~~~~-~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~ 89 (322)
T 2ppq_A 18 QYDV-GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGE 89 (322)
T ss_dssp TBCC-CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCC
T ss_pred hCCC-CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCC
Confidence 3444 34445677888888999998642 33 6889987541 12234567888887775222 22222110 000
Q ss_pred --cCCCCcEEEEEecCCCC-H---------------HHHHHhCCC--------CCHHHHHHH---------------HHH
Q 044076 87 --RREFKDIYVVFELMESD-L---------------DQVIKANDD--------LTPEHHQFF---------------LYQ 125 (506)
Q Consensus 87 --~~~~~~~ylV~E~~~~~-L---------------~~~i~~~~~--------ls~~~~~~i---------------~~Q 125 (506)
....+..++|+++++|. + ..+...... ......... -..
T Consensus 90 ~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~ 169 (322)
T 2ppq_A 90 LLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREE 169 (322)
T ss_dssp SCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHH
T ss_pred EEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHH
Confidence 01124578999999862 1 111111111 111110100 011
Q ss_pred HHHHHHHHHh-------CCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 126 LLRALKYIHS-------ANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 126 Il~gL~yLH~-------~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
+...+..+.. .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3344455542 369999999999999877656899999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0064 Score=59.21 Aligned_cols=77 Identities=10% Similarity=0.006 Sum_probs=51.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCC---CcceeceeecCCCcCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP---DIVEIKHIMLPPCRREF 90 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hp---nIv~l~~v~~~~~~~~~ 90 (506)
.+..-++.+|.|..+.||+... .+|+.|++|+-... .......+.+|...|+.|.-- -+.+++.+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~--~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--------- 82 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDD--APALDGLFRAEALGLDWLGRSFGSPVPQVAGW--------- 82 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTT--CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---------
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCC--CcchhhHHHHHHHHHHHHHhhCCCCcceEEec---------
Confidence 3566688999999999999974 67899999986432 112223467899999888522 23333332
Q ss_pred CcEEEEEecCCC
Q 044076 91 KDIYVVFELMES 102 (506)
Q Consensus 91 ~~~ylV~E~~~~ 102 (506)
+.-++|||++++
T Consensus 83 ~~~~lv~e~l~~ 94 (288)
T 3f7w_A 83 DDRTLAMEWVDE 94 (288)
T ss_dssp ETTEEEEECCCC
T ss_pred cCceEEEEeecc
Confidence 234789999863
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0037 Score=65.06 Aligned_cols=72 Identities=13% Similarity=0.092 Sum_probs=47.5
Q ss_pred EeEEEeecCceEEEEEEECC-------CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCc-ceeceeecCCCcCC
Q 044076 18 IQEIIGIGSYGVVASAIDTH-------TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI-VEIKHIMLPPCRRE 89 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~-------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnI-v~l~~v~~~~~~~~ 89 (506)
-++.|+.|....||++.... .+..|++|+.... . ....+.+|..+++.|...++ .++++.+ .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~- 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIF-----S- 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEE-----T-
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEe-----C-
Confidence 35678889899999997542 3578999987421 1 11345589999988863333 4555554 1
Q ss_pred CCcEEEEEecCCC
Q 044076 90 FKDIYVVFELMES 102 (506)
Q Consensus 90 ~~~~ylV~E~~~~ 102 (506)
. .+|+||++|
T Consensus 147 --~-g~v~e~l~G 156 (429)
T 1nw1_A 147 --G-GRLEEYIPS 156 (429)
T ss_dssp --T-EEEECCCCE
T ss_pred --C-CEEEEEeCC
Confidence 1 389999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0034 Score=62.11 Aligned_cols=139 Identities=16% Similarity=0.101 Sum_probs=77.7
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC--cceeceeecCCC--cCCCCcEE
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD--IVEIKHIMLPPC--RREFKDIY 94 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn--Iv~l~~v~~~~~--~~~~~~~y 94 (506)
+..++ |....||++.. .+|+.+++|..... ......+.+|..+++.+.... +.+++.. ... ....+..+
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~---~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYF 103 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCC---CCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEE
Confidence 34566 88889998753 35667999998521 113345677888888875222 3333332 110 01134668
Q ss_pred EEEecCCC-C-----HH---H---HH----H--hC------CCCCHHHH----------------------HHHHHHHHH
Q 044076 95 VVFELMES-D-----LD---Q---VI----K--AN------DDLTPEHH----------------------QFFLYQLLR 128 (506)
Q Consensus 95 lV~E~~~~-~-----L~---~---~i----~--~~------~~ls~~~~----------------------~~i~~QIl~ 128 (506)
+||++++| . .. . .+ . .. ..++.... ...+.+++.
T Consensus 104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 183 (328)
T 1zyl_A 104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA 183 (328)
T ss_dssp EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence 89999986 1 11 1 11 0 00 01221111 111222222
Q ss_pred HHHHH----HhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 129 ALKYI----HSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 129 gL~yL----H~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22222 234689999999999999 4 899999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0019 Score=64.32 Aligned_cols=32 Identities=25% Similarity=0.460 Sum_probs=27.7
Q ss_pred hCCeeecCCCCCcEEECCC----CCEEEeecCCccc
Q 044076 135 SANVFHRDLKPKNILANAD----CKLKICDFGLARV 166 (506)
Q Consensus 135 ~~gIvHrDLKp~NILv~~~----~~lKL~DFGla~~ 166 (506)
...++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999875 6799999999864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0029 Score=64.81 Aligned_cols=135 Identities=13% Similarity=0.151 Sum_probs=79.2
Q ss_pred eEEEeecCceEEEEEEECC-------CCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCC
Q 044076 19 QEIIGIGSYGVVASAIDTH-------TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~-------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~ 90 (506)
++.|..|-...+|++.... +++.|++|+.... ......+.+|..+++.|. +.-..+++..+ ++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC-
Confidence 4667778889999997532 3578999986321 123445668999998885 32234455554 11
Q ss_pred CcEEEEEecCCC-CH-----------HHHH---H---hCC-----CC--CHHHHHHHHHHHHH-----------------
Q 044076 91 KDIYVVFELMES-DL-----------DQVI---K---AND-----DL--TPEHHQFFLYQLLR----------------- 128 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L-----------~~~i---~---~~~-----~l--s~~~~~~i~~QIl~----------------- 128 (506)
.+||||++| .| ..+. . ... .. -...+..++.|+..
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 299999975 11 1111 1 110 11 23556666655432
Q ss_pred --HHHHHH----h----CCeeecCCCCCcEEECCC----CCEEEeecCCcc
Q 044076 129 --ALKYIH----S----ANVFHRDLKPKNILANAD----CKLKICDFGLAR 165 (506)
Q Consensus 129 --gL~yLH----~----~gIvHrDLKp~NILv~~~----~~lKL~DFGla~ 165 (506)
.+..|. . ..++|+|+.+.||+++.+ +.+.|+||..|.
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 123332 2 258999999999999876 789999998875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0045 Score=62.60 Aligned_cols=73 Identities=7% Similarity=-0.012 Sum_probs=41.7
Q ss_pred EeEEEeecCceEEEEEEECC--------CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC-cceeceeecCCCcC
Q 044076 18 IQEIIGIGSYGVVASAIDTH--------TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD-IVEIKHIMLPPCRR 88 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~--------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn-Iv~l~~v~~~~~~~ 88 (506)
-++.|+.|....+|++.... .+..+++|+..... .......+|..+++.+...+ +.++++.. .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~ 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF-----N 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec-----C
Confidence 35677888889999997542 13688888864311 11112357888888875323 33555443 1
Q ss_pred CCCcEEEEEecCCC
Q 044076 89 EFKDIYVVFELMES 102 (506)
Q Consensus 89 ~~~~~ylV~E~~~~ 102 (506)
-++||||++|
T Consensus 109 ----~~~v~e~i~G 118 (369)
T 3c5i_A 109 ----GGRIEEWLYG 118 (369)
T ss_dssp ----TEEEEECCCS
T ss_pred ----CcEEEEEecC
Confidence 2689999876
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.071 Score=55.78 Aligned_cols=72 Identities=19% Similarity=0.196 Sum_probs=45.4
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCc-ceeceeecCCCcCCCCcEEEEE
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI-VEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnI-v~l~~v~~~~~~~~~~~~ylV~ 97 (506)
++.|+.|-...+|++.....+..+++|+.........+ ..+|..+|+.|...++ .++++++ . . .+|+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~-----~---~-G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFF-----T---N-GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEE-----T---T-EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEe-----C---C-eEEE
Confidence 56788899999999976544578999987432111111 2489999999874444 4555554 1 1 2599
Q ss_pred ecCCC
Q 044076 98 ELMES 102 (506)
Q Consensus 98 E~~~~ 102 (506)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.011 Score=59.39 Aligned_cols=31 Identities=19% Similarity=0.326 Sum_probs=27.9
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888999999988864
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.38 E-value=0.047 Score=56.58 Aligned_cols=73 Identities=10% Similarity=-0.032 Sum_probs=45.2
Q ss_pred EeEEEeecCceEEEEEEECC-------CCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCC
Q 044076 18 IQEIIGIGSYGVVASAIDTH-------TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~-------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~ 89 (506)
-++.|..|-...+|++.... .+..|++++......... ...+|..+++.+. +.-..++++.+ .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i---dR~~E~~~l~~L~~~gi~P~l~~~~-----~- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY---DSKVELDVFRYLSNINIAPNIIADF-----P- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC---CHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc---CHHHHHHHHHHHHhcCCCCCEEEEc-----C-
Confidence 35667778889999997642 157899998643211111 1347888888875 32233444433 1
Q ss_pred CCcEEEEEecCCC
Q 044076 90 FKDIYVVFELMES 102 (506)
Q Consensus 90 ~~~~ylV~E~~~~ 102 (506)
-++|++|++|
T Consensus 145 ---~~~I~efI~G 154 (424)
T 3mes_A 145 ---EGRIEEFIDG 154 (424)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CCEEEEEeCC
Confidence 2789999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.58 E-value=0.36 Score=49.30 Aligned_cols=29 Identities=31% Similarity=0.421 Sum_probs=24.8
Q ss_pred eeecCCCCCcEEE------CCCCCEEEeecCCccc
Q 044076 138 VFHRDLKPKNILA------NADCKLKICDFGLARV 166 (506)
Q Consensus 138 IvHrDLKp~NILv------~~~~~lKL~DFGla~~ 166 (506)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998854
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.36 E-value=0.06 Score=56.45 Aligned_cols=62 Identities=16% Similarity=0.112 Sum_probs=16.6
Q ss_pred EeEEEeecCceEEEEEEECCCCcEEEE------EEecccccChhHHHHHHHHHHHHHhCCCCCcceeceee
Q 044076 18 IQEIIGIGSYGVVASAIDTHTGEKVAI------KKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIM 82 (506)
Q Consensus 18 i~~~LG~G~~g~V~~a~d~~t~~~vAI------K~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~ 82 (506)
+.+.|| ||.||++.......+||+ |..+...........+.+|..+++.++|||+++.+.+.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 345565 999999987665568898 76653222333445678899999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 506 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-88 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-82 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-80 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-71 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-70 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-68 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-68 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-64 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-63 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-60 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-60 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-59 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-59 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-56 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-55 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-55 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-52 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-45 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-45 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-41 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-24 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 272 bits (695), Expect = 5e-88
Identities = 157/358 (43%), Positives = 212/358 (59%), Gaps = 23/358 (6%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
+Y IG G+YG+V SA D +VAIKK+ FEH + R LREIK+L +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRH 65
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+I+ I I+ P + KD+Y+V LM +DL +++K L+ +H +FLYQ+LR LKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
IHSANV HRDLKP N+L N C LKICDFGLARV+ D F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
+ YT +IDIWS+GCI AE+L+ RP+FPG++ QL+ + +LG+PS E + I N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLF 312
KA+ YL SL K VP++ FP AD AL LL ++L F+P R E+
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ------------ 291
Query: 313 LYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370
ALA PY + +EP + K F+ E L K+ ++ELI+ E + P
Sbjct: 292 ------ALAHPYLEQYYDPSDEPIAEAPFK--FDMELDDLPKEKLKELIFEETARFQP 341
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (657), Expect = 2e-82
Identities = 147/364 (40%), Positives = 213/364 (58%), Gaps = 30/364 (8%)
Query: 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL 67
T + +Y+ +G G+YG V +A DT TG +VA+KK+ F+ + A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 68 RMLKHPDIVEIKHIMLPP-CRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQL 126
+ +KH +++ + + P EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
LR LKYIHSA++ HRDLKP N+ N DC+LKI DFGLAR + T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
RAPE+ + + Y +DIWS+GCI AELLTGR LFPG + QL L+ L+GTP AE +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEI 306
I +E A+ Y+ SL + + F++ F GA+PLA+ LL+++L D R +A +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ------ 297
Query: 307 VFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREIL 366
ALA YF + ++EP P FE R L+ D+ + L Y E++
Sbjct: 298 ------------ALAHAYFAQYHDPDDEPVADPYD---QSFESRDLLIDEWKSLTYDEVI 342
Query: 367 EYHP 370
+ P
Sbjct: 343 SFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (644), Expect = 2e-80
Identities = 132/364 (36%), Positives = 206/364 (56%), Gaps = 30/364 (8%)
Query: 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL 67
T + + Y + +G G+YG V SA+D TG KVAIKK+ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 68 RMLKHPDIVEIKHIMLPPCRRE-FKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQL 126
+ ++H +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQ+
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
L+ L+YIH+A + HRDLKP N+ N DC+LKI DFGLAR + ++ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
RAPE+ + + +YT +DIWS+GCI AE++TG+ LF G + QL + + GTP AE +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEI 306
+++++AK Y+ L F+ A PLA+ LL+++L D + R +A E
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE------ 297
Query: 307 VFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREIL 366
ALA PYF L + E+EP + K F+ D+ + + Y+E+L
Sbjct: 298 ------------ALAHPYFESLHDTEDEPQ---VQKYDDSFDDVDRTLDEWKRVTYKEVL 342
Query: 367 EYHP 370
+ P
Sbjct: 343 SFKP 346
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 8e-71
Identities = 104/296 (35%), Positives = 144/296 (48%), Gaps = 7/296 (2%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK 71
E S+YE IG G++G V A TG+KVA+KK+ E LREIK+L++LK
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67
Query: 72 HPDIVEIKHIML---PPCRREFKDIYVVFELMESD-LDQVIKANDDLTPEHHQFFLYQLL 127
H ++V + I P R IY+VF+ E D + T + + LL
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR-VSFTDTPSAIFWTDYVATRWY 186
L YIH + HRD+K N+L D LK+ DFGLAR S +T+ V T WY
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
R PEL Y P ID+W GCI AE+ T P+ G HQL L++ L G+ + E
Sbjct: 188 RPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 247 AGIRNEKAKRYLSSLR-RKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ N + L ++ +K V K DP AL L+ +LL DP R +++
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (573), Expect = 8e-70
Identities = 119/372 (31%), Positives = 190/372 (51%), Gaps = 41/372 (11%)
Query: 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLL 67
+ + +Y+ + IG G+ G+V +A D VAIKK+ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 68 RMLKHPDIVEIKHIMLPP-CRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQL 126
+ + H +I+ + ++ P EF+D+Y+V ELM+++L QVI+ D E + LYQ+
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 127 LRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
L +K++HSA + HRDLKP NI+ +DC LKI DFGLAR + T T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYY 184
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
RAPE+ Y +DIWS+GCI E++ + LFPGR+ Q + V + LGTP E +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGA------------DPLALRLLQRLLAFDPKD 294
+ + Y+ + + + F FP + A LL ++L DP
Sbjct: 243 KKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 295 RPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIK 354
R S ++ AL PY + + E + P + + R+
Sbjct: 302 RISVDD------------------ALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTI 342
Query: 355 DDVRELIYREIL 366
++ +ELIY+E++
Sbjct: 343 EEWKELIYKEVM 354
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 1e-68
Identities = 103/348 (29%), Positives = 167/348 (47%), Gaps = 39/348 (11%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
Y ++IG GS+GVV A +GE VAIKK+ + D RE++++R L H +I
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNI 75
Query: 76 VEIKHIMLPPCRREFKD-IYVVFELME----SDLDQVIKANDDLTPEHHQFFLYQLLRAL 130
V +++ ++ + + +V + + +A L + + ++YQL R+L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 131 KYIHSANVFHRDLKPKNILANADCKL-KICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
YIHS + HRD+KP+N+L + D + K+CDFG A+ P Y+ +R+YRAP
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRAP 191
Query: 190 ELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
EL YT +ID+WS GC+ AELL G+P+FPG + QL + +LGTP+ E I +
Sbjct: 192 ELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 250 RNEKAKRYLSSLRRKWAVPFSHKF-PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVF 308
+ ++ P++ F P P A+ L RLL + P R + E
Sbjct: 251 NPNYTEFKFPQIKAH---PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE-------- 299
Query: 309 NWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDD 356
A A +F L + + + +F F ++L +
Sbjct: 300 ----------ACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 7e-68
Identities = 104/331 (31%), Positives = 151/331 (45%), Gaps = 40/331 (12%)
Query: 17 EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDAT---RILREIKLLRMLKHP 73
E + +G G + V A D +T + VAIKK+K + LREIKLL+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+I+ + +I +VF+ ME+D + + LTP H + ++ L+ L+Y
Sbjct: 61 NIIGLLD-----AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+H + HRDLKP N+L + + LK+ DFGLA+ + + +T V TRWYRAPEL
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL 172
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
Y +D+W++GCI AELL P PG + QL + + LGTP+ E + +
Sbjct: 173 -FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLF 312
S P H F A L L+Q L F+P R +A +
Sbjct: 232 PDYVTFKSFPGI---PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ------------ 276
Query: 313 LYFYVLALADPYFHGLANLEEEPSRKPISKL 343
AL YF P P +L
Sbjct: 277 ------ALKMKYF------SNRPGPTPGCQL 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 7e-65
Identities = 114/330 (34%), Positives = 163/330 (49%), Gaps = 39/330 (11%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
++ E IG G+YGVV A + TGE VA+KK++ E + +REI LL+ L HP+I
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKAND--DLTPEHHQFFLYQLLRALKYI 133
V++ ++ +Y+VFE + DL + + A+ + + +L+QLL+ L +
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
HS V HRDLKP+N+L N + +K+ DFGLAR +T V T WYRAPE+
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILL 175
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253
Y+ A+DIWS+GCIFAE++T R LFPG + QL + LGTP G
Sbjct: 176 G-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG--VTS 232
Query: 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFL 313
Y S + FS P D LL ++L +DP R SA+
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA------------- 279
Query: 314 YFYVLALADPYFHGLANLEEEPSRKPISKL 343
ALA P+F + KP+ L
Sbjct: 280 -----ALAHPFFQDV--------TKPVPHL 296
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 9e-65
Identities = 103/325 (31%), Positives = 150/325 (46%), Gaps = 34/325 (10%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHT-GEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-- 71
QYE IG G+YG V A D G VA+K+++ +RE+ +LR L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 72 -HPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDD--LTPEHHQFFLYQLLR 128
HP++V + + + +VFE ++ DL + + + E + ++QLLR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
L ++HS V HRDLKP+NIL + ++K+ DFGLAR+ T V T WYRA
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRA 183
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
PE+ S Y +D+WS+GCIFAE+ +PLF G + QL + D++G P E
Sbjct: 184 PEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVF 308
+ + K A P D L LL + L F+P R SA
Sbjct: 242 DVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS-------- 289
Query: 309 NWLFLYFYVLALADPYFHGLANLEE 333
AL+ PYF L +E
Sbjct: 290 ----------ALSHPYFQDLERCKE 304
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-64
Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 28/301 (9%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+E +G G+ GVV +G +A K + + + +I+RE+++L P I
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPYI 66
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V +I + E M+ LDQV+K + + +++ L Y+
Sbjct: 67 VGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 135 SAN-VFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
+ + HRD+KP NIL N+ ++K+CDFG++ +V TR Y +PE
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERL- 175
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAH-QLDLVTDLLGTPSAESIAGIRNE 252
+ Y+ DIWS+G E+ GR P + +L + G +
Sbjct: 176 -QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 253 KAKRYLSSLRRKWAVPFS----------HKFPGA--DPLALRLLQRLLAFDPKDRPSAEE 300
+ R F K P + + L +P +R ++
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 301 I 301
+
Sbjct: 295 L 295
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 205 bits (522), Expect = 3e-63
Identities = 98/287 (34%), Positives = 151/287 (52%), Gaps = 11/287 (3%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y E IG G+YGVV A + + GE A+KK++ E + +REI +L+ LKH +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
IV++ + + + + V L + + L + FL QLL + Y H
Sbjct: 62 IVKLYDV----IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
V HRDLKP+N+L N + +LKI DFGLAR +T + T WYRAP++
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLMG 174
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254
KY+ IDIWS+GCIFAE++ G PLFPG + A QL + +LGTP++++ + +
Sbjct: 175 -SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--EL 231
Query: 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+Y + +P+ G D + LL ++L DP R +A++
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-63
Identities = 106/288 (36%), Positives = 145/288 (50%), Gaps = 11/288 (3%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+YE E IG G+YG V A + T E VA+K+++ + + LREI LL+ LKH +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
IV + + + K V + N DL PE + FL+QLL+ L + H
Sbjct: 63 IVRLHDV----LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
S NV HRDLKP+N+L N + +LK+ +FGLAR ++ V T WYR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFG 175
Query: 195 FFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253
Y+ +ID+WS GCIFAEL RPLFPG +V QL + LLGTP+ E + K
Sbjct: 176 -AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--K 232
Query: 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
Y + P + LLQ LL +P R SAEE
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-61
Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 37/288 (12%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+++ + +G G+YG V A++ T E VA+K + + V I +EI + +ML H ++
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENV 65
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDL-DQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V+ Y+ E I+ + + Q F +QL+ + Y+H
Sbjct: 66 VKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
+ HRD+KP+N+L + LKI DFGLA V F T Y APEL
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254
+ +D+WS G + +L G + + + Q
Sbjct: 180 -REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---------------------- 216
Query: 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
K + + + D L LL ++L +P R + +I+
Sbjct: 217 ------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 7e-61
Identities = 71/287 (24%), Positives = 115/287 (40%), Gaps = 40/287 (13%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y E IG G+ G V +A+D TG++VAI++M + I+ EI ++R K+P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
IV +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 135 SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGS 194
S V HRD+K NIL D +K+ DFG + + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 195 FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKA 254
Y P +DIWS+G + E++ G P + N L L+
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------------- 228
Query: 255 KRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
P + L R L D + R SA+E+
Sbjct: 229 --------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-60
Identities = 64/290 (22%), Positives = 114/290 (39%), Gaps = 45/290 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
+EI +G G +G V A + + +A+K + K E ++ RE+++ L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
P+I+ + + +Y++ E + + ++ + ++ +L AL
Sbjct: 66 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
Y HS V HRD+KP+N+L + +LKI DFG + + + T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-----TTLCGTLDYLPPEM 175
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
+ +D+WS+G + E L G+P F +
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------- 216
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
R ++ P A L+ RLL +P RP E+
Sbjct: 217 ---------SRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREV 252
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-60
Identities = 68/336 (20%), Positives = 115/336 (34%), Gaps = 68/336 (20%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+EI +G G++G V A + T A K + + + + EI +L HP+I
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNI 71
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMESDL--DQVIKANDDLTPEHHQFFLYQLLRALKYI 133
V++ +++++ E +++ LT Q Q L AL Y+
Sbjct: 72 VKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
H + HRDLK NIL D +K+ DFG++ + ++ T ++ APE+
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVVM 183
Query: 194 SFFSK---YTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
SK Y D+WS+G E+ P N L +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---------------- 227
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNW 310
K P + L++ L + R + ++
Sbjct: 228 ------------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL--------- 266
Query: 311 LFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFE 346
L P+ S KPI +L+ E
Sbjct: 267 ---------LQHPFV-------TVDSNKPIRELIAE 286
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (503), Expect = 5e-60
Identities = 74/363 (20%), Positives = 127/363 (34%), Gaps = 63/363 (17%)
Query: 5 EFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILRE 63
E F + + IG GS+G V A D E VAIKKM + I++E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 64 IKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFF 122
++ L+ L+HP+ ++ + L ++V E S D + L
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 123 LYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
+ L+ L Y+HS N+ HRD+K NIL + +K+ DFG A + +V
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVG 173
Query: 183 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
T ++ APE + +Y +D+WS+G EL +P N L +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------- 226
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ + S + + L P+DRP++E +
Sbjct: 227 -------------------AQNESPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVL 264
Query: 302 RFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELI 361
L + +K E L +++++
Sbjct: 265 ------------------LKHRFVLRERPPTVIMDLIQRTKDAVR-ELDNLQYRKMKKIL 305
Query: 362 YRE 364
++E
Sbjct: 306 FQE 308
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-60
Identities = 81/299 (27%), Positives = 113/299 (37%), Gaps = 48/299 (16%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
A YE+ IG GSYG G+ + K++ ++ ++ E+ LLR LKH
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD----LTPEHHQFFLYQLL 127
P+IV ++ R +Y+V E E DL VI L E + QL
Sbjct: 63 PNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 128 RALKYIH-----SANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVA 182
ALK H V HRDLKP N+ + +K+ DFGLAR+ DT A +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
T +Y +PE Y DIWS+GC+ EL P F + + +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 228
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
F ++ R+L RPS EEI
Sbjct: 229 ------------------------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 7e-60
Identities = 79/341 (23%), Positives = 134/341 (39%), Gaps = 61/341 (17%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
Y+ ++++G G++ V A D T + VAIK + + + EI +L +KHP+I
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNI 69
Query: 76 VEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V + I +Y++ +L+ +L I T ++Q+L A+KY+H
Sbjct: 70 VALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 135 SANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
+ HRDLKP+N+L + D K+ I DFGL+++ + + T Y APE+
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL----STACGTPGYVAPEV 180
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
Y+ A+D WSIG I LL G P F N A + +
Sbjct: 181 LAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD--------- 229
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWL 311
S + A ++ L+ DP+ R + E+
Sbjct: 230 ------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA---------- 261
Query: 312 FLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKL 352
L P+ G L++ + ++ F + K
Sbjct: 262 --------LQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKW 294
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 197 bits (502), Expect = 1e-59
Identities = 93/338 (27%), Positives = 158/338 (46%), Gaps = 45/338 (13%)
Query: 2 FDKEFFT-EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRI 60
+D E E+G Y++ +G G Y V AI+ EKV +K +K V + +I
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KI 76
Query: 61 LREIKLLRMLK-HPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEH 118
REIK+L L+ P+I+ + I+ P R +VFE + +D Q+ + LT
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---LTDYD 130
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLARVSFTDTPSAIFW 177
+F++Y++L+AL Y HS + HRD+KP N++ + + KL++ D+GLA +
Sbjct: 131 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----Y 186
Query: 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR-PLFPGRNVAHQLDLVTD 236
VA+R+++ PEL + Y ++D+WS+GC+ A ++ + P F G + QL +
Sbjct: 187 NVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245
Query: 237 LLGTPSAESIAGIRNEKAKRYLSSLRRKWA------VPFSHKFPGADPLALRLLQRLLAF 290
+LGT N + + + + + S P AL L +LL +
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305
Query: 291 DPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328
D + R +A E A+ PYF+ +
Sbjct: 306 DHQSRLTARE------------------AMEHPYFYTV 325
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-59
Identities = 77/326 (23%), Positives = 130/326 (39%), Gaps = 54/326 (16%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHPD 74
++ +I+G GS+ V A + T + AIK + K + + RE ++ L HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
V++ ++ + +Y + +L + I+ +F+ +++ AL+Y+
Sbjct: 70 FVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
H + HRDLKP+NIL N D ++I DFG A+V ++ A +V T Y +PEL
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELLT 183
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253
+ D+W++GCI +L+ G P F N +
Sbjct: 184 E--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------- 222
Query: 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFL 313
K F KF P A L+++LL D R EE+ +
Sbjct: 223 ---------IKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPL------ 264
Query: 314 YFYVLALADPYFHGLANLEEEPSRKP 339
A P+F + E + P
Sbjct: 265 ------KAHPFFESV-TWENLHQQTP 283
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 197 bits (502), Expect = 2e-59
Identities = 73/349 (20%), Positives = 125/349 (35%), Gaps = 63/349 (18%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
Y+I E +G G++GVV + TG A K + H SD + +EI+ + +L+HP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPT 84
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+V + + ++ +++E M ++V ++ ++ + ++ Q+ + L +
Sbjct: 85 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 133 IHSANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
+H N H DLKP+NI+ +LK+ DFGL T + APE
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEFAAPE 195
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
+ D+WS+G + LL+G F G N L V
Sbjct: 196 VA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------- 245
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNW 310
F G +++LL DP R + +
Sbjct: 246 -------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQA--------- 277
Query: 311 LFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRE 359
L P+ N S+ P S+ + K D E
Sbjct: 278 ---------LEHPWLTP-GNAPGRDSQIPSSRYTKIRDSIKTKYDAWPE 316
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-59
Identities = 76/362 (20%), Positives = 139/362 (38%), Gaps = 72/362 (19%)
Query: 4 KEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILRE 63
KE + +Y I E +G G +G+V ++T + + K +K +D + +E
Sbjct: 1 KELY------EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKE 51
Query: 64 IKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKAND-DLTPEHHQF 121
I +L + +H +I+ + +++ ++FE + D+ + I + +L
Sbjct: 52 ISILNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVS 106
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFTDTPSAIFWTD 179
+++Q+ AL+++HS N+ H D++P+NI+ +KI +FG AR + +T
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT- 165
Query: 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239
Y APE+ + A D+WS+G + LL+G F ++ + +
Sbjct: 166 ---APEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
Query: 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE 299
T E F A+ + RLL + K R +A
Sbjct: 221 TFDEE---------------------------AFKEISIEAMDFVDRLLVKERKSRMTAS 253
Query: 300 EIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRE 359
E L P+ E S K I L LIK D+
Sbjct: 254 EA------------------LQHPWL---KQKIERVSTKVIRTLKHRRYYHTLIKKDLNM 292
Query: 360 LI 361
++
Sbjct: 293 VV 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 194 bits (493), Expect = 6e-59
Identities = 72/300 (24%), Positives = 115/300 (38%), Gaps = 49/300 (16%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDA-------TRILREIKLL 67
YE +EI+G G VV I T ++ A+K + A L+E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 68 RMLK-HPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQ 125
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTF-----FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW 185
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 186 YRAPELC----GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241
Y APE+ Y +D+WS G I LL G P F R L ++
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
S ++ L+ R L P+ R +AEE
Sbjct: 228 --------------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 196 bits (499), Expect = 6e-59
Identities = 70/332 (21%), Positives = 120/332 (36%), Gaps = 64/332 (19%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
Y+I E +G G++GVV ++ TG K + + D + EI ++ L HP +
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKL 88
Query: 76 VEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD-LTPEHHQFFLYQLLRALKYI 133
+ + + ++ ++ E + +L I A D ++ ++ Q LK++
Sbjct: 89 INLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 134 HSANVFHRDLKPKNIL--ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
H ++ H D+KP+NI+ +KI DFGLA D AT + APE+
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPEI 199
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
D+W+IG + LL+G F G + L V +
Sbjct: 200 VDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED------- 250
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWL 311
F P A ++ LL +P+ R + +
Sbjct: 251 --------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDA---------- 280
Query: 312 FLYFYVLALADPYFHGLANLEEEPSRKPISKL 343
L P+ G + SR P S+
Sbjct: 281 --------LEHPWLKG--DHSNLTSRIPSSRY 302
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-57
Identities = 63/290 (21%), Positives = 119/290 (41%), Gaps = 41/290 (14%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDI 75
+ IG GS+ V +DT T +VA ++++ S+ R E ++L+ L+HP+I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 76 VEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIH 134
V + + K I +V ELM S L +K + + + + Q+L+ L+++H
Sbjct: 71 VRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 135 SAN--VFHRDLKPKNIL-ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
+ + HRDLK NI +KI D GLA + + T + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPEM 184
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
+ KY ++D+++ G E+ T + A Q+
Sbjct: 185 ---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------------------- 221
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
R ++S + + A P +++ + + +R S +++
Sbjct: 222 ---YRRVTSGVKPASFD-----KVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-56
Identities = 63/292 (21%), Positives = 108/292 (36%), Gaps = 40/292 (13%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
Q + + IG GS+G V VA+K + E+ +LR +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD-LTPEHHQFFLYQLLRALK 131
+I+ P + +V + E S L + + Q + +
Sbjct: 65 NILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE- 190
Y+H+ ++ HRDLK NI + D +KI DFGLA V + S F + + APE
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEV 177
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
+ + Y+ D+++ G + EL+TG+ + N Q+ +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---------------- 221
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALR-LLQRLLAFDPKDRPSAEEI 301
+ R + P K P A++ L+ L +RP +I
Sbjct: 222 ----------VGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-55
Identities = 76/362 (20%), Positives = 140/362 (38%), Gaps = 64/362 (17%)
Query: 15 QYEI-QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIK-LLRMLKH 72
Y++ +++G+G G V + T EK A+K ++ D + RE++ R +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQC 64
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDD--LTPEHHQFFLYQLLRA 129
P IV I + K + +V E ++ +L I+ D T + + A
Sbjct: 65 PHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 130 LKYIHSANVFHRDLKPKNIL---ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWY 186
++Y+HS N+ HRD+KP+N+L + LK+ DFG A+ + + T T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYY 179
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
APE+ G KY + D+WS+G I LL G P F + +
Sbjct: 180 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------ 225
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEI 306
+ +R + ++ L++ LL +P R + E
Sbjct: 226 -----------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF----- 269
Query: 307 VFNWLFLYFYVLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREIL 366
+ P+ + + P L + ER + +K+++ + +
Sbjct: 270 -------------MNHPWIMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRV 315
Query: 367 EY 368
+Y
Sbjct: 316 DY 317
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 184 bits (467), Expect = 4e-55
Identities = 71/291 (24%), Positives = 116/291 (39%), Gaps = 33/291 (11%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
+YE+ EI+G G V A D VA+K + ++ S R RE + L HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
IV + Y+V E ++ L ++ +TP+ + +AL +
Sbjct: 68 AIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
H + HRD+KP NI+ +A +K+ DFG+AR S + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
D++S+GC+ E+LTG P F G +
Sbjct: 187 RG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----------------- 227
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-SAEEIR 302
R+ +P S + G ++ + LA +P++R +A E+R
Sbjct: 228 ----------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-52
Identities = 75/310 (24%), Positives = 121/310 (39%), Gaps = 52/310 (16%)
Query: 1 MFDKEFFTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF----EHVSD 56
+F +E +Y Y+ E +G G + VV + TG + A K +K+
Sbjct: 2 VFRQENVDDY-----YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS 56
Query: 57 ATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKANDDLT 115
I RE+ +L+ ++HP+++ + + D+ ++ EL+ L + + LT
Sbjct: 57 REDIEREVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLT 111
Query: 116 PEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD----CKLKICDFGLARVSFTDT 171
E FL Q+L + Y+HS + H DLKP+NI+ ++KI DFGLA
Sbjct: 112 EEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQL 231
+ T + APE+ D+WSIG I LL+G F G L
Sbjct: 172 EF----KNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 225
Query: 232 DLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFD 291
V+ + F LA ++RLL D
Sbjct: 226 ANVSAVNYEFE---------------------------DEYFSNTSALAKDFIRRLLVKD 258
Query: 292 PKDRPSAEEI 301
PK R + ++
Sbjct: 259 PKKRMTIQDS 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 7e-52
Identities = 70/335 (20%), Positives = 125/335 (37%), Gaps = 66/335 (19%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRM-LKHP 73
+ + +++G GS+G V A T + AIK + K+V D + E ++L + +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+ + + ++++ V E + DL I++ F+ +++ L++
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+HS + +RDLK NIL + D +KI DFG+ + + + T Y APE+
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEIL 175
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
KY ++D WS G + E+L G+ F G++ +
Sbjct: 176 LG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------------------ 215
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLF 312
R + A LL +L +P+ R +I
Sbjct: 216 ----------RMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRG----DI------ 252
Query: 313 LYFYVLALADPYFHG-----LANLEEEPSRKPISK 342
P F L E +P +P K
Sbjct: 253 -------RQHPLFREINWEELERKEIDPPFRPKVK 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-50
Identities = 72/332 (21%), Positives = 129/332 (38%), Gaps = 61/332 (18%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
++ +++G G++G V + TG A+K + KEV + + E ++L+ +HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESD-LDQVIKANDDLTPEHHQFFLYQLLRALKY 132
+ +K+ R + V E L + T E +F+ +++ AL+Y
Sbjct: 66 FLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 IHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELC 192
+HS +V +RD+K +N++ + D +KI DFGL + +D + + T Y APE+
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVL 177
Query: 193 GSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252
+ Y A+D W +G + E++ GR F ++ +L+
Sbjct: 178 ED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------ 217
Query: 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLF 312
+ F P A LL LL DPK R E+
Sbjct: 218 ----------LMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEV------ 258
Query: 313 LYFYVLALADPYFHG-----LANLEEEPSRKP 339
+ +F + + P KP
Sbjct: 259 -------MEHRFFLSINWQDVVQKKLLPPFKP 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-50
Identities = 67/299 (22%), Positives = 117/299 (39%), Gaps = 57/299 (19%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK----EVFEHVSDATRILREIKLLR 68
SQY++ ++G G +G V S I VAIK ++ + + + TR+ E+ LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 69 MLK--HPDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLY 124
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 125 QLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFGLARVSFTDTPSAIFWTDYVAT 183
Q+L A+++ H+ V HRD+K +NIL + + +LK+ DFG + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 184 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243
R Y PE + + + +WS+G + +++ G F
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------------- 214
Query: 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+R + L++ LA P DRP+ EEI+
Sbjct: 215 ---------------EIIRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQ 253
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-50
Identities = 60/293 (20%), Positives = 113/293 (38%), Gaps = 52/293 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ ++ + IG G +G V + G KVA+K +K + + A L E ++ L+H
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHS 60
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD--LTPEHHQFFLYQLLRAL 130
++V++ + E +Y+V E M L +++ L + F + A+
Sbjct: 61 NLVQLLGV----IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
+Y+ N HRDL +N+L + D K+ DFGL + + + + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPE 170
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
K++ D+WS G + E+ + GR +P + + V
Sbjct: 171 AL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--------------- 213
Query: 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ + + P P +++ D RPS ++R
Sbjct: 214 ------------EKGYKMDAPDGCP---PAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (429), Expect = 1e-48
Identities = 64/318 (20%), Positives = 109/318 (34%), Gaps = 57/318 (17%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMK----EVFEHVSDATRILREIKLLRMLK 71
+ + IIG G +G V TG+ A+K + ++ + + A + L+
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRAL 130
P IV + + + + +LM DL + + + +F+ +++ L
Sbjct: 66 CPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
+++H+ V +RDLKP NIL + ++I D GLA P A T Y APE
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMAPE 175
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
+ Y + D +S+GC+ +LL G F + ++
Sbjct: 176 VLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---------------- 218
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNW 310
R P LL+ LL D R E+
Sbjct: 219 ------------RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV---- 262
Query: 311 LFLYFYVLALADPYFHGL 328
P+F L
Sbjct: 263 ---------KESPFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (423), Expect = 3e-48
Identities = 70/309 (22%), Positives = 121/309 (39%), Gaps = 55/309 (17%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKH 72
++I +G GS+G V H G A+K + KE+ + E +L ++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLRALK 131
P I+ + ++ + I+++ + +E + P +F+ ++ AL+
Sbjct: 64 PFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 118
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
Y+HS ++ +RDLKP+NIL + + +KI DFG A+ T Y APE+
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEV 172
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251
+ Y +ID WS G + E+L G F N + +
Sbjct: 173 VST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----------------- 213
Query: 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDR-----PSAEEIR---- 302
L + P P + LL RL+ D R E+++
Sbjct: 214 ---------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259
Query: 303 FTEIVFNWL 311
F E+V+ L
Sbjct: 260 FKEVVWEKL 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 3e-48
Identities = 59/296 (19%), Positives = 99/296 (33%), Gaps = 41/296 (13%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD 74
+Y + IG GS+G + D GE+VAIK +H ++ E K+ +M++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGV 63
Query: 75 IVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
+ C E +V EL+ S D + + + Q++ ++YI
Sbjct: 64 GIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 134 HSANVFHRDLKPKNILAN---ADCKLKICDFGLARVSFTDTPSAIFW----TDYVATRWY 186
HS N HRD+KP N L + I DFGLA+ + T Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 187 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246
+ + + D+ S+G + G + G A +
Sbjct: 180 ASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-------------- 223
Query: 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+Y +K + P G L + D+P +R
Sbjct: 224 ---------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-47
Identities = 66/304 (21%), Positives = 113/304 (37%), Gaps = 30/304 (9%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
A +QE IG G +G V GE+VA+K + EI ML+H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 56
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALK 131
+I+ + +++V + E L + +T E L
Sbjct: 57 ENILGFIAADNKD-NGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 132 YIHSA--------NVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA-IFWTDYVA 182
++H + HRDLK KNIL + I D GLA + T + I V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 183 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLL 238
T+ Y APE+ + + DI+++G +F E+ + G + +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
PS E + + E+ R +P + A + ++++ + R +A
Sbjct: 234 SDPSVEEMRKVVCEQKLRP--------NIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 299 EEIR 302
I+
Sbjct: 286 LRIK 289
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 5e-47
Identities = 59/294 (20%), Positives = 105/294 (35%), Gaps = 44/294 (14%)
Query: 16 YEIQEIIGIGSYGVVASAI---DTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLK 71
+ E +G GS+GVV + VA+K + +V +RE+ + L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 72 HPDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRA 129
H +++ + ++ + +V EL S LD++ K + Q+
Sbjct: 70 HRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 130 LKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAP 189
+ Y+ S HRDL +N+L +KI DFGL R + + + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 190 ELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
E + ++ A D W G E+ T G+ + G N + L +
Sbjct: 184 ESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------------- 227
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ +P P ++ + A P+DRP+ +R
Sbjct: 228 ------------DKEGERLPRPEDCP---QDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-46
Identities = 55/284 (19%), Positives = 106/284 (37%), Gaps = 42/284 (14%)
Query: 22 IGIGSYGVVASAI--DTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIK 79
+G G++G V + VA+K +K + +L E +++ L +P IV +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 80 HIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANV 138
I E + +V E+ E L++ ++ N + ++ ++Q+ +KY+ +N
Sbjct: 75 GIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 139 FHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSK 198
HRDL +N+L KI DFGL++ D T + APE K
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--YK 186
Query: 199 YTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRY 257
++ D+WS G + E + G+ + G + ++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML----------------------- 223
Query: 258 LSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ + P L+ +D ++RP +
Sbjct: 224 ----EKGERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAV 260
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (407), Expect = 3e-46
Identities = 47/300 (15%), Positives = 96/300 (32%), Gaps = 43/300 (14%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
Y++ IG GS+GV+ + ++VAIK SDA ++ E + ++L
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLAG 59
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFLYQLLRALK 131
+ + +E +V +L+ L+ ++ Q+L ++
Sbjct: 60 CTGIPNVYY----FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 132 YIHSANVFHRDLKPKNILANADC-----KLKICDFGLARVSFTDTPSAIFW----TDYVA 182
IH ++ +RD+KP N L + + DFG+ + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 183 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242
T Y + + + D+ ++G +F L G + G A
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---------- 223
Query: 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+Y +K + P G + + P + ++
Sbjct: 224 -------------KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 7e-46
Identities = 64/303 (21%), Positives = 117/303 (38%), Gaps = 46/303 (15%)
Query: 7 FTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEK---VAIKKMKEVFEHVSDATRILRE 63
F + + S +I+++IG G +G V S G++ VAIK +K + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 64 IKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHH-QF 121
++ HP+++ ++ ++ + ++ E ME LD ++ ND
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 122 FLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT--D 179
L + +KY+ N HRDL +NIL N++ K+ DFGL+R DT + +
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 180 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLL 238
+ AP + K+T A D+WS G + E+++ G + ++ +
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---- 246
Query: 239 GTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSA 298
+ + +P P +L+ D RP
Sbjct: 247 -----------------------EQDYRLPPPMDCP---SALHQLMLDCWQKDRNHRPKF 280
Query: 299 EEI 301
+I
Sbjct: 281 GQI 283
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-45
Identities = 63/293 (21%), Positives = 108/293 (36%), Gaps = 48/293 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
++ E +G G +G V + KVA+K +K+ L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQ 68
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVI---KANDDLTPEHHQFFLYQLLRAL 130
+V + ++ + IY++ E ME+ + LT Q+ +
Sbjct: 69 RLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
+I N HRDL+ NIL + KI DFGLAR + + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPE 180
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
+ +T D+WS G + E++T GR +PG + +
Sbjct: 181 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--------------- 223
Query: 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
R + + P +L++ P+DRP+ + +R
Sbjct: 224 ------------ERGYRMVRPDNCP---EELYQLMRLCWKERPEDRPTFDYLR 261
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (407), Expect = 1e-45
Identities = 59/329 (17%), Positives = 114/329 (34%), Gaps = 59/329 (17%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKM-KEVFEHVSDATRILREIKLLRMLKHP 73
Q++ + +G GS+G V +G A+K + K+ + L E ++L+ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYI 133
+V+++ V+ + ++ ++ + H +F+ Q++ +Y+
Sbjct: 102 FLVKLEFSFKDNSNL----YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 134 HSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCG 193
HS ++ +RDLKP+N+L + +++ DFG A+ T APE+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIIL 211
Query: 194 SFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEK 253
S Y A+D W++G + E+ G P F + +
Sbjct: 212 S--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------- 250
Query: 254 AKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFL 313
V F F LL+ LL D R + +I
Sbjct: 251 ---------VSGKVRFPSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDI------- 291
Query: 314 YFYVLALADPYFHGL--ANLEEEPSRKPI 340
+F + + P
Sbjct: 292 ------KNHKWFATTDWIAIYQRKVEAPF 314
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-45
Identities = 65/293 (22%), Positives = 110/293 (37%), Gaps = 48/293 (16%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
++ +G G +G V T VAIK +K L+E ++++ L+H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP---GTMSPEAFLQEAQVMKKLRHE 72
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME---SDLDQVIKANDDLTPEHHQFFLYQLLRAL 130
+V++ ++ + IY+V E M + L Q+ +
Sbjct: 73 KLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
Y+ N HRDL+ NIL + K+ DFGLAR+ + +A + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTAPE 184
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
++T D+WS G + EL T GR +PG LD V
Sbjct: 185 AALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------------- 227
Query: 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
R + +P + P L+ + +P++RP+ E ++
Sbjct: 228 ------------ERGYRMPCPPECP---ESLHDLMCQCWRKEPEERPTFEYLQ 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-45
Identities = 68/319 (21%), Positives = 122/319 (38%), Gaps = 69/319 (21%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGE-----KVAIKKMKEVFEHVSDATRILREIKLLR 68
E +++G G++G V +A + +VA+K +KE + S+ ++ E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMT 95
Query: 69 ML-KHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD------------- 113
L H +IV + IY++FE DL +++ +
Sbjct: 96 QLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 114 ----------LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL 163
LT E F YQ+ + ++++ + HRDL +N+L +KICDFGL
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLF 222
AR +D+ + + + APE F YT D+WS G + E+ + G +
Sbjct: 211 ARDIMSDSNY-VVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 223 PGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALR 282
PG V + ++ + +
Sbjct: 268 PGIPVDANFYKL--------------------------IQNGFKMDQPFYAT---EEIYI 298
Query: 283 LLQRLLAFDPKDRPSAEEI 301
++Q AFD + RPS +
Sbjct: 299 IMQSCWAFDSRKRPSFPNL 317
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-45
Identities = 65/339 (19%), Positives = 128/339 (37%), Gaps = 57/339 (16%)
Query: 15 QYEIQEIIGIGSYGVVASAIDTH---TGEKVAIKKMK--EVFEHVSDATRILREIKLLRM 69
+E+ +++G G+YG V TG+ A+K +K + + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 70 LKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLR 128
++ + + L + ++++ + + +L + + T Q ++ +++
Sbjct: 85 IRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
AL+++H + +RD+K +NIL +++ + + DFGL++ F + + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAP 199
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
+ G S + A+D WS+G + ELLTG F + +
Sbjct: 200 DIVRGGD-SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------------- 244
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVF 308
++R L S LA L+QRLL DPK R EI
Sbjct: 245 -----SRRILKSEPPYP--------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI-- 289
Query: 309 NWLFLYFYVLALADPYFHG-----LANLEEEPSRKPISK 342
+F LA + KP+ +
Sbjct: 290 -----------KEHLFFQKINWDDLAAKKVPAPFKPVIR 317
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-45
Identities = 50/291 (17%), Positives = 101/291 (34%), Gaps = 46/291 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ +G G +GVV VAIK +KE + E K++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHE 59
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLRALK 131
+V++ + + + I+++ E M L+ + + + + A++
Sbjct: 60 KLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
Y+ S HRDL +N L N +K+ DFGL+R D ++ + PE+
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPPEV 172
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
SK++ DIW+ G + E+ + G+ + + + +
Sbjct: 173 LMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------------- 214
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ + H ++ +RP+ + +
Sbjct: 215 -----------AQGLRLYRPHLAS---EKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (397), Expect = 8e-45
Identities = 60/293 (20%), Positives = 116/293 (39%), Gaps = 46/293 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
+ ++ +G G YG V + VA+K +KE + L+E +++ +KHP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHP 73
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVI---KANDDLTPEHHQFFLYQLLRAL 130
++V++ + Y++ E M +++ + Q+ A+
Sbjct: 74 NLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPE 190
+Y+ N HRDL +N L + +K+ DFGL+R+ DT +A + APE
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPE 186
Query: 191 LCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249
+K++ D+W+ G + E+ T G +PG +++ +L+
Sbjct: 187 SLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------------- 229
Query: 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+ + + P L++ ++P DRPS EI
Sbjct: 230 ------------EKDYRMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-44
Identities = 58/291 (19%), Positives = 108/291 (37%), Gaps = 46/291 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHP 73
S+ + IG G +G+V +KVAIK ++E + E +++ L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHP 60
Query: 74 DIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHH-QFFLYQLLRALK 131
+V++ + L I +VFE ME L ++ L + +
Sbjct: 61 KLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 132 YIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPEL 191
Y+ A V HRDL +N L + +K+ DFG+ R F T + +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR--FVLDDQYTSSTGTKFPVKWASPEV 173
Query: 192 CGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250
FS+Y+ D+WS G + E+ + G+ + R+ + ++ +
Sbjct: 174 F--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---------------- 215
Query: 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ + +++ P+DRP+ +
Sbjct: 216 -----------STGFRLYKPRLAS---THVYQIMNHCWKERPEDRPAFSRL 252
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-44
Identities = 62/305 (20%), Positives = 115/305 (37%), Gaps = 48/305 (15%)
Query: 4 KEFFTEYGEASQYEIQEI-IGIGSYGVVASAIDTHTGEK--VAIKKMKEVFEHVSDATRI 60
K+ F + I +I +G G++G V + ++ VAIK +K+ E +D +
Sbjct: 1 KKLFLK---RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEM 56
Query: 61 LREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKA-NDDLTPEH 118
+RE +++ L +P IV + + + + + +V E+ L + + +++ +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSN 110
Query: 119 HQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWT 178
L+Q+ +KY+ N HRDL +N+L KI DFGL++ D +
Sbjct: 111 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 179 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDL 237
+ APE K++ D+WS G E L+ G+ + + +
Sbjct: 171 AGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ- 227
Query: 238 LGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS 297
G R E P P L+ + +DRP
Sbjct: 228 ----------GKRMECP-------------------PECPPELYALMSDCWIYKWEDRPD 258
Query: 298 AEEIR 302
+
Sbjct: 259 FLTVE 263
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-43
Identities = 60/296 (20%), Positives = 115/296 (38%), Gaps = 43/296 (14%)
Query: 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEK----VAIKKMKEVFEHVSDATRILREIKLL 67
S Q++IG G +G V + + K VAIK +K + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQ 125
H +I+ ++ ++ ++K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 126 LLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRW 185
+ +KY+ + N HRDL +NIL N++ K+ DFGL+RV D + +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 186 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAES 245
+ APE K+T A D+WS G + E++T H++
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 246 IAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
+ ++ + +P P +L+ + + RP +I
Sbjct: 223 ------------MKAINDGFRLPTPMDCP---SAIYQLMMQCWQQERARRPKFADI 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 8e-43
Identities = 56/294 (19%), Positives = 106/294 (36%), Gaps = 43/294 (14%)
Query: 13 ASQYEIQEIIGIGSYGVVASAIDTHTGE----KVAIKKMKEVFEHVSDATRILREIKLLR 68
++++ +++G G++G V + GE VAIK+++E ++ IL E ++
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLR 128
+ +P + + I C + LD V + D++ ++ + Q+ +
Sbjct: 67 SVDNPHVCRLLGI----CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
+ Y+ + HRDL +N+L +KI DFGLA++ + A
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMA 181
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
E YT D+WS G EL+T G + G + ++
Sbjct: 182 LESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----------- 228
Query: 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
G R + P ++ + D RP E+
Sbjct: 229 GERLP-------------------QPPICTIDVYMIMVKCWMIDADSRPKFREL 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-41
Identities = 64/295 (21%), Positives = 107/295 (36%), Gaps = 47/295 (15%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHT---GEKVAIKKMKEVFEHVSDATRILREIKLLRML 70
+ E+ IG G +G V I VAIK K S + L+E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQF 65
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELME--SDLDQVIKANDDLTPEHHQFFLYQLLR 128
HP IV++ ++ ++++ EL + L + YQL
Sbjct: 66 DHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 129 ALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRA 188
AL Y+ S HRD+ +N+L +++ +K+ DFGL+R + + + + + A
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMA 177
Query: 189 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247
PE ++T A D+W G E+L G F G + +
Sbjct: 178 PESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI------------- 222
Query: 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIR 302
+P P P L+ + A+DP RP E++
Sbjct: 223 --------------ENGERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELK 260
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 2e-41
Identities = 60/319 (18%), Positives = 105/319 (32%), Gaps = 70/319 (21%)
Query: 14 SQYEIQEIIGIGSYGVV-----ASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLR 68
+ E IG G++G V + VA+K +KE RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD-------------- 113
+P+IV++ + K + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 114 ----------LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL 163
L+ Q+ + Y+ HRDL +N L + +KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLF 222
+R ++ D + RW + ++YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 223 PGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALR 282
G + V D E+
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENC------------------------------PLELYN 273
Query: 283 LLQRLLAFDPKDRPSAEEI 301
L++ + P DRPS I
Sbjct: 274 LMRLCWSKLPADRPSFCSI 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-41
Identities = 60/293 (20%), Positives = 107/293 (36%), Gaps = 44/293 (15%)
Query: 16 YEIQEIIGIGSYGVVASAID---THTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH 72
E+IG G +G V A+K + + + + ++ L E +++ H
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSH 87
Query: 73 PDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQ--FFLYQLLRAL 130
P+++ + I C R VV M+ + N+ P F Q+ + +
Sbjct: 88 PNVLSLLGI----CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 143
Query: 131 KYIHSANVFHRDLKPKNILANADCKLKICDFGLAR-VSFTDTPSAIFWTDYVATRWYRAP 189
K++ S HRDL +N + + +K+ DFGLAR + + S T + A
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 190 ELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248
E + K+T D+WS G + EL+T G P +P N + + G
Sbjct: 204 ESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-----------LQG 250
Query: 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301
R + + L ++ + + RPS E+
Sbjct: 251 RRLLQPEYCPDPLY-------------------EVMLKCWHPKAEMRPSFSEL 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-41
Identities = 67/309 (21%), Positives = 109/309 (35%), Gaps = 63/309 (20%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGEK--VAIKKMKEVFEHVSDATRILREIKLLRML- 70
+ + Q++IG G++G V A G + AIK+MKE D E+++L L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLG 68
Query: 71 KHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD---------------- 113
HP+I+ + +Y+ E +L ++ +
Sbjct: 69 HHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 114 LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPS 173
L+ + F + R + Y+ HRDL +NIL + KI DFGL+R
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 174 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLD 232
T + A E S YT D+WS G + E+++ G + G A +
Sbjct: 184 ----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 233 LVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDP 292
+ G R E K D L+++ P
Sbjct: 238 KLPQ-----------GYRLE-------------------KPLNCDDEVYDLMRQCWREKP 267
Query: 293 KDRPSAEEI 301
+RPS +I
Sbjct: 268 YERPSFAQI 276
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (374), Expect = 6e-41
Identities = 70/356 (19%), Positives = 119/356 (33%), Gaps = 65/356 (18%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD- 74
Y + +G G + V A D VA+K ++ EIKLL+ + D
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDADN 71
Query: 75 ----------IVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHH-QFFL 123
I+++ + V L E+ L + K P + +
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 124 YQLLRALKYI-HSANVFHRDLKPKNILANAD------CKLKICDFGLARVSFTDTPSAIF 176
QLL L Y+ + H D+KP+N+L ++KI D G A
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------ 185
Query: 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNV------AHQ 230
+T+ + TR YR+PE+ + + DIWS C+ EL+TG LF
Sbjct: 186 YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
Query: 231 LDLVTDLLGTPSAESIAGIRNEK----AKRYLSSLRRKWAVPFSHKFPG-------ADPL 279
+ + +LLG + + + + ++ L ++ + P
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
Query: 280 ALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANLEEEP 335
L +L DP+ R A + P+ +EE
Sbjct: 304 ISDFLSPMLQLDPRKRADAGG------------------LVNHPWLKDTLGMEEIR 341
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-41
Identities = 66/314 (21%), Positives = 113/314 (35%), Gaps = 64/314 (20%)
Query: 14 SQYEIQEIIGIGSYGVVASA-----IDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLR 68
++ + +G G++G V A I + VA+K +K H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 69 MLK-HPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD------------- 113
L H +IV + V+ E DL ++ D
Sbjct: 82 YLGNHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 114 -----LTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168
L E F YQ+ + + ++ S N HRDL +NIL KICDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNV 227
D+ + + +W + YT D+WS G EL + G +PG V
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 228 AHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRL 287
+ + ++ + + P +++
Sbjct: 254 DSKFYKM--------------------------IKEGFRMLSPEHAP---AEMYDIMKTC 284
Query: 288 LAFDPKDRPSAEEI 301
DP RP+ ++I
Sbjct: 285 WDADPLKRPTFKQI 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-39
Identities = 63/314 (20%), Positives = 118/314 (37%), Gaps = 65/314 (20%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTHTGE-------KVAIKKMKEVFEHVSDATRILREIKL 66
+ + + +G G++G V A + KVA+K +K D + ++ E+++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 67 LRML-KHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIK--------------- 109
++M+ KH +I+ + + +YV+ E +L + ++
Sbjct: 72 MKMIGKHKNIINLLG-----ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 110 -ANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168
+ L+ + YQ+ R ++Y+ S HRDL +N+L D +KI DFGLAR
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNV 227
+ +W L YT D+WS G + E+ T G +PG V
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 228 AHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRL 287
L+ + G R +K + L +++
Sbjct: 244 EELFKLLKE-----------GHRMDKPSNCTNELY-------------------MMMRDC 273
Query: 288 LAFDPKDRPSAEEI 301
P RP+ +++
Sbjct: 274 WHAVPSQRPTFKQL 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-38
Identities = 63/311 (20%), Positives = 113/311 (36%), Gaps = 59/311 (18%)
Query: 14 SQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLR 68
+ ++ + +G G++G V A T T VA+K +KE H + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKAN---------------- 111
+ H ++V + C + + V+ E + +L +++
Sbjct: 73 IGHHLNVVNLLGA----CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 112 DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171
D LT EH + +Q+ + ++++ S HRDL +NIL + +KICDFGLAR
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKD 187
Query: 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQ 230
P + D + APE YT D+WS G + E+ + +PG + +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAF 290
L+ + P + +
Sbjct: 246 F--------------------------CRRLKEGTRMRAPDYTT---PEMYQTMLDCWHG 276
Query: 291 DPKDRPSAEEI 301
+P RP+ E+
Sbjct: 277 EPSQRPTFSEL 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-38
Identities = 54/305 (17%), Positives = 102/305 (33%), Gaps = 56/305 (18%)
Query: 14 SQYEIQEIIGIGSYGVVASAIDTH-----TGEKVAIKKMKEVFEHVSDATRILREIKLLR 68
+ + +G GS+G+V + +VAIK + E + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMK 78
Query: 69 MLKHPDIVEIKHIMLPPCRREFKDIYVVFELME-SDLDQVIKANDD----------LTPE 117
+V + ++ + V+ ELM DL +++ +
Sbjct: 79 EFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 118 HHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIFW 177
++ + Y+++ HRDL +N + D +KI DFG+ R +T
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKG 192
Query: 178 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQLDLVTD 236
+ + +PE +T D+WS G + E+ T + G + L V +
Sbjct: 193 GKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 237 LLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP 296
K + L++ ++PK RP
Sbjct: 251 ------------------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRP 280
Query: 297 SAEEI 301
S EI
Sbjct: 281 SFLEI 285
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.2 bits (241), Expect = 5e-24
Identities = 27/205 (13%), Positives = 61/205 (29%), Gaps = 31/205 (15%)
Query: 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKE--------VFEHVSDATRILREIKLL 67
I +++G G V + + +K K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 68 RMLKHPDIVEIKHIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLL 127
+ + +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPKVY-AWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 128 RALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSA--IFWTD-YVATR 184
+ + + H DL N+L ++ + I DF + I D
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVE--VGEEGWREILERDVRNIIT 170
Query: 185 WYRAPELCGSFFSKYTPAIDIWSIG 209
++ Y DI S
Sbjct: 171 YFS---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 506 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.26 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.82 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.47 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.61 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.29 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-63 Score=507.56 Aligned_cols=334 Identities=40% Similarity=0.734 Sum_probs=284.2
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
+.|...++|++++.||+|+||+||+|++..+|+.||||+++....+....+.+.+|+.+|+.++|||||+++++|.....
T Consensus 12 ~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 34667899999999999999999999999999999999998665666677889999999999999999999999976532
Q ss_pred -CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 -REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 -~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
....++|+||||++.+|..+++. +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 92 ~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 34457899999998889888765 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... .+..++|++|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+++..+....|.|+.+.+
T Consensus 171 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 171 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCCc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 4322 2567899999999998762 56799999999999999999999999999999999999999999999999
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
..........+...++.....++...+++++++++|||.+||++||.+||||+| +|+||||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e------------------iL~Hp~f~ 305 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE------------------ALAHPYFE 305 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH------------------HHHSGGGT
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHH------------------HhcChhhC
Confidence 888888888888888888888888888999999999999999999999999999 89999999
Q ss_pred CCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCc
Q 044076 327 GLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHP 370 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~ 370 (506)
++.+..++|..+ +++..++....+.++||+++++||++|+|
T Consensus 306 ~~~~~~~~~~~~---~~~~~~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 306 SLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp TTC------CCC---CCCCC-----CCHHHHHHHHHHHHHTCCC
T ss_pred cCCCccccccCC---CCCCchhhhhcCHHHHHHHHHHHhhcCCC
Confidence 998877777654 35566777778899999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-60 Score=487.73 Aligned_cols=342 Identities=45% Similarity=0.787 Sum_probs=288.2
Q ss_pred ccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 9 EYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 9 ~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.|....||++++.||+|+||+||+|++..+|+.||||+++.. ......+++.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 467889999999999999999999999999999999999642 3445567889999999999999999999999766544
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
....+|+|+++++++|.++++.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55678899888889999999764 69999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
............+||+.|+|||++... ..|+.++||||+||++|+|++|++||.+.+..++...+...++.|..+....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 433333334567899999999998652 6789999999999999999999999999999999999999999999988777
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
........+....+.....++...++++++++++||.+||+.||.+||||+| +|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e------------------~L~hpf~~~~ 301 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ------------------ALAHPYLEQY 301 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH------------------HHTSGGGTTT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCHhhccC
Confidence 6666667777777777777777888999999999999999999999999999 8999999988
Q ss_pred CCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCchhH
Q 044076 329 ANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHPHML 373 (506)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~~~~ 373 (506)
..+.+++.... .+.+..+...+..+++++++++|...++|.-+
T Consensus 302 ~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~e~~~~~~~~~ 344 (345)
T d1pmea_ 302 YDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGYR 344 (345)
T ss_dssp CCGGGSCCCSS--CC--------CCHHHHHHHHHHHSGGGSTTTC
T ss_pred CCCccCccccC--ccCCChhhhhCCHHHHHHHHHHHHHhcCCCCC
Confidence 87776665443 34455567788999999999999999999743
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-61 Score=490.43 Aligned_cols=335 Identities=44% Similarity=0.795 Sum_probs=292.2
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
+.|++++||++++.||+|+||+||+|++..+|+.||||+++....+....+++.+|+.+|+.++||||+++++++.....
T Consensus 12 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp SEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 45777899999999999999999999999999999999998766666777889999999999999999999999876532
Q ss_pred -CCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 -REFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 -~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
++...+|+++++.+++|.+++.. +.+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||+|..
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred cccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence 34455677777777899998864 5799999999999999999999999999999999999999999999999999965
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
... ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|....|.+..+..
T Consensus 171 ~~~------~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 171 TDD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CTG------GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCc------ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 322 12456799999999997762 56789999999999999999999999999999999999999999999988
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
..........+...........+...+++++++++|||.+||++||.+||||+| +|+||||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e------------------lL~Hp~f~ 305 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ------------------ALAHAYFA 305 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH------------------HHTSGGGT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH------------------HhcCHhhC
Confidence 888777777777777777777777778899999999999999999999999999 89999999
Q ss_pred CCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHhhCch
Q 044076 327 GLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILEYHPH 371 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~~~~~ 371 (506)
++.++..+|...+ +..+++...+..+++|+++++|+++|.|.
T Consensus 306 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~k~~~~~e~~~~~p~ 347 (348)
T d2gfsa1 306 QYHDPDDEPVADP---YDQSFESRDLLIDEWKSLTYDEVISFVPP 347 (348)
T ss_dssp TTCCTTSCCCCCC---CCCGGGGCCCCHHHHHHHHHHHHHTCCCC
T ss_pred CCCCCccCCCCCC---CCCcccchhcCHHHHHHHHHHHhhccCCC
Confidence 9998888887765 45677888999999999999999998874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-59 Score=478.64 Aligned_cols=330 Identities=36% Similarity=0.639 Sum_probs=260.8
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-C
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-R 88 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~ 88 (506)
|...++|+++++||+|+||+||+|+|+.+|+.||||+++....+.....++.+|+.+|+.++||||++++++|..... +
T Consensus 13 f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 344589999999999999999999999999999999998766666777889999999999999999999999975432 4
Q ss_pred CCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSF 168 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~ 168 (506)
...++|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 93 ~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp TCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred cCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 557899999999998888764 569999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... ..+..++|+.|+|||++.+ ..+++++||||+||++++|++|++||.+.+...++.+|...++.|.++.+..
T Consensus 171 ~~~----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 171 TSF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp --------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccc----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 322 2356789999999999987 7899999999999999999999999999999999999999999999988876
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCC------------CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKF------------PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFY 316 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~ 316 (506)
... ....+...........+...+ ...+++++|||++||++||++||||+|
T Consensus 245 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e---------------- 307 (355)
T d2b1pa1 245 LQP-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD---------------- 307 (355)
T ss_dssp SCH-HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH----------------
T ss_pred hhh-hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH----------------
Confidence 543 233343333222222211111 124678999999999999999999999
Q ss_pred hhhccCcccCCCCCCCCCCCCCCCccchhhHHhhcCCHHHHHHHHHHHHHh
Q 044076 317 VLALADPYFHGLANLEEEPSRKPISKLVFEFERRKLIKDDVRELIYREILE 367 (506)
Q Consensus 317 ~~aL~HP~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ei~~ 367 (506)
+|+||||+...++..+....| ..++.+++.+.++.++|+++|+.||++
T Consensus 308 --lL~Hpw~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (355)
T d2b1pa1 308 --ALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVMN 355 (355)
T ss_dssp --HHTSTTTGGGCCHHHHTCCCC--------CCCCCCHHHHHHHHHHHHHC
T ss_pred --HhcCcccCCCCCcccccCCCC-CCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence 899999998776544443333 345567778899999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-59 Score=467.23 Aligned_cols=284 Identities=36% Similarity=0.578 Sum_probs=232.8
Q ss_pred EEeEEEeecCceEEEEEEECCCCcEEEEEEecccccCh---hHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 17 EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHV---SDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 17 ~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~---~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
+.+++||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+|+.++|||||++++++.. .+.+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~ 75 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNI 75 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCC
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCce
Confidence 46789999999999999999999999999996432211 123468899999999999999999999954 4789
Q ss_pred EEEEecCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESDLDQVIK-ANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~-~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+||||+.+++...+. .+..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 76 ~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred eehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9999999976555554 456799999999999999999999999999999999999999999999999999976433222
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
.....+||++|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..|.+.+|+|..+.+......
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 ---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp ---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ---cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 12456899999999998752 57899999999999999999999999999999999999999999998876554321
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
... ..+......++...++.++++++|||.+||++||++||||+| +|+||||++...
T Consensus 232 ~~~---~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e------------------~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 232 PDY---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ------------------ALKMKYFSNRPG 288 (299)
T ss_dssp TTC---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH------------------HHTSGGGTSSSC
T ss_pred chh---hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH------------------HhCCHhhCCCCC
Confidence 110 011122333444556788999999999999999999999999 899999997554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-59 Score=457.09 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=220.8
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.. .+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CC
Confidence 368999999999999999999999999999999986422 223345678899999999999999999999954 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 8999999998 599999998889999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. .....||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+.-.
T Consensus 160 ~-----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----------- 221 (263)
T d2j4za1 160 R-----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----------- 221 (263)
T ss_dssp C-----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----------
T ss_pred c-----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 1 245679999999999988 7899999999999999999999999999887776666533111
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
...+.+++++.+||.+||+.||.+|||++| +|+||||++
T Consensus 222 --------------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~e------------------il~hp~~~~ 260 (263)
T d2j4za1 222 --------------------TFPDFVTEGARDLISRLLKHNPSQRPMLRE------------------VLEHPWITA 260 (263)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH------------------HHTCHHHHH
T ss_pred --------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHH------------------HHcCcCcCC
Confidence 011347899999999999999999999999 899999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-59 Score=459.23 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=215.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|+.++||||+++++++.. .+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Cce
Confidence 468999999999999999999999999999999996431 22234568899999999999999999999854 478
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+||||+++ +|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999985 999999888899999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccccCCcccCcccccccCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~-~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
. ....+..+||+.|+|||++.+ .. ++.++||||+||++|+|++|++||.+.+...+...+....
T Consensus 158 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~------------ 222 (271)
T d1nvra_ 158 R-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------ 222 (271)
T ss_dssp E-ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT------------
T ss_pred c-cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC------------
Confidence 1 122356789999999999977 44 4688999999999999999999998766543332221110
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
......++++++++.+||.+||+.||.+|||++| +|+||||+.
T Consensus 223 ----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e------------------il~hpwf~~ 265 (271)
T d1nvra_ 223 ----------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPD------------------IKKDRWYNK 265 (271)
T ss_dssp ----------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH------------------HTTCTTTTC
T ss_pred ----------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHH------------------HhcCHhhCc
Confidence 0111223468999999999999999999999999 899999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-58 Score=459.02 Aligned_cols=267 Identities=26% Similarity=0.429 Sum_probs=223.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
.+++|++++.||+|+||+||+|+++.+|+.||||+++... ........+.+|+.+|++++||||+++++++.. .
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~ 80 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----D 80 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----S
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----C
Confidence 3467999999999999999999999999999999996421 223345678999999999999999999999843 4
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+.+|+||||+++ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 789999999985 9999999889999999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+.- +
T Consensus 161 ~~~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--~-------- 227 (288)
T d1uu3a_ 161 ESKQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--Y-------- 227 (288)
T ss_dssp ----------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--C--------
T ss_pred CCcc-cccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--C--------
Confidence 2221 12345689999999999987 789999999999999999999999999988777666663311 0
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
.....+++++.+||.+||+.||.+|||++|++.+ .++++||||+++.
T Consensus 228 ---------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~------------~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 228 ---------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY------------GPLKAHPFFESVT 274 (288)
T ss_dssp ---------------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH------------HHHHTSGGGTTCC
T ss_pred ---------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC------------HHHHcCCccCCCC
Confidence 0113589999999999999999999999995322 2268999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-58 Score=457.68 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=219.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.+|+.++||||+++++++.. .+.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG--GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc--cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCE
Confidence 46899999999999999999999999999999999643 22345678999999999999999999999854 478
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+|||||++ +|.+++.. +.+++..++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 92 ~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999985 89988765 469999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..+.... .|.
T Consensus 171 ~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~--------- 235 (293)
T d1yhwa1 171 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE--------- 235 (293)
T ss_dssp C---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC---------
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCC---------
Confidence 2 2356689999999999987 789999999999999999999999999888777666553321 110
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
....+.+++++++||.+||+.||.+|||++| +|+||||+.
T Consensus 236 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e------------------il~Hp~~~~ 275 (293)
T d1yhwa1 236 ------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE------------------LLQHQFLKI 275 (293)
T ss_dssp ------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHH------------------HTTCGGGGG
T ss_pred ------------------CCCcccCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCHhhCC
Confidence 0112458999999999999999999999999 899999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-58 Score=458.54 Aligned_cols=290 Identities=35% Similarity=0.589 Sum_probs=240.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCC-CcEEEEEEecccccChhHHHHHHHHHHHHHhC---CCCCcceeceeecCCCcC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHT-GEKVAIKKMKEVFEHVSDATRILREIKLLRML---KHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t-~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l---~HpnIv~l~~v~~~~~~~ 88 (506)
.++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++.....+
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999999766 56799999965433333344466788887766 799999999998655444
Q ss_pred CCCcEEEEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELMESDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
....+|+||||+++++..+... ...+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 5578999999999876655543 34699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.... ......+||+.|+|||++.+ ..|+.++||||+||++|||++|++||.+.+..+++..|...+|.|....+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 3322 22356789999999999987 78999999999999999999999999999999999999999999988876
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
......... ........+.....+.++++++|||.+||++||.+||||+| +|+||||+
T Consensus 240 ~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e------------------~L~Hpff~ 297 (305)
T d1blxa_ 240 PRDVALPRQ----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS------------------ALSHPYFQ 297 (305)
T ss_dssp CTTCSSCGG----GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH------------------HHTSGGGT
T ss_pred cccccchhh----hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH------------------HhcChhhc
Confidence 543221111 11222333445566789999999999999999999999999 89999999
Q ss_pred CCCC
Q 044076 327 GLAN 330 (506)
Q Consensus 327 ~~~~ 330 (506)
++..
T Consensus 298 ~i~~ 301 (305)
T d1blxa_ 298 DLER 301 (305)
T ss_dssp TCCC
T ss_pred Cchh
Confidence 8754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-58 Score=458.01 Aligned_cols=289 Identities=38% Similarity=0.628 Sum_probs=239.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
++|++++.||+|+||+||+|.+..+|+.||||+++...........+.+|+.+|++++||||+++++++.. .+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence 58999999999999999999999999999999996543333445678899999999999999999999954 4789
Q ss_pred EEEEecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 94 YVVFELMESDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
|+||||+++++...+.. ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999987777754 3469999999999999999999999999999999999999999999999999997643322
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
......+||+.|+|||++... ..++.++||||+||++|+|++|+.||.+.+..+++..+....|.|....+.....
T Consensus 157 ---~~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 ---RTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp ---BCTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 123556899999999998762 4568999999999999999999999999999999999999999998877665432
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
. ..+....+.....++...++.+++++.|||.+||+.||.+|||++| +|+||||+++.++
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e------------------ll~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 M--PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA------------------ALAHPFFQDVTKP 292 (298)
T ss_dssp S--TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH------------------HHTSGGGTTCCCC
T ss_pred c--cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHH------------------HhCCHhhccCCCC
Confidence 1 1111222222333334456788999999999999999999999999 8999999987653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-58 Score=469.13 Aligned_cols=283 Identities=22% Similarity=0.339 Sum_probs=217.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|++..+|+.||||+++... ......++.+|+.+|+.++|||||++++++.. .+.
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 578999999999999999999999999999999996532 33455678999999999999999999999954 378
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
+|+|||||++ +|.+++.+.+.+++..++.+++||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999985 999999988899999999999999999999997 59999999999999999999999999999864322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchh-hHHHHHhhcCCCChHHHhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAH-QLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~-~l~~I~~~~g~p~~e~~~~~ 249 (506)
. .+.++||++|+|||++.+ ..|++++||||+||++|||++|+.||.+.+..+ ++..+....|.+........
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 1 245789999999999988 789999999999999999999999998766433 33333344443322111000
Q ss_pred hh--------------hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHh
Q 044076 250 RN--------------EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYF 315 (506)
Q Consensus 250 ~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~ 315 (506)
.. ....+.........+..+ .-...+++++|||.+||++||.+||||+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e--------------- 294 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQ--------------- 294 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHH---------------
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHH---------------
Confidence 00 000011111111111110 01236899999999999999999999999
Q ss_pred hhhhccCcccCCC
Q 044076 316 YVLALADPYFHGL 328 (506)
Q Consensus 316 ~~~aL~HP~f~~~ 328 (506)
+|+||||++.
T Consensus 295 ---~L~Hpf~~~~ 304 (322)
T d1s9ja_ 295 ---LMVHAFIKRS 304 (322)
T ss_dssp ---HHTSHHHHHH
T ss_pred ---HhhCHhhCcC
Confidence 8999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-57 Score=451.05 Aligned_cols=263 Identities=29% Similarity=0.444 Sum_probs=226.0
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc----ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE----HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~----~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
...++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++..
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 84 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-- 84 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 456789999999999999999999999999999999964321 22245778999999999999999999999944
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC----CEEEeec
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC----KLKICDF 161 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~----~lKL~DF 161 (506)
.+.+|||||||+ |+|.+++...+.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 85 ---~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 85 ---KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp ---SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred ---CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence 488999999998 59999999888999999999999999999999999999999999999998876 4999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
|+|+...... ......+|+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+..+.+..|...-..+
T Consensus 162 G~a~~~~~~~----~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 162 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp TTCEECTTSC----BCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred hhhhhcCCCc----cccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9997643322 1245679999999999987 689999999999999999999999999998888877775543333
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
.... ++++++++.+||++||+.||.+|||++| +|+
T Consensus 236 ~~~~---------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e------------------il~ 270 (293)
T d1jksa_ 236 EDEY---------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQD------------------SLQ 270 (293)
T ss_dssp CHHH---------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHH------------------HHH
T ss_pred Cchh---------------------------cCCCCHHHHHHHHHHccCChhHCcCHHH------------------Hhc
Confidence 2221 2458999999999999999999999999 899
Q ss_pred CcccCCCC
Q 044076 322 DPYFHGLA 329 (506)
Q Consensus 322 HP~f~~~~ 329 (506)
||||+...
T Consensus 271 hp~~~~~~ 278 (293)
T d1jksa_ 271 HPWIKPKD 278 (293)
T ss_dssp STTTCC--
T ss_pred CcccCCCC
Confidence 99998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-57 Score=445.04 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=216.5
Q ss_pred CCCE-EEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQY-EIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY-~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.+|| ++.+.||+|+||+||+|++..+++.||+|++..........+.+.+|+.+|+.++||||+++++++.... .+..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCC
Confidence 4566 7788999999999999999999999999999765555666778999999999999999999999985431 2236
Q ss_pred cEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCcEEEC-CCCCEEEeecCCcccc
Q 044076 92 DIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVS 167 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~g--IvHrDLKp~NILv~-~~~~lKL~DFGla~~~ 167 (506)
.+|+||||+++ +|.+++.....+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 78999999985 99999998889999999999999999999999999 99999999999997 5799999999999753
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+......+...... |.++.
T Consensus 166 ~~~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~---- 232 (270)
T d1t4ha_ 166 RAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA---- 232 (270)
T ss_dssp CTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG----
T ss_pred cCC-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCc----
Confidence 221 1245689999999999865 5999999999999999999999999876655443322111 11111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
......++++.+||.+||+.||++|||++| +|+||||+
T Consensus 233 -----------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~e------------------ll~Hp~fk 270 (270)
T d1t4ha_ 233 -----------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKD------------------LLNHAFFQ 270 (270)
T ss_dssp -----------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHH------------------HHTSGGGC
T ss_pred -----------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHH------------------HhCCcccC
Confidence 011347889999999999999999999999 89999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-58 Score=460.44 Aligned_cols=260 Identities=30% Similarity=0.466 Sum_probs=208.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++||||+++++++.. .+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~ 80 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYES-----GG 80 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CC
Confidence 346799999999999999999999999999999999643222 233567899999999999999999999843 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC---CCCCEEEeecCCcccc
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN---ADCKLKICDFGLARVS 167 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~---~~~~lKL~DFGla~~~ 167 (506)
.+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 8999999998 59999999988999999999999999999999999999999999999995 5789999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... .....+||+.|+|||++.+ ..|++++|||||||++|+|++|++||.+.+..+....|......++
T Consensus 161 ~~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~----- 229 (307)
T d1a06a_ 161 DPGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD----- 229 (307)
T ss_dssp ----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-----
T ss_pred cCCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-----
Confidence 3322 1245689999999999987 7899999999999999999999999999887776666643221111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
...++++++++.+||.+||+.||.+|||++| +|+||||++
T Consensus 230 ----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e------------------il~hp~~~~ 269 (307)
T d1a06a_ 230 ----------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ------------------ALQHPWIAG 269 (307)
T ss_dssp ----------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH------------------HHHSTTTTS
T ss_pred ----------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHH------------------HhcCHhhCC
Confidence 1234578999999999999999999999999 899999986
Q ss_pred C
Q 044076 328 L 328 (506)
Q Consensus 328 ~ 328 (506)
.
T Consensus 270 ~ 270 (307)
T d1a06a_ 270 D 270 (307)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.7e-57 Score=461.85 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=226.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++.. ......+.+.+|+.+|+.++||||+++++++.. .+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 97 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNE 97 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcc--cchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 3589999999999999999999999999999999964 344556778999999999999999999999843 478
Q ss_pred EEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC--CCCEEEeecCCccccc
Q 044076 93 IYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA--DCKLKICDFGLARVSF 168 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~--~~~lKL~DFGla~~~~ 168 (506)
+|+|||||+ |+|.+++.. .+.+++..++.+++||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999998 599999854 457999999999999999999999999999999999999964 6889999999998643
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... ......||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......+..
T Consensus 178 ~~~----~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----- 246 (350)
T d1koaa2 178 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----- 246 (350)
T ss_dssp TTS----CEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-----
T ss_pred ccc----ccceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence 322 2345789999999999987 78999999999999999999999999999888888877654433322
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
..++++++++++||.+||+.||.+|||++| +|+||||+..
T Consensus 247 ----------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e------------------il~hp~~~~~ 286 (350)
T d1koaa2 247 ----------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQ------------------ALEHPWLTPG 286 (350)
T ss_dssp ----------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHH------------------HHHSTTTSCT
T ss_pred ----------------------ccccCCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCcccCCC
Confidence 123458999999999999999999999999 8999999976
Q ss_pred CCC
Q 044076 329 ANL 331 (506)
Q Consensus 329 ~~~ 331 (506)
..+
T Consensus 287 ~~~ 289 (350)
T d1koaa2 287 NAP 289 (350)
T ss_dssp TCC
T ss_pred CCC
Confidence 543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-57 Score=446.56 Aligned_cols=257 Identities=32% Similarity=0.477 Sum_probs=210.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
+++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|+.++||||+++++++.+. ....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 5789999999999999999999999999999999976555566677899999999999999999999998643 2367
Q ss_pred EEEEEecCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCCCcEEECCCCCEEEeecC
Q 044076 93 IYVVFELME-SDLDQVIKA----NDDLTPEHHQFFLYQLLRALKYIHSAN-----VFHRDLKPKNILANADCKLKICDFG 162 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~----~~~ls~~~~~~i~~QIl~gL~yLH~~g-----IvHrDLKp~NILv~~~~~lKL~DFG 162 (506)
+|+|||||+ |+|.+++.. +..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 899999998 599998853 467999999999999999999999876 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
+|+....... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+....|... .
T Consensus 160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~--~-- 230 (269)
T d2java1 160 LARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--K-- 230 (269)
T ss_dssp HHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--C--
T ss_pred ceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC--C--
Confidence 9986533221 2355789999999999987 78999999999999999999999999988776666555321 0
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
+.....++++++.+||.+||+.||.+|||++| +|+|
T Consensus 231 --------------------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~e------------------ll~h 266 (269)
T d2java1 231 --------------------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEE------------------ILEN 266 (269)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH------------------HHTS
T ss_pred --------------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHH------------------HHhC
Confidence 01122358999999999999999999999999 8999
Q ss_pred ccc
Q 044076 323 PYF 325 (506)
Q Consensus 323 P~f 325 (506)
||+
T Consensus 267 p~i 269 (269)
T d2java1 267 PLI 269 (269)
T ss_dssp TTC
T ss_pred CcC
Confidence 995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-57 Score=457.61 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=223.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++.. .+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-----cc
Confidence 367999999999999999999999999999999996432 223346778899999999999999999999954 48
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 8999999998 599999999899999999999999999999999999999999999999999999999999999864332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. .....+||++|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+....|... .+
T Consensus 159 ~~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~--------- 222 (337)
T d1o6la_ 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EI--------- 222 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC---------
T ss_pred Cc---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CC---------
Confidence 22 2356789999999999988 78999999999999999999999999998877666655321 10
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...+.+++++++||.+||+.||.+|++ ++| +++||||
T Consensus 223 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~e------------------il~Hp~f 264 (337)
T d1o6la_ 223 --------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE------------------VMEHRFF 264 (337)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH------------------HHTSGGG
T ss_pred --------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHH------------------HHcCccc
Confidence 112458999999999999999999995 889 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
+++
T Consensus 265 ~~i 267 (337)
T d1o6la_ 265 LSI 267 (337)
T ss_dssp TTC
T ss_pred ccC
Confidence 875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-57 Score=449.72 Aligned_cols=260 Identities=24% Similarity=0.343 Sum_probs=219.3
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..+.|++++.||+|+||+||+|++..+|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~ 82 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----EN 82 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CC
Confidence 345799999999999999999999999999999999643 33455678899999999999999999999854 37
Q ss_pred cEEEEEecCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELMES-DLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+|+|||||++ +|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 89999999985 99998765 45799999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCCcccCccccccc---CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
.. ......+||+.|+|||++... ...|+.++|||||||++|+|++|++||.+.+..+.+..|...- +
T Consensus 163 ~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~----- 232 (288)
T d2jfla1 163 TI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--P----- 232 (288)
T ss_dssp HH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--C-----
T ss_pred Cc---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C-----
Confidence 11 112456799999999998431 2568999999999999999999999999988877776664311 1
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
+.....+++++++.+||.+||+.||.+|||++| +|+||||+
T Consensus 233 ---------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e------------------ll~hp~~~ 273 (288)
T d2jfla1 233 ---------------------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ------------------LLQHPFVT 273 (288)
T ss_dssp ---------------------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHH------------------HTTSGGGC
T ss_pred ---------------------CCCCccccCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCcccC
Confidence 001112458999999999999999999999999 89999997
Q ss_pred C
Q 044076 327 G 327 (506)
Q Consensus 327 ~ 327 (506)
.
T Consensus 274 ~ 274 (288)
T d2jfla1 274 V 274 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.7e-57 Score=460.22 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=225.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||+||+|++..+|+.||||+++.. ...+...+.+|+.+|+.++||||+++++++.. .+.
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 100 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYE 100 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 35799999999999999999999999999999999652 33455678899999999999999999999943 488
Q ss_pred EEEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC--CCCCEEEeecCCccccc
Q 044076 93 IYVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN--ADCKLKICDFGLARVSF 168 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~--~~~~lKL~DFGla~~~~ 168 (506)
+|||||||+ |+|.+.+...+ .+++..++.+++||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999998 59998876554 699999999999999999999999999999999999998 57899999999998754
Q ss_pred CCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 169 TDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 169 ~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......++
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~------ 248 (352)
T d1koba_ 181 PDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------ 248 (352)
T ss_dssp TTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred CCCc----eeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 3322 345679999999999987 7899999999999999999999999999988888877755333222
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCC
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGL 328 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~ 328 (506)
...++++++++.+||.+||+.||.+|||++| +|+||||++.
T Consensus 249 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e------------------il~Hp~~~~~ 289 (352)
T d1koba_ 249 ---------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD------------------ALEHPWLKGD 289 (352)
T ss_dssp ---------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHH------------------HHTSTTTSSC
T ss_pred ---------------------cccccCCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCHhhCCC
Confidence 1334678999999999999999999999999 8999999874
Q ss_pred C
Q 044076 329 A 329 (506)
Q Consensus 329 ~ 329 (506)
.
T Consensus 290 ~ 290 (352)
T d1koba_ 290 H 290 (352)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-56 Score=445.28 Aligned_cols=284 Identities=37% Similarity=0.647 Sum_probs=236.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
+||+++++||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++.+.. .+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCce
Confidence 69999999999999999999985 88999999997544344446778999999999999999999999954 4789
Q ss_pred EEEEecCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMESDLDQVIK-ANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~~L~~~i~-~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
|+|||++.+++...+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999999986655554 467899999999999999999999999999999999999999999999999999976432221
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNE 252 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~ 252 (506)
.....++++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++..+...+|.|....+......
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 12455799999999998762 56799999999999999999999999999999999999999999988877654321
Q ss_pred HHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 253 KAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
..+..........++...++.+++++.|||++||++||++|||++| +|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~e------------------ll~Hp~f~~ 286 (286)
T d1ob3a_ 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ------------------ALEHAYFKE 286 (286)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH------------------HHTSGGGGC
T ss_pred --hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCcccCc
Confidence 1122223333444556667889999999999999999999999999 899999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=454.65 Aligned_cols=287 Identities=35% Similarity=0.599 Sum_probs=235.4
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc-CCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-REFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-~~~~~ 92 (506)
-+|+.+++||+|+||+||+|++..+|+.||||+++.... ...+|+.+|+.++||||+++++++..... .+..+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 379999999999999999999999999999999964221 13479999999999999999999865432 34467
Q ss_pred EEEEEecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-CEEEeecCCcccc
Q 044076 93 IYVVFELMESDLDQVIK----ANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-KLKICDFGLARVS 167 (506)
Q Consensus 93 ~ylV~E~~~~~L~~~i~----~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-~lKL~DFGla~~~ 167 (506)
+|+|||||++++...+. ....+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999987655553 456799999999999999999999999999999999999999875 8999999999764
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
..... ....+||+.|+|||++.+. ..|+.++||||+||++|||++|++||.+.+..+++..|.+.+|.|..+.+.
T Consensus 174 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTSC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cCCcc----cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 33322 2456899999999998762 679999999999999999999999999999999999999999999988876
Q ss_pred hhhhhHHHHHHhhhhccCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPF-SHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
........ ..++.....++ ....+..++++.|||.+||++||.+||||.| +|+||||+
T Consensus 249 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e------------------~L~Hp~f~ 307 (350)
T d1q5ka_ 249 EMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE------------------ACAHSFFD 307 (350)
T ss_dssp HHCC---C---CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHH------------------HHTSGGGG
T ss_pred hhccchhh---ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCHhhc
Confidence 54322111 01111122222 2234578999999999999999999999999 89999999
Q ss_pred CCCCCC
Q 044076 327 GLANLE 332 (506)
Q Consensus 327 ~~~~~~ 332 (506)
++.++.
T Consensus 308 ~~~~~~ 313 (350)
T d1q5ka_ 308 ELRDPN 313 (350)
T ss_dssp GGGCTT
T ss_pred cccCCC
Confidence 987644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-56 Score=448.69 Aligned_cols=255 Identities=26% Similarity=0.355 Sum_probs=217.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.+|++++.||+|+||+||+|++..+|+.||||+++.... .....+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence 469999999999999999999999999999999964332 33445678999999999999999999999854 378
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+|||||.+ +|..++..++.+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999986 5666667778899999999999999999999999999999999999999999999999999975322
Q ss_pred CCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
....+||+.|+|||++.+. ...|+.++|||||||++|||++|++||.+.+..+.+..+....-.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~---------- 232 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------- 232 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC----------
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence 1346799999999998642 246899999999999999999999999988877666655331100
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
. ...+.+++++.+||.+||+.||.+|||++| +|+||||..
T Consensus 233 -----------------~--~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e------------------ll~Hp~~~~ 272 (309)
T d1u5ra_ 233 -----------------A--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEV------------------LLKHRFVLR 272 (309)
T ss_dssp -----------------C--CSCTTSCHHHHHHHHHHTCSSGGGSCCHHH------------------HTTCHHHHS
T ss_pred -----------------C--CCCCCCCHHHHHHHHHHCcCChhHCcCHHH------------------HHhCHHhcC
Confidence 0 111357899999999999999999999999 899999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-56 Score=447.07 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=222.1
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++||||+++++++.. .+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence 57999999999999999999999999999999996422 223446778899999999999999999999854 478
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
+|+|||||+| +|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999985 89999999999999999999999999999999999999999999999999999999999999864322
Q ss_pred CCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 172 PSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 172 ~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
.+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|...-.
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------ 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------ 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------
T ss_pred -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC------------
Confidence 245679999999999987 6899999999999999999999999999887776666643110
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCcccC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYFH 326 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f~ 326 (506)
...+.+++++.+||.+||+.||.+|+ |++| +|+||||+
T Consensus 219 -------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~------------------il~Hp~f~ 261 (316)
T d1fota_ 219 -------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTED------------------VKNHPWFK 261 (316)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHH------------------HHTSGGGS
T ss_pred -------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHH------------------HHcCcccc
Confidence 11245899999999999999999996 8999 89999999
Q ss_pred CCC
Q 044076 327 GLA 329 (506)
Q Consensus 327 ~~~ 329 (506)
++.
T Consensus 262 ~i~ 264 (316)
T d1fota_ 262 EVV 264 (316)
T ss_dssp SCC
T ss_pred cCC
Confidence 863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-56 Score=453.27 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=221.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccc-ccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV-FEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~-~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .........+.+|+.+|+.++||||+++++++.. ..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----cc
Confidence 36899999999999999999999999999999999532 1233445678899999999999999999999844 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+||||+. |+|...+...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 8999999998 589999998889999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.....||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|.....
T Consensus 195 ------~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------- 255 (350)
T d1rdqe_ 195 ------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----------- 255 (350)
T ss_dssp ------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred ------cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-----------
Confidence 245679999999999987 7899999999999999999999999999887777666643211
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhccCccc
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALADPYF 325 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~HP~f 325 (506)
...+.+++++.+||++||+.||.+|+ |++| +|+||||
T Consensus 256 --------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~e------------------ll~Hp~f 297 (350)
T d1rdqe_ 256 --------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND------------------IKNHKWF 297 (350)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHH------------------HHTSGGG
T ss_pred --------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHH------------------HHcCccc
Confidence 11245899999999999999999995 9999 8999999
Q ss_pred CCC
Q 044076 326 HGL 328 (506)
Q Consensus 326 ~~~ 328 (506)
+++
T Consensus 298 ~~~ 300 (350)
T d1rdqe_ 298 ATT 300 (350)
T ss_dssp TTC
T ss_pred cCC
Confidence 875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.3e-55 Score=433.33 Aligned_cols=262 Identities=29% Similarity=0.435 Sum_probs=223.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC-------hhHHHHHHHHHHHHHhCC-CCCcceeceeecC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH-------VSDATRILREIKLLRMLK-HPDIVEIKHIMLP 84 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~-------~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~ 84 (506)
.++|++++.||+|+||+||+|++..+|+.||||+++..... ......+.+|+.+|+.++ ||||+++++++..
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999999999999999999643221 112346889999999997 9999999999944
Q ss_pred CCcCCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCC
Q 044076 85 PCRREFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 85 ~~~~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
.+.+|||||||+ |+|.++++.++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 -----~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 -----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp -----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred -----CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 488999999997 59999999988999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccc----cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcC
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLG 239 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~----~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g 239 (506)
|+...... ..+..+||..|+|||++.+ ....++.++||||+||++|+|++|+.||.+.+..+.+..|...--
T Consensus 157 a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 157 SCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp CEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred eeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 98643322 2356789999999999853 124578999999999999999999999999887777766643211
Q ss_pred CCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhh
Q 044076 240 TPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLA 319 (506)
Q Consensus 240 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~a 319 (506)
.+ ....++++|+++++||.+||+.||.+|||++| +
T Consensus 233 ~~---------------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~e------------------i 267 (277)
T d1phka_ 233 QF---------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE------------------A 267 (277)
T ss_dssp CC---------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH------------------H
T ss_pred CC---------------------------CCcccccCCHHHHHHHHHHccCChhHCcCHHH------------------H
Confidence 11 11223568999999999999999999999999 8
Q ss_pred ccCcccCCC
Q 044076 320 LADPYFHGL 328 (506)
Q Consensus 320 L~HP~f~~~ 328 (506)
|+||||+..
T Consensus 268 l~h~~~~~~ 276 (277)
T d1phka_ 268 LAHPFFQQY 276 (277)
T ss_dssp TTSGGGCTT
T ss_pred HcCHHHHHh
Confidence 999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-56 Score=446.77 Aligned_cols=299 Identities=34% Similarity=0.542 Sum_probs=233.6
Q ss_pred cCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc--
Q 044076 10 YGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR-- 87 (506)
Q Consensus 10 ~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~-- 87 (506)
....+||++++.||+|+||+||+|++..+|+.||||++...........++.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 344689999999999999999999999999999999986544444556678899999999999999999999865321
Q ss_pred -CCCCcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 -REFKDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 -~~~~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.....+|+||||+++++...+.. ...+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 22367999999999876665543 4579999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCC-CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDTP-SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~~-~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
....... ........+||++|+|||++.+. ..|++++||||+||++|||++|++||.+.+..+.+..|....|.+..+
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 5432221 11222446799999999998762 578999999999999999999999999999999999999999999888
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKF--PGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
.+....+............. ..+....+ ...+++++|||.+||++||++||||+| +|.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e------------------lL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD------------------ALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH------------------HHHS
T ss_pred hccccchhhhhhhhcccccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH------------------HHcC
Confidence 76665443322222111111 00000000 024788999999999999999999999 8999
Q ss_pred cccCCC
Q 044076 323 PYFHGL 328 (506)
Q Consensus 323 P~f~~~ 328 (506)
|||+..
T Consensus 306 pff~~~ 311 (318)
T d3blha1 306 DFFWSD 311 (318)
T ss_dssp GGGSSS
T ss_pred hhhccC
Confidence 999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=444.98 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=223.6
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.-++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+.+|+.++||||+++++++. +.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~ 74 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFE-----SME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETT
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECC
Confidence 357899999999999999999999999999999999642 234456889999999999999999999994 347
Q ss_pred cEEEEEecCCC-CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC--CCEEEeecCCcccc
Q 044076 92 DIYVVFELMES-DLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD--CKLKICDFGLARVS 167 (506)
Q Consensus 92 ~~ylV~E~~~~-~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~--~~lKL~DFGla~~~ 167 (506)
.+|||||||+| +|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 89999999985 9999998765 79999999999999999999999999999999999999854 58999999999864
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ......+|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+....++...
T Consensus 155 ~~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-- 226 (321)
T d1tkia_ 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-- 226 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH--
T ss_pred ccCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh--
Confidence 3322 1245678999999999987 7899999999999999999999999999998888888866444443322
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHG 327 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~ 327 (506)
++.+++++.+||.+||+.||.+|||++| +|+||||++
T Consensus 227 -------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e------------------il~hp~~~~ 263 (321)
T d1tkia_ 227 -------------------------FKEISIEAMDFVDRLLVKERKSRMTASE------------------ALQHPWLKQ 263 (321)
T ss_dssp -------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHH------------------HHHSHHHHS
T ss_pred -------------------------ccCCCHHHHHHHHHHccCChhHCcCHHH------------------HhcCHhhcc
Confidence 2458999999999999999999999999 899999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.5e-55 Score=448.32 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=214.9
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc----cChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF----EHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~----~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
.++|++++.||+|+||.||+|++..+|+.||||++.... .......+..+|+.+++.++||||+++++++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~---- 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----
Confidence 468999999999999999999999999999999985321 111222233345777888889999999999854
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccc
Q 044076 89 EFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVS 167 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~ 167 (506)
.+.+|+|||||+ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 79 -~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 79 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred -CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 478999999998 599999998889999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHh
Q 044076 168 FTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIA 247 (506)
Q Consensus 168 ~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~ 247 (506)
.... ....+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+....+......+
T Consensus 158 ~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------ 225 (364)
T d1omwa3 158 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------ 225 (364)
T ss_dssp SSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC------
T ss_pred CCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC------
Confidence 3322 2456799999999998652 578999999999999999999999998876554433222111111
Q ss_pred hhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 248 GIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPS-----AEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpT-----a~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
....+++++++.+||.+||+.||.+||| |+| +|+|
T Consensus 226 ----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~e------------------il~H 265 (364)
T d1omwa3 226 ----------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE------------------VKES 265 (364)
T ss_dssp ----------------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHH------------------HHTS
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHH------------------HHcC
Confidence 1122468999999999999999999999 789 8999
Q ss_pred cccCCCC
Q 044076 323 PYFHGLA 329 (506)
Q Consensus 323 P~f~~~~ 329 (506)
|||+++.
T Consensus 266 p~f~~i~ 272 (364)
T d1omwa3 266 PFFRSLD 272 (364)
T ss_dssp GGGTTCC
T ss_pred ccccCCC
Confidence 9999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=431.59 Aligned_cols=288 Identities=38% Similarity=0.582 Sum_probs=239.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
+||++++.||+|+||+||+|++..+|+.||||+++..........++.+|+.+|+.++||||+++++++.. ....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-----ccce
Confidence 68999999999999999999999999999999997554555667889999999999999999999999954 3789
Q ss_pred EEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCC
Q 044076 94 YVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTP 172 (506)
Q Consensus 94 ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~ 172 (506)
++|++++.+ +|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999986 6777777788999999999999999999999999999999999999999999999999999986433222
Q ss_pred CcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCC-CCCCCchhhHHHHHhhcCCCChHHHhhhhh
Q 044076 173 SAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPL-FPGRNVAHQLDLVTDLLGTPSAESIAGIRN 251 (506)
Q Consensus 173 ~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~p-F~~~~~~~~l~~I~~~~g~p~~e~~~~~~~ 251 (506)
......++++|+|||++.+. ..++.++||||+||++|||++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22455688999999998762 4579999999999999999998765 678888899999999999988776554321
Q ss_pred hHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCC
Q 044076 252 EKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLAN 330 (506)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~ 330 (506)
.. .+................+..++++.|||++||+.||.+||||+| +|+||||+++.+
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e------------------~L~Hp~f~~~~~ 291 (292)
T d1unla_ 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE------------------ALQHPYFSDFCP 291 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH------------------HTTSGGGSSCSC
T ss_pred cc--cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHH------------------HhcChhhcCCCC
Confidence 10 000000011122344556788999999999999999999999999 899999998765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-55 Score=439.63 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=219.9
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccc-cChhHHHHHHHHHHHHH-hCCCCCcceeceeecCCCcCCCC
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVF-EHVSDATRILREIKLLR-MLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~-~~~~~~~~~~rEi~iL~-~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
++|+++++||+|+||+||+|.++.+|+.||||++++.. ........+.+|+.++. .++||||+++++++.. .+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence 57999999999999999999999999999999996421 12234456677777765 6899999999999954 47
Q ss_pred cEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCC
Q 044076 92 DIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTD 170 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~ 170 (506)
.+|+|||||+ |+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 8999999998 499999999889999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhhh
Q 044076 171 TPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIR 250 (506)
Q Consensus 171 ~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~ 250 (506)
.. ..+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|.. +.|
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~--------- 220 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNP--------- 220 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC---------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC---------
Confidence 22 2355789999999999988 7899999999999999999999999999887776666632 111
Q ss_pred hhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHh-hhhhhhhhhhHHHHHhhhhhccCcccCCCC
Q 044076 251 NEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAE-EIRFTEIVFNWLFLYFYVLALADPYFHGLA 329 (506)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~-eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~ 329 (506)
...+.+++++.+||.+||+.||.+|||+. | +++||||+++.
T Consensus 221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~------------------l~~hpff~~~~ 262 (320)
T d1xjda_ 221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGD------------------IRQHPLFREIN 262 (320)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSC------------------GGGSGGGTTCC
T ss_pred --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHH------------------HHhCchhccCC
Confidence 11135899999999999999999999996 8 79999998763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.7e-54 Score=436.04 Aligned_cols=290 Identities=31% Similarity=0.561 Sum_probs=229.8
Q ss_pred ccccCCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCC
Q 044076 7 FTEYGEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPP 85 (506)
Q Consensus 7 ~~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~ 85 (506)
-..|+..++|++++.||+|+||+||+|++..+|+.||||+++. ...+++.+|+.+|+.++ ||||+++++++...
T Consensus 28 ~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 28 VVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp CCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred ccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 3457788899999999999999999999999999999999964 23466889999999996 99999999998543
Q ss_pred CcCCCCcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCC-CEEEeecCC
Q 044076 86 CRREFKDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADC-KLKICDFGL 163 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~-~lKL~DFGl 163 (506)
....+|+|||||++ +|..+ .+.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 103 ---~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 103 ---VSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp ---TTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred ---CCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccc
Confidence 33679999999985 67654 34699999999999999999999999999999999999998655 599999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCchhhHHHHHhhcCCCC
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPG-RNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~-~~~~~~l~~I~~~~g~p~ 242 (506)
|+....... ....++|+.|+|||++.+. ..|+.++||||+||++|+|++|+.||.. .+..++...+...+|.|.
T Consensus 177 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~ 251 (328)
T d3bqca1 177 AEFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251 (328)
T ss_dssp CEECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred ceeccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence 986543322 2566799999999998762 5689999999999999999999999864 556778888888888765
Q ss_pred hHHHhhhhhhH-HHHHHhhhhccCCCCCC-----CCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhh
Q 044076 243 AESIAGIRNEK-AKRYLSSLRRKWAVPFS-----HKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFY 316 (506)
Q Consensus 243 ~e~~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~ 316 (506)
...+....... ...+...........+. .....++++++|||++||++||.+||||+|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e---------------- 315 (328)
T d3bqca1 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE---------------- 315 (328)
T ss_dssp HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH----------------
T ss_pred hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHH----------------
Confidence 54443221111 11111111111111111 122357899999999999999999999999
Q ss_pred hhhccCcccCCCCC
Q 044076 317 VLALADPYFHGLAN 330 (506)
Q Consensus 317 ~~aL~HP~f~~~~~ 330 (506)
+|+||||+++..
T Consensus 316 --~L~Hp~F~~v~~ 327 (328)
T d3bqca1 316 --AMEHPYFYTVVK 327 (328)
T ss_dssp --HHTSGGGTTSCC
T ss_pred --HhcCcccCCCCC
Confidence 899999998653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=428.16 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=210.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC----hhHHHHHHHHHHHHHhCC--CCCcceeceeecCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH----VSDATRILREIKLLRMLK--HPDIVEIKHIMLPP 85 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~----~~~~~~~~rEi~iL~~l~--HpnIv~l~~v~~~~ 85 (506)
..++|++.+.||+|+||+||+|++..+|+.||||+++..... .....++.+|+.+|+.++ ||||+++++++..
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~- 80 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 80 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-
Confidence 357999999999999999999999999999999999643211 112344678999999987 9999999999844
Q ss_pred CcCCCCcEEEEEecCCC--CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCC-CCEEEeecC
Q 044076 86 CRREFKDIYVVFELMES--DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANAD-CKLKICDFG 162 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~~--~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~-~~lKL~DFG 162 (506)
.+.+|+||||+.+ ++.+++..+..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 81 ----~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 81 ----PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp ----SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ----CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence 4789999999974 889999888899999999999999999999999999999999999999854 799999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
+|+..... ..+..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+ .|..
T Consensus 157 ~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~------ 218 (273)
T d1xwsa_ 157 SGALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------ 218 (273)
T ss_dssp TCEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH------
T ss_pred cceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCch------HHhh------
Confidence 99764322 23567899999999998762 345788999999999999999999996532 1110
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
.. . ...+.+|+++.+||.+||+.||.+|||++| +|+|
T Consensus 219 --------------------~~--~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~e------------------il~h 255 (273)
T d1xwsa_ 219 --------------------GQ--V---FFRQRVSSECQHLIRWCLALRPSDRPTFEE------------------IQNH 255 (273)
T ss_dssp --------------------CC--C---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHH------------------HHTS
T ss_pred --------------------cc--c---CCCCCCCHHHHHHHHHHccCCHhHCcCHHH------------------HhcC
Confidence 00 0 112458999999999999999999999999 8999
Q ss_pred cccCCCC
Q 044076 323 PYFHGLA 329 (506)
Q Consensus 323 P~f~~~~ 329 (506)
|||+++.
T Consensus 256 p~~~~~~ 262 (273)
T d1xwsa_ 256 PWMQDVL 262 (273)
T ss_dssp GGGSSCC
T ss_pred HhhCCCC
Confidence 9998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-53 Score=421.79 Aligned_cols=259 Identities=27% Similarity=0.380 Sum_probs=210.4
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
..++|++++.||+|+||+||+|++..+|+.||||+++.... +.....++.+|+.+|+.++||||+++++++.... ...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence 46899999999999999999999999999999999975433 4455667899999999999999999999986531 122
Q ss_pred CcEEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 91 KDIYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 91 ~~~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
..+|+||||++| +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 458999999985 9999999888999999999999999999999999999999999999999999999999999976444
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
...........+||+.|+|||++.+ ..|++++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~--------- 232 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI--------- 232 (277)
T ss_dssp ---------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC---------
T ss_pred ccccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC---------
Confidence 3333333456789999999999987 78999999999999999999999999988877666555332111
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-CHhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-SAEE 300 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-Ta~e 300 (506)
+.....+++++++.+||.+||+.||.+|| |+++
T Consensus 233 ------------------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~ 266 (277)
T d1o6ya_ 233 ------------------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 266 (277)
T ss_dssp ------------------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred ------------------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHH
Confidence 12233467899999999999999999999 6776
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=436.52 Aligned_cols=261 Identities=26% Similarity=0.432 Sum_probs=209.5
Q ss_pred CCCCEEEeE-EEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHh-CCCCCcceeceeecCCCcCC
Q 044076 12 EASQYEIQE-IIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRM-LKHPDIVEIKHIMLPPCRRE 89 (506)
Q Consensus 12 ~~~rY~i~~-~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~-l~HpnIv~l~~v~~~~~~~~ 89 (506)
..++|++++ +||+|+||+||+|++..+|+.||||+++. ...+.+|+.++.+ ++||||++++++|.... ..
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cC
Confidence 356899875 69999999999999999999999999863 2346789998754 57999999999985321 22
Q ss_pred CCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC---CCCEEEeecCC
Q 044076 90 FKDIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA---DCKLKICDFGL 163 (506)
Q Consensus 90 ~~~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~---~~~lKL~DFGl 163 (506)
...+|+|||||+ |+|.++++.. ..+++.+++.+++||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 367999999998 5999999874 36999999999999999999999999999999999999986 46799999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
|+....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+........
T Consensus 161 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~- 233 (335)
T d2ozaa1 161 AKETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ- 233 (335)
T ss_dssp CEECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS-
T ss_pred eeeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC-
Confidence 986443322 255689999999999987 7899999999999999999999999988776555444422211100
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhhhhhhhhhhHHHHHhhhhhccC
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPF-SHKFPGADPLALRLLQRLLAFDPKDRPSAEEIRFTEIVFNWLFLYFYVLALAD 322 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL~~~~~~~~~~~~~~~~~aL~H 322 (506)
..+ ...++.+++++.+||.+||+.||.+|||++| +|+|
T Consensus 234 -----------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e------------------il~h 272 (335)
T d2ozaa1 234 -----------------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE------------------FMNH 272 (335)
T ss_dssp -----------------------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHH------------------HHHS
T ss_pred -----------------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHH------------------HHcC
Confidence 000 0112357999999999999999999999999 8999
Q ss_pred cccCCC
Q 044076 323 PYFHGL 328 (506)
Q Consensus 323 P~f~~~ 328 (506)
|||.+-
T Consensus 273 p~~~~~ 278 (335)
T d2ozaa1 273 PWIMQS 278 (335)
T ss_dssp HHHHTT
T ss_pred HHhhCC
Confidence 999753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=414.55 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=201.1
Q ss_pred EEEeecCceEEEEEEEC--CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcEEEEE
Q 044076 20 EIIGIGSYGVVASAIDT--HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 20 ~~LG~G~~g~V~~a~d~--~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
++||+|+||+||+|.+. .+++.||||+++....+....+.+.+|+.+|++++||||+++++++.. +..||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 47999999999999854 456789999997654455566789999999999999999999998732 4579999
Q ss_pred ecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCCCCccc
Q 044076 98 ELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDTPSAIF 176 (506)
Q Consensus 98 E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 176 (506)
||++ |+|.++++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...........
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9998 599999999889999999999999999999999999999999999999999999999999999865443332222
Q ss_pred ccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHH
Q 044076 177 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAK 255 (506)
Q Consensus 177 ~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~ 255 (506)
.....||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....|.+ |.
T Consensus 167 ~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~--~~--------------- 227 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GE--------------- 227 (277)
T ss_dssp ----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--TC---------------
T ss_pred ccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--CC---------------
Confidence 344578999999999987 689999999999999999998 8999998877665555432 10
Q ss_pred HHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 256 RYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ...+++++++.+||.+||+.||.+|||+++|
T Consensus 228 ----------~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i 260 (277)
T d1xbba_ 228 ----------RM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260 (277)
T ss_dssp ----------CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ----------CC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 01 1114578999999999999999999999995
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=411.29 Aligned_cols=255 Identities=22% Similarity=0.277 Sum_probs=206.1
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
..++|++++.||+|+||+||+|+. +..||||+++.........+.+.+|+.+|++++||||++++++... .
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~ 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------c
Confidence 357899999999999999999964 3469999997655556677889999999999999999999998632 4
Q ss_pred cEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+|+|||||+ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 6899999998 5999999764 5699999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCccccccc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
... ....+...||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.+...++..+......+
T Consensus 157 ~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------- 228 (276)
T d1uwha_ 157 WSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS------- 228 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC-------
T ss_pred cCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence 221 1223556799999999998642 2458999999999999999999999999877666554443221111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+....+++++++.+||.+||+.||.+|||++||
T Consensus 229 ------------------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i 263 (276)
T d1uwha_ 229 ------------------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263 (276)
T ss_dssp ------------------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 11123345689999999999999999999999995
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-52 Score=413.01 Aligned_cols=253 Identities=24% Similarity=0.441 Sum_probs=207.8
Q ss_pred ccccC-CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 7 FTEYG-EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 7 ~~~~~-~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
+..|. ..++|++.+.||+|+||+||+|++..+|+.||||+++.. ....+.+.+|+.+|+.++|||||++++++..
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~- 84 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR- 84 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEee-
Confidence 44554 347999999999999999999999999999999998642 2345678999999999999999999999854
Q ss_pred CcCCCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecC
Q 044076 86 CRREFKDIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFG 162 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFG 162 (506)
.+.+|+|||||+ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 85 ----~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 85 ----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred ----CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccc
Confidence 378999999998 5999998764 478999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCC-CCCCCCCchhhHHHHHhhcCCC
Q 044076 163 LARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGR-PLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 163 la~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~-~pF~~~~~~~~l~~I~~~~g~p 241 (506)
+|+....... ...+...||..|+|||++.+ ..|+.++||||+||++|||++|. ++|.+.+.......+...
T Consensus 161 ~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~---- 232 (287)
T d1opja_ 161 LSRLMTGDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---- 232 (287)
T ss_dssp CTTTCCSSSS--EEETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT----
T ss_pred ceeecCCCCc--eeeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC----
Confidence 9986433322 12234568899999999987 78999999999999999999965 455555544333332110
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... ...+.+++++.+||.+||+.||.+|||++||
T Consensus 233 -----------------------~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei 266 (287)
T d1opja_ 233 -----------------------YRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266 (287)
T ss_dssp -----------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------------CCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 000 1224588999999999999999999999994
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=411.38 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=209.2
Q ss_pred CCCCCEEEeEE-EeecCceEEEEEEECC--CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 11 GEASQYEIQEI-IGIGSYGVVASAIDTH--TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 11 ~~~~rY~i~~~-LG~G~~g~V~~a~d~~--t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
...++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+.+.+|+.+|+.++|||||++++++..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--- 80 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--- 80 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---
Confidence 34568999985 9999999999998764 4558999999743 344566789999999999999999999998732
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 REFKDIYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
+.+|+|||||+ |+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 81 ---~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 81 ---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp ---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ---CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhh
Confidence 45899999998 499998765 4579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
................||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+.+..|.+. .
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~--~---- 229 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--K---- 229 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--C----
T ss_pred cccccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C----
Confidence 75443332222345568999999999987 689999999999999999998 99999988776665555321 0
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ...+++++++.+||.+||+.||++|||+.+|
T Consensus 230 ---------------------~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i 262 (285)
T d1u59a_ 230 ---------------------RM---ECPPECPPELYALMSDCWIYKWEDRPDFLTV 262 (285)
T ss_dssp ---------------------CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred ---------------------CC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 00 1124688999999999999999999999995
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-51 Score=411.02 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=198.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCc---EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGE---KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~---~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~ 88 (506)
..++|++.+.||+|+||+||+|.+..+++ .||||++... ......+.+.+|+.+|+.++|||||++++++..
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---- 98 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK---- 98 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee----
Confidence 45789999999999999999999987765 5899988642 234456679999999999999999999999854
Q ss_pred CCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 89 EFKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 89 ~~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
.+.+|+|||||++ +|.+++... +.+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 99 -~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 99 -STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred -CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 3779999999984 899988774 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCc--ccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCCh
Q 044076 167 SFTDTPSA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSA 243 (506)
Q Consensus 167 ~~~~~~~~--~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~ 243 (506)
........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+.+..|......|
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-- 253 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP-- 253 (299)
T ss_dssp ------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence 44332211 11233568899999999987 789999999999999999998 899999888776666553311111
Q ss_pred HHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 244 ESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 244 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...++++++.+||.+||+.||.+|||+.||
T Consensus 254 ----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei 283 (299)
T d1jpaa_ 254 ----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283 (299)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 113578999999999999999999999996
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=404.19 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=197.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.+++|++++.||+|+||+||+|++. +++.||||+++.. ....+.+.+|+.+|+.++||||+++++++... +
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~ 73 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----A 73 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccC-----C
Confidence 3678999999999999999999975 5778999999742 22345688999999999999999999998543 6
Q ss_pred cEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+|+||||++ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 7999999998 5999988765 4689999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ......||..|+|||++.+ ..|+.++||||+||++|||++ |.+||.+.+..+.+..|......+
T Consensus 154 ~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~------- 222 (263)
T d1sm2a_ 154 DQYT--SSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------- 222 (263)
T ss_dssp -------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC-------
T ss_pred CCce--eecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC-------
Confidence 3221 1234678999999999987 789999999999999999999 678887777666665553311110
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....++++.+||.+||+.||.+|||++||
T Consensus 223 -----------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~i 252 (263)
T d1sm2a_ 223 -----------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRL 252 (263)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------------CccccCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 012468899999999999999999999994
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=408.81 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=204.6
Q ss_pred cccCC-CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCC
Q 044076 8 TEYGE-ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPC 86 (506)
Q Consensus 8 ~~~~~-~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~ 86 (506)
..|.+ .++|++++.||+|+||.||+|.+. +++.||||+++.. ....+.+.+|+.+|++++|||||++++++..
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-- 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-- 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc--
Confidence 44533 369999999999999999999975 6788999999642 2334568999999999999999999998732
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCC
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAN--DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~--~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
+.+|+||||++ |+|.+++... ..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ----~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 80 ----EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp ----SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ----CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence 45799999998 5898877543 3699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
|+....... ...+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.++|.+.+..+.+..+....-.
T Consensus 156 a~~~~~~~~--~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-- 229 (272)
T d1qpca_ 156 ARLIEDNEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-- 229 (272)
T ss_dssp CEECSSSCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--
T ss_pred eEEccCCcc--ccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--
Confidence 987533221 12245678999999999987 689999999999999999999 56777776665555554321100
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+++++++.+||.+||+.||++|||++||
T Consensus 230 ----------------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei 260 (272)
T d1qpca_ 230 ----------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260 (272)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----------------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 0113588999999999999999999999995
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=415.55 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=206.0
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCc-----EEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGE-----KVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~-----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|+++++||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|+++ +|||||++++++..
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 3689999999999999999999876543 79999986432 233455688999999998 79999999999954
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND-----------------------DLTPEHHQFFLYQLLRALKYIHSANVFHRD 142 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~-----------------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrD 142 (506)
.+.+|+|||||+ |+|.++++... .+++..+..++.||+.||+|||++||+|||
T Consensus 113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 113 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ---CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 478999999998 59999997642 489999999999999999999999999999
Q ss_pred CCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCC
Q 044076 143 LKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPL 221 (506)
Q Consensus 143 LKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~p 221 (506)
|||+|||++.++.+||+|||+|+........ .......||+.|+|||++.+ ..|+.++|||||||++|||++ |++|
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CchhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCC
Confidence 9999999999999999999999864433222 22345678999999999987 789999999999999999997 8999
Q ss_pred CCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 222 FPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 222 F~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
|.+.+....+..+......+ ...+.+++++.+||.+||+.||++|||++||
T Consensus 267 f~~~~~~~~~~~~~~~~~~~-----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKM-----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCC-----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99887766665553321111 1113578999999999999999999999994
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=397.75 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=208.8
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~ 91 (506)
.+++|+++++||+|+||+||+|++ .++..||||+++... .....+.+|+.+++.++||||+++++++.. .+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CC
Confidence 357899999999999999999997 478899999997532 234568899999999999999999999854 37
Q ss_pred cEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 92 DIYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 92 ~~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
.+|+||||++ |+|.+++.. ...+++..+..++.||++||+|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 8999999997 688888765 45799999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ......+|..|+|||++.+ ..|+.++||||+||++|||++ |+.||.+.+..+....|.+....+.
T Consensus 153 ~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~------ 222 (258)
T d1k2pa_ 153 DEYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------ 222 (258)
T ss_dssp SSCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC------
T ss_pred CCce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 2221 2245679999999999987 789999999999999999998 8999999887776666643211111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....++++.+||.+||+.||.+|||++||
T Consensus 223 ------------------------p~~~~~~l~~li~~cl~~dP~~RPt~~ei 251 (258)
T d1k2pa_ 223 ------------------------PHLASEKVYTIMYSCWHEKADERPTFKIL 251 (258)
T ss_dssp ------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred ------------------------cccccHHHHHHHHHHccCCHhHCcCHHHH
Confidence 12477899999999999999999999994
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=415.54 Aligned_cols=264 Identities=24% Similarity=0.375 Sum_probs=216.9
Q ss_pred CCEEEeEEEeecCceEEEEEEEC---CCCcEEEEEEecccc--cChhHHHHHHHHHHHHHhCCC-CCcceeceeecCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDT---HTGEKVAIKKMKEVF--EHVSDATRILREIKLLRMLKH-PDIVEIKHIMLPPCR 87 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~---~t~~~vAIK~i~~~~--~~~~~~~~~~rEi~iL~~l~H-pnIv~l~~v~~~~~~ 87 (506)
++|++++.||+|+||+||+|.+. .+|+.||||+++... .+....+.+.+|+.+|++++| |||+++++++..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence 67999999999999999999874 478999999996432 223345568899999999986 899999999843
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 88 REFKDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
...+|+||||+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 101 --~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 --ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 478999999998 59999999988999999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCChHHH
Q 044076 167 SFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPSAESI 246 (506)
Q Consensus 167 ~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~~e~~ 246 (506)
...... .......|++.|+|||++.+....++.++|||||||+||+|++|+.||.+.+..+....+.....
T Consensus 179 ~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~------- 249 (322)
T d1vzoa_ 179 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL------- 249 (322)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-------
T ss_pred hccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-------
Confidence 432221 12345679999999999976435678899999999999999999999998876665555532110
Q ss_pred hhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHhhhhhhhhhhhHHHHHhhhhhcc
Q 044076 247 AGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRP-----SAEEIRFTEIVFNWLFLYFYVLALA 321 (506)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~Rp-----Ta~eL~~~~~~~~~~~~~~~~~aL~ 321 (506)
.... ...+.+++++.+||++||++||.+|| |++| +|+
T Consensus 250 ---------------~~~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~e------------------il~ 291 (322)
T d1vzoa_ 250 ---------------KSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE------------------IKE 291 (322)
T ss_dssp ---------------HCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHH------------------HHT
T ss_pred ---------------cCCC-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHH------------------HHc
Confidence 0011 12245899999999999999999999 5899 899
Q ss_pred CcccCCCC
Q 044076 322 DPYFHGLA 329 (506)
Q Consensus 322 HP~f~~~~ 329 (506)
||||+++.
T Consensus 292 Hpff~~i~ 299 (322)
T d1vzoa_ 292 HLFFQKIN 299 (322)
T ss_dssp SGGGTTCC
T ss_pred CHhhcCCC
Confidence 99998765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=397.63 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=199.1
Q ss_pred cCCC-CCEEEeEEEeecCceEEEEEEECCCC---cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC
Q 044076 10 YGEA-SQYEIQEIIGIGSYGVVASAIDTHTG---EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP 85 (506)
Q Consensus 10 ~~~~-~rY~i~~~LG~G~~g~V~~a~d~~t~---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~ 85 (506)
|.+. ++|++++.||+|+||+||+|++..++ ..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 79 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 79 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3344 69999999999999999999987554 46999998643 344556678999999999999999999999832
Q ss_pred CcCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCC
Q 044076 86 CRREFKDIYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGL 163 (506)
Q Consensus 86 ~~~~~~~~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGl 163 (506)
+.+|+||||++ |+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 -----~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 -----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp -----SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred -----CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchh
Confidence 56899999998 588887765 45799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 164 ARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 164 a~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
|+....... ...+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..|.+..-
T Consensus 155 a~~~~~~~~--~~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~--- 227 (273)
T d1mp8a_ 155 SRYMEDSTY--YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--- 227 (273)
T ss_dssp ------------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred heeccCCcc--eeccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---
Confidence 986433221 12244568999999999987 789999999999999999998 8999998887776666532110
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ...+++++++.+||.+||+.||.+|||++||
T Consensus 228 ------------------------~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei 259 (273)
T d1mp8a_ 228 ------------------------L---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259 (273)
T ss_dssp ------------------------C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------------C---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 0 1235689999999999999999999999995
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=394.85 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=196.2
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCC----cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTG----EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~----~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++.|++.++||+|+||+||+|.+..++ ..||||+++.. ........+.+|+.+|+.++|||||++++++..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--- 80 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--- 80 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec---
Confidence 3578999999999999999999877654 47999999643 233455678899999999999999999999854
Q ss_pred CCCCcEEEEEecCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 REFKDIYVVFELMES-DLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 ~~~~~~ylV~E~~~~-~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
...+|+|||||.+ ++.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 81 --~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 81 --YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred --CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence 3779999999985 787777654 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhC-CCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G-~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
................||..|+|||++.+ ..|+.++|||||||++|||++| .++|.+.+..+.+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------ 230 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------ 230 (283)
T ss_dssp ---------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------
T ss_pred cccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC------
Confidence 75443322222344568999999999987 7899999999999999999995 55565555544444332211
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ....++++.+.+||.+||+.||++|||+.||
T Consensus 231 ---------------------~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei 263 (283)
T d1mqba_ 231 ---------------------RL---PTPMDCPSAIYQLMMQCWQQERARRPKFADI 263 (283)
T ss_dssp ---------------------CC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ---------------------CC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence 01 1113578899999999999999999999995
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=396.58 Aligned_cols=245 Identities=26% Similarity=0.371 Sum_probs=198.2
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++.+.||+|+||+||+|++..+ +.||||+++... ...+.+.+|+.+|++++|||||++++++.. +.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 47899999999999999999998655 579999996432 234668899999999999999999998732 45
Q ss_pred EEEEEecCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELME-SDLDQVIKA--NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~--~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+|+||||++ |+|..++.. .+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 799999998 578887754 35799999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.... ..+...+|+.|+|||++.. ..++.++||||+||++|||++ |+++|.+.+..+.+..+......
T Consensus 166 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------- 233 (285)
T d1fmka3 166 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 233 (285)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred CCce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------
Confidence 2211 2244678999999999987 789999999999999999999 56667777766666655331111
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
...+.+++++.+||.+||+.||++|||+++|
T Consensus 234 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 264 (285)
T d1fmka3 234 ----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYL 264 (285)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 1224688999999999999999999999994
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=399.72 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=199.5
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCc----EEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGE----KVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~----~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
..++|+++++||+|+||+||+|.+..+|+ +||||+++.. ......+.+.+|+.+|+.++|||||++++++..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--- 82 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 82 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 45679999999999999999999988876 5888888643 233446678999999999999999999999853
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN-DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~-~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
+..++|+|++. ++|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 83 ---~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 83 ---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp ---SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred ---CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence 35677777776 6888877764 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChH
Q 044076 166 VSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAE 244 (506)
Q Consensus 166 ~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e 244 (506)
........ .......||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 160 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~----- 231 (317)
T d1xkka_ 160 LLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER----- 231 (317)
T ss_dssp HTTTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-----
T ss_pred eccccccc-ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 75433222 12244578999999999987 789999999999999999998 8999988776655544422110
Q ss_pred HHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 245 SIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
. ...+.+++++.+||.+||+.||.+|||+.||
T Consensus 232 ----------------------~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 263 (317)
T d1xkka_ 232 ----------------------L---PQPPICTIDVYMIMVKCWMIDADSRPKFREL 263 (317)
T ss_dssp ----------------------C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----------------------C---CCCcccCHHHHHHHHHhCCCChhhCcCHHHH
Confidence 0 1114578999999999999999999999995
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=393.12 Aligned_cols=257 Identities=22% Similarity=0.307 Sum_probs=202.4
Q ss_pred cccCCCCCEEEeEEEeecCceEEEEEEECC-CC--cEEEEEEeccccc-ChhHHHHHHHHHHHHHhCCCCCcceeceeec
Q 044076 8 TEYGEASQYEIQEIIGIGSYGVVASAIDTH-TG--EKVAIKKMKEVFE-HVSDATRILREIKLLRMLKHPDIVEIKHIML 83 (506)
Q Consensus 8 ~~~~~~~rY~i~~~LG~G~~g~V~~a~d~~-t~--~~vAIK~i~~~~~-~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~ 83 (506)
|.+...++|++++.||+|+||+||+|+... ++ ..||||+++.... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 2 t~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ceEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 455667889999999999999999998643 33 3789999865332 3445677899999999999999999999984
Q ss_pred CCCcCCCCcEEEEEecCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeec
Q 044076 84 PPCRREFKDIYVVFELME-SDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 84 ~~~~~~~~~~ylV~E~~~-~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DF 161 (506)
. ..+|+||||++ ++|.+.+.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 T------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp S------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred e------cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 3 35799999998 588877654 457999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCC
Q 044076 162 GLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGT 240 (506)
Q Consensus 162 Gla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~ 240 (506)
|+++................+|.+|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+.+..|....-.
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC
Confidence 999875444333333445678889999999987 789999999999999999998 89999998887777666432111
Q ss_pred CChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 241 PSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 241 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+ ...+++++++.+||.+||+.||++|||++||
T Consensus 234 ~-----------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei 265 (273)
T d1u46a_ 234 L-----------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265 (273)
T ss_dssp C-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred C-----------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1 1224688999999999999999999999995
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=392.10 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=196.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECC-----CCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTH-----TGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~-----t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|++++.||+|+||.||+|.+.. +++.||||+++.. ......+.+.+|+.++.++ .|+||+.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence 3689999999999999999999754 4578999998643 2334556678888888777 589999999887432
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEE
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNIL 149 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NIL 149 (506)
...+|+|||||+ |+|.++++.. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 90 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp ---TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ---CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 357899999998 6999999753 24899999999999999999999999999999999999
Q ss_pred ECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhC-CCCCCCCCch
Q 044076 150 ANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVA 228 (506)
Q Consensus 150 v~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G-~~pF~~~~~~ 228 (506)
++.++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++||||+||++|||++| .+||.+.+..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp ECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999864333222 22345679999999999987 7899999999999999999986 6789877665
Q ss_pred hhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 229 HQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 229 ~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+.+..+......+ ...+.+++++.+||.+||+.||.+|||++||
T Consensus 244 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ei 287 (299)
T d1ywna1 244 EEFCRRLKEGTRM-----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287 (299)
T ss_dssp HHHHHHHHHTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhcCCCC-----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 5444332211100 1123578999999999999999999999995
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-48 Score=389.72 Aligned_cols=250 Identities=23% Similarity=0.293 Sum_probs=206.6
Q ss_pred CCCEEEeEEEeecCceEEEEEEEC-----CCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDT-----HTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~-----~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++|++++.||+|+||+||+|+.. .+++.||||+++.. ......+++.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--- 87 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV--- 87 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeecc---
Confidence 357999999999999999999865 35678999998642 234456678999999999999999999999854
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAND------------------------DLTPEHHQFFLYQLLRALKYIHSANVFHRD 142 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~~------------------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrD 142 (506)
....++||||++ |+|.+++.... .+++..+..|+.||+.||+|||++||+|||
T Consensus 88 --~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 88 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred --CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 378999999997 59999986532 388999999999999999999999999999
Q ss_pred CCCCcEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhC-CCC
Q 044076 143 LKPKNILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPL 221 (506)
Q Consensus 143 LKp~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G-~~p 221 (506)
|||+|||++.++.+||+|||+|+....... ....+...+|+.|+|||++.+ ..|+.++|||||||++|||++| .+|
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999976433221 112245668899999999987 7899999999999999999998 578
Q ss_pred CCCCCchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 222 FPGRNVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 222 F~~~~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
|.+.+..+.+..+.+... .....++++++.+||.+||+.||.+|||+.||
T Consensus 243 ~~~~~~~e~~~~v~~~~~------------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGNI------------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp TTTSCHHHHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHcCCC------------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 988887766665532110 01124688999999999999999999999995
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=381.78 Aligned_cols=241 Identities=24% Similarity=0.416 Sum_probs=196.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~ 92 (506)
.++|++++.||+|+||.||+|.+ +|+.||||+++. ....+.+.+|+.+|++++||||+++++++... .+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~ 75 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 75 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC----CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCc
Confidence 46799999999999999999987 578999999964 23456688999999999999999999988542 355
Q ss_pred EEEEEecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccC
Q 044076 93 IYVVFELME-SDLDQVIKAND--DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFT 169 (506)
Q Consensus 93 ~ylV~E~~~-~~L~~~i~~~~--~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~ 169 (506)
+|+||||++ |+|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 899999997 59999986543 599999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCchhhHHHHHhhcCCCChHHHhh
Q 044076 170 DTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRNVAHQLDLVTDLLGTPSAESIAG 248 (506)
Q Consensus 170 ~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~~~~~l~~I~~~~g~p~~e~~~~ 248 (506)
.. ....+|..|+|||++.+ ..+++++|||||||++|||++ |++||.+.+..+....|.+.
T Consensus 156 ~~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~----------- 216 (262)
T d1byga_ 156 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------- 216 (262)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----------
T ss_pred CC------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----------
Confidence 21 33458899999999987 689999999999999999998 79999887766665555221
Q ss_pred hhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 249 IRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
... ...+.+++++.+||.+||+.||.+|||+.+|
T Consensus 217 ----------------~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l 250 (262)
T d1byga_ 217 ----------------YKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 250 (262)
T ss_dssp ----------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----------------CCC---CCCccCCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 011 1224578999999999999999999999995
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-48 Score=384.63 Aligned_cols=258 Identities=21% Similarity=0.241 Sum_probs=200.9
Q ss_pred CCCCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 11 GEASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 11 ~~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
...++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.++|+|++..+..+. .+.
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~ 75 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCG----AEG 75 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEE----EET
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEE----ecC
Confidence 346799999999999999999999999999999999864322 234678999999999877666655442 234
Q ss_pred CcEEEEEecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC---CCCEEEeecCCccc
Q 044076 91 KDIYVVFELMESDLDQVIKA-NDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA---DCKLKICDFGLARV 166 (506)
Q Consensus 91 ~~~ylV~E~~~~~L~~~i~~-~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~---~~~lKL~DFGla~~ 166 (506)
+..++||||++++|...+.. ...+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.
T Consensus 76 ~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 76 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 77899999999988887765 457999999999999999999999999999999999999864 45799999999987
Q ss_pred ccCCCCC----cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCCC
Q 044076 167 SFTDTPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTPS 242 (506)
Q Consensus 167 ~~~~~~~----~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p~ 242 (506)
....... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+....+....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~--- 230 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--- 230 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH---
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc---
Confidence 5432221 112245679999999999988 7899999999999999999999999988765544333321100
Q ss_pred hHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 243 AESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 243 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.....+.....+++++++.+||.+||+.||.+||++++|
T Consensus 231 --------------------~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i 269 (299)
T d1ckia_ 231 --------------------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269 (299)
T ss_dssp --------------------HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHH
T ss_pred --------------------ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 000011112235689999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=383.51 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=202.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCC-------cEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeec
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTG-------EKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIML 83 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~-------~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~ 83 (506)
..++|++++.||+|+||.||+|++..++ ..||||+++.. ........+.+|...+.++ +||||+++++++.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3579999999999999999999876554 47999999643 2334566788999999888 6999999999995
Q ss_pred CCCcCCCCcEEEEEecCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 044076 84 PPCRREFKDIYVVFELME-SDLDQVIKAND----------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPK 146 (506)
Q Consensus 84 ~~~~~~~~~~ylV~E~~~-~~L~~~i~~~~----------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~ 146 (506)
. .+.+|+|||||+ |+|.++|.... .+++..+..+++||+.||+|||++||+||||||+
T Consensus 90 ~-----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 90 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp S-----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred c-----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 4 378999999998 59999997542 5899999999999999999999999999999999
Q ss_pred cEEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCC
Q 044076 147 NILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGR 225 (506)
Q Consensus 147 NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~ 225 (506)
|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999999875443322 22345678999999999987 789999999999999999998 79999887
Q ss_pred CchhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 226 NVAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 226 ~~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+..+....+... . .. ...+++++++.+||.+||+.||.+|||+.||
T Consensus 242 ~~~~~~~~i~~~--~-------------------------~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~ei 287 (299)
T d1fgka_ 242 PVEELFKLLKEG--H-------------------------RM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287 (299)
T ss_dssp CHHHHHHHHHTT--C-------------------------CC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CHHHHHHHHHcC--C-------------------------CC---CCCccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence 765544443221 0 00 1113588999999999999999999999995
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=388.74 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=201.7
Q ss_pred CCCCEEEeEEEeecCceEEEEEEECCCCcE--EEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCCcC
Q 044076 12 EASQYEIQEIIGIGSYGVVASAIDTHTGEK--VAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPCRR 88 (506)
Q Consensus 12 ~~~rY~i~~~LG~G~~g~V~~a~d~~t~~~--vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~~~ 88 (506)
.-++|++.++||+|+||+||+|+++.+|.. ||||+++... .....+.+.+|+.+|.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~---- 82 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH---- 82 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec----
Confidence 347899999999999999999999888874 7788875432 223456689999999999 69999999999854
Q ss_pred CCCcEEEEEecCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEEC
Q 044076 89 EFKDIYVVFELME-SDLDQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILAN 151 (506)
Q Consensus 89 ~~~~~ylV~E~~~-~~L~~~i~~~----------------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~ 151 (506)
.+.+|+||||++ |+|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 83 -~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 83 -RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp -TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred -CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 378999999998 5999999754 4699999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhC-CCCCCCCCchhh
Q 044076 152 ADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQ 230 (506)
Q Consensus 152 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G-~~pF~~~~~~~~ 230 (506)
.++.+||+|||+|+....... .....||..|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp GGGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCceEEcccccccccccccc----ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999976432221 123468999999999987 7899999999999999999996 567888776655
Q ss_pred HHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 231 LDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 231 l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+..|.+. ... ....++++++.+||.+||+.||++|||++||
T Consensus 236 ~~~i~~~---------------------------~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei 276 (309)
T d1fvra_ 236 YEKLPQG---------------------------YRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276 (309)
T ss_dssp HHHGGGT---------------------------CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHhc---------------------------CCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 5544221 000 1224588999999999999999999999995
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=385.32 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=208.5
Q ss_pred CCCEEEeEEEeecCceEEEEEEECC-----CCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCc
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTH-----TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCR 87 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~-----t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~ 87 (506)
.++|++++.||+|+||+||+|.+.. +++.||||+++.. ........+.+|+.++++++||||+++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--- 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec---
Confidence 4899999999999999999998753 4578999999743 344556678999999999999999999999843
Q ss_pred CCCCcEEEEEecCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCE
Q 044076 88 REFKDIYVVFELME-SDLDQVIKAN----------DDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKL 156 (506)
Q Consensus 88 ~~~~~~ylV~E~~~-~~L~~~i~~~----------~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~l 156 (506)
...+++|||||. |+|.+++... ..++...+..++.||++||+|||+++|+||||||+|||++.++.+
T Consensus 95 --~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 367899999997 6999988642 247899999999999999999999999999999999999999999
Q ss_pred EEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhC-CCCCCCCCchhhHHHHH
Q 044076 157 KICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-RPLFPGRNVAHQLDLVT 235 (506)
Q Consensus 157 KL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G-~~pF~~~~~~~~l~~I~ 235 (506)
||+|||+|+....... ........+|+.|+|||.+.+ ..++.++||||+||++|||++| .+||.+.+..+.+..|.
T Consensus 173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999986433222 122244578999999999987 7899999999999999999997 58898888777666664
Q ss_pred hhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 236 DLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 236 ~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
+... ....+.+++.+.+||.+||+.||.+|||++||
T Consensus 250 ~~~~------------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~i 285 (308)
T d1p4oa_ 250 EGGL------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285 (308)
T ss_dssp TTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hCCC------------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 3111 01124578999999999999999999999995
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=380.51 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=209.7
Q ss_pred CCCEEEeEEEeecCceEEEEEEE-----CCCCcEEEEEEecccccChhHHHHHHHHHHHHHhC-CCCCcceeceeecCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAID-----THTGEKVAIKKMKEVFEHVSDATRILREIKLLRML-KHPDIVEIKHIMLPPC 86 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d-----~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l-~HpnIv~l~~v~~~~~ 86 (506)
.++|+++++||+|+||.||+|++ ..+++.||||+++.. ........+.+|+.+++.+ +|||||++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 48999999999999999999985 356779999999743 3455667789999999999 59999999999844
Q ss_pred cCCCCcEEEEEecCC-CCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCc
Q 044076 87 RREFKDIYVVFELME-SDLDQVIKAND------------------DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKN 147 (506)
Q Consensus 87 ~~~~~~~ylV~E~~~-~~L~~~i~~~~------------------~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~N 147 (506)
.+.+|+|||||+ |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 99 ---~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 367999999998 59999987543 58999999999999999999999999999999999
Q ss_pred EEECCCCCEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCC
Q 044076 148 ILANADCKLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GRPLFPGRN 226 (506)
Q Consensus 148 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~-G~~pF~~~~ 226 (506)
||++.++.+||+|||+++....... ....+...||+.|+|||++.+ ..++.++|||||||++|||++ |.++|.+.+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987543322 223355689999999999987 789999999999999999998 788888877
Q ss_pred chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 227 VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 227 ~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
..+.+..+....-.+ .....+++++.+||.+||+.||.+|||++||
T Consensus 253 ~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRM-----------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp SSHHHHHHHHHTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhcCCCC-----------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 766665553211110 1113478999999999999999999999995
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.2e-47 Score=385.62 Aligned_cols=285 Identities=23% Similarity=0.335 Sum_probs=214.3
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-----------CCCcceecee
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-----------HPDIVEIKHI 81 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-----------HpnIv~l~~v 81 (506)
.+||+++++||+|+||+||+|++..+|+.||||+++. +......+.+|+++++.+. |+||++++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~---~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec---cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 3689999999999999999999999999999999974 2334456788999988875 4788889888
Q ss_pred ecCCCcCCCCcEEEEEecCC--CCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCcEEECCCC--
Q 044076 82 MLPPCRREFKDIYVVFELME--SDLDQVIK--ANDDLTPEHHQFFLYQLLRALKYIHS-ANVFHRDLKPKNILANADC-- 154 (506)
Q Consensus 82 ~~~~~~~~~~~~ylV~E~~~--~~L~~~i~--~~~~ls~~~~~~i~~QIl~gL~yLH~-~gIvHrDLKp~NILv~~~~-- 154 (506)
+... .....++|++++. ++...... ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 89 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred eeec---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 7432 2245566666554 34444333 34579999999999999999999998 8999999999999998765
Q ss_pred ----CEEEeecCCcccccCCCCCcccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC----
Q 044076 155 ----KLKICDFGLARVSFTDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRN---- 226 (506)
Q Consensus 155 ----~lKL~DFGla~~~~~~~~~~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~---- 226 (506)
.+||+|||.|...... ....+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||.+.+
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cccceeeEeecccccccccc------cccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 3999999999753222 134579999999999987 789999999999999999999999997554
Q ss_pred --chhhHHHHHhhcCCCChHHHhhhhhhHHHHHHhhhhccCCCC-------------CCCCCCCCCHHHHHHHHHhhhcC
Q 044076 227 --VAHQLDLVTDLLGTPSAESIAGIRNEKAKRYLSSLRRKWAVP-------------FSHKFPGADPLALRLLQRLLAFD 291 (506)
Q Consensus 227 --~~~~l~~I~~~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~s~~~~dLI~~mL~~D 291 (506)
..+.+..+...+|.++.+.+...... ..+........... .....+..+++++|||.+||++|
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cchhHHHHHHHHHhCCCCHHHhhccccc--ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 35677888889999887765442211 11111100000000 00111235678999999999999
Q ss_pred CCCCCCHhhhhhhhhhhhHHHHHhhhhhccCcccCCCCCC
Q 044076 292 PKDRPSAEEIRFTEIVFNWLFLYFYVLALADPYFHGLANL 331 (506)
Q Consensus 292 P~~RpTa~eL~~~~~~~~~~~~~~~~~aL~HP~f~~~~~~ 331 (506)
|.+||||+| +|+||||++....
T Consensus 316 P~~Rpta~e------------------~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 316 PRKRADAGG------------------LVNHPWLKDTLGM 337 (362)
T ss_dssp TTTCBCHHH------------------HHTCGGGTTCTTC
T ss_pred hhHCcCHHH------------------HhcCcccCCCCCc
Confidence 999999999 8999999976543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=374.26 Aligned_cols=248 Identities=22% Similarity=0.314 Sum_probs=195.9
Q ss_pred EEeEEEeecCceEEEEEEECCCC---cEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCCCcCCCCcE
Q 044076 17 EIQEIIGIGSYGVVASAIDTHTG---EKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPPCRREFKDI 93 (506)
Q Consensus 17 ~i~~~LG~G~~g~V~~a~d~~t~---~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~~~~~~~~~ 93 (506)
...++||+|+||+||+|++..++ ..||||+++. ..+....+++.+|+.+|++++||||+++++++... .+..
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence 33679999999999999986654 3699999964 24556678899999999999999999999987432 3578
Q ss_pred EEEEecCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEeecCCcccccCCC
Q 044076 94 YVVFELME-SDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKICDFGLARVSFTDT 171 (506)
Q Consensus 94 ylV~E~~~-~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~~~~~~ 171 (506)
|+|||||+ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||+++++.+||+|||+++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999998 58988887543 57888899999999999999999999999999999999999999999999998643332
Q ss_pred CC-cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-CchhhHHHHHhhcCCCChHHHhhh
Q 044076 172 PS-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGR-NVAHQLDLVTDLLGTPSAESIAGI 249 (506)
Q Consensus 172 ~~-~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~-~~~~~l~~I~~~~g~p~~e~~~~~ 249 (506)
.. ........||..|+|||++.+ ..++.++|||||||++|||++|..||... +..+....+.. |.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~--------- 251 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GR--------- 251 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TC---------
T ss_pred cccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CC---------
Confidence 21 222345678999999999987 78999999999999999999976666443 33333322211 10
Q ss_pred hhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 250 RNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ...+.+++++.+||.+||+.||++|||+.||
T Consensus 252 ----------------~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei 284 (311)
T d1r0pa_ 252 ----------------RL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 284 (311)
T ss_dssp ----------------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----------------CC---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 00 0113578999999999999999999999995
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.8e-46 Score=370.87 Aligned_cols=255 Identities=18% Similarity=0.244 Sum_probs=205.4
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCC-CCcceeceeecCCCcCCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKH-PDIVEIKHIMLPPCRREFK 91 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~H-pnIv~l~~v~~~~~~~~~~ 91 (506)
.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.+.| +||+.+++++. ...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCC
Confidence 579999999999999999999999999999999985432 22346789999999985 89999998874 347
Q ss_pred cEEEEEecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECC-----CCCEEEeecCCcc
Q 044076 92 DIYVVFELMESDLDQVIKAND-DLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANA-----DCKLKICDFGLAR 165 (506)
Q Consensus 92 ~~ylV~E~~~~~L~~~i~~~~-~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~-----~~~lKL~DFGla~ 165 (506)
..|+||||++++|.+++...+ .++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 899999999999999997754 6999999999999999999999999999999999999974 5789999999998
Q ss_pred cccCCCCC----cccccccccCCcccCcccccccCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHhhcCCC
Q 044076 166 VSFTDTPS----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTDLLGTP 241 (506)
Q Consensus 166 ~~~~~~~~----~~~~~~~vgt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~~~g~p 241 (506)
........ .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~--- 229 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG--- 229 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH---
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH---
Confidence 74332211 112345689999999999987 789999999999999999999999998766543333221100
Q ss_pred ChHHHhhhhhhHHHHHHhhhhccCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 242 SAESIAGIRNEKAKRYLSSLRRKWAVPFSHKFPGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 242 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
.. ....+.....+++++++.+|+..|+..+|.+||+.+.|
T Consensus 230 ---------~~-----------~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l 269 (293)
T d1csna_ 230 ---------EK-----------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269 (293)
T ss_dssp ---------HH-----------HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred ---------hc-----------cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 00 00011122335688999999999999999999998885
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=373.98 Aligned_cols=269 Identities=23% Similarity=0.248 Sum_probs=192.1
Q ss_pred CCCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHH--HHHHHHhCCCCCcceeceeecCCCcCCC
Q 044076 13 ASQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILR--EIKLLRMLKHPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 13 ~~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~r--Ei~iL~~l~HpnIv~l~~v~~~~~~~~~ 90 (506)
+.+|.+.+.||+|+||+||+|+. +|+.||||+++.. ......+ |+..+..++||||+++++++.... ...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccc
Confidence 57899999999999999999975 6899999998631 2233334 555556788999999999986542 222
Q ss_pred CcEEEEEecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCeeecCCCCCcEEECCCCCEEEeec
Q 044076 91 KDIYVVFELME-SDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS--------ANVFHRDLKPKNILANADCKLKICDF 161 (506)
Q Consensus 91 ~~~ylV~E~~~-~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~--------~gIvHrDLKp~NILv~~~~~lKL~DF 161 (506)
..+|+|||||+ |+|.+++++. .+++.....++.|++.||+|||+ +||+||||||+||||+.++.+||+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 46899999997 5999999875 69999999999999999999996 59999999999999999999999999
Q ss_pred CCcccccCCCCC-cccccccccCCcccCcccccccC----CCCCchhhhhhhhHHHHHHHhCCCCCCCCCchhhHHHHHh
Q 044076 162 GLARVSFTDTPS-AIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAELLTGRPLFPGRNVAHQLDLVTD 236 (506)
Q Consensus 162 Gla~~~~~~~~~-~~~~~~~vgt~~Y~APE~l~~~~----~~~s~~~DIWSlG~il~eLl~G~~pF~~~~~~~~l~~I~~ 236 (506)
|+++........ .......+||+.|+|||++.+.. ..++.++|||||||++|||++|.+||......... ....
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDL 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhhc
Confidence 999865433221 11234578999999999986521 13677999999999999999999888543322110 0000
Q ss_pred hcCCCChHHHhhhhhhHHHHHHhhhhccCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHhhh
Q 044076 237 LLGTPSAESIAGIRNEKAKRYLSSLRRKWAVPFSHKF--PGADPLALRLLQRLLAFDPKDRPSAEEI 301 (506)
Q Consensus 237 ~~g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLI~~mL~~DP~~RpTa~eL 301 (506)
....+..+... .....-...+ ++...+ ......+.+|+.+||+.||.+|||+.||
T Consensus 232 ~~~~~~~~~~~--------~~~~~~~~~p--~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 288 (303)
T d1vjya_ 232 VPSDPSVEEMR--------KVVCEQKLRP--NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp SCSSCCHHHHH--------HHHTTSCCCC--CCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred ccccchHHHHH--------HHHhccccCC--CCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 11112211111 1110000001 111111 1123468899999999999999999995
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3.3e-25 Score=205.40 Aligned_cols=134 Identities=18% Similarity=0.172 Sum_probs=106.5
Q ss_pred EEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccC----------------hhHHHHHHHHHHHHHhCCCCCcceec
Q 044076 16 YEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEH----------------VSDATRILREIKLLRMLKHPDIVEIK 79 (506)
Q Consensus 16 Y~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~----------------~~~~~~~~rEi~iL~~l~HpnIv~l~ 79 (506)
|.+.++||+|+||+||+|.+ .+|+.||||+++..... ........+|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999998 47899999987521100 11123455789999999999999887
Q ss_pred eeecCCCcCCCCcEEEEEecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCcEEECCCCCEEEe
Q 044076 80 HIMLPPCRREFKDIYVVFELMESDLDQVIKANDDLTPEHHQFFLYQLLRALKYIHSANVFHRDLKPKNILANADCKLKIC 159 (506)
Q Consensus 80 ~v~~~~~~~~~~~~ylV~E~~~~~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~~gIvHrDLKp~NILv~~~~~lKL~ 159 (506)
+.. ..++||||+++... ..++...+..++.||+.||+|||++||+||||||+|||++++ .++|+
T Consensus 81 ~~~---------~~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEE---------TTEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred Eec---------CCEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 653 23799999997321 125566678899999999999999999999999999999865 59999
Q ss_pred ecCCccc
Q 044076 160 DFGLARV 166 (506)
Q Consensus 160 DFGla~~ 166 (506)
|||+|+.
T Consensus 145 DFG~a~~ 151 (191)
T d1zara2 145 DFPQSVE 151 (191)
T ss_dssp CCTTCEE
T ss_pred ECCCccc
Confidence 9999965
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.26 E-value=1.3e-06 Score=82.01 Aligned_cols=139 Identities=14% Similarity=0.123 Sum_probs=85.5
Q ss_pred CCEEEeEEEeecCceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCCCc
Q 044076 14 SQYEIQEIIGIGSYGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREFKD 92 (506)
Q Consensus 14 ~rY~i~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~~~ 92 (506)
..|+..+..+.++.+.||+.. .++..+++|+...... .....+.+|...++.+. +--+-+++.+. ++.+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCc
Confidence 467777766556667899884 4667788898753221 12334678888888775 32244445443 22367
Q ss_pred EEEEEecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 044076 93 IYVVFELMES-DLDQVIKANDDLTPEHHQFFLYQLLRALKYIHS------------------------------------ 135 (506)
Q Consensus 93 ~ylV~E~~~~-~L~~~i~~~~~ls~~~~~~i~~QIl~gL~yLH~------------------------------------ 135 (506)
.|+||++++| .+.+..... .....+..++.+.|..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 8999999987 443332110 1111122333333333331
Q ss_pred -----------------------CCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 136 -----------------------ANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 136 -----------------------~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999776667999998854
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.82 E-value=2.4e-05 Score=78.29 Aligned_cols=77 Identities=19% Similarity=0.071 Sum_probs=47.5
Q ss_pred eEEEeecCceEEEEEEECCCCcEEEEEEeccc----cc-ChhHHHHHHHHHHHHHhCC-C-C-CcceeceeecCCCcCCC
Q 044076 19 QEIIGIGSYGVVASAIDTHTGEKVAIKKMKEV----FE-HVSDATRILREIKLLRMLK-H-P-DIVEIKHIMLPPCRREF 90 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~t~~~vAIK~i~~~----~~-~~~~~~~~~rEi~iL~~l~-H-p-nIv~l~~v~~~~~~~~~ 90 (506)
.+.||.|....||++.+..+++.|++|.-... .. ......+..+|...|+.+. + | .+.+++.+- .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence 56789999999999998778889999964321 11 1223445667888887764 2 2 344444332 1
Q ss_pred CcEEEEEecCCC
Q 044076 91 KDIYVVFELMES 102 (506)
Q Consensus 91 ~~~ylV~E~~~~ 102 (506)
...++|||++++
T Consensus 104 ~~~~lvmE~L~~ 115 (392)
T d2pula1 104 EMAVTVMEDLSH 115 (392)
T ss_dssp TTTEEEECCCTT
T ss_pred CCCEEEEeccCC
Confidence 345799999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.47 E-value=7.4e-05 Score=69.04 Aligned_cols=71 Identities=11% Similarity=0.054 Sum_probs=44.7
Q ss_pred EEeecCc-eEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCC--cceeceeecCCCcCCCCcEEEEE
Q 044076 21 IIGIGSY-GVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPD--IVEIKHIMLPPCRREFKDIYVVF 97 (506)
Q Consensus 21 ~LG~G~~-g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~Hpn--Iv~l~~v~~~~~~~~~~~~ylV~ 97 (506)
.+..|.. +.||+... ..+..+++|..... ....+.+|...|+.+.... +.+++.+.. +.+..|+||
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEE
Confidence 4455553 67898864 45667888876432 2234667888888775322 444555442 236789999
Q ss_pred ecCCC
Q 044076 98 ELMES 102 (506)
Q Consensus 98 E~~~~ 102 (506)
++++|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 99975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.0023 Score=61.51 Aligned_cols=134 Identities=16% Similarity=0.131 Sum_probs=73.5
Q ss_pred ceEEEEEEECCCCcEEEEEEecccccChhHHHHHHHHHHHHHhCCCCCcceeceeecCC--CcCCCCcEEEEEecCCC--
Q 044076 27 YGVVASAIDTHTGEKVAIKKMKEVFEHVSDATRILREIKLLRMLKHPDIVEIKHIMLPP--CRREFKDIYVVFELMES-- 102 (506)
Q Consensus 27 ~g~V~~a~d~~t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~HpnIv~l~~v~~~~--~~~~~~~~ylV~E~~~~-- 102 (506)
--.||++.. .+|..|++|+.+. .......+..|+..|..|....|.-..-+.... .....+..+.|+++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp---~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRP---ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECT---TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEc-CCCCEEEEEEeCC---CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 358999964 5788899998753 122345577899998888532221111111111 01223567889998864
Q ss_pred ----CHHHH------H----H---hC-----CCCC-------------------HH---HHHHHHHHHHHHHHHHH----
Q 044076 103 ----DLDQV------I----K---AN-----DDLT-------------------PE---HHQFFLYQLLRALKYIH---- 134 (506)
Q Consensus 103 ----~L~~~------i----~---~~-----~~ls-------------------~~---~~~~i~~QIl~gL~yLH---- 134 (506)
+.... + . .. ..++ .. .....+.+++..+.-+-
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 11111 1 0 00 0111 11 12223333333333221
Q ss_pred hCCeeecCCCCCcEEECCCCCEEEeecCCccc
Q 044076 135 SANVFHRDLKPKNILANADCKLKICDFGLARV 166 (506)
Q Consensus 135 ~~gIvHrDLKp~NILv~~~~~lKL~DFGla~~ 166 (506)
..++||+|+.+.|||++. + ..++||+.+..
T Consensus 191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 136999999999999974 3 45899998853
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.61 E-value=0.0057 Score=60.21 Aligned_cols=71 Identities=13% Similarity=0.035 Sum_probs=47.2
Q ss_pred eEEEeecCceEEEEEEECC-------CCcEEEEEEecccccChhHHHHHHHHHHHHHhCC-CCCcceeceeecCCCcCCC
Q 044076 19 QEIIGIGSYGVVASAIDTH-------TGEKVAIKKMKEVFEHVSDATRILREIKLLRMLK-HPDIVEIKHIMLPPCRREF 90 (506)
Q Consensus 19 ~~~LG~G~~g~V~~a~d~~-------t~~~vAIK~i~~~~~~~~~~~~~~rEi~iL~~l~-HpnIv~l~~v~~~~~~~~~ 90 (506)
++.|+.|-.-.+|++.... .++.|.+++.... .......+|..+++.+. +.-..+++.++. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~-----~- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFS-----G- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T-
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcC-----C-
Confidence 4678889999999997643 3466878776421 12233558999999886 433346666651 1
Q ss_pred CcEEEEEecCCC
Q 044076 91 KDIYVVFELMES 102 (506)
Q Consensus 91 ~~~ylV~E~~~~ 102 (506)
.+|+||++|
T Consensus 117 ---g~I~efi~g 125 (395)
T d1nw1a_ 117 ---GRLEEYIPS 125 (395)
T ss_dssp ---EEEECCCCE
T ss_pred ---ceEEEEecc
Confidence 688999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.29 E-value=0.0033 Score=59.71 Aligned_cols=30 Identities=33% Similarity=0.339 Sum_probs=26.9
Q ss_pred CCeeecCCCCCcEEECCCCCEEEeecCCcc
Q 044076 136 ANVFHRDLKPKNILANADCKLKICDFGLAR 165 (506)
Q Consensus 136 ~gIvHrDLKp~NILv~~~~~lKL~DFGla~ 165 (506)
.|+||+|+.++||+++.+...-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999884
|